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Introduction In this study we aimed to investigate the relationship 
between thyroid hormone abnormalities and major cardiovascular 
events and sudden cardiac death at 3 and 6 months after discharge in 
patients who were admitted to the Emergency Department with acute 
coronary syndrome.
Methods  The study group included 110 patients without known 
thyroid dysfunction who were referred to the Emergency Department 
with acute coronary syndrome. FT3, FT4 and TSH levels were measured 
in all patients on admission. Patients were divided into STEMI, NSTEMI 
and UAP groups. Patient records were checked at 3 and 6 months of 
discharge in terms of sudden cardiac death and major cardiovascular 
events. The relationship between thyroid hormone levels and acute 
cardiac death and major cardiovascular disorders at 3 and 6 months of 
discharge was evaluated.
Results The mean TSH, FT3 and FT4 levels of the study group versus 
control group were as follows: TSH levels of study group 1.87 ± 1.73 μIU/
ml, FT3 3.2 ± 1.34 pg/ml, FT4 1.45 ± 0.64 ng/dl. Abnormalities in the 
thyroid function tests were noted in 26 patients (23.6%). Of these seven 
patients (6.36%) had subclinical hypothyroidism, two patients (1.8%) 
had euthyroid sick syndrome and 10 patients (9%) had high serum FT4 
levels despite normal FT3 and TSH values.
Conclusions  We noted subclinical hypothyroidism, less frequently 
euthyroid sick syndrome and hyperthyroidism. No relationship was 
noted between thyroid hormone levels and sudden cardiac death and 
major cardiovascular disorders at 3 and 6 months follow-up. However, 
studies including larger patient groups are needed to clarify if there 
is a relationship between thyroid hormone levels on admission and 
sudden death and major cardiovascular events in patients with acute 
coronary syndrome.
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Introduction  Acute ischemia alters action potentials and aff  ects 
myocardial repolarization. Dispersion of repolarization is arrhythmogenic. 
QT dispersion has been suggested to give information about the 
heterogeneity of myocardial repolarization.
Methods  Our study included 60 patients presented with acute 
STEMI, the study populations were divided into two groups: Group 
I: 30 patients who underwent primary PCI. Group II: 15 patients who 
received streptokinase. Group III: 15 patients who did not receive 
reperfusion therapy. QTd and QTcd were measured and compared in 
the three groups on admission, after 24 hours and after 5 days.
Results QTd and QTcd were signifi  cantly higher in patients with anterior 
compared with inferior MI (79.16 ± 25.67 ms vs. 62 ± 18.17 ms, P = 0.004
regarding QTd and 91.95 ± 28.76 ms vs. 68.33 ± 23.52 ms, P <0.001 
regarding QTcd). After 24 hours, QTd and QTcd were signifi  cantly lower 
in group I than groups II and III (34.33 ± 13.56 ms vs. 48 ± 18.2 ms vs. 
66 ± 24.43 ms respectively, P <0.05 as regards QTd and 39.33 ± 11.72 
ms vs. 56 ± 23.84 ms vs. 74.60 ± 26.7 ms respectively, P <0.05 as regards 
QTcd). On the 5th day reduction in QTd and QTcd was statistically 
signifi  cantly lower in group I than groups II and III (23 ± 9.52 ms vs. 
45.33 ± 15.97 ms vs. 58.66 ± 23.25 ms respectively, P <0.05 for QTd and 
26 ± 11.63 ms vs. 52.66 ± 21.2 ms vs. 60.66 ± 23.25 ms respectively, 
P <0.05 for QTcd). QT and QTcd on admission were higher in patients 
who developed ventricular arrhythmias than patients who did not 
(90 ± 11.55 ms vs. 70 ± 24.54 ms; P = 0.05 regarding QTd and 110 ± 8.61 
ms vs. 80.53 ± 28.78 ms with P = 0.028 regarding QTcd). Patients with 
early peaking of enzymes had more reduction in QTd and QTcd early 
after reperfusion (43.2 ± 11.44 vs. 60.5 ± 13.16, P <0.001 regarding QTd 
and 49.60 ± 15.93 vs. 68.5 ± 17.55, P <0.001 regarding QTcd).
Conclusions  QTd is higher in patients with acute MI (AMI) who 
developed ventricular arrhythmias. So QTd and QTcd on admission may 
be a helpful parameter that can detect patients with AMI who are at 
risk for development of ventricular arrhythmias. Reperfusion therapy 
with primary PCI or thrombolytic agents reduces QTd and QTcd in 
patients with AMI, however; QTd and QTcd are shorter with primary PCI 
compared with thrombolytic therapy.
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Introduction Myocardial infarction (MI) is a key component of the 
burden of cardiovascular disease (CVD). The main causal and treatable 
risk factors for MI include hypertension, hypercholesterolemia or 
dyslipidemia, diabetes mellitus, and smoking. Acute MI results in 
cellular necrosis with release of constituent proteins into the circulation. 
Measurement of specifi  c enzymes has become an important clinical 
tool for the diagnosis and management of MI. The aim of this study was 
to demonstrate the role of arginase and adenosine deaminase (ADA) in 
patients suff  ering from MI, and in a group of patients with chronic renal 
failure (CRF) with cardiovascular diseases (CVD).
Methods In this prospective study including 90 consecutive subjects 
were included the MI group (GI) consisting of 30 patients with mean 
age = 51.7 admitted to critical care medicine (CCM) in Cairo University  © 2010 BioMed Central Ltd
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© 2011 BioMed Central LtdHospital, Egypt. (GII) included 30 patients of the CRF with CVD group with 
mean age = 49.1 undergoing periodic hemodialysis three times per week, 
compared with 30 normal volunteers included as the control group.
Results The mean value of serum arginase enzyme activity in the control 
group was 27.9 ± 4.59 U/l. In (GI) the mean value was 70.42 ± 11.9 U/l. On 
the other hand, the activity of serum arginase enzyme in patients with 
CRF with CVD has mean value 32.43 ± 6.5 U/l, P <0.05 compared with 
the control group. ADA in the control group was 20.1 ± 2.39 U/l. But in 
(GI) the mean value was 44.99 ± 9.4 U/l, indicating a highly signifi  cantly 
increase was observed as compared with the control group (P <0.001). 
The activity of ADA in CRF (GII) was also high (59.83 ± 9.8 U/l; P <0.001).
Conclusions  ADA may be considered good diagnostic enzymes in 
patients suff  ering from MI, and ADA for patients with CRF with CVD.
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Introduction  This study sought to determine the chronic eff  ects 
of pharmacological blockade of the chemokine receptor CCR1 via 
application of the potent, selective antagonist BX471 in a murine model 
of myocardial ischemia/reperfusion (I/R). CCR1 is a prominent receptor in 
mediating infl  ammatory leukocyte recruitment. The intense infl  ammatory 
response is considered to be a key component of cardiac remodelling. 
Thus, limiting the post-reperfusion infl  ammatory pattern seems to be a 
promising therapeutic approach in limiting reperfusion injury. Previously, 
we demonstrated that CCR1–/– mice exhibit attenuated infarct expansion 
and preserved LV function in a chronic model of myocardial no-refl  ow 
infarction due to an abrogated infl  ammatory response.
Methods C57/B6 mice underwent a 60-minute coronary occlusion in 
a closed-chest model of myocardial I/R. Mice were treated with the 
specifi  c CCR1 antagonist, BX471 (50 mg/ kg BW, s.c.), or placebo, for 
96 hours at 8-hour intervals starting 15 minutes prior to reperfusion. At 
21 days of reperfusion, cardiac function was assessed using a pressure–
volume catheter (Millar) inserted in the left ventricle. Infarct size was 
analysed and cardiac content for collagen was elucidated.
Results  Infarct size was signifi   cantly smaller in the BX471-treated 
group (placebo: 20.7 ± 2.8% vs. BX471: 11.6 ± 4.2%, P <0.05; area at risk 
did no diff  er between the groups). At 21 days of reperfusion BX471-
treated mice exhibited a tendency towards improved cardiac function. 
Signifi  cantly improved diastolic function was documented in BX471-
treated mice (dP/dtmin placebo: –7,635 ± 1,090 vs. BX471: –9,845 ± 657, 
P <0.01). In histochemical analysis, collagen content was elevated in 
the hearts of BX471-treated mice.
Conclusions  Pharmacological CCR1 antagonism leads to improved 
diastolic function and attenuated infarct size in a chronic model 
of ischemia/reperfusion, suggesting that CCR1 antagonism might 
provide a promising therapeutic approach in myocardial infarction. 
The increased cardiac collagen documented in the treated group of 
our study might point towards a benefi  cial eff  ect in the restructuring 
of the extracellular collagen matrix. Further studies of the underlying 
mechanisms and a detailed analysis of structural remodelling after 
pharmacological CCR1 blockade are warranted.
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Introduction Metabolic syndrome (MS) is a constellation of disorders that 
increases the risk for coronary heart disease. This study was conducted to 
examine the incidence of metabolic syndrome in coronary artery bypass 
graft (CABG) patients and to determine if metabolic syndrome aff  ects 
clinical outcomes in the perioperative setting.
Methods  A cohort study of elective CABG surgery patients. 
Metabolic syndrome was defi  ned using recent established criteria [1]. 
Demographic variables, comorbid conditions, surgical procedures and 
postoperative variables were collected. SPSS 15 was used.
Results We studied 508 patients. MS was defi  ned in 333 (66%) patients, 
241 (72%) males and 92 (28%) females, mean age 66 ± 9 years. MS had 
greater glucose levels at all postoperative time points (F: 41.6, P <0.001), 
higher leptins levels (F: 4.7, P  <0.044), higher thrombomodulin at 
0 hours and 4 hours after surgery (F: 6, P = 0.016), and lower 24-hour-
postoperative blood loss after adjusting by tranexamic acid (F: 4.6, 
P = 0.032). MS had higher incidence of renal dysfunction (RIFLE: I) 13 
(4%) versus 1 (0.6%) (P = 0.027).
Conclusions MS was associated with a procoagulant state that may 
decrease postoperative blood loss. Nevertheless MS was associated 
with worse adverse events as renal dysfunction.
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Introduction Gastrointestinal (GI) complications are rare but often fatal 
consequences of cardiac surgery, especially after cardiopulmonary 
bypass (CPB) operations. The therapy can be conservative or – in critical 
cases – surgical; however, an early and safe diagnosis may prevent the 
development of life-threatening GI complications. The aim of our study 
was to characterize the risk factors and perioperative predictors for GI 
complications treated by laparotomy after CPB operations.
Methods In a retrospective analysis of 12 years of CPB operations, 
13,553 consecutive patients were involved in the study. Laparotomy 
was performed after CPB in 277 (2.01%) cases, the mean follow-up time 
was 63.9 months.
Results  Logistic regression analysis of the preoperative data 
demonstrated RR = 1.585 (OR: 1.340 to 1.876, P <0.001) for heart failure 
according to the NYHA classifi  cation. The postoperative data analysis 
showed an RR = 12.257 (OR: 9.604 to 15.643, P <0.001) for the need 
of an IABP implantation and an RR = 13.455 (OR: 10.516 to 17.215, 
P <0.001) of low output syndrome in the GI complications group. In 
contrast, GI disease in the patient history seemed not to be a signifi  cant 
risk factor. Preoperative renal failure had an RR = 2.181 (OR: 1.686 to 
2.821, P <0.001) until postoperative renal failure had an RR = 29.145 
(OR: 21.322 to 39.839, P <0.001).
Conclusions A failing heart may play a signifi  cant role in critical GI 
complications after CPB, whereas history of GI disease does not seem 
to determine its incidence.
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Introduction The purpose of this study was to examine the prevalence 
of endotoxemia-supported aortocoronary bypass grafting surgery 
(ACB), using the endotoxin activity assay (EAA), and to explore the 
association between endotoxemia and postoperative infection.
Methods  The study was a single-center prospective observational 
study measuring EAA during the perioperative period for elective 
ACB. Blood samples were drawn at induction of anesthesia (T1), 
immediately prior to release of the aortic cross-clamp (T2), and on 
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S2the fi  rst postoperative morning (T3). The primary outcome was the 
prevalence of endotoxemia. The secondary outcome was rate of 
postoperative infection. An EAA of <0.40 was interpreted as low, 0.41 
to 0.59 as intermediate, and >0.60 as high.
Results  Fifty-seven patients were enrolled and 54 patients were 
analyzable. The mean EAA at T1 was 0.38 ± 0.14, at T2 0.39 ± 0.18, and 
at T3 0.33 ± 0.18. At T2 only 13.5% of patients had an EAA in the high 
range. There was a positive correlation between EAA and the duration 
of cross-clamp (P  =  0.02). Eight patients developed postoperative 
infections (14.6%). EAA at T2 was strongly correlated with the risk of 
postoperative infection (P = 0.02) as was the maximum EAA over the 
fi  rst 24 hours (P = 0.02). See Figure 1.
Conclusions High levels of endotoxin occurred less frequently during 
ACB than previously documented. However, endotoxemia is associated 
with a signifi  cantly increased risk of the development of postoperative 
infection – a complication associated with an over doubling of risk 
of death. Measuring endotoxin levels may provide a mechanism to 
identify and target a high-risk population.
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Introduction Cardiac surgical patients show deterioration of functional 
residual capacity (FRC) after surgery. Manual hyperinfl  ation (MH) aims 
at preventing airway plugging, and as such could prevent the reduction 
of FRC after surgery. The purpose of this study was to determine the 
eff  ect of MH on FRC in cardiac surgical patients.
Methods  This was a randomized controlled trial of patients after 
elective coronary artery bypass graft and/or valve surgery admitted to 
the ICU of a university hospital. Patients were randomly allocated to 
routine MH strategy (MH within 30 minutes after arrival in the ICU and 
every 6 hours until tracheal extubation) or on-demand MH (MH only in 
cases of perceptible (audible) sputum in the larger airways or in case of 
a drop in SpO2) during mechanical ventilation. The primary endpoint 
was the change of FRC from the day before cardiac surgery to 1, 3, and 
5 days after tracheal extubation. Secondary endpoints were SpO2, on 
the same time points, and chest radiograph abnormalities at day 3.
Results One hundred patients were enrolled. In the routine MH group 
FRC decreased to 72% of the preoperative measurement, versus 59% 
in the on-demand MH group (P  =  0.002). Diff  erences in FRC were 
not longer statistically signifi  cant at day 5 (Figure 1). There were no 
diff   erences in SpO2 between the two groups. Chest radiographs 
showed more abnormalities in the on-demand MH group compared 
with patients in the routine MH group (P = 0.002).
Conclusions MH attenuates the reduction of FRC in the fi  rst three 
postoperative days after cardiac surgery.
P9
Incidence of cerebral desaturation events in the ICU following 
cardiac surgery
S Greenberg, A Garcia, L Howard, R Fasanella, J Vender
North Shore University Health System, Evanston, IL, USA
Critical Care 2011, 15(Suppl 1):P9 (doi: 10.1186/cc9429)
Introduction We hypothesize that there is a high incidence of cerebral 
desaturation events (CDE – an absolute decrease in SctO2 to <55% for 
≥15 seconds) during the fi  rst 6 hours of ICU admission following cardiac 
surgery. Clinical trials have validated transcranial cerebral oximetry, 
a non-invasive tool that uses near-infrared spectroscopy to measure 
cerebral oxygen saturation, as a way to detect cerebral ischemia [1]. 
Cerebral oximetry is frequently used in the intraoperative setting, but 
rarely utilized postoperatively [2]. We attempted to identify if CDEs 
occur in the ICU.
Methods This IRB-approved, prospective, observational study captures 
the CDE incidence from 40 ASA IV patients in the ICU period following 
elective cardiac surgery. Exclusion criteria were: age  <18, patients 
presenting for emergency surgery, and patients undergoing off  -pump 
procedures. The FORE-SIGHT (CAS Medical Systems Inc., Branford, 
CT, USA) absolute cerebral oximeter monitor remained on patients 
for the fi  rst 6 hours in the ICU. All patients were managed according 
to the usual ICU standard of care. All care providers were blinded to 
CDEs during the 6-hour study period. During this time, a portable 
computer was attached to the cerebral oximeter, bedside physiologic 
monitor and mechanical ventilator, which recorded all data at 1-minute 
intervals and allowed data to be stored on a computer database.
Results  Complete data were collected on 40 high-risk patients 
(mean age of patients = 71 (36 to 86), mean duration of intubation 
(hours) = 22.8 (6 to 240), mean duration of ICU stay (days) = 3.3 (1 to 
20)). A majority of the patients underwent coronary bypass grafting 
only or valve only procedures. A high incidence, 13/40 (32.5%), of CDEs 
was observed in our study cohort, with some episodes exceeding 
2 hours. A higher incidence of postoperative nausea/vomiting (PONV) 
was observed in patients with CDEs (3/13 vs. 0/27).
Figure 1 (abstract P7). Endotoxin levels in subjects with and without 
postoperative infections.
Figure 1 (abstract P8). Pulmonary function measurements. Preoperative 
functional residual capacity (FRC (l); mean, 95% CI) and FRC at 1, 3, and 
5 days after extubation in the routine MH group (closed circles) and in the 
on-demand MH group (open circles).
Critical Care 2011, Volume 15 Suppl 1 
http://ccforum.com/supplements/15/S1
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incidence of CDEs in the immediate postoperative period (32.5%) 
among cardiac surgical patients. Our ongoing observational study will 
attempt to demonstrate correlations between physiologic parameters 
and these postoperative CDEs.
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Introduction Coronary artery bypass grafting (CABG) has traditionally 
been performed with the use of cardiopulmonary bypass (ONCAB). 
CABG without cardiopulmonary bypass (OPCAB) might reduce the 
number of complications. Thus, this study aims to compare between 
on-pump and off  -pump surgery concerning postoperative morbidity 
and mortality, also to evaluate 6-month graft patency in Egyptian 
patients.
Methods  This is a nonrandomized single-centre control trial pros-
pec  tively conducted on 65 patients who were subjected to coronary 
artery bypass surgery followed by stay in the Open Heart Intensive 
Care Center of the Police Authority Hospital, in the period from July 
2009 to January 2010. Patients were divided into two groups; group 
A: 25 patients underwent ONCAP, and group B: 40 patients underwent 
OPCAB. All of the demographic, operative and postoperative data were 
prospectively collected and analyzed statistically. Six months later, the 
patients underwent coronary angiography.
Results  There was no signifi  cant  diff  erence between both groups 
intraoperatively concerning arrhythmias, blood transfusion, and 
hemodynamic support. Off  -pump patients had a signifi  cantly higher 
mean number of constructed grafts than in the ONCAB group 
(mean, 3.30 ± 0.88 vs. 2.84 ± 0.80, P = 0.02). There were no signifi  cant 
diff  erences between off  -pump and on-pump regarding postoperative 
blood loss, blood transfusion, length of the ICU and the hospital stay, 
the ventilation time, the use of IABP, renal complications, respiratory 
complications, and reopening. However, graft occlusion, MI, ventricular 
tachycardia, cardiogenic shock, and disturbed conscious level 
signifi  cantly occurred in the OPCAB group. Postoperative mortality rate 
was signifi  cantly higher in the OPCAB group than in the ONCAB group 
(15% vs. 0%, P = 0.046). Follow-up angiograms in 40 patients (61.5%) 
who underwent 124 grafts revealed no signifi  cant diff  erence between 
off  -pump and on-pump groups regarding overall rate of graft patency 
(83.5% vs. 84.4%, P = 0.84). No mortality was reported in both groups 
at 6-month follow-up.
Conclusions  There was a higher incidence in postoperative 
complications and mortality in off   -pump procedure than the on-
pump. At 6-month follow-up, no signifi  cant diff  erences between both 
techniques were found in graft patency and mortality.
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Introduction Arterial–venous extracorporal membrane oxygenation 
(ECMO) is a rescue tool in acute heart failure after cardiopulmonary 
bypass (CPB) when separation from CPB cannot be achieved by 
conventional means (volume, inotropes, intra-aortic counterpulsation 
IABP). The role of ECMO in this scenario is far from clear and factors 
predicting a poor outcome are lacking. However, such indices would be 
helpful to fi  nd a reasonable approach.
Methods Analysis of a prospective evaluated dataset in a surgical ICU 
of a university teaching hospital.
Results  In 19 patients (mean age 58 years) with postcardiotomy 
cardiogenic shock despite high-dose medication with inotropes and 
normal fi  lling pressures, separation from CPB was not possible. These 
patients were scheduled for ECMO. The mean preoperative EF was 
20.8% and in 47.3% of the patients cardiopulmonary resuscitation 
(CPR) had to be performed already before CPB. Eleven patients (57.8%) 
received an IABP before ECMO. The most frequent complications in the 
ICU were: arrhythmia (63.1%), bleeding (78.9%), renal failure with CRRT 
(47.3%) and respiratory failure (paO2/FiO2 <250 mmHg) (100%). The 
mean duration on ECMO was 6.8 days, mean stay in the ICU was 13.1 
days and mean hospital stay was 44.5 days. Only 6/19 patients survived 
(31.5%) and were discharged from hospital. These patients except one 
had no CPR in the preoperative period.
Conclusions ECMO in acute heart failure after adult open heart surgery 
in this series had an enormous high mortality of 68.5%. However, these 
results are in line with other series with a reported mortality of 67 to 
75.2% [1,2]. CPR in the preoperative setting seems to be a grave sign 
for survival and in these patients ECMO is not recommended since 
mortality reaches an unacceptable high rate. This statement needs to 
be confi  rmed by an adequate powered trial.
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Introduction  An increasing number of cardiac surgery procedures 
are performed today in patients >80 years [1]. However, only limited 
data are available regarding the postoperative outcome in this patient 
group. The aim of this study was to assess quality of life in patients 
>80 years after elective cardiac surgery (CS80) compared with younger 
patients (60 to 70 years; CS60).
Methods Consecutive CS80/CS60 patients during a 1-year period were 
contacted 12 months after cardiac surgery. A structured interview 
was performed and quality of life was assessed (SF-36 health survey). 
Norm-based scoring (transformed to mean = 50 ± 10) was analysed. 
Sociodemographic and procedure-related data were obtained from 
the hospital database. Student’s t-test and the chi-square test were 
used to compare both groups.
Results Fifty-three and 52 datasets for CS80 and CS60, respectively, 
were available for statistical analysis: mean age was 82.2 ± 2.7 years 
(CS80) and 64.7 ± 2.7 years (CS60, P <0.001). There was no signifi  cant 
diff   erence of preoperative cardiac function or risk score (ejection 
Figure 1 (abstract P12). Norm-based SF-36 scoring profi  le: (a) single 
components and (b) component summaries.
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9.3 ± 0.24, CS60: 6.9 ± 3.7, P = 0.09). ICU length of stay was 5.3 ± 9.1 days 
(CS80) and 2.6 ± 2.7 days (CS60, P <0.04); hospital length of stay was 
15.6 ± 10.1 days (CS80) and 15.1 ± 8.5 days (CS60, P = 0.79). The 30-day 
mortality rate was 11.5% (CS80) and 5.6% (CS60, P = 0.27), and 1-year 
mortality was 16.3% (CS80) and 7.6% (CS60, P = 0.13). SF-36 physical 
and mental health components ranged from 44.8 ± 10.8 to 54.2 ± 7.6 
(CS80) and from 48.7 ± 13.5 to 52.7 ± 7.9 (CS60; Figure 1); physical 
function (PF) was signifi  cantly lower for CS80 (P  =  0.002). Physical 
component summary (PCS) was 46.9 ± 9.9 (CS80) and 51.3 ± 8.8 CS60; 
P = 0.03); mental component summary (MCS) was 54.7 ± 7.9 (CS80) and 
50.8 ± 12.0 (CS60; P = 0.75; Figure 1).
Conclusions Quality of physical health with only minor limitations was 
observed in patients after cardiac surgery aged >80 years as compared 
with younger patients (60 to 70 years). There was no diff  erence of 
mental health quality between both patient groups. These results 
could only be achieved with increased ICU length of stay for patients 
>80 years.
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Introduction The incidence, presentation and risk factors of peripartum 
cardiomyopathy in Singapore are not known.
Methods  Seven patients’ case notes were reviewed following IRB 
approval.
Results  Incidence was 1:2,285 deliveries. Symptoms appeared 
1 hour post-LSCS delivery intraoperatively to postpartum day 5, with 
diagnosis within a few days. Dyspnoea, desaturation, frusemide-
induced diuresis, and CXR evidence of pulmonary congestion/
oedema occurred in all. Troponin I (measured in 6/7 cases) and CKMB 
(measured in 5/7) were raised, and then (troponin I repeated in 4/6 
and CKMB repeated in 3/5) showed a declining trend. BNP and CRP 
(measured in Case 6 only) were raised. 2D-ECHO showed worst LVEF 
25 (19 to 35)%, median (range), at time of diagnosis, <25% (Cases 1 
and 3), valvular abnormalities (4/7), LV diastolic dysfunction (2/7), 
two-chamber enlargement (3/7), one-chamber enlargement (1/7), 
and follow-up 2D-ECHO (done in 5/7) showed last LVEF 55 (35 to 65)%, 
median (range) (Cases 1 and 6, <45%), and valvular abnormalities (3/7). 
All were Asian (except for one German, typical of our hospital’s ethnic 
mix), mean age was 29.7 years (with only one older: 38 years), mean 
parity was 1.67 (6/7), all had singleton pregnancy, mean BMI was 28.2 
(6/7, one with BMI: 36.1), and preterm labour (3/7, two of which had 
failed tocolysis with oral adalat and i.v. salbutamol), prostin induction 
of labour (3/7), caesarean delivery (3/7), and postpartum haemorrhage 
(3/7) were also noted. They were all managed aggressively without 
delay. Treatment included oxygen therapy (all), intubation, sedation 
and ventilation (6/7), BiPAP (3/7), pleural drainage (2/7), frusemide, 
digoxin and ACE inhibitors (for example, perindopril, enalapril) (all), 
antibiotic(s) for pneumonia (for example, tazocin, coamoxiclav, 
ceftriaxone, clarithromycin, doxycycline, gentamicin, metronidazole) 
(6/7), anticoagulant/antiplatelet prophylaxis (for example, fraxiparine, 
clexane, aspirin, warfarin) (6/7), beta-blockers (for example, carvedilol, 
bisoprolol, labetalol) (5/7), other inotropes, namely dobutamine (2/7, in 
one patient with noradrenaline) and milrinone (1/7), and vasodilators, 
namely GTN and hydralazine (1/7). Total hospitalisation from time of 
diagnosis was 5 to 9 days. Following 4 (1 to 8) months, median (range), 
follow-up, 4/7 made full recovery, 1/7 partial recovery, 1/7 temporary 
recovery, and 1/7 defaulted. Case 2 resulted in a neonatal death.
Conclusions  Possible risk factors are multiparity, preterm labour 
requir  ing tocolysis, prostin induction of labour, and postpartum 
haemorrhage.
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Introduction The aim of this study was to compare with control and 
each other the levels of serum B12, folic acid and homocysteine at 
admission in the cases with thromboembolic diseases.
Methods  This study included 100 subjects with acute myocardial 
infarctus (AMI), acute pulmonary embolism, deep vein thrombosis, 
ischemic cerebrovascular disease (ICD), acute mesentery embolism, 
and peripheric artery embolism (PAE), and 110 healthy voluntary 
subjects were included in the control group. Vitamin B12, folic acid and 
homocysteine levels were examined in the blood samples obtained at 
admission, The data were loaded onto SPSS 16 for Windows program. 
P ≤0.05 was considered signifi  cant.
Results  Mean serum homocysteine and plasma vitamin B12 levels 
were signifi  cantly higher in the patient group than the control group 
(P = 0.002 and 0.000 respectively). There was no signifi  cant diff  erence 
in the levels of folic acid between the patient and control groups. Mean 
serum B12 values of the AMI and ICD groups in the patient group were 
signifi  cantly lower than those of the control group (P <0.05). Serum 
folic acid values of the PAE and AMI groups were considerably lower 
than the control group (P <0.05). Plasma homocysteine levels were 
signifi  cantly higher in all patient groups according to their diagnosis 
than the control group (P <0.05).
Conclusions Mean serum homocysteine and plasma vitamin B12 levels 
were signifi  cantly higher in the patient group than the control group 
(P = 0.002 and 0.000 respectively). There was no signifi  cant diff  erence 
in the levels of folic acid between the patient and control groups. Mean 
serum B12 values of the AMI and ICD groups in the patient group were 
signifi  cantly lower than those of the control group (P <0.05). Serum 
folic acid values of the PAE and AMI groups were considerably lower 
than the control group (P <0.05). Plasma homocysteine levels were 
signifi  cantly higher in all patient groups according to their diagnosis 
than the control group (P <0.05).
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Introduction The purpose of this study was to determine the incidence 
of asymptomatic deep venous thrombosis (DVT) in long-stay critically 
ill patients.
Methods Over an 8-month period, 53 patients were admitted and 
anticipated to stay in the ICU for >48  hours. DVT prophylaxis was 
provided using low molecular weight heparin (LMWH) or a sequential 
leg compression device as medically indicated. Patients had a baseline 
Duplex Ultrasound Screening (DUS) examination on admission and 
screening on a weekly basis regardless of clinical or laboratory evidence 
for DVT. Demographics and ultrasound data were also collected.
Results We studied 53 patients (42 males, mean age (SEM) 57.6 (2.8) 
years, illness severity scores APACHE II 21.3 (0.9); SAPS II 53.3 (2.3); 
SOFA 10.2 (0.2); and ICU stay 35.9 (4.8) days). Eleven (20.8%) of them 
developed DVT on day 7.4 (1.8), on DUS. Six patients had lower limb 
DVT, fi  ve upper limb DVT. Another one had DVT on admission. In 
group A (Table 1), six patients (37.5%) developed DVT on day 7.0 (2.4) 
without receiving LMWH due to underlying disease (hemorrhagic 
stroke, brain injury), but only pneumatic compression. In group B 
(Table 1), fi  ve patients (13.5%) developed DVT on day 7.7 (2.9) despite 
timely and appropriate LMWH administration since ICU admission. 
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The diff  erence regarding the incidence between the two groups was 
statistically signifi  cant (P = 0.042, RR: 2.847 (CI: 1.050 to 7.721), OR: 4.167 
(CI: 0.989 to 17.55)).
Conclusions According to our results the application of DUS screening 
in ICU patients seems to be justifi  ed for early, accurate diagnosis of 
silent DVT and appropriate therapy.
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Introduction This study was to defi  ne characteristics of patients with 
pulmonary embolism (PE) admitted to the ICU, and to determine the 
usefulness of predictive models of empirical prognostic stratifi  cation.
Methods Retrospective study of patients who developed PE during 
the ICU stay or were admitted to the ICU for PE for 5 years (2005 to 
2010). We analyzed: age, sex, history, diagnosis, complications and 
mortality. Univariate analysis using Student t and chi-square tests, and 
multivariate using logistic regression. 
Results We found 64 patients. Mean age was 64 years (SD 16.2); 51.6% 
were women, 18.8% had a neoplasia, 65.5% were admitted for PE 
from the emergency room. The rest were: medical (18.8%), surgical 
(7.8%) or traumatic (6.3%). In total, 79.7% dyspnea, 34.4% chest 
pain, 14.1% cardiorespiratory arrest. The diagnosis was mainly by CT 
(71.4%), echocardiography (15.9%) and clinical (12.7%). Of patients, 
92.1% had higher D-dimer, 33.3% had elevated troponin I; 66.7% had 
right ventricular dysfunction (RVD), 86.1% had pulmonary arterial 
hypertension (PAH); 57.8% metabolic acidosis; 42.2% hemodynamic 
instability; 44.4% catecholamines, 50% volume administration, 30% 
developed ARDS. Of the patients, 31.3% received systemic thrombolysis, 
3.1% endovascular treatment. In 4.7% a vena cava fi  lter was placed. In 
univariate analysis with regard to mortality we fi  nd signifi  cant: ARDS 
(P <0.00), catecholamines (P = 0.00), acidosis (P = 0.01), hemodynamic 
instability (P  =  0.02). In multivariate analysis: predictor of mortality 
SAPS II scale (P = 0.04, OR 0.06 (CI 0.99 to 1.12)). ROC curves for scales 
(Geneva, Wells, PESI), fi  nding an area of 0.55, 0.65, 0.47, respectively. In 
a univariate analysis with regard to PESI (III to V), we found signifi  cant: 
SAPS II (P = 0.01), age (P = 0.005), PAH (P = 0.03), volume (P = 0.01), 
catecholamines (P = 0.00), hemodynamic instability (P = 0.00). In the 
multivariate analysis: SAPS II (P = 0.046, OR 0.071 (CI 0.86 to 0.99)). In 
the univariate analysis with regard to fi  brinolysis: SAPS II (P = 0.00), PESI 
(P = 0.00), hemodynamic instability (P = 0.00). The median stay in ICU 
was 4 days, ICU mortality was 14.1%.
Conclusions  Diagnosis of PE is primarily radiological. The majority 
of patients requiring ICU admission have RVD. Troponin has little 
sensitivity for the diagnosis of PE. Prognostic stratifi  cation scales do not 
seem to be reliable predictors of mortality; however, high PESI grades 
correlates with high severity illness. Fibrinolysis was not signifi  cantly 
associated with reduced mortality. Hemodynamic instability, metabolic 
acidosis and ARDS were independent predictors of mortality.
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Introduction  Diagnosis and treatment of cardiac and circulatory 
dysfunction can be error-prone and relies heavily on clinical intuition 
and experience. Model-based approaches utilising measurements 
available in the ICU can provide a clearer physiological picture of a 
patient’s cardiovascular status to assist medical staff   with diagnosis and 
therapy decisions. This research tests a subject-specifi  c cardiovascular 
system (CVS) modelling technique on measurements from a porcine 
model of acute pulmonary embolism (APE).
Methods  Measurements were recorded in fi   ve pig trials, where 
autologous blood clots were inserted every 2 hours into the jugular 
vein to simulate pulmonary emboli. Of these measurements only a 
minimal set of clinically available or inferable data were used in the 
identifi  cation process (aortic and pulmonary artery pressure, stroke 
volume, heart rate, global end diastolic volume, and mitral and tricuspid 
valve closure times). The CVS model was fi  tted to 46 sets of data taken 
at 30-minute intervals (t = 0, 30, 60, …, 270) during the induction of 
APE to identify physiological model parameters and their change 
over time in APE. Model parameters and outputs were compared with 
experimentally derived metrics and measurements not used in the 
identifi  cation method to validate the accuracy of the model and assess 
its diagnostic capability.
Results Modelled mean ventricular volumes and maximum ventricular 
pressures matched measured values with median absolute errors 
of 4.3% and 4.4%, which are less than experimental measurement 
noise (~10%). An increase in pulmonary vascular resistance, the main 
hemodynamic consequence of APE, was identifi  ed in all the pigs and 
related well to experimental values (R = 0.68). Detrimental changes in 
refl  ex responses, such as decreased right ventricular contractility, were 
noticed in two pigs that died during the trial, diagnosing the loss of 
autonomous control. Increases in the ratio of the modelled right to left 
ventricular end diastolic volumes, signifying the leftward shift of the 
intraventricular septum seen in APE, compared well with the clinically 
measured index (R = 0.88).
Conclusions  Subject-specifi   c CVS models can accurately and 
continuously diagnose and track acute disease-dependent cardio-
vascular changes resulting from APE using readily available measure-
ments. Human trials are underway to clinically validate these animal 
trial results.
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Introduction  Ventricular driver functions are not readily measured 
in the ICU, but can clearly indicate the development of pulmonary 
embolism (PE) otherwise diffi     cult to diagnose. Recent work has 
developed accurate methods of measuring these driver functions 
from readily available ICU measurements. This research tests those 
methods by assessing the ability of these driver functions to diagnose 
the evolution of PE.
Methods  PE was induced in fi   ve pigs with cardiac measurements 
taken every 30 minutes. Pig-specifi  c driver functions are estimated at 
each time point from aortic artery pressure waveforms. Increases over 
time in two validated model-based metrics indicate PE: pulmonary 
artery resistance (Rpul); and the Right Ventricle Expansion Index (RVEI). 
Rpul and RVEI at each time point were paired to specifi  c points on 
the right driver function that change as PE is induced. The signifi  cant 
points of interest are: (1) left-shoulder (LS) of the right driver function 
Table 1 (abstract P15)
  Group A  Group B  P value
n (patients)  6/16  5/37  0.042
APACHE II  25.8 (3.3)  21.8 (2.1)  0.49
SAPS II  55.5 (6.3)  66.4 (9.8)  0.55
SOFA  10.5 (1.2)  11 (2.19)  1.0
Day DVT  7.0 (2.4)  7.7 (2.4)  0.36
LOS ICU  60.2 (37)  71.2 (39)  0.53
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gradient (MPG) of the right driver function (related to compliance); and 
(3) the total area (TA) of the right driver function (analogous to work 
done by the ventricle). Correlations are calculated for each pig, and for 
measurements and driver functions averaged across all fi  ve pigs to see 
a general trend.
Results Pig-specifi  c correlations were median (range): (1) RVEI to LS: 
0.56 (range: 0.33 to 0.99); (2) RVEI to MPG: 0.59 (range: 0.25 to 0.99); 
and (3) Rpul to TA: 0.53 (range: 0.04 to 0.85). Correlation levels were 
not consistent across pigs or metrics with the maximum for each pig 
across the three metrics of (0.99, 0.85, 0.56, 0.54, 0.59), indicating inter-
pig variability in the experimental response to PE and its impact on the 
identifi  ed driver functions. Averaging the data and driver functions 
over the fi  ve-pig cohort yielded excellent correlations between Rpul, 
RVEI and the estimated right driver function of: (1) RVEI to LS: R = 0.98, 
(2) RVEI to MPG: R = 0.98; and (3) Rpul to TA: R = 0.96. These results 
show the potential diagnostic capability of this approach in this limited 
animal trial.
Conclusions This research suggests that PE can be diagnosed and 
tracked from knowledge of a model-based driver function developed 
from readily available ICU measurements. Further animal and human 
validation is required to confi  rm these results.
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Introduction  Pulmonary embolism (PE) is a feared complication 
of critical illness. PE is diffi     cult to diagnose during critical illness 
due to the nonspecifi  city of signs and symptoms and low index of 
suspicion in practice. Our objective was to examine the antecedent 
characteristics and hospital course of patients who were diagnosed 
with PE during critical illness in the context of an international trial of 
thromboprophylaxis (NCT00182143).
Methods Research coordinators documented all clinical, laboratory, 
radiologic and autopsy criteria relevant to PE, which was a secondary 
outcome for this multicenter trial. Patients with a possible PE were 
adjudicated in quadruplicate; those considered possible, probable 
or defi  nite PE were considered in this analysis. PEs were considered 
clinically suspected if the ICU team conducted tests seeking a diagnosis; 
otherwise, they were incidental.
Results In 3,659 patients, PE was clinically suspected in most patients 
who were diagnosed with a prevalent PE at ICU admission (12/14, 
85.7%) or incident over the course of the ICU stay (57/64, 89.1%). 
Among 64 patients who developed a PE, only three (4.7%) had 
prehospital DVT or PE. Within the index hospitalization, before or after 
the PE diagnosis, additional acute deep venous thromboses occurred 
at any site in 27 (42.2%) patients with PE. Patients without PE compared 
with those with PE appear to have a shorter duration of ventilation 
(median, interquartile range) (5 (2, 11) days vs. 12 days (5.5, 20.5), 
P <0.001), duration of ICU stay (9 (6, 16) days vs. 20.5 (13, 35), P <0.001), 
and hospital stay (21 (13, 40) days vs. 35 (21.5, 58.5), P <0.001), and a 
lower ICU mortality (15.2% vs. 31.8%, P = 0.005) and hospital mortality 
(22.8% vs. 31.3%, P = 0.13).
Conclusions The majority of PEs in these medical–surgical ICU patients 
were clinically suspected rather than incidental fi  ndings. More than 
one-half of the PEs developed in the absence of leg or other venous 
thromboses; in some cases, additional venous thromboses post-dated 
rather than pre-dated the PE. PE was associated with signifi  cantly 
increased morbidity and mortality in this ICU population.
Acknowledgements  For the PROTECT Investigators, CCCTG and 
ANZICS-CTG.
P20
Deep venous thrombosis in ICU patients: exploring the submerged 
part of the iceberg by an expanded intra-ICU ultrasound 
surveillance program
A Cecchi, M Boddi, M Ciapetti, F Barbani, M Bonizzoli, J Parodo, L Perretta, 
G Zagli, E Spinelli, A Peris
Careggi Teaching Hospital, Florence, Italy
Critical Care 2011, 15(Suppl 1):P20 (doi: 10.1186/cc9440)
Introduction  Deep venous thrombosis (DVT) of lower extremities 
is a well-known complication in critically ill patients, but data for 
DVT prevalence in upper venous districts are rare. To explore the real 
prevalence of DVT in ICU patients, intensivists’ routine ultrasound (US) 
surveillance was extended to include upper vein districts.
Methods This before-and-after intervention study included patients 
admitted to our ICU of a tertiary referral center for trauma and ECMO 
assistance (Careggi Teaching Hospital, Florence, Italy). The level I vascular 
US consists of evaluation of the lumen, and complete compressibility of 
the vein compression: it is performed by the intensivist on duty within 
the fi  rst 24 hours after ICU admission, every 7 days of the ICU stay or 
in cases of suspected DVT. A level II US examination is performed by a 
vascular specialist as a second opinion in cases of unclear or positive 
level I examinations. In 2010, the DVT surveillance protocol was 
extended to assess from lower extremities to include also the proximal 
upper extremities (axillary, brachial, cephalic veins) and internal jugular 
veins. DVTs already present at ICU admission were not included in the 
study, as well as central venous catheter (CVC)-related thrombosis less 
than 3 mm of thickness.
Results  In 2009, 436 patients were admitted to our ICU (male sex 
44%, mean age 57 years, mean SAPS II 36.6). Among the 436 patients 
admitted, a total of 466 level I examinations: eight cases of lower 
extremities DVT were diagnosed (1.8% of patients admitted) at level 
I examination. After introduction of expanding level I US surveillance 
(January to October 2010), 321 patients were admitted to our ICU (male 
sex 64%, mean age 55 years, mean SAPS II 37.6). A total of 358 level I 
examinations were performed. Expanding surveillance to upper venous 
districts, a signifi  cantly higher DVT rate (25 cases, 7.8%; P <0.0001) at 
level I examination was found, all confi  rmed by the level II examination. 
In details, lower extremities DVTs were nine (2.8%), upper extremities 
DVTs 16 (5%), 11 of which were CVC-related at internal jugular vein. 
Mean time between admission and DVT diagnosis was 9.1 days.
Conclusions The lower extremities DVT represent only the tip of the 
DVT iceberg in critically ill patients. Our results suggest that routine 
intra-ICU US surveillance should include all venous districts, with 
particular care of those in which intravascular devices are positioned.
P21
Antiembolic stockings and pneumatic compression devices in a 
medical–surgical thromboprophylaxis trial
N Zytaruk1, D Heels-Ansdell1, S Vallance2, J Marshall3, Y Skrobik4, 
DJ Cooper2, S Finfer5, I Seppelt6, M Ostermann7, I Qushmaq8, 
M Alsultan9, Y Arabi9, J Alhashemi10, M Al-Hazmi11, A Alzem11, N Shaikh12, 
Y Mandourah12, DJ Cook1
1McMaster University, Hamilton, Canada; 2Alfred Hospital, Melbourne, 
Australia; 3St Michael’s Hospital, Toronto, Canada; 4Maisonneuve Rosemont, 
Montreal, Canada; 5The George Institute, Sydney, Australia; 6Nepean Hospital, 
Sydney, Australia; 7Guy’s & St Thomas’ Hospital, London, UK; 8King Faisal 
Hospital, Jeddah, Saudi Arabia; 9King Abdulaziz Hospital, Ryiadh, Saudi 
Arabia; 10King Abdulaziz Hospital, Jeddah, Saudi Arabia; 11King Fahad 
Hospital, Ryiadh, Saudi Arabia; 12Riyadh Military Hospital, Riyadh, Saudi 
Arabia
Critical Care 2011, 15(Suppl 1):P21 (doi: 10.1186/cc9441)
Introduction  A recent randomized trial (CLOTS-1) has called into 
question the utility of antiembolic stockings (AESs); another trial 
(CLOTS-2) suggested harm with below-knee compared with above-
knee AESs. AESs and pneumatic compression devices (PCD)s could 
represent important co-interventions in a heparin thromboprophylaxis 
trial if exposure was lengthy and frequent. Our objective was to 
document the use of AESs and PCDs applied per protocol and by 
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surgical ICU patients (NCT00182143).
Methods A total of 3,659 patients were recruited internationally. The 
blinded study drug was administered daily in the ICU. Mechanical 
prophylaxis was only protocolized for use if anticoagulant prophylaxis 
was contraindicated (major bleeding, high risk for major bleeding, or 
suspected or proven heparin-associated thrombocytopenia). Research 
coordinators prospectively documented daily exposure to study drugs 
and mechanical prophylaxis.
Results A total of 3,659 patients were enrolled for a median (IQR) ICU 
stay of 9 (5, 16) days. AESs were used per protocol in 17.1% of patients 
for 1 (1, 1) day; 14.1% of the patients had knee-length stockings. AESs 
used in violation of the protocol occurred in only 2.6% of patients (1.9% 
of the patients had knee-length stockings), for which the duration of 
exposure was 1.5 (1, 4) days. PCDs were used per protocol in 11.1% 
of patients for 1 (1, 3) days, and in 1.8% of patients for 2 (1, 3) days in 
violation of protocol.
Conclusions In keeping with uncertain eff  ectiveness of mechanical 
thromboprophylaxis, and emerging evidence about harm with 
knee-length stockings, the co-intervention of mechanical thrombo-
prophylaxis on the results of the PROTECT testing anticoagulant 
thromboprophylaxis trial will be minimal. AES and PCD use was brief, 
and largely reserved for days when heparin was contraindicated, as per 
clinical practice.
Acknowledgements  For the PROTECT Investigators, CCCTG and 
ANZICS-CTG.
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Introduction  Venous thrombosis of the upper extremity is a 
recognized complication of critical illness. The objective of this study 
was to describe the incidence and characteristics of upper-extremity 
thromboses in patients who were enrolled in an international trial that 
compared UFH versus LMWH as prophylaxis for VTE (NCT00182143).
Methods We recorded the location, extent and prior catheterization of 
all patients who had upper-extremity venous thromboses confi  rmed by 
compression ultrasonography or computed tomography. No patients 
were routinely screened for upper-extremity thromboses. We excluded 
prevalent thromboses found within 72 hours of ICU admission. If a 
patient had both deep and superfi  cial thromboses, we categorized 
as deep; if a patient had both proximal and distal thromboses, we 
categorized as proximal. We defi  ned catheter-related thromboses as 
partial or complete noncompressibility of the same or a contiguous 
segment in which a catheter had been inserted within the previous 
72 hours. Events were adjudicated in duplicate by physicians blinded 
to study drug and each others’ assessments.
Results Among 3,659 patients, 72 (2.0%) developed upper extremity 
thrombosis involving 129 unique venous segments. Of 72 patients, 
35 (48.6%) patients had thromboses in more than one segment. Most 
thromboses (86, 66.7%) were on the right side. Most of these were 
deep (56, 77.8%), but a few were superfi  cial (16, 22.2%). Most had 
proximal thromboses (65, 90.3%), but a few had distal (7, 9.7%). The 
three commonest sites of thrombosis were the internal jugular (29.5%), 
subclavian (18.6%) and cephalic (17.8%) veins. Less commonly aff  ected 
were the brachial (12.4%), axillary (8.5%), basilic (8.5%), innominate 
(3.9%) and external jugular (0.8%) veins. Overall, 69 (53.5%) thromboses 
were catheter-related.
Conclusions In medical–surgical patients who are receiving heparin 
prophylaxis, upper extremity DVT was uncommon, occurring in 2% of 
patients. These thromboses may be clinically important, because the 
majority is proximal and three-quarters are deep. Revisiting the need 
for central vascular access daily is underscored by the fi  nding that half 
were catheter-related.
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Introduction  Recent studies reported that real-time ultrasound 
guidance for internal jugular vein catheterization is useful in infants. 
However, this technique is sometimes diffi     cult even for skilled 
physicians. The aim of our study is therefore to evaluate the success rate 
and the complication rate of this technique performed by ultrasound-
trained pediatric intensivists in neonates.
Methods Fifteen consecutive term neonates (mean weight 3.9 ± 1.1 kg) 
needing a central venous access for intensive care treatment were 
prospectively studied for ultrasound-guided internal jugular vein 
cannulation. Patients’ age, weight, time for cannulation, catheter size, 
central venous time permanence, success rate and complications rate 
were recorded.
Results Cannulation was successful in all 15 infants. The right internal 
jugular vein was used in 90% of the patients enrolled, while in the 
remaining 10% the left internal jugular vein was used. The overall 
complication rate was 22%. We had only one major complication (2%): 
lung pneumothorax. Minor complications were: multiple skin and vein 
punctures (9%), Seldinger wire kinking (7%) and venous hematomas 
(4%). Time required for complete cannulation was 8 ± 4.3 minutes, 
while the mean duration of the central venous catheter was 5 ± 5 days.
Conclusions Our results suggest that ultrasound assistance for central 
vein cannulation can be easily performed by well-trained physicians in 
neonates. Particular solutions (increase of the tilting angle of the bed, 
use of soft nitilon tip guide wire and the transfi  xation technique) can be 
sometimes requested to increase the success rate of our procedures. In 
accordance to these considerations, US-guided CVC placement should 
be probably considered as the fi  rst choice method for catheterization 
in infants.
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Introduction  Gallbladder (GB) abnormalities are frequently seen 
in critically ill ICU patients. The purpose of the study was to evaluate 
protocolized GB US examination in medical decision-making.
Methods In this prospective study a twice per week GB US examination 
was performed in critically ill patients under mechanical ventilation 
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identify GB abnormalities. Hepatic dysfunction was defi  ned as bilirubin 
>2 mg/dl and/or alkaline phosphatase >200 IU/l [1]. US fi  ndings that 
were evaluated included: gallbladder wall thickening, gallbladder 
distention, striated gallbladder wall, pericholecystic fl  uid  and 
gallbladder sludge. We also recorded associated clinical and laboratory 
parameters: fever, WBC, MV status, liver function and administration 
of parenteral nutrition, analgesics, pressor agents, and predisposing 
factors that were associated with high incidence of acute acalculous 
cholecystitis (AAC).
Results  We included 53 consecutive patients (42 males, mean age 
57.6  ±  2.8 years, illness severity scores APACHE II 21.3  ±  0.9; SAPS 
II 53.3 ± 2.3; SOFA 10.2 ± 0.2; and mean ICU stay 35.9 ± 4.8 days) of 
which 25 (47.2%) had at least one US fi  ndings. Sixteen patients (30.2%) 
had two or more US fi  ndings. Only six patients (24%) with ultrasound 
fi  ndings had also concomitant hepatic dysfunction while 19 (76%) 
with positive ultrasound fi  ndings did not have; diff  erence statistically 
signifi  cant (c2, P = 0.03). Of the remaining 19 patients, three patients 
had increased γ-GT only (≥150 IU/l, 415.3 ± 50.2), and two patients had 
increased SGPT only (≥150 IU/l, 217.5 ± 31.2). Three patients having US 
fi  ndings compatible with AAC underwent open cholecystectomy. Only 
one of them had concomitant hepatic dysfunction, as defi  ned. Patients 
experiencing two or more US fi  ndings and/or liver dysfunction but not 
ACC were medically managed including gastric drainage, modulation 
of antibiotic therapy and/or interruption of nutrition until resolution 
of US fi  ndings or improvement in laboratory fi  ndings. In nine patients 
with US fi  ndings without hepatic dysfunction or increased γ-GT /SGPT, 
enteral or parenteral nutrition was stopped and were monitored, until 
improvement.
Conclusions Routine GB US examination was able to guide surgical 
therapy for AAC despite the absence of liver dysfunction. Also, it was 
useful to guide the medical therapy and the administration of nutrition 
during the ICU stay.
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Introduction Transthoracic echocardiography (TTE) has an important 
role in the diagnosis of shock in the ICU. There is evidence that 
noncardiologist residents can address simple clinical questions in the 
ICU with TTE [1]. We conducted this study to evaluate whether ICU 
fellows, with minimal focused training in TTE, could reliably acquire 
good-quality images in critically ill patients.
Methods  After research ethics board approval, 19 adult patients 
requiring echocardiography as per the attending physician were 
enrolled. Patients were enrolled if they were hemodynamically 
unstable and were adapted on the ventilator. Each patient underwent 
TTE by one of the certifi  ed echocardiographers and then subsequently 
by a blinded ICU fellow with minimal training in TTE (3-day ultrasound 
course, 7 hours hands-on training). All images were reviewed offl   ine 
independently and graded [2] by two blinded reviewers. Interobserver 
agreement was measured using the intraclass correlation (ICC). Image 
quality was graded on a scale from 1 (excellent) to 4 (very poor) and 
the composite image score (total score out of a possible 20 for fi  ve 
views: parasternal short and long axis, apical, subcostal and IVC views) 
was compared between groups using the Wilcoxin paired test. Each 
patient’s images were further analysed to assess whether the images of 
LV, RV and IVC had been acquired.
Results Nine patients were diagnosed with cardiogenic, eight with 
distributive and two patients with hypovolemic shock at the time of 
enrollment in the study. A total of 169 images were analysed. The ICC 
for interobserver agreement was good (0.8). There was no statistical 
diff  erence between the composite image scores acquired by ICU fellows 
(12.3 ± 0.7) (mean ± SE) in comparison with certifi  ed echocardiographers 
(11 ± 0.6, P = 0.08). However, the ICU fellows could not acquire images 
of the RV or LV in fi  ve out of 19 patients (26%) in comparison with 
corresponding images by certifi  ed echocardiographers.
Conclusions  ICU fellows, with minimal focused training in TTE, 
can acquire images that are comparable in quality with certifi  ed 
echocardiographers in our institution. However, they are not able to 
acquire images of the LV or RV in over 25% patients as compared with 
certifi  ed echocardiographers. Minimal focused training in TTE may not 
be enough when managing critically ill patients.
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Introduction Echocardiography in the intensive care unit (ITU) has 
been shown to be a valuable aid to clinical decision-making [1-3]. 
Currently, there is no formal training process for intensivists wishing 
to learn echocardiography in the United Kingdom, and there is little 
information on the current state of clinical practice.
Methods A structured questionnaire was sent to each intensive care 
unit in the United Kingdom. The questionnaire detailed information 
regarding the availability of echocardiography and the frequency 
that echocardiograms are performed in the ITU. We enquired after 
the level of training in echocardiography by intensivists, the reporting 
process and availability of currently provided training. Opinions on the 
necessity of formalised training and the level of that training were also 
sought.
Results Responses were obtained from 32 units ranging in size from 
fi  ve to 35 critical care beds. A total of 53.13% have their own dedicated 
echo machine. Only 15.6% have a transoesophageal probe. In 28% of 
ITUs echocardiograms are performed by intensivists; however, only 
25% of ITUs currently off  er echocardiography training to intensive 
care trainees. Seventy-eight per cent of respondents believed that ITU 
physicians should have at least intermediate echocardiography skills; 
97% respondents believed that a national training programme should 
be established for echocardiography practice by ITU physicians.
Conclusions  Echocardiography is currently widely used in ITUs 
throughout the United Kingdom but is often being performed by 
physicians with little or no formal training. There is almost unanimous 
support for a national structure and a formalised curriculum to achieve 
safe widespread training.
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Introduction The purpose of this study was to determine the clinical 
and economic impact of hemodynamic monitoring in intensive care 
with the ImaCor TEE monitoring system, including a miniaturized, 
detachable, single-use probe (the ImaCor ClariTEE™). TEE has been 
cited as especially appropriate for hemodynamic monitoring because 
abnormalities are multifactorial; or example, hypovolemia, LV and RV 
dysfunction, tamponade. Unlike conventional probes, the ClariTEE™ 
was designed and cleared by the FDA to remain indwelling for 72 hours 
of episodic hemodynamic monitoring.
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surgery patients at two institutions and 68 general ICU patients at 
eight institutions. Eff  ects on management were recorded and analyzed 
retrospectively. Economic impact was estimated from [1-4].
Results In 46 postcardiac surgery patients, surgical re-exploration was 
avoided in fi  ve patients (11%), and fl  uid and pressor administration 
changed in 23 patients (50%). TEE monitoring also detected tamponade 
requiring reoperation and helped optimize the LVAD fl  ow rate. Even 
without including likely reductions in acute kidney injury, a common 
complication [5], estimated hospital charges (see [1-4]) were reduced 
by $12,000 per patient. In 68 general ICU patients, fl  uid and pressor 
administration was changed in 28 patients (41%), reducing estimated 
hospital charges by $7,400 per patient.
Conclusions TEE monitoring demonstrated the potential to improve 
hemodynamic management; expected to reduce hospital stay [6,7]: 
even small amounts of mild instability signifi  cantly increase hospital 
stay and charges [4]. TEE monitoring also demonstrated the potential 
to avoid reoperation postcardiac surgery. Reoperation signifi  cantly 
increases morbidity (low cardiac output, acute renal failure, sepsis), 
vent time, ICU stay and mortality [8]; also cost [1]. Although further 
study is needed, TEE monitoring has shown potential for signifi  cant 
clinical and economic impact.
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Introduction  Acute respiratory failure does not always present in 
conditions that are ideal for immediate diagnosis, which sometimes 
compromises outcome. Physical examination and bedside radiography 
are imperfect, resulting in a need for sophisticated test results that 
delay management. Recently, a decision tree utilizing bedside 
ultrasonography has been proposed to guide diagnosis of severe 
dyspnoea. This study examines the relevance of this approach to 
diagnose acute respiratory failure in the emergency room (ER).
Methods This prospective study was conducted in university teaching 
hospitals over 1 year investigating 59 consecutive adults patients 
admitted to the ER with acute respiratory failure. At arrival, two 
diagnosis approaches have been performed: Standard (established 
using standardized tests and not including ultrasound data), and 
Ultrasound (derived from the ultrasound decision tree). Investigators 
did not participate in patient management, and were blinded to the 
data from the other group. We compared diagnosis results from both 
approaches (Standard and Ultrasound) with the offi   cial  diagnosis 
established at the end of the hospitalization by the ER staff  . The internal 
review board of the hospital approved this study. The MacNemar test 
was used to analyse the error rate. The means were compared using 
Student’s t test.
Results The error rates were 30% and 10% in the Standard and Ultra-
sound groups, respectively (MacNemar test, P <0.02). The number of 
erroneous initial diagnoses was signifi  cantly greater using conventional 
tools in patients with pneumonia and pulmonary oedema (Standard vs. 
Ultrasound, P <0.05). More patients received inappropriate therapy in 
the Standard than in the Ultrasound group (35% vs. 15%, P <0.05).
Conclusions  Ultrasound generates standardized and reproducible 
patterns, which have been proposed to help bedside diagnosis in 
patients admitted to the ER with acute respiratory failure. Our data 
highlight a signifi  cant improvement of initial diagnosis accuracy using 
this tool. Chest ultrasound performed by physicians in charge of ERs 
appears to be one of the most promising techniques for management 
of patients admitted to the ER with acute respiratory failure and should 
rapidly expand in the near future.
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Introduction There is increasing recognition of the utility of focused 
echocardiography in critically ill patients and a need for suitable 
training programmes to be developed to meet the specifi  c needs of 
critical care. Critical care communities across Europe have struggled 
to implement focused echocardiography into everyday clinical 
practice. We aim to determine whether a training programme could 
be implemented during a year of advanced intensive care training 
in a region where none of the critical care consultant body had 
accreditation in echocardiography, and to establish the perceived 
training requirements in critical care echocardiography in our region 
and to evaluate what information clinicians wished to obtain from a 
focused echocardiography examination.
Methods Trainees attended a course designed for echocardiography 
in a peri-arrest situation. Local cardiac anaesthetists with experience 
in transthoracic echocardiography were recruited as mentors. Data 
archiving protocols were established. Trainees performed an initial 
10 scans directly supervised on the cardiac ICU. A further 40 scans 
were completed independently on the general ICU. A logbook was 
maintained and the scans reviewed with a mentor prior to fi  nal sign 
off  . This process was supported by a regional educational meeting 
where personnel interested in echocardiography reviewed the types of 
training provided and how this matched local needs and resources. This 
included trainees and trainers in intensive care medicine, anaesthesia 
and acute medicine.
Results  Although 91% of doctors wished to incorporate focused 
echocardiography into their clinical practice, only 36% had undergone 
any focused echocardiography training and only 5% had focused 
echocardiography accreditation. The majority of respondents wished 
only to incorporate eyeball assessments of ventricular function but 
did not wish to perform more complex examinations such as Doppler 
assessment.
Conclusions It is possible to implement a simple training programme 
in echocardiography in an intensive care medicine department with no 
prior experience in critical care echocardiography. Within our region 
there is strong demand for simple training in focused echocardiography 
rather than a higher level of accreditation currently off  ered by many 
courses.
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Introduction Left ventricular mass (LVM) is considered an independent 
cardiovascular risk factor. Today we have new cardiac imaging methods 
for its calculation, which are incorporated into the already established 
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the correlation of LVM between two diff  erent diagnostic techniques, 
transthoracic echocardiography (TTE) and 64-slice multidetector 
computed tomography (MDCT).
Methods A prospective cohort of 102 patients’ LVM was quantifi  ed by 
TTE and MDCT in a row and blind study. We used the following test: 
intraclass correlation coeffi   cient absolute agreement (ICCA) as a mixed 
model, concordance correlation coeffi   cient of Lin (CCCL) to evaluate 
the accuracy, Passing–Bablock regression (PBR) to detect systematic 
errors and fi  nally the range of Bland–Altman agreement.
Results There were 57 (55.8%) males, mean age 65 ± 13 years. ICCA 
was 0.67 (95% CI: 0.30 to 0.84), P <0.001; the CCCL was 0.67. The PBR 
(Y = A + B * X) was: A = –29 (95% CI: –170 to 64), B = 0.70 (95% CI: 0.51 
to 0.98). The range of agreement of Bland–Altman showed a mean of 
X (TTE) – Y (MDCT) = –37.8 (95% CI: –47 to 72) g, there were two cases 
below the lower limit.
Conclusions Both methods show a level of consistency and acceptable 
accuracy, showing no systematic error constant rate (interval A contains 
0) but there seems to be a discrete proportional error (interval B does 
not contain 1). As shown, the Bland–Altman range seems to slightly 
overestimate the TTE value against the MDCT, probably related to the 
quality of the echocardiography window.
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Introduction Valvular calcifi  cation represents a form of atherosclerosis 
similar to that produced in the wall of the coronary arteries, so that the 
presence of mitral annular calcifi  cation (MAC), aortic valvular sclerosis 
and aortic root (AVRS) detected by transthoracic echocardiography 
(TTE) is associated with an increased risk for developing coronary 
artery disease (CAD). Coronary calcifi  cation and intracoronary lesions 
can be assessed by non-invasive coronary multidetector computed 
tomography (MDCT). The aim of this study was to determine whether 
a global valvular calcium score (GVCS) and/or partial (MAC and AVRS) 
assessed by TTE can predict critical values of calcium at the level of 
the coronary wall, the Agatston score (AS) and/or the presence of 
signifi  cant coronary lesions detected using MDCT.
Methods  A prospective cohort of 82 patients with intermediate 
probability of CAD was referred for MDCT and then a TTE was performed 
in a blind way to calculate the GVCS and partial (range 0 to 15).
Results Mean age 65 ± 13 years, 46 (56.1%) males. The area under the 
curve (AUC) of AS was 0.69 (95% CI: 0.5 to 0.82), P = 0.05. The cut-off   
value of AS for a higher predictive value to identify the presence of 
CAD was ≥350 with a sensitivity (S) of 46%, specifi  city (E) of 86% and 
a positive predictive value (PPV) and negative predictive value (NPV) 
of 60% and 78%, respectively. The GVCS value for an AS ≥350 with 
a higher predictive value was 9. The AUC of GVCS was 0.73 (95% CI: 
0.57 to 0.90), P = 0.01 so that a GVCS ≥9 predicts the presence of CAD 
with S = 36%, E = 97%, PPV = 83% and NPV = 79%. Spearman’s rho 
correlation coeffi   cient showed a direct association between AS and 
GVCS (r = 0.29, P = 0.03), between AS and MAC (r = 0.30, P = 0.03) as well 
as between AS and AVRS (r = 0.42, P = 0.004). The same coeffi   cient was 
used to calculate the association between the presence of signifi  cant 
CAD (≥50% stenosis) detected by MDCT and GVCS (r = 0.32, P = 0.005), 
MAC (r = 0.06, P >0.05) and AVRS (r = 0.26, P = 0.03). When studying 
the relationship between single-vessel, double-vessel or triple-vessel 
CAD and GVCS, MAC and AVRS the following results were obtained 
respectively: r = 0.33 (P = 0.004), r = 0.06 (P >0.05) and r = 0.26 (P = 0.03).
Conclusions The quantifi  cation of valvular calcifi  cation using a GVCS 
by TTE correlates well with the presence of CAD detected by MDCT. This 
association was stronger when AVRS was used compared with MAC.
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Introduction Haemodynamic monitoring is essential for the manage-
ment of critically ill patients. Currently there are various techniques 
available in clinical practice to measure cardiac output (CO) in ICUs 
including pulmonary artery catheter (PAC), oesophageal Doppler, 
lithium dilution cardiac output (LiDCO) and pulse-induced contour 
cardiac output (PiCCO) studies. In recent times PAC has been used less 
with less invasive methods becoming more popular. We conducted a 
telephone survey of the current CO monitoring practices in adult ICUs 
in the United Kingdom.
Methods All general adult ICUs in the United Kingdom were surveyed 
via telephone. The nurse-in-charge or the senior physician for the shift 
was consulted to ascertain which cardiac output monitors (COMs) were 
available for use, which was their fi  rst choice and if they used PAC in the 
past 12 months.
Results A total of 225 adult ICUs were surveyed and all the replies were 
recorded on paper (98% response). Two hundred and eleven (96%) 
units used at least one form of COM while the rest of the 14 units did not 
use any COM tool. One hundred and two (48%) use more than one form 
of cardiac output monitoring.  Oesphageal Doppler was most popular 
(86/211, 41%), followed by LiDCO and PICCO both used in 73/211 (35%) 
of the units, and pulse contour analysis (14/109, 7%). Seven out of 211 
(3%) units still use PAC as the preferred method of COM, of these two 
had other COM devices available and fi  ve used PAC only. Forty-six out 
of 211 (22%) units were using PAC at least occasionally. In contrast, a 
similar survey performed in 2005 [1] found PAC (76%) and oesophageal 
Doppler (53%) devices to be most commonly available. Among the 
other techniques. 33% of the ICUs use PiCCO and a further 19% use 
LiDCO systems for CO monitoring (Table 1).
Table 1 (abstract P32). Frequency of cardiac output monitoring across the 
United Kingdom
 2005  [1]  2010
PAC 76% 22%  (46)
Doppler 53%  41%  (86)
LiDCO 19%  35%  (73)
PICCO n/a  35%  (73)
WC analysis  33%  7% (14)
Other 8%  n/a
Conclusions  The results show the changes in COM over the past 
5 years in comparison with a previous survey in 2005 [1]. There appears 
to be a steady decline in the use of PACs, with oesophageal Doppler 
becoming the most popular method of COM. LiDCO and PiCCO are 
used equally throughout the United Kingdom, with pulse contour 
analysis becoming less popular.
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Introduction Adequate and prompt implementation of hemodynamic 
monitoring is an essential component in the management of critically 
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monitoring strategies in Swiss ICUs.
Methods  A self-reported Web-based questionnaire (36 multiple-
choice questions) was sent by email to available physicians in charge 
of adult critically ill patients in Swiss ICUs. The survey examined two 
subjects: the monitoring tool used and how the clinicians address fl  uid 
responsiveness. Results where expressed as frequency (% of all replies) 
and/or presented as a mean rate.
Results  We obtained 130 replies from 71% of selected Swiss ICUs 
(general, surgical, medical, etc.). Devices available were: echocardio-
graphy (Echo): 94.5%, PiCCO: 87.3%, Swan–Ganz: 80%, FloTrac™: 21.8%, 
oesophageal Doppler: 16.4%, LiDCO: 10.9%. The most often device 
used was: PiCCO: 56.7%, Swan–Ganz: 30.7%, Echo: 8.7%, FloTrac™: 3.1%, 
LiDCO: 0.8% respectively. Clinicians classifi  ed (from 1 to 5) the available 
devices in various situations as follows: during cardiogenic shock: 
Swan–Ganz (4.27), Echo (4.26), PiCCO (3.62), FloTrac™ (2.43); during 
septic shock: PiCCO (4.32), Swan–Ganz (3.76), Echo (3.32), FloTrac™ 
(2.59); during ARDS: PiCCO (4.09), Swan–Ganz (4.01), Echo (3.39), 
FloTrac™ (2.4). For most of the clinicians, the targeted arterial blood 
pressure was: 60 to 65 mmHg for 56.2%, 65 to 70 mmHg: 26.9%, 55 
to 60 mmHg: 7.7%, 70 to 75 mmHg: 4.6% respectively. The parameters 
used to predict fl  uid responsiveness were: PPV: by 58.5% of clinicians, 
Echo parameters: 55.8%, passive leg rising (PLR) test: 53.8%, SVV: 50.0%, 
GEDV: 45.5%, CO: 45.4%, ScVO2: 43.1%, systemic arterial pressure: 41.5%, 
pulmonary artery occlusion pressure (PAOP): 34.6%, EVLW: 33.3%, SVO2: 
31.9%, central venous pressure: 30.8%, variation of inferior vena cava 
diameter: 27.5%, ITBV: 21.4%, fl  uid balance: 14.6%, inferior vena cava 
diameter: 12.5%. Parameters used to stop the vascular fi  lling were: 
high EVLW: by 51.8% of clinicians, high PAOP: 50.9%, low PPV: 42.6%, 
high GEDV: 42.0%, disappearance of lactates: 41.9%, Echo parameters: 
39.5%, negative PLR test: 38.0%, high ITBV: 30.4%, increase in oxygen 
requirement: 25.6%, normal CO: 23.3%, elevated CO: 6.2%, high ScVO2: 
18.6%, high SVO2: 13.3%.
Conclusions This study suggests that clinicians use diverse monitoring 
methods. Moreover, regarding the parameters used for the fl  uid 
management strategy, several parameters are used without a clear 
predominance for one of them. Furthermore, static indices remain 
used.
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Introduction Monitoring of the cardiac index (CI) is a cornerstone of 
intensive care. Nevertheless, most of the techniques based on indicator 
dilution and/or pulse contour analysis require central venous and/or 
arterial catheters. Several surrogate markers have been suggested to 
estimate CI including ScvO2, central venous–arterial CO2 diff  erence 
(CVACO2D) as well as body surface temperatures and their diff  erences 
to body core temperature (BCT). It was the aim of our prospective 
study to evaluate the predictive capabilities of CVACO2D, ScvO2, surface 
temperatures and lactate regarding CI.
Methods In 53 patients (33 male; 20 female) with PiCCO monitoring, 
106 datasets including surface temperatures of great toe, fi  nger pad, 
forearm and forehead using an infrared noncontact thermometer 
(Thermofocus; Tecnimed) as well as lactate, ScvO2, CVACO2D and pulse 
pressure (PP) were measured immediately before PiCCO thermodilution 
providing CI and SVRI. Statistics: SPSS 18.0.
Results Patients: 17/53 (32%) ARDS; 14/53 (26%) liver cirrhosis; 13/53 
(25%) sepsis; 4/53 (8%) cardiogenic shock; 5/53(9%) various aetiologies. 
Thermodilution-derived CI signifi  cantly correlated to the temperatures 
of the forearm (r = 0.465; P <0.001), great toe (r = 0.454; P <0.001), fi  nger 
pad (r = 0.447; P <0.001) and forehead (r = 0.392; P <0.001) as well as to 
ScvO2 (r = 0.355; P <0.001), SCVACO2D (r = –0.244; P = 0.011) and pulse 
pressure (r = 0.226; P = 0.019), but not to lactate (r = –0.067; P = 0.496). 
ROC analysis regarding the critical threshold of CI <2.5 l/minute*sqm 
demonstrated the highest predictive capabilities for the diff  erences 
(BCT – T-forearm) (ROC-AUC 0.835; P = 0.002; cut-off   4.6°; sensitivity 
89%; specifi   city 71%) and (BCT – T-fi   nger pad) (ROC-AUC 0.757; 
P = 0.017) as well as ScvO2 (ROC-AUC 0.744; P = 0.024). SCVACO2D (ROC-
AUC 0.706; P = 0.056) and lactate (ROC-AUC 0.539; P = 0.718) were not 
predictive. Multiple regression analysis (R = 0.725) demonstrated that 
age (P <0.001), PP (P <0.001), T-forearm (P = 0.024) and the diff  erence 
(BCT – T-toe; P = 0.035) were independently associated with CI.
Conclusions Body surface temperatures and their diff  erences to BCT 
are useful to estimate CI. The diff  erence (BCT – T-forearm) provided the 
largest ROC-AUC (0.835; P = 0.002) regarding CI <2.5 l/minute*sqm. 
SCVACO2D does not provide information in addition to body surface 
temperatures and ScvO2.
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Introduction  The diff   erence between central venous (ScvO2) and 
mixed venous oxygen saturation (SvO2) may vary widely. The objective 
of this study was to evaluate the impact of hepatic and renal venous 
oxygen effl   ux, femoral oxygen saturation and carotid artery blood fl  ow 
on the diff  erence between ScvO2 and SvO2 (Δ[ScvO2 – SvO2]).
Methods Nineteen sedated and mechanically ventilated pigs (weight: 
41.0 ± 3.6 kg) were subjected to sepsis (n = 8), hypoxic hypoxia (n = 3) 
and cardiac tamponade (n = 3) or served as controls (n = 5). Mixed, 
central and regional venous oxygen saturations (spectrophotometry), 
and carotid, hepatic and renal blood fl  ows (ultrasound Doppler fl  ow) 
were measured at baseline and 3 hourly, up to 24 hours. Hepatic venous 
oxygen effl   ux was determined as hepatic arterial + portal venous 
blood fl  ow times hepatic venous oxygen content, and renal venous 
oxygen effl   ux as twice renal artery blood fl  ow times renal venous 
oxygen content. A multiple linear regression analysis with backward 
elimination procedure was undertaken to defi  ne contributions of the 
variables to Δ[ScvO2 – SvO2].
Results  Ninety-eight assessments were obtained (one to seven/
animal). The backward elimination procedure yielded a best model 
containing hepatic venous oxygen effl   ux (r = –0.46, P <0.01) and carotid 
artery blood fl  ow (r = 0.56, P <0.01; Figure 1). This fi  nal model accounted 
for 49.8% of variation in Δ[ScvO2 – SvO2] (R2 = 0.498).
Conclusions  Carotid artery blood fl   ow and hepatic but not renal 
venous oxygen effl   ux predict some of the diff  erences between mixed 
Figure 1 (abstract P35). Scatterplot of standardized predicted values 
versus ScvO2 – SvO2.
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be predicted by ScvO2 alone.
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Introduction  Perioperative hemodynamic optimization has been 
shown to be useful to improve the postoperative outcome of 
patients undergoing major surgery. We designed a pilot study in 
patients undergoing major abdominal, urologic or vascular surgery to 
investigate the eff  ects of a goal-directed (GD) fl  uid management based 
on continuous stroke volume variation (SVV) and stroke volume (SV) 
monitoring on postoperative outcomes.
Methods Fifty-two high-risk-surgical patients (ASA 3 or 4, arterial and 
central venous catheter in place, postoperative admission in ICU) were 
randomized either to a control group (Group C, n = 26) or to a goal-
directed group (Group G, n = 26). Patients with cardiac arrhythmia or 
ventilated with a tidal volume <7 ml/kg were excluded. In Group G, 
SVV and SV were continuously monitored with the FloTrac™/Vigileo™ 
system (Edwards Lifesciences, USA) and patients were brought to and 
maintained on the plateau of the Frank–Starling curve (SVV <10% and 
SV increase <10% in response to fl  uid loading). During the ICU stay, 
organ dysfunction was assessed using the SOFA score and resource 
utilization using the TISS score. Patients were followed up to 28 days 
after surgery for infectious, cardiac, respiratory, renal, hematologic and 
abdominal complications.
Results Group G and Group C were comparable for ASA score, co-
morbidities, type and duration of surgery (275 vs. 280 minutes), heart 
rate, MAP and CVP at the start of surgery. However, Group G was 
younger than Group C (68 vs. 73 years, P <0.05). During surgery, Group 
G received more colloids than Group C (1,589 vs. 927 ml, P <0.05) and 
SVV decreased in Group G (from 9.0 to 8.0%, P <0.05) but not in Group 
C. The number of postoperative wound infections was lower in Group 
G (0 vs. 7, P <0.01). Although not statistically signifi  cant, the proportion 
of patients with at least one complication (46 vs. 62%), the number of 
postoperative complications per patient (0.65 vs. 1.40), the maximum 
ICU SOFA score (5.9 vs. 7.2), and the cumulative ICU TISS score (69 vs. 
83) were also lower in Group G. ICU and hospital length of stay were 
similar in both groups.
Conclusions Although the two groups were not perfectly matched, this 
pilot shows that fl  uid management based on SVV and SV optimization 
decreases wound infections. It also suggests that such a GD strategy 
may decrease postoperative organ dysfunction and resource utilization. 
However, this remains to be confi  rmed by a larger study.
P37
Prognosis value of dynamic variation of tissue oxygen saturation 
during severe cardiogenic shock
P Gaudard, J Eliet, O Attard, P Colson
CHRU, Montpellier, France
Critical Care 2011, 15(Suppl 1):P37 (doi: 10.1186/cc9457)
Introduction To evaluate the prognosis value of dynamic thenar O2 
saturation (StO2) response using a vascular occlusion test (VOT) during 
cardiogenic shock.
Methods A retrospective clinical observational analysis was performed 
on adult patients treated for severe cardiogenic shock in a surgical ICU. 
The non-invasive InSpectra near-infrared spectrometer was used to 
assess the eff  ect of VOT on thenar eminence StO2. The VOT manoeuvre 
was repeated within the fi  rst 24 hours of admission. StO2 VOT-induced 
changes were compared between surviving and nonsurviving patients 
between the fi  rst 8 hours and the next 16 hours.
Results Ten patients suff  ering from cardiogenic shock (age 59.8 ± 13.8 
years; APACHE score 21.3 ± 5.9) were treated with inotropes (n = 7) and/
or circulatory mechanical assistance (four IABP, three ELS, one LVAD) 
and vasopressors (n = 9). Mortality in the ICU was 50%. Hemodynamic 
and metabolic parameters were not diff  erent between survivors and 
nonsurvivors (Table 1). The post-VOT StO2 recovery slope tended to be 
faster within the fi  rst 8 hours in survivors than in nonsurvivors (2.8 ± 1.1 
vs. 1.7 ± 0.4%/s, P = 0.09) and improved signifi  cantly in the H8 to H24 
period (4.5 ± 1.2 vs. 2 ± 1.1%/s, P = 0.007). The post-VOT StO2 recovery 
slope increased signifi  cantly within the fi  rst 24 hours in all survivors 
(Figure 1).
Conclusions Our results suggest that, in patients treated for cardio-
genic shock, rapid improvement in the post-VOT StO2 recovery slope is 
associated with a better prognosis.
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Introduction Tissue hypoperfusion is a key trigger of postoperative 
organ dysfunction. Our objective was to evaluate the prognostic value 
of the central venous-to-arterial carbon dioxide diff  erence (PCO2) gap, 
a global index of tissue perfusion, in patients after major abdominal 
surgery.
Methods  A prospective and observational study of 115 patients 
admitted to the ICU following major abdominal surgery. In all patients, 
measurements of the PCO2 gap, central venous oxygen saturation 
(ScvO2), serum lactate and conventional hemodynamic and biological 
parameters were performed on admission (H0), and over 6 hours until 
12 hours after admission. Postoperative complications, the duration of 
mechanical ventilation, and the hospital length of stay and mortality 
up to 28 days were characterized using standard defi  nitions. Area 
under the ROC curves for PCO2 gap, ScvO2 and lactate were calculated 
and compared to discriminate between patients with and without 
complications.
Results A total of 78 patients developed at least one complication 
including 57 (50%) patients with postoperative septic complications. 
Figure 1 (abstract P37). StO2 recovery slope (mean).
Table 1 (abstract P37). Hemodynamic parameters within the fi  rst 8 hours in 
the ICU
 Survivors  Nonsurvivors  P value
MAP 85  70  0.08
CI 2.4  2.3  1
ScvO2 65  57  0.45
Lactate 4.4  8  0.47
StO2 77  81  0.35
Critical Care 2011, Volume 15 Suppl 1 
http://ccforum.com/supplements/15/S1
S13At T0 there was no signifi  cant  diff   erence in demographic and 
hemodynamic data, type and duration of surgical procedures between 
patients with and without complications. There were nine deaths 
(7.8%). There was a signifi  cant diff  erence for PCO2 gap (8.1 ± 3.2 mmHg 
vs. 5.5 ± 2.8 mmHg, P <0.001), ScvO2 (76.5 ± 6.4% vs. 78.9 ± 5.8%) 
and serum lactate (P  <0.001) between patients with and without 
complications. After multivariate analysis, PCO2 gap and lactate level, 
but not ScvO2, were associated with postoperative complications 
(P <0.001 and P = 0.018, respectively). Areas under the ROC curves were 
0.66 (95% CI = 0.55 to 0.76) for lactate, 0.57 (95% CI = 0.46 to 0.68) for 
ScvO2 and 0.85 (95% CI = 0.77 to 0.93) for PCO2 gap, with 6 mmHg as 
the best threshold value for discriminating patients with and without 
complications. Patients with a PCO2 gap >6 mmHg (68%) had a longer 
duration of mechanical ventilation (4.1 ± 3.4 days vs. 5.6 ± 3.8 days, 
P = 0.047), and a longer hospital stay. Patients who died all had an 
enlarged PCO2 gap (P = 0.056).
Conclusions Both low and supranormal values of ScvO2 were found to 
be warning signals of impaired tissue oxygenation. A PCO2 gap larger 
than 6 mmHg could be a useful prognostic factor to identify patients 
at risk of postoperative complications following major abdominal 
surgery, especially when ScvO2 exceeds 75%.
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Introduction  Central venous oxygen saturation (ScvO2) is a useful 
therapeutic target in septic shock. ScvO2 is an indirect index of the balance 
between oxygen supply and demand, thus in critically ill patients a fall in 
ScvO2 refl  ects a decrease in tissue oxygenation. ScvO2 depends on arterial 
oxygen saturation, oxygen consumption, cardiac output and hemoglobin. 
The aim of the study was to evaluate events of tissue oxygenation 
impairment that could be unrecognized by simple blood gas analysis, 
by continuously monitoring ScvO2 and to establish whether peripheral 
oxygen saturation (SpO2), mean arterial pressure (MAP), heart rate (HR), 
and central venous pressure (CVP) could predict LowScvO2 events.
Methods Ventilated critically ill patients requiring a central venous 
catheter (CVC) for clinical use were enrolled. Continuous ScvO2 
monitoring was obtained by a fi  beroptic sensor inserted in the CVC and 
recorded for 72 hours with SpO2, HR, MAP and CVP. LowScvO2 events 
were defi  ned as ScvO2 <65% maintained for at least 5 minutes.
Results  Thirty-seven patients (24 males) were enrolled. The mean 
clinical characteristics at admission to intensive care were: age 59 ± 16 
years, BMI 26.1 ± 4.5 kg/m2, SAPS II 40 ± 13 (on 33 patients), PaO2/FiO2 
206 ± 79, MAP 80 ± 13 mmHg, HR 92 ± 21 bpm, CVP 12 ± 3 mmHg, Hb 
10.6 ± 1.9 g/dl. Continuous monitoring analysis detected 147 LowScvO2 
events in 15 patients; while central venous blood gas analysis identifi  ed 
only nine LowScvO2 events in eight patients (6%). Table 1 summarizes 
patients’ variables according to three ScvO2 ranges. SpO2, HR, MAP and 
CVP were not correlated with LowScvO2 events. Most patients had long 
periods of ScvO2 >75 (supranormal ScvO2).
Conclusions Continuous ScvO2 monitoring showed that most events 
of poor tissue oxygenation are relatively common, are not recognized 
by extemporary central venous blood gas analysis and are not mirrored 
by changes in SpO2, HR, MAP or CVP.
P40
Femoral venous oxygen saturation is no surrogate for central 
venous oxygen saturation
A Van der Schors1, P Van Beest2, H Liefers1, L Coenen1, R Braam1, P Spronk1
1Gelre Hospitals, Apeldoorn, the Netherlands; 2University Medical Center, 
Groningen, the Netherlands
Critical Care 2011, 15(Suppl 1):P40 (doi: 10.1186/cc9460)
Introduction Shock is defi  ned as global tissue hypoxia secondary to 
an imbalance between systemic oxygen delivery (DO2) and oxygen 
demand (VO2), refl  ected by mixed venous oxygen saturation (SvO2). 
Intervention based on markers of tissue hypoperfusion may improve 
outcome. Central venous oxygen saturation (ScvO2) has been used 
as a surrogate marker for SvO2. In order to monitor ScvO2 during 
resuscitation, an internal jugular or subclavian line must be inserted. 
However, sometimes the femoral vein is the preferred or only possible 
site for access. The purpose of our study is to determine whether 
ScvO2 and femoral venous oxygen saturation (SfvO2) can be used 
interchangeably.
Methods A single-center, prospective, controlled, observational study 
was conducted at the Gelre Hospitals Apeldoorn. One hundred stable 
cardiac patients who underwent elective right heart catherization in 
daycare served as a control group. In the study group (high-risk surgery, 
ASA >2, n = 30) we determined SfvO2 and ScvO2 simultaneously at the 
start (T = 0) and at the end (T = 1) of the procedure. For each time point 
we calculated the agreement and diff  erence between both values.
Results  Control group: ScvO2 and SfvO2 correlated signifi  cantly 
(r = 0.67, 95% CI = 0.50 to 0.80; P <0.0001) with large limits of agreement 
(bias 2.0 ± 7.1; –11.8 to 15.9). In the surgical patients at T = 0, mean 
values were similar (SfvO2 82.5 ± 6.6% vs. ScvO2 81.1 ± 8.1; P = 0.28). 
According to Bland–Altman analysis, the mean bias between ScvO2 and 
SfvO2 was 2.7 ± 7.9% and 95% limits of agreement were large (–12.9% 
to 18.2%), while correlation between ScvO2 and SfvO2 was signifi  cant 
(r2 = 0.35; P <0.01). At both time points SfvO2 and ScvO2 did not correlate 
signifi  cantly (P = 0.26 and P = 0.66 respectively) with similar negligible 
r2. Univariate analysis did not show any parameter (including dosages 
of dopamine or norepinephrine, total infusion, fl  uid balance, FiO2, type 
of surgery, lactate, and haemoglobin level) aff  ecting either SfvO2 or 
ScvO2. Results were similar for changes in SfvO2 and changes in ScvO2.
Conclusions  Absolute values of SfvO2 are unsuitable as surrogate 
for absolute values of ScvO2. Also, the trends of both values are not 
interchangeable. Further studies should investigate the eff  ects  of 
treatment on SfvO2.
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Introduction Microvascular dysfunction and inadequate delivery of 
oxygen to the tissues is a feature of septic shock. The degree of this 
microcirculatory impairment has not been assessed in the early phases 
of Emergency Department (ED) sepsis management. The purpose 
of this study was to assess the relationship between tissue oxygen 
saturation (StO2) and conventional vital signs and in-hospital mortality 
for ED patients with severe sepsis or septic shock.
Methods Prospective cohort study of adult ED patients with severe 
sepsis or septic shock. Standard vital signs were monitored in all 
patients. StO2 measurements using near-infrared spectroscopy were 
commenced as soon as possible after the patients’ arrival in the ED. The 
measurements were continued throughout the stay in the ED whilst 
receiving normal treatment. StO2 readings were repeated after 24 hours 
of sepsis management. All patients were followed up for 30 days.
Results  Forty-nine patients were included in this study, of which 
24 (49%) died. Nonsurvivors were signifi  cantly older than survivors 
(79 vs. 64, P = 0.008) but there were no signifi  cant diff  erences in co-
morbidities or conventional vital signs. On arrival in the ED there was 
no diff  erence in mean StO2 between survivors and nonsurvivors (72% 
vs. 72%, P = 0.97). With treatment, StO2 improved signifi  cantly to 78% 
Table 1 (abstract P39). Patients’ variables according to ScvO2 range
 ScvO2 <65 ScvO2 65 to 75  ScvO2 >75
Patients 15/37  36/37  36/37
SpO2 (%)  95.8 ± 3.0  95.0 ± 3.3  96.4 ± 2.3
HR (bpm)  90.6 ± 16.1  90.5 ± 18.1  90.7 ± 16.5
MAP (mmHg)  82.5 ± 10.6  83.4 ± 12.7  82.2 ± 11.7
CVP (mmHg)  18.3 ± 4.6  20.2 ± 8.2  19.2 ± 5.5
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The AUROC for StO2 was 0.63 on ED departure and 0.71 after 24 hours 
of treatment, performing far better than heart rate (0.53), SpO2 (0.50) 
and systolic blood pressure (0.51). There was no correlation between 
StO2 and any of the routine vital signs.
Conclusions Our results demonstrate that a consistently low tissue 
oxygen saturation despite initial sepsis resuscitation is associated with 
an increased in-hospital mortality. We have further shown that tissue 
oxygen saturation is a better prognostic indicator than conventional 
vital signs in severely septic ED patients.
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Introduction Central venous oxygen saturation (ScvO2) is increasingly 
used as a surrogate for mixed venous oxygen saturation (SvO2). On 
average, there is a positive gradient between ScvO2 and SvO2 that 
has been explained by the low inferior vena cava saturation (SivcO2). 
We aimed to clarify the dynamics and associations between diff  erent 
venous saturations in an experimental setting of porcine peritonitis.
Methods Thirty-two anaesthetized pigs (40.3  ±  3.8 kg (mean  ±  SD)) 
were randomly assigned (n = 8 per group) to a nonseptic control group 
or one of three septic groups in which the pigs were observed for 6, 
12 or 24 hours. Thereafter, resuscitation was performed for 48 hours. 
The pulmonary artery, superior vena cava and inferior vena cava (IVC) 
were catheterized. The catheter for IVC measurements was placed 5 cm 
below the diaphragm. SvO2, ScvO2 and SivcO2 were measured at 12-hour 
intervals starting at study baseline. Diff  erences between saturations at 
diff  erent time points were tested with a t test for paired measurements.
Results One hundred and ninety-two (136 in septic and 56 in control 
animals) simultaneous measurements of SvO2, ScvO2 and SivcO2 were 
analysed. Mean SvO2 was 58.7 ± 7.2%, ScvO2 61.5 ± 8.3% and SivcO2 
66.7 ± 8.5%. Dynamics of the saturations throughout the study are 
presented in Figure 1. ScvO2 was numerically higher than SvO2 in 
133 (69.3%) of all measurements. In 122 of these 133 measurements 
(91.7%), SivcO2 exceeded SvO2 as well.
Conclusions In most of the measurements, both ScvO2 and SivcO2 
were higher than SvO2. Our results suggest a high oxygen extraction 
of splanchnic organs as the reason for positive ScvO2–SvO2 gradients.
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Introduction Severe sepsis is characterised by profound metabolic 
and infl  ammatory derangement, which can lead to multiorgan failure 
and death. During septic shock, oxygen delivery may fail to meet tissue 
demand resulting in increased oxygen extraction. Once tissue needs 
are no longer met, an oxygen debt with global tissue hypoxia and 
associated hyperlactataemia ensues. Several studies have shown that 
blood lactate may be used as a marker of global tissue hypoxia and 
prognosis in shock states.
Methods Forty patients requiring adrenaline therapy for a fi  rst episode 
of septic shock acquired >24 hours after admission to the ICU had blood 
lactate levels measured 2-hourly over a 24-hour period. Adrenaline 
therapy was escalated until the target mean arterial pressure was 
reached. The lactate index was calculated as the ratio of maximum 
lactate increase to the adrenaline increase.
Results  Lactate increased from 2.3 to 2.9 mmol/l (P  =  0.024) and 
the mean adrenaline increase was 0.14 μg/kg/minute. Peak lactate 
correlated with peak adrenaline (rho = 0.34, P = 0.032). Lactate index 
was the only independent predictor of survival after controlling for age 
and APACHE II score (OR = 1.14, 95% CI = 1.03 to 1.26, P = 0.009).
Conclusions A high lactate following adrenaline administration may 
be a benefi  cial and appropriate response.
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Introduction The central venous-to-arterial carbon dioxide diff  erence 
(P(cv-a)CO2, dPCO2) is a global index of tissue perfusion. A normal 
dPCO2 indicates cardiac output (CO) is high enough to wash out CO2 
production from peripheral tissues. An increased dPCO2 suggests that 
CO is not high enough with respect to global metabolic conditions. 
PCO2 depends on alveolar ventilation. We hypothesized that minute 
ventilation (MV) has an eff  ect on dPCO2.
Methods  A prospective experimental, pilot study was performed 
on 19 patients admitted to a medical ICU with septic shock between 
August 2010 and November 2010. All patients were intubated and on 
a mechanical ventilator with continuously monitoring end-tidal CO2, 
central venous pressure (CVP), blood pressure (BP), and CO. Mechanical 
ventilator was set consecutively in three steps every 30 minutes (T0, 
T30, T60) by increasing the respiratory rate (RR) for MV of 8 l, 15 l, and 
8 l, respectively. Tidal volume, RR, MV, auto-PEEP, CO and dPCO2 were 
recorded at each step of MV changed for all patients.
Results Patients’ age and APACHE II scores were 67.3 ± 13.2 years and 
24.4 ± 6.6, respectively. There was a signifi  cant diff  erence between the 
dPCO2 between T0 and T30 (3.5 ± 3.5 vs. 5.9 ± 2.0, P = 0.04) (Table 1). 
Moreover, there was signifi  cantly decreased CO from T0 to T30 (5.1 ± 1.4 
Figure 1 (abstract P42). Dynamics of mixed venous, superior and inferior 
vena cava saturations. §Diff  erence between SvO2 and ScvO2, P <0.05. 
*Diff  erence between SvO2 and SivcO2, P <0.005.
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S15vs. 4.5 ± 1.11, P = 0.002) and, also, T30 and T60 (4.5 ± 1.1 vs. 5.0 ± 1.3, 
P = 0.009). Auto-PEEP values were inversely correlated with decreased 
CO (P <0.001) at T30.
Conclusions Minute ventilation had an eff  ect on dPCO2 by reduced 
CO due to development of auto-PEEP. The dPCO2 should be measured 
during normal minute ventilation without auto-PEEP.
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Introduction For years the role of the pulmonary artery catheter (PAC) 
in ICU patients has been a topic of discussion. The use of PAC itself is not 
associated with improved outcome, and might contribute to increased 
morbidity [1]. However, the infl  uence of a therapeutic strategy, based 
on dynamic PAC-derived variables, has never been investigated. The 
aim of this study is to evaluate whether such PAC-based strategy 
infl  uences therapeutic behaviour in septic patients.
Methods  We performed a single-centre retrospective case–control 
study in a 22-bed mixed ICU. Seventy patients with severe sepsis 
or septic shock, treated after introduction of a strict PAC-based 
resuscitation protocol, were compared with 70 matched controls, 
treated at the discretion of the attending physician. Continuous PAC 
measurements (Vigilance®) were started within 4 hours of admission. 
In short, the treatment algorithm only allowed infusion of fl  uids in 
cases of a 10% rise in left ventricular stroke volume; administration 
of dopamine was titrated on cardiac index in combination with 
central venous oxygen saturation. Norepinephrine was administered 
in cases of persistent hypotension despite the fi   rst two steps [2]. 
Primary outcomes were cumulative fl   uid balance and maximum 
dose of dopamine and norepinephrine in the fi  rst 24 hours. Statistical 
comparison between groups was performed with applicable tests; data 
are expressed as median (IQR).
Results  At ICU admission there were no diff  erences in severity of 
disease or predicted mortality using the APACHE IV model. The 
cumulative fl  uid balance in the fi  rst 24 hours was signifi  cantly higher 
in the PAC group, in comparison with controls (6.0 (4.3 to 7.5) l vs. 3.6 
(1.8 to 5.0) l, P = 0.00). However, after 7 days cumulative fl  uid balance 
was signifi  cantly lower in the PAC group (7.5 (4.6 to 13.1) l vs. 13.0 (6.7 
to 17.7) l, P = 0.002). Maximum dose of norepinephrine in the fi  rst 
24 hours was signifi  cantly higher in the PAC group (0.12 (0.03 to 0.19) 
μg/kg/minute vs. 0.02 (0 to 0.07) μg/kg/minute, P = 0.00). No diff  erence 
in use of dopamine was found. There was a signifi  cant diff  erence in 
days on mechanical ventilation in favour of the PAC group (7 (5.0 to 
11.3) days vs. 10 (5.8 to 18.3) days, P = 0.01).
Conclusions  A treatment strategy, based on dynamic PAC-derived 
parameters in septic patients, signifi  cantly alters fl  uid administration, 
use of norepinephrine and days on mechanical ventilation, in 
comparison with historic controls.
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Introduction  When validating new methods of cardiac output, 
measure  ment comparisons are made using Bland–Altman and 
percentage errors are generated that rely on a precision error for 
thermodilution of ±20% [1]; data collected 30 years ago [2]. We have 
re-evaluated this precision against an aortic fl  ow probe.
Methods Four domestic pigs, weight 30 to 32 kg, were anaesthetized. 
An aortic fl  ow probe was placed via a left thoracotomy. Both Arrow 
(n  =  6) and Edwards (n  =  6) 7F pulmonary artery catheters and a 
Siemens SC9000 monitor were used. Sets of cardiac output readings 
were taken (three to six pairs). Catheters were changed frequently 
and cardiac output increased (for example, dopamine and adrenaline) 
and decreased (for example, trinitrate and beta-blocker) using drug 
infusions. Baseline and drug treatment data were compared.
Results Forty-fi  ve sets (259 pairs) of averaged data (21 baseline and 
24 following treatment) were collected. Baseline cardiac outputs 
(mean (SD)) were 1.9 (0.4) and 1.8 (0.3) l/minute for fl  ow meter and 
thermodilution readings, respectively. MAP (mean (range)) was 82 (69 
to 95) mmHg. Following circulatory treatment, cardiac output ranged 
from 0.5 to 3.4 l/minute and from 0.7 to 3.5 l/minute, respectively. MAP 
ranged from 44 to 118 mmHg. For baseline data, bias was 0.0 l/minute, 
limits of agreement  ±  0.45 l/minute and percentage error ±24.3%. 
Following treatment, the bias was unchanged at 0.0 l/minute, but the 
limits of agreement widened to ±0.78 l/minute and percentage error 
widened to 42.0% (Figure 1).
Conclusions The fl  ow probe has a relatively low (1 to 2%) precision 
error, thus the baseline percentage error of 24.3% is in keeping the 
quoted precision error for thermodilution of ±20%. However, under 
more extreme circulatory conditions thermodilution behaved less 
reliably with widened limits of agreement and precision errors 
(42.0%). Thermodilution is less accurate than originally thought in 
haemodynamically unstable patients.
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Introduction  Cardiac output (CO) can be measured using the 
transpulmonary thermodilution (TPTD) technique. TPTD is considered 
to be the gold standard in pediatric patients. We studied the infl  uence 
of high levels of EVLW on the reliability of CO measurement using the 
TPTD technique in a pediatric animal model.
Figure 1 (abstract P46). Plots showing widening distribution.
Table 1 (abstract P44)
 P  value
Variable  T0  T30   T60  T0 vs. T30  T30 vs. T60  T0 vs. T60 
dPCO2 3.5 ± 3.5 5.9 ± 2.0 4.8 ± 2.1  0.040  0.15  0.49
CO 5.1 ± 1.4  4.5 ± 1.1  5 ± 1.3  0.002  0.009 0.97
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mented with a COLD® (Pulsion Medical Systems, Munich, Germany) 
catheter and underwent repetitive saline lavage (10 to 30 ml/kg) of 
the lung. CO was measured using the single indicator TPTD method 
(COTPTD) and compared with simultaneous measurement of CO 
using an ultrasound perivascular fl  owprobe (Transonic Systems, USA) 
around the main pulmonary artery (COMPA). EVLW was assessed by 
the transpulmonary double indicator technique with intravenous 
injections of ice-cold indocyanine green (ICG).
Results A total of 62 simultaneous measurements in 11 lambs were 
analyzed. The mean body weight was 8.6 (range 4.1 to 12.3) kg. The 
initial EVLWI was 13.8 (range 9.3 to 21.5) ml/kg. After lung injury this 
increased to 38.3 (range 16.2 to 60.9) ml/kg. The mean COMPA was 
1.52 (range 0.40 to 3.05) l/minute. The correlation coeffi   cient between 
the COMPA and COTPTD was 0.93. The Bland–Altman analysis showed 
a mean bias of –0.09 l/minute (limits of agreement ± 0.37 l/minute) 
(Figure 1). The percentage error was 25%.
Conclusions In circumstances of largely increased extravascular lung 
water, CO can reliably be measured using the TPTD technique.
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Introduction  Although pulse pressure variation (PPV) is essentially 
proposed as a predictor of fl  uid responsiveness [1], it has also been 
appointed as an early detector of hypovolemia [2]. Still, caution has 
been recommended for its employment in certain conditions, as during 
pulmonary hypertension (PH) [2,3]. Endotoxin-induced PH produces 
biphasic increase in mean pulmonary artery pressure (MPAP) in several 
animal models, in which the early phase is acute and transient [4]. The 
objective of this study was to analyze the early hemodynamic eff  ects of 
endotoxemia on PPV, during severe hypovolemic shock.
Methods  Fifty-one anesthetized, mechanically ventilated pigs 
were randomly allocated to four groups: control (n = 8), intravenous 
endotoxin (n  =  8), hemorrhagic shock (50% blood volume in 
20 minutes; HEM, n = 8) or hemorrhagic shock with endotoxin (H+L, 
n = 27). Hemodynamic parameters, measured by pulmonary artery 
and femoral arterial catheters, were assessed at baseline (TB) and at 20 
(T20), 40 (T40), 60 (T60) and 80 (T80) minutes. Groups and times were 
compared with two-way ANOVA followed by Tukey test (P <0.05).
Results At T20, the systolic volume index in groups HEM and H+L 
dropped signifi  cantly (P <0.001), with no diff  erence between groups. 
MPAP was signifi   cantly higher in group H+L than in HEM at T20 
(P <0.001), T40 (P <0.001), T60 (P = 0.009) and T80 (P = 0.013). Within 
group H+L, MPAP was signifi  cantly above TB in all timepoints, but was 
highest at T20 and T40 (36 ± 13 and 34 ± 7 mmHg, respectively), decreasing 
signifi  cantly at T60 and T80 (to 26 ± 5 mmHg). PPV increased signifi  cantly in 
groups HEM and H+L (both P <0.001) from T20 to T80. There was, however, 
a statistical diff  erence between HEM and H+L at T20 (27 ± 13% vs. 20 ± 8%, 
respectively; P = 0.044) and T40 (27 ± 7% vs. 18 ± 7%; P = 0.006), which 
disappeared at T60, when PPV in group H+L increased further.
Conclusions Even though PPV was aff  ected by the magnitude of MPAP 
during the peak hemodynamic eff  ects of early endotoxemia, its ability to 
detect acute decreases in preload was not entirely compromised, in the 
conditions of the present study. Additional research should help determine 
possible associated factors that interfere with PPV in related conditions.
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Introduction Pulse pressure variation (PPV) and stroke volume varia-
tion (SVV) are indices of fl  uid responsiveness. We tested whether delta 
central venous pressure (δCVP) could be used to see if enough volume 
has been given in order to produce a response in SV and therefore 
improve the accuracy of PPV and SVV [1].
Methods  Forty-nine fully ventilated patients in sinus rhythm were 
admitted postoperatively to the ICU monitored with pulse power 
analysis (PulseCO; LIDCO, Cambridge, UK). Fluid challenge (FC) 
consisted of 250 ml colloid over 5 minutes. Responder: SV increase 
>10%. δCVP was used to defi  ne two groups of patients: A (δCVP 0 to 
1  mmHg) and B (δCVP >2).
Results Eighty-two FCs were performed. There were 33% responders 
in A versus 36% in B (not signifi  cant). For A + B, SVV and PPV AUCs were 
0.81 and 0.78. There was no statistically signifi  cant diff  erence in the 
AUC for SVV and PPV between A and B, but there were diff  erent best 
cut-off   values (Table 1).
Table 1 (abstract P49)
All  AUC groups A + B,   AUC group A, 
patients best  cut-off   groups A + B  best cut-off   group A
SVV  0.81 (SE 0.06), 11.5% (77%/76%)  0.89 (SE 0.07), 15.5% (88%/88%)
PPV  0.78 (SE 0.06), 13.5% (75%/76%)  0.84 (SE 0.09), 15.5% (81%/75%)
Conclusions Our data suggest that SVV/PPV effi   cacy in predicting a 
fl  uid response cannot be improved by looking at δCVP. More patients 
are needed to investigate the relationship between δCVP and best cut-
off   values for SVV and PPV.
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Introduction  Volume expansion is often used in anesthesia and 
critical care to improve oxygen delivery and, in mechanically ventilated 
Figure 1 (abstract P47). Bland–Altman analysis of COtptd and COmpa.
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to aid in the assessment of the appropriate amount of fl  uids to be 
administered to this end [1]. The objective of this study was to compare 
PPV with conventional parameters as guides to resuscitation, in an 
experimental model of severe hemorrhagic shock with endotoxemia.
Methods Twenty-seven anesthetized, mechanically ventilated pigs were 
submitted to acute hemorrhagic shock with infusion of endotoxin. 
Animals were randomly allocated to three groups: control (n  =  9); 
conventional treatment with lactated Ringer’s (LR) to achieve and 
maintain central venous pressure (CVP) ≥12 mmHg, mean arterial 
pressure (MAP) ≥65 mmHg and SvO2 ≥65% (CNV, n = 9); or LR to achieve 
and maintain PPV ≤13% and MAP ≥65 mmHg (dPP, n = 9). Hemodynamic 
parameters, measured by pulmonary artery catheter and femoral 
arterial catheter, and blood gases were assessed at baseline (TB), 1 hour 
after hemorrhage (TS), and hourly during the treatment period (T1 to 
T3). Groups and times were compared with two-way ANOVA followed 
by Tukey test and t test was used for comparisons of treatment times 
and LR amounts (P <0.05).
Results At TS all groups presented equivalent, signifi  cant decreases 
in cardiac index (CI), MAP, CVP, SvO2 and oxygen delivery index (DO2I) 
and an increase in PPV (all P  <0.001). At T3, both treated groups 
presented hemodynamic recovery, with no statistical diff  erence from 
TB or each other for CI, MAP, SvO2, DO2I or PPV. Statistically, there 
were no diff  erences in times or amounts of LR to achieve endpoints, 
for maintenance or in total amounts of LR given. The only statistical 
diff  erence between treatment groups involved CVP, which was higher 
in group CNV than in group dPP at T2 (P = 0.009) and T3 (P <0.001). CVP 
was also higher at T3, in group CNV, when compared with TB (P = 0.006).
Conclusions Although early fl  uid management guided by PPV yielded 
similar hemodynamic results to those achieved by management 
through conventional parameters, a diff   erence could be noted 
regarding CVP, which was maintained higher in group CNV, but was 
restored to baseline values by PPV-guided therapy. The clinical impacts 
of such occurrences remain to be determined.
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Introduction  Closed-loop management of fl   uid resuscitation has 
historically been diffi     cult. Given the dynamic predictors of fl  uid 
responsiveness, automated management is now feasible. We present 
simulation data for a novel patient-adaptive closed-loop fl  uid 
management algorithm using pulse pressure variation (PPV) as the 
input variable.
Methods Using a simulator that includes physiologic PPV output, 20 
practicing anesthesiology residents and faculty were asked to manage 
fl  uids and pressors for a 1-hour simulated hemorrhage case of 2 l blood 
loss over 20 minutes (group 1). One week later, they repeated the 
simulation, but this time fl  uids were secretly managed by the closed-
loop system while practitioner fl  uid administrations were ignored and 
only the pressors were entered (group 2). The simulation was also run 
20 times with only the closed-loop (group 3) and 20 times with no 
management (group 4).
Results Conditions across all groups were similar at baseline for simu-
lated patient weight, height, heart rate (HR), mean arterial pressure 
(MAP), and cardiac output (CO). Once the hemorrhage began, the 
closed loop groups (2 and 3) intervened signifi  cantly earlier than the 
practitioners (group 1) and gave more fl  uid. The mean and fi  nal CO was 
higher in both closed-loop groups than in the practitioner group, and 
the coeffi   cient of variance was lower. There was no diff  erence in MAP 
between intervention groups, but all were signifi  cantly higher than the 
unmanaged group. See Figure 1.
Conclusions Our data demonstrate that closed-loop management of 
fl  uid resuscitation is feasible using our novel dynamic-parameter based 
algorithm and that this approach can be used to optimize cardiac 
output.
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Introduction  Respiratory variations in pulse pressure (PPV) during 
mechanical ventilation predict fl  uid responsiveness when the tidal 
volume is >8 ml/kg [1]. The eff  ect of airway pressure on the ability 
of PPV to predict fl  uid responsiveness is less explored. In patients 
undergoing major abdominal surgery, we found low specifi  city of PPV 
and therefore explored the relation between peak airway pressure 
(Paw) and PPV in fl  uid challenge nonresponders.
Methods  Twenty-fi   ve patients scheduled for open abdominal 
surgery with volume controlled ventilation 8 ml/kg, I:E ratio 1:2 and 
PEEP 5 cmH2O were included. Fluid challenges of 250 ml colloid 
were administered at the discretion of the anesthesiologist. PPV, 
hemo  dynamic variables, Paw and stroke volume (SV) measured by 
oesophageal Doppler were recorded before and after fl  uid challenges. 
Responders were defi  ned by an increase in SV >15%.
Results Thirty-four fl  uid challenges were performed. Further data are 
from analysis of nonresponders; 12 fl  uid challenges in 11 patients. 
Figure 1 (abstract P51). Data are mean ± SD. *P <0.05 versus groups 2, 3, 
4; **P <0.05 versus groups 1 and 4.
Figure 1 (abstract P52). PPV versus peak airway pressure before fl  uid 
challenge in nonresponders.
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7.4 (6.2 to 15.2)% to 6.0 (4.4 to 9.8)% (median, 25th to 75th percentiles), 
whereas Paw and SV were unchanged. Before fl  uid challenge, Paw was 
signifi  cantly correlated with PPV (r = 0.91, P <0.001) (Figure 1).
Conclusions In this study on patients undergoing open abdominal 
surgery ventilated with 8 ml/kg, specifi  city of PPV was low. Paw and 
PPV were strongly correlated and false positive PPVs were associated 
with high Paw. This fi  nding indicates that not only tidal volume, but 
also airway pressures may aff  ect the ability of PPV to predict fl  uid 
responsiveness.
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Introduction The aim of this study was to assess and compare the 
ability of the automatically and continuously measured pulse pressure 
variation (PPV) obtained by an IntelliVue MP monitor and stroke 
volume variation (SVV) measured by FloTrac™/Vigileo™ to predict fl  uid 
responsiveness in septic shock patients.
Methods  We conducted a prospective study on 42 mechanically 
ventilated septic shock patients. SVV, PPV and other hemodynamic 
data were recorded before and after fl  uid administration with 500 ml of 
6% tetrastarch. Responders were defi  ned as patients with an increase 
in cardiac index ≥15% after fl  uid loading.
Results  The agreement (mean bias  ±  SD) between PPV and SVV 
was –0.59 ± 1.72% (Figure 1). The baseline PPV correlated with the 
baseline SVV (r = 0.96, P <0.001). Twenty-seven (64.3%) patients were 
classifi  ed as fl  uid responders. PPV and SVV were signifi  cantly higher 
in responders than in nonresponders (16.2  ±  4.9 vs. 7.1  ±  2% and 
15.3 ± 4.3 vs. 6.9 ± 1.9%, respectively, P <0.001 for both). There was no 
diff  erence between the area under the receiver operating characteristic 
curves of PPV (0.983) and SVV (0.99). The optimal threshold values to 
predicting fl  uid responsiveness were 10% for PPV (sensitivity 92.6%, 
specifi  city 86.7%) and 10% for SVV (sensitivity 92.6%, specifi  city 100%).
Conclusions The automated PPV, obtained by the Intellivue MP 
monitor, and the SVV, obtained by FloTrac™/Vigileo™, showed 
comparable performance in terms of predicting fl  uid responsiveness in 
mechanically ventilated patients with septic shock.
References
1. Cannesson  M,  et al.: Anesth Analg 2008, 106:1195-1200.
2. Derichard  A,  et al.: Br J Anaesth 2009, 103:678-684.
P54
Dynamic indices of preload in postcardiac surgery patients by pulse 
power analysis
E Barbon, F Caliandro, J Kamdar, M Puntis, H Meeran, A Rhodes, 
A Dewhurst, M Cecconi
St Georges Hospital, London, UK
Critical Care 2011, 15(Suppl 1):P54 (doi: 10.1186/cc9474)
Introduction The ability to predict fl  uid responsiveness during the 
perioperative period is important in order to minimize the risk of 
hypovolemia and fl  uid overload. We studied the ability of dynamic 
indices [1] such as pulse pressure variation (PPV) and stroke volume 
variation (SVV) measured with the LiDCO™rapid to predict the response 
in stroke volume (SV) after a fl  uid challenge (FC).
Methods This was a prospective observational study of FCs (250 ml 
colloid given in less than 5 minutes) in the immediate postoperative 
period in cardiac surgery patients. A positive response to a FC was 
defi  ned as an increase in SV >10% measured with LiDCO™rapid. FCs were 
repeated according to the unit protocol. PPV and SVV were recorded 
before FC, together with static haemodynamic measurements: mean 
arterial pressure (MAP), central venous pressure (CVP) and heart rate 
(HR). Receiving operator characteristic (ROC) analysis was performed 
in order to identify haemodynamic variables suitable to predict fl  uid 
responsiveness.
Results Sixteen patients were enrolled; fi  ve females, 11 males, age 70 
(±11) years, weight 82 (±13) kg, height 167 (±10) cm. Of the 16 patients, 
seven (44%) were fl  uid responders to the fi  rst FC. A total number of 47 
FCs were given. There were no diff  erences in HR, CVP and MAP between 
responders and nonresponders. PPV and SVV were signifi  cantly 
diff  erent between responders and nonresponders. Areas under the 
curve for ROC curves were: for PPV 0.76 (0.61 to 0.92), P = 0.003, and for 
SVV 0.80 (0.67 to 0.93), P = 0.0006. The best cut-off   values (sensitivity 
and specifi   city) to predict a SV increase >10% after FC were: PPV 
>13.5% (79%, 72%), and SVV >10.5% (84%, 68%).
Conclusions Dynamic indices measured by LiDCO™rapid have a high 
sensitivity and specifi  city in predicting fl  uid responsiveness in fully 
sedated and mechanically ventilated patients postcardiac surgery.
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Introduction Cardiac cycle effi   ciency (CCE) can be calculated by the 
pressure recording analytical method (PRAM), a mini-invasive pulse-
contour system that can provide beat-to-beat monitoring of cardiac 
output [1]. CCE is a new parameter that ranges from –1 to +1, with –1 
being the worse and +1 the best possible performance of the cardiac 
cycle in terms of hemodynamic balance maintenance [2]. These 
characteristics make CCE a possible prognostic index, especially in 
critical patients who often present hemodynamic instability.
Methods  We recruited 157 consecutive patients admitted to the 
ICU undergoing hemodynamic monitoring, and the following 
parameters were registered in the fi  rst 24 hours from the admission: 
hemodynamic parameters (cardiac index, dp/dtmax and CCE) detected 
from the MostCare monitor (based on the PRAM algorithm), PaO2/FiO2 
ratio, arterial lactates, SAPS II. We also divided the patients into seven 
diagnostic categories and take note of the outcome.
Results We inserted all data into the logistic regression analysis model. 
The signifi  cant variables that take place in the regression equation 
Figure 1 (abstract P53). Bland–Altman analysis for the agreement 
between SVV and PPV.
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and the diagnostic category (P = 0.020). CCE was not signifi  cant and 
was not included in the model. See Table 1.
Conclusions We demonstrate that CCE registered in the fi  rst 24 hours 
from admission is not a good prognostic index. The diff  erences of 
CCE value between patients with good and negative outcome was 
not statistically signifi  cant. This result may suggest that a low CCE 
value in 24 hours from admission does not necessarily mean a bad 
outcome but, on the contrary, can be successfully improved by a 
therapeutic approach. It will be interesting to study whether there are 
some correspondences between CCE variations and modifi  cations of 
the clinical conditions of the patients that may predict a positive or 
negative outcome.
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Introduction Pulse pressure variation (PPV) has been shown to predict 
preload fl  uid responsiveness in mechanically ventilated patients [1]. 
Inhalant anesthetic agents have dose-dependent hemodynamic and 
direct myocardial contractility eff  ects. The aim of this study was to 
compare the behavior of PPV under desfl  uorane, sevofl  uorane and 
isofl  uorane anesthesia.
Methods  Twenty-four anesthetized and mechanically ventilated 
pigs were randomly assigned into three groups of eight animals: 
desfl  uorane (DESF), sevofl  uorane (SEVO) and isofl  uorane (ISO). Static 
hemodynamic parameters and PPV, measured by pulmonary artery 
and femoral arterial catheters, were assessed at baseline (T1) using 1 
MAC of the volatile agent; T2 (1.25 MAC); T3 (1 MAC) and T4 (1.0 MAC 
associated with a 30% hemorrhage of estimated average volemia). Two-
way ANOVA and Tukey test were used for statistical analysis (P <0.05).
Results  At T2 there was an increase in PPV in all groups but not 
statistically signifi  cant compared with T1 or among groups. At T4 the 
increase in PPV was signifi  cant compared with basal values in the three 
groups: DESF (11 ± 4 vs. 7 ± 2%, P <0.001); SEVO (15 ± 5 vs. 6 ± 2%, 
P <0.001) and ISO (14 ± 5 vs. 7 ± 3%, P <0.001). No statistical diff  erence 
between groups was found for PPV. Mean arterial pressure (MAP) 
decreased after 25% increment of MAC (T2) and after hemorrhage. At 
T4, MAP decreased signifi  cantly lower than basal values (T1) in groups 
DESF (P <0.001), SEVO (P <0.001) and ISO (P <0.001). Cardiac index (CI) 
decreased in T2 compared with T1: DESF (3.6 ± 0.6 vs. 2.9 ± 0.5 l/min/
m2, P <0.001), SEVO (4.0 ± 0.1 vs. 3.1 ± 0.4 l/min/m2, P <0.001) and ISO 
(4.2 ± 0.1 vs. 3.6 ± 0.9, P <0.001). The CI drop after hemorrhage showed 
no statistical diff  erence when compared with T1.
Conclusions PPV behaved similarly with diff  erent inhaled anesthetics. 
Although PPV did not refl   ect the hemodynamic depression of 
incrementing MAC values, it increased after bleeding 30% of estimated 
volemia.
Acknowledgements Grants received were FAPESP 08/57247-0 and 
08/57248-6.
Reference
1. Michard  F:  Anesthesiology 2005, 103:419-428.
P57
E/Ea ratio could not predict fl  uid response in ICU mechanically 
ventilated patients
J Cousty1, A Mari2, P Marty1, B Riu1, P Sanchez1, O Mathe1, J Ruiz1, S Silva1, 
F Vallée1, M Génestal1, O Fourcade1
1Reanimation polyvalente CHU Purpan, Toulouse, France; 2CHU Purpan, 
Toulouse, France
Critical Care 2011, 15(Suppl 1):P57 (doi: 10.1186/cc9477)
Introduction  Transthoracic echocardiography (TTE) is now widely 
used in the ICU to assess hemodynamic status. Combined mitral 
index measured by TTE, as the mitral Doppler infl  ow E wave velocity 
to annular tissue Doppler Ea wave velocity ratio (E/Ea), is a reliable 
diastolic indicator in cardiologic patients. In ICU, E/Ea has only been 
investigated as a pulmonary arterial occlusion pressure surrogate 
which poorly refl  ects fl  uid responsiveness (FR). Therefore, the aim of 
this study was to evaluate the reliability of E/Ea to FR in the setting of 
ICU ventilated patients.
Methods  We carried out a TTE prospective observational study 
in mechanically ventilated patients receiving fl   uid challenge for 
circulatory failure. Complete TTE examination involving stroke volume 
(SV) estimation, mitral and tissue Doppler measurements (E, A, Ea, Aa 
velocities) were performed at end-expiratory time, before and after a 
500 ml saline solution over 15 minutes of fl  uid challenge. A positive 
hemodynamic response was defi  ned as a 15% minimal increment of 
SV. General characteristics, mitral parameters and combined index (E/A 
and E/Ea) were compared between responders (R) and nonresponders 
(NR) (using Student t test or chi-square test, ROC analysis and LHR 
method).
Results Ninety-four case-mix patients were enrolled: 43 R and 51 NR, 
with similar baseline characteristics. LV ejection fraction was: altered 
(<50%) n = 24, or preserved (>50%) n = 69, with no diff  erence (R vs. NR). 
E/Ea values before fl  uid loading were not statistically diff  erent between 
R and non-NR for which we observed a huge overlap (7.4 ± 2.4 vs. 
8.4 ± 3.1 R vs. NR; P = 0.09). The results were similar when considering 
the population with baseline under the median value; that is, E/Ea <8: 
28 R versus 24 NR, E/Ea = 6.0 ± 1.5 versus 5.6 ± 1.5 R versus NR, P = 0.28. 
The E/A index was signifi  cantly lower in R (1.1 ± 0.4 vs. 1.3 ± 0.4; P <0.01) 
but poorly predicted FR: ROC curve AUC = 0.64 (0.54 to 0.74), best cut-
off  : 0.8 (LHR+ 3.1; LHR– 0.7). Extreme values were predictive in our 
population: R was likely with E/A <0.6 (Sp 100%, LHR+ >5) and unlikely 
with E/A >1.8 (Se 100%, LHR– <0.2).
Conclusions  The E/Ea ratio is not statistically diff  erent  between 
responders and nonresponders in the ICU and no low discriminant 
threshold value of E/Ea could identify patients likely to respond to fl  uid 
expansion. While E/A is statistically signifi  cant, only extreme values 
could be clinically relevant (<0.6 or >1.8).
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Introduction The reliability of the pulse contour methods (PCMs) in 
cardiac output (CO) monitoring has been questioned when changes 
in arterial tone occur spontaneously (for example, pain, hypovolemia) 
or after a therapeutic intervention (for example, nitroglycerin, nor-
epinephrine). The purpose of this study was to compare the CO values 
assessed with the MostCare system (Vygon, Padova, Italy) (MC-CO) with 
those obtained with transthoracic echocardiography (Esaote Mylab 70, 
Genova, Italy) (TTE-CO) in trauma patients treated with norepinephrine.
Methods Twenty-seven adult trauma patients admitted to a seven-
bed ICU and requiring norepinephrine infusion were enrolled in the 
study. Inclusion criteria were: age >18, no aortic valve pathologies, 
sinus rhythm. TTE-CO and MC-CO were evaluated simultaneously 
Table 1 (abstract P55). Results of logistic regression analysis
Variable Signifi  cance  Odds ratio
dp/dtmax 0.032  0.191
SAPS II  0.0001  1.174
Diagnostic category  0.020 
Lactates 0.033  1.018
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raising mean arterial pressure to 90 mmHg by starting norepinephrine 
infusion (T2). The MostCare system, an uncalibrated PCM, was 
connected directly to the main monitor of the patient for the analysis 
of the radial artery pressure wave. Bland–Altman and linear regression 
analyses were performed.
Results  Fifty-four paired CO values were obtained; TTE-CO values 
ranged from 2.9 to 6.8 l/minute and MC-CO from 2.8 to 6.9 l/minute. At T1 
the mean bias between the techniques was –0.07 l/minute (2SD = 0.69 
l/minute), with a percentage of error (PE) of 15% and R = 0.9; at T2 the 
mean bias between the techniques was –0.13 l/minute (2SD = 0.83 l/
minute), PE was 17% and R = 0.88. Overall, a good correlation between 
TTE-CO and MC-CO was observed (R = 0.9, P <0.01), with a mean bias of 
–0.10 l/minute (2SD ± 0.76 l/minute), 95% limits of agreement of –0.86 
to 0.66 l/minute, and a PE of 16%. Mean arterial pressure was 82.2 ± 11.6 
mmHg at T1 and 94.1 ± 3.8 mmHg at T2 (P <0.05). Heart rate did not 
change signifi  cantly from T1 to T2 (78.9 ± 13.6 bpm vs. 78.3 ± 18.7 bpm, 
respectively, P >0.05). Mean dosage of norepinephrine was 0.22 ± 0.1 
μg/kg/minute (range 0.1 to 0.65 μg/kg/minute).
Conclusions MC-CO values showed a good agreement with TTE-CO at 
the two diff  erent hemodynamic states of trauma patients. Under the 
studied conditions, the reliability of the MostCare system seemed not to 
be aff  ected by the changes in vascular tone induced by norepinephrine 
infusion.
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Introduction Postoperative hemodynamic optimization (PHO) [1] can 
be performed with mini invasive devices that showed diff  erent level 
of agreement when compared with the pulmonary artery catheter 
[2]. The aim of the study was to evaluate the concordance on stroke 
volume index changes (ΔSVI) obtained from calibrated (LiDCO™plus) 
and uncalibrated pulse contour (Vigileo™) devices in a surgical patient 
cohort during early PHO.
Methods The setting was a prospective study in the ICU of a university 
hospital. Twenty-seven patients undergoing abdominal surgery and 
a PHO protocol were enrolled. We compared the paired SVI values 
obtained by the two devices 30 seconds before and 2 minutes after 
ending a volume challenge (VC) of HES 130/0.4 (3 ml/kg). In the protocol 
a SVI increase >5% after volume expansion defi   ned a responder 
patient. Concordance of the response in terms of SVI direction of 
changes detected by each monitor (Vigileo-SVI and LiDCO-SVI) was 
analysed as proposed by Critchley and colleagues [3]. A Bland–Altman 
plot was used to defi  ne bias and accuracy between SVI obtained from 
the studied devices.
Results  The mean bias between LiDCO-SVI and Vigileo-SVI was 
1.16  ml/m2 with SD of 12.51 ml/m2. The 95% limit of agreement was 
from –23.36 to 25.68 ml/m2. During all of the study period 47 VCs were 
administered. In eight out of 27 patients also 13 dobutamine tests were 
performed. The two devices showed the same direction of changes in 
78% of the cases. In detail, they showed the same direction in 83% of 
cases after VC and in 62% of cases after dobutamine administration. 
Among the concordant data pairs, the devices agreed in 81% of cases 
to defi  ne responder and nonresponder and in 82% and 75% of cases 
after VC and dobutamine tests, respectively.
Conclusions LiDCO™plus and Vigileo™ tests during a PHO protocol 
identifi  ed the same direction of changes in 78% of cases. Among this 
78%, the devices agreed both in 81% of cases to defi  ne responder and 
nonresponder.
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Introduction  Pulse wave velocity (PWV) is defi  ned as the speed of 
conduction of a pressure wave generated by cardiac systole through 
the arterial tree. It may be non-invasively estimated from the pulse 
transit time that is measured as the interval between the R wave 
on an electrocardiogram and fi  rst  infl   exion point of the paired 
plethysmographic wave recorded from a fi  nger pulse oximeter [1]. Within 
a simple two-component Windkessel model of the arterial system, PWV 
is proportional to the square root of arterial elastance [2]. Elastance is 
defi  ned as the ratio of pulse pressure (PP) to stroke volume (SV). PWV 
might therefore provide a non-invasive estimate of cardiac output.
Methods  Adult patients undergoing major elective surgery were 
eligible. PWV was recorded using HypnoPTT (Nelco Puritan-Bennet). 
Invasive arterial blood pressure measurements were preferred when 
available. Stroke volume was measured via ODM (Deltex Ohmeda). 
Values were recorded every 5 minutes, smoothed (median of fi  ve 
consecutive values) and converted to the centimetre gram second 
system. SV was derived from PWV: SVPWV  PWV2 x PP–1.
Results  Eleven patients (aged 45 to 74 years; fi  ve men, six women) 
were enrolled. Data are presented as (mean, SD). PWV was successfully 
measured on 287 occasions (324 cm/second, 48.5). SVPWV was calculated 
(62.4 ml, 18.3). SVODM values were (88.7, 4.86). Individual plots of SVPWV 
and paired SVODM were generated for each patient (Figure 1).
Conclusions Estimated SVPWV values were within a clinically expected 
range; however, visual inspection of the plots demonstrated no 
relationship between SVPWV and gold standard SVODM. Furthermore 
there was no relationship between raw PWV data and SVODM. It is 
possible that PWV recordings were unreliable. The limited range of 
SVODM will have compressed our data, making any relationship less 
evident. We conclude SVPWV is not an accurate estimate of SVODM.
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Figure 1 (abstract P60). Stroke volume during the fi  rst 90 minutes of 
surgery.
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Introduction This study compares the ability of two arterial waveform 
monitors, the calibrated PiCCOplus and the nomogram scaled 
LiDCOrapid, to detect fl   uid responsiveness using the functional 
hemodynamic parameters stroke volume variation (SVV) and pulse 
pressure variation (PPV) in a surgical ICU population (ventilated, closed 
chest). The passive leg raising test (PLRT) is an alternative reversible test 
that can be carried out before administering volume.
Methods  We recruited 20 patients who had undergone major 
abdominal or neurosurgery and 10 patients in the SICU with progressive 
circulatory instability. The femoral artery was cannulated to obtain the 
arterial blood pressure waveform. Simultaneous measurements were 
made at four time points, M1 to M4: (M1) baseline, (M2) after PLRT, (M3) 
baseline (M4), after 500 ml Tetraspan® 6% over 10 minutes via pressure 
infusion. The PiCCO was calibrated via transpulmonary thermodilution 
at each time point. A change in SV >10% was considered as volume 
responsive.
Results Data were collected from 30 patients, age 31 to 90, ASA 2 (2), 
ASA 3 (24) or ASA 4 (4), BSA 1.54 to 2.52 m2. Patients were ventilated 
with at least 6 ml/kg (IBW), and RR of 10 to 15/minute. PiCCO identifi  ed 
15 patients as responders (50%) and LiDCO identifi  ed 18 patients as 
responders (60%) to the fl  uid challenge, both within the normal range 
of established studies. ROC curve analysis results are shown in Figure 1. 
Bland–Altman analysis comparing the PPVL with SVVL and SVVP give 
a bias of 0.3% and 0%, and limits of agreement of ±3.8% and ±4.4%, 
respectively.
Conclusions This study has demonstrated that SVV, PPV, and PLRT to 
a lesser extent, are eff  ective for predicting volume response and can 
be used perioperatively for fl  uid management as part of goal-directed 
therapy. The sensitivity and specifi  city of the SVVL and PPVL were both 
greater than the SVVP. This is probably due to the diff  erence in each 
algorithm’s ability to identify responders to the fl  uid challenge.
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Introduction This study aims to compare two arterial pressure wave-
form monitors: the nomogram scaled LiDCOrapid (LiDCO Ltd, London, 
UK) with the calibrated PiCCOPlus, (Pulsion, Munich, Germany), to 
determine agreement for cardiac index (CI) measurement and trending 
during positional changes of passive leg raise test (PLRT) and volume 
expansion in the SICU.
Methods  We recruited 20 patients who had undergone major 
abdominal or neurosurgery and 10 patients in the SICU with progressive 
circulatory instability. The femoral artery was cannulated to obtain the 
arterial blood pressure waveform. Simultaneous measurements were 
made at four time points, M1 to M4: (M1) baseline, (M2) after PLRT, (M3) 
baseline (M4) after 500 ml Tetraspan® 6% over 10 minutes via pressure 
infusion. The PiCCO was calibrated via transpulmonary thermodilution 
at each time point.
Results Data were collected from 30 patients, age 31 to 90, ASA 2 (2), 
ASA 3 (24) or ASA 4 (4), BSA 1.54 to 2.52 m2. CI ranged from 1.5 to 7.2 l/
minute/m2 for PiCCO and from 1.5 to 7.1 l/min/m2 for LiDCO. Regression 
plots were made at each time point and show good agreement across 
the full range of CI values (r2 = 0.89 to 0.95). Bland–Altman analysis at 
each time point found low bias (10 to 50 ml/min/m2) and acceptable 
limits of agreement (16 to 30%), with the greatest diff  erence occurring 
after the PLRT. Trending analysis was conducted by four-quadrant plot 
concordance assessment using an optimised exclusion zone of <5% 
ΔCI on changes at timepoints M2 to M4 relative to baseline (M1). 
Concordance was calculated as 97.8% overall agreement (44/45) for ΔCI 
>5%. Regression analysis found a high degree of correlation (r2 = 0.86 
to 0.92) and all intercepts equal to 0.
Conclusions  In a heterogeneous patient population, LiDCOrapid 
CI values are in agreement with PiCCO CI values according to the 
accepted standard of ±30% with minimal bias. Trending analysis 
showed excellent concordance of 97.8%, which meets the recently 
proposed standard of >90% [1]. The LiDCOrapid is a valid measure 
of CI and trends in CI. It is easier to set up, does not require central 
venous access, is independent of the arterial site and can be used both 
intraoperatively in the OR and in the ICU.
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Introduction  Hemodynamic monitoring is important for diagnosis 
and therapy of critically ill patients. Thermodilution is now the gold 
standard method; however, it cannot be used routinely since it is very 
invasive. We investigated the agreement between the cardiac index (CI) 
obtained by mini-invasive monitor MostCare, based on the pressure 
recording analytical method (PRAM), and by PiCCO thermodilution in 
hemodynamic unstable patients.
Methods  We performed a prospective clinical study at our university 
hospital ICU. Twenty adult patients with hemodynamic instability were 
enrolled. All patients were sedated and mechanically ventilated with 
intermittent positive pressure ventilation. The MostCare and PiCCO systems 
were connected to each patient by a catheter inserted into the femoral 
artery. For each patient three measurements of CI were simultaneously 
carried out and the mean was considered for statistical analysis.
Results  We enrolled 10 severe sepsis/septic shock, four interstitial 
pneumonia, three COPD, one subarachnoid hemorrhage, one abdomi-
nal compartment syndrome, and one polytrauma. The age range 
Figure 1 (abstract P61).
Figure 1 (abstract P63). Linear regression analysis between PRAM-CI and 
PiCCO-CI.
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(25 ± 6) and SAPS II score range was 22 to 81 (50 ± 16). The correlation 
coeffi   cient between PRAM-CI and PiCCO-CI was 0.95 (95% CI = 0.89 to 
0.99; P <0.001) (Figure 1). The Bland–Altman analysis showed a mean 
diff  erence between the two methods (bias) of 0.67 ± 0.38 l/minute/
m2 with lower and upper 95% limits of confi  dence of –0.07 and 1.41 l/
minute/m2, respectively (Figure 2). The percentage of error was 22%.
Conclusions This study showed a suffi   cient agreement between the 
two techniques. MostCare could be a useful fi  rst-level  monitoring 
system, particularly in the fi  rst phase of critically ill patients’ care or 
when more invasive systems are not advisable.
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Introduction Variation in stroke volume (SV) or related parameters 
induced by passive leg raising (PLR) measured by several non-
invasive methods has been demonstrated to reliably predict fl  uid 
responsiveness [1]. The aim of this study was to assess whether 
variation in SV measured by LiDCO can predict fl  uid responsiveness in 
shock states.
Methods  ICU patients with signs of shock were enrolled. History, 
clinical information and echocardiogram were obtained. After 
calibra  tion, hemodynamic evaluation was performed by LiDCO in 
four subsequent steps: T1 in semi-recumbent position; T2 during 
PLR; T3 in baseline position; T4 after infusion of 500 ml NaCl 0.9% in 
15 minutes. On each step, the heart rate (HR), mean arterial pressure 
(MAP), absolute and indexed cardiac output and stroke volume (CO/CI, 
SV/SVI) were measured by LiDCO and the aortic velocity time integral 
(VTI) by transthoracic echocardiography. Patients whose SVI increased 
at least 10% after volume load were classifi   ed as responders. The 
ability to predict responder state was assessed for four potential fl  uid 
responsiveness indices: variation in SVI, CO, CI and VTI induced by PLR 
(ΔSVI-PLR, ΔCO-PLR, ΔCI-PLR, ΔVTI-PLR) by means of three statistical 
methods: comparison (Mann–Whitney) between the mean value 
of index in responders and nonresponders, correlation (Spearman) 
between the baseline value of index and increase in SVI after fl  uids, and 
the receiver operator characteristic (ROC) curve.
Results Fifteen determinations were collected in 13 patients in septic, 
cardiogenic and hypovolemic shock (males 9/13, age 73.2 ± 5.8, ejection 
fraction 54% ± 8). Ten patients had spontaneous breathing activity, 
fi  ve had arrhythmias, 11 were under inotropes. The responder rate 
was 46.7%. Among the studied indices, only ΔSVI-PLR was signifi  cantly 
diff  erent in responders and nonresponders (26.9 vs. 1.9, P <0.001). Three 
indices, ΔSVI-PLR, ΔCO-PLR and ΔCI-PLR, were signifi  cantly correlated 
with increase in SVI after fl  uids (rho = 0.854 (P <0.001), 0.727 (P = 0.002), 
0.710 (P = 0.003)). ΔSVI-PLR correctly predicted responders state in all 
cases with a threshold of 9.1%, (sensitivity 100%, specifi  city 100%, area 
under the ROC curve (AUC) 1.00 (P <0.001 95% CI = 1.00 to 1.00)). The 
other indices had values of AUC not signifi  cantly diff  erent from 0.5.
Conclusions The ΔSVI-PLR, measured with the LiDCO system, is a very 
reliable predictor of fl  uid responsiveness in a population of ICU patients 
in shock, including patients with spontaneous breathing activity and 
arrhythmias.
Reference
1. Cavallaro  et al.: Intensive Care Med 2010, 36:1475-1483.
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Introduction  Profound hemodynamic changes seen in acute liver 
failure (ALF) resemble those found in later stages of septic shock. 
Vasopressor support is frequently required and indiscriminate fl  uid 
resuscitation can worsen intracranial hypertension (ICH) and lung 
injury. Markers of preload dependency have thus far not been studied 
in this patient group and response to dynamic manoeuvres such as 
passive leg raising or end expiratory hold cannot be considered safe 
due to the high incidence of ICH.
Methods ALF patients admitted to a tertiary specialist ICU in vasoplegic 
shock, requiring multiorgan support including controlled mechanical 
ventilation, had their cardiac output monitored via transpulmonary 
thermodilution and pulse contour analysis (PiCCO). Markers of fl  uid 
responsiveness were compared between responders (CI ≥15%) and 
nonresponders to a colloid fl  uid challenge (5 ml/kg IBW). All patients 
had a transthoracic echocardiogram performed before and after fl  uid 
administration. The predictive capacity of stroke volume, pulse pressure 
variation (SVV, PPV) and respiratory change in peak aortic velocity ΔV 
peak for preload dependency was analyzed.
Results Twenty-six patients (mean age 40 (13), 15 male:11 female) were 
assessed, mean APACHE II 23 (4) and SOFA 15 (2). Changes in CI and SVI 
were closely correlated (R = 0.726, P <0.001). There was no diff  erence 
between those defi  ned as responders using a cut-off   value of CI or SVI 
of 10%. When using 15%, seven patients would have been classifi  ed 
diff  erently. The intraclass correlation coeffi   cient for CI and SVI change 
was 0.83 (0.62 to 0.92), confi  rmed using Pasing and Blakock regression 
(A = –0.278, –0.88 to 0.16, B = 1.26, 0.88 to 1.72), suggesting hemodynamic 
changes in both measures are interchangeable. Using a cut-off   value of 
a change in CI of 15%, only PPV predicted fl  uid responsiveness (AUROC 
0.79, 0.58 to 0.93, P = 0.005, cut-off   >9%, sensitivity 75%, specifi  city 62%). 
SVV weakly predicted fl  uid responsiveness in this cohort (AUROC 0.73, 
0.52 to 0.87, P = 0.005, cut-off   >11%). While there was a trend toward 
reduction in ΔV peak (mean diff  erence –3%, P = 0.080) this was not 
diff  erent between those defi  ned as fl  uid responders by CI (repeated-
measures ANOVA P = 0.124) and ΔV peak prior to fl  uid bolus did not 
predict a CI response (AUROC 0.637, 0.413 to 0.825, P = 0.322).
Conclusions Baseline PiCCO parameters predict fl  uid responsiveness 
but the respiratory variability in ΔV peak did not predict a CI response 
to fl  uid bolus in this cohort. PPV may be a more suitable PiCCO index for 
assessing fl  uid requirements in patients with ALF than SVV.
P66
Functional haemodynamic monitoring: the relative merits of SVV, 
SPV and PPV as measured by the LiDCOrapid in predicting fl  uid 
responsiveness in high-risk surgical patients
C Willars, A Dada, D Green
Kings College Hospital, London, UK
Critical Care 2011, 15(Suppl 1):P66 (doi: 10.1186/cc9486)
Introduction Standard anaesthetic practice in the high-risk surgical 
patient is to insert invasive arterial and central venous catheters and then 
Figure 2 (abstract P63). Bland–Altman plot for comparison between 
PRAM-CI and thermodilution CI.
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of evidence to suggest that fi  lling pressures are inadequate predictors 
of fl  uid status and responsiveness. Recent interest has been directed 
towards dynamic measures of cardiac fi  lling such as SVV, SPV, PPV and 
Δdown and ΔVpeak. A number of large multicentre trials are underway 
using the LiDCOrapid. There is, however, little information about the 
utility of this device or, indeed, any other minimally-invasive cardiac 
output monitor in the prediction of fl  uid responsiveness.
Methods  The haemodynamic parameters of 70 high-risk patients 
(mean age 71  ±  11.3, median ASA 3) undergoing major vascular 
surgery (mean duration 4.2 ± 1.1 hours) were evaluated retrospectively 
using LiDCOviewPro. All patients underwent standard induction and 
maintenance of anaesthesia, with propofol/remifentanil TIVA and IPPV 
(tidal volume ≥7 ml/kg) via a supraglottic airway. Monitoring included 
BIS, NICO and LiDCOrapid. Fluids were administered according to 
clinical assessment of need and available haemodynamic parameters. 
Only fl  uid boluses given in the absence of HRV >10%, brisk ongoing 
blood loss and of volume ≥250 ml were included in the evaluation. 
Positive response to a fl   uid challenge was defi   ned as ΔSVI ≥10%. 
Statistical analysis was performed using SPSS 17.0.
Results  Thirty-two out of 43 valid fl   uid challenges were positive 
(74.4%). The correlation coeffi   cients between the baseline SVV, SPV and 
PPV with ΔSVI were 0.27 (P = 0.08), –0.01 and 0.18 (nonsignifi  cant). The 
AUROCs were 0.75 (95% CI = 0.57 to 0.93), 0.587 (0.36 to 0.82) and 0.67 
(0.48 to 0.86), respectively. The best cut-off   value for SVV using Youden’s 
index was 13.5%, with J = 0.48. The positive likelihood ratio was 2.74 
and the negative likelihood ratio 0.34, with diagnostic odds ratio 8.06 
at this level.
Conclusions It has been reported that only 50% of critically unwell 
patients respond to fl   uid challenge, compared with 74.4% in this 
intraoperative study of noncardiac surgical patients. The SVV was an 
adequate predictor of fl  uid responsiveness. The diagnostic threshold of 
13.5% was consistent with previous studies.
P67
Pressure recording analytical method for cardiac output monitoring 
in children with congenital heart disease
Z Ricci
Bambino Gesù Hospital, Rome, Italy
Critical Care 2011, 15(Suppl 1):P67 (doi: 10.1186/cc9487)
Introduction The Swan–Ganz catheter cannot be considered the gold 
standard in the pediatric setting for cardiac output (CO) monitoring, 
due to the unavailability of pulmonary artery catheters (PACs) of 
adequate size for children of all ages and weights and due to peculiar 
cardiovascular anatomies of some children with congenital heart 
disease (CHD). The pressure recording analytical method (PRAM) is 
designed for arterial pressure-derived continuous CO measurement 
and it does not need any starting calibration, central venous 
catheterization, or adjustments based on experimental data. The aim 
of this study was to validate PRAM in a cohort of children with CHD.
Methods  An observational study was conducted on 25 children 
with CHD who underwent diagnostic cardiac catheterization (seven 
corrected tetralogy of Fallot, three corrected complete atrioventricular 
canal, 10 corrected transposition of great arteries and fi  ve dilative 
cardiomyopathy), aiming to compare CO measurement by PRAM and 
by PAC. Enrollment criteria were: biventricular anatomy in the absence 
of intracardiac shunts, weight <20 kg, prescheduled need for Swan–
Ganz measurement of CO and arterial cannulation. The Swan–Ganz CO 
value considered in our study was the average measure deriving from 
three thermodilution boluses. The corresponding PRAM CO value was 
the average measure of those picked simultaneously with the three 
thermodilution boluses. All patients were anesthetized (2% inhaled 
sevofl  urane and intravenous remifentanil at 0.1 μg/kg/minute) and 
mechanically ventilated.
Results The median patient age was 4 years (IQR 2.5 to 6) and median 
weight was 13 kg (IQR 9 to 17). A signifi  cant linear correlation between 
PRAM and Swan–Ganz measurements was found (P  <0.0001). In 
particular, Bland–Altman analysis showed a bias of 0.2 l/minute (SD 
0.47) and 95% limits of agreement from –0.7 to 0.9 l/minute: the 
performance of this method seemed optimally coupled with PAC 
measurements when CO ranged from 1 to 2 l/minute whereas for higher 
COs the diff  erence between the two methods increased. However, only 
three measurements fell out of the limits of agreement and all were at 
CO levels over 2.5 l/minute (more rarely observed in pediatric patients 
with CHD). Age, weight, heart rate and cardiac diagnosis were not 
signifi  cantly correlated with PRAM to Swan–Ganz diff  erence.
Conclusions PRAM may be considered an accurate method in pediatric 
patients with CHD: these results should be validated in the pediatric 
ICU, also verifying PRAM’s impact on clinical decision-making.
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Accuracy of stroke volume variation as a predictor of volume 
responsiveness in patients with raised intra-abdominal pressure
WO Bauer1, M Cecconi2, A Rhodes2, W Bernal1, J Wendon1, G Auzinger1
1King’s College Hospital, London, UK; 2St George’s Hospital, London, UK
Critical Care 2011, 15(Suppl 1):P68 (doi: 10.1186/cc9488)
Introduction  Dynamic predictors of fl   uid responsiveness such as 
stroke volume variation (SVV) are gaining popularity. Intra-abdominal 
hypertension (IAH) aff  ects heart–lung interactions and may invalidate 
SVV as a preload indicator, as indeed suggested in a recent animal 
study [1]. We studied SVV in liver patients, who have a high incidence 
of raised intra-abdominal pressure (IAP).
Methods  Patients admitted to a specialist liver ICU with acute or 
decompensated chronic liver disease were studied. All were in shock 
and received controlled mechanical ventilation. Cardiac output monit-
or  ing via transpulmonary thermodilution (PiCCO; Pulsion Medical 
Systems) and pulmonary artery catheterisation (CCombo; Edwards 
Lifesciences) was performed. Measurements before and after a 
300 ml colloid bolus (Voluven; Fresenius Kabi) were recorded; fl  uid 
responsiveness was defi  ned as an increase in stroke volume (SV) >10%. 
IAP was monitored via a Foley manometer and patients were divided 
into two groups: none/mild versus clinically signifi  cant IAH, cut-off   
value 15 mmHg. Volume responsiveness according to SVV and severity 
of IAH was analysed via receiver operating characteristic. Demographic 
parameters are displayed as the median and range.
Results  Twenty-three measurements were made in 18 patients 
(in fi   ve patients, two fl   uid boluses were given on separate days). 
Median age was 45 years (47), 11 were females. Diagnoses were 
acetaminophen-induced acute liver failure (ALF, n = 6), acute decom-
pensation of alcoholic liver disease (n  =  4), Budd–Chiari syndrome 
(n = 3), seronegative ALF (n = 2), post-transplant septic shock (n = 2) 
and leptospirosis (n = 1). The median SOFA score was 18 (12), nor-
epinephrine dose 0.26 μg/kg/minute (1.25). Clinically signifi  cant IAH 
was present in 15 measurements (IAP 17 to 27). Ten fl  uid boluses 
resulted in an increase in SV >10%. As a whole SVV failed to predict fl  uid 
responsiveness (area under curve (AUC) 0.53, P = 0.82). The subgroup 
with IAP <15 showed a trend towards signifi  cance (AUC 0.91, P = 0.06). 
In the latter group a SVV of 13.5% had 75% sensitivity and specifi  city in 
predicting fl  uid responders.
Conclusions SVV does not predict fl  uid responsiveness in patients with 
signifi  cant intra-abdominal hypertension. If IAP is mildly raised, higher 
cut-off   levels for SVV may need to be considered.
Reference
1. Renner  J,  et al.: Crit Care Med 2009, 37:650-658.
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Perfusion index as a predictor for central hypovolemia in humans
A Lima, M Van Genderen, E Klijn, S Bartels, J Van Bommel, J Bakker
Erasmus MC University Medical Centre Rotterdam, the Netherlands
Critical Care 2011, 15(Suppl 1):P69 (doi: 10.1186/cc9489)
Introduction In low fl  ow shock, almost 30% of the circulating volume 
may be lost before hypotension occurs. Thus, shock should be early 
recognized prior to the development of hypotension. An earlier sign to 
look for is vasoconstriction in peripheral tissues due to neurohumoral 
response to the low circulating volume. The perfusion index (PI) 
derived from the pulse oximetry signal permits a quantitative analysis 
of variations of peripheral circulation. However, its ability to detect 
peripheral vasoconstriction due to neurohumoral response in central 
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never been studied.
Methods The PI was measured in 24 healthy volunteers during the 
LBNP test using the pulse oximetry Masimo SET Perfusion Index. The 
LBNP protocol consisted of 5-minute baseline measurements in the 
supine position followed by stepwise increases of negative pressure 
from 0 to –20, –40, –60, –80 and 0 mmHg. HR, BP, and cardiac output 
were recorded during all of the procedure using a Finometer Blood 
Pressure Monitor.
Results Subjects were all male (age mean: 23 ± 6). Figure 1 shows 
that in all subjects the PI decreased signifi  cantly by 40% (P = 0.03) 
during the fi  rst –20 mmHg, and kept in this range during the whole 
experiment. SV decreased signifi  cantly by 20% at –40 mmHg. The 
HR increased signifi  cantly by 15% at –40 mmHg. SV and HR changes 
were proportional to the level of negative pressure in the chamber. No 
signifi  cant changes in BP and CO were observed.
Conclusions PI is a sensitive indicator of acute hemodynamic responses 
to the LBNP-induced central hypovolemia. In addition, it could detect 
hypovolemia earlier than the 20% decrease in stroke volume.
P70
Carotid blood fl  ow is correlated with cardiac output but not with 
arterial blood pressure in porcine fecal peritonitis
T Correa, A Reintam Blaser, J Takala, S Djafarzadeh, M Vuda, M Dünser, 
S Mathias Jakob
University Hospital Bern – Inselspital and University of Bern, Switzerland
Critical Care 2011, 15(Suppl 1):P70 (doi: 10.1186/cc9490)
Introduction Cerebral blood fl  ow may be impaired in sepsis [1]. The 
objective of this study is to evaluate whether and how carotid blood 
fl  ow (CBF) depends on cardiac output and mean arterial blood pressure 
in abdominal sepsis.
Methods  Thirty-two anesthetized pigs (weight: 40.3  ±  3.7  kg 
(mean ± SD)) were randomly assigned (n = 8 per group) to a nonseptic 
control group (CG) or one of three groups in which resuscitation was 
initiated 6, 12 or 24 hours after induction of fecal peritonitis (instillation 
of 2 g/kg autologous feces). In the treatment groups, resuscitation was 
performed for 48 hours according to the Surviving Sepsis Campaign. 
The CG was observed for 72  hours. CBF (carotid artery; ultrasound 
Doppler fl   ow), cardiac output (intermittent thermodilution) and 
arterial blood pressure (MAP) were measured at 6-hour intervals. 
Pearson correlation were performed between CBF index (CBFI) and 
cardiac index (CI) and MAP, respectively, both in individual animals and 
in pooled septic and control groups.
Results Altogether 227 measurements were obtained during sepsis 
and 128 in controls. In septic animals, CBFI and CI (r = 0.53, P <0.001; 
Figure 1) but not CBFI and MAP correlated (Figure 2). In controls, CBFI 
and MAP correlated weakly and inversely (r = –0.246, P = 0.005; data 
not shown).
Conclusions Under the experimental conditions, increasing systemic 
blood fl  ow but not blood pressure has the potential to improve CBF.
Reference
1. Taccone  FS:  Cerebral microcirculation is impaired during sepsis: an 
experimental study. Crit Care 2010, 14:R140.
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Afterload-related cardiac performance: a hemodynamic parameter 
with prognostic relevance in patients with sepsis in the Emergency 
Department
J Wilhelm, S Hettwer, M Schürmann, S Bagger, F Gerhardt, S Mundt, 
S Muschick, J Zimmermann, H Ebelt, K Werdan
Martin-Luther-University, Halle (Saale), Germany
Critical Care 2011, 15(Suppl 1):P71 (doi: 10.1186/cc9491)
Introduction  Afterload-related cardiac performance (ACP) was 
developed to describe cardiac function in patients with sepsis, when 
cardiac output (CO) is increased due to a decline in systemic vascular 
resistance (SVR). We now studied the prognostic relevance of ACP in 
comparison with the cardiac index (CI) and cardiac power index (CPI) in 
patients at a very early stage of community-acquired sepsis (CAS) in the 
Emergency Department.
Figure 1 (abstract P69). Correlation between HR, SV and PI. Figure 1 (abstract P70). Correlation between CBFI and CI.
Figure 2 (abstract P70). Correlation between CBFI and MAP.
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Department with CAS (infection and ≥2 SIRS criteria), CI, CPI, and ACP 
were measured either non-invasively (TaskForce-Monitor; CNSystems, 
Austria) or invasively. ACP was calculated as ACP = 100 x CO / (560.68 x 
SVR–0.64). Cardiac function was graded into normal (>80%), slightly (61 
to 80%), moderately (41 to 60%) or severely impaired (≤40%).
Results  Of 137 patients studied, 48.2% had sepsis, 33.6% severe 
sepsis, and 18.2% septic shock. Overall 30-day mortality was 10.9%. On 
admission ACP was 86.7 ± 27.7% in severe sepsis and 85.5 ± 25.8% in 
septic shock, signifi  cantly lower than in patients with sepsis without 
signs of organ dysfunctions (98.6  ±  22.3%, P  <0.01), whereas no 
diff  erences were observed for CI or CPI, respectively. In severe sepsis 
or septic shock, impairment of ACP was observed more often than 
in sepsis (Figure 1A). Nonsurvivors showed a signifi  cantly depressed 
ACP already on admission and after 72  hours (Figure 1B), whereas 
CPI diff  ered only after 72 hours between survivors and nonsurvivors 
(0.52 ± 0.18 vs. 0.32 ± 0.17, P <0.05) and CI showed no diff  erences in 
this regard. ACP correlated better with APACHE II score (r = –0.371, 
P <0.001) than CPI (r = –0.330, P <0.001) or CI (r = –0.220, P <0.001). Only 
ACP correlated with serum levels of procalcitonin (r = 0.224, P <0.01) 
and IL-6 (r = –0.173, P <0.05).
Conclusions Taken together, only the parameter ACP but not CI nor 
CPI is able to detect an early impairment of cardiac function in patients 
with CAS and provides prognostic information on admission.
P72
Evaluation of a continuous non-invasive arterial blood pressure 
monitoring device in comparison with an arterial blood pressure 
measurement in the ICU
K Smolle1, M Schmid2
1University Hospital, Graz, Austria; 2Department of Internal Medicine, Graz, 
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Critical Care 2011, 15(Suppl 1):P72 (doi: 10.1186/cc9492)
Introduction  Due to a lower risk of complications, non-invasive 
monitoring methods gain importance. Measuring arterial blood 
pressure belongs to the standard hemodynamic monitoring. A 
newly developed continuous non-invasive arterial blood pressure 
(CNAP) measurement method is available and has been validated 
perioperatively [1].We compared the CNAP monitoring device with 
invasive arterial blood pressure measurement (IBP) as the gold standard 
in critically ill patients.
Methods We performed a prospective study on 49 critically ill patients 
at a medical ICU. All patients were sedated and mechanically ventilated 
(BIPAP, tidal volume 7 to 8 ml/kg ideal body weight). Furthermore, all 
patients were under vasopressor therapy. CNAP was applied on two 
fi  ngers of the hand contralateral to the invasive arterial blood pressure 
catheter in the A. radialis. All measurements were digitally recorded 
with a sample frequency of 100 Hz, every pulse beat was automatically 
identifi   ed by an algorithm [2] and subsequently artefacts were 
removed from the datasets. The average recording time in each patient 
was 163 minutes (±37 minutes/patient).
Results In total we analysed 500,000 beats. Overall we observed a 
bias in mean pressure of –7.49 mmHg with a standard deviation of 
10.90 mmHg. The Bland–Altman plot (Figure 1) showed a uniform 
distribution of the variances over all measured blood pressure values 
and a good agreement of the mean blood pressure between CNAP 
and IBP. When analysing the data of each individual patient, larger 
diff  erences were found. The bias ranged from 0.28 to 23.9 mmHg 
(median = –6.6 mmHg), with a standard deviation between 2.0 and 
14.9 mmHg (median = 5.8 mmHg).
Conclusions  In our study we detected a good overall agreement 
between CNAP and IBP. The future perspective of this study is to 
investigate whether the continuous non-invasive blood pressure 
waveform is suitable for deriving further hemodynamic parameters of 
fl  uid responsiveness.
References
1. Jeleazcov  et al.: Br J Anaesth 2010, 105:264-272.
2. Zong  et al.: Comput Cardiol 2003, 30:259-262.
Figure 1 (abstract P71). (A) Frequency of impairment of cardiac function defi  ned by ACP. (B) Time course of ACP patients with CAS.
Figure 1 (abstract P72). Comparison between IBP and CNAP in 46 
patients (50 beats per patient).
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Brachial cuff   measurements for fl  uid responsiveness prediction in 
the critically ill
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Introduction The passive leg raising maneuver (PLR) with concomitant 
measurement of invasive arterial pressure (AP) or cardiac output 
(CO) changes are used to test volume responsiveness. The initial 
hemodynamic evaluation of shocked patients often relies on the sole 
non-invasive measurement of AP. We assessed the performance of PLR-
induced changes in oscillometric measurements of systolic, mean and 
pulse AP (ΔplrSAP, ΔplrMAP and ΔplrPP).
Methods CO and AP measurements were performed before/during 
PLR and then after 500 ml volume expansion.
Results In 112 patients, the area under the ROC curve (AUC) of ΔplrSAP 
was 0.75 (0.66 to 0.83). When ΔplrSAP was >17%, the positive likelihood 
ratio (LHR) was 26 (18 to 38). Non-invasive ΔplrPP and non-invasive 
ΔplrMAP were associated with an AUC of 0.70 (0.61 to 0.79) and 0.69 
(0.59 to 0.77), respectively. If PLR induced change in central venous 
pressure (CVP) it was ≥2 mmHg (n = 60), suggesting that PLR actually 
changed the cardiac preload, AUC of ΔplrSAP was 0.90 (0.80 to 0.97). 
In these patients, ΔplrSAP >9% was associated with a positive and 
negative LHR of 5.7 (4.6 to 6.8) and 0.07 (0.009 to 0.5), respectively. See 
Figure 1.
Conclusions  Regardless of CVP (blind PLR), ΔplrSAP >17% reliably 
identifi  ed responders. CVP-guided PLR allowed ΔplrSAP to perform 
better in the case of suffi   cient change in preload during PLR.
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Are the calf and the thigh reliable alternatives to the arm for cuff   
non-invasive measurements of blood pressure?
K Lakhal1, C Macq1, S Ehrmann2, T Boulain3, X Capdevila1
1CHU, Montpellier, France; 2CHRU, Tours, France; 3CHR, Orléans, France
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Introduction Non-invasive measurement of blood pressure (NIBP) is 
widely used in the critically ill, the cuff   being often placed on the calf or 
the thigh in case of contraindication for placing it on the arm (wounds, 
fracture, vascular access, and so forth) [1]. However, this common 
practice has never been validated. We assessed the reliability of NIBP at 
these diff  erent anatomic sites.
Methods  Included: adult ICU patients carrying an arterial catheter. 
Excluded: mean arterial pressure (MAP) increase >5 mmHg during cuff   
infl  ation (infl  ation-induced pain); nonperception of the distal pulse 
despite the resolution of an eventual circulatory failure. For each site 
(arm, calf, thigh (if Ramsay score >4)), three pairs of NIBP and invasive 
measurements were respectively averaged. Patients in circulatory 
failure (MAP <65 mmHg and/or skin mottling and/or cathecholamine 
infusion) underwent a second set of measurements, after hemodynamic 
intervention (volume expansion and/or initiation and/or increase in 
catecholamine dosage). The agreement was assessed via a Bland–
Altman analysis.
Results Ten patients were excluded and 11 NIBP measurements failed 
to display any fi  gure: one patient for each site, eight others for the 
thigh only. Thus, 150 patients were analyzed (41 ± 26 years, BMI 26 ± 6, 
SAPS II 46 ± 18, Ramsay score = 5 or 6: 83%, mechanical ventilation 
99%), comprising 79 patients with circulatory failure (MAP 70 ± 12 
mmHg, norepinephrine (n = 62) 0.3 ± 0.3 μg/kg/minute, epinephrine 
(n = 2) 0.15 ± 0.14 μg/kg/minute). Absolute value of BP – for MAP 
measurement, NIBP performed better if the cuff   was placed on the 
arm: bias/upper and lower limits of agreement (mmHg) of 3 ± 5/13/–6, 
3  ±  8/18/–12 and 6  ±  7/20/–8 on the arm, the calf and the thigh, 
respectively. NIBP accuracy was similar in case of (mild) circulatory 
failure. Whatever the anatomic site, NIBP accuracy was better for 
MAP than for SAP or DAP. MAP changes – among the 57 patients with 
circulatory failure who underwent a second set of measurements after 
hemodynamic intervention, MAP changes (%) were better refl  ected 
when the cuff   was placed on the arm, rather than on the calf or the 
thigh: 3 ± 5/12/–7, 3 ± 9/20/–14 and 3 ± 7/17/–10, respectively.
Conclusions  For better reliability of MAP (and its changes) 
measurements, the cuff   should be placed on the arm (if possible) rather 
than the thigh or the calf.
Reference
1. Chatterjee  A,  et al.: Crit Care Med 2010, 38:2335-2338.
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critically ill patients
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Introduction Thermodilution (TD) is a gold standard for cardiac output 
(CO) measurement in critically ill patients [1]. Although transpulmonary 
thermodiluation is less invasive than the Swan–Ganz catheter, it still 
requires an arterial and deep venous line. This study will compare 
intermittent bolus transpulmonary TDCO with continuous CO (CCO) 
obtained by pulse contour analysis (PiCCO2; Pulsion Medical Systems) 
and non-invasive CO (NexCO) measurement via fi  nger  cuff    using 
Finapres technology (Nexfi  n BMEYE).
Methods  A prospective study in 45 patients (43 mechanically 
ventilated, 32 male). Age 57.6 ± 19.4, BMI 25.3 ± 4.4, SAPS II 51.5 ± 16.9, 
APACHE II 25.3 ± 10.3 and SOFA score 9.4 ± 3.3. In an 8-hour period, 
simultaneous CCO and NexCO measurements were obtained every 
2 hours while simultaneous TDCO and NexCO were obtained every 
4 hours. The CCO and NexCO values were recorded within 5 minutes 
before TDCO was determined. Statistical analysis was performed using 
Pearson correlation and Bland–Altman analysis.
Results In total, 585 CO values were obtained: 225 paired CCO–NexCO; 
135 paired CCO–TDCO and 135 NexCO–TDCO. Thirty-fi  ve  patients 
received norepinephrine at a dose of 0.2 ± 0.2 μg/kg/minute (range 
0.02 to 1). TDCO values ranged from 2.4 to 14.9 l/minute (mean 
6.6 ± 2.2), CCO ranged from 1.8 to 15.6 l/minute (6.4 ± 2.3) and NexCO 
from 0.8 to 14.9 l/minute (6.1 ± 2.3). The Pearson correlation coeffi   cient 
comparing NexCO with TDCO and CCO was similar with an R2 of 0.68 
and 0.71 respectively. Bland–Altman analysis comparing NexCO 
with TDCO revealed a mean bias ± 2SD (limits of agreement (LA)) of 
0.4 ± 2.32 l/minute (with 36.1% error) while analysis of NexCO versus 
CCO showed a bias (± LA) of 0.2 ± 2.32 l/minute (37% error). TDCO was 
highly correlated with CCO (R2 = 0.95) with bias 0.2 ± 0.86 (% error 13.3). 
Figure 1 (abstract P73).
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PiCCO2 and from 44 to 131 (85 ± 17) for Nexfi  n. The MAP obtained with 
Nexfi  n correlated well with invasive MAP via PiCCO2 (R2 = 0.89) with a 
bias (± LA) of 2.3 ± 12.4 (% error 14.7).
Conclusions These preliminary results indicate that in unstable critically 
ill patients CO and MAP can be reliably monitored non-invasively 
with Nexfi  n technology. Although TPTD remains a gold stand for the 
measurement of CO in ICU patients, Nexfi  n non-invasive monitoring 
may provide useful information in the emergency or operating room 
when an arterial or CVL is not available.
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Introduction  In patients with acute circulatory failure related to 
sepsis or hypovolemia, volume expansion is used as fi  rst-line therapy 
in an attempt to improve cardiac output. Dynamic indices based on 
cardiopulmonary interactions and variation in left ventricular stroke 
volume like respiratory variations in arterial pulse pressure (ΔPP) are 
able to predict response to fl  uid loading in mechanically ventilated 
patients. The Pleth Variability Index (PVI) (Masimo® Corp., Irvine, CA, 
USA) is a new non-invasive technique based on perfusion index (PI) 
variations during the respiratory cycle in mechanically ventilated 
patients. The objective of the study is to investigate whether PVI, a 
non-invasive and continuous tool, can predict fl  uid responsiveness in 
mechanically ventilated patients with circulatory insuffi   ciency.
Methods A prospective study in a surgical ICU of a university hospital. 
Forty mechanically ventilated patients with circulatory insuffi   ciency 
were included in whom volume expansion was planned by the attending 
physician. Exclusion criteria included spontaneous respiratory activity; 
cardiac arrhythmia; known intracardiac shunt; severe hypoxemia (PaO2/
FIO2 <100 mmHg); contraindication for passive leg raising (PLR); altered 
left ventricular ejection fraction; hemodynamic instability during 
the procedure. We performed fl  uid challenge with 500 ml of 130/0.4 
hydroxyethylstarch if ΔPP ≥13% or with PLR otherwise. PVI, ΔPP and 
cardiac output (CO) estimated by echocardiography were recorded 
before and after fl  uid challenge. Fluid responsiveness was defi  ned as 
an increase in CO ≥15%.
Results  Twenty-one patients were responders and 19 were non-
responders. Median (interquartile range) PVI (26% (20 to 34%) vs. 10% 
(9 to 14%)) and ΔPP (20% (15 to 29%) vs. 5% (3 to 7%)) values at baseline 
were signifi  cantly higher in responders than in nonresponders. A PVI 
threshold value of 17% allowed discrimination between responders 
and nonresponders with a sensitivity of 95% (95% CI = 74 to 100%) and 
a specifi  city of 91% (95% CI = 70 to 99%). PVI at baseline correlated 
(r = 0.72; P <0.0001) with percentage changes in CO (ΔCO) induced by 
fl  uid challenge, suggesting the higher PVI at baseline, the higher ΔCO 
after volume expansion.
Conclusions PVI can predict fl  uid responsiveness non-invasively in ICU 
patients under mechanical ventilation.
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Introduction  Recent studies have suggested that microvascular 
perfusion impairment may play a role in the development of 
postoperative organ dysfunction in patients undergoing high-risk 
or cardiac surgery [1,2]. Postoperative monitoring of tissue perfusion 
parameters could therefore be used for early detection of tissue 
hypoperfusion and serve as an endpoint for resuscitation. For this 
purpose we measured regional and microvascular perfusion parameters 
in relation to systemic hemodynamics in patients undergoing open 
heart surgery.
Methods  We observed 10 consecutive patients who underwent 
elective coronary artery bypass grafting with cardiopulmonary bypass 
during the immediate postoperative resuscitation in the ICU. Tissue 
perfusion was measured directly after admission and repeated before 
detubation, and consisted of sublingual SDF imaging, forearm Tskin-
diff  , fi  nger peripheral perfusion index, fi  nger capillary refi  ll time (CRT) 
and thenar tissue oxygenation (StO2). Cardiac output was measured 
with NICOM bioreactance.
Results CO (4.33 ± 1.63 vs. 5.37 ± 1.29) (P <0.05) and central temperature 
(35.30 ± 0.24 vs. 36.56 ± 0.13) (P <0.01) increased signifi  cantly. All tissue 
perfusion parameters (that is, SDF parameters (MFI ≥2.5; PPV ≥95%), 
StO2 ≥80%, CRT ≥5 seconds, Tskin-diff   ≤3 and PFI ≥1.4) were within 
the normal range at admission and did not change signifi  cantly until 
detubation. Even the central-to-toe temperature diff  erence showed no 
signifi  cant diff  erence or correlation between cardiac output and any 
other peripheral tissue perfusion parameter. The postoperative course 
was uncomplicated in all patients.
Conclusions In the postoperative period, peripheral and microvascular 
tissue perfusion parameters are not impaired in our CABG patients. 
Although from a small population, these data suggest that these 
parameters are not suitable for routine use as an extra hemodynamic 
resuscitation endpoint. This is in contrast with previous studies and 
might be explained by diff  erences in study population or measurement 
interval.
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Introduction In ICU settings arterial catheters (AC) are used to manage 
critically ill patients. Maintaining the patency of these catheters is 
important for continuous hemodynamic evaluation and therapeutic 
adjustment. Heparinized solutions are used for this purpose although 
the increasing literature describes the use of saline solutions for the 
same reason. The authors compare the use of heparinized versus 
saline solution in the maintenance of ACs and to detect changes in 
aPTT, platelet count, and local infl  ammatory signs, in a double-blind 
randomized trial.
Methods During 80 days all ICU patients with ACs were randomized 
to receive heparinized solution (5 IU/ml) or saline solution. AC patency 
and functionality was compared in both every 6  hours, and aPTT, 
platelet count and local infl  ammatory signs each 24 hours. Patients 
with thrombocytopenia, receiving anticoagulant or fi  brinolytic 
treatment were excluded.
Results  Two hundred days of ACs were observed in 49 patients, 
during which 110 days were with saline solutions and the rest were 
heparinized. Seven patients were excluded. The median duration 
of catheters in place was 4.4 days in the saline group and 3.8 days in 
the heparinized group. We recorded two ACs with local infl  ammatory 
signs in the heparinized group that were replaced in a septic context. 
One local hemorrhage and one AC obstruction were observed in the 
heparinized group versus no hemorrhage and three AC obstructions in 
the saline group. No other diff  erences were obtained.
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does not seem to be adequate. In this study the comparison of the two 
populations revealed the same results despite the solution used. These 
results do not encourage the use of heparinized solutions because they 
do not have an eff  ective cost/benefi  t relation and due to the potential 
iatrogenic problems described in the literature.
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Introduction The aim of this study was the validation of continuous 
intragastric pressure (IGP) measurement and correlation with 
intramucosal pH (pHi) in a pig model of intra-abdominal hypertension 
(IAH).
Methods In 51 pigs, 611 paired IAP measurements were performed. IAP 
was measured at end-expiration using two diff  erent methods: the gold 
standard via an indwelling bladder catheter (IVP), and via a balloon-
tipped nasogastric tube (IGP). During the same period 86 simultaneous 
pHi and IGP measurements were performed in 40 pigs. The abdominal 
perfusion pressure (APP) was defi  ned as mean arterial pressure (MAP) 
minus IAP. Statistical analysis was done via Pearson correlation and 
Bland–Altman analysis; values are mean ± SD unless stated otherwise.
Results Mean IGP was 22.3 ± 12.7 mmHg (range 0 to 43.1), and IVP was 
22.9 ± 12.6 (0 to 48). There was a very good correlation between IGP and 
IVP. For the whole set of paired measurements (n = 611), IVP = 1.02 x IGP 
(R2 = 0.96, P <0.0001); and for the means per individual pig (n = 51), 
IVP = 1.03 x IGP (R2 = 0.96, P <0.0001). The analysis according to Bland–
Altman for the whole set (n = 611) showed a mean IAP of 22.6 ± 12.6 
(0.1 to 44) with a bias (±1.96 x SD) of 0.6 ± 2.4 mmHg; the limits of 
agreement (LA) were –4.2 to 5.5 mmHg (% error of 21.5). Looking at the 
mean values in each individual animal mean IAP was 22 ± 9.4 (2.5 to 
37.9), with a bias of 0.8 ± 1.9 (LA –3 to 4.6) and a % error of 17.2. These 
intervals are small and refl  ect a good agreement between the two IAP 
methods. The mean pHi was 7.02 ± 0.28 (6.34 to 7.37) and correlated 
well with IGP (R2 = 0.7, P <0.001). Analysis further showed that changes 
in IGP correlated well with changes in pHi (R2 = 0.66, P <0.001). The MAP 
was 48.3 ± 14 (3 to 138) and APP was 24.9 ± 17.4 (0.2 to 92). During 
388 paired measurements APP correlated signifi  cantly with pHi (in 
a logarithmic fashion, R2 = 0.18), the correlation was linear and even 
better in conditions when APP <45 mmHg (n = 334): pHi = 0.016 x APP 
+ 6.63 (R2 = 0.55, P <0.0001). Thus increased APP above 45mmHg did 
not result in a further increase of pHi.
Conclusions We found a very good correlation between IGP and IVP. 
Measurement via the stomach has major advantages over the standard 
intravesical method: continuous measurement of IAP as a trend over 
time is possible and there is no interference with estimation of urine 
output. Moreover, APP is correlated with pHi while IAP and pHi are 
inversely correlated.
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Introduction End-tidal carbon dioxide (CO2) correlates with cardiac 
output during cardiopulmonary resuscitation (CPR) in cardiac arrest 
patients. Increasing CO2 during CPR can also indicate the return of 
spontaneous circulation.
Methods CO2 was continuously monitored and recorded every 4 hours 
in 43 patients who were intubated and on vasopressor medications.
Results Mean CO2 values were signifi  cantly higher in normal patients 
when compared with those in patients who had a cardiac arrest 
(30.18 ± 4.93 vs. 17.45 ± 4.76; P <0.001). CO2 levels were signifi  cantly 
lower in cardiac arrest patients when compared with hypotensive 
patients 1, 2, 3, and 4 hours prior to a cardiac arrest (see Table 1). 
CO2 levels were signifi  cantly lower in cardiac arrest patients when 
compared with patients who were acutely withdrawn from care 1, 2, 3, 
and 4 hours prior to the event (see Table 2).
Table 1 (abstract P80). End-tidal CO2 5 hours prior to cardiac arrest 
compared with hypotension
Hour prior  Arrest  Hypotension  P value
1 16.50  20.67  0.013
2 16.25  21.83  0.013
3 16.50  22.67  0.002
4 16.75  21.33  0.024
5 21.25  21.33  0.99
Table 2 (abstract P80). End-tidal CO2 5 hours prior to cardiac arrest versus 
acute withdrawal of care
Hour prior  Arrest  Acute withdrawal of care  P value
1 16.50  23.29  0.016
2 16.25  24.43  0.001
3 16.50  25.29  <0.001
4 16.75 26  <0.001
5 21.25  24.86  0.43
Conclusions CO2 levels decrease prior to cardiac arrest and are signi-
fi  cantly lower than prior to hypotensive or acute withdrawal of care 
events. Further study needs to be done on a larger scale to see whether 
these results hold true.
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Introduction  Distributive shock with high output cardiac failure is 
frequently seen in acute liver failure (ALF). A previous study suggested 
a high incidence of myocardial injury coupled with adverse outcome 
in this population [1]. Correlation of cardiac biomarkers with invasive 
hemodynamic parameters or results of echocardiographic studies has 
thus far not been performed.
Methods NT-proBNP (NTpBNP) and troponin I (TI) were measured in 
ALF patients with shock within 48 hours after admission to a tertiary 
specialist ICU. Transpulmonary thermodilution cardiac output monitor-
ing (PiCCO) was performed in all patients. Values of cardiac index 
(CI), stroke volume index (SVI), global end diastolic index (GEDI) and 
markers of contractility – global ejection fraction (GEF) and cardiac 
function index (CFI) – as well as severity of illness scores were correlated 
with cardiac biomarker levels. Correlation was assessed using Pearson’s 
coeffi   cient for normally distributed data.
Results Twenty-six ALF patients with a mean (SD) APACHE II score of 23 
(4) and SOFA 15 (2) were assessed. NTpBNP (median 715 (46 to 10, 484) 
pg/ml) and TI (median 0.28 (0 to 50) u/l) levels were both signifi  cantly 
elevated without any signifi  cant ECHO abnormalities and 24 patients 
required renal replacement therapy. Serum NTpBNP correlated with 
serum lactate (correlation coeffi   cient 0.61, P  =  0.001) and TI (0.63, 
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or preload (SVI –0.28, P = 0.161, CI –0.08, 0.695, GEF –0.26, 0.200, GEDI 
–0.32, 0.12) and neither cardiac marker correlated with APACHE II score. 
There was a trend toward correlation of TI with CFI (0.367, P = 0.084) but 
not with CI (0.021, 0.92). CFI was correlated with GEF (0.55, P = 0.001) 
and lactate (0.53, P  =  0.003). APACHE and SOFA did not correlate 
signifi  cantly with PiCCO indices.
Conclusions Levels of cardiac biomarkers are frequently elevated in 
ALF. We could not fi  nd any correlation of TI and NTpBNP with surrogate 
markers of cardiac function on invasive hemodynamic monitoring, or 
indeed signifi  cant abnormalities on ECHO.
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Introduction  The endothelial glycocalyx (EGX) modulates vascular 
permeability and infl   ammation. It is disrupted by ischaemia–
reperfusion. We hypothesised that cardiopulmonary bypass would 
elevate markers of EGX shedding, which would be associated with 
increased postoperative infl  ammation.
Methods A prospective cohort of 25 infants (median weight 5 kg) 
under  going surgery for congenital heart disease. Blood temporal pro-
fi  les of two markers of EGX disruption – heparan sulphate (HEP) and 
syndecan-1 (SYND) – were correlated with a biochemical marker of 
systemic infl  ammation (IL-6) and clinical outcome variables.
Results Infants showed a dramatic rise in SYND, which peaked at the 
end of bypass, returning to baseline at 48 hours (Figure 1). The median 
(IQR) peak SYND levels were 144 ng/ml (113 to 190), representing 
a sixfold rise from baseline. A less pronounced rise was seen for HEP 
(median 22.5 μg/ml), which approximately doubled. Peak IL-6 occurred 
at 12 hours post bypass: median 118 pg/ml (44 to 217). Absolute peak 
values of both SYND and HEP correlated poorly with IL-6 and all clinical 
variables. Conversely, peak IL-6 correlated with bypass time (r = 0.53), 
length of ventilation (r = 0.69) and ICU stay (r = 0.58).
Conclusions Although markers of EGX disruption show a reproducible 
temporal profi  le after bypass, the lack of correlation with IL-6 and 
clinical markers means that their signifi  cance is unclear.
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Introduction  Our goal was to evaluate the eff  ect of hyperoxia on 
sublingual and ileostomal microcirculation during hemorrhagic and 
reperfusion shock in a porcine model simulating the rupture of an 
abdominal aortic aneurysm (AAA). We wanted to test the eff  ect of 
hyperoxia on these two vascular beds because hyperoxia is known to 
cause diff  erent arteriolar responses [1].
Methods Pigs were randomized into four groups: HEM n = 11, HEM-
HYPEROX n = 11, SHAM n = 6, SHAM-HYPEROX n = 5. Hyperoxia (FiO2 
1.0) started 1 hour after hemorrhagic shock and was maintained until 
the end of the experiment. Microcirculation was recorded with SDF 
imaging (MicroScan Video Microscope) in eight time points during 
the whole experiment (T0 before bleeding, T1 to T4 every hour of the 
4 hours bleeding, T5 2 hours after the volume was reinfusioned and 
aorta clamped, T6 after 2 hours of declamping, and T7 after 11 hours 
of intensive care). In every time point, recordings were sampled 
three times at 20-second intervals sublingually and from ileostoma. 
Videodocumentation was elaborated with software AVA 3.0 by 
single blinded investigator. The following vessel density parameters 
(TVD, PVD, De Backer score), perfusion parameters (PPV, MFI) and 
heterogeneity index for MFI and TVD were monitored. Nonparametric 
statistic methods were used for the evaluation (Statistica 9 CZ). The 
Mann–Whitney U test was used for comparison of sublingual and 
ileostomal microcirculations.
Results  Sublingually there was a signifi   cant increase in density 
parameters TVD and PVD and a decline in TVD heterogeneity index 
in T5 (end clamping) in the hyperoxia group (P <0.05). In ileostoma 
there was a signifi  cant decline in density parameters TVD in T3 (3 hours 
bleeding) and De Backer score in T3 and T4 (end bleeding) and in 
perfusion parameter MFI in T4 in the hyperoxia group (P <0.05). The 
rest of the parameters remained unchanged. There were no statistically 
signifi   cant changes when comparing sham and sham-hyperoxia 
groups both sublingually and in ileostoma.
Conclusions In this model of ruptured AAA it seems that hyperoxia 
might compromise microcirculation during bleeding and improved it 
during resuscitation.
Acknowledgements  Supported by NS 10109-4 and VZ MSM 
0021620819.
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Introduction Previous studies showed an increased risk for developing 
acute kidney injury in septic patients receiving synthetic colloids [1]. 
However, little is known about eff  ects of synthetic colloids on other 
organs. Ginz and colleagues found altered organ morphology and 
considerable colloidal storage in parenchymal and reticuloendothelial 
cells of the liver, lung and kidney in a septic patient after synthetic 
colloid administration [2]. For this reason we analyzed the eff  ects of 
HES and gelatin on kidney, liver and lung function in comparison with 
crystalloids in septic patients.
Methods  A prospective controlled before-and-after study in 1,046 
patients with severe sepsis. Acute kidney injury (AKI) was defi  ned by 
RIFLE criteria and/or by new occurrence of renal replacement therapy 
(RRT). Liver function was determined by aspartate aminotransferase 
(AST), alanine aminotransferase (ALT), bilirubin blood levels during 
Figure 1 (abstract P82). Syndecan-1 profi  le.
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Between 2004 and 2006, standard colloid was HES (mainly 6% HES 
130/0.4 (87%) and 10% HES 200/0.5). Between 2006 and 2008, standard 
colloid was changed to 4% gelatin (Gel). From 2008 until April 2010, 
patients received only crystalloids (Crys).
Results Groups were comparable at baseline concerning SAPS II and 
SOFA scores, age and renal function. Patients who received synthetic 
colloids more often met the criteria for AKI (Crys 58.4%, HES 70.6% 
P = 0.001, Gel 67.6% P = 0.012) or required RRT (Crys 27.8%, HES 34.2% 
P = 0.072, Gel 35.5% P = 0.031) than patients receiving only crystalloids. 
On day 3, liver enzymes peaked in both colloid groups but not in 
the crystalloid group (AST (μmol/l), median (IQR): HES 2.2 (0.9 to 6.3) 
P = 0.001, Gel 1.7 (0.7 to 3.7) P = 0.158, Crys 1.0 (0.6 to 3.2); ALT: HES 1.1 
(0.5 to 3.1) P = 0.003, Gel 0.9 (0.4 to 2.1) P = 0.109, Crys 0.6 (0.3 to 1.9). 
Bilirubin levels remained signifi  cantly elevated from day 0 to 14 in the 
HES and Gel groups. Median ventilation time (hours) was signifi  cantly 
longer in the HES and Gel groups: HES 214 (60 to 368) P <0.001, Gel 146 
(48 to 333) P = 0.002, Crys 105 (15 to 280). The PaO2/FiO2 ratio and ICU 
or hospital mortality did not show signifi  cant diff  erences.
Conclusions HES and gelatin may be associated with an increased risk 
of renal failure, impaired liver function and longer ventilation time in 
septic patients.
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Introduction  We compared intraoperative volume eff  ectiveness of 
crystalloid and colloid substitution aimed to maintain the cardiac 
index (CI) within the normal range measured by transesophageal 
Doppler ultrasonography (TED) [1]. We also evaluated the frequency 
of postoperative complications, length of in-hospital stay and 
postoperative in-hospital mortality.
Methods One hundred and fi  fteen urological patients were enrolled 
into the prospective observational clinical study and then randomized 
into two groups. The fi  rst group was treated by volumotherapy based 
on crystalloids (Cry) n = 57, and the second group with colloids (Col) 
n  =  58. High-risk surgery criteria were fulfi   lled in 47% patients in 
the Cry group and 45% in the Col group. Each patient obtained an 
esophageal Doppler probe (Hemosonic™100®; Arrow International, 
USA) after induction to general anesthesia and then hemodynamic 
optimalization (fl  uid therapy with Ringer’s solution or HES 6% 130/0.4 
and administration of vasoactive drugs) was started according to 
TED variables to keep the CI between 2.6 and 3.8 l/min/m2. The 
supplementation of immeasurable fl  uid losses in the Col group was 
provided by infusion of Ringer’s solution 0.05 ml/kg/minute.
Results  We observed high initial incidence of CI  <2.6 l/min/m2 
after induction of general anesthesia (75%) in both groups. There 
were no signifi  cant diff  erences in demographic characteristics, ASA 
classifi  cation, length of surgical procedure, estimated blood loss and 
CI during surgery. To maintain the CI we used signifi  cantly diff  erent 
amounts of crystalloids compared with colloids: means 5,182 ml versus 
1,692 ml, respectively. The number of administered blood units was 
also higher in the Cry group versus the Col group: RBC 52 versus 19, 
P = 0.018, FFP 55 versus 16, P = 0.006, respectively. There was more GIT 
dysfunction in group Cry 31.6% versus 15.5% in the Col group, P = 0.05. 
The number of complications during 28 days on the ICU, overall in-
hospital stay and mortality were not statistically signifi  cant.
Conclusions  Crystalloids and colloids are eff  ective in correction of 
intraoperative fl  ow-related perfusion abnormalities. Diff  erent amounts 
of used crystalloids and colloids proved their unequal pharmacological 
characteristics (that is, distribution between compartments). The high 
amount of used transfusion units and postoperative incidence of GIT 
dysfunction in the Cry group suggests possibly more adverse eff  ects of 
crystalloids in the perioperative period.
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Introduction  Crystalloids have diff   erent electrolyte composition 
and therefore diff  erent strong ion diff  erences (SIDinf). The aim of the 
study was to investigate the response of the kidney to plasmatic acid–
base changes induced by dilution with three crystalloid solutions at 
diff  erent SID.
Methods Six pigs (22  ±  4 kg) were anesthetized and mechanically 
ventilated. The respiratory rate was adjusted to maintain pCO2 
constant. A urinary catheter was placed and connected to a urinary 
analyzer (Orvim, Paderno Dugnano, Italy) [1]. Pigs were randomly 
assigned to a sequence of dilutions (10% of body weight in 2 hours, 
followed by 4 hours of washout period) with the following three fl  uids: 
normal saline (NS), SID = 0, [Na] = 154, [Cl] = 154; lactated Ringer’s 
(LR), SID = 29, [Na] = 132, [Cl] = 112; and polysaline RIII (RIII), SID = 55, 
[Na] = 140, [Cl] = 103. Blood gases and electrolytes as well as urinary pH 
(pHu), urinary electrolytes and urinary output (UO) were recorded at 
baseline and at the end of each dilution. Plasmatic SID was defi  ned as 
[Na] + [K] + 2[Ca] – [Cl] – [Lac]. Variations (d) were defi  ned as baseline 
– 2-hour value.
Results Plasmatic changes are consistent with previous in vitro studies 
[2]. dSID was mainly due to d[Cl]: 9.0 ± 1.7 for NS, no change for LR, 
–1.5 ± 1.6 for RIII. Of note, while no diff  erence was yet observed for 
urinary electrolytes and UO, pHu signifi  cantly diff  ered between the 
three solutions. See Table 1.
Table 1 (abstract P86)
 NS  LR  RIII
dpHa –0.08 ± 0.02  –0.00 ± 0.03*  0.04 ± 0.03*#
dSID (mEq/l)  –4.56 ± 1.36  0.21 ± 1.41*  3.56 ± 1.95*#
dpHu –0.16 ± 0.47  0.23 ± 0.44  1.00 ± 0.75*#
UO (ml)  639 ± 235  768 ± 172  896 ± 293
Data presented as mean ± standard deviation. *P <0.05 vs. NS. #P <0.05 vs. LR. 
One-way ANOVA RM.
Conclusions The quality of infused fl  uids aff  ects greatly the acid–base 
and electrolyte equilibrium of plasma. This in turn alters the quality of 
urine (pHu).
References
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Introduction Hydroxyethyl starch (HES) solutions are commonly used 
for perioperative volume replacement. Whereas older HES specimens 
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on haemostasis, more recent products (for example, HES 130/0.4) are 
characterised by improved pharmacological properties. The present 
study was designed to compare the effi   cacy and safety of 10% HES 
130/0.4 and 10% HES 200/0.5.
Methods  In this post-hoc analysis of a prospective, randomised, 
double-blind, multicenter therapeutic equivalence trial, 76 patients 
undergoing elective on-pump cardiac surgery received perioperative 
volume replacement using either 10% HES 130/0.4 (n = 37) or 10% HES 
200/0.5 (n = 39) up to a maximum dose of 20 ml/kg.
Results  Equivalent volumes of investigational medications were 
infused until 24  hours after the fi   rst administration (1,577 vs. 
1,540 ml; treatment diff   erence 37 [–150; 223] ml; P  <0.0001 for 
equivalence). Whereas standard laboratory tests of coagulation were 
comparable between groups, von Willebrand factor activity on the fi  rst 
postoperative morning tended to be higher following treatment with 
10% HES 130/0.4 as compared with 10% HES 200/0.5 (P = 0.025), with 
this diff  erence being statistically signifi  cant in the per-protocol analysis 
(P = 0.02). Treatment groups were comparable concerning other safety 
parameters and the incidence of adverse drug reactions. In particular, 
renal function was well preserved in both groups.
Conclusions  10% HES 130/0.4 was equally eff   ective and safe as 
compared with 10% HES 200/0.5 for volume therapy in patients 
undergoing cardiovascular surgery. Postoperative coagulation and 
renal function, as measured by standard laboratory tests, were similar 
among groups.
P88
Nicorandil versus nitroglycerin: a pilot study
V Singh1, S Momin2, B Shah3
1Addenbrooke’s NHS Foundation Trust, Cambridge, UK; 2West Suff  olk Hospital 
NHS Trust, Bury St Edmunds, UK; 3NHL Medical college, Ahmedabad, India
Critical Care 2011, 15(Suppl 1):P88 (doi: 10.1186/cc9508)
Introduction  Continuous exposure to nitrates is associated with 
tachyphylaxis. This study compares the eff  ects and tolerance during 
intravenous treatment with nitroglycerin and nicorandil over a 48-hour 
period.
Methods Twenty patients with congestive heart failure and pulmonary 
capillary wedge pressure (PCWP) ≥18 mmHg were randomly assigned 
to nitroglycerin or nicorandil intravenous infusions. Doses were titrated 
to obtain a reduction of PCWP of at least 30% at 6 hours and then 
maintained for 48 hours.
Results There was no statistical diff  erence between the groups in terms 
of age, sex, and NYHA grade. The pretreatment PCWP for nitroglycerin 
was 25.7 mmHg, decreasing to 18.4 mmHg at 6 hours. The values for 
nicorandil were 25.4 mmHg and 17.3 mmHg, respectively. There was 
no statistical diff  erence between the two groups (P = 0.79 pretreatment 
and 0.23 at 6 hours). The mean PCWP values for 24 hours were 19.7 
and 17.4, respectively, which was statistically signifi  cant (P = 0.036). 
Similarly, the values for 48  hours were 20.6 and 17.9, which was 
signifi  cant (P = 0.026) (see Table 1).
Table 1 (abstract P88). PCWP values before and after treatment
Variable Nitroglycerin  Nicorandil
Number  10 (8/2)  10 (7/3)
Age 49.9  51.4
Pretreatment 25.7  25.4
6 hours 18.4  17.3
24 hours 19.7  17.4
48 hours 20.6  17.9
Conclusions  Intravenous nicorandil administration gives similar 
reductions in PCWP compared with nitroglycerin with signifi  cantly 
less haemodynamic tolerance over a 48-hour period compared with 
nitroglycerin. This might represent a clinical advantage of nicorandil 
in the short-term treatment of patients with congestive heart failure.
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Introduction The aim of this meta-analysis is to compare the changes 
in hemodynamic parameters among patients with septic shock who 
have received either of the two agents in their management and try to 
deduce the superiority of one over the other.
Methods A total of 880 articles were identifi  ed by a computerized search 
using MEDLINE, OVID and the Cochrane Central Register of Controlled 
Trials, of which six randomised controlled studies were included in 
the study. Observational data, retrospective studies or animal-based 
studies were excluded. Main outcome measures evaluated were the 
changes from the baseline in heart rate, mean arterial pressure, oxygen 
delivery index, oxygen extraction, systemic vascular resistance index 
(SVRI), cardiac index (CI), central venous pressure, blood lactate levels, 
urine output, mean pulmonary artery pressure (MPAP), pulmonary 
capillary wedge pressure, right ventricular ejection fraction (RVEF), 
arrhythmias and 28-day mortality rates. The statistical analysis was 
performed using Comprehensive Meta-Analysis software.
Results  No signifi  cant  diff   erence was found in mortality between 
the two groups (RR = 1.067, CI = 0.984 to 1.157, P = 0.115). In the 
norpinephrine group, heart rate was signifi  cantly lower in comparison 
with baseline (mean change = –16.32 beats/minute, CI = –22.23 to 
–10.31,  P  <0.001) and so also was the occurrence of arrhythmias 
(RR  =  2.34, CI  =  1.456 to 3.775, P  <0.001). The SVRI, however, was 
signifi  cantly higher in this group (diff  erence in mean 185 dynes/cm5m2, 
CI = 141.214 to 229.05, P <0.001). Patients who were on dopamine had 
signifi  cantly better RVEF% (mean diff  erence = 2.38%, CI = 1.058 to 3.671, 
P <0.001) and a lower lactate level (mean diff  erence = –0.170 mmol/l, 
CI = –0.331 to –0.009, P = 0.038). Urine output, oxygen delivery, MPAP 
and oxygen consumption were not signifi  cantly diff  erent between the 
two groups.
Conclusions  Patients who received dopamine had a better right 
ventricular ejection fraction, lower lactate levels, lower systemic 
vascular resistance index and a trend towards a better cardiac index. 
However, this group was noted to have more arrhythmias and a higher 
baseline heart rate versus the norepinephrine group. Overall, there 
was no diff  erence in the 28-day mortality between the two groups. 
Although there are certain hemodynamic advantages, we were unable 
to deduce the superiority of one pressor. The results support the 
current practice of individualizing the choice of an initial vasopressor 
based on patient profi  le.
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Introduction Resuscitation of patients with hemorrhagic shock (HS) 
represents a challenge in emergency medicine. The uncontrollable 
bleeding and subsequent cardiovascular collapse are responsible for 
40% of the early mortality rate in trauma.
Methods Twelve Large White pigs at 5 months of age, weighing 25 kg, 
were submitted to a surgical procedure for liver resection or autologous 
liver transplantation. Ketamine S+ (5  mg/kg, i.m.) and midazolam 
(0.5 mg/kg, i.m.) were used as a premedicant. Anesthesia was induced 
with propofol (3  mg/kg, i.v.) and maintained with 1.5% isofl  urano 
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40% inspired oxygen fraction. Analgesia and neuromuscular blockade 
were accomplishments with continuous infusion of fentanyl (0.4 mg/
kg/minute) and pancuronium (0.3  mg/kg/hour). The shock was 
diagnosed when blood loss exceeds 40% of the total blood volume. 
The HS results in mean arterial pressure reduce (MAP ≤50 mmHg), 50% 
cardiac output reduction (CO) and central venous saturation (SvO2) 
decreased to 70 mmHg. The animals underwent hemodynamic, arterial 
blood gases and venous monitoring, at baseline (t0), impact moment 
(t1), after treatment (t2), intervals of 15 minutes after shock treatment 
(t3, t4, t5, t6), and 120 minutes after treatment (t7). Subsequent to shock 
diagnosis, the animals were randomly divided into GI treated with 
vasopressin (0.01 IU/kg/minute), norepinephrine (0.3 mg/kg/minute) 
and Ringer’s lactate solution (aliquots of 20 ml/kg/20 minutes until 
MAP >60 mmHg). GII was equal to GI but ringer lactate administration 
was replaced during 20 minutes of whole blood stored during 10 days 
at half blood loss volume.
Results  See Table 1. Both groups showed a signifi  cant  parameter 
decrease during hemorrhagic shock (t1) compared with t0. After 
treatment GI showed improvements in all parameters, GII showed 
improvement until t3. During t4 the animals presented a signifi  cant 
increase in K levels, lactate and decreased SvO2, CO, MAP followed by 
an increase in SvO2 (89%). The diff  erences between the two groups 
and moments were statistically signifi  cant (P >0.01). GII had a 50% 
of mortality rate between t4 and t5 related with potassium increase. 
Subsequent to animal blood treatment, the patients showed an 
increase in T wave, ventricular fi  brillation and death.
Table 1 (abstract P90)
 CO  MAP  SvO2 PAP  K Lactate
  (l/min)   (mmHg)   (%)   (mmHg)   (mmol/l)   (mg/dl)
t0  GI  3.6 ± 0.4  86 ± 10 75 ± 3  18 ± 2 3.5 ± 0.4 19 ± 8
t1 GI  1.3 ± 0.3  48 ± 10  58 ± 5  8 ± 3  4 ± 0.3  47 ± 8
t0  GII  4 ± 0.4 84 ± 8 76 ± 3 20 ± 3 4 ± 0.2  20 ± 10
t2  GII  1.5 ± 0.5  44 ± 5 57 ± 3 10 ± 2  4.3 ± 0.3  50 ± 108
Conclusions It is possible to conclude that whole blood replacement in 
animals with HS should be slow and steady to avoid the eff  ects of high 
K administration during a short period. Those therapeutic interventions 
are indicated to avoid the consequences of HS.
Reference
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Introduction  Arginine vasopressin (AVP) and terlipressin (TP) are 
increasingly used to stabilize mean arterial pressure in the setting of 
septic shock. Whether these vasopressor agents negatively impact on 
microcirculatory perfusion is still not fully understood. The objective 
of the present study was, therefore, to elucidate the eff  ects of AVP 
and TP on microcirculatory perfusion in patients with catecholamine-
dependent septic shock.
Methods  We enrolled 60 fl   uid-resuscitated septic shock patients 
requiring norepinephrine (NE) to maintain mean arterial pressure 
(MAP) between 65 and 75 mmHg. Patients were randomly allocated to 
be treated with either continuous TP infusion (1 μg/kg/hour), or AVP 
(0.04 U/minute), or titrated NE (control; each n = 20). In both the TP 
and AVP groups, NE was titrated to achieve a MAP between 65 and 
75 mmHg. Data from right heart catheterization and sidestream dark-
fi  eld imaging were obtained at baseline and after 6 hours.
Results No signifi  cant diff  erences were found between groups in terms 
of MAP, cardiac index, mixed-venous oxygen saturation, arterial lactate, 
and microvascular fl  ow index of the small vessels (2.1 (1.8; 2.4) vs. 3.0 
(2.6; 3.0) for TP, 1.9 (1.7; 2.3) vs. 2.7 (2.0; 3.0) for AVP, 2.3 (2.1; 2.6) vs. 
3.0 (2.9; 3.0) for NE). Conversely, AVP and TP signifi  cantly reduced NE 
requirements over time (0.57 (0.29; 1.04) vs. 0.16 (0.03; 0.37) μg/kg/
minute for TP and 0.40 (0.20; 1.05) vs. 0.23 (0.03; 0.77) μg/kg/minute for 
AVP; all P <0.05). However, no diff  erences were found between TP and 
AVP after 6 hours.
Conclusions  The results of the present study suggest that vaso-
pressinergic V1 agonists allow a reduction in catecholamine require-
ments without negative impact on microvasular perfusion as compared 
with sole NE therapy.
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Introduction We examine benefi  ts and risks of vasopressin/terlipressin 
use in patients with vasodilatory shock on mortality and morbidity.
Methods  We searched the CENTRAL, MEDLINE, Embase, and LILACS 
(through to August 2010) databases. Randomized and quasi-
randomized trials of vasopressin/terlipressin versus placebo or suppor-
tive treatment in adult and pediatric patients with vasodilatory shock 
were included. The primary outcome for this review was short-term all-
cause mortality.
Results We computed data from 10 randomized trials (n = 1,111). The 
overall (28-day, 30-day, ICU, hospital and 24-hour) mortality for those 
treated with vasopressin and terlipressin versus control patients was 
237 of 582 (40.7%) versus 226 of 528 (42.8%) (RR, 0.92; 95% CI, 0.81 to 
Figure 1 (abstract P92). Overall mortality.
Figure 2 (abstract P92). Norepinephrine dosage.
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59/585, 10.0% vs. 55/529, 10.3%) (RR, 1.81; 95% CI, 0.62 to 1.86; P = 0.78; 
I2 = 0%). See Figure 1. Patients receiving vasopressin/terlipressin are 
associated with a lower dosage of norepinephrine (seven trials, –0.79 
μg/kg/minute (95% CI, –1.25 to –0.33; P <0.001; I2 = 73.6%) and a trend 
towards a higher urine output within 24 hours of treatment (six trials, 
0.40 ml/kg/hour (95% CI, –0.11 to –0.92; P = 0.12; I2 = 67.7%). See Figure 2.
Conclusions No signifi  cant eff  ect of vasopressin/terlipressin therapy 
on all-cause mortality was demonstrated. Overall, there is no evidence 
to support the routine use of vasopressin or terlipressin in the 
management of patients with vasodilatory shock. There was, however, 
a reduction in the dose of norepinephrine used for those patients 
receiving vasopressin/terlipressin.
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Introduction Terlipressin (TP) is increasingly used in catecholamine-
dependent septic shock. Whereas recent data suggest advantages of 
continuous infusion over repetitive bolus infusion, the optimal time 
of TP initiation remains unclear. The present study was designed as 
a prospective laboratory experiment to compare the impact of early 
versus delayed TP infusion on key hemodynamic variables, as well as 
fl  uid and catecholamine requirements in ovine septic shock.
Methods Twenty-three healthy female sheep were anesthetized and 
instrumented for hemodynamic monitoring. A median laparotomy 
was performed and 1.5 g/kg feces were taken from a cecal incision. 
After gut suture and insertion of peritoneal drains, the abdomen was 
closed. Following baseline measurements, autologous feces were 
injected into the abdominal cavity via a drain. When septic shock had 
established (MAP <60 mmHg and arterial lactate >1.8 mmol/l), causal 
therapy (meropenem infusion and peritoneal lavage every 8 hours) 
and supportive treatment (volume therapy guided by stroke volume 
variation and global end-diastolic volume, as well as norepinephrine 
infusion to maintain MAP >60 mmHg) were initiated. Sheep were 
randomized to placebo (n = 7), or to continuous TP infusion (2 μg/
kg/hour) started at shock onset (early TP; n = 8), or to continuous TP 
infusion (2 μg/kg/hour) started when NE requirements exceeded 
0.3 μg/kg/minute (delayed TP; n = 8). After 24 hours of therapy, the 
surviving sheep were killed in deep anesthesia.
Results Whereas two out of seven sheep allocated to the placebo 
group survived, three out of eight survived in both TP groups. Whereas 
hemodynamic variables were similar among groups, cumulative 
open-label NE requirements were signifi  cantly lower in the early TP 
group (0.8 ± 0.6 mg/kg) as compared with both the placebo group 
(2.7  ±  0.6  mg/kg) or the delayed TP group (2.2  ±  0.5  mg/kg; each 
P <0.05). Total fl  uid requirements and increase in body weight tended 
to be lower in the early TP group as compared with the other two 
groups.
Conclusions  Early TP infusion reduces catecholamine and fl  uid 
requirements as compared with delayed TP therapy and placebo in 
ovine septic shock.
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Introduction  Acute heart failure (AHF) is common among trauma 
patients with pre-existing coronary artery disease (CAD) and 
myocardial perfusion defect. The therapy is aimed at increased 
contractility while decreasing afterload and includes β1-adrenergic 
agents and phosphodiesterase III inhibitors, which act by increasing 
the intracellular calcium (Ca) concentration, thus markedly increasing 
myocardial energy consumption and risk of arrhythmias. The new 
Ca sensitizer levosimendan enhances cardiac performance without 
increasing myocardial energy demand and oxygen consumption. We 
report new use of levosimendan in polytrauma victims with AHF.
Methods  In this prospective randomized clinical trial we studied 
eff  ects of levosimendan on myocardium of polytrauma victims with 
a history of CAD who subsequently developed AHF as diagnosed by 
invasive monitoring and transthoracic echocardiography. Dobutamine 
was administered initially to maximum dose or eff   ect and later 
combined with levosimendan (Group I, n  =  12) or with adrenaline 
(Group II, n = 14). The hemodynamic data were recorded every 6 hours. 
The primary outcome measures were ECG, cardiac index (CI), troponin I 
(TnI), and incidence and type of complication. The secondary measures 
were global perfusion indices: atrial natriuretic peptide (ANP), serum 
lactate (SL), and inotropic therapy duration.
Results  A second inotropic drug infusion was added when AHF 
persisted with average CI of 2.1 ± 0.15 l/minute/m2 and left ventricular 
ejection fraction of 41  ±  7% despite achieved normovolemia (CVP 
11 ± 2 mmHg, pulmonary artery wedge pressure 15 ± 1 mmHg) and 
continued dobutamine infusion to the maximum eff  ective dose. CI 
improved to 3.5 ± 0.14 and 2.6 ± 0.33 l/minute/m2 in Groups I and II, 
respectively (P <0.03). Group I patients had lower levels of TnI, and 
rate of arrhythmias. ANP was signifi  cantly lower in Group I, as well as 
SL. Duration of inotropic therapy was 71 ± 10.5 hours in Group I and 
102 ± 13.5 hours in Group II (P = 0.001).
Conclusions Levosimendan eff  ectively enhances myocardial contract-
ility and improves global circulation in polytrauma patients with 
refractory AHF. It had a signifi  cantly lower rate of complications related 
to increased work of the heart compared with what is usually reported 
with the use of catecholamines.
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Introduction We report a case in which cardiovascular collapse after 
suicidal calcium channel blocker (CCB) overdose was successfully 
treated with levosimendan with traditional treatment.
Methods A 20-year-old male who had taken 250 mg amlodipin besilat 
was admitted to the ICU from the Emergency Department. His blood 
pressure was 70/52 mmHg, heart rate 95 bpm and oxygen saturation 
99%. An arterial catheter was inserted and arterial blood pressure 
(ABP) of 52/20 mmHg was measured. He was tracheally intubated 
and dopamine infusion of 10 μg/kg/minute, dobutamine infusion of 
5 μg/kg/minute was initiated. Dopamine and dobutamine infusions 
were increased to 20 μg/kg/minute and 15 μg/kg/minute, respectively. 
Despite very high doses of vasopressors, his ABP tended to decrease 
below 50 mmHg and frequent epinephrine boluses were given. Upon 
arrival 8  hours later, levosimendan was initiated without an initial 
loading dose infusion of 0.2 μg/kg/minute. In 4 hours from initiation 
of levosimendan treatment, dobutamine and dopamine infusions were 
stopped respectively. After full recovery the patient was discharged 
72 hours after arrival.
Results  CCB overdose causes intractable hypotension, bradycardia, 
cardiac conduction abnormalities and depression of myocardial 
contractility, leading to central nervous system, respiratory and 
metabolic disorders that are often refractory to standard resuscitation 
methods. Therapy of intoxication includes measures to inhibit further 
ingestion and absorption with gastric lavage and activated charcoal, to 
maintain adequate blood pressure with high doses of catecholamine 
and fl  uid replacement and to reverse negative inotropic eff  ects by 
β-adrenergic agonists, phosphodiesterase inhibitors, glucagon, 
insulin with dextrose and calcium salt. Well-known inotropic agents 
show their eff  ects via increasing intracellular calcium level. In CCB 
overdose patients, the effi   ciency of these drugs was limited because 
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levosimendan, acts as a calcium sensitizer and increases the association 
rate of myosin actin cross-bridges and slows down their dissociation 
rate by binding to troponin C. It also exhibits systemic and coronary 
vasodilatation via ATP-sensitive potassium channels in vascular smooth 
muscle cells and on mitochondria.
Conclusions  We suggest that levosimendan can be considered an 
additional treatment option in patients with cardiovascular collapse 
due to CCB intoxication that is refractory to standard management.
P96
Eff  ect of diff  erent antioxidants in ischemia–reperfusion syndrome
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Introduction  The ischemia–reperfusion syndrome commonly seen 
in diff  erent clinical scenarios leads to acute renal failure and it is 
known that the free oxygen radicals play an important role in the 
pathophysiology of this injury. Recent studies suggest that the use 
of antioxidants can provide renal protection, reducing parenchymal 
lesions and expression of infl  ammatory mediators, improving renal 
function, resulting in a better outcome.
Methods We studied the eff  ect of DMSO, DMSO–ascorbic acid and 
DMSO–N-acetylcysteine administration on renal injury induced 
by I/R. Thirty minutes renal ischemia was induced in 50 male, New 
Zealand rabbits. The subjects were divided into fi  ve groups: (A) Sham, 
unilateral nephrectomy, no ischemia induced. (B) Control group. (C) 
DMSO, unilateral nephrectomy, I/R treated with DMSO 3.8 mg/kg. (D) 
DMSO–ascorbic acid, unilateral nephrectomy, I/R treated with ascorbic 
acid 150  mg/kg and DMSO 3.8  mg/kg. (E) DMSO–N-acetylcysteine 
unilateral nephrectomy, I/R treated with N-acetylcysteine 20  mg/kg 
and DMSO 3.8 mg/kg. All subjects were given 8 hours of reperfusion. 
Two blood samples were taken at baseline and after the reperfusion 
phase. Each sample was tested for serum creatinine. After reperfusion 
left nephrectomy was performed on each subject before euthanasia. 
A pathological analysis evaluated tubular and basement membrane 
changes. The level of injury was scaled in three stages: mild, moderate 
and severe.
Results  The histological analysis showed a total damage in 59% 
of the control group, compared with DMSO 33%, DMSO–AA 51%, 
and DMSO–NAC 44% (Figure 1). Also, infl  ammatory properties were 
absent or to a lesser extent in those groups who used antioxidants. 
Serum creatinine analysis in the control group showed higher values 
compared with the association of DMSO–AA, DMSO–NAC where the 
increases were lower (Figure 2).
Conclusions  The fi   ndings imply that reactive oxygen species play 
a causal role in I/R-induced renal injury, and that antioxidants exert 
renoprotective eff  ects, probably by radical scavenging and antioxidant 
activities, in this way diminishing renal function deterioration.
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Introduction  Both hemodynamic and nonhemodynamic factors 
are implicated in the pathogenesis of sepsis-induced acute kidney 
injury (SAKI). However, despite similar septic insult, not all patients 
develop SAKI. The reasons for the diff  erence in sensitivity to AKI are 
unknown. Therefore, we sought to analyze dynamic changes in renal 
hemodynamic and non-hemodynamic responses to sepsis in animals 
who developed AKI and those who do not.
Methods Thirty-six pigs were anesthetized, mechanically ventilated 
and instrumented. After a recovery period, progressive sepsis was 
induced either by peritonitis (n = 13) or by i.v. infusion of Pseudomonas 
aeruginosa ( n  =  15). Eight sham-operated animals served as time-
matched controls. All animals received standard ICU care including 
goal-directed hemodynamic management. Before and at 12, 18 and 
24 hours of sepsis systemic and renal hemodynamic, microcirculatory 
and infl   ammatory variables were measured. AKI development was 
defi  ned using AKIN criteria.
Results  Fourteen pigs (50%) developed AKI (62% in peritonitis 
model, 40% in bacteria infusion model) with a signifi  cant increase 
in serum creatinine observed already at 18  hours of sepsis. There 
were no diff  erences in the systemic hemodynamics and vasopressor 
support between AKI and non-AKI groups. Although time-dependent 
reduction in cortical microvascular perfusion was comparable in both 
groups, only AKI animals developed a progressive increase in renal 
vascular resistance. This intrarenal vasoconstriction was preceded by a 
marked overproduction of serum cytokines (TNFα, IL-6) and markers 
of oxidative stress (TBARS), observed already at 12 hours of sepsis. 
This induction of proinfl  ammatory response was delayed in non-AKI 
animals.
Conclusions The observed variability in susceptibility to SAKI in our 
models replicates that of human disease. This heterogeneity allowed 
us to isolate and study factors discriminating AKI from non-AKI. Early 
systemic infl  ammation coupled with late intrarenal vasoconstriction 
appears to be major determinant of the initiation of SAKI. Genetic and 
proteomic analyses underlying the observed diff  erences are being 
analyzed.
Acknowledgements The study was supported by the Research Project 
MSM 0021620819.
Figure 1 (abstract P96). Total histopathological renal damage.
Figure 2 (abstract P96). Mean serum creatinine values in the diff  erent 
groups.
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independently associated with mortality in patients with 
decompensated alcoholic liver disease
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Introduction  Patients with decompensated alcoholic liver disease 
have a high mortality if they require critical care. Previous studies have 
indicated that patients who required renal replacement therapy have 
high mortality, but there is little research on the mortality rate of those 
with renal impairment not requiring support.
Methods A retrospective cohort study of patients with a diagnosis of 
decompensated alcoholic liver disease admitted to the critical care 
department of two hospitals over a 3-year period was conducted 
(n = 51).
Results There was no signifi  cant diff  erence in the ages (50.8 and 50.3, 
P = 0.9) or sexes of those who survived and those who died during 
hospital stay. Hospital, 6-month and 1-year mortality rates were 45%, 
49% and 51%, respectively. There was no signifi  cant diff  erence in the 
number of patients requiring advanced respiratory support (69% 
vs. 74%, P = 0.76). Ninety-four per cent of patients who had a serum 
creatinine of 150 mmol/l or greater at admission to critical care died 
during their hospital stay.
Conclusions The futility of admitting patients with decompensated 
alcoholic liver disease with serum creatinine of 150 mmol/l or greater 
should be considered at the time of referral to critical care, as they have 
a 94% mortality.
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Introduction Contrast-induced nephropathy (CIN) is a signifi  cant and 
preventable cause of renal failure associated with increased mortality, 
hospital stay and long-term haemodialysis. Critically ill patients have 
increased risks of developing CIN due to pre-existing disease and 
sepsis. A university hospital audit in 2007 found that 22.2% of ITU 
patients had signifi   cant rises in creatinine following intravenous 
contrast medium (IVCM). In 2008, IVCM guidelines were implemented 
trust-wide to detect patients with pre-existing renal impairment and 
provide guidance for pre-optimisation and prophylactic measures 
depending on CKD stage, including early renal team involvement. 
A re-audit assessed the impact of IVCM guidelines in decreasing the 
incidence of CIN in ITU.
Methods ITU patients who received IVCM for CT studies from March 
to December 2010 were identifi  ed. Patients on haemodialysis pre-
contrast or who died within 48  hours post-contrast administration 
were excluded. Pre-contrast (within 48 hours) and post-contrast (48 
to 72 hours) creatinine levels were analysed. CIN was defi  ned as an 
increase in serum creatinine exceeding 25% or 44 μmol/l from baseline 
within 3 days of administration of contrast media in the absence of 
alternative causes.
Results  Ninety patients were identifi  ed. Ten patients who required 
haemodialysis pre-contrast or died within 48  hours post-contrast 
were excluded. Mean age was 59 years (range 25 to 89 years) with a 
male:female ratio of 46:34. Fourteen (17.5%) patients had signifi  cant 
rises in creatinine post-contrast. Patients who died within 48 hours had 
ruptured AAA, severe sepsis, ischaemic bowel, and so forth.
Conclusions The incidence of CIN has decreased to 17.5% in medical 
and surgical ITU patients since the introduction of the IVCM guidelines.
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Introduction  Acute kidney injury (AKI) is a serious complication 
associated with increased morbidity and mortality in pediatric patients 
undergoing surgery for congenital heart disease. The aim of this study 
was to evaluate children with AKI after pediatric cardiac surgery using 
pediatric-modifi  ed RIFLE (pRIFLE) criteria and to investigate the value 
of serum cystatin C in patients with AKI.
Methods  Eighty-one children undergoing cardiopulmonary bypass 
(CPB) for surgical correction of acyanotic congenital heart disease 
were prospectively enrolled in the study. Serial blood samples were 
collected to measure serum cystatin C and creatinine levels. The 
primary outcome measure was AKI, defi  ned as ≥50% increase in serum 
creatinine from baseline.
Results  Twenty-one children (26%) developed AKI, in which risk 
occurred in 12 (15%), injury in three (4%) and failure in six (7%) of 
the patients diagnosed with serum creatinine. Patients with AKI 
were signifi  cantly younger than patients without AKI (P = 0.002). No 
diff  erences were noted with respect to CPB and aortic cross-clamp 
durations in those with and without AKI (P  >0.05). Postoperative 
24-hour inotrope scores were signifi   cantly higher in children who 
developed AKI (P  =  0.003). Serum cystatin C concentrations were 
signifi  cantly increased in AKI patients at 2 hours after CPB (P = 0.029) 
and remained elevated at 24 hours (P <0.001) and 48 hours (P = 0.001). 
There was a signifi  cant positive correlation between presence of AKI 
and serum cystatin C levels (P <0.05). A signifi  cant negative correlation 
was found between age and AKI (r = –0.344, P = 0.002).
Conclusions AKI develops in 26% of patients after pediatric cardiac 
surgery. Our results suggest that patients with AKI were younger and 
had postoperative higher serum cystatin C levels and higher inotrope 
scores when compared with patients without AKI.
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Introduction  Acute kidney injury (AKI) after coronary artery bypass 
grafting (CABG) surgery is associated with increased postoperative 
morbidity and mortality. The aim of this study was to apply the RIFLE (risk 
(R), injury (I), failure (F), loss (L) and end-stage kidney disease (E)) criteria 
in patients after CABG surgery, to identify intraoperative risk factors for 
occurrence of AKI and to analyze the impact of AKI on mortality.
Methods  Five hundred consecutive patients who underwent 
CABG surgery between December 2004 and December 2007 were 
retrospectively studied. Those who had combined valve and coronary 
surgery, off   -pump surgery and those receiving renal replacement 
therapy preoperatively were excluded from the study. The primary 
outcome measure was AKI, defi   ned as ≥50% increase in serum 
creatinine from baseline.
Results The mean age of the patients (74% male) was 60.9 ± 9.8 years. 
The incidence of AKI was 4%, in which risk occurred in 2%, injury in 1% 
and failure in 1% of the patients. The cardiopulmonary bypass (CPB) 
time and duration of the surgery was signifi  cantly longer in patients 
who developed AKI (P = 0.024, P = 0.002). The amounts of fl  uid and 
blood administered and vasopressor requirements during surgeries 
were similar between patients who developed AKI and those without 
AKI (P >0.05). The need for intraoperative cardiopulmonary resuscitation 
(CPR), the use of intra-aortic balloon pump (IABP) and total circulatory 
arrest (TCA) was signifi  cantly higher in AKI patients (P = 0.002, P = 0.001 
and P = 0.036, respectively). When compared with non-AKI patients, 
postoperative mortality for patients experiencing AKI was signifi  cantly 
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presence of postoperative mortality and AKI (r = 0.232, P <0.001).
Conclusions The results suggest that AKI develops in 4% of patients 
after CABG surgery. Intraoperative risk factors for occurrence of AKI 
include longer duration of surgery, CPB time and requirements of CPR, 
IABP and TCA usage. In addition, postoperative development of AKI is 
associated with mortality.
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Introduction  Acute kidney injury (AKI) increases either in-hospital 
mortality or long-term mortality. The severity of AKI has been associated 
with early mortality; however, studies on its role in long-term mortality 
have shown contradictory results.
Methods We studied 300 critically ill patients who had survived an AKI 
episode defi  ned by AKIN creatinine criteria. All patients were attended by 
nephrologists in 2005 to 2006 and studied in May 2008. Exclusion criteria: 
age <18 years, presumed etiology other than acute tubular necrosis, 
baseline creatinine >3.5  mg/dl, nephrology follow-up  <2 days and 
renal transplant. Analyzed variables: age; gender; type of admission; AKI 
etiology (ischemia, nephrotoxicity, sepsis or multifactorial); baseline and 
hospital discharge GFR (evaluated by MDRD equation); AKIN classifi  cation 
(1, 2, 3); need for dialysis, mechanical ventilation or vasoactive drugs; 
presence of comorbidities (hypertension, diabetes, heart failure, cancer 
or chronic liver disease); and functional recovery at hospital discharge 
(discharge GFR ≤1.1 baseline GFR). Survivors and nonsurvivors were 
compared by t test, Mann–Whitney test, Fischer’s test or chi-square test, 
as appropriate. Causes of death were identifi  ed by death certifi  cate. Data 
are presented as median (25 to 75 IQ) or percentage.
Results At the end of the study 105 patients had died (35%). Death 
occurred 194 days (69 to 444) after hospital discharge. The main 
cause of death was cardiovascular diseases (39%). The comparison 
between survivors and nonsurvivors showed that survivors had higher 
percentage of males (67 and 52%, P = 0.01), were younger (63 (49 to 72) 
and 70 years (56 to 79), P <0.0001), had more multifactorial AKI etiology 
(26 and 41%, P = 0.01) and less heart failure as comorbidity (17 and 
32%, P = 0.006). Unexpectedly, more survivors had needed mechanical 
ventilation (57 and 32%, P = 0.006) but neither vasoactive drugs (60 
and 61%, P >0.05) nor dialysis (38 and 39%, P >0.05). See Table 1.
Table 1 (abstract P102). AKI characteristics
 Survivors  Nonsurvivors  P value
AKIN 1; 2; 3 (%)  39; 25; 36  40; 30; 30  0.38
Baseline GFR  63 (41 to 88)  54 (33 to 74)  0.015
Hospital discharge GFR  53 (36 to 73)  42 (27 to 65)  0.02
Functional recovery (%)  49  47  0.8
Conclusions Long-term survival after AKI is not associated with the AKI 
severity but with baseline renal function.
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Any level of acute kidney injury may be associated with mortality in 
critically ill patients
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Introduction  Acute kidney injury (AKI) is a common condition in 
critically ill patients [1]. It is an independent risk factor for in-hospital 
mortality in this population [2]. The goal of this research is to classify 
critically ill patients within RIFLE criteria [3] and assess its impact on 
30-day in-hospital mortality.
Methods From September 2009 to July 2010, all patients admitted 
to two ICUs of Santa Casa Hospital were included in this study. Age, 
gender, SOFA and APACHE scores, origin, serum creatinine, whether 
they were clinical or surgical, and outcome were noted. Then patients 
were classifi  ed as ‘no AKI’, ‘risk’, ‘injury’, or ‘failure’ according to RIFLE 
criteria. The 30-day in-hospital mortality was also evaluated. A 
multivariate analysis model was created from potentially confusing 
variables that were statistically signifi   cant in an unvaried analysis. 
P <0.05 was considered statistically signifi  cant.
Results Two hundred and six patients were included. Most of them were 
women (54%), with an average age of 62 years. The mean APACHE score 
was 17 and the mean SOFA score was 5.8. The proportion, according 
to the RIFLE criteria, for patients at ‘risk’ was 17%, at ‘injury’ was 14%, 
‘failure’ was 26% and ‘no AKI’ was 42%. The relative risk for 30-day in-
hospital mortality for the group ‘no AKI’ was 0.5 (95% CI = 0.39 to 0.63; 
P <0.001); for the ‘risk’ group was 1.7 (95% CI = 1.03 to 3.06; P = 0.037); 
for the ‘injury’ group was 1.66 (95% CI = 0.97 to 2.85; P = 0.062); and for 
the ‘failure’ group was 2.03 (95% CI = 1.22 to 3.37; P = 0.006).
Conclusions AKI incidence, according to RIFLE classifi  cation, is high in 
critically ill patients. There is an association between AKI severity and 
mortality. It is noticeable that patients in the ‘risk’ group have increased 
mortality.
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Introduction RIFLE provides standardized criteria for defi  ning acute 
kidney injury (AKI) [1]. It is based on changes in serum creatinine (sCr), 
in relation to a premorbid sCr, and on urine output. When premorbid 
sCr is unknown, baseline sCr is estimated. Often only sCr is used 
(RIFLEcreat). Thus there are four methods for defi  ning AKI: actual RIFLE, 
actual RIFLEcreat, estimated RIFLE and estimated RIFLEcreat. There 
is much interest for biomarkers predicting early AKI [2]. Critical for 
determining a biomarker’s performance of AKI is the diagnosis of the 
fi  rst day of AKI (AKI-0). We compared the impact of four AKI defi  nitions 
on determining AKI-0.
Methods An observational study for 6 months in ICU patients admitted 
≥48  hours. For the fi  rst 7 days we calculated daily the number of 
patients diagnosed with AKI-0 using the four AKI defi  nitions.
Results One hundred and one patients (39%) had a known premorbid 
sCr. Mean age and APACHE was respectively 64 (13) and 22 (7). Figure 1 
(overleaf) shows the distribution of AKI-0.
Conclusions The early diagnosis of AKI is signifi  cantly reduced when 
urine output criteria are neglected in the RIFLE defi  nition, and also 
when baseline sCr is estimated. This may signifi   cantly impact the 
assessment of biomarker performance.
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Introduction Recently the Acute Kidney Injury (AKI) Network proposed 
criteria for the defi  nition of AKI in the critically ill. The minimum hourly 
urine output rate used to defi  ne oliguria (<0.5 ml/kg/hour) is based 
exclusively on clinical experience and animal models, not on clinical 
investigation. Moreover, the minimum duration of oliguria (6 hours) 
is based on clinical experience and was never experimentally 
determined. We used a massive database of ICU patients (MIMIC) to 
continuously vary the observation period and threshold of urine output 
measurements to determine optimal AKI defi  nitions for improved in-
hospital mortality prediction.
Methods After excluding end-stage renal disease, 14,536 adult patients 
were included. Various AKI thresholds corresponding to diff  erent 
observation periods and urine output measurement thresholds were 
analyzed using a multivariate logistic regression model for each 
choice of thresholds. A total of 470 regression models were plotted. 
We controlled for sex, age, SOFA and co-morbidities (ICD-9 codes). 
To visualize dependence of adjusted mortality rate and mortality 
predictive power on AKI defi  nition, we generated 3D and contour plots.
Results The UO versus mortality plot demonstrates that when UO <0.5 
the mortality rate increases rapidly as urine output decreases. Mortality 
increases sharply for observation periods up to 5 hours and then the 
rate of increase is reduced until a plateau is reached at approximately 
24 hours. Cross-sections at 6, 12 and 24 hours of the UO mortality plot 
shows that the mortality rate of AKI 1 and AKI 2 are similar but diff  er 
signifi  cantly from AKI 3. See Figure 1.
Conclusions  The current AKIN recommendation that uses a urine 
output of 0.5 ml/kg/hour is valid. Since AKIN’s stages 1 and 2 were 
found to exhibit similar mortality rates, we propose a reduction in the 
AKI 2 threshold to 0.4 ml/kg/hour to better delineate among the three 
stages. We demonstrated that the mortality rate increases sharply 
during the fi  rst 5 hours of oliguria. Hence, the current used observation 
period (6 hours) seems to be valid.
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Urine biomarkers for gentamicin-induced acute kidney injury in the 
neonatal ICU
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Introduction Gentamicin (GM) is an aminoglycoside frequently used in 
the neonatal ICU to treat infections. Despite low resistance and costs, 
GM is also nephrotoxic and may cause acute kidney injury (AKI). Serum 
creatinine appears to be an insensitive and unreliable marker in this 
setting. The objective of this study was to determine whether urine 
biomarkers are useful for early detection of gentamicin-induced AKI in 
neonates in the neonatal ICU.
Methods  Subjects Thirty-three neonates (26 male/seven female, 
gestational age ±36 weeks) with a bladder catheter without pre-existent 
kidney disease were divided into a GM group (n = 20) and a reference 
group (n  =  13).  Study design and procedures A prospective, clinical 
observational trial with non-invasive procedures. Demographics, vital 
signs and clinical conditions were recorded. Every 2 hours, during the 
period of bladder catheter, urine samples were collected and renal 
injury biomarkers glutathione-S-transferase A1-1 (GSTA1-1), GSTP1-
1, kidney injury marker-1 (KIM-1), N-acetyl-β-D-glucosaminidase 
(NAG) and neutrophil gelatinase-associated lipocalin (NGAL) were 
determined. Residual blood samples were used to measure serum 
creatinine (sCr).
Results  Demographics were similar between both groups expect 
for baseline BUN (P <0.04), which disappeared after the fi  rst day of 
the study. No signifi  cant diff  erences were found in baseline kidney 
function, hemodynamics, ventilation support and reason for admission. 
Treatment with GM resulted in higher levels of sCr compared with the 
reference group (58.5 (44.8 to 78.5) vs. 34 (28.3 to 58.8) mmol/l; P <0.05). 
The average time until the highest peak was shorter for both GSTA1-1 
and GSTP1-1 compared with sCr (P <0.05). Furthermore, higher levels 
of sCr corresponded with higher levels of urine biomarkers and KIM-1, 
NAG and GSTP1-1 could diff  erentiate between the GM and reference 
group.
Figure 1 (abstract P104). Distribution of AKI-0.
Figure 1 (abstract P105). (a), (b) Urine output mortality plot. (c) Cross-section at 6, 12, 24 hours.
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excretion of all biomarkers, especially after GM use. In addition, the 
urinary biomarker GSTP1-1 might be useful for early detection of AKI 
in the neonatal ICU.
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Introduction  Plasma neutrophil gelatinase-associated lipocalin 
(pNGAL) is an early biomarker of acute kidney injury (AKI) [1].
Methods  A prospective observational study enrolling adult ICU 
patients developing a fi  rst episode of oliguria defi  ned as urinary output 
lower than 0.5 ml/kg/hour for at least only 2 consecutive hours despite 
conventional treatment and appropriate fl  uid resuscitation. pNGAL 
(Biosite, Inverness, San Diego, CA, USA), plasma cystatin C, plasma 
and urinary sodium and creatinine, were measured to determine on 
1 hour the fraction of excretion of the fi  ltered sodium (FeNa) and the 
glomerular fi  ltration rate (GFR). The SOFA score and RIFLE score [2] were 
calculated. Hospital mortality was recorded.
Results Ninety-three patients were enrolled: 52 presented with 0, 15 
with R, 13 with I and 10 with F RIFLE score. The median SOFA score 
was 3 (minimum: 0 to maximum: 17). Sepsis was the main diagnostic 
in 38 patients, 27 were cardiac surgery patients who underwent 
cardiopulmonary bypass (CBP) and 28 were miscellaneous other 
category patients (hemorrhagic shock, hypotensive surgery, trauma 
with crush, and so on). In-hospital mortality of the studied cohort 
was 20%. Eighty-fi  ve percent of FeNa were less than 1%, suggesting 
active antidiuresis and sodium reabsorption. The distribution of pNGAL 
between survivors (median 61 ng/ml, 95% CI = 59 to 91 ng/ml) and 
nonsurvivors (median 182 ng/ml, 95% CI  =  86 to 594 ng/ml) was 
statistically signifi  cant (P = 0.006, Wilcoxon rank test). Distribution of 
pNGAL in patients post CPB (median 59 ng/ml; 95% CI = 59 to 59), was 
statistically diff  erent from patients with sepsis (median 180 ng/ml; 95% 
CI = 92 to 276) and the last group (median 85 ng/ml; 95% CI = 59 to 166) 
with respectively P <0.0001 and 0.024 after Bonferroni’s correction. 
No correlation between pNGAL and FeNa was found (Spearman’s 
rho = 0.309; 95% CI = 0.11 to 0.48), nor between pNGAL and 1-hour 
GFR (Spearman’s rho = –0.55; 95% CI = –0.68 to –0.38), neither between 
pNGAL and plasma cystatin C (Spearman’s rho = 0.62; 95% CI = 0.47 to 
0.73).
Conclusions pNGAL rises in early oliguria independently while kidney 
function markers such as GFR, FeNa and cystatin C may have remained 
unaff  ected at this stage. Sepsis is a stronger trigger for pNGAL elevation.
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Introduction Acute kidney injury (AKI) is common in septic shock and 
there is no good marker to predict it. Neutrophil gelatinase-associated 
lipocalin (NGAL) is a novel renal biomarker showing promising results 
in prediction of AKI in patients across diff  erent clinical settings. Another 
potential marker is the resistive index (RI) of renal interlobar artery 
(calculated as (peak systolic velocity – end diastolic velocity) / peak 
systolic velocity), which has been shown to be useful in identifying those 
who will develop AKI in patients with septic shock. The aim of this study 
is to evaluate the usefulness of RI and NGAL in the early detection of AKI.
Methods  A prospective, observational study in a 20-bed medical/
surgical ICU of a university teaching hospital. All patients with septic 
shock were recruited, excluding those with chronic renal failure (serum 
creatinine >120 μmol/l). Within the fi  rst 24 hours after the introduction 
of vasopressor, urine and serum were collected for NGAL measurement 
and RI was determined by two independent operators. The occurrence 
of AKI was measured at day 3, according to RIFLE criteria. RI and NGAL 
were compared between patients with (RIFLE-F) and without (RIFLE-
0/R/I) AKI.
Results During the period from August to November 2010, 20 patients 
(age 58  ±  16) with septic shock were recruited. Eleven patients 
were classifi  ed as having AKI. No signifi  cant diff  erence in baseline 
characteristics such as APACHE II score and baseline creatinine was 
shown at enrollment. RI, serum-NGAL and urine-NGAL were all higher 
in patients with AKI (RI: 0.749 ± 0.0697 (mean ± SD) vs. 0.585 ± 0.0983, 
P <0.001; serum-NGAL: 2,182 ± 838 ng/ml (mean ± SD) vs. 1,075 ± 1,006, 
P = 0.015; urine-NGAL: 2,009 ± 3,370 vs. 993 ± 1,789 (median ± IQR), 
P  =  0.025). Area under the ROC curve for RI and serum-NGAL was 
0.909 (±0.088, P = 0.002) and 0.808 (±0.113, P = 0.02), respectively. For 
RI, using 0.65 as the cut-off  , sensitivity and specifi  city was 1 and 0.89, 
respectively. For serum-NGAL, using a cut-off   of 1,200 ng/ml, it had a 
sensitivity of 1 and specifi  city of 0.67. Inter-observer diff  erence of RI 
was low (0.0015 ± 0.0074 (mean ± SD)).
Conclusions  Doppler ultrasound renal RI is non-invasive, rapidly 
available and easily reproducible, and is at least as good as NGAL as a 
predictor of AKI in patients with septic shock.
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Introduction The objectives of this study were to model and visualise 
fl  ow in a central vein during continuous venovenous haemodiafi  ltration 
(HDF), to measure drug removal when an HDF catheter is co-located 
with a central venous catheter (CVC) infusing medication. Dual lumen 
HDF catheters are commonly used to deliver continuous venovenous 
renal replacement therapy in critical care. These catheters are often co-
located with a CVC used to infuse drugs, with the tips lying in close 
approximation in a great vein. The eff  ect of this co-location on drug 
delivery to the patient due to aspiration by the HDF machine may be 
of serious import, with the elimination of important vasoactive drugs 
or minimally protein-bound antibiotics just two possibilities. This eff  ect 
has never been studied.
Methods A model of a human central vein was constructed using 
transparent polyvinyl chloride piping. A CVC and an HDF catheter were 
inserted into this and water fl  ow in the central vein and extracorporeal 
circuit was generated by centrifugal pumps at physiological volume 
fl  ow rates. Ink was used as a visual tracer and creatinine solution as a 
quantifi  able tracer to determine the extent of removal of CVC infusate 
via the HDF catheter. The longitudinal distance of the CVC infusion 
point from the arterial port of the HDF catheter was altered to quantify 
its eff  ect on tracer removal.
Results  Volume fl   ow rates of 1.45 l/minute and 200 ml/minute 
were achieved in the central vein model and the HDF circuit model, 
respectively, with laminar fl  ow in the central vein confi  rmed by Duplex 
imaging and ink fl  ow analysis. All visible ink and 100% of creatinine 
tracer infused via the CVC were aspirated by the HDF catheter unless 
the point of infusion was ≥1 cm downstream of the proximal aspect of 
the arterial port. No measurable tracer was aspirated when the infusion 
was ≥2 cm downstream. Orientation of side ports did not signifi  cantly 
aff  ect tracer removal.
Conclusions This initial study suggests that drugs infused via a CVC co-
located with an in-use HDF catheter may be completely and immediately 
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to signifi  cant drug underdosing with potentially severely deleterious 
consequences for patients. When co-location cannot be avoided, drugs 
with important immediate eff  ects or high membrane clearance should 
be infused suffi   ciently distal to the inlet of an adjacent HDF catheter.
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Introduction An eff  ective haemofi  lter circuit is essential for performing 
continuous renal replacement therapy (CRRT) effi   ciently and without 
interruption. Premature clotting is a major problem in the daily practice 
of CRRT associated with blood loss [1], increased workload and cost 
implications. Early clotting is related to various factors ranging from 
bio-incompatibility of the CRRT circuit material, the modality used, 
ineff  ective anticoagulation, to site of catheter placement. Shortened 
haemofi  lter circuit survival time due to high lipid content in total 
parenteral nutrition (TPN) has also been described in a case report 
[2]. We wish to determine whether TPN infusion led to shortening of 
haemofi  lter circuit duration.
Methods We conducted a retrospective analysis of notes of patients 
who had undergone CRRT in an adult general ICU over 2 years. 
Demographic (age, sex) and clinical (platelet count, INR, APTT, 
anticoagulant used and the rate of infusion of anticoagulant) data that 
are known to infl  uence the duration of CRRT circuit were compared. 
Cycles terminated because of high Pin pressure or documented failure 
of the circuit were included in the study and the duration of the circuit 
was determined. Note was made if the patient was on TPN during CRRT. 
They were divided in two groups: CRRT with TPN, and CRRT without 
TPN. All patients had the similar make vascath (14Fr, polyurethane 
catheter; Logitech) and the same CRRT machine and circuit.
Results One hundred and twenty-one patients had undergone CRRT in 
the unit in the past 2 years. In total, 246 CRRT circuits were used. A linear 
regression model was fi  tted to the duration of fi  ltration with TPN as a 
categorical predictor, along with other covariates. The mean duration 
of haemofi  lter circuit was 24.51 (24.08 to 29.08) hours without TPN and 
17.22 (14.98 to 23.59) hours on TPN. With the maximal model, TPN use 
was signifi  cantly (P <0.002) associated with a decrease in duration of 
fi  ltration, but none of the other factors were signifi  cant. There was a 
tendency for platelet count to be signifi  cant.
Conclusions So considering the eff  ect sizes, both TPN and increase 
in platelet count were associated with signifi  cant reduction in the 
duration of haemofi  ltration circuit. TPN led to decrease in duration of 
the haemofi  lter circuit by 7 hours. The eff  ect of TPN was found to be 
independent of the platelet count.
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Introduction  The relationship between systemic hemodynamic 
parameters and microcirculatory perfusion remains unclear. This is 
especially apparent in the concept of fl   uid responsiveness, where 
stroke volume (SV) can fl  uctuate strongly without being paralleled 
by changes in microcirculatory perfusion. Therefore, we hypothesized 
that large decreases in volume status due to ultrafi  ltration (UF) with 
intermittent hemodialysis in patients with end-stage kidney disease 
(ESKD) would decrease systemic hemodynamics but would not aff  ect 
parameters of microcirculatory perfusion.
Methods Consecutive patients on chronic intermittent hemodialysis 
for ESKD were eligible for our study. SV and heart rate were measured 
continuously and non-invasively using NICOM, a technique based on 
chest bioreactance. Blood pressure was measured intermittently with 
a sphygmomanometer. Peripheral and microcirculatory perfusion were 
measured intermittently with sidestream dark-fi   eld (SDF) imaging 
(sublingual area), and continuously with forearm-to-fi  nger temperature 
gradient (Tskin-diff   ) and photopletysmography (PPG) (fi  nger).  All 
parameters were assessed before (baseline) and after 4 hours at the 
end of UF.
Results Data are presented as median (IQR). Twenty-one patients (13 
males, median age 59 (51 to 66) years) were included in our study. 
A median volume of 2,200 (1,850 to 2,850) ml was removed. SV and 
mean arterial pressure decreased during UF from 75 (58 to 84) ml to 
51 (37 to 67) ml (P <0.01) and from 102 (88 to 109) mmHg to 85 (75 
to 95) mmHg (P <0.001), respectively, while heart rate did not change. 
At baseline all parameters of peripheral and microcirculatory perfusion 
were undisturbed. During UF, Tskin-diff   and the PPG of the fi  nger did 
not change. Sublingual microvascular fl  ow index and vessel density 
measured with SDF slightly decreased from 3.0 (3.0 to 3.0) to 2.8 (2.7 to 
2.9) (P <0.001) and from 10.6 (9.9 to 11.1) n/mm to 9.9 (9.2 to 10.5) n/mm 
(P <0.05), respectively.
Conclusions  UF leads to a signifi   cant and uniform decrease in 
volume status in patients with ESKD but surprisingly this was not 
associated with large decreases in peripheral and microcirculatory 
perfusion. Therefore caution is warranted when interpreting systemic 
hemodynamic parameters in terms of hypovolemia and hypoperfusion 
when peripheral perfusion is not evidently impaired.
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Introduction  Postoperative acute kidney injury requiring dialysis 
(AKI-D) occurs in 1 to 5% of patients after cardiac surgery with cardio-
pulmonary bypass (CPB) and is associated with a high mortality (30 to 
60%) and prolonged increased ICU length of stay. There are four models 
using diff  erent covariates that aim to predict the risk for postoperative 
AKI-D in cardiac surgery patients [1-4]. We aim to investigate which 
model best predicts AKI and AKI-D in our cardiac surgery population.
Methods  All adult patients undergoing cardiac surgery with CPB, 
between October 2006 and January 2009, in our hospital were included 
in this study. Data on preoperative risk factors and postoperative 
changes in serum creatinine levels of all patients were collected with 
the use of hospital databases and medical records. AKI was defi  ned 
according to RIFLE (Risk, Injury, Failure, Loss and End-stage Kidney 
Disease). AKI-D was defi  ned as the need for hemodialysis during the 
fi  rst 6 days following cardiac surgery. We assessed the discrimination 
of each model using the area under the curve of the receiver operating 
characteristics (AUC-ROC, see Table 1) curve for prediction of AKI and 
AKI-D.
Results A total of 966 patients were included in this study, of which 926 
medical records were available for review. The procedures performed 
were coronary artery bypass grafting CABG (n = 733, 79%), single valve 
surgery (n = 79, 9%) or CABG and valve or other surgery (n = 114, 12%). 
Table 1 (abstract P112). AUC-ROC for four models for the prediction of AKI-D 
and AKI
Model  n  AKI-D (95% CI)  AKI (95% CI)
Chertow  918  0.80 (67 to 93)  0.65 (58 to 72)
Thakar  928  0.95 (90 to 99)  0.77 (70 to 83)
Mehta  866  0.81 (66 to 96)  0.74 (67 to 81)
Wijeysundera  924  0.93 (90 to 97)  0.73 (67 to 80)
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during the fi  rst 6 days after surgery. AKI developed in 32 (3.4%) and 
in 19 (2.0%) patients classifi  ed as Risk and Injury, respectively. AKI-D 
developed in 13 (1.7%) patients. Table 1 shows the AUC-ROC curve 
value for each model (P <0.001 for all data) for the prediction of AKI 
and AKI-D.
Conclusions The model of Thakar is the best predictor of AKI and AKI-D 
in our population.
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Introduction Patients who suff  er from acute kidney injury (AKI) show 
electrolyte abnormalities that can be corrected using renal replacement 
therapy (RRT). But some reports showed hypercalcemia during RRT 
and they reasoned this as the eff  ect of citrate used for anticoagulant. 
We report eight post-liver transplantation (LT) recipients who suff  ered 
from AKI requiring RRT without citrate, but showed abnormal increase 
of ionized calcium (iCa) levels.
Methods  We retrospectively identifi  ed the recipients who suff  ered 
from AKI requiring CRRT after LT. Then we picked up those who had 
increased iCa over 1.25 mmol/l as hypercalcemia (group H). We 
compared these recipients with those who matched in graft–recipient 
weight ratio (G/R) and intraoperative transfusion (units/kg) as controls 
(group N). Data were expressed as means with standard deviations. 
Analyses were made using Student’s t test. We considered P  <0.05 
statistically signifi  cant.
Results Among 250 recipients who had undergone LT in our hospital, 
12 recipients received RRT. All RRT patients received nafamostat 
mesilate for anticoagulation. Eight patients had increased iCa (group 
H). All recipients in group H died during their index hospitalization. 
Compared with group N, group H had a higher iCa (1.3 ± 0.1 vs. 1.1 ± 0.0 
mmol/l) and total bilirubin (T.Bil; 17 ± 9 vs. 4 ± 0 mg/dl). See Table 1.
Table 1 (abstract P113). Characteristics
  Group H  Group N  P value
G/R 0.9 ± 0.4 0.9 ± 0.3  0.5
RCC 0.3 ± 0.3 0.3 ± 0.4  0.41
FFP 0.8 ± 0.7  0.6 ± 0.5  0.33
PLT 0.2 ± 0.3  0.3 ± 0.3  0.33
iCa 1.3 ± 0.1  1.1 ± 0.0 <0.01
T.Bil 17 ± 9  4 ± 0  <0.01
Conclusions We reported eight LT recipients who suff  ered from AKI and 
required RRT and had abnormally increased iCa levels without using 
citrate as anticoagulant. Only T.Bil was higher in the hypercalcemic 
group compared with the matched control. Because all of the eight 
hypercalcemic patients with CRRT died, this abnormality would be 
important for patient outcome.
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Introduction  The high mobility group box 1 protein (HMGB1) is 
an alarmin that plays an important role in sepsis. HMGB1 is hardly 
removable by normal hemofi  ltration because of its large molecular 
weight of 30 kDa. Here we show the possibility of removing HMGB1 
from the blood.
Methods The test solution contained 100 μg HMGB1 and 35 g albumin 
in 1,000 ml of a substitution fl   uid. Experimental hemofi  ltration 
(solution fl  ow of 100 ml/minute and ultrafi  ltrate fl  ow of 1,000 ml/hour) 
was conducted for 360 minutes in a closed loop circulation system, and 
the sieving coeffi   cient (SC) and ultrafi  ltrate and blood clearance rates of 
HMGB1 were calculated. High cut-off   (HCO), AN69ST, polysulfone (PS), 
and polymethylmethacrylate (PMMA) membranes were tested (n = 4).
Results  The concentrations (means  ±  SD) of HMGB1 at 0, 60 and 
360  minutes of hemofi   ltration for AN69ST (74.0  ±  11.8, 2.1  ±  1.2, 
and 0.5 ± 0.6 ng/ml) decreased signifi  cantly by adsorption. Relative 
concentrations of HMGB1 as determined by western blot analysis 
and the calculated clearance rates were obtained. Among the four 
membranes, AN69ST showed the highest capacity to adsorb HMGB1; 
it adsorbed 100 μg of HMGB1 in the initial 60 minutes and showed 
a markedly high clearance (60.8  ±  5.0 ml/minute) at 15 minutes. 
Although the highest SC for HMGB1 was 0.7 with the HCO membrane, 
which correlated with a constant fi  ltrate clearance rate, albumin loss 
was observed. No such removal of both HMGB1 and albumin was 
observed with the PS membrane and tubing. See Figure 1.
Conclusions Continuous hemofi  ltration using HCO or AN69ST mem-
brane will be a promising approach for HMGB1-related sepsis.
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Introduction Sustained high-effi   ciency daily hemodiafi  ltration using 
a cytokine-adsorbing membrane (SHEDD-fA) is an eff  ective modality 
Figure 1 (abstract P114). Percentage of HMGB1 remaining in the test 
solutions with HCO and AN69ST membrane.
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which makes the best use of three principles for solute removal, in the 
treatment of severe sepsis.
Methods  Twenty-nine septic shock patients were analyzed retro-
spectively. SHEDD-fA was initiated after adequate fl  uid resuscitation 
and catecholamine support. Operation conditions were QB = 150 ml/
minute, QF = 1,500 ml/hour (post-dilution) and QD = 300 to 500 ml/
minute using an HD machine over 8 to 12 hours daily. For the purpose 
of maximizing cytokine adsorption effi   ciency, we used a large-size 
(2.1 m2) PMMA dialyzer.
Results Decrease in blood IL-6 level: SHEDD-fA was performed for 3 days. 
The percentage of IL-6 removed from the blood was 84.4  ±  25.8% 
(mean ± SD; P <0.01; n = 25; Figure 1). In addition, we simultaneously 
assayed both inlet and outlet IL-6 and found a 21.0 ± 13.4% (P <0.01; 
n = 25) removal ratio, showing that IL-6 is eff  ectively removed after 
one pass through the hemofi   lter. Moreover, depressed monocytic 
HLA-DR ratio was improved from 40.6 to 51.9% in one typical case. 
Hemodynamics and PaO2/FiO2 improvement In 22 out of the 29 septic 
shock patients, signifi  cant decreases in the catecholamine index/mean 
blood pressure were observed 3 hours after the initiation of SHEDD-fA 
(P <0.01). In septic ARDS patients, PaO2/FiO2 was signifi  cantly improved 
at 1 hour (P <0.01). The improvement of the abovementioned para-
meters continued afterwards for 72 hours. As a result, 13 of 16 patients 
survived.
Conclusions We propose the use of a large-size, cytokine-adsorbing 
hemofi  lter (PMMA or AN69 based membrane) and the selection of a 
suitable duration modality in the treatment of severe sepsis.
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Introduction The aim of this research is to test the ability of a model-
based method to track disease-dependent hemodynamic changes in 
sepsis. Thus, subject-specifi  c models of the cardiovascular system (CVS) 
are identifi  ed using measurements from a porcine model of septic 
shock with hemofi  ltration [1].
Methods  Hemodynamic measurements were recorded every 
30 minutes in four (porcine model) trials of 4 hours. Animals received a 
0.5 mg/kg endotoxin infusion over the fi  rst 30 minutes and underwent 
zero-balance continuous venovenous fi  ltration with 0.7 m2 large pore 
substrate (80 kDa cut-off  ) from 60 minutes onwards [1]. Subject-specifi  c 
CVS models were fi  tted to 34 sets of data from the four trials. Each 
dataset represents a minimal set of measurements available in an ICU. 
Identifi  ed physiological model parameters and model outputs were 
compared with experimentally derived indices and measurements for 
validation.
Results  The model predicted the left and right ventricular end-
diastolic volumes and maximum left and right ventricular pressures to 
mean absolute errors of 7.1% and 6.7%. Changes in the modelled right 
ventricular end systolic elastance and pulmonary vascular resistance 
compared well (R  =  0.68 and 0.73) with the same metrics derived 
experimentally (via caval occlusion manoeuvre and four-element 
Windkessel model) from an earlier study on right ventricular–vascular 
coupling [1]. Clinically, the systemic vascular resistance (SVR) model 
parameter decreased initially in all four pigs and stabilised to a level 
26% (on average) below baseline during hemofi  ltration. Hyperdynamic 
states were observed in two pigs, where increases in left ventricle 
contractility were unable to counteract the loss in SVR, resulting in 
decreased mean arterial pressure (MAP) and increased cardiac output 
(CO) in the model, consistent with the experimental measurements. In 
contrast, for the other two pigs, increases in SVR after hemofi  ltration 
helped maintain MAP, with CO remaining relatively constant over the 
duration of these trials.
Conclusions Subject-specifi  c CVS models are capable of accurately 
capturing acute disease-dependent hemodynamic changes due to 
endotoxic shock in pigs using a minimal set of measurements that are 
available in a typical ICU setting.
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Introduction A decrease of IL-6 and procalcitonin (PCT) correlates with 
survival during sepsis [1]. Coupled plasma fi  ltration and adsorption 
(CPFA) supports the renal function and removes proinfl  ammatory 
mediators, but few clinical studies compare the eff  ects of CPFA and 
CVVHDF, the standard of care in septic patients with renal failure [2]. 
The aim of this study is to evaluate whether CPFA and CVVHD have a 
diff  erent eff  ect on IL-6 and PCT in septic patients.
Methods Seventy septic patients have been enrolled in this study. 
Fifty-fi  ve patients were submitted to CPFA. Every patient had four CPFA 
treatments (LINDA; Bellco-Mirandola, Italy) for 8 hours with Qb = 200 
ml/minute, Q ultrafi  ltration = 30 ml/kg/hour and Q plasma = 20% of Qb. 
Fifteen septic patients submitted to CVVHDF were used as the control 
group. At T0 (basal), T1 (after 24 hours), T2 (after 76 hours), plasma IL-6 
and plasma PCT was evaluated. ANOVA was used to compare changes 
during times study. P <0.05 was considered statistically signifi  cant.
Results Tables 1 and 2 present the main results of this study. In the CPFA 
group at T2 IL-6 and PCT decreased to lower levels than T0, whereas 
in CVVHDF no signifi  cant change was observed. Hemodynamic data 
and adrenergic support improved more in the CPFA group than in the 
CVVHDF group.
Table 1 (abstract P117). IL-6 and procalcitonin during CPFA
CPFA T0  T1  T2
IL-6 (pg/ml)  393 ± 87  235 ± 56  113 ± 23*
Procalcitonin (ng/ml)  23 ± 9  16 ± 5  5 ± 2*
*P <0.001 between T2 and T0.
Table 2 (abstract P117). IL-6 and procalcitonin during CVVHDF
 T0  T1  T2
IL-6 (pg/ml)  262 ± 67 433 ± 96  144 ± 35
Procalcitonin (ng/ml)  18 ± 6  17 ± 7  14 ± 4
Conclusions CPFA seems more effi   cient then CVVHDF to remove either 
IL-6 or PCT and to improve hemodynamic status. Further studies are 
warranted to show whether these data may translate into a better 
clinical outcome.
Figure 1 (abstract P115). Decrease in blood IL-6 level over 3 days (left) 
and the removal ratio in one pass (right).
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Introduction  Septic shock is a condition associated with diff  use 
coagulo pathy and multiple organ failure, and frequently ends in death. 
The eff  ectiveness of continuous venovenous hemodiafi  ltration using a 
polymethylmethacrylate membrane hemofi  lter (CVVHDF using PMMA) 
for critically ill patients has also been reported. This treatment was 
showed as cytokine adsorption therapy, but there are not so many 
reports in the world.
Methods We treated 16 septic shock patients by CVVHDF using PMMA. 
The patients were checked for 17 kinds of cytokines (IL-1, IL-2, IL-4, IL-5, 
IL-6, IL-7, IL-8, IL-10, IL-12, IL-13, IL-17, TNFα, G-CSF, GM-CSF, IFNγ, MIP-1, 
MCP-1/MCAF) using a multiplex suspension array system. We also 
checked the PMMA column.
Results The average APACHE II score and the average sepsis-related 
organ failure assessment (SOFA) score were 25.8 ± 12.5 and 10.1 ± 3.3 
(Bio-Plex™). The survival rate was 83.3%. One day after treatment 
by CVVHDF using PMMA, IL-1β (P  =  0.0473), IL-4 (P  =  0.0206), IL-5 
(P = 0.0436), IL-7 (P = 0.0061), IL-12 (P = 0.0049), IL-13 (P = 0.0150), IL-17 
(P = 0.0036), IFNγ (P = 0.0308) and TNFα (P = 0.0208) were signifi  cantly 
decreased. And 3 days after this treatment, IL-6 (P = 0.0498), GC-SF 
(P = 0.0144) and MCP (P = 0.0134) were signifi  cantly decreased.
Conclusions Therapies aimed at blood purifi  cation, such as CVVHDF, 
continuous hemofi  ltration (CVVHF) and plasma exchange, have been 
reported to be eff  ective for the removal of infl  ammatory cytokines and 
various mediators. Few reports have shown the infl  uence of the column 
used for CVVHDF on the removal effi   ciency of the above-mentioned 
factors, although several columns have been used in CVVHDF. CVVHDF 
using PMMA has been reported to be eff  ective for cytokine removal. 
Our fi   ndings suggest that many cytokines were decreased after 
CVVHDF using PMMA treatment. On the other hand, we checked 
adsorption of many sepsis-related factors on a PMMA column.
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Introduction Polymyxin B hemoperfusion therapy has been used for 
the treatment of sepsis to reduce blood endotoxin levels and a variety 
of infl  ammatory mediators. There are many reports that polymyxin B 
hemoperfusion therapy potentially improves circulatory dynamics 
and reduces mortality [1,2]. However, it is still controversial what is 
an important predictive factor to defi  ne the mortality. We analyzed a 
relationship between circulatory dynamics and mortality in our cases 
of polymyxin B hemoperfusion therapy.
Methods From January 2007 to June 2010, 69 patients who received 
polymyxin B hemoperfusion therapy were retrospectively reviewed. 
Two child cases, six cases of 24-hour death and the seven cases in whom 
bacteremia was not detected by blood culture test were excluded. In 
total, for 54 patients information including characteristics, etiological 
microorganisms, circulatory dynamics (catecholamine index (CAI) and 
mean arterial pressure (MAP)), lactate concentration and mortality was 
investigated. We divided the patients into survivor and nonsurvivor 
groups and compared these two groups. The statistical analyses were 
performed by unpaired t test.
Results Thirty-four patients (63.0%) survived and 20 patients (37.0%) 
died. Before polymyxin B hemoperfusion therapy, there were no 
signifi  cant  diff  erences in CAI, MAP and lactate concentration (CAI: 
23.6 ± 26.5 (mean ± SD) vs. 34.0 ± 25.3, MAP: 69.7 ± 16.7 vs. 62.0 ± 16.7 
mmHg, lactate: 4.0  ±  2.6 vs. 4.4  ±  3.6 mmol/l). But 2  hours after 
polymyxin B hemoperfusion therapy, only the CAI of the survivor group 
was signifi  cantly lower than in the nonsurvivor group (14.2 ± 14.1 vs. 
30.4 ± 25.5; P <0.01). However, MAP and lactate concentration did not 
show signifi  cant diff  erences between the two groups (MAP: 80.1 ± 13.0 
vs. 78.0 ± 15.4, lactate: 2.5 ± 1.3 vs. 3.6 ± 3.2). At 24 hours after polymyxin 
B hemoperfusion therapy, the CAI diff  erence between the two groups 
was became more remarkable (6.09 ± 9.02 vs. 27.18 ± 29.31; P <0.01).
Conclusions The CAI after polymyxin B hemoperfusion therapy was 
highly related to mortality, although the CAI before that therapy was 
not. Polymyxin B hemoperfusion therapy improve the circulatory 
dynamics of most sepsis patients, but the effi   cacy of that therapy to 
decreasing catecholamine is one of the important prognosis predictors 
for bacteremic patients.
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Introduction  The equivalency of continuous venovenous hemo-
fi  ltra  tion and intermittent hemodialysis (2B) was described as a key 
recommendation of the Surviving Sepsis Campaign guidelines in 2008. 
However, there are some discrepancies associated with the evaluation 
of blood purifi  cation in severe sepsis and septic shock in Japan. Direct 
hemoperfusion with polymyxin-B immobilized fi  ber  (PMX-DHP), 
developed and currently in use in Japan, has not yet been evaluated 
abroad. We performed a retrospective study to re-evaluate PMX-DHP 
for severe sepsis or septic shock patients in our ICU.
Methods We enrolled 302 patients (survival (S) group: 201, nonsurvival 
(NS) group: 101) in whom PMX-DHP had been performed for severe 
sepsis and septic shock from 1994 to 2010. These patients were 
allocated into two groups: those who survived for at least 28 days after 
the start of PMX-DHP therapy (S group: 201 patients) and those who did 
not (NS group: 101 patients). Background factors (age, gender, APACHE 
II scores, sepsis-related organ failure assessment score, Goris multiple 
organ failure (MOF) score), hemodynamics (blood pressure, PaO2/FiO2 
ratio, catecholamine requirement), infl  ammatory mediators (IL-6, IL-8, 
IL-1ra), endothelial-related markers (PAI-1, ELAM-1) and procalcitonin 
levels were examined in each group.
Results On background factors, only the Goris MOF score showed a 
statistically signifi  cant diff  erence among the groups. Blood pressure 
and the PaO2/FIO2 ratio both improved markedly immediately after 
PMX-DHP. Also, the average required amount of catecholamine 
decreased after PMX-DHP. IL-6 and IL-1ra levels decreased immediately 
after PMX-DHP in both groups, but these values before PMX-DHP did 
not show any statistically signifi  cant diff  erence between the groups. 
PAI-1 levels showed a signifi   cant decrease after PMX-DHP in both 
groups.
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and hemodynamic parameters using PMX-DHP for severe sepsis and 
septic shock patients. The levels of various infl  ammatory mediators 
decreased using PMX-DHP, but we did not fi  nd any correlation between 
these changes and outcome.
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Introduction Endotoxin adsorption therapy by direct hemoperfusion 
with a polymyxin B-immobilized fi  ber column (PMX-DHP) has been 
widely used in patients with septic shock in Japan. Many Japanese 
doctors use each PMX cartridge only for 2  hours; however, the 
mechanisms and optimal duration of PMX treatment remain unclear. 
We have performed PMX-DHP for longer than 2 hours to confi  rm that 
an extended duration of PMX-DHP for patients with septic shock would 
give signifi  cant improvements of hemodynamics.
Methods We performed an extended PMX-DHP on 13 patients whose 
hemodynamics did not achieved the target of mean arterial pressure 
(MAP) >65 mmHg and inotropic score <5.0 at the time point of 2 hours 
after PMX-DHP. Hemodynamic parameters such as MAP, heart rate and 
the dose of vasoactive agents were assessed before treatment, 2 hours 
after the start of PMX-DHP, immediately and 24 hours after completion 
of PMX-DHP. The following were also recorded during the study: 
microbiological data, the APACHE II score, the Sequential Organ Failure 
Assessment (SOFA) score and 28-day mortality.
Results APACHE II and SOFA scores were 26.0 ± 9.0 and 10.4 ± 3.0, 
respectively. The 28-day mortality rate was 15.4%. The average 
duration of PMX-DHP was 14.9 ± 7.5 hours. PMX-DHP was well tolerated 
and showed no side eff  ect over extended duration in treatment. MAP 
was increased: 64.2 ± 8.8 mmHg (baseline), 79.7 ± 10.5 mmHg (2 hours 
after the start of PMX-DHP), 88.4  ±  13.8 mmHg (immediately after 
completion) and 89.8 ± 12.8 mmHg (24 hours after completion). The 
inotropic score was also decreased: 16.4 ± 9.2 (baseline), 13.5 ± 7.2 
(2  hours after the start of PMX-DHP), 5.7  ±  6.8 (immediately after 
completion) and 2.8 ± 3.6 (24 hours after completion). These improve-
ments for 2 hours were statistically signifi  cant (P <0.01).
Conclusions  The hemodynamics kept improving during extended 
duration of DHP with one PMX cartridge. And we could use these 
cartridges safely. Thus we suggest that an extended duration of PMX 
treatment aff  ords benefi  cial eff  ects and may contribute to improve the 
mortality of patients with septic shock.
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Introduction The aim of our study was to determine the correlation 
between activated clotting time (ACT) and APTT values in patients 
receiving unfractionated heparin (UFH) for renal replacement therapy 
(RRT).
Methods  A retrospective analysis was made of case notes and 
laboratory data of 39 critically ill patients who were on UFH for RRT over 
a 1-year period. There were 183 paired APTT and ACT measurements 
done at the same time (29 patients). APTT was done at the laboratory 
and ACT was done at the bedside using an ACTALYKE monitor (Array 
Medical). Target APTT and ACT ranges for UFH during RRT were 45 to 
55 seconds (control 27 to 32 seconds) and 250 to 270 seconds (control 
180 to 220 seconds). Datasets were divided into three groups and the 
correlation coeffi   cient (Pearson’s) was calculated using SPSS software.
Results Mean APTT was 129.5 ± 68.29 (range 25.6 to 360) seconds and 
mean ACT was 234.6 ± 47.02 (range 125 to 387) seconds. APTT and ACT 
values were divided into three datasets in a 3 x 3 table. There was no 
correlation between APTT and ACT values (kappa score being 0.12). 
There were more above-range APTT values (140/183) against above-
range ACT values (36/183). See Table 1 and Figure 1.
Conclusions Our data demonstrate that monitoring of anticoagulation 
with UFH using ACT cannot be recommended.
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Introduction Adequate anticoagulation is essential to achieve effi   cient 
and cost-eff   ective renal and liver replacement therapy. However, 
critically ill patients with advanced liver cirrhosis are associated with 
low antithrombin III (ATIII) serum levels and increased tendency to both 
coagulation and bleeding disorder. Thus, we hypothesized that single-
dose application of antithrombin III prolongs fi  lter lifetime during renal 
and liver replacement therapy in critically ill patients with advanced 
liver cirrhosis without causing additional bleeding problems.
Methods  In this retrospective study, data of 33 extracorporeal 
therapies in nine critically ill patients with advanced liver cirrhosis 
admitted to a medical ICU in 2007 and 2008 were analyzed. Included 
patients underwent either continuous renal replacement therapy 
(CRRT), intermittent hemodialysis (IHD) or liver replacement using the 
molecular adsorbents recirculation system (MARS) with single doses of 
ATIII as sole anticoagulant. Bleeding complications and fi  lter lifetimes 
were used as outcome parameters.
Results Data were available for 13 CRRT, 14 IHD, and six MARS fi  lters 
with total fi  lter lifetimes of 661 (CRRT), 66 (IHD), and 42 hours (MARS), 
respectively. Mean fi  lter lifetimes were 44.0 ± 27.9 (CRRT), 4.7 ± 1.6 
(IHD), or 4.6 ± 12.6 hours (MARS). Fifteen percent (two out of 13) of 
CRRT fi  lters, 7% (one out of 14) of IHD fi  lters and 0% (zero out of six) of 
MARS fi  lters were lost due to clotting of the dialysis circuit. New onset 
of bleeding was not observed during IHD, MARS and CRRT.
Table 1 (abstract P122). ACT versus APTT
 High  ACT  Low  Normal
High  APTT  35 70 36
Low  0 29 2
Normal  1 7 0
Figure 1 (abstract P122). Scatterplot of ACT versus APTT.
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eff  ective and safe as alternative anticoagulation in critically ill patients 
with advanced liver cirrhosis. However, prospective controlled trials are 
necessary to confi  rm our fi  ndings.
P124
Safety of drotrecogin alfa (activated) treatment in patients with 
severe sepsis on renal replacement therapy without additional 
anticoagulation
L Mirea, I Luca Vasiliu, R Ungureanu, A Balanescu, I Grintescu
Clinical Emergency Hospital, Bucharest, Romania
Critical Care 2011, 15(Suppl 1):P124 (doi: 10.1186/cc9544)
Introduction  Patients with sepsis-induced acute renal failure on 
continuous renal replacement therapy (CRRT), who receive heparin, 
may be at higher risk of bleeding when drotrecogin alfa activated 
(DAA) is administered in addition to standard anticoagulation, 
especially surgical patients. There are some previous observations that 
no additional anticoagulation is necessary during simultaneous DAA 
infusion and CRRT. The aim of this study was to evaluate the safety of 
CRRT during DAA infusion without additional anticoagulant therapy.
Methods An observational, prospective study was conducted in an 
adult ICU. Sixteen surgical patients with severe sepsis on CRRT were 
divided into two groups: group A (eight patients) with DAA infusion, 
group B (eight patients) without DAA infusion. Baseline demographics, 
APACHE II score, serious bleeding events, and in-hospital mortality 
were reported. CRRT was performed using the Multifi  ltrate® system, 
heparin-free continuous venovenous hemodialysis mode in group A. 
After the completion of the DAA infusion, intravenous standard heparin 
was administered for the remaining time on hemofi  ltration. In group 
B concomitant heparin was administered as necessary to achieve an 
aPTT of approximately 60 seconds.
Results The mean fi  lter survival time (defi  ned as the time until the 
circuit clotted) was 30 hours on DAA infusion versus 22 hours after 
DAA infusion in group A and 19.6 hours in group B. All survivors had 
recovery of dialysis-free renal function. The mean APACHE II score was 
31.25 in group A and 22.12 in group B. Hospital mortality was 50% in 
group A (4/8) and 37.5% in group B (3/8); no mortality was attributed 
to bleeding. One case of severe thrombocytopenia was recorded with 
premature interruption of DAA infusion. The need for transfusion 
of blood and blood products infusion was compared (61% during 
DAA infusion vs. 52% after DAA infusion; 55% in group B); no serious 
bleeding event in both groups.
Conclusions The use of DAA in patients with severe sepsis requiring 
RRT is safe and is not associated with an increased of major bleeding 
events. No additional anticoagulation is necessary during simultaneous 
DAA infusion and CRRT.
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Introduction Renal replacement therapy (RRT) is an essential compo-
nent of modern critical care. Anticoagulation is necessary to prevent 
premature clotting of the extracorporeal circuit. We aimed to determine 
whether regional anticoagulation with citrate is associated with the 
reported reduced need for blood transfusions compared with heparin 
or epoprostenol.
Methods We retrospectively analysed all of the adult patients who 
received RRT in the general ICU at Guy’s & St Thomas’ Hospital, London 
between October 2008 and March 2009. Our fi  rst-line anticoagulation 
was heparin delivered via the circuit. It was clinical practice to maintain 
patients’ haemoglobin (Hb) at 8 g/dl. We calculated the number of units 
of red blood cells (RBC) transfused during the course of RRT and for 
24 hours after.
Results  In total, 156 patients were treated with RRT during the 
6-month period. One hundred and forty-two patients received a single 
type of anticoagulation throughout the whole course of RRT (heparin 
via the circuit or systemically, n = 85; citrate, n = 12; epoprostenol, 
n = 45). Among patients without overt clinical bleeding episodes, the 
number of RBCs needed per day of RRT to maintain Hb at 8 g/dl was 
0.5 units on citrate, 0.6 units on heparin and 0.6 units on epoprostenol 
(P = NS). Among 14 patients who had clinically recognized bleeding 
problems and did not change their anticoagulation, the requirements 
for RBC transfusion were 4.8 units/day in patients on heparin, 2.8 units/
day on epoprostenol and 1.7 units on citrate (P = NS). In 11 patients, 
anticoagulation was changed during the course of RRT because of 
bleeding problems. Of the seven patients started on heparin, three 
were changed to citrate and four to epoprostenol. Four patients had 
a change from epoprostenol to citrate. Change from heparin to citrate 
resulted in reduced transfusion requirements from 0.8 units RBC 
per RRT day to 0.6 units per day (P = NS). Changing from heparin to 
epoprostenol was associated with a reduction from 8.1 to 0.73 units 
RBC per day on RRT (P = NS).
Conclusions Citrate-based anticoagulation for RRT in patients with 
contraindications to heparin was not associated with lower transfusion 
requirements.
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Introduction  Regional citrate anticoagulation is associated with 
increased mean fi  lter life and greater completion of scheduled fi  lter 
life compared with heparin [1]. Studies report mean fi  lter lifespans of 
44 hours [2] and that 80% of patients reach 72 hours [3]. The potential 
cost saving from this reduced fi  lter kit purchase is only realised if the 
treatment is stopped due to fi  lter clotting and needs to be recommenced. 
In order to identify this we set out to evaluate the fi  lter life and stopping 
reason for CVVHF treatment in general critically ill patients.
Methods  One hundred sequential patients receiving CVVHF were 
identifi  ed. For each patient, the number of treatments, fi  lter life and 
reason for stopping treatment were recorded. A subset of treatments 
in which stopping was due to fi  lter clotting and therapy resumed was 
identifi  ed. These were then analysed to see how many fi  ltration sets 
could be saved if the fi  lter life was 44 hours [2]. Sensitivity analysis was 
performed based on a 50% change in fi  lter life improvement.
Results A total of 304 fi  lter sets were used in 100 patients (one to 14 per 
patient) – median duration 18.3 hours (IQR 8.5 to 38.3) (Table 1). Cost 
analysis demonstrated 75 fi  lters could be saved if fi  lter lives were prolonged 
to 44 hours, equivalent to €4.01/treatment-hour (€3.26 to €5.03).
Table 1 (abstract P126). Treatments by stopping reason
Stopping   Filter   End   
reason Access  clot  Elective  therapy  Miscellaneous  Total
Treatment   Yes  Yes  Yes  No  Yes 
resumed 
n  10 149  41 100  4  304
Duration   13.4  16  38.0  22.8  11.2  18.3
(median) (hours)
Conclusions Prolonged fi  lter life associated with citrate CVVHF leads 
to a potential saving of €4.01/treatment-hour. This information is of 
benefi  t when considering the business case for introducing citrate 
continuous venovenous haemofi  ltration.
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Introduction  Regional citrate anticoagulation in continuous veno-
venous hemodialysis (citrate-CVVHD) has become a widely used tech-
nique in the ICU, which decreases risk of bleeding. However, concern 
exists about safety of citrate in liver failure patients. The aim of our study 
was to evaluate safety and effi   cacy of regional citrate anticoagulation 
in ICU patients with normal and impaired liver function.
Methods One hundred and thirty-three consecutive adult ICU patients 
were prospectively observed for 72 hours of citrate-CVVHD. Patients 
were stratifi  ed into three groups according to their serum bilirubin 
(mg/dl) (normal: ≤2, n = 47, mild: >2 to ≤7, n = 44, severe: >7, n = 42). 
Citrate-CVVHD was performed with variable treatment dose using the 
multiFiltrate device (Fresenius Medical Care, Germany). End-points for 
safety were: severe acidosis or alkalosis (pH ≤7.2; ≥7.55) and severe 
hypocalcemia or hypercalcemia (≤0.9; ≥1.5 mmol/l) of any cause. End-
point for effi   cacy was the fi  lter lifetime.
Results  Main types of ICU admission were: 56% medical and 38% 
post-surgery. Liver failure was predominantly due to ischemia (39%) 
or multiple organ dysfunction syndrome (27%). The frequency of 
safety end-points of any cause did not diff  er between the three patient 
strata: severe alkalosis (normal: 2%, mild: 0%, severe: 5%; P = 0.41); 
severe acidosis (normal: 13%, mild: 16%, severe: 14%; P  =  0.95); 
severe hypocalcemia (normal: 8%, mild: 16%, severe: 12%; P = 0.57); 
severe hypercalcemia (0% in all strata). Only in three patients was 
an increased ratio of total to ionized calcium (≥2.5) detected (2%). 
Overall fi  lter lifetime was 49% after 72 hours; however, after censoring 
for discontinuation due to non-clotting causes (for example, renal 
recovery, death) 96% of all fi  lters were running after 72 hours.
Conclusions Our data demonstrate that citrate-CVVHD can be safely 
used in patients with liver dysfunction. Furthermore, it yields excellent 
fi  lter patency and avoids bleeding, and thus can be recommended also 
in patients with liver dysfunction.
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Introduction  Regional citrate anticoagulation (RCA) is a new anti-
coagulation mode for continuous renal replacement therapy (CRRT). 
Compared with heparin anticoagulation, RCA prolongs fi  lter lifetime, 
decreases transfusion requirements, and yields good metabolic control 
[1,2]. However, RCA was not investigated in patients requiring dialysis 
doses of >3 l/hour because of severe metabolic derangements or 
obesity. We investigated whether RCA for CVVHD is safe and eff  ective 
also in patients in need of such intensifi  ed treatment. We focused on 
the fi  lter lifetime, delivered dialysis dose, and control of acid–base 
balance.
Methods In a prospective observational study we enrolled 75 patients 
with acute kidney failure (AKF) following extended surgery. High-
volume CVVHD was applied using RCA for at least 72 hours. Minimum 
dialysis dose was targeted at 45 ml/kg/hour. According to the protocol, 
for eff  ective anticoagulation, a citrate dose of 4 mmol/l blood and a 
calcium infusion of 1.7 mmol/l dialysate was required. We measured 
arterial blood gases and levels of ionized calcium pre-fi  lter and post-
fi  lter every 4 hours. Blood fl  ow, dialysis dose and doses of citrate and 
calcium were registered as well as fi  lter lifetime and the reason for 
downtime.
Results The mean dialysis dose during the fi  rst 72 hours of treatment 
was 49 ± 14 ml/kg/hour, corresponding to a dialysate fl  ow of 3,736 ± 88 
ml/hour. Mean blood fl  ow was 177 ± 4 ml/minute. The mean citrate 
dose applied during the fi  rst 72 hours was 3.83 ± 0.07 mmol/l. The 
mean calcium dose was 1.85  ±  0.06 mmol/l. Severe hypocalcemia/
hypercalcemia did not occur. In one case an increasing demand for 
calcium substitution occurred after 84  hours that was indicative of 
citrate accumulation but the total/ionized calcium index was never 
higher than 2.5. After 72 hours of CVVHD, acidosis (pH <7.35) occurred 
in 7% (5/75) of all patients, an alkalosis (pH >7.45) in 22% (16/73) while 
71% (52/73) showed a normal pH. Mean fi  lter lifetime was 78 ± 2 hours. 
Thirteen treatments were stopped because of fi  lter clotting, in all the 
remaining 87 fi  lters stopping of treatment was caused by other reasons 
(surgery, diagnostic procedures, restored diuresis, death). There were 
no bleeding complications related to renal replacement therapy. In-
hospital mortality was 57% (43/75).
Conclusions Regional citrate anticoagulation for CVVHD is safe and 
eff  ective to deliver a high dialysis dose, to control acid–base status, and 
to yield excellent fi  lter lifetimes in postoperative AKF.
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Introduction Data on signifi  cance of systemic gain of citrate during 
continuous renal replacement therapy (CRRT) are missing. Direct 
citrate measurements are scarcely available. The quantifi  cation using 
a diff  erence of unmeasured anions (UA) on the fi  lter and the method 
using correlation between concentration of citrate (Cf) in effl   uent to 
the proportion of citrate fl  ow to blood fl  ow (Qc/Qb) were compared 
with the control exact methods.
Methods A prospective controlled observational study was performed 
in a 20-bed general ICU. Patients on 2.2% acid-citrate-dextrose (ACD, 
n = 41) were compared with controls on unfractioned heparin (n = 17). 
All were treated with an Aquarius Baxter device on 1.9 m2 polysulfone 
fi   lters. Samples were taken from a central venous catheter, ports 
pre fi   lter and post fi   lter and from dialysate/fi   ltrate 24  hours after 
commencing with CRRT and 60 minutes later.
Results There were no signifi  cant diff  erences (P >0.05) between CVVH 
(n = 18) and CVVHDF (n = 23) in measured citratemias nor in systemic 
gain of citrate. The diff  erence between post-fi  lter and pre-fi  lter UA 
correlated with diff  erence of citrate concentrations (r2 = 0.66). Citrate 
gain was calculated as 31.5 ± 10.5 mmol/hour utilizing this relationship. 
Cf showed tight correlation with the Qc/Qb ratio (r2 = 0.72). Gain of 
citrate calculated as citrate input minus citrate removal (effl   uent fl  ow 
x Cf) where the regression equation replaces Cf was 29.4 ± 7.2 mmol/
hour. The fi   rst exact method used post-fi   lter and pre-fi  lter  citrate 
concentrations multiplied by matching blood fl  ows. Gain of citrate 
obtained by this method was 29.3 ± 11.0 mmol/hour. The second exact 
method deducted citrate removal (15.7 ± 5.9 mmol/hour) in effl   uent 
from citrate input (45.1 ± 8.8 mmol/hour) and produced a citrate gain 
of 29.3 ± 7.2 mmol/hour. Comparing two studied methods of citrate 
gain estimation with exact methods showed no signifi  cant diff  erences 
(P  =  0.5, Kruskal–Wallis ANOVA). Bland–Altman analysis showed no 
systematic bias in results.
Conclusions  Systemic load of citrate is not negligible and can be 
predicted without taking direct citrate levels. Proposed indirect methods 
showed reasonable accuracy in systemic citrate load estimation.
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Introduction  Acute kidney injury (AKI) is a common problem in 
critically ill patients, with a reported incidence of 1 to 25% and a poor 
prognosis. Although optimal dosing of renal replacement therapy 
(RRT) is relatively well understood, appropriate timing of commencing 
and ceasing RRT in patients with AKI has been under debate for a long 
time. From the viewpoint of an early renal support strategy, the goal of 
early RRT is to maintain solute clearance and fl  uid balance to prevent 
subsequent multiorgan damage, while waiting for the recovery of 
renal function. It has previously been noted that 2-hourly creatinine 
clearance accurately refl   ects the more cumbersome 24-hour value 
[1]. The aim of the present study was to evaluate whether routine 
measurement of creatinine clearance (CrCl) could help to predict when 
to cease dialysis, and determine what value for CrCl best predicted 
remaining dialysis-free in critically ill patients receiving CRRT.
Methods Two-hourly creatinine clearance is calculated daily on most 
patients on CRRT in our ICU. If CrCl is greater than 20 ml/minute, CRRT 
is ceased. Our retrospective chart review examined records for all 
patients admitted to our ICU in 2008 and determined whether a CrCl 
greater than 20 ml/minute accurately predicted remaining dialysis-free 
5 days later.
Results Forty-one patients were suitable for analysis. Of these, 12 (30%) 
never reached CrCl >20 ml/minute and remained on dialysis leaving 
the ICU. Of the remaining 29 patients, in 23 (79%) having a CrCl >20 ml/
minute meant they remained dialysis-free for at least the following 
5  days. Six patients (21%), despite having a CrCl >20 ml/minute, 
resumed dialysis within 5 days for metabolic or fl  uid-removal reasons.
Conclusions Although this is a small retrospective study it suggests 
that 2-hourly creatinine clearance values may accurately predict when 
CRRT should be discontinued. These pilot results should be used to 
inform a larger prospective study.
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Introduction  Myocardial injury and cardiac marker elevation may 
occur in ARDS patients without a structural heart disease, which might 
aff  ect cardiac markers [1,2].
Methods  The study was conducted in Cairo University Hospital 
between 1 June 2008 and 1 April 2009. The inclusion criterion was any 
adult patient diagnosed to have ARDS according to the criteria of the 
American–European Consensus Conference of 1994. Exclusion criteria 
were any pre-existing structural heart disease, pulmonary embolism, 
atrial fi  brillation, renal insuffi   ciency, age <18. Plasma levels of cardiac 
markers NT-proBNP, troponin I and troponin T were measured on day 
0 and on day 2 and day 7 of ARDS diagnosis. All patients benefi  ted 
from mechanical ventilation with a lung-protective ventilation strategy 
according to the NHBLI ARDS Network Treatment Protocol.
Results The study comprised a total of 20 patients with mean age of 
58.9 ± 20.69 years, 11 men versus nine women (P> 0.05). The ARDS 
aetiology was fi  ve (25%) patients due to sepsis, four (20%) due to 
pneumonia, three (15%) aspiration, three (15%) lung contusions due to 
road traffi   c accidents (RTA), two (10%) drug overdose, one (5%) burns, 
one (5%) pancreatitis, one (5%) drowning. NT-proBNP mean values were 
8,903.3 ± 12,852.8 versus 6,083.6 ± 8,467.9 versus 9,914.8 ± 12,574.1 on 
day 0, day 2 and day 7, respectively (P >0.05). Troponin I mean values 
were 3.0 ± 7.7 versus 2.2 ± 6.6 versus 1.5 ± 4.4 on day 0, day 2 and 
day 7, respectively (P >0.05). Troponin T mean values were 0.3 ± 0.6 
versus 0.6 ± 1.5 versus 0.5 ± 1.1 on day 0, day 2 and day 7, respectively 
(P >0.05).
Conclusions  ARDS patients with structurally normal hearts show 
persistent elevated levels of cardiac markers NT-proBNP, troponin I 
and troponin T over the fi  rst week with no signifi  cant change between 
levels of day 0, day 2 and day 7. A single reading of cardiac markers on 
any day of the fi  rst week of ARDS may not be diff  erent from serial daily 
readings.
References
1. Phua  J,  et al.: B-type natriuretic peptide: issues for the intensivist and 
pulmonologist. Crit Care Med 2005, 33:2094.
2. Leuchte  et al.: Clinical signifi  cance of brain natriuretic peptide in primary 
pulmonary hypertension. J Am Coll Cardiol 2004, 43:764.
P132
Comparison of three diff  erent multi-analyte point-of-care devices 
during clinical routine on a medical ICU
V Stadlbauer1, S Wallner1, T Stojakovic2, KH Smolle1
1University Hospital Graz, Austria; 2Clinical Institute of Medical and Chemical 
Laboratory Diagnostics, Medical University of Graz, Austria
Critical Care 2011, 15(Suppl 1):P132 (doi: 10.1186/cc9552)
Introduction Multi-analyte point-of-care (POC) devices are important 
to guide clinical decisions in critical care. However, the use of diff  erent 
devices in one hospital might cause problems. We therefore evaluated 
three commonly used POC devices and analysed accuracy, reliability 
and bias.
Methods Seventy-four arterial blood samples were analysed with three 
POC devices (Cobas, Roche (CO); ABL800 Flex, Radiometer (ABL); Gem 
Premiere, Instrumentation Laboratory (IL)). For selected parameters, 
samples were also analysed in the central laboratory. pCO2, pO2, SO2, 
bicarbonate and standard bicarbonate (HCO3 and HCO3std), sodium, 
potassium, calcium, pH, lactate, base excess (BE(B) and BEecf), glucose, 
hemoglobin and hematocrit were compared.
Results  For most parameters only minor, although statistically 
signifi  cant, changes were observed between the POC devices. For pO2, 
BE(B), hemoglobin and hematocrit, clinically signifi  cant  diff  erences 
were found. When for example looking at a pO2 of 60 mmHg, in six out 
of 74 samples, IL and/or CO showed a pO2 below 60 mmHg and ABL 
showed a pO2 of above 60 mmHg. For hematocrit and hemoglobin, 
diff  erences between the devices would result in diff  erent decisions 
regarding the use of packed red cells in 11 to 19% of the samples. For 
BE(B) in a total of 15% of measurements, the results obtained from the 
diff  erent devices would not agree whether a BE(B) is normal or not.
Conclusions Although POC devices are of high standard and overall 
comparability between devices is high, there might be a clinically 
relevant bias between devices, as found in our study for pO2, BE(B), 
hemoglobin and hematocrit. This can be of importance when 
interpreting results of the same patient obtained from diff  erent POC 
devices, as could happen when a patient is transferred within a hospital 
where diff  erent devices are used.
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Introduction Traditionally within our ICU, comprehensive daily bloods 
were taken on a routine basis without direct clinician involvement. 
Such routine blood testing can be costly [1], time consuming, labour 
intensive, and can contribute to patient anaemia [2]. Recognising these 
concerns, a new clinician-centred system for ordering blood tests was 
implemented in July 2010. This was based on a blood investigation 
order chart completed by medical personnel to specify the blood tests 
required for individual patients for the following day. The objective of 
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blood investigation order chart reduced the number of blood tests 
performed and the associated costs.
Methods Data on the numbers and types of blood investigations were 
collated for all patients with a length of stay greater than 24 hours in 
our six-bed critical care unit. The audit period covered 100 days prior to 
implementation of the order chart and 100 days post implementation. 
The blood tests assessed were; full blood picture (FBP), urea and 
electrolytes (U&E), coagulation screen, liver function tests (LFT), 
magnesium, bone profi  le (Ca, PO4 and albumin), and C-reactive protein 
(CRP). A comparative analysis of the numbers, types and costs of blood 
testing pre and post implementation was conducted. The study did 
not seek to assess patient outcomes mainly due to the small number 
of patients involved.
Results  The implementation of the ordering chart resulted in a 
reduction in the number of blood investigations ordered, from a total 
of 2,209 pre implementation to 1,477 post implementation; that is, a 
33% net reduction. The tests that showed the largest reductions were 
coagulation screens, LFT and bone profi  les, with reductions of 52%, 
54% and 53%, respectively. A moderate reduction was observed in 
magnesium and CRP tests, at 43% and 21% respectively. Only a very 
small reduction in the number of FBP and U&E tests was found. When 
the fi  nancial costs of these reductions are assessed, the analysis showed 
an overall saving for the ICU of £17,914 per annum, or £2,986 per bed.
Conclusions The results of this audit suggests that the implementation 
of simple low-cost measures, such as a blood investigation order chart 
to specify and customise blood testing in the ICU, can signifi  cantly 
reduce the costs associated with patient stay in the ICU.
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Introduction Chloride shift is the movement of chloride between red 
blood cells (RBC) and plasma (and vice versa) caused by variations in 
pCO2. The aim of our study was to investigate changes in plasmatic 
strong ion diff  erence (SID) during acute variations in pCO2 and their 
possible role in the compensation for hypocapnic alkalosis.
Methods Patients admitted in this year to our ICU requiring extra-
corporeal CO2 removal were enrolled. Couples of measurements 
of gases and electrolytes on blood entering (v) and leaving (a) the 
respiratory membrane were analyzed. SID was calculated as [Na+] 
+ [K+] + 2[Ca2+] – [Cl–] – [Lac–]. Percentage variations in SID (SID%) 
were calculated as (SIDv – SIDa) x 100 / SIDv. The same calculation was 
performed for pCO2 (pCO2%). Comparison between v and a values was 
performed by paired t test or the signed-rank test, as appropriate.
Results Analysis was conducted on 205 sample-couples of six enrolled 
patients. A signifi  cant diff  erence (P <0.001) between mean values of 
v–a samples was observed for pH (7.41 ± 0.05 vs. 7.51 ± 0.06), pCO2 
(48 ± 6 vs. 35 ± 7 mmHg), [Na+] (136.3 ± 4.0 vs. 135.2 ± 4.0 mEq/l), [Cl–] 
(101.5 ± 5.3 vs. 102.8 ± 5.2 mEq/l) and therefore SID (39.5 ± 4.0 vs. 
36.9 ± 4.1 mEq/l). pCO2% and SID% signifi  cantly correlated (r2 = 0.28, 
P <0.001). Graphical representation by quartiles of pCO2% is shown in 
Figure 1.
Conclusions  As a reduction in SID decreases pH, the observed 
movement of anions and cations probably limited the alkalinization 
caused by hypocapnia. In this model, the only source of electrolytes 
are blood cells (that is, no interstitium and no infl  uence of the kidney 
is present); it is therefore conceivable to consider the observed 
phenomenon as the contribution of RBC for the compensation of acute 
hypocapnic alkalosis.
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Introduction ICUs generate vast amounts of valuable data. The size 
and complexity of the data make analysis technically demanding and 
time-consuming. We used interactive visual analysis (IVA) to analyse 
a large ICU database using the association between sodium and 
mortality as a case study.
Methods We analysed routinely collected longitudinal clinical ICU data 
using ComVis©, an IVA tool developed for research in nonmedical fi  elds. 
Coordinated multiple views enable the simultaneous visualisation of 
multiple variables of any data type (including time series). Individual 
variables and relationships between multiple variables are displayed 
in multiple linked views using user-selected box plots, histograms, 
scatter-plots, time series, parallel coordinates, and so forth. Visually 
selecting data by brushing with the cursor simultaneously highlights 
corresponding data in all other views. Multiple brushes are combined 
using Boolean logic, and the new selection is automatically updated 
across all views. We used IVA to analyse the univariate eff  ect of sodium 
(Na) longitudinal trends (and rate of change) on mortality in 1,447 
ICU patients. We defi  ned high sodium as >150 mmol/l, low Na as 
<130 mmol/l, and a rapid rise and fall as a change >3 mmol/l/hour at 
any time. Trends of interest were identifi  ed using IVA while OR and P 
values were calculated using standard statistical techniques.
Results Overall ICU mortality was 22.5% (95% CI = 0.20.3 to 24.7%). 
Mean Na was 140 mmol/l (SD 4.3, within-patient minimum and 
maximum 123 and 166). Mortality was associated with: high Na versus 
Na <150 (28.6% vs. 20.9%, OR = 1.5, P = 0.004); rapid Na fall versus no 
rapid fall (27.6% vs. 17.7%, OR = 1.8, P <0.001); and rapid Na rise versus 
no rapid rise (27.6% vs. 17.7%, OR = 1.8, P <0.001). In contrast, low Na 
versus Na >130 (24.8% vs. 21.9%, OR = 1.2, P = 0.3), low Na with a rapid 
rise versus low Na with no rapid rise (26.3% vs. 20.7%, OR = 1.4, P = 0.3) 
and high Na with a rapid fall versus high Na with no rapid fall (30.6% vs. 
24.2%, OR = 1.4, P = 0.3) were not associated with mortality.
Conclusions  IVA facilitates a visual approach to data analysis that 
is both intuitive and effi   cient. This hypothesis can fi  rst be explored 
visually before further analysis using conventional statistical methods. 
Advanced statistical modeling can be used to confi  rm any potential 
hypothesis identifi  ed by visual analyses.
Figure 1 (abstract P134). *P <0.05 versus fi  rst quartile. §P <0.05 versus 
second. #P <0.05 versus third. One-way ANOVA.
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Introduction Base excess (BE) is the measure of nonrespiratory change 
of acid–base status in the body. It is calculated after correcting the 
blood sample’s pH to 7.4, temperature to 37°C and pCO2 to 40 mmHg. 
Actual HCO3 level is a metabolic parameter derived directly from 
the Henderson–Hasselbalch equation. There is some evidence that 
temporary changes in pCO2 aff  ect BE [1,2], but little is known about the 
response of HCO3. Therefore, the aim of this study was to investigate the 
relationship between BE and HCO3 in critically ill patients immediately 
after admission to the ICU.
Methods The fi  rst arterial blood gas samples (within 1 hour of admis-
sion) of patients admitted to our ICU were retrospectively evaluated 
and pH, HCO3, pCO2 and BE were registered and analysed. After testing 
the data distribution, correlation was determined with Pearson’s 
correlation.
Results Arterial blood gas samples from 88 patients were analysed. 
There was a strong, signifi   cant correlation between BE and HCO3 
(r2 = 0.93, P <0.001) in the whole sample. In blood samples with pCO2 
>45 mmHg, in 26 cases the pH was >7.3, and in 15 cases pH was <7.3 
(that is, acute respiratory acidosis). In these cases with a cut-off   
BE <0 mmol/l, the BE had sensitivity = 73% and specifi  city = 85% for 
predicting acidosis. With a cut-off   for HCO3 <24 mmol/l, the HCO3 had 
sensitivity = 27% and specifi  city = 100% for acidosis. Choosing a cut-
off   for BE <–2 mmol/l, sensitivity = 47%, specifi  city = 100%; for HCO3 
<22 mmol/l, sensitivity = 13%, specifi  city = 100%.
Conclusions Although BE and HCO3 had very good correlation in the 
whole sample, in acute respiratory acidosis BE indicated metabolic 
acidosis with high sensitivity, while the high specifi   city and low 
sensitivity of HCO3 showed that there was no metabolic component of 
the acid–base imbalance. Therefore, in accord with previous studies, our 
preliminary results give further evidence that HCO3 is a more reliable 
parameter to analyse acid–base balance in acute circumstances, 
especially in acute respiratory acidosis, than BE.
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Introduction  Prescribing daily routine chest radiographs (CXRs) in 
ICU patients is a matter for debate. We aimed at describing current 
strategies of CXR prescriptions and their diagnostic and therapeutic 
impacts in a large panel of French ICUs.
Methods We performed a postal survey recording ICU habits of CXR 
prescription and a snapshot single-day (called RadioDay) observational 
study analyzing all of the prescribed CXRs.
Results Survey (n = 104 ICUs) CXR prescription was made on a daily 
routine basis for every patient and only in mechanically ventilated 
patients in 7% and 37% of the 104 ICUs, respectively. Depending on the 
ICUs, ICU admission (55% of the ICUs), endotracheal intubation (87%), 
tracheostomy (87%), superior vena cava device (96%), nasogastric 
tube (48%), chest tube insertion (98%) and chest tube removal (60%) 
were systematically followed by a CXR. A written procedure for CXR 
prescription was available in 12% ICUs. Snapshot study On RadioDay, 
854 CXRs were performed (8.2 ± 4.6 per center) in 804 patients: 36.5% 
were prescribed on a daily routine basis. The most frequent indications 
for on-demand CXR were: follow-up of pleuropulmonary pathology 
(32%), control after invasive device placement (20%), search for an 
etiology of respiratory or circulatory failure (13%) and ICU admission 
(11%). On-demand CXRs were mostly (62%) performed during the 
morning round. On-demand CXR showed more frequently a tissue 
abnormality than daily routine CXR (69 vs. 48%, P <0.001) and this 
radiographic fi   nding was unexpected in 20 and 15%, respectively 
(P  =  0.22). On-demand CXR was more frequently associated with 
treatment modifi   cation (which would not have occurred without 
the CXR) than daily routine CXR (38 vs. 19%, P <0.001): placement/
modifi  cation/or removal of an invasive device (18 vs. 9%, P <0.001), 
prescription of another paraclinical investigation (15 vs. 3%, P <0.001), 
initiation/continuation/or discontinuation of medications (25 vs. 
11%, P <0.001). CXR fi  ndings were expected and had no impact on 
management in 56 and 77% (P <0.001) of the on-demand and daily 
routine CXR, respectively.
Conclusions There is an obvious lack of consensus for CXR prescription 
in French ICUs. The clinical impact of on-demand CXR is higher than 
that associated with a daily routine prescription.
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Introduction  Intraosseous (IO) needles play an important role in 
medical emergencies, when venous access is diffi   cult to establish. 
IO needles are suitable for infusion, but their use for blood sampling 
has been questioned, since aggregates of marrow substances may 
block analysers [1]. However, portable laboratory instruments have 
been developed, where the blood may be analysed within a separate 
cartridge. We decided to evaluate whether such a portable device 
is suitable for analysis of blood gases and electrolytes in aspirates 
obtained from IO needles during a 6-hour period. A second aim of this 
study was to compare such IO aspirates with arterial blood samples, 
both of them analysed by a handheld laboratory analysis system.
Methods  IO needles (Im-Medico) were inserted bilaterally in the 
proximal tibiae of fi  ve anaesthetised healthy pigs. Blood gases and 
electrolytes (Na, K, Ca) were taken  hourly. IO aspirates and arterial 
blood samples were immediately analysed by an i-STAT handheld 
(Abbott Point of Care) equipped with EG7+ and CG4+ cartridges. A 
coeffi   cient of variance (CV) >20%, was regarded as the upper limit of 
quantifi  cation [2]. Bland–Altman curves were used to assess agreement 
between the two methods [3].
Results Repeated IO aspirates were easily obtained during the entire 
6-hour period. There were excellent consistencies in blood gases 
and electrolytes, between IO aspirates from the left and right tibiae, 
except for BE, where CV >20%. IO aspirates were compared with 
arterial samples. There were compliant values between these sources 
regarding electrolytes, Hb, pH, pCO2 and SBC. This was in contrast to 
BE, lactate, PO2 and SO2, which all exhibited CV >20%. Although both 
SO2 and PO2 were higher in arterial samples as compared with IO 
samples, there were high correlations between these two variables in 
arterial blood and IO aspirates (R >0.9; P <0.001 and R = 0.7; P <0.001, 
respectively). There were only minor changes over time in any of these 
variables during the entire experimental period.
Conclusions Blood gases and electrolytes in IO blood aspirates are 
easily analysed by a handheld device during a 6-hour period. The 
development of this cartridge-based laboratory analysis system 
strengthens the concept of using IO needles as a valuable tool in 
medical emergency situations. If blood gases are to be evaluated in IO 
aspirates, SBC seems to refl  ect arterial conditions better than BE does.
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Capnography activation is improved by better ventilator interface 
ergonomics
E Hodge, M Blunt, P Young
Queen Elizabeth Hospital, King’s Lynn, UK
Critical Care 2011, 15(Suppl 1):P139 (doi: 10.1186/cc9559)
Introduction In critical care, capnography is recommended [1]. Upon 
intubation this is important to rapidly confi  rm  endotracheal  tube 
position. Often capnography is built into critical care ventilators, but 
as these are frequently used for non-invasive ventilation it is necessary 
that this monitoring may be switched off   and on. We postulated that 
the ease with which this could be done would relate to the ergonomic 
design of the ventilation interface and compared the Drager Evita 
4 and Drager V500. The Evita 4 has a button hidden within the alarm 
limits section, whereas on the V500, which has locally confi  gurable 
interface, this had been placed on the main screen.
Methods Thirty-one nursing and medical ICU staff   were studied. The 
ventilator was set up in a controlled mode with the default front screen 
visible with capnography disabled. The time to successful activation of 
capnography was recorded. Each subject performed the same test on 
both ventilators in a randomized crossover design.
Results  More subjects failed to activate capnography within 120 
seconds with the Evita 4 compared with the V500 (14 vs. 1) and survival 
analysis identifi  ed signifi  cantly faster time to successful activation in 
the V500 (see Figure 1). Analysis identifi  ed no period eff  ect due to the 
crossover design.
Conclusions  Despite the extensive experience and training on 
the Evita 4, many subjects were not able to activate capnography 
within 2  minutes; however, by confi  guring the screen of the V500 
this was almost eliminated in staff   even without specifi  c  training. 
Immediate availability of capnography is an important safety issue and 
manufacturers should consider this in the ergonomic design of their 
equipment interfaces.
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Introduction Pulmonary dysfunction after cardiac arrest is a common 
phenomenon. Evidence appears to support the usefulness of quanti-
ta  tive assessment of pulmonary dysfunction using extravascular lung 
water (EVLW) and the pulmonary vascular permeability index (PVPI). 
We hypothesized that the duration of cardiac arrest (CPA TIME) would 
impact the pulmonary dysfunction in patients with postcardiac 
arrest syndrome. The aim of the present study was to investigate the 
lung dysfunction quantitatively using EVLW and PVPI in successfully 
resuscitated patients after cardiac arrest (CPA).
Methods This was a prospective observational study of 106 (59 male, 
47 female) postcardiac arrest syndrome patients. Eligible patients 
included all who were in CPA on arrival at the hospital and experienced 
eff   ective resuscitation resulting in resumption of spontaneous 
circulation. All patients were resuscitated per therapeutic protocol in 
our hospital. The CPA TIME from the scene was recorded. The patients 
were divided into two groups by the cause of CPA; cardiogenic (CG) or 
noncardiogenic (NCG). Thermodilutional EVLW and PVPI measurements 
were performed using the PiCCO monitoring system (Pulsion Medical 
Systems, Munich, Germany) as soon as the patients were admitted to 
the ICU.
Results A moderate positive correlation was documented between the 
CPA TIME, EVLW (r = 0.36, P <0.001) and PVPI (r = 0.43, P <0.001) in all 
106 patients. In the CG group, we found a very close positive correlation 
between the CPA TIME, EVLW (r = 0.52, P <0.001) and PVPI (r = 0.75; 
P <0.001). No correlations were documented between the CPA TIME, 
EVLW (r = 0.25, P = 0.05) and PVPI (r = 0.24, P = 0.06) in the NCG group.
Conclusions The duration of cardiac arrest impacts on the increase in the 
EVLW and PVPI, especially in patients with CG postcardiac arrest syndrome.
Acknowledgements Clinical trial registration UMIN-CTR: UMIN00000 3224.
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Introduction  The aim of this study was to evaluate the value of 
ultrasonography of the lung in order to determine the level of volume 
load defi   ned as the extravascular lung water index (ELWI). Hereto 
the presence of bilateral interstitial syndrome found by pulmonary 
ultrasonography is compared with ELWI as measured by thermodilution 
with PiCCO technology.
Methods  A prospective study was carried out. The study was 
performed in the ICU of a medium-sized teaching hospital. Adult 
patients who were suff  ering from severe sepsis were included in the 
study. Ultrasonography (OptiGo; Philips) of the lung was categorized as 
an A-profi  le in cases of no signs of interstitial syndrome and a B-profi  le 
in cases of interstitial syndrome. Ultrasonography of both sides of the 
lung was performed. Therefore, the following profi  les were determined: 
AA, AB and BB. The BB-profi  le, bilateral interstitial syndrome, is regarded 
as being associated with volume overload [1]. The ELWI was calculated 
after thermodilution by PiCCO technology in all patients and compared 
between the three diff   erent ultrasonographic profi  les.  Statistical 
analysis was performed by independent-sample t test. P <0.05 was 
considered statistically signifi  cant.
Results In 11 consecutive patients (six men), ultrasonography of the 
lung was performed 27 times. Mean age was 70 years (SD 3.4), mean 
APACHE IV score 88 (SD 23) and APACHE II score 26 (SD 6). Most frequent 
reasons for ICU admission were sepsis, respiratory and renal failure. 
Mean ELWI in patients with the AA-profi  le (48.1% of the profi  les) and 
the BB-profi  le (29.6%) was respectively 8.5 (SD 1.7) and 13.8 (SD 2.9). 
This diff  erence was signifi  cant (P = 0.001). Mean ELWI of the AB-profi  le 
(22.2%) was 7.8.(SD 2.3). The mean ELWI of this profi  le also diff  ered 
signifi  cantly with the BB-profi  le (P = 0.002). See Figure 1.
Conclusions Our study demonstrates the potential of ultrasonography 
in the detection of extravascular lung water in adult intensive care 
patients, suff  ering from severe sepsis. Since ultrasonography is an 
inexpensive, non-invasive and eff   ective modality, the small study 
supports the use of ultrasonography as a possible tool in the evaluation 
of volume status in patients with severe sepsis. Larger studies are 
necessary to confi  rm these fi  ndings.
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Figure 1 (abstract P139). Survival analysis for time to capnography 
activation for Evita 4 and V500.
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increases the correlation with lung injury score in patients 
with acute lung injury/acute respiratory distress syndrome: a 
prospective, multicenter study conducted in a Japanese population
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Introduction Since predicted body weight derived from height and 
gender refl  ects lung size better than actual body weight, it is reported 
that extravascular lung water indexed to the predicted body weight 
(EVLWIp) is more closely correlated with severity of illness and mortality 
than EVLW indexed to the actual body weight (EVLWIa). However, the 
usefulness of EVLWIp has not been evaluated in a multicenter study or 
in the Asian population.
Methods We conducted a prospective, multicenter observational study 
in Japan with the following inclusion criteria: adult (≥18 years) patients 
needing mechanical ventilation, PaO2/FiO2 ratio below 300, and acute 
bilateral infi  ltrates in both lung fi  elds on chest X-ray. The diagnosis of acute 
lung injury/acute respiratory distress syndrome (ALI/ARDS) was based 
on peer review. Predicted body weight was calculated as 50 (for male) or 
45.5 (for female) +0.91(centimeters of height –152.4). The normal range of 
body mass index (BMI) was defi  ned as 18.5 to 22.9. Obesity was defi  ned 
as BMI ≥25. Data are presented as medians and interquartile ranges (IQR). 
A Wilcoxon’s rank sum test and the Mann–Whitney test were used to 
compare the values, and correlations were analyzed using Spearman’s rank 
correlation coeffi   cient. Statistical signifi  cance was tested at a level of 0.05.
Results Seventy-eight patients with ALI/ARDS were enrolled. The values 
of EVLWIp (17.1 ml/kg; IQR, 12.9 to 21.4) were not diff  erent from EVLWIa 
(16.6 ml/kg; IQR, 12.3 to 21.7). Although the overall correlation with 
APACHE II score, SOFA score, or mortality was not stronger for EVLWIp 
compared with EVLWIa, in patients weighing under or over the normal 
range (BMI  <18.5 or BMI ≥23, 41 cases), EVLWIp was more closely 
correlated with Lung Injury Score (LIS) than ELWIa (EVLWIa; rs = 0.228, 
P = 0.152 vs. EVLWIp; rs = 0.333, P = 0.033). Furthermore, in patients with 
BMI ≥25 (19 cases), the correlation of EVLWIp with LIS was much higher 
(rs = 0.611. P = 0.005) compared with EVLWIa (rs = 0.283, P = 0.240).
Conclusions Even in the Japanese population, EVLWIp is more highly 
correlated to the LIS, especially in obese patients.
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mechanically ventilated critically ill patients
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Introduction Pulmonary elimination of volatile molecules (so-called 
volatile organic compounds (VOCs)) is altered in a variety of pulmonary 
and nonpulmonary diseases [1]. Because breath of intubated and 
mechanically ventilated critically ill patients is continuously available, 
detection of changes in VOC patterns could be used to monitor these 
patients. We hypothesized that an electronic nose (eNose) provides 
a reliable and continuous read-out of changes in patterns of exhaled 
VOCs (so-called breathprints).
Methods An observational pilot study of six intubated and mechanically 
ventilated critically ill patients. Breathprints were collected by means of 
an eNose every 10 seconds for ±7 hours. The patient sample size is too 
small for statistical analysis between patients, but varying fl  uctuations 
could be analysed within each patient.
Results  Breathprints fl   uctuated considerably over time (SEM 1.18). 
However, typical changes could be detected: for example, salbutamol 
inhalation, decreased static compliance and increased minute volumes 
all caused a rapid change in the breathprints (illustrated in Figure 1).
Conclusions Continuous monitoring of exhaled breath using an eNose 
is feasible in intubated and mechanically ventilated patients. Our data 
suggest that changes of breathprints within patients could be used to 
assess the clinical course of the patients.
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is related to the characteristics of mechanical ventilation
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Introduction  Ventilator-associated lung injury (VALI) is an infl  am-
matory response of the lung caused by mechanical ventilation (MV) 
and is related to tidal volumes (TV), positive end-expiratory pressure 
(PEEP) and peak pressures (Ppeak) [1]. In experimental settings, VALI is 
characterized by a local infl  ammatory response measured in tissue or 
lavate. It is diffi   cult to obtain this material in the critically ill [2]. Exhaled 
breath condensate (EBC) is obtained in patients on MV using an easy 
non-invasive technique. In this pilot study we examined the relation 
Figure 1 (abstract P141). Boxplots of the relationship between 
extravascular lung water (ELW, ml/kg) and the diff  erent profi  les determined 
by ultrasonography of both lung sides, in patients with severe sepsis.
Figure 1 (abstract P143). Changes in resistance of sensors during 
7 hours of mechanical ventilation.
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characteristics of MV.
Methods A prospective study was performed in 13 patients on MV. 
EBC was obtained from the connection-swiffl   e between ventilator and 
tube. IL-1β, IL-4, IL-6, IL-8, IL-10, IL-12, IL-17, IFNγ, MCP-1 and MIP-1β 
were determined by multiplex immunoassay. Levels of infl  ammatory 
mediators were correlated with parameters of MV.
Results  In 13 (seven males) patients, 29 samples were obtained. 
Median age of the patients was 69 years, median APACHE II score 25 
points. Samples were taken during MV: seven during pressure control 
(PC) and 22 during pressure support (PS) mode. Median Ppeak was 
18 cmH2O, median PEEP 8 cmH2O, median TV 7.22 ml/kg and median 
P/F ratio 33.62 kPa. Levels of all infl  ammatory proteins except for IL-12 
were lower in patients on PC, reaching statistical signifi  cance for IL-17 
(median PS 1.96 vs. PC 0.96, P = 0.002) and MCP-1 (median PS 0.72 
vs. PC 0.38, P = 0.033). Signifi  cant lower levels were found in patients 
ventilated with TV ≤8 for MCP-1 (median TV ≤8 ml/kg 0.75 vs. TV >8 ml/
kg 3.41, P = 0.032) and MIP-1β (median TV ≤8 ml/kg 0.00 vs. TV >8 ml/
kg 1.30, P = 0.028). Levels of cytokines were lower in case of low Ppeak 
(≤20  cmH2O) reaching the level of statistical signifi   cance for IFNγ 
(median Ppeak ≤20 cmH2O 0.00 vs. > 20 cmH2O 6.23, P = 0.025).
Conclusions In a small group of patients, cytokine and chemokine 
patterns in EBC were related with characteristics of MV. MV with a TV ≤8 
may limit infl  ammatory response.
References
1. Frank  JA,  et al.: Pathogenetic signifi  cance of biological markers of 
ventilator-associated lung injury in experimental and clinical studies. 
Chest 2006, 130:1906-1914.
2. Perkins  GD,  et al.: Safety and tolerability of nonbronchoscopic lavage in 
ARDS. Chest 2005, 127:1358-1363.
P145
Divergent changes in regional pulmonary fi  lling characteristics 
during endotoxin-induced acute lung injury in pigs
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Introduction  Divergent regional fi   lling characteristics of the lung 
may explain ventilator-induced lung injury. In this descriptive study, 
the potential of electrical impedance tomography (EIT) to determine 
progressive changes in regional fi  lling characteristics during acute lung 
injury was explored.
Methods Endotoxin was infused during 150 minutes in 11 mechanically 
ventilated pigs (VC, TV 10 ml/kg, PEEP 5, RR set to normocapnia at I:E 
1:2). EIT (Evaluation Kit 2; Dräger Medical) was used to monitor global 
and regional (four equal ventrodorsal regions of interest, ROIs 1 to 4) 
impedance changes at the mid-thoracic level. The tidal regional versus 
global impedance changes were normalized and analysed by second-
degree polynomial correlation [1]. A square coeffi   cient (x2) <0 indicates 
hyperinfl  ation, >0 indicates recruitment and a value around 0 indicates 
homogeneous regional to global fi  lling. Statistical evaluation was by 
ANOVA and Kruskal–Wallis post-hoc test, signifi  cance was set at P <0.05.
Results  Endotoxinaemia increased the A–a O2 gradient and shunt, 
Qs/Qt, from 5.7 ± 3.6 to 33 ± 24 kPa and from 9.2 ± 2 to 27 ± 6%. 
Homogeneous fi  lling in all four ROIs occurred at baseline (Figure 1) 
but progressively changed to hyperinfl  ation in ROI 1 (x2 = –0.36) and 
recruitment (x2 = 0.66) in ROI 4 at 150 minutes, with ROIs 2 and 3 showing 
intermediate but similar changes. The x2 gradient from ROIs 1 to 4 
(dotted line) increased signifi  cantly consistent with increased regional 
heterogeneity comprising hyperinfl  ation as well as recruitment.
Conclusions  EIT can identify lung areas showing hyperinfl  ation, 
recruitment or homogeneous fi  lling, allowing ventilator settings to be 
adjusted to optimize pulmonary fi  lling characteristics. Monitoring by 
EIT may thus potentially be used to minimize ventilator-induced lung 
injury.
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Introduction  Implementation of assisted mechanical ventilation 
in acute lung injury (ALI) patients may decrease ventilator-induced 
lung injury by redistribution of tidal ventilation towards dependent 
lung regions. Up to now, tidal ventilation regional distribution has 
been measured by expensive and complicated methods, not readily 
available at the bedside. Electrical impedance tomography (EIT) 
is a relatively new non-invasive bedside method to monitor tidal 
ventilation distribution, validated in preclinical studies. We verifi  ed the 
feasibility of using EIT to monitor tidal ventilation regional distribution 
in patients undergoing assisted ventilation and we describe the eff  ect 
of diff  erent pressure support levels on regional ventilation.
Methods We enrolled 11 consecutive ALI patients admitted to our 
ICU, intubated and undergoing pressure support (PS) ventilation. 
We monitored the regional tidal ventilation distribution by means of 
a new EIT monitor (PulmoVista 500®; Dräger Medical GmbH, Lübeck, 
Germany), dividing the lung imaging fi  eld into four contiguous same-
size regions of interest (ROI): ventral right (ROI 1) and left (ROI 2), dorsal 
right (ROI 3) and left (ROI 4). We randomly performed two steps of PS 
ventilation for 15 minutes, leaving the positive end-expiratory pressure 
(PEEP) and FiO2 unchanged: PSlow (p0.1 ≥2 cmH2O) and PShigh (p0.1 <2 
cmH2O). At the end of each step, we recorded: ventilation parameters, 
arterial blood gas analysis and percentage of tidal ventilation 
distribution in the four ROIs. Analyses were performed by paired t test.
Results  The ALI etiology was: trauma (18%), septic shock (18%), 
pneumonia (46%) and postoperative respiratory failure (18%). PSlow was 
set at 3 ± 2 cmH2O and PShigh at 12 ± 3 cmH2O. An increase in PS level 
determined a signifi  cant increase of tidal volume (7 ± 2 vs. 9 ± 3 ml/
kg, P = 0.003) and peak inspiratory pressure (12 ± 4 vs. 18 ± 4 cmH2O, 
P  =  0.0001). At PShigh, proportional distribution of tidal ventilation 
signifi  cantly changed in all four ROIs (ROIs 1 to 4: 25 ± 9 vs. 33 ± 10%, 
P = 0.0003; 32 ± 13 vs. 37 ± 12%, P = 0.02; 20 ± 8 vs. 14 ± 8%, P = 0.0008; 
23 ± 8 vs. 16 ± 5%, P = 0.005), moving from dorsal to ventral.
Conclusions  EIT may be a useful tool to monitor lung regional 
ventilation at the bedside. PS levels that blunt patient eff  ort may 
promote redistribution of tidal ventilation towards ventral lung regions.
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Introduction To resolve confl  icting issues of volume/pressure relation-
ships in endotracheal (ETT) cuff  s, we examined this using an animal 
Figure 1 (abstract P145).
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fairly consistent despite varying tracheal and ETT sizes [1]. Hoff  man 
and colleagues concluded that the volume/pressure relationships in 
ETT cuff  s are linear and that additional air volume above that necessary 
to reach safe sealing pressure would not result in a precipitous increase 
in pressure [2].
Methods In a study approved by the Animal Care and Use Committee, 
excised canine tracheas with four diameters (18, 20, 23 and 26 
mm) were intubated with six diff  erent 7.5 mm ETTs from diff  erent 
manufacturers (Hi-Lo, TaperGuard and Hi-Lo Intermediate, Tyco 
Healthcare, Pleasanton, CA, USA; Blue Line SACETT Portex, Smith 
Medical, Keene, NH, USA; Telefl  ex ISIS HVT, Research Triangle Park, NC, 
USA; MicroCuff  , Kimberly Clark, Roswell, GA, USA). Cuff   pressure was 
determined with a pressure transducer located at the same level as 
the cuff   and connected via the air-fi  lled infl  ation line. The cuff  s were 
infl  ated stepwise adding 1 ml of air per step.
Results  The volume/pressure relationship for all cuff   s is initially 
dependent on the resting volume of the cuff  . Once the cuff   pressure 
is equal to the force of the tracheal durometer, the cuff   pressure 
increases linearly, refl  ecting the compliance of the trachea. This occurs 
at a cuff   pressure of 30 cmH2O. In high-volume low-pressure cuff  s 
(Hi-Lo, SACETT, ISIS) the infl  ation volume was greater compared with 
low-volume low-pressure cuff  s (TaperGuard, Hi-Lo Intermediate). The 
polyurethane cuff   (PU, MicroCuff  ) exhibited a unique volume/pressure 
relationship.
Conclusions The tracheal diameter infl  uences the volume necessary 
to reach a certain cuff   pressure with the same-size cuff  , contrary to the 
fi  ndings of Sengupta and colleagues [1]. The type of cuff  , high-volume 
low-pressure versus low-volume low-pressure, greatly infl  uences 
the behavior of the cuff    pressure. The high-volume low-pressure 
cuff   s required the largest infl   ation volume. The type of material 
changes the behavior of the volume/pressure relationship. A PU cuff   
has a more nonlinear volume/pressure relationship compared with 
polyvinylchloride cuff  s since PU is less distensible. It should be noted 
that the commonly recommended infl  ation pressure (25 to 30 cmH2O) 
[3] was the point at which the steep linear rise in pressure was seen 
with small increments of added infl  ation volume. In conclusion, we 
have demonstrated that ETT cuff   pressure is multifactorial including 
cuff   volume, material and tracheal diameter.
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Introduction There are many inaccurate teachings and a paucity of 
quality evidence about oxygen. We aimed to assess knowledge levels 
amongst healthcare professionals who administer oxygen with respect 
to basic physiology, delivery devices and the potential to cause harm in 
commonly encountered emergency situations.
Methods The salient clinical points from the British Thoracic Society 
guidance on Emergency Oxygen use in Adults Patients [1], as 
deter  mined independently by three doctors, were incorporated 
into a questionnaire. The survey was conducted at a large district 
general hospital amongst frontline staff  . Clinicians of all grades and 
backgrounds including emergency, surgical, anaesthetic and medical 
staff   were surveyed under direct supervision.
Results A total of 196 people were surveyed, including 107 doctors (D), 
69 nurses (N), 10 midwives (M) and 10 physiotherapists (P). Only 70% 
knew how to set up a non-rebreathe mask (D 62%, N 87%, P 80%, M 
40%). Further, just 74% selected this as their fi  rst-line delivery device in a 
critically ill patient. For a simple facemask a fl  ow rate of 5 to 10 l/minute 
is recommended (D 51%, N 54%, P 60%, M 90%), whilst the maximum 
fl  ow rate by nasal cannulae is 6 l/minute, known by 14% of participants. 
Interestingly mouth breathing does not reduce the inspired oxygen 
concentration delivered by nasal cannulae, which was known by 37%. 
Recent evidence suggests the physiology of hypercapnic respiratory 
failure due to excessive oxygen therapy in some COPD patients is 
mainly due to worsening V/Q mismatching rather than a loss of hypoxic 
drive (D 16%, N 6%, P 0%, M 20%). In the absence of hypoxia, oxygen 
is not recommended in myocardial infarction (MI) or stroke because of 
hyperoxaemia-induced vasoconstriction. There was better awareness 
of oxygen use in stroke, with 41% answering correctly compared with 
18% in MI. Of the vital signs, respiratory rate is the best predictor of 
severe illness (D 64%, N 71%, P 80%, M 70%). A >3% drop in saturations, 
even if within the normal range, is signifi  cant (D 83%, N 78%, P 60%, 
M 60%). Therefore oxygen should be titrated to a target saturation (D 
47%, N 52%, P 40%, M 80%) rather than administering maximal oxygen 
therapy, which may mask acute deterioration.
Conclusions In our hospital there is a widespread lack of awareness 
about emergency oxygen. Patients are potentially being administered 
or deprived of oxygen in a manner detrimental to their care. Education 
is needed to protect patients and ensure correct teaching to future 
generations of medical professionals.
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Introduction Little evidence exists about how to wean patients from 
NIV. We assess the effi   cacy and tolerance of a rapid weaning sequence.
Methods The population was consecutive patients admitted to our ICU 
during 1 year with COPD or pulmonary edema (PE) who underwent NIV. 
Criteria for weaning: improvement of acute disease, pH >7.33, RR <25, 
pO2 >65, FiO2 <0.6, EPAP <8. Day 1: withdrawal of NIV (could be placed 
for a maximum of 8 hours the fi  rst day). If no reintroduction of NIV: 
discharge. If reintroduction <8 hours: observation for 24 hours more, 
and discharge if no need for NIV. If deterioration or need to extend NIV 
time: change to a standard protocol (decremental NIV time).
Results  Twenty-one patients were included, 89% male. Mean age 
was 67 years. Fifty per cent had previous history of COPD, 25% heart 
disease (mostly ischemic and hypertensive) and 35% both. Reason for 
admission was PE (80%), and 20% COPD exacerbation. Mean APACHE 
II score: 20. Mean FiO2/pH/pCO2: 0.6/7.22/72. Mean EPAP/IPAP: 6/19. 
Mean time of NIV: 48 hours. Mean time of weaning: 35 hours. Eighteen 
patients were weaned successfully in 48  hours (50% discharged in 
24 hours). No patient needed readmission. We found no diff  erences 
in weaning success related with NYHA, APACHE, reason for admission 
or NIV time. All patients with PE were weaned successfully. Mean 
basal LVEF: 54%. Mean LVEF in acute disease: 50%. Those with LVEF 
deterioration showed the same success rates. Patients with history 
of severe COPD (FVC <38%) needed more NIV time during weaning, 
longer ICU stay and were more likely to fail weaning (three patients 
failed weaning, all with severe COPD).
Conclusions Evidence about how to wean patients from NIV is scarce. 
The usual practice is to decrease NIV time, but extending weaning 
time can lead to higher costs and NIV failure. Pinto showed in 65 
COPD patients that a 3-day approach with decreasing time of NIV was 
feasible. All patients were discharged in 4 days without complications. 
In our case, a more aggressive approach was attempted. Our results 
suggest that rapid weaning sequence could be feasible in PE patients, 
although further studies are needed.
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Introduction  Non-invasive ventilation (NIV) decreases the need 
for mechanical ventilation in the early period of acute hypercapnic 
respiratory failure and factors for success have been studied well. On 
the other hand, little is known about what kind of factors infl  uence the 
NIV response in the subacute period. This study aimed to determine 
the factors infl  uencing PaCO2 reduction below 50 mmHg in the fi  rst 
24 hours of therapy.
Methods In this retrospective study we investigated the diff  erences 
in NIV strategies and patient characteristics between the responsive 
group (PaCO2 levels drop below 50 mmHg in fi  rst 24 hours) (group 2) 
and the nonresponsive group (group 1).
Results In 34% of the patients, PaCO2 reduced to below 50 mmHg 
in fi  rst 24 hours. There were no signifi  cant diff  erences between the 
length of NIV application time and ICU stay, intubations and mortality 
rates, across the groups. Despite a signifi  cantly higher level of pressure 
support usage in group 1 than in group 2, PaCO2 did not reduce 
below 50 mmHg in group 1 within the fi  rst 24 hours. While 91% of 
the responsive group had received nocturnal NIV therapy, only 74% 
of the nonresponsive group had received NIV therapy all night long 
(P = 0.036). The home ventilation usage rate was signifi  cantly higher in 
the nonresponsive group than the responsive group.
Conclusions Results of this study showed that, although nocturnal 
application of NIV in the ICU is associated with a faster drop rate in 
PaCO2 levels, the higher pressure support requirement and prior home 
ventilation usage are predictors for late and poorer response to NIV.
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Introduction Formal airway assessment prior to tracheal intubation is 
one of the core skills taught to trainees in anaesthesia and forms part 
of routine perioperative practice. In the United Kingdom, anaesthetists 
perform the vast majority of emergency intubations of critically ill 
patients. We conducted a survey of usual practice and opinion regarding 
airway assessment in the emergency setting by trainees in anaesthesia.
Methods  An online survey tool was used to create a structured 
questionnaire pertaining to participants’ experience of emergency 
tracheal intubation of critically ill patients in hospital wards, emergency 
departments and critical care units. This was distributed to trainees in 
anaesthesia across London. Participants were asked how often they 
had performed a formal airway assessment and whether they felt this 
would have changed patients’ clinical outcome.
Results  We received 178 responses from anaesthetists with recent 
experience of diffi   cult tracheal intubations in critically ill patients. One 
hundred and fi  fty had encountered grade III/IV views at laryngoscopy. 
Interestingly, the frequency of these encounters had no relationship 
to anaesthetic experience. The mean anaesthetic experience was 4.8 
(SD 2.6) years. Table 1 highlights how often individuals performed 
an airway assessment and shows that the majority (73.4%) felt that 
a formal airway assessment beforehand would not have changed 
eventual patient outcome. Situational urgency and patient factors 
(for example, level of consciousness) were cited as factors limiting 
respondents’ ability to perform an airway assessment.
Conclusions Previous studies have highlighted diffi   culties in formal 
airway assessment of critically ill patients in the Emergency Department 
[1]. These diffi   culties – for example, lack of patients’ ability to cooperate 
with an assessment – are mirrored in our survey. The majority of 
anaesthetists surveyed felt that formal airway assessment prior to 
emergency tracheal intubation of critically ill patients would make 
no diff  erence to patient outcome. This suggests that most of those 
surveyed would question the usefulness of formal airway assessment 
in context of these circumstances.
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Introduction  The aim of this study is to analyze the incidence of 
diffi     cult intubation, and likewise characteristics, complications and 
mortality of urgent orotracheal intubation (OTI) in critically ill patients.
Methods  An observational, descriptive and prospective study. We 
analyze the impact of diffi   cult OTI, morbidity and mortality in urgent OTI, 
in the noncoronary ICU of a third-level university hospital in Madrid. We 
collected all OTIs during the period of 1 year. Demographic data, blood 
pressure and O2 saturation with pulsioximetry, before and after OTI, 
indications, type of technique, medication administrated, place where 
the technique was performed, and complications were collected.
Results Patients: 277. OTIs: 305. Average attempts: 1.15 (SD: 0.41). Sex: 
male (M): 197 (64.6%), female (F): 108 (35.4%). Age: 56 years (15 to 87). 
Indications for OTI: low level of consciousness: 103 (34%), excessive 
work of breathing: 88 (29%), airway protection: 58 (19%), poor secretion 
management: 44 (14.4%), endotracheal tube change: 29 (9.5%), combative 
patient: 27 (8.8%), autoextubation: 6 (2.1%), glottis or laryngeal edema: 
5 (1.7%), others: 6 (2%). Two or more indications agreed in 36%. Place 
technique was performed: ICU: 172 (56.4%), Emergency Department 
(ED): 85(27.9%), hospital ward: 29 (9.5%), burn unit: 16 (5.2%), others: 3 
(1%). Complications: 113 (37%): hemodynamic deterioration: 72 (23.6%), 
hypoxemia: 22 (7.2%), esophageal intubation: 5 (1.6%), selective bronchial 
intubation: 4 (1.3%), bronchoaspiration: 4 (1.3%), impossible OTI: 3 (0.9%), 
others: 3 (0.9%). Diffi   cult and impossible OTI: 7 (2.3%): diffi   cult OTI: 4 (1.3%), 
impossible OTI: 3 (0.98%). Average age: 52 years (38 to 81). Sex: M: 3 (42.8%), 
F: 4 (57.2%). Place technique was performed: ICU: 3 (42.9%), ED: 2 (28.5%), 
hospitalization ward: 1 (14.3%), burn unit: 1 (14.3%). Average attempts: 4.5 
(SD 0.5). Total mortality of the study: 3 (0.98%).
Conclusions In our study, diffi   cult intubation rates were lower than 
those reported in other series, so it is remarkable the low mortality 
of the series, less than 1%, which was determined by hemodynamic 
deterioration after the technique and not associated with the 
procedure. In view of the results it is advisable to carry out predictive 
tests, taking into account the characteristics of the critical patients who 
require urgent intubation, to provide technical diffi   culties in carrying 
out the process and anticipate the preparation of necessary materials 
before starting sequence intubation; likewise, new systems have access 
to the airway for risk.
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Introduction We performed a multicentre, prospective, observational 
study across nine hospitals in the Severn Deanery (UK). Choice of 
Table 1 (abstract P151)
 Never  Sometimes  Always
Airway assessment?  8 (4.5%)  121 (68%)  49 (27.5%)
Changed outcome?  124 (73.4%)  42 (24.8%)  3 (1.8%)
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historical controls.
Methods  Data were collected prospectively on all out-of-theatre 
tracheal intubations occurring within the region during a 1-month 
period. We included all intubations performed outside areas normally 
used for elective or emergency surgery. Neonates and cardiac arrests 
were excluded from analysis. Data were collected locally using a 
standardised proforma and centrally collated. All intubations were 
performed according to the preference of the treating team.
Results  Hypnotics were used for 164 out-of-theatre intubations. 
Seventy-six per cent of intubations were accomplished by the use of 
propofol. Propofol was more likely to cause hypotension than other 
hypnotics (27.4% vs. 14.3%). Use of alternatives increased with seniority 
of the intubator. Consultants and senior trainees were less likely to use 
propofol than junior trainees (73% vs. 93%). Etomidate was not used 
at all. Previous studies from North American and European centres 
demonstrate greater use of alternative induction agents, particularly 
etomidate and ketamine [1-4]. UK practice has also changed over time, 
comparing our study with historical controls [5,6].
Conclusions There is signifi  cant geographical variation in choice of 
induction agent for critically ill patients. There has been an increase in 
the use of propofol amongst UK physicians over the past 7 years. Choice 
of hypnotic agent has a signifi  cant impact on physiological stability 
and out-of-theatre intubations are commonly performed in emergent 
circumstances on unstable patients. This study raises concerns that UK 
physicians choose induction agents based on familiarity rather than 
the pharmacodynamic profi  le.
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Introduction  Arterial hypotension is known to follow emergency 
intubation but the signifi  cance of this event is poorly described. We 
aimed to measure the incidence of post-intubation hypotension (PIH) 
following emergency intubation and determine its association with in-
hospital mortality.
Methods  A retrospective cohort study of endotracheal intubations 
performed in a large, urban emergency department over a 1-year 
period. Patients were included if they were >17 years old and had 
systolic blood pressure (SBP) >90 mmHg for 30 consecutive minutes 
prior to intubation. Patients were analyzed in two groups: those with 
PIH defi  ned by SBP <90 mmHg within 60 minutes of intubation, and 
those with no PIH. The primary outcome was hospital mortality.
Results Emergency intubation was performed on 465 patients, of which 
336 met inclusion criteria and were analyzed. The median patient age 
was 49 years, 59% of patients presented with nontraumatic illness and 
92% underwent induction with etomidate. PIH occurred in 76/336 
(23%) of patients. The median time to fi  rst PIH was 11 minutes (IQR 2 to 
27). Intubation for acute respiratory failure was the only independent 
predictor of PIH (OR = 2.1, 95% CI = 1.1 to 4.0). Patients with PIH had 
signifi  cantly higher in-hospital mortality (33% vs. 21%; 95% CI for 12% 
diff  erence = 1 to 23%) and longer mean ICU length of stay (9.7 vs. 5.9 
days, P <0.01) and hospital length of stay (17.0 vs. 11.4 days, P <0.01). 
Multivariate logistic regression analysis confi  rmed PIH as an independent 
predictor of hospital mortality (OR = 1.9, 95% CI = 1.1 to 3.6).
Conclusions PIH occurs in nearly one-quarter of normotensive patients 
undergoing emergency intubation. Intubation for acute respiratory 
failure is an independent predictor of PIH. PIH is associated with a 
signifi  cantly higher in-hospital mortality and longer ICU and hospital 
lengths of stay.
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Introduction  Both elective and emergency thoracic surgical 
procedures may require one-lung ventilation (OLV) for lung isolation 
[1]. Although in the majority of the cases a double lumen endotracheal 
tube (DLT) is the fi  rst choice, there are situations when insertion of 
DLT is not feasible [2]. We therefore intended to test the applicability 
of a recently developed endobronchial blocker (BB), the EZ-Blocker, in 
clinical practice.
Methods Data were obtained from 10 patients undergoing thoracic 
surgery necessitating OLV. For lung isolation, a single lumen tube (SLT) 
and EZ-Blocker as BB were used. The time of insertion and positioning 
of BB, the lung defl  ation time with the BB cuff   infl  ated and defl  ated, 
the minimal occlusion volume (MOV) of the BB cuff   with 25 cmH2O 
positive airway pressure (PAP) and intracuff   pressure (ICP) at MOV were 
registered. Based on the CT scan the diameter of the right (RMB) and 
left main bronchus (LMB) at 1 cm distal apart from the bifurcation was 
measured offl   ine. Lung defl  ation was defi  ned as 5.5 cm distance of the 
upper lobe from the rib cage at open chest.
Results The insertion time was 76 ± 15 seconds. The lung defl  ation time 
through the lumen with the BB cuff   infl  ated was 700 ± 83 seconds, and 
with a defl  ated cuff   through the lumen of SLT was 9.4 ± 0.7 seconds. The 
MOV was 6.7 ± 1 ml in LMB versus 8 ± 1 ml in RMB (P = 0.03). The ICP 
was 40 ± 4 mmHg in LMB versus 85 ± 5 mmHg in RMB (P <0.001). With 
linear regression there were strong positive relationships between the 
diameter of MB and MOV/ICP.
Conclusions The use of EZ-Blocker is easy and safe for infrequent users, 
too. The short insertion time and short lung defl  ation time allows use 
in an emergency situation or in case of a diffi   cult airway. Only a small 
fraction of ICP (10 to 20%) is transmitted to the bronchial wall and it 
does not cause mucosal ischemia. The diameter of the MB has great 
impact on the MOV and ICP. The MOV is similar but ICP is smaller than 
published in previous reports with other BBs [3].
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Introduction The purpose of the study was to apply a method by which 
to measure Rohrer’s constant, k2, in order to estimate endotracheal tube 
(ETT) resistance (RETT). The resistance drop across the ETT is expressed 
by the equation RETT = k1 + k2V’, as Rohrer described, where k1 is the 
constant of laminar fl  ow (V’) and k2 is the constant of turbulent fl  ow. In 
our past study we graphed RETT over inspiratory V’ for ETTs with inner 
diameters of 6.5 to 9.0 mm [1]. This graph provided us with k1 and k2 
constant values, for each ETT size.
Methods Ten intubated patients with ETTs with diffi   culty in patency 
were included in the study. Patients were all fully sedated and 
mechanically ventilated, by a Siemens Servo 300 ventilator, under 
constant fl  ow. Pressure data were obtained: at the proximal end of 
the ETT (Pproximal), refl  ecting the impedance distally to the proximal 
end of the ETT; and at the distal end of the ETT (Pdistal), refl  ecting the 
resistance distally to the distal end of the ETT. Pdistal was recorded by an 
intratracheal catheter, placed 2 cm above the carinal end of the ETT. 
Each resistance was calculated by dividing ΔP (Ppeak – Pplateau) by V’, at 
every point of interest (either proximal or distal sites), using the rapid 
end-inspiratory occlusion method. RETT resulted from the diff  erence: 
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variances) was used to analyse the diff  erence between data and the 
level of signifi  cance P was set at 0.05.
Results Ten patients (fi  ve men), with mean age of 66 ± 17 years, were 
tested. Figure 1 demonstrates the diff  erence in measured k2 constant 
values compared with baseline in vitro values of the corresponding 
ETT size, for every patient. This is based on the assumption that at the 
moment of endotracheal intubation, the k2 constant has approximately 
the same value as the one measured in vitro. Figure 1 shows that the in 
vivo values were signifi  cantly higher (P = 0.0012).  
Conclusions  Our data suggest a signifi   cant discrepancy between 
predicted and in situ ETT resistance, raising concern for the presence of 
unrecognized ETT obstruction. Comparing the k2 constant, measured 
in vivo, with its corresponding in vitro value provides an estimation of 
ETT’s resistive behaviour.
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Introduction The purpose of the study was to record the incidence, 
the etiology and management of acute desaturation (AD) in intubated 
critically ill ICU patients.
Methods We collected demographics of the patients developing AD 
defi  ned as a documented fall in SaO2 (>3%) in combination with clinical 
signs of respiratory distress requiring medical intervention. Etiology 
of AD was investigated by clinical evaluation, ABG analysis and chest 
X-ray. Numerical data are presented as mean (SEM) or median.
Results We included 57 patients (37 men) admitted to our ICU within 
6 months of mean age 54.4 (2.7) and mean ICU stay of 25.9 (5.7) days. 
We recorded 42 episodes of AD in 19 patients (33%). Mean age was 
51.4 (3.8), mean ICU stay 51.1 (15.3) days and illness severity APACHE II 
20.8 (1.6), SAPS II 52.2 (3.3) and SOFA 9.2 (0.8). The incidence was one 
episode per 30 ventilator-days or one every 4.3 days, corresponding 
to 2.3 (1.1) episodes per patient. Mean fall in SaO2 was 5%, in PaO2 
44 mmHg and in PaO2/FiO2 113. Eight episodes developed while 
on T-piece due to atelectasis/secretion retension (6) or respiratory 
muscle fatigue (2). The remaining episodes developed in patients 
under sedation: atelectasis/secretion retention (10), pulmonary edema 
(6), fever/SIRS (5), occlusion/displacement of endotracheal tube (5), 
patient–ventilator asychrony (4), bronchospasm (2), patient transfer (1) 
and pneumothorax (1). Management included FiO2 increase (53.5%), 
physiotherapy/bronchial toilet/patient poisoning (39.5%), change 
in ventilator mode (23.3%), PEEP increase (23.3%), drugs (sedation, 
diuresis, bronchodilators, 16.2%), change in respiratory rate (11.6%), 
use of Ambu bag (4.6%), reintubation (2.3%), insertion of chest tube 
(2.3%) and other measures (11.6%). Most patients required at least two 
interventions. Patients developing AD had signifi  cantly higher (P <0.05) 
SAPS II (median 54 vs. 42), SOFA (9 vs. 6) scores and ICU stay (41 vs. 
8). None of the episodes had fatal outcome. Most common hours for 
developing AD were 07.00, 14.00 and 23.00.
Conclusions AD is a common medical emergency condition requiring 
prompt interventions. One over three patients developed at least two 
episodes of AD corresponding to one episode per 4.3 days. The most 
common etiology is atelectasis and secretion retention.
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Introduction  Underinfl  ation of a tracheal cuff   frequently occurs in 
critically ill patients, and results in microaspiration of contaminated 
oropharyngeal secretions and gastric contents that plays a major role 
in the pathogenesis of VAP. The aim of this study was to determine the 
impact of continuous control of cuff   pressure (Pcuff  ) on microaspiration 
of gastric contents.
Methods  Patients requiring mechanical ventilation through a PVC-
cuff  ed tracheal tube >48 hours were eligible. Patients were randomly 
allocated to continuous control of Pcuff   using a pneumatic device 
(Nosten®) (intervention group, n = 61) or routine care of Pcuff   (control 
group, n = 61). Target Pcuff   was 25 cmH2O in the two groups. The primary 
outcome was microaspiration of gastric contents as defi  ned by the 
presence of pepsin at a signifi  cant level (>200 ng/ml) in tracheal secretions. 
Secondary outcomes included incidence of microbiologically confi  rmed 
VAP (tracheal aspirate >105 cfu/ml), incidence of tracheobronchial 
colonization, and tracheal ischemic lesions as defi  ned by a macroscopic 
score. Pepsin was quantitatively measured in all tracheal aspirates 
during the 48 hours following randomization. A patient was considered 
as having abundant microaspiration when >65% of tracheal aspirates 
were pepsin positive. Patients remained in a semirecumbent position 
in bed, and a written enteral nutrition protocol was used. All analyses 
were performed on an intention-to-treat basis.
Results  Patient characteristics were similar in the two groups. The 
pneumatic device was effi   cient in controlling Pcuff  . Pepsin was measured 
in 1,205 tracheal aspirates. The percentage of patients with abundant 
microaspiration (18% vs. 46%, P = 0.002, OR (95% CI) 0.25 (0.11 to 
0.59)), pepsin level (median (IQ) 195 (95 to 250) vs. 251 (130 to 390), 
P = 0.043), and VAP rate (9.8% vs. 26.2%, P = 0.032, 0.30 (0.11 to 0.84)) 
were signifi   cantly lower in the intervention group compared with 
control group. However, no signifi  cant diff  erence was found in rate of 
patients with tracheobronchial colonization (34% vs. 39%, P = 0.7) or 
in tracheal ischemia score (4.5 (1 to 6) vs. 4.5 (1 to 7), P = 0.9) between 
the two groups.
Conclusions Continuous control of Pcuff   is associated with signifi  cantly 
decreased microaspiration of gastric contents in critically ill patients.
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Introduction Tracheostomy is now an established standard of care in 
the management of some critically ill patients. Despite this, however, 
the eff  ect of its timing on patient outcome remains unclear [1].
Methods  We interrogated the database of our clinical information 
system (MetaVision, iMDSoft) and identifi   ed 75 patients who 
underwent tracheostomy insertion. Outcome data, including 28-day 
mortality, length of stay (LOS) and weaning interval, were captured 
Figure 1 (abstract P156). Comparison of the k2 constant in vivo value 
with the corresponding in vitro k2 value.
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admission (early group) and >4 days into critical care admission (late 
group). Continuous data when expressed as mean (SD) were analysed 
using t-test and when expressed as median (IQR) were analysed using 
the Mann–Whitney U test. Binary outcome data were analysed using 
the chi-square test. P <0.05 was considered statistically signifi  cant.
Results The early group (n = 32) had a mean LOS of 19 days (SD = 16.57), 
median weaning interval of 9 days (IQR = 9.5) and a mortality of 12.5% 
(n = 4). The late group (n = 43) had a mean LOS of 21.6 days (SD = 12.62), 
median weaning interval of 8 days (IQR = 13) and a mortality of 27.9% 
(n = 12). More tracheostomies were performed late at our institution, 
but despite this there was no signifi  cant diff  erence in LOS (P = 0.481, 
t test), weaning interval (P = 0.852, Mann–Whitney U test) or 28-day 
mortality (P = 0.107, chi-square test) between the two groups.
Conclusions Many clinicians believe that early tracheostomy insertion 
may benefi  t critically ill patients requiring mechanical ventilation. This 
benefi  t does not seem to extent to 28-day survival, critical care LOS or 
weaning from mechanical ventilation.
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Introduction To investigate the infl  uence of duration of mechanical 
ventilation on the diaphragmatic function.
Methods  Patients included in this study were those mechanically 
ventilated for at least 24 hours and were preparing to wean from December 
2008 to December 2009 in the ICU of Nanjing Zhong-Da Hospital. Patients, 
according to the duration of mechanical ventilation, were divided into 
group A (ventilated less than 3 days) and group B (ventilated more than 3 
days). A 30-minute spontaneous breathing test (SBT) was carried out on the 
patients satisfying the weaning permission. Indices of diaphragm function 
such as electrical activity of diaphragm (Edi), neuromuscular strength 
index (NMS), neuromechanical coupling (NMC) and neuroventilatory 
coupling (NVC) at 0, 5 and 30 minutes of SBT were monitored.
Results Forty-four patients were included fi  nally, of whom 19 patients 
(43.2%) were ventilated more than 3 days (group B), while the average 
duration of mechanical ventilation was 6.2 ± 3.9 days. Twenty-fi  ve patients 
were ventilated less than 3 days (group A), whom had an average duration 
of mechanical ventilation for 2.2  ±  0.7 days. There was no signifi  cant 
diff  erence in Edi, NMS, NMC or NVC at 0 minutes of SBT between the 
two groups. Edi and NMS in group B were 20 ± 11 μV and 571 ± 338 
μV•cpm at 5 minutes of SBT, which were both largely more than group 
A (16 ± 8 μV and 387 ± 208 μV•cpm, P <0.05). Then, NMC and NVC had 
no signifi  cant diff  erence. At SBT 30 minutes, Edi and NMS in group B both 
were signifi  cantly higher than group A (23 ± 11 μV vs. 15 ± 8 μV, 598 ± 309 
μV•cpm vs. 362 ± 224 μV•cpm, P <0.05). Whereas NVC in group B (20 ± 12 
ml/μV) was lower than group A (35 ± 21 ml/μV, P <0.05).
Conclusions The contractility and endurance of diaphragm decreased 
in patients whom were ventilated more than 3 days at 30 minutes of 
SBT. It seemed that an incremental duration of mechanical ventilation 
could exacerbate diaphragm dysfunction, which might be one of the 
important factors leading to failed weaning.
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ICU patients
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Introduction Ventilator weaning protocols have been published during 
the past 20 years. Although patients fulfi  ll weaning criteria, they may still 
experience extubation failure. Risk factors include respiratory muscle 
weakness. This is accompanied by peripheral muscle weakness. The 
aim of the study is to evaluate the possible relation between peripheral 
(hand) muscle strength and extubation success in ICU patients.
Methods Fifty-four consecutive patients (62 ± 14 years) extubated in 
the ICUs of the Brugmann University Hospital and the Etterbeek-Ixelles 
General Hospital were included in the study. Extubation failure was 
defi  ned as reintubation within 48 hours after extubation. Hand muscle 
strength is measured by a grip test method.
Results  Maximal hand grip strength is statistically (14.8  ±  7.7 vs. 
5.3  ±  3.8 kg, P  <0.001) higher in patients successfully undergoing 
extubation compared with patients failing extubation. See Figure 1.
Conclusions  Hand grip strength testing is a good predictor of 
successful extubation in ICU patients. The positive predictive value 
of 100% is obtained if maximal strength is >13 kg. Further studies 
are needed before grip testing could be routinely used as a decision-
making test for extubation in ICU patients.
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Use of NT-proBNP in weaning from mechanical ventilation
A Martini, B Benedetti, N Menestrina, E Polati, E Bresadola, L Gottin
University Hospital, Verona, Italy
Critical Care 2011, 15(Suppl 1):P162 (doi: 10.1186/cc9582)
Introduction  Our objective is to evaluate the role of the levels of 
B-type natriuretic peptide (BNP), released in response to increased wall 
tension, as a predictor of weaning failure.
Methods  We enrolled 98 patients, admitted to the ICU for acute 
respiratory failure, who underwent mechanical ventilation and were 
considered ready for a weaning trial. Patients were divided by means of 
echocardiographic criteria into four groups according to the severity of 
heart dysfunction: Group 1: normal left and right ventricular function 
and absence of relevant valvulopathy; Group 2: mild left systolic 
ventricular dysfunction, ejection fraction >40%, mild valvulopathy, 
diastolic dysfunction >II; Group 3: moderate to severe left systolic 
ventricular dysfunction, ejection fraction <40%; and Group 4: severe 
right ventricular dysfunction: ventricular volumes R/L >0.6, arterial 
pulmonary pressure >30 mmHg. Plasma NT-proBNP was measured 
just before (BNP 1) and at the end (BNP 2) of the weaning trial in all 
patients. Patients who passed the weaning test were fi  nally extubated. 
Extubation was considered failed if the patient required reintubation 
within 48  hours. We compared plasma BNP concentrations in the 
diff   erent groups with Mann–Whitney or chi-square tests and we 
considered also ΔBNP (BNP 2 – BNP1) and %Variation (Δ / BNP1).
Results In the whole sample NT-proBNP levels were not signifi  cantly 
diff  erent in patients who had a positive weaning and in those who 
failed it. ΔBNP and %Variation were higher (P  <0.001) in patients 
who failed the test than in patients who passed the test. In Group 1 
Figure 1 (abstract P161). Diff  erence between maximal grip forces.
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correlated with weaning failure. In Group 4, instead, the plasma BNP 
concentration decreased during the weaning test. ROC curve analysis 
was performed to assess ΔBNP and %Variation’s ability to discriminate 
between patients who had a positive weaning and those who failed. In 
Group 1 the area under the ROC curve values were 0.88 for ΔBNP and 
0.94 for %Variation. In Group 2 the area under the ROC curve values 
were 0.64 for ΔBNP and 0.86 for %Variation.
Conclusions Recent papers evaluated the role of BNP in patients who 
had undergone mechanical ventilation. In our population ΔBNP and 
%Variation before and after the weaning test are more reliable than 
NT-proBNP levels to detect extubation failure in patients with mild 
cardiopathy or without relevant cardiopathy. In patients with severe 
cardiopathy because of the complexity of clinical pattern, NT-pro-BNP 
cannot be used as a predictive marker of extubation failure.
P163
Effi   cacy of implementation strategies of an evidenced-based 
awakening and breathing protocol
O Almuslim, M Rezk, N Hassan
King Fahad Specialist Hospital – Dammam, Saudi Arabia
Critical Care 2011, 15(Suppl 1):P163 (doi: 10.1186/cc9583)
Introduction  A protocol that paired spontaneous awakening trials 
(SAT) and spontaneous breathing trials (SBT) decreased duration of 
mechanical ventilation (DMV), ICU length of stay (LOS) and mortality 
[1]. We studied the effi   cacy of multifaceted implementation strategies 
(MIS) of an evidenced-based protocol at a tertiary academic center.
Methods  This was a prospective observational cohort study with 
historical control. The cohort consisted of consecutive patients who 
were extubated at least once during the ICU stay. The intervention 
was MIS of a quality improvement (QI) protocol pairing SAT and SBT. 
These strategies included: preprinted daily order sheets, structured 
daily multidisciplinary rounds, QI monitoring and regular feedback to 
the ICU staff  . The outcomes: DMV, ICU LOS, reintubation and hospital 
mortality. Chi-square and t tests, adjusted logistic and Cox regressions 
were used.
Results Total patients n = 120 (2009, n = 40; 2010, n = 80). The baseline 
characteristics were imbalance for age and APACHE II. The 2010 group 
(after QI) had less DMV, ICU LOS and hospital mortality (Table 1). The 
adjusted hazard ratio in reducing time to extubation  =  0.57 (95% 
CI = 0.37 to 0.88) and adjusted odds ratio for hospital mortality = 0.27 
(95% CI = 0.12 to 0.67) in the 2010 group. See Figure 1.
Conclusions MIS of a paired SAT and SBT protocol reduced duration of 
MV, ICU LOS and hospital mortality.
Reference
1. Girard  T,  et al.: Lancet 2008, 371:126-134.
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failure? Invasive and echocardiographic evaluation
A Abdelbary, W Ayoub, Y Nassar, K Hussein
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Critical Care 2011, 15(Suppl 1):P164 (doi: 10.1186/cc9584)
Introduction The aim was to study the relation of weaning failure to 
development of diastolic dysfunction using echocardiography and PA 
catheter.
Methods Thirty invasively mechanically ventilated patients fulfi  lling 
criteria of weaning from mechanical ventilation were shifted to SBT 
(using low PSV (8 cmH2O)) for 30 minutes. Two sets of variables were 
measured at the beginning and end of the SBT. Weaning failure was 
defi  ned as: failed SBT, reintubation and/or ventilation or death within 
48 hours following extubation. A Swan–Ganz catheter was used to 
obtain the right atrial (RAP), pulmonary artery (PAP), pulmonary artery 
occlusion (PAOP) pressures, and cardiac index (CI). Echocardiography: 
the LV internal diameter at end diastole (LVIDd) and end systole 
(LVIDs), ejection fraction (LVEF), E/A ratio, deceleration time (DT) (ms), 
isovolumetric relaxation time (IVRT), and E/E’ ratio.
Results Mean age was 56.6 ± 15.9 years, 53% were males. The outcome 
of weaning was successful in 76.6% of patients. The patients were 
subdivided into two groups according to weaning outcome: Group 
I, 23 patients (successful weaning); Group II, seven patients (failed 
weaning). RAP, PAOP and SVO2 were similar at the start of SBT (6.3 ± 1.9 
vs. 7.6 ± 2.3, P = 0.1; 12 ± 3.7 vs. 14.6 ± 3, P = 0.4; 72 ± 2.4 vs. 71 ± 3.1, 
P = 0.1) between Groups I and II yet signifi  cantly diff  erent at the end 
(6.2 ± 2.4 vs.10 ± 3.5, P = 0.01; 12.8 ± 3.5 vs.19 ± 5.4, P = 0.004; 73 ± 2.8 
vs. 66.6 ± 7, P = 0.009), respectively. CI was similar between Groups 
I and II at both ends of the SBT, P = 0.5 and P = 0.9. Groups I and II 
had similar LVIDs and EF at the beginning of SBT (3 ± 0.7 vs. 3.3 ± 0.5, 
P = 0.2; 68 ± 8 vs. 62 ± 6, P = 0.08) yet diff  erent at the end (3 ± 0.6 vs. 
3.5 ± 0.5, P = 0.048; 66 ± 8 vs. 58 ± 7, P = 0.03), respectively. There was 
no signifi  cant diff  erences in E/A, IVRT, DT yet a signifi  cant diff  erence in 
E/E’ between Group I and Group II at both ends of the trial (1.04 ± 0.4 
vs. 0.97 ± 0.3, P = 0.78; 1.02 ± 0.4 vs. 1.07 ± 0.4, P = 0.78; 94 ± 26 vs. 
99.6 ± 18, P = 0.52; 97 ± 22 vs. 91 ± 24, P = 0.57; 194 ± 31 vs. 196 ± 30, 
P = 0.98; 197 ± 27 vs. 189 ± 33, P = 0.6; 8.9 ± 2 vs. 12.2 ± 4, P = 0.02; 
9.4 ± 2.3 vs. 13 ± 5, P = 0.02), respectively.
Conclusions LV dysfunction may have an impact on weaning outcome. 
Invasive monitoring as well as echocardiography and tissue Doppler 
indices may be reliable in monitoring and detection of LV dysfunction, 
and subsequently may be possibly useful in improving weaning 
outcome. RAP may be a particularly reliable and easy method to 
monitor during the period of weaning.
P165
High-fl  ow oxygen therapy through nasal cannulae versus low-fl  ow 
oxygen therapy via Venturi mask after extubation in adult, critically 
ill patients
F Antonicelli, A Cataldo, R Festa, F Idone, A Moccaldo, M Antonelli, 
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Introduction Oxygen therapy, usually delivered with the Venturi mask, 
is frequently used in critically ill patients after extubation. This device 
delivers low-fl  ow oxygen with cold humidifi  cation. Recently available is 
Table 1 (abstract P163). Main outcomes
  2009 group  2010 group 
 ( n = 40) (n = 80)  P value
MV duration (days)  10.3 (SD 8.6)  5.3 (SD 6.7)  <0.01
ICU LOS (days)  12.4 (SD 8.3)  8.6 (SD 9.1)  0.03
Reintubation 33%  (n = 13) 18%  (n = 14) 0.06
Hospital mortality  60% (n = 24) 20%  (n = 16) <0.01
Figure 1 (abstract P163). Time to extubation KM curve.
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device delivers up to 60 l/minute oxygen, with heated humidifi  cation. 
The aim of this study was to compare the eff  ects of these two devices 
for oxygen therapy on arterial blood gases, discomfort and adverse 
events in critically ill patients after extubation.
Methods Inclusion criteria were mechanical ventilation for more than 
24  hours and a successful spontaneous breathing trial with PaO2/
FiO2 <300 at the end of the trial. Exclusion criteria were tracheostomy, 
age  <18 and anticipated need for non-invasive ventilation after 
extubation. Patients were randomized to receive oxygen therapy with 
NHF or Venturi mask after extubation. With both devices, nominal 
FiO2 was set to obtain SpO2 between 92 and 98% (between 88 and 
95% in hypercapnic patients). Arterial blood gas, respiratory rate, 
and discomfort were recorded at 1, 3, 6, 12, 24, 36, and 48 hours from 
inclusion. Discomfort was assessed by asking patients to rate their 
discomfort related to the interface and to the upper airway dryness 
(mouth, throat, and nose dryness, diffi   culty to swallow and throat 
pain), using a numerical scale from 0 (no discomfort) to 10 (maximum 
discomfort).
Results Seventy-fi  ve patients were enrolled (40 NHF, 35 Venturi mask). 
No diff  erence was observed in the baseline characteristics at inclusion. 
PaO2/FiO2 was higher in the NHF group, being statistically signifi  cant 
at 1, 3, 24, and 36 hours (317 ± 78 vs. 253 ± 84 at 24 hours, P <0.01). 
PaCO2 was similar in the two groups. Nominal FiO2 and the respiratory 
rate were always lower with NHF than with Venturi mask (30 ± 6 vs. 
37 ± 10%, P = 0.01, and 21 ± 4 vs. 27 ± 4 breaths/minute at 24 hours, 
P <0.01, respectively). Discomfort due to the interface was higher with 
the Venturi mask at 12, 24, 36, and 48 hours (4 ± 3 vs. 6 ± 3 at 24 hours, 
P <0.01). Discomfort related to dryness of the upper airways was also 
higher with the Venturi mask than with NHF at all time steps (2 ± 2 
vs. 4 ± 2 at 24 hours, P <0.01). Oxygen desaturations and interface 
displacements were more frequent with the Venturi mask than with 
NHF (94 vs. 40% patients, P <0.01, and 71 vs. 30% patients, P <0.01, 
respectively).
Conclusions NHF is an eff  ective method for delivering oxygen therapy 
after extubation, allowing better oxygenation with less patient 
discomfort and adverse events than the Venturi mask.
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Introduction Prolonged mechanical ventilation of critically ill patients 
may be complicated by formation of post-intubation tracheal stenosis 
(PITS) with respiratory disorders of diff  erent grades. Critical post-intu-
bation tracheal stenosis (CPITS) may create life-threatening condi  tions. 
However, organized teamwork on the ground in the ICU may give 
positive results.
Methods  We reviewed retrospectively the medical records of 17 
patients admitted to our ICU with PITS and CPITS during 2003 to 2010. 
Ten of them were males with mean age 68 years old and seven females 
with mean age 72. In relatively stable patients, computed tomography 
(CT) and virtual tracheoscopy (VT) were used, followed by rigid (RB) 
or fi  beroptic (FOB) bronchoscopy. In emergency cases we used RB for 
diagnosis and treatment. All procedures in the operating room were 
done under general anesthesia, the majority with high-frequency jet 
ventilation (HFJV).
Results In 13 patients PITS had diameter of about 5 to 6 mm and 
produced dyspnea. Four of 13 patients had soft PITS that were dilated 
with boogie; in another fi   ve patients with hard stenosis, balloon 
dilation was used. In the remaining four patients with severe respiratory 
distress, CPITS was diagnosed as having diameter of 3 to 4 mm. 
Emergency tracheostomy was performed in two patients; excision of 
large granulations in one case, and intubation with small endotracheal 
tube after partial dilation in one case.
Conclusions Management of PITS in the ICU was benefi  cial for some 
of our patients and especially those with CPITS. VT allowed precise 
measurements of PITS. HFJV created stable conditions for work.
P167
Can extubation failure be related to high unit activity?
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Introduction  Extubation failure has become an important quality 
indicator. The aim of our study was to ascertain whether extubation 
failure was related to unit activity; that is, whether it was more frequent 
on days of greater unit activity.
Methods We retrospectively analysed 520 consecutive admissions to 
our seven-bed ICU over an 18-month period. We defi  ned extubation 
failure as the need for reintubation within 24 hours. Bed occupancy 
was used as a surrogate marker of unit activity. Bed occupancy was 
based upon the number of hours patients were nursed in the ICU each 
day and was summed and expressed as a percentage of the maximum 
available (24 x 7). Data were collected from our national audit database 
and analysed using SPSS software.
Results We studied 520 intubated patients over an 18-month period 
after excluding children, tracheostomised patients and patients 
who were receiving end-of-life care. Sixty-fi  ve patients (12.5%) were 
reintubated within the 24 hours. Bed occupancy was not diff  erent in 
the extubation success group as compared with the failure group (70.6 
CI ± 1.75 vs. 72.9 CI ± 4.9; P = 0.37). The two groups were similar in terms 
of their severity of illness; that is, APACHE II scores. Length of stay was 
increased in the extubation failure group. There was no correlation 
between bed occupancy and extubation failure using the Pearson 
correlation coeffi   cient (R = 0.05; P = 0.68). See Table 1 and Figure 1.
Conclusions We could not demonstrate any correlation between high 
unit activity and reintubation rates.
Reference
1. Beckmann  U,  et al.: Chest 2001, 120:538-542.
Table 1 (abstract P167).
 Control  Failure  P value
Number 455  65 
Age 57.26  51.2  0.01
APACHE 20.33  21.5  0.69
Bed occupancy  70.6  72.9  0.37
Admitted 1.21  1.21  0.84
Discharged 1.4  1.32  0.37
Figure 1 (abstract P167). Scatterplot of reintubation rates versus bed 
occupancy.
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Decannulation: in the ICU or in the ward? Does it really matter?
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Critical Care 2011, 15(Suppl 1):P168 (doi: 10.1186/cc9588)
Introduction The aim of our study was to evaluate the in-hospital 
mortality of patients who underwent tracheostomy during their ICU 
admission, and were discharged to diff  erent areas of the hospital prior 
to decannulation.
Methods A prospective observational study of a group of patients who 
underwent tracheostomy in our ICU from January 2001 to December 
2007 and were discharged to diff  erent areas of the hospital prior to 
decannulation. The mortality of patients decannulated or not in the 
wards was reviewed.
Results Between January 2001 and December 2007, 6,333 patients 
were admitted to our unit. A total of 1,528 needed mechanical 
ventilation (MV) for more than 48  hours. Four hundred and forty-
three underwent tracheostomy (29% of patients needed prolonged 
MV). Mean age was 56 years, 66% were male. Mean APACHE II 
score was 20. The main diagnoses were polytrauma that included 
head injury (24.2%), other structural neurological diseases (21%), 
prolonged weaning of several etiologies – sepsis, post-surgical (35%). 
Tracheostomy was performed with the percutaneous dilatational 
technique (PDT) in most cases (90%). The most frequent complication 
was subglottic stenosis presenting in 15 patients. Ninety-two patients 
(20.77%) died in the ICU and 351 were discharged to diff  erent wards. Of 
these 351, 161 (45.8%) could be decannulated in the ICU and 109 (31%) 
in the wards. Eighty-one patients (23%) could not be decannulated. The 
ward mortality in patients decannulated in the ICU was 5.6% (9/161), 
for those decannulated in the wards was 10% (11/109). In patients 
not decannulated the mortality reached 37% (30/81). There were no 
diff  erences of statistical signifi   cance in mortality between patients 
decannulated in the ICU and patients decannulated in the wards (5.6% 
vs. 10%; OR = 1.9 CI = 0.8 to 4.2). The main diagnoses in the patients 
who died on the wards were: 31 residual encephalopathy (post-anoxic, 
post-traumatic, others), fi  ve severe chronic respiratory failure, three 
spinal cord injury, two neuromuscular disease.
Conclusions Mortality was not related to whether decannulation was 
done in the ICU or on the ward. Although mortality was higher in the 
group of patients that could not be decannulated in either setting 
due to their poor neurological or functional status. Several authors 
suggest tracheostomy in these patients only delays their death without 
improving overall in-hospital survival due to their poor vital prognosis.
References
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P169
Assessment of the impact of unplanned extubation on ICU patient 
outcome
E Bastos de Moura, J Aires de Araújo Neto, M De Oliveira Maia, 
F Beserra Lima, R Fernandes Bomfi  m
Hospital Santa Luzia, Brasília, Brazil
Critical Care 2011, 15(Suppl 1):P169 (doi: 10.1186/cc9589)
Introduction The objective of this study is to investigate and analyze 
the events of unplanned extubation (UE) in the ICU of Santa Luzia 
Hospital, Brasília, Brazil. Incidence rates of unplanned extubation vary; 
reported rates range from 3% to 14%. This phenomenon occurs during 
procedures performed by healthcare workers, or in self-extubation if 
the patient removes the endotracheal tube. Unplanned extubations are 
considered an indicator of healthcare quality in the ICU. Reintubation 
may be necessary and is associated with complications, including 
emergency cricothyrotomy, cardiac arrest, and death.
Methods  A retrospective cohort study, analysing the cases of UE 
reported between January 2009 and June 2010 in Santa Luzia 
Hospital’s ICU. In this period 3,302 patients were admitted, and 551 
were submitted to mechanical ventilation (MV). The cases of UE are 
notifi  ed through proper form by the physiotherapy. The incidence rate 
of unplanned is calculated by the relationship between the number of 
patients extubated accidentally and the number of patients intubated/
day, multiplied by 100.
Results The incidence rate of UE was 0.21% (nine patients in 4,232 
days of MV). Only two extubations (22.22%) occurred accidentally 
while seven cases (77.78%) were self-extubation. Patients were 
predominantly female (55.56%; n = 5), mean age was 59.86 ± 27.28 
years, mean SAPS II score of 35.33 ± 12.50 (RISK: 21.56 ± 18.32%), mean 
APACHE II score of 10.44 ± 6.27 (RISK: 17.11 ± 15.35%), mean duration of 
MV 8.68 ± 9.81 days, mean length of stay in ICU 15.89 ± 8.75 days. Two 
patients (22.22%) needed reintubation. In only one patient (11.11%) 
urgent cricothyrotomy was required due to diffi   culty on reintubation. 
Most patients had already started the weaning process (77.78%). The 
leading cause of accidental extubation was failure of restraint (88.89%) 
associated with psychomotor agitation (55.56%). We had three 
(33.33%) cases of death in the group, but not associated with the UE.
Conclusions In the studied population we observed a low incidence 
of this adverse event, which demonstrates eff  ectiveness in prevention 
strategies adopted. Reintubation and urgent cricothyrotomy rates 
were low, which resulted in increased length of stay in the ICU and MV.
References
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Introduction Extracorporeal membrane oxygenation (ECMO) provides 
temporary life support for children with severe respiratory or cardiac 
failure. Since 1990, more than 27,000 children have received ECMO and 
an overall survival rate of 76% [1] has been observed. The objective of 
this study was to compare outcomes and complications of the two-site 
venovenous versus the double-lumen ECMO in infants with respiratory 
failure.
Methods  The Extracorporeal Life Support Organization (ELSO, Ann 
Arbor, MI, USA) registry database collected between 1999 and 2009 
was provided for research. A total of 9,086 children ≤7 kg BW were 
treated with ECMO. From these children, those who were older than 
32 days and received VV ECMO were extracted for analysis. A total of 
270 children met the inclusion criteria. Two hundred and thirty-six 
children were treated with VVDL ECMO and 34 children received VV 
two-site ECMO. ELSO registry records were reviewed for the following 
information: demographic data, type of ventilation, ventilator days and 
settings during an ECMO run, complications during an ECMO run and 
outcome.
Results In this study 87% (n = 236) of the children were cannulated with 
VVDL and 13% (n = 34) using the VV two-site technique. APGAR scores 
were signifi  cantly lower in the VV two-site group. Twenty-four hours 
after ECMO onset, ventilator settings were signifi  cantly higher in the VV 
two-site group. ECMO duration was signifi  cantly shorter in the VV two-
site group (137 hours vs. 203 hours, P <0.01). The total complication 
rate, however, did not diff  er between the groups. Survival rates (71% 
in the VVDL group and 56% in the VV group) were not signifi  cantly 
diff  erent either.
Conclusions The total complication rate was found to be similar in 
both groups. The ECMO duration period was signifi  cantly  shorter 
in the VV two-site group. No diff  erence was found in survival rates 
between the two groups. Neither of the two-cannulation methods – 
venovenous two-site or venovenous double-lumen ECMO – has shown 
any signifi  cant superiority. The decision about which technique to use 
for infants depends mainly on the best practice experience of each 
individual ECMO centre and their routinely-used technical equipment.
Reference
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Introduction The aim was to study LV dysfunction during weaning 
from mechanical ventilation (MV).
Methods Thirty invasively MV patients fulfi  lling the criteria of weaning 
were shifted to SBT (using low PSV (8 cmH2O)) for 30 minutes. Two 
sets of variables were measured at the beginning and end of the SBT: 
respiratory rate (F), tidal volume (VT), minute ventilation (VE), peak 
inspiratory pressure (PIP), PaO2/FIO2 ratio (P/F ratio); and one reading 
at the start of the SBT of: airway resistance (Raw), static respiratory 
compliance (Ceff  ), maximum negative inspiratory pressure (NIP), (F/
VT), arterial blood gases. Weaning failure was defi  ned as: failed SBT, 
reintubation and/or reventilation or death within 48 hours. Swan–Ganz 
catheterization was used to obtain the right atrial (RAP), pulmonary 
artery (PAP), pulmonary artery occlusion (PAOP) pressures, and cardiac 
index (CI). Echocardiography was used to obtain the LV internal 
diameter at end diastole (LVIDd) and end systole (LVIDs), ejection 
fraction (LVEF), E/A ratio, deceleration time (DT) (ms), isovolumetric 
relaxation time (IVRT), Doppler tissue imaging (DTI) and E/E’.
Results Mean age 56.6 ± 15.9 years, 53% were male. Weaning was 
successful in 76.6% of patients. There was reduction in VT with increase 
in F and VE (0.53 ± 0.06 vs. 0.45 ± 0.1 l, P = 0.0003; 12.5 ± 2 vs. 20.3 ± 7.5, 
P <0.0001; 6.6 ± 1.5 vs. 8.8 ± 2.4 l, P <0.0001), respectively. P/F_1 was 
higher than P/F_2 (278 ± 86 vs. 252 ± 74, P = 0.005). ABG showed a 
reduction in PaO2 (126 ± 32 vs. 115 ± 29, P = 0.01) without change 
in PaCO2 (37.6 ± 6.4 vs. 36.5 ± 6.2, P = 0.24). There was a rise in PAOP 
with insignifi  cant change in RAP, PAP, and CI (12.6 ± 4.7 vs. 14.2 ± 4.7, 
P = 0.003; 6.6 ± 2 vs. 7.2 ± 3, P = 0.16; 29.7 ± 7.2 vs. 29.7 ± 7, P = 1; 3.2 ± 0.6 
vs. 3.22 ± 0.5, P = 0.4), respectively. There was a reduction in LVEF 
with insignifi  cant LVIDd and LVIDs change (66.4 ± 8.1 vs. 64.5 ± 8.4%, 
P = 0.01; 4.83 ± 0.68 vs. 4.7 ± 0.7 cm, P = 0.5; 3.1 ± 0.7 vs. 3.12 ± 0.6 cm, 
P = 0.8), respectively. There was no diff  erences between E/A, IVRT, and 
DT or E/E’ at both ends of the trial (1.02 ± 0.38 vs. 1.04 ± 0.37, P = 0.6; 
95.5 ± 24 vs. 95.8 ± 22, P = 0.8; 194.6 ± 30 vs. 195 ± 28 ms, P = 0.8; and 
9.7 ± 3.1 vs. 10.3 ± 3.5, P = 0.09), respectively. E/E’ and RAP correlated 
signifi  cantly before and after SBT (r = 0.54, P = 0.002; and r = 0.79, 
P <0.0001), respectively. Despite insignifi  cant correlation between E/E’ 
and PAOP at the beginning of SBT, there was signifi  cant correlation 
between them at the end of SBT (r = 0.6, P = 0.001).
Conclusions  LV dysfunction during weaning is mainly diastolic. 
Changes in E/E’ and RAP and/or PAOP may be the most convenient 
methods for monitoring diastolic function during weaning from MV.
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Introduction Open lung concept ventilation is a method of ventilation 
intended to maintain end-expiratory lung volume by increased airway 
pressure [1]. Since this could increase right ventricular (RV) afterload, 
we investigated the eff  ect of this method on RV outfl  ow impedance 
during inspiration and expiration using transoesophageal echo-
Doppler in a trial to diff  erentiate the RV consequence of increasing lung 
volume from those secondary to increasing airway pressure during 
mechanical ventilation.
Methods Thirty stable patients on MV because of diff  erent causes were 
enrolled prospectively in this single-center, cross-sectional clinical 
study. Each patient was fi  rstly subjected to conventional ventilation 
(CV) with volume-controlled ventilation, followed by OLC ventilation by 
switching to a pressure-controlled mode, then a recruitment maneuver 
applied until PaO2/FiO2 >375 torr. Hemodynamic (MAP, CVP and HR) 
and respiratory (peak, plateau and mean airway pressure and total 
and dynamic lung compliance) measurements were recorded before, 
20 minutes after a steady state of both CV and 20 OLC ventilation. 
Also, transoesophageal ECHO Doppler was performed at the end of 
inspiration and end of expiration to calculate the mean acceleration 
(ACmean), as a marker of the RV outfl  ow impedance, 20 minutes after a 
steady state of both CV and OLC ventilation.
Results During inspiration, ACmean was signifi  cantly lower during CV 
compared with OLC ventilation (P <0.001). Inspiration did not cause 
a signifi  cant decrease in ACmean compared with expiration during OLV 
(P <0.001) but did do so during CV. In comparison with baseline and 
CV, OLC ventilation was associated with a statistically signifi  cant higher 
CVP (P  <0.001 for both), higher total quasi-static lung compliance 
(P <0.001 for both) and dynamic lung compliance (P = 0.001 for both). 
Moreover, the PaO2/FiO2 ratio of OLV was signifi  cantly higher than in 
baseline and CV (P <0.001 for both).
Conclusions  OLC ventilation does not change RV afterload during 
inspiration and expiration as RV afterload appears primarily mediated 
through the tidal volume. Moreover, OLC ventilation provides a more 
stable hemodynamic condition and better oxygenation and lung 
dynamics.
Reference
1.  Hartog A, Vazquez de Anda G, et al.: At surfactant defi  ciency, application of 
‘the open lung concept’ prevents protein leakage and attenuates changes 
in lung mechanics. Crit Care Med 2000, 28:1450-1454.
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Introduction There is no valid estimation of the presence of airway 
secretions in mechanically ventilated patients. Secretions may amplify 
breath sounds by increasing turbulence in the airways or alternatively 
decrease breath sounds by obstructing air fl  ow. Vibration response 
imaging (VRI) was recently suggested as a tool to assess secretion 
removal following physiotherapy [1]. The objective of our analysis was 
to describe the acoustic eff  ects of secretion removal by measuring the 
lung sound amplitudes pre and post airway suction in both lungs.
Methods Twenty-two recordings pre-suction and 22 recordings post-
suction (19 patients) were performed with VRI while the mode of 
ventilation remained constant. The sound amplitude measurements 
before and after the suction procedure were compared.
Results After suction a decrease in total lung sound amplitude was 
detected in all of the recordings. The lung sound amplitude of the 
right lung decreased signifi  cantly by 3.3-fold from 52.05 ± 16.11 to 
15.54 ± 5.36 arbitrary units (AU) (mean ± SEM) (n = 22, P <0.01). The 
left lung sound amplitude decreased by 2.4-fold from 28.42 ± 11.28 to 
11.69 ± 3.15 AU (mean ± SEM) (n = 22, P >0.01). The fl  ow rate (measured 
by the VRI D-lite fl  ow meter) of both lungs increased signifi  cantly after 
secretion removal (n = 22, P <0.01). See Figure 1.
Conclusions The fi  nding that the VRI signal amplitude decreased after 
a suction procedure in ventilated patients suggests that secretions 
are usually noisy. This eff  ect was more pronounced on the right side 
Figure 1 (abstract P173). Lung sound amplitude of secretion removal 
(mean ± SEM).
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that eff  ective removal of secretions may be inferred by a combination 
of a decrease in VRI signal coupled with an increase in air fl  ow rate.
Reference
1.  Ntoumenopoulos G, Glickman Y: Computerized lung sound monitoring to 
assess eff  ectiveness of physiotherapy and secretion removal: a feasibility 
study [abstract]. Crit Care 2010, 14(Suppl 1):P169.
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Introduction Vibration response imaging (VRI) is a bedside lung sound 
monitoring system. We previously reported that vibration intensity 
can be signifi  cantly elevated in patients with congestion, as opposed 
to pleural eff  usion, atelectasis, or normal lung [1]. We hypothesized 
that changes in lung water content (that is, pulmonary edema) may 
infl  uence breath sound amplitude and explored the possibility of using 
continuous digitalized lung sound monitoring as a means to track 
changes in extravascular lung water (EVLW).
Methods  EVLW was increased in three pigs: in two animals by 
installation of saline into the endotracheal tube, and in one animal with 
sepsis-induced edema. In both models the increase in extravascular 
lung water index (EVLWi) was evaluated by the PiCCO system, and lung 
sound amplitude was monitored with the VRI. Animals were ventilated 
at a fi  xed fl  ow rate.
Results  In both the saline installation and sepsis animal models, 
signifi  cant elevation in lung sound amplitude was measured. In the 
saline installation animals, sound amplitude increased from 2.21  x 
105 ± 1.58 x 104 au to 9.49 x 105 ± 8.02 x 104 au (average ± SEM), 
concomitant with an increase in EVLWi from 10 ml/kg to 14 ml/kg. 
Similarly, sound amplitudes changed in correspondence with elevation 
of EVLWi in the septic animal (see Figure 1).
Conclusions  These preliminary results suggest that continuous 
elevation of lung sound amplitudes, recorded at fi  xed fl  ow rate, may 
indicate an increase in lung water content.
Reference
1. Lev  S,  et al.: Respiration 2010, 80:509-516.
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Introduction Physiologically, an approximately 5 to 10 mmHg diff  er-
ence exists between end-tidal carbon dioxide (EtCO2) and arterial 
carbon dioxide (PaCO2) measured during double-lung ventilation (DLV) 
that may increase during one-lung ventilation (OLV) especially if low 
tidal volume is applied. There is no evidence that during OLV the EtCO2 
or PaCO2 should be kept in the normal range. The aim of the present 
work was to test whether diff  erent ventilatory strategies to maintain 
EtCO2 or PaCO2 in the normal range during OLV have any impact on 
arterial oxygenation (PaO2).
Methods Data were obtained from 100 patients undergoing thoracic 
surgery necessitating OLV. Patients were randomized into two groups. 
In GrEtCO2 ( n  =  50) the OLV was guided by capnography, and the 
respiratory rate (RR) was adjusted to maintain EtCO2 in the normal 
range. In GrPaCO2 (n = 50) the OLV was guided by arterial blood gas 
analysis (ABG) and RR was adjusted to maintain PaCO2 in the normal 
range. ABG was performed in a supine position after induction and in 
a lateral decubitus position during DLV and every 15 minutes during 
OLV. During OLV 5 ml/kg tidal volume with 5 cmH2O PEEP, I:E = 1:2 ratio 
and FiO2 1.0 was used.
Results There were no signifi  cant diff  erences in PaO2 values between 
groups during DLV and at the 15th minute of OLV. There were signifi  cant 
diff  erences in PaO2 at the 30th and 45th minutes between groups. In 
GrPaCO2 mean airway pressure and RR was higher, and the inspiratory 
and expiratory time was shorter than in GrEtCO2.
Conclusions The relatively high RR impairs the emptying of alveoli and 
results in increased functional residual capacity. So the normocapnic 
lung-protective OLV results in signifi  cantly higher PaO2 than permissive 
hypercapnic OLV.
References
1. Russel  GB,  et al.: Anesth Analg 1995, 81:806-810.
2. Ip  Yam  PC,  et al.: Br J Anaesth 1994, 72:21-24.
3. Morisaki  H,  et al.: Acta Anaesth Scand 1999, 43:845-849.
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Introduction The patient–ventilator asynchrony (PVA) is a cause of 
oversedation that prolongs mechanical ventilation unnecessarily. The 
current tools for measurement of sedation are inadequate for assessing 
the PVA. Neurally adjusted ventilatory assist (NAVA) is an innovative 
ventilatory mode that provides an excellent real-time monitor of 
the neural signal of diaphragmatic electrical activity (EAdi) and 
consequently highlights the PVA. Whether EAdi can be of help to titrate 
the level of sedation has not yet been proved, so we want to verify this 
conjecture. To titrate the level of analgosedation, we used this signal, 
which informs us continuously on changes in lung mechanics and 
synchrony.
Methods  A prospective observational study on 50 coma patients, 
ventilated with Maquet SERVO-I, was performed, following monitoring 
chart EAdi and recording the numerical values of Edi peak and Edi min 
during the diff  erent ventilatory modes. We recorded the analgosedation 
via continuous infusion; the dose was titrated to achieve a score of the 
Richmond Agitation-Sedation Scale from –2 to +1 and the Behavioral 
Pain Scale ≤4.
Results The average duration of mechanical ventilation was 5.9 days 
(P  =  0.004), the average of analgosedation was 4.8 days while the 
average length of stay was 6.4 days (P = 0.02). The average dose of 
remifentanil was varied between 0.075 ± 0.025 μg/kg/minute, propofol 
0.5  ±  0.2  mg/kg/hour and clonidine 0.025  ±  0.02 μg/kg/minute. 
Comparing the pressure, volume and EAdi traces we identifi  ed all 
Figure 1 (abstract P174). Sound intensity and EVLWi versus time, in a 
septic pig model (average ± SEM).
Critical Care 2011, Volume 15 Suppl 1 
http://ccforum.com/supplements/15/S1
S62degrees of PVA. The Edi peak (16.8 ± 7.6 mV) and Edi min (0.1 ± 1.3 mV) 
values were used to adjust the level of sedation. The analgosedation 
quality was 97%.
Conclusions NAVA has been a real monitoring tool that provided a 
continuous dynamic lung overview. Monitoring NAVA avoided the more 
serious complications of the PVA: prolonged mechanical ventilation, 
barotrauma, and inadequate or excessive sedation. It was the only 
mode able to determine the asynchrony, allowing us to administer a 
tailored analgosedation, until the suspension. Moreover this protocol 
permitted us to save valuable resources. The measurement of PVA is a 
priority for the optimal sedation and NAVA can become an indicator for 
rating of analgosedation scales.
References
1. Rowley  DD,  et al.: Respiratory Therapy 2009, 4:51-53.
2. Kress  JP:  N Engl J Med 2000, 342:1471-1477.
3.  Sucre MJ, De Nicola A: Crit Care 2010, 14(Suppl 1):P205.
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Introduction  A large number of predictive indices are used for 
evalua  tion of the capability for transition to spontaneous breathing 
in critically ill, mechanically ventilated patients. The great number of 
these indices and the diffi   culties in the interpretation causes signifi  cant 
obstacles and unclear points during the early attempts for transition 
to spontaneous breathing. In our study we investigated the role of 
predictive indices that are signifi   cant for weaning after long-term 
mechanical ventilation. The purpose is to determine predictive indices, 
which have early and signifi  cant predictive value concerning successful 
transition to spontaneous breathing.
Methods  The study covers 45 critically ill patients who were 
mechanically ventilated for more than 7 days in our ICU. The weaning 
eff   orts were made through a T-circuit for spontaneous breathing 
according to the local protocol. The patients were allocated into two 
groups – group A (38 patients with successful 2-hour spontaneous 
breathing through a T-circuit) and group B (seven patients with 
unsuccessful 2-hour test of weaning with a T-circuit system). The 
monitored parameters in this period were: respiratory rate/tidal 
volume ratio (f/Vt), occlusive pressure (Po.1), inspiratory time/tidal 
time ratio (Ti/Ttot), pressure time index, pressure time product and 
work of breathing (WOBp) together with SAPS II score and clinical and 
paraclinical parameters, concerning successful weaning.
Results Clinical research of f/Vt and WOBp between the two groups 
gives a reliable index in transition to spontaneous breathing. Changes 
in Po.1, Ti/Ttot, pressure time index and pressure time product are later 
and thus less important in the early assessment of withdrawal after 
long-term mechanical ventilation.
Conclusions  Respiratory rate/tidal volume ratio (f/Vt) and work of 
breathing (WOBp) are the earliest predictive indices for the possible 
outcome in the process of weaning after long-term mechanical 
ventilation.
References
1. Burns  S,  et al.: Am J Crit Care 1995, 4:4-22.
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Introduction In the context of lung-protective mechanical ventilation, 
knowledge about the global respiratory mechanics (for example, 
lung resistance and compliance) can be essential to guide the ventila-
tory therapy. From recent work it is known that the lung shows a 
signifi  cantly diff  erent mechanical behaviour when examined under 
static conditions (continuous ventilation interrupted by zero-fl  ow or 
low-fl  ow respiratory manoeuvres) compared with dynamic conditions 
(no interruption). However, the signifi  cance of this diff  erence at the 
anatomical level of the alveoli has not yet been fully examined. This 
study aims to determine changes in morphology of subpleural alveoli 
under static and dynamic conditions in an animal model.
Methods  A method for endoscopic intravital microscopy of lung 
tissue [1] was used to record videos of subpleural alveolar structures 
in a rat model. This specialized method allowed the continuously 
focused recording of the lung surface during any kind of respiratory 
manoeuvre, including continuous mechanical ventilation. Videos 
of alveolar structures were recorded during continuous mechanical 
ventilation (dynamic) at diff   erent levels of positive end-expiratory 
pressure (PEEP) and during low-fl  ow manoeuvres (static) where the 
lung was slowly infl  ated up to an airway pressure of 40 mbar. Alveolar 
morphology was analysed using a dedicated semiautomatic image 
processing algorithm by tracking the change of area-size of the visible 
subpleural alveoli in the videos. The simultaneous change of area-size 
of diff  erent alveoli was averaged to get the mean alveolar area-size 
depending on the respective airway pressure. Comparison was done 
by calculating the diff  erence of relative area-size increase in identical 
ranges of airway pressure under dynamic and static conditions.
Results Data from fi  ve animals mechanically ventilated at PEEP levels 
of 6 and 15 mbar showed a signifi  cantly smaller increase in area-
size under dynamic compared with static conditions: 12% smaller at 
6 mbar; 40% smaller at 15 mbar.
Conclusions  Under dynamic conditions, the pressure-dependent 
change in alveolar morphology is signifi  cantly diff  erent compared with 
static conditions. We conclude that, to guide mechanical ventilation 
therapy, it is essential to determine respiratory mechanics under 
dynamic conditions.
Reference
1. Schwenninger  D,  et al.: J Biomech in press. doi: 10.1016/j.jbiomech.2010.09.019.
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Introduction Several indices exist to monitor adequate oxygenation, 
but no such index exists for ventilatory effi   ciency. The ventilatory ratio 
(VR) is a simple tool to monitor changes in ventilatory effi   ciency using 
variables commonly measured at the bedside [1]:
                                                                   V
•
Emeasured × PaCO2 measured
VR = ________________
                                                                   V
•
Epredicted × PaCO2 predicted
See Figure 1 overleaf (where predicted values are VE 100 ml/kg/minute 
and PaCO2 5 kPa). 
Methods  The Nottingham Physiology Simulator (NPS), a validated 
computational model of cardiopulmonary physiology [2], was used to 
validate the ability of VR to refl  ect ventilatory effi   ciency ex vivo. Three 
virtual patients were confi  gured, representing healthy lung, ARDS and 
COPD. VR was calculated while minute ventilation, ventilation rate and 
VCO2 were each varied in isolation. The clinical uses of VR were then 
examined in a database comprising 122 patients with ALI and ARDS [3]. 
Standard respiratory data and VR values were analysed in all patients.
Results The NPS model showed signifi  cant correlation between VR 
and physiological deadspace fraction (Vd/Vtphys) at constant VCO2 
(P <0.001, r = 0.99). Similarly, VCO2 had a linear relationship with VR at 
constant Vd/Vtphys. Across the various ventilatory confi  gurations the 
median values and ranges of calculated VR for the three patients were 
as follows: normal patient VR 0.89 (0.61 to 1.36), COPD 1.36 (0.95 to 
1.89) and ARDS 1.73 (1.2 to 2.62). In the ALI /ARDS database the range 
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a signifi  cantly higher VR in comparison with patients with ALI (1.44, 
1.25 to 1.77 vs. 1.25, 0.94 to 1.6, P = 0.02). VR was signifi  cantly higher 
in nonsurvivors as compared with survivors (1.7 ± 0.64 vs. 1.45 ± 0.56, 
P <0.03). There was poor correlation between PaO2/FiO2 ratio and VR in 
the population (r = –0.32, 95% CI = –0.47 to –0.15).
Conclusions Ex vivo modling shows that VR can be simply and reliably 
used to monitor ventilatory effi   ciency at the bedside. VR is infl  uenced 
by changing CO2 production and deadspace ventilation. As a clinical 
tool it is a predictor of outcome and is independent to PaO2/FiO2 ratio.
References
1. Sinha  et al.: Br J Anaesth 2009, 102:692-697.
2. Hardman  et al.: Br J Anaesth 1998, 81:327-329.
3. Bersten  et al.: Am J Respir Crit Care Med 2002, 165:443-448.
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Introduction In this study we investigated the long-term eff  ects of 
a combined therapy with recombinant human antithrombin (rhAT), 
heparin (hep) and tissue plasminogen activator (tPA) in our established 
model of acute lung injury, resulting from burn and smoke inhalation 
injury (BSII). We hypothesised that this triple therapy decreases the 
requirement of ventilation, reduces ventilation days and improves 
survival.
Methods Ten female sheep (34.4 ± 2.1 kg) were operatively prepared 
for chronic study, and were randomly allocated either to control or 
treatment groups (n = 5 each). After tracheostomy, BSII (48 breaths of 
cotton smoke) and third-degree burn of 40% total body surface area 
was performed under deep anesthesia. The sheep were mechanically 
ventilated and fl  uid resuscitated for 96 hours in an awake state. The 
therapy group received combined therapy of rhAT, nebulized heparin 
and nebulized tPA. The continuous i.v. infusion of 0.7  mg/kg/hour 
rhAT was started 1  hour post-injury. The nebulizations of 5,000  IE 
heparin every 4  hours were started 2  hours post-injury and 2  mg 
tPA were nebulized every 4 hours, starting 4 hours post-injury. The 
treatment was stopped at 48 hours. Ventilator weaning was started 
at 48 hours, if PaO2/FiO2 ratio ≥250. The control group received saline 
nebulization. Measurements were taken in intervals ranging from 3 to 
12 hours. Statistical analysis: two-way ANOVA and Bonferroni post-hoc 
comparison. Data are expressed as mean ± SEM. Signifi  cance P <0.05.
Results The PaO2/FiO2 ratio was signifi  cantly decreased in the control 
group versus baseline (BL: 530 ± 16 vs. 96 hours: 267 ± 51). The ratio 
showed signifi  cantly higher values in the treatment versus control 
sheep (96  hours: 377  ±  32). All treated sheep survived and were 
weaned from the ventilator. Four out of fi  ve treatment sheep could be 
decannulated from the tracheostomy tube at 72 hours. Only three out 
of fi  ve control sheep survived 96 hours and none of the control sheep 
could be weaned from the ventilator.
Conclusions  This triple therapy with nebulization of heparin and 
tPA and intravenous application of rhAT may be a novel and effi   cient 
therapeutic alternative to improve the outcome of burn patients with 
smoke inhalation injury.
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Introduction Hypercapnic acidosis is often seen in critically ill patients 
and during protective mechanical ventilation. Confl  icting  fi  ndings 
regarding the eff  ect of hypercapnic acidosis on endogenous nitric 
oxide (NO) production and hypoxic pulmonary vasoconstriction (HPV) 
have been reported. The aim of this study was to test the eff  ects of 
hypercapnic acidosis on HPV, and the endogenous NO production in 
hypoxic and hyperoxic lung regions.
Methods Sixteen healthy anesthetized pigs were separately ventilated 
with hypoxic gas to the left lower lobe (LLL) and hyperoxic gas to the 
rest of the lung. The pigs were then randomized into two groups. 
Eight pigs received 10% CO2 inhalation (Hypercapnia group) to both 
lung regions, and eight pigs served as the Control group. The NO 
concentration in exhaled air (ENO), nitric oxide synthase (NOS) activity 
in lung tissue, and regional pulmonary blood fl  ow were measured.
Results There were no signifi  cant diff  erences between the Hypercapnia 
and Control groups for ENO, Ca2+-independent, or Ca2+-dependent NOS 
activity in hypoxic or hyperoxic lung regions. The relative perfusion 
to the hypoxic LLL (QLLL/QT) increased during the fi  rst 90 minutes 
of hypercapnia from 6 (1)% (mean (SD)) to 9 (2)% (P <0.01), and then 
decreased to the same level as in the Control group where QLLL/QT 
remained unchanged over time (P >0.05). In addition, hypercapnia 
increased cardiac output (QT) (P <0.01), resulting in increased oxygen 
delivery (P <0.01), despite a signifi  cant decrease in PaO2 (P <0.01).
Conclusions Hypercapnic acidosis does not aff  ect the endogenous 
pulmonary NO production, nor does it potentiate HPV.
References
1. Ketabchi  F,  et al.: Eff  ects of hypercapnia with and without acidosis on 
hypoxic pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol 2009, 
297:L977-L983.
2. Pfeiff  er B, et al.: Mechanical ventilation with permissive hypercapnia 
increases intrapulmonary shunt in septic and nonseptic patients with 
acute respiratory distress syndrome. Crit Care Med 2002, 30:285-289.
P182
Stenotrophomonas maltophilia in the respiratory tract of medical 
ICU patients
B Saugel, K Eschermann, R Schmid, W Huber
Klinikum Rechts der Isar, München, Germany
Critical Care 2011, 15(Suppl 1):P182 (doi: 10.1186/cc9602)
Introduction  Stenotrophomonas maltophilia can cause pneumonia 
in critically ill patients. The aim of the study was to investigate 
characteristics of critically ill patients with S. maltophilia isolated 
from the respiratory tract and to identify risk factors for S. maltophilia 
pneumonia and ICU mortality and to analyze antibiotic susceptibility 
of S. maltophilia.
Figure 1 (abstract P179). Chi-squared test for trends P = 0.0015.
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to December 2009) for three medical ICUs in a university hospital.
Results  Sixty-four patients with S. maltophilia isolated from the 
respiratory tract (median age 66.0 years). Thirty-six patients fulfi  lled 
the criteria for diagnosis of pneumonia. Mechanical ventilation was 
needed in 51 patients. A signifi  cantly higher lung injury score was 
observed in patients with pneumonia compared with patients with 
colonization (P = 0.010). Independent risk factors for S. maltophilia-
related pneumonia were higher Sequential Organ Failure Assessment 
(SOFA) score (P = 0.009) and immunosuppression (P = 0.014). Patients 
with S. maltophilia pneumonia had higher ICU mortality within a follow-
up of 28 days (P = 0.040) and higher hospital mortality (P = 0.018) 
than patients with colonization. The highest antibiotic susceptibility 
rates were observed to trimethoprim-sulfamethoxazole, tigecycline, 
and moxifl   oxacin. A higher SOFA score when S. maltophilia was 
isolated (P = 0.001) and development of renal failure (P = 0.021) were 
independent risk factors for ICU mortality.
Conclusions  Higher SOFA score and immunosuppression are 
independent risk factors for S. maltophilia pneumonia. Patients with 
pneumonia caused by S. maltophilia have a signifi  cantly higher ICU 
mortality within a follow-up of 28 days, hospital mortality and lung 
injury score compared with patients with S. maltophilia colonization.
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Introduction  Lymphocyte homeostasis is dependent on the γc 
cytokines. We hypothesised that infection in humans is associated with 
diff  erential gene expression of the γc cytokines and their associated 
apoptosis mediators.
Methods Sixty patients undergoing elective lung resection surgery 
were recruited. Nineteen patients developed postoperative 
pneumonia. Pneumonia was diagnosed by CDC NNIC criteria. Gene 
expression in peripheral blood leukocytes (PBLs) of IL-2, IL-7, IL-15 and 
IFNγ, Bax, Bim, Bcl-2 was determined by qRT-PCR preoperatively and 
again on day 1 and day 5 postoperatively. IL-2 and IL-7 serum protein 
levels were determined by ELISA preoperatively and again on day 1 and 
day 5 postoperatively.
Results In lung resection surgery patients, postoperative pneumonia 
was associated with a perioperative decrease in IL-2 mRNA (P <0.0001) 
and IL-7 mRNA (P = 0.003). IL-15 gene expression was similar between 
both groups at all three points. Bcl-2 and Bax gene expressions 
were similar between both pneumonia and nonpneumonia groups 
at all three time points. Bim gene expression was greater in the 
pneumonia group compared with the nonpneumonia group on day 5 
postoperatively (P = 0.04). IL-2 protein levels were similar in pneumonia 
and nonpneumonia groups. IL-7 protein levels were similar in all 
groups.
Conclusions Patients with postoperative pneumonia display defi  cient 
IL-2 and IL-7 gene expression in PBLs. Aberrant cytokine gene 
expression may precede the onset of infection.
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Introduction  Pseudomonas aeruginosa (PA) pneumonia (PN) repre-
sents a serious complication of long-term hospitalization [1]. The aim 
of our study is to analyze the clinical characteristics and predictors of 
mortality of PAPN in critically ill patients.
Methods All patients admitted to the 18-bed ICU of our university 
hospital between 1 January 2009 and 30 June 2010, aff  ected by PAPN, 
were retrospectively enrolled in a cohort study.
Results Over the study period 1,109 patients were admitted and 322 
bacterial PN were diagnosed. Sixty-fi  ve PAPN occurred: 52 ICU-acquired 
(ICUa) and 13 non-ICU-acquired (nICUa). Patients were mainly admitted 
because of a medical condition (71%), with a median length of ICU stay 
of 29.2 ± 27.6 days. The median SAPS II and SOFA scores were 40 ± 13.5 
and 6.2 ± 3. A total of 35.4% of PA isolated were multidrug-resistant 
(MDR), 49.2% of patients with PAPN received a >24  hour delayed 
adequate antimicrobial treatment (DAAT >24 hours) and 57% received 
an anti-pseudomonas combination therapy; 25 patients (38.5%) died in 
the ICU. Comparing patients with ICUaPN with those with nICUaPN, the 
former group were younger (P <0.01), with a longer length of ICU stay 
(P <0.01), more frequently admitted for a traumatic reason (P = 0.02) 
and presented less severe SAPS II (P  <0.05). The independent risk 
factors associated with ICU mortality are listed in Table 1.
Table 1 (abstract P184). Chronic renal failure (CRF)
  P value  OR
CRF  0.01  12.2 (1.6 to 91)
MDR PA  0.01  5.9 (1.4 to 25.6)
DAAT >24 hours  0.01  5.8 (1.4 to 23.6)
SAPS II score  0.01  1.1 (1.01 to 1.13
Conclusions PA has appeared as a relevant respiratory pathogen in our 
cohort of critically ill patients, either in ICU or pre/ICU settings. Patients’ 
(baseline clinical condition), PA (MDR) and physicians’ (DAAT >24 hours) 
related factors can infl  uence the outcome of PN. The knowledge of local 
bacterial epidemiology and the prompt use of an anti-pseudomonas 
empiric treatment in patients with recognized PA risk factors could 
improve the outcome of severe MDR PAPN.
Reference
1. Jones  RN:  Clin Infect Dis 2010, 51:S81-S87.
P185
Safety and effi   cacy of intratracheal DNase with physiotherapy in 
severe status asthmaticus
A Nyman, K Puppala, S Colthurst, S Parsons, S Tibby, I Murdoch, A Durward
Evelina Childrens Hospital, Guy’s and St Thomas’ NHS Trust, London, UK
Critical Care 2011, 15(Suppl 1):P185 (doi: 10.1186/cc9605)
Introduction Diff  use airway plugging with thick viscous secretions is 
recognised in acute severe asthma, and contributes to airfl  ow limitation 
in ventilated asthmaticus. Since 2004, we have used intratracheal 
DNase with physiotherapy as second-line therapy in mechanically 
ventilated children with severe status asthmatics who are refractory 
to conventional medical management. Our aim is to report the safety 
profi  le and effi   cacy of intratracheal DNase mucolytic therapy in this 
cohort.
Methods A retrospective cohort analysis in a 20-bed PICU. Forty-six 
ventilated children, median (IQR) age 74 months (45 to 141), received 
intratracheal DNase with physiotherapy (January 2004 to August 2010). 
Indication for DNase was peak inspiratory pressure (PIP) >28 cmH2O 
with hypercarbic acidosis (pCO2 >10 kPa). Eleven patients required 
additional doses of DNase. In 40 episodes DNase was given blindly 
(n = 40) or bronchoscopically (n = 17).
Results The median (IQR) time to DNase following PICU admission was 
2.1 hours (1.3 to 3.8). At the time of DNase, median PIP was 34 cm (30 
to 40), pH was 7.12 (7.01 to 7.22) and pCO2 was 11 kPa (7.9 to 14.1). 
Overall DNase produced an improvement in ventilation (see Figure 1). 
Salbutamol IV was constant at 1 μg/kg/minute (0.5 to 2). The therapy 
was well tolerated with no hypoxic or hypotensive episodes, or air 
leaks. Median length of ventilation was 22 hours (15 to 37). No patient 
required extracorporeal membrane oxygenation and there were no 
deaths.
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eff   ective therapy for refractory ventilated patients with status 
asthmatics. A randomised control trial is warranted.
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Introduction  The aim of the study was to investigate the relation 
between the mortality rate, the hospitalization period in the emergency 
department or ICU and the obtained levels of TNFα, IL-6 and catalase 
before they underwent attack treatment at admission of the cases 
applying to the emergency department with COPD attack.
Methods The cases diagnosed with COPD before and who applied to 
the emergency department with COPD attack were included in the 
study. Venous blood samples were obtained to evaluate the levels of 
TNFα, IL-6, catalase, leucocyte, sedimentation and CRP when the cases 
applied to the emergency department. Their hospitalization in the 
service or ICU, the follow-up period in mechanical ventilation and leaving 
hospital (dead or discharged) were followed. The mean levels of TNFα, 
IL-6, catalase, leucocyte, sedimentation and CRP values were compared 
with the average period of hospitalization in the service or ICU and with 
each other. The Mann–Whitney U test and chi-square test were used as 
nonparametric tests. P ≤0.05 values were regarded as signifi  cant.
Results All of the cases that died (n = 7) were followed in intensive care, 
they underwent invasive mechanical ventilation treatment and their 
mean hospitalization period was 25 days. The cases discharged (n = 80) 
were all followed in the service and their average hospitalization 
duration was 6.2 days. Non-invasive mechanical ventilation was 
applied to 12 of these cases. Of the dead cases, the mean leukocyte 
value was 12.665, sedimentation 29.68, CRP 49.7, TNFα 27.3, IL-6 32 and 
catalase was 81. Of the cases discharged, the mean leukocyte value 
was 8.200, sedimentation 19.0, CRP 49.7, TNFα 29.3, IL 13.6 and catalase 
was 85.9. The mean value of leukocyte, sedimentation, CRP and IL-6 of 
the dead cases were signifi  cantly higher than those of the cases in the 
discharged group (P = 0.040, 0.038, 0.02, 0.017, respectively).
Conclusions  A high level of leukocyte, sedimentation, CRP values 
and low IL-6 values at the admission of cases with COPD attack to the 
emergency department may indicate the requirement to follow in the 
ICU and treatment with mechanical ventilation, and a high mortality rate.
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Introduction Induced hypothermia is protective in ischemia–reper-
fusion injury by reducing the infl  ammatory response and is increasingly 
applied in the ICU. Hypothermia may dampen host response during 
an infection and it is believed that induced hypothermia may carry 
the risk of acquiring or aggravating an infection. We investigated the 
eff  ect of hypothermia on bacterial outgrowth and on the infl  ammatory 
response in a rat model of pneumococcal pneumonia.
Methods  Sprague–Dawley rats (350 to 400 g) were inoculated 
intratracheally with ~5.5 x 106 cfu of Streptococcus pneumonia, 
controls received saline. After 40  hours, the animals developed 
pneumonia and mechanical ventilation was started via a tracheotomy. 
Hypothermia (32°C) was induced using icepacks on the abdomen. In 
controls, normothermia was maintained by a thermomatrass. After 
4 hours, rats were sacrifi  ced, bronchoalveolar lavage fl  uid (BALF) was 
obtained and blood and organs were collected. Data are shown in 
percentages or median (range).
Results Induced hypothermia reduced pulmonary infl  ammation during 
pneumonia, exemplifi  ed by a reduction in pulmonary cell infl  ux (1.3 (0.8 
to 1.6) x 106 vs. 3.1 (1.6 to 4.6) x 106 mg/ml, hypothermia vs. normothermia; 
P <0.05) and BALF protein levels (0.9 (0.6 to 1.3) vs. 1.5 (1.4 to 1.6) mg/ml; 
P <0.05). Hypothermia also reduced BALF level of IL-1 (0.4 (0.1 to 0.6) vs. 
0.8 (0.6 to 0.9) ng/ml; P <0.05), but had no eff  ect on BALF levels of CINC3 
and IL-6. Hypothermia, however, did not aff  ect bacterial outgrowth in 
the BALF (1.4 (0.3 to 20) vs. 0.5 (0.2 to 5.2) x 106 cfs/ml; P = NS) nor in 
homogenized lungs (13.5 (0.2 to 69.2) vs. 0.8 (0.1 to 14.5) x 106 cfu/g; 
P = NS). Hypothermia tended to reduce bacterial dissemination to the 
blood (38 vs. 50%, P = NS), spleen (0 vs. 50% culture positivity, P = 0.08) 
and liver (38 vs. 63% culture positivity, P = NS).
Conclusions  Although hypothermia reduces pulmonary cell infl  ux 
and protein leakage, it does not aff   ect local bacterial outgrowth 
during pneumonia and even tends to reduce bacterial dissemination 
in this animal model of pneumococcal pneumonia. In contrast to 
current belief, induced hypothermia seems protective in a model of 
pneumococcal pneumonia.
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Introduction Strategies to prevent the progression to nonrespiratory 
multiorgan failure (nrAOF) in patients receiving invasive or non-invasive 
ventilation are needed. We performed a pilot international prospective 
cohort study to determine the incidence of and risk for nrAOF in ICU 
patients receiving respiratory support.
Methods  All consecutive ICU admissions to 11 ICUs (UK, Australia 
and Canada) were screened during the fi  rst 24 hours over a 4-week 
period. Patients receiving positive pressure ventilatory support for at 
least 1 hour during the fi  rst 24 hours were eligible. Those with nrAOF 
(SOFA 3 to 4), or elective postsurgical patients extubated and ready for 
discharge within 24 hours after admission, were excluded. Follow up 
lasted for the fi  rst of 14 days after enrolment or ICU discharge.
Results In total, 123/766 (16.1%) patients were enrolled. Elective postsurgery 
ventilation (22.1%) and type I respiratory failure (29.5%) were the most 
frequent indications for respiratory support. n = 49 (39.8%, 95% CI = 31.1 to 
48.6%) developed nrAOF after an average 3.7 (SD 1.5) days. The 28-day ICU 
mortality was 8.1%. In univariate analysis, APACHE II >14.5 (OR = 3.0, 95% 
CI = 1.2 to 7.1) and nonrespiratory SOFA score >1 (OR = 2.3, 95% CI = 1.1 to 4.7 
excluding GCS) were associated (P <0.05) with AOF. See Table 1.
Figure 1 (abstract P185). Fractional polynomial regression of PIP/PCO2 
following DNAse.
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is relatively small. APACHE II and baseline SOFA may predict risk. These 
data inform future trials of preventive strategies but a study with more 
outcome events is needed to reduce the confi  dence intervals.
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Introduction Acute lung injury and acute respiratory distress syndrome 
are common conditions encountered in the ICU. Whether mortality has 
decreased over time or not, they are still many unanswered questions 
about the impact of pharmacological treatment on ALI/ARDS mortality.
Methods The objectives were to perform a review of the literature in 
search of the randomized control trials that asses the pharmacological 
impact in ALI/ARDS on all-cause mortality. We included all RCTs 
of pharmacological treatments in ALI/ARDS that had an impact in 
mortality in adults. We excluded RCTs that included patients <18 years 
old and animals. We also excluded trials that tested fl  uid therapy, 
mechanical ventilation, nonpharmacological treatments, antibiotics 
and reviews. No date or language restriction was applied.
Results We included 37 RCTs involving 6,303 patients in diff  erent ALI/
ARDS treatment modalities: steroids (n = 271), enteral nutrition (n = 411), 
surfactant (n = 1,754), nitric oxide (n = 1,342), APC (n = 75), muscle 
relaxants (n = 340), prostaglandins (n = 550), NAC (n = 127), silvelastat 
(n  =  492), rPAF-HD (n  =  127) lisofylline (n  =  235), rFVIIa antagonist 
(n = 214), OTZ (n = 215) and verapamile-procaine compound (n = 150).
Conclusions Only steroid treatment (methylprednisolone) and nutritional 
therapy (EPA + GLA + antioxidants) showed a trend towards reduced 
mortality. Other treatments were associated with reduced morbidity. 
However, many empirical treatments are still used in day-to-day practice.
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Introduction  Positive end-expiratory pressure (PEEP) improves 
oxygenation in acute lung injury (ALI) patients by increasing end-
expiratory lung volume (EELV). Electrical impedance tomography 
(EIT) is a relatively new non-invasive bedside method to monitor 
regional distribution of tidal ventilation and EELV changes, validated 
in preclinical studies. We tested EIT as a monitor of PEEP-induced tidal 
redistribution and EELV changes in ALI patients, and the relationship 
between EIT parameters and oxygenation.
Methods We enrolled 14 consecutive ALI patients admitted to our ICU, 
intubated and undergoing mechanical ventilation. We monitored the 
regional tidal ventilation distribution by means of a new EIT system 
(PulmoVista 500®; Dräger Medical GmbH, Lübeck, Germany) dividing 
the lung imaging fi   eld into four contiguous same-size regions of 
interest (ROIs): ventral right (ROI 1) and left (ROI 2) and dorsal right 
(ROI 3) and left (ROI 4). EIT allowed us to measure changes in EELV at 
diff  erent PEEP levels by measuring diff  erences in end-expiratory total 
lung electrical impedance. We randomly performed the following 
two steps for 15 minutes, leaving tidal volume and FiO2 unchanged: 
PEEPlow (clinical) and PEEPhigh (PEEPlow +5 cmH2O). At the end of each 
step, we recorded: ventilation parameters, arterial blood gas analysis, 
percentage of tidal ventilation distribution in the four ROIs and EELV 
change. Analyses were performed by paired t test and linear regression.
Results Patients were 55 ± 12 years old and seven were women. ALI 
etiology was: trauma (14%), septic shock (21%), pneumonia (37%) and 
postoperative respiratory failure (28%). PEEPlow was 7 ± 2 cmH2O and 
PEEPhigh 12 ± 3 cmH2O. At PEEPhigh, PaO2/FiO2 signifi  cantly ameliorated 
(266 ± 98 vs. 287 ± 102 mmHg, P = 0.0003), the proportional distribution 
of tidal ventilation changed in all four ROIs (ROI 1 to ROI 4: 34 ± 14 vs. 
29 ± 9%, P = 0.03; 33 ± 13 vs. 30 ± 11%, P = 0.12; 16 ± 9 vs. 20 ± 10%, 
P = 0.002; 17 ± 7 vs. 21 ± 6%, P = 0.002), moving from ventral to dorsal, 
and EELV increased by 349 ± 121 ml. Changes in PaO2/FiO2 correlated 
better with ventral-to-dorsal shifts of tidal ventilation than with EELV 
changes (r = 0.499, P = 0.08; r = –0.399, P = 0.18).
Conclusions EIT allowed us to detect ventral-to-dorsal tidal ventilation 
redistribution at higher PEEP levels. This mechanism may be a key 
determinant of PEEP-induced oxygenation improvement.
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Introduction Assisted ventilation may prevent muscle atrophy and 
reduce sedation needs in severe acute respiratory distress syndrome 
(ARDS) patients undergoing extracorporeal membrane oxygenation 
(ECMO). However, pressure support (PS) is diffi   cult  to  implement 
in these patients: inspiratory fl  ow peaks and drops rapidly and the 
ventilator expiratory phase may overlap patient inspiration causing 
asynchrony and barotrauma. Neurally adjusted ventilatory assist (NAVA) 
is an assisted ventilation mode driven by diaphragmatic electrical 
activity (EAdi) and should adapt better to patients’ respiratory pattern. 
We measured whether NAVA could reduce asynchrony in severe ARDS 
patients undergoing ECMO.
Methods We enrolled seven consecutive adult patients undergoing 
ECMO for severe ARDS. Twenty-four hours after their ventilation 
mode was switched from controlled to assisted, we randomly tested 
the following strategies for 30 minutes each, leaving positive end-
expiratory pressure (PEEP), FiO2 and ECMO settings unchanged: (1) PS 
with expiratory trigger at 30% of fl  ow peak value (PS30); (2) PS with 
expiratory trigger at 1% (PS1); (3) NAVA. The PS level and NAVA gain 
were chosen to obtain a similar tidal volume (VT). From continuous 
recordings of airway pressure, fl  ow, volumes and EAdi we calculated 
the average VT, respiratory rate (RR) and asynchrony index (AI: number 
of asynchrony events / (ventilator cycles + wasted eff  orts) x 100) of each 
step and, at the end, we measured arterial blood gases and p0.1. Data 
are the median (IQR) and were compared by nonparametric Friedman 
test and linear regression.
Results At enrolment, patients were 44 (42 to 56) years old. Respiratory 
system compliance (Crs) was 12 (9 to 23) ml/cmH2O, PEEP 10 (7 to 
12) cmH2O, FiO2 0.5 (0.4 to 0.5) and VT 2.9 (2.8 to 4) ml/kg. Patients 
were on 3.2 (2.9 to 3.6) l/minute venovenous ECMO since 22 (16 to 29) 
days. Switching from PS30 to PS1 to NAVA, PaO2/FiO2 did not change 
Table 1 (abstract P188).
Variable No  AOF  AOF  P value
Age  54.3 (19.6)  58.2 (19.6)  0.56
Female  24 (58.5%)  17 (41.5%)  0.007
APACHE II  12.1 (6.7)  17.5 (7.1)   <0.0001
SOFA   1.52 (1.52)  2.9 (2.5)  0.0002
AOF, acute nonrespiratory organ failure; SOFA, excluding respiratory and GCS.
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(0.9 to 2.3) cmH2O, P = 0.003) together with RR (P = 0.129) and AI (55 
(29 to 66) vs. 46 (26 to 56) vs. 16 (8 to 18)%, P = 0.004). The diff  erence 
between AI during PS30 and NAVA was signifi  cantly correlated with Crs 
(R2 = 0.87, P = 0.02).
Conclusions  Implementation of NAVA in severe ARDS patients 
undergoing ECMO may decrease patient eff  ort and asynchrony events. 
The advantage of NAVA over PS is more evident in patients with lower 
Crs.
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Introduction Endogenous molecules released during tissue injury can 
trigger an innate immune response and are termed damage-associated 
molecular patterns (DAMPs). Uric acid is considered an important DAMP 
and causes acute lung infl  ammation when administered locally. The 
exact role of the innate immune response in ventilator-induced lung 
injury (VILI) is not yet completely understood. We hypothesized that 
uric acid is released during VILI and that reduction of uric acid levels 
attenuates lung injury induced by short-term mechanical ventilation 
(MV).
Methods  Uric acid levels in bronchoalveolar lavage fl  uid (BALF) of 
wildtype C57BL/6 mice ventilated for 5 hours with low tidal volume (LVT 
~7.5 ml/kg) or high tidal volume (HVT ~15 ml/kg) and spontaneously 
breathing mice were determined. In addition, mice were treated with 
allopurinol (25 mg/kg; inhibits uric acid synthesis) or uricase (0.2 mg/
kg; degrades uric acid) or vehicle (10% DMSO), 1 hour before start of 
HVT MV. Endpoints of VILI were lung wet/dry ratio, total protein, IgM 
and sRAGE concentrations in BALF as well as neutrophil infl  ux and 
pulmonary cytokine and chemokine levels.
Results Injurious MV leads to uric acid release in BALF of previously 
healthy mice. HVT ventilation signifi  cantly increased all endpoints of 
VILI as compared with the unventilated control group. Allopurinol and 
uricase treatment signifi  cantly decreased the wet/dry ratio and alveolar 
protein leak as compared with the HVT ventilated vehicle-treated 
group. IgM levels were also signifi   cantly lower in the allopurinol-
treated group indicating protection of alveolar barrier function. 
Reduction of lung injury by allopurinol and uricase treatment was also 
demonstrated by the reduction of sRAGE concentrations, a marker of 
alveolar type I cell injury. Interestingly, treatment in the HVT group with 
allopurinol or uricase did not signifi  cantly reduce neutrophil infl  ux or 
cytokine and chemokine levels.
Conclusions The danger signal uric acid is released due to injurious 
mechanical ventilation. Reduction of uric acid concentrations with 
allopurinol or uricase decreased VILI and specifi  cally epithelial injury 
and alveolar barrier dysfunction
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Introduction The aim was to describe the epidemiological profi  le of 
adult patients who were treated with HFOV like a rescue method after 
conventional mechanical ventilation failure, during 2009 in our ICU, in 
Santiago, Chile, and to describe patient characteristics, HFOV strategies 
and outcomes.
Methods  A descriptive study. We evaluated the medical record of 
all adult patients treated with HFOV during 2009 at Clínica INDISA. 
We evaluated sex, age, associated co-morbidities, laboratory test 
results and main diagnosis at ICU admission, hours in conventional 
mechanical ventilation previous to HFOV connection, indication of 
HFOV, laboratory test results at the connection time to HFOV, and 
patient outcome.
Results A total of 15 patients were treated with HFOV during 2009 in 
our ICU; the mean age was 47 years, being 80% men. Three patients 
did not have, at ICU admission or during the course of the current 
hospitalization, description of associated co-morbidities, while 53.3% 
had report of two or more co-morbidities. The main diagnosis at ICU 
admission was severe pneumonia (53.3%) with a mean APACHE II score 
of 27.7. The mean values for PaFi and IOX prior to HFOV connection 
were 108.8 and 25, respectively. The main indication observed in those 
patients was very high FiO2 requirement to achieve an adequate arterial 
oxygen saturation (60% of the cases). Twenty percent of the sample 
required reconnection to HFOV, the mortality in this group of patients 
was 100%. Of all patients that were exposed to HFOV, there was an 
eff  ective weaning to CMV and medical discharge in 40% of them, while 
the mortality during HFOV was 60%.
Conclusions  We present the epidemiological profi   le of the patients 
exposed to HFOV during 2009 at our medical center, the mean age at 
admission was 47 years old; the main diagnosis was severe pneumonia, 
40% of all patients survived. HFOV has benefi  cial eff  ects on PaO2/FiO2 
ratios and OI, and may be an eff  ective rescue therapy for adults with severe 
oxygenation failure. This is the fi  rst study of its kind at a national level.
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Introduction  Analysing the eff   ects of mechanostimulation on 
pulmonary cells improves the understanding of the stress–strain 
relationship in the lungs. While there are plenty of diff  erent methods 
to apply strain on cells and thereby to analyze intracellular and 
extracellular processes, it remains diffi   cult to measure the resulting 
strain, in other words the forces produced by cells to counteract the 
applied strain. Recently we presented a bioreactor to cyclically defl  ect 
cells by co-defl  ecting them with a carrier membrane [1]. The air-tight 
highly pliant siloxane-carrier membranes [2] used in our bioreactor 
were modifi  ed with Sulfo-SANPAH and RGD peptide [3] to allow cell 
adherence. Here we present actual data demonstrating changes in 
mechanical properties of pulmonary cell monolayers as a response to 
strain levels of up to 20% surface increase.
Methods Diff  erent alveolar epithelial cell lines (A549 and RLE-6TN) 
were grown on RGD-coated, highly fl   exible polydimethyl siloxane 
membranes and were mechanically stimulated in a bioreactor [1,2]. 
After becoming 100% confl  uent, microscopic images of cell monolayers 
were taken before subjecting them to increasing sinusoidal mechanical 
strain of up to 20% surface increase. The resulting stress was measured 
as the force that the cells opposed to the applied strain. Immediately 
after the procedure, additional images of cells were taken.
Results  Stretching pulmonary cells bidirectionally led to a loss of 
intercellular connections and/or loss of integrin-binding sites to the 
RGD-labeled carrier membranes as indicated by comparing microscopic 
images before and after application of strain to cell monolayers. This 
was accompanied by a loss of the cell’s counterforce on strain.
Conclusions The investigation of cell forces with our strain applicator 
allows us to analyze mechanical properties of cell constructs at the 
same time as we can track visually changes in cellular morphology. 
Strain-related cell damages as found in this study could play a role in 
development of ventilator-induced lung injury.
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Introduction  The optimal level of positive end-expiratory pressure 
(PEEP) is still widely debated in treating acute respiratory distress 
syndrome (ARDS) patients. Current methods of selecting PEEP only 
provide a range of values and do not provide unique patient-specifi  c 
solutions. Model-based methods off   er a novel way of using non-
invasive pressure–volume (PV) measurements to estimate patient 
recruitability. This paper examines the clinical viability of such models 
in pilot clinical trials to assist therapy, optimise patient-specifi  c PEEP, 
and assess the disease state and response over time.
Methods  Ten patients with acute lung injury or ARDS underwent 
incremental PEEP recruitment manoeuvres. PV data were measured 
in increments of 5 cmH2O and fi  tted to the recruitment model using 
volume-controlled ventilation. Inspiratory and expiratory breath holds 
were performed to measure airway resistance and auto-PEEP. Three 
model-based metrics are used to optimise PEEP based on threshold 
opening pressures (TOP), threshold closing pressures (TCP) and net 
recruitment. ARDS status was assessed by model parameters capturing 
recruitment and compliance. Two patients underwent multiple 
recruitment manoeuvres over time and four model metrics refl  ected 
and tracked the state or their ARDS.
Results  Median model fi  tting error across all patients for infl  ation 
and defl   ation was 2.8% and 1.02%, respectively, with all patients 
experiencing auto-PEEP. In all three metrics cases, model-based optimal 
PEEP was higher than clinically selected PEEP. Ranges for optimal PEEP 
were (5, 27), (10, 25) and (10, 30) cmH2O for TOP, TCP and net recruitment 
metrics, respectively. Disease-tracking metrics corresponded with 
the physiological status of two patients, indicating the potential for 
tracking disease state. In particular, monitoring TOP, standard deviation, 
TOP gradient and TCP gradient refl  ected compliance and recruitability 
changes as a function of time. Normalised SD refl  ected compliance 
changes in an exponential manner with the equation 72.6 x exp–0.0664 x SD, 
indicating the model’s utility in evaluating true lung linear compliance.
Conclusions For ARDS patients, the model-based method presented 
in this paper provides a unique, non-invasive method to select optimal 
patient-specifi  c PEEP. In addition, the model has the capability to assess 
disease state over time and monitor patient status.
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Introduction  Positive pressure ventilation involves ventilator-
controlled infl  ation of the lungs followed by passive expiration driven 
by the elastic recoil forces of the respiratory system. In contrast to 
inspiration where the fl  ow is controlled by the ventilator, expiration is 
passive, and the only clinically available means of infl  uencing expiration 
is positive end-expiratory pressure (PEEP). During passive expiration, 
the fl  ow curve starts with a high peak fl  ow followed by an exponential 
decay in airfl  ow rate so that typically there is no fl  ow during more than 
50% of expiration time. Prolonging the phase of expiratory fl  ow may be 
expected to be lung protective.
Methods  Sixteen pigs with oleic acid-induced lung injury were 
mechanically ventilated for 6 hours with volume-controlled ventilation 
either without or with fl  ow-balanced expiration. Following insertion 
of a controllable expiratory resistance into the expiratory outlet of the 
ventilator, expiratory resistance markedly increased at the beginning 
of expiration and decreased continuously during the expiration phase. 
As a result, the expiratory fl  ow curve changed from an exponentially 
decaying curve to a balanced fl  ow pattern with lower fl  ow rates at the 
beginning and higher ones at the end of the expiration phase, thereby 
achieving complete expiration. Ventilation settings were tidal volume 
8 ml/kg, I:E ratio 1:2, RR 15/minute, Tinsp 1.5 seconds. Initially PEEP was 
set at 8 cmH2O. During the experiment, PEEP was adjusted to maintain 
PaO2 ≥60 mmHg.
Results  To maintain PaO2 ≥60  mmHg, after 6  hours of mechanical 
ventilation PEEP had to be increased from 8 to 13 ± 3 cmH2O in the 
conventionally ventilated animals but to only to 10  ±  1  cmH2O in 
the animals ventilated with fl  ow-balanced expiration (P <0.05). Lung 
biopsies from animals ventilated without fl  ow-balanced  expiration 
showed more infi   ltrations and thicker septa compared with those 
ventilated with fl   ow-balanced expiration (all P  <0.05). The wet-to-
dry ratio of tissue samples from lungs ventilated with without fl  ow-
balanced expiration were higher than those from lungs ventilated with 
fl  ow-balanced expiration (10 ± 5 vs. 5 ± 4, P <0.05).
Conclusions Flow-balanced expiration during mechanical ventilation 
reduces oedema formation in the injured lung. Reduced expiratory 
peak fl  ow and increased mean airway pressure during expiration are 
likely to have contributed to this benefi  cial eff  ect.
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Introduction We have previously shown that the desaturation index 
(DI) and the continuous desaturation index (CDI) displayed on the 
desaturation index monitoring system (DIMS) have a high sensitivity 
and specifi  city to identify lung dysfunction [1,2]. However, dynamic 
changes during mechanical ventilation (MV) that may refl  ect  the 
patient’s response for MV treatment have not yet been tested.
Methods Fifty-eight patients with and without ALI/ARDS were followed 
during the fi  rst 24 hours of MV with the DIMS. The system computes 
the CDI from the positive end-expiratory pressure (PEEP), the inspired 
fraction of oxygen (FiO2) and arterial saturation by pulse oximetry 
(SpO2) [1,2]. The CDI is a percentage that is displayed graphically and 
numerically. Patients were divided into three groups according to the 
initial (fi  rst hour) CDI. Group (G) I (n = 16), CDI above 90%. GII (n = 22), 
CDI between 70 and 90%. GIII (n = 20), CDI below 70%. Then, changes in 
the CDI were calculated every hour (CDIh1 minus CDIh2, CDIh2 minus 
CDIh3, and so forth), three types of changes were expected: no change 
(even), negative changes (improvement of lung function) and positive 
changes (worsening of lung function). The mean of CDI changes was 
calculated at 6, 12, 18 and 24  hours after the initial recording. All 
patients were followed and mortality associated with acute respiratory 
failure (ARF) was recorded.
Results  Changes (mean  ±  standard deviation) at 6  hours for GI: 
–1.82 ± 4.2, GII: –2.27 ± 9.2 and GIII: 2.52 ± 5.2 (P = 0.061). At 12 hours: 
GI: –2.2 ± 4.9, GII: –2.2 ± 9.1 and GIII: 6.07 ± 13.7 (P = 0.014). At 18 hours: 
GI: –1.36 ± 5.2, GII: –4.24 ± 11 and GIII: 5.47 ± 19.2 (P = 0.068). At 
24 hours: GI: –2.09 ± 4.7, GII: –4.24 ± 12.8 and GIII: 8.53 ± 27.8 (P = 0.058). 
The mortality rate was 17.9% for GI, 33.3% for GII and 73.3% for GIII 
(P = 0.01). The association between positive changes and mortality was 
30.8% for GI, and 100% for GII and GIII (P = 0.01).
Conclusions  We conclude that positive changes in the CDI during 
the MV are associated with mortality due to ARF. The CDI may help to 
improve the MV settings according to the patient’s response to the FiO2 
and PEEP treatment.
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Introduction  Unphysiological lung strain (tidal volume/functional 
residual capacity, TV/FRC) may cause ventilator-induced lung injury 
(VILI) [1]. Whether VILI develops proportionally to the applied strain or 
only above a critical threshold remains unknown.
Methods In 20 healthy, mechanically ventilated pigs, FRC and lung 
weight were measured by computed tomography. Animals were then 
ventilated for up to 54 hours with a TV set to produce a predetermined 
strain. At the end, lung weight was measured with a balance. VILI was 
defi  ned as fi  nal lung weight exceeding the initial one.
Results  Lung weight either did not increase at all (no-VILI group; 
lung weight change –73 ± 42 g, n = 9) or markedly augmented (VILI 
group; 264 ± 80 g, n = 11). In the two groups, strain was 1.38 ± 0.68 and 
2.16 ± 0.50 (P <0.01), respectively. VILI occurred only when lung strain 
reached or exceeded a critical threshold, between 1.5 and 2.1 (Figure 1).
Conclusions In animals with healthy lungs VILI only occurs when lung 
strain exceeds a critical threshold.
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Introduction  Tidal volume (Vt) for ALI/ARDS is 6  ml/kg. However, 
professional athletes have higher forced vital capacity (FVC) and forced 
expiratory volume in 1 second (FEV1) than predicted for the same body 
weight and thus a higher Vt could be required.
Methods To answer this question, the predicted Vt (Vt Pr = 6 ml/kg) 
was calculated as the percentage of measured (Ms) and predicted (Pr) 
FEV1 and FVC, and their diff  erence (Δδ = Ms – Pr) was extracted to 
calculate the additional Vt (VtA) required according to measured PFTs. 
Values are expressed as the mean (SEM).
Results We included 156 males and 95 females of mean duration of 
sporting of 11.8 (6.4) and 11.6 (6.9) years, respectively. Ms and Pr FEV1 
and FVC were recorded (data not shown). Vt Pr, the percentage to Ms 
and Pr FEV1 and FVC, their diff  erence Δδ, the corresponding VtA and 
the new Vt (VtN) are presented in Table 1.
Conclusions  According to our hypothesis an additional Vt of 0.6 
for males and 0.5 ml/kg for females maybe required for professional 
athletes under mechanical ventilation.
Acknowledgements Partially funded by OPAP.
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Introduction Prevention of gastroesophageal refl  ux (GER) may reduce 
the incidence of ventilator-associated pneumonia (VAP). The aim of 
this study was to assess the safety and tolerance of a novel peristaltic 
feeding tube (PFT/LunGuard) in a pig model and healthy volunteers, 
and to assess its initial effi   cacy in preventing GER.
Methods The PFT is a NG feeding tube with three longitudinal balloons 
located at its distal end. The distal balloon is positioned 3 cm above 
the GE junction. The balloons are infl  ated/defl  ated sequentially in a 
peristaltic manner by an external monitor to prevent GER. Initially in 
six ventilated pigs, safety parameters including vital signs, macroscopic 
and microscopic inspection of the esophagus were assessed after 
sacrifi  cing the animals. Prevention of GER was assessed by pH meter 
in one pig. In three healthy volunteers where the PFT was placed 
and operated for 8  hours, safety and tolerance were assessed by 
questionnaire given to the study subjects and by gastroscopy done 
pre/post PFT operation.
Results Each balloon was cyclically infl  ated for 30 seconds and then 
defl  ated. Average intermittent pressure against the esophageal wall 
while the balloons were infl  ated was approximately 30 mmHg. Visual 
inspection of the esophagus in both animals and humans showed no 
damage to the esophageal wall. Full thickness biopsies taken from 
esophagus under the area of the balloons as well as control biopsies 
taken from the proximal esophagus above showed no evidence of 
Figure 1 (abstract P198).
Table 1 (abstract P199). Calculations to extract additional Vt according to predicted and measured PFTs
    Vt to PFTs (%)  Vt to PFTs (%)  δ  VtA (ml)  VtN (ml)
  Vt Pr (ml)  FEV1 Pr  FEV1 Ms  FEV1  FEV1  FEV1
Males  476.3 (6.1)  10.0 (016)  10.9 (0.13)  0.87 (0.1)  47.7 (5.1)  524 (8.1)
Females  384.9 (6.0)  10.4 (0.2)  11.1 (0.16)  0.67 (0.1)  29.9 (4.7)  414.8 (7.8)
  Vt Pr (ml)  FVC Pr  FVC  Ms  FVC FVC FVC
Males  476.3 (6.1)  8.35 (0.12)  9.1 (0.1)  0.75 (0.1)  51.3 (5.7)  527 (9.1)
Females  384.9 (6.0)  8.9 (0.17)  9.6 (0.14)  0.67 (0.1)  34.7 (5.5)  419 (8.6)
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reported a minimal sensation of PFT rhythmic movement at the nares 
and minimal discomfort in the nose and hypopharynx from the tube 
itself. The PFT did not interfere with normal drainage of oropharyngeal 
secretions. PH measurements made in the pig following injection of 
diluted HCl (pH = 4.0) into the distal esophagus at a maximum rate of 
16 ml/second over 5 seconds showed that GER was prevented by the 
PFT.
Conclusions The PFT is safe, well tolerated and may serve to reduce 
risk of VAP by preventing GER in ICU patients on mechanical ventilation 
who are receiving enteral nutrition. Prospective clinical trials to assess 
PFT effi   cacy will be conducted.
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Introduction Increased respiratory pattern variability is associated with 
improved oxygenation. Pressure support (PS) is a widely used partial-
assist mechanical ventilation (MV) mode, in which each breathing 
cycle is initiated by fl  ow or pressure variation at the airway due to 
patient inspiratory eff  ort. Neurally adjusted ventilatory assist (NAVA) is 
relatively new and uses the electrical activity of the diaphragm (Eadi) 
to deliver ventilatory support proportional to the patient’s inspiratory 
demand. We hypothesize that respiratory variability should be greater 
with NAVA compared with PS.
Methods Twenty-two patients underwent 20 minutes of PS followed 
by 20 minutes of NAVA. Flow and Eadi curves were used to obtain tidal 
volume (Vt) and ∫Eadi for 300 to 400 breaths in each patient. Patient-
specifi  c cumulative distribution functions (CDF) show the percentage 
Vt and ∫Eadi within a clinically defi  ned (±10%) variability band for each 
patient. Values are normalized to patient-specifi  c medians for direct 
comparison. Variability in Vt (outcome) is thus expressed in terms of 
variability in ∫Eadi (demand) on the same plot.
Results Variability in Vt relative to variability in ∫Eadi is signifi  cantly 
greater for NAVA than PS (P = 0.00012). Hence, greater variability in 
outcome Vt is obtained for a given demand in ∫Eadi, under NAVA, as 
illustrated in Figure 1 for a typical patient. A Fisher 2 x 2 contingency 
analysis showed that 45% of patients under NAVA had a Vt variability in 
equal proportion to ∫Eadi variability, versus 0% for PS (P <0.05).
Conclusions NAVA yields greater variability in tidal volume, relative to 
∫Eadi demand, and a better match between Vt and ∫Eadi. These results 
indicate that NAVA could achieve improved oxygenation compared 
with PS when suffi   cient underlying variability in ∫Eadi is present, due 
to its ability to achieve higher tidal volume variability from a given 
variability in ∫Eadi.
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Introduction A suspended animation-like state induced by hydrogen 
sulphide (H2S) was shown before to protect lungs from ventilator-
induced lung injury by reducing metabolism and infl  ammation. This 
benefi  cial eff  ect of H2S seems promising, but the eff  ects of H2S during 
prolonged infusion are unknown. We hypothesized that reducing 
metabolism in a rat model of LPS-induced systemic infl  ammation 
during 8 hours is more protective than during 4 hours.
Methods After anesthesia, rats (400 g) received an intravenous injection 
with 7.5 ml/kg LPS and were subsequently randomized to 4 or 8 hours 
of mechanical ventilation and treated with intravenous H2S donor 
NaHS (2 mg/kg/hour). Controls received saline. During the experiment, 
mean arterial pressure (MAP) was kept above 65 mmHg with fl  uids and 
noradrenalin infusion. After exsanguination, bronchoalveolar lavage 
fl  uid was obtained and organs were harvested. Data are mean ± SEM.
Results H2S reduced metabolism, exemplifi  ed by a reduction in heart 
rate, body temperature and etCO2 compared with saline controls. Also, 
oxygenation was improved in these groups. The H2S-treated animals 
required more noradrenalin to keep the MAP above 65 mmHg. LPS-
induced lung injury was reduced after 4 hours of H2S infusion compared 
with controls, with lower BALF protein levels (399 ± 46 vs. 655 ± 85 μg/
ml), IL-6 levels (4.5 ± 0.3 vs. 6.2 ± 0.6 ng/ml) and CINC3 levels (2.4 ± 0.09 
vs. 2.9 ± 0.2 ng/ml) (P <0.05 for all), whereas 8 hours of infusion did not 
enhance protection. Kidney injury, measured by wet-to-dry ratio, was 
reduced after 8 hours of H2S infusion compared with saline controls 
(5.5 ± 0.1 vs. 6.1 ± 0.1 ratio, P <0.05). The cumulative fl  uid balance was 
the same in all groups. In contrast to the protective eff  ect at tissue level, 
H2S infusion resulted in enhanced systemic levels of IL-1, IL-6, TNF and 
CINC3 compared with saline controls.
Conclusions During endotoxemia, 4 hours of H2S infusion protected 
against lung injury, which was not further enhanced by 8 hours of 
infusion. In contrast, kidney damage was diminished after 8 hours but 
not after 4 hours of H2S infusion. However, H2S aggravated systemic 
infl  ammation in endotoxemia, suggesting that administration of H2S 
gas may be preferable.
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Introduction The objective of this study is to evaluate the value of 
dead space fraction (VD/VT) as a method for indicating the optimal 
PEEP titration.
Methods Twenty-three patients with ARDS were enrolled in the study. 
After lung recruitment using sustained infl  ation (SI), the optimal PEEP 
was respectively titrated by the optimal oxygenation, the maximum 
static pulmonary compliance (Cst), and the lowest VD/VT. The infl  uence 
of these methods on oxygenation, Cst, VD/VT and FRC were observed.
Results The PEEP level titrated by the lowest VD/VT (10.1 ± 2.8 cmH2O) 
had no signifi  cant  diff   erence from the PEEP level titrated by the 
maximum Cst (11.3  ±  2.5  cmH2O) (P  >0.05). However, the PEEP 
level titrated by the lowest VD/VT was signifi  cantly lower than that 
determined by optimal oxygenation (P  <0.05). The oxygenation at 
the PEEP titrated by VD/VT was signifi  cantly lower than the optimal 
oxygenation, but no signifi  cant diff  erence in PaO2/FiO2 was observed 
Figure 1 (abstract P201).
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Additionally, the VD/VT and the FRC at the PEEP chosen by the three 
methods also had no signifi  cant diff  erence.
Conclusions The lowest VD/VT could be one of the methods to choose 
the optimal PEEP in ARDS patients.
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Introduction Respiratory dendritic cells (DCs), especially conventional 
DCs, are centrally involved in the induction phase of the immune 
response in our respiratory system. However, their role in acute lung 
injury (ALI) is largely unknown and little information concerning cDCs 
of blood and spleen is available on ALI.
Methods c57BL/6 mice were intratracheally challenged with Escherichia 
coli LPS (2 mg/kg). At 6 hours, 12 hours, and 24 hours after i.t. delivery of 
LPS (ALI group) or PBS alone (Control group), mice were sacrifi  ced, and 
blood, lungs and spleens were collected. cDCs were detected using 
fl  ow cytometry in enzyme-digested lung, blood, and spleen.
Results  The sepsis-induced ALI showed divergent kinetics of cDCs 
in peripheral blood, lung and spleen, respectively. ALI resulted 
in a rapid cDC accumulation in the lung, the frequencies of cDCs 
in ALI mice were signifi   cantly increased during all time points, 
compromised (2.38  ±  0.78)% at 12  hours, and peaked at 24  hours 
postchallenge (2.86 ± 0.55)%, relative to lung nucleated cells (P <0.05 
vs. Control). However, splenic cDCs only showed a markedly transient 
augmentation to a peak (1.92 ± 0.25)% at 12 hours (P <0.05 vs. Control), 
but subsequently declined to baseline (0.96 ± 0.21)% at 24 hours. In 
contrast to the lung cDC accumulation at 6 hours, sepsis-induced ALI 
led to a decreased percentage (0.32 ± 0.10)% of circulating cDCs at the 
same time point (P <0.05 vs. Control), then the percentage of circulating 
cDCs was signifi  cantly increased (1.50 ± 0.31)% compared with that 
of control mice at 12 hours, and further increased (2.20 ± 0.92)% at 
24 hours after LPS-induced ALI (P <0.05 vs. Control). All cDCs within the 
blood, lungs and spleens had undergone a modest maturation in ALI 
from sepsis.
Conclusions  ALI by sepsis produces diff   erent quantitative and 
phenotypical changes in pulmonary, circulatory and splenic cDCs. 
Lung cDCs may participate in the early infl  ammatory response to ALI.
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Introduction  In ALI/ARDS patients the amount of potentially 
recruitable lung is extremely variable and it is poorly predictable by 
the changes of oxygenation, carbon dioxide or compliance during a 
PEEP trial [1]. At the present time the gold standard to compute the 
lung recruitability is the quantitative lung CT scan, in which each lung 
image, after being manually drawn, is analyzed by dedicated software. 
However, this is both a laborious and time-consuming technique. The 
aim of this study was to evaluate the ability of a visual radiological scale 
compared with lung CT scan analysis to predict the lung recruitability 
in ALI/ARDS patients.
Methods A whole lung CT scan was performed at 5 and 45 cmH2O 
airway pressure. For CT scan analysis each lung image was manually 
outlined and analyzed by a dedicated software. The potentially 
recruitable lung was defi  ned as the proportion of the nonaerated 
lung tissue in which aeration was restored [1]. For radiological visual 
scale analysis, two radiologists performed a blinded evaluation of the 
consolidation/collapsed areas in each lobe by visual inspection [2]. The 
overall lung change in consolidation/collapsed was obtained by the 
sum of each lobe and computed as the diff  erence between the two 
conditions.
Results  Twenty-four ALI/ARDS patients (age 59  ±  15  years, BMI 
26 ± 4 kg/m2, PaO2/FiO2 170 ± 60, PEEP 10 ± 2 cmH2O) were enrolled. 
The percentage of potentially recruitable lung was 16.2 ± 7.1% and 
14.7 ± 7.0%, computed by CT scan and by the visual radiological scale, 
respectively. The mean diff  erence between CT scan analysis and visual 
radiological analysis was 3.3 ± 4.6% (median: 2.91, interquartile range: 
0.38 to 6.56). The error of the visual method was lower than 5% in 14 
patients (58.3%), between 5% and 10% in eight patients (33.3%) and 
between 10% and 15% in two patients (8.3%).
Conclusions The application of a radiological visual scale is able to 
predict the amount of potentially recruitable lung similarly to those 
obtained by a dedicated software avoiding the need of manually 
drawing each lung image.
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Introduction  The present randomized, controlled, experimental 
study was performed to compare the eff  ects of two diff  erent doses 
of nebulized heparin on the effi     ciency of the combined therapy 
with intravenous (i.v.) recombinant human antithrombin (rhAT) and 
nebulized tissue plasminogen activator (TPA) in an established ovine 
model of acute lung injury.
Methods Chronically instrumented sheep were subjected to a 40% total 
body surface area third-degree burn and 48 breaths of cotton smoke 
under deep anesthesia. Sheep were randomly assigned to receive an 
i.v. infusion of 6 U/kg/hour rhAT (started 1 hour post injury) combined 
with nebulized TPA (2 mg every 4 hour, started 4 hours post injury) and 
heparin (5,000 (low-dose) or 10,000 IU (high-dose), respectively, every 
4 hours, started 2 hours post injury) or 0.9% NaCl i.v. and aerosolized 
(control; n = 6 each). All sheep were awake, mechanically ventilated and 
fl  uid resuscitated according to international guidelines for 48 hours. 
Data are expressed as mean ± SEM at 48 hours.
Results  Both strategies attenuated lung injury, as suggested by 
higher PaO2/FiO2 ratios (low-dose: 276  ±  44  mmHg, high-dose: 
352 ± 25 mmHg, control: 134 ± 30 mmHg) and lower airway peak 
pressures (27 ± 2 cmH2O, 27 ± 1 cmH2O, 36 ± 2 cmH2O). Notably, the 
combination with low-dose heparin reduced pulmonary transvascular 
fl  uid fl  ux (16 ± 2 ml/hour, 40 ± 5 ml/hour, 51 ± 4 ml/hour) and the 
permeability index (9 ± 1 ml/hour, 19 ± 2 ml/hour, 25 ml/hour) and 
increased plasma protein (4.6 ± 0.1 g/dl, 3.9 ± 0.2 g/dl, 4.0 ± 0.3 g/dl) 
versus both other groups (P <0.05 each). Cumulative net fl  uid balance 
was lower in the low-dose heparin group (2.1 ± 0.2l) versus control 
animals (3.5 ± 0.4 l; P <0.05).
Conclusions  With the lower dose of heparin the systemic anti-
infl  ammatory  eff   ects of i.v. rhAT on vascular leakage are more 
pronounced, while the local, benefi  cial eff  ects of nebulized heparin 
on gas exchange are preserved. Therefore, lower doses of heparin may 
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treatment of combined burn and smoke inhalation injury. A reduction 
of the systemic interaction between heparin and rhAT represents a 
possible explanation.
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Introduction  Ventilator-induced lung injury is characterized by 
release of infl  ammatory mediators and increased vascular permeability 
resulting in alveolar edema formation. Thrombopoietin (TPO), 
whose most known function is the stimulation of the proliferation 
of megakaryocytes, has also shown several proinfl  ammatory 
eff   ects. Moreover, TPO receptor, c-Mpl, is constitutively expressed 
on endothelial cells and may modulate the permeability of the 
endothelium. We investigated the role of TPO in the impairment of the 
alveolar-capillary membrane resulting in alveolar edema formation 
during mechanical ventilation.
Methods  An  ex vivo model of isolated, ventilated and perfused 
mouse lung was set up: ventilation was performed for 2 hours with 
both low-stress pressure (peak inspiratory pressure =  7  cmH2O, 
PEEP = 2 cmH2O, RR = 90 beats/minute) and high-stress pressure (peak 
inspiratory pressure = 20 cmH2O, PEEP = 0, RR = 90 beats/minute), in 
the presence or absence of TPO (1 ng/ml) in the perfusate (2% bovine 
serum albumin RPMI medium at 1 ml/minute fl  ow rate). At the end of 
the experiment, lung compliance, assessed through tidal volume, and 
protein concentration in the bronchoalveolar lavage (BAL) fl  uid were 
measured.
Results  During high-stress ventilation, lung compliance was 
signifi  cantly reduced by the presence of TPO in the perfusate. TPO did 
not aff  ect compliance during low-stress pressure. BAL fl  uid protein 
concentration was increased by the presence of TPO in both pressure 
setup, but the increase was statistically signifi  cant only after high-stress 
ventilation. See Table 1.
Conclusions  TPO may enhance the permeability of the alveolar-
capillary membrane contributing to the mechanisms of ventilator-
induced lung injury.
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Introduction Infl  uenza-related mortality is often caused by secondary 
bacterial pneumonia. We have previously shown that the tryptophan-
catabolizing enzyme indoleamine-2,3-dioxygenase (IDO) critically 
impairs host defense against secondary bacterial pneumonia [1]. Since 
inhibition of IDO resulted in increased neutrophil numbers during 
primary viral infection, we hypothesized that tryptophan degradation 
and/or the generation of downstream metabolites induces neutrophil 
apoptosis. In the present study we aimed to investigate the impact of 
IDO-mediated tryptophan metabolism on neutrophil apoptosis in vitro 
and in vivo.
Methods Freshly isolated neutrophils were cultured in the presence 
or absence of tryptophan, kynurenine and 3-hydroxy-anthranilic acid. 
Apoptosis was identifi   ed by annexin V/propidium iodine staining 
(%, mean  ±  SD). To confi  rm our in vitro data, transgenic mice that 
conditionally express IDO in the airway epithelium upon doxycycline 
(dox) treatment and control mice were challenged with LPS (1 μg) 
or Klebsiella pneumoniae (104 colony-forming units) intranasally and 
sacrifi  ced after 24 hours to count neutrophils in bronchoalveolar lavage 
fl  uid (total number, mean ± SD). Statistical analysis was performed by 
Student’s t test or Mann–Whitney U test where appropriate. P <0.05 was 
considered signifi  cant.
Results  Both kynurenine and 3-hydroxy-anthranilic acid enhanced 
apoptosis in freshly isolated neutrophils (60.3 ± 8.7% and 45.5 ± 1.7% 
respectively vs. 33.5 ± 8.1% under control conditions, both P <0.05), 
which was reversed by adding tryptophan. Conditional transgenic 
mice, which showed marked expression of IDO in the pulmonary 
compartment, had reduced neutrophil numbers in bronchoalveolar 
lavage fl  uid after challenge with K. pneumoniae (3.36 ± 1.92 x 105 vs. 
12.1 ± 9.0 x 105 in dox-treated littermates, P <0.05) and LPS (1.88 ± 1.22 
x 105 vs. 5.21 ± 3.81 x 105 in control-treated transgenic mice, P <0.05), 
which was associated with active caspase-3 staining in dox-treated 
mice, but not in control mice.
Conclusions Neutrophils undergo apoptosis in presence of kynurenine 
or 3-hydroxy-anthranilic acid and the absence of tryptophan. 
Pulmonary IDO expression, as occurs during infl  uenza  infection, 
enhances neutrophil apoptosis in vivo and may impair host defense 
against secondary bacterial infections.
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Introduction According to Consensus Conference [1] and PROWESS 
study criteria [2], the diagnosis of sepsis requires evidence of infection 
and the presence of a systemic infl  ammatory response syndrome (SIRS) 
that is characterized by specifi  c physiological alterations. Although 
these criteria are widely accepted in clinical practice and research, 
they have been criticized for being nonspecifi  c and nonrobust in both 
clinical practice and clinical research settings [3]. With regard to these 
issues, it remains unknown to what extent diff  erences in the frequency 
(every minute vs. hourly), timing (SIRS criteria transiently present at 
any time point in the last 24 hours vs. simultaneously present during 
a longer period) and method (automated vs. manual) of data capture 
may aff  ect the diagnosis of sepsis. In this study we aimed to quantify 
the eff  ect of minor variations in the defi  nition of SIRS on the apparent 
incidence of sepsis.
Methods We performed an observational study in consecutive patients 
admitted to a large tertiary ICU in The Netherlands between January 
2009 and October 2010. Patients following elective surgery who had 
an uncomplicated stay <96 hours were excluded from analysis. We 
collected data on SIRS criteria and information on infectious status 
during the fi  rst 24 hours of admission.
Results In total 1,216 patients met the inclusion criteria. The incidence of 
SIRS varied from 99.5% (defi  ned as having two or more criteria transiently 
present during a 24-hour period of automatic recording) to 66.4% 
(defi  ned as having three or four criteria simultaneously present with 
manual recording at hourly intervals), and the incidence of sepsis ranged 
subsequently from 31.1% to 25.1% (RR = 0.81, 95% CI = 0.71 to 0.92). 
The PPV of having an infection was 31.2% and 37.7% for the respective 
settings, the NPV was 100% and 82.1%. In non-infected patients, 60.0% 
of patients had three or more SIRS criteria. The frequency of having two 
Table 1 (abstract P207)
  High-stress MV  High-stress MV + TPO  Low-stress MV  Low-stress MV + TPO
Lung elastance (cmH2O/ml) 14.1 ± 1.43  16.5 ± 0.4*  10.2 ± 0.3  9.6 ± 0.4
BAL (μg/g body weight)  19.18 ± 1.69  29.80 ± 3.25*  13.22 ± 1.29  17.71 ± 1.54
Data presented as mean ± SE. *P <0.05.
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compared with 70.2% 12 to 24 hours after admission.
Conclusions  The measured incidence of SIRS and sepsis heavily 
depended on minor variations in modes of data recording and 
interpretation of diagnostic criteria. A more precise defi  nition of sepsis 
should be incorporated into the design of future clinical trials in sepsis 
in order to ensure the uniform recruitment of patients.
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Introduction The aim of our study is to evaluate the mortality, clinical 
impact and causative microorganisms of nosocomial bacteremia in the 
ICU of a tertiary university hospital.
Methods  A prospective observational study in a 20-bed medical/
surgical ICU, during a 16-month period. We included all patients 
admitted to the ICU >24 hours, excluding patients with acute coronary 
disease, from February 2009 to June 2010. We collected all episodes of 
bacteremia occurring in patients, demographics and epidemiological 
data, clinical impact, overall hospital mortality, ICU mortality and 
mortality related to bacteremia. Bacteremia type (primary, secondary, 
or connected to the catheter), microbiologic agents and empirical 
antibiotic therapy used.
Results  A total of 1,112 patients were admitted to the ICU from 
February 2009 to June 2010. During this period, 63 nosocomial 
bacteremias were diagnosed in 45 patients, which represented 4% 
from the total admissions. The median age was 52 ± 16. Sixty-four 
percent were male. The median APACHE II score was 24 ± 9 versus 16 
of all patients admitted during this period in the ICU (P <0.05). The 
average stay of patients with bacteremia was 39 ± 25 versus 8 days of 
all patients (P <0.01). Seventy-two percent of patients with bacteremia 
developed septic shock. The type of bacteremia: primary 35%: 
bacteremia/100 patients rate: 1.98; secondary 65%: bacteremia/100 
patients rate: 3.68 (respiratory 25%, abdominal 19%, urinary 5%, skin 
5%, CNS 2%, catheter 9%: bacteremias/1,000 VCC rate: 0.8). Seventy-
eight percent were multidrug-resistant microorganisms. Mortality of 
patients admitted was 16% versus 40% overall mortality in patients 
with bacteremia (P <0.01). Bacteremia was the direct cause of death 
of the patient in 27% of cases. Mortality with adequate empirical 
treatment was 8.2% versus 52% with inadequate treatment (P <0.01). 
No patient died of bacteremia drug-sensitive organisms.
Conclusions Nosocomial bloodstream infections in the ICU make a 
major impact, with a high percentage of patients with septic shock, high 
morbi-mortality and hospital stay. Multidrug-resistant microorganisms 
played an important role in these results. It is necessary to optimize 
the control measures of the RBC and other devices, minimizing the 
multidrug-resistant microorganisms as well as empirical treatment 
protocols with broad-spectrum antibiotics.
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Introduction While many severe sepsis (SS) patients go to the ICU on 
hospital admission, others with community-acquired infection (CAI) 
either progress to SS later in the hospitalization or are not considered 
severely ill on admission. The proportion of SS cases falling into these 
two groups is not known, and their outcomes are not well described.
Methods We identifi  ed all adult hospitalizations in the 2008 Premier 
database that had an ICD-9-CM code for SS (995.92, 785.52), a CAI, and 
who entered the hospital through the ED (for example, not transferred 
from another hospital). Patients were characterized by the sequence 
of ICU and fl  oor care, the number of antibiotic classes (AbxC) on day 1, 
and the duration of fl   oor stay before ICU admission. We assessed 
resource use via length of stay (LOS) and total cost. We also examined 
hospital mortality.
Results  The cohort included 33,059 discharges (49.1% male, mean 
age 69.0 years), of whom 17,690 (53.5%) were admitted to the ICU at 
hospital presentation. Mortality in direct to ICU subjects equaled 31.2%, 
and these patients had an average LOS of 12.0 days with a mean cost 
of $30,174, with only 22.8% given a single AbxC. Those admitted to the 
fl  oor initially (46.5%) had a similar LOS (11.7 days) and mortality (31.1%) 
but had lower mean costs ($22,728) and nearly half (49.3%) had a single 
AbxC. Of these initial fl  oor patients, those that were never admitted to 
the ICU (28.0% of all cases) had the shortest stay (7.6 days), lowest cost 
($11,753), and lowest mortality (24.2%) with 44.3% receiving a single 
AbxC on day 1. Those starting on the fl  oor and later transferred to 
the ICU (18.4% of all cases) had the longest stay (17.7 days), highest 
cost ($39,332) and highest mortality (41.5%), and were most likely to 
have a single AbxC on day 1 (56.8%). Even those admitted to the ICU 
after 1 day on the fl  oor (3,179, 52.1% of delayed ICU cases) had higher 
mortality (36.0%) than those starting in the ICU (P <0.0001). Mortality 
increased with longer delays before ICU admission (40.7%, for a 2-day 
delay (14.1% of delayed cases) and 50.3% for those with a 3-day or 
more delay (33.8% of delay cases)).
Conclusions  SS patients with CAI admitted to the fl   oor and later 
transferred to the ICU are a major fraction of all SS cases and have the 
worst outcomes. While many may have developed organ dysfunctions 
later in the hospitalization, nearly two-thirds were admitted to the ICU 
after just 1 or 2 days on the ward, indicating that they may have been 
mis-triaged. Interventions to better identify and aggressively treat 
these cases may improve outcomes.
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Introduction Incidence of septic shock in France ranges from 8 to 
10% among patients admitted to intensive care. Mortality at 28 days 
is 55 to 60% [1]. We aimed to investigate epidemiology, treatment and 
mortality of patients with septic shock further to the Surviving Sepsis 
Campaign international guidelines [2].
Methods  A prospective, multicentre, observational cohort study 
supported by the Collège Interrégional des Réanimateurs du Nord-Est 
(CIRNE) including 14 ICUs in 10 university or nonacademic hospitals. 
Inclusion criteria were: patients presenting with documented/
sus  pected infection requiring initiation of vasopressor amines 
despite adequate vascular fi  lling, with at least one of the following 
hypoperfusion criteria: metabolic acidosis (base excess ≥5 mEq/l or 
alkaline reserve <18 mEq/l or lactate ≥2.5 mmol/l); oliguria/renal insuf-
fi  ciency (<0.5 ml/kg/hour for 3 hours or elevation >50% of baseline 
creatinine); or hepatic dysfunction (AST or ALT >500 IU/l or bilirubin 
>20 mg/l (34 μmol/l)). Quality control was performed by the Dijon 
Clinical Investigation Center (INSERM).
Results  Mean inclusion was 80 patients/month for all centres. We 
analysed the fi  rst 350 patients with validated fi  les of 876 patients 
included up to 1 December 2010. Mean age was 69 ± 13 years, 66% 
men. Indication for admission was medical in 84%. Mean SAPS II score 
was 60.9 ± 21.8, mean SOFA score at time of shock was 11.7 ± 3.5. Sepsis 
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origin, with 23.8% other causes. Sepsis was mainly community-acquired 
(63.7%) and was documented in 67% (234/350), of which 53.4% were 
Gram-negative bacilli, 30.3% Gram-positive cocci and 16.3% others. 
Replacement techniques used were: invasive mechanical ventilation 
(82.6%), continuous dialysis (31.1%) and discontinuous dialysis (19.7%). 
Activated protein C was used in 17 patients (5%) and hydrocortisone 
hemisuccinate in 238 (68.6%). Mortality was 49.1% in intensive care, 
58.8% in-hospital.
Conclusions  Our fi   ndings raise hope of improved knowledge of 
epidemiology and management of septic shock in intensive care 
patients, and should have a benefi  cial eff  ect on prognosis.
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Introduction A hospital program named Sopravvivere alla Sepsi nel 
Policlinico di Modena (www.policlinico.mo.it) started in 2005 with the 
main objective to improve the survival rate of septic patients by means 
of continuous education and implementation of a sepsis operative 
protocol including the activation of a specifi   c consultation by an 
intensivist and an infectious disease specialist. The aim of this study 
was to evaluate the long-term eff  ects of this in-hospital program on 
compliance to treatments indicated by the evidence-based guidelines 
and on outcome in patients admitted to the ICU with septic shock (SS).
Methods In patients admitted with SS to a 10-bed ICU from January 
2005 to December 2009 we collected: age, type of admission (medical or 
surgical), site of infection, SAPS II, 30-day mortality and the application 
of fi  ve resuscitative (blood cultures before antibiotics, antibiotics within 
3 hours, source control, adequate fl  uid resuscitation, SvO2 optimization 
within 6 hours) and four management interventions (glycemia control, 
steroid use, rhAPC administration and plateau inspiratory pressure 
<30 cmH2O) as suggested by the surviving sepsis guidelines. Patients 
with end-stage liver disease, age <18 years and indications for end-of-
life treatment were excluded.
Results A total of 129 patients have been evaluated and the number of 
SS admissions increased from a mean value of 19 patients/year in the 
period 2005 to 2007 to a value of 36 patients/year in the past 2 years. 
Age, SAPS II and site of infection were similar throughout the analyzed 
period whereas the percentage of medical admission increased from 
33% to 42% in the past 2 years. Compliance to the fi  ve resuscitative 
interventions improved progressively from 24% in 2005 to 63% in 2007. 
Subsequently, they came back to values observed at the starting of the 
project (21% in 2008 and 25% in 2009). Similarly, the adherence to 
management interventions increased quickly after 2005 (from 14% to 
50% in 2006) but decreased to a mean value of 35% in the past 3 years. 
Immediately after 2005, the observed 30-day mortality rate became 
lower than that predicted by the SAPS II, but it slightly increased from 
31% in 2006 to 48% in 2009.
Conclusions The eff  ects of an in-hospital program devoted to severe 
sepsis and SS management allowed an increase of ICU admissions for 
sepsis, a better management and an improvement of patients’ survival 
rate. However, as expected, the adherence to guidelines gradually 
worsened with a slight increased in mortality rate in the past 2 years.
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Introduction  Healthcare-associated infection (HCAI) is a growing 
phenomena associated with the increase of the outpatient clinical 
Figure 1 (abstract P214). Microbiological profi  le according to the focus of infection.
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associated bloodstream infections, suggesting that they are diff  erent 
from nosocomial and community-acquired infections [1]. The authors 
extend this classifi  cation to other main focus of infection: respiratory, 
urinary and intra-abdominal.
Methods  A prospective cohort study (1  year), in fi   ve wards of a 
university hospital, including all consecutive adult patients that met 
the CDC defi  nition of infection. Only the fi  rst episode of infection was 
characterized. They were classifi  ed in community-acquired (CAI), HCAI 
(using Friedman’s classifi  cation [1]) and hospital-acquired (HAI), and 
data on the host and the infectious episode were collected.
Results See Figure 1. We included 1,035 patients: 493 (48%) with CAI, 
225 (22%) with HCAI and 317 (31%) with HAI.
Conclusions  Diff  erences were observed according to the type and 
focus of infection. These results reinforce the need for this classifi  cation 
and probably the need for specifi  c antibiotic therapy guidelines for this 
group of patients.
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Introduction  Traditionally infections are divided into community 
acquired (CAI) or hospital acquired (HAI). The authors study the 
association between healthcare-associated infections (HCAI) and 
inappropriate antibiotic therapy and hospital mortality.
Methods  A prospective cohort study (1  year), in fi   ve wards of a 
university hospital, including all consecutive adult patients that met 
the CDC defi  nition of infection. They were classifi  ed in: CAI, HCAI (using 
Friedman’s classifi  cation [1]) and HAI. A multivariable logistic regression 
was used with inappropriate antibiotic therapy as the dependent 
variable and sex, age, previous co-morbidities, type of infection (CAI, 
HCAI or HAI), severity of infection, SAPS II, total SOFA score, focus of 
infection, polymicrobial infection, previous antibiotic therapy, positive 
blood cultures, number of hospitalizations in the previous year and 
Karnovsky index as independent variables, and a similar model with 
also inappropriate antibiotic therapy and microbiological diagnosis 
with hospital mortality as the dependent variable.
Results We included 1,035 patients: 493 (48%) with CAI, 225 (22%) with 
HCAI and 317 (31%) with HAI. HCAI (adjusted OR = 1.905, 95% CI = 1.152 
to 3.152) was associated with inappropriate antibiotic therapy. The 
following variables were associated with hospital mortality: HAI 
(adjusted OR  =  2.095, 95% CI  =  1.275 to 3.441), cancer (adjusted 
OR = 2.768, 95% CI = 1.316 to 5.823), diabetes (adjusted OR = 0.420, 
95% CI = 0.228 to 0.775), Karnovsky index (adjusted OR = 0.968, 95% 
CI = 0.958 to 0.978), SAPS II (adjusted OR = 1.107, 95% CI = 1.085 to 
1.128) and inappropriate antibiotic therapy (adjusted OR = 1.663, 95% 
CI = 1.006 to 2.747). HCAI was not associated with increased hospital 
mortality (adjusted OR = 0.808, 95% CI = 0.449 to 1.453), although this 
group of patients had higher SAPS II (median = 30 vs. 28 in the other 
two groups, P = 0.002), no diff  erences were found regarding median 
SOFA score or severity of infection.
Conclusions HCAI was not associated with increased hospital mortality 
but it was associated with inappropriate antibiotic therapy, an 
independent prognostic factor. Doctors might not be suffi   ciently aware 
of this new group of patients. Locally driven information campaigns are 
needed.
Reference
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Introduction Our goal was to develop an antimicrobial stewardship 
program (ASP) and integrate it within a medical/surgical ICU clinical 
practice. During a 3-month pilot ASP, one pharmacist (Ph) provided 
clinical service and one antimicrobial (AM) stewardship pharmacist 
(ASPh) participated in the ICU ASP. Two ASP Phs worked routinely as 
designated ICU Phms. Post ASP implementation, the ICU Ph added AM 
stewardship to their role.
Methods From 1 April to 30 June 2010, a pilot ASP was implemented in 
a 490-bed urban community hospital ICU on weekdays. The pilot ASP 
goals were to optimize/reduce AM usage, improve clinical outcomes 
and reduce nosocomial C. diffi   cile infection rates [1]. The ASPh collected 
information on ICU patients receiving an AM on a standardized data 
collection tool. Identifi  ed patients were reviewed with the infectious 
disease (ID) physician, then the ASPh and ID physician met with the 
ICU care team to discuss ways to optimize AM use. After the pilot ASP, 
this process was reduced to 3 weekdays and conducted by the ICU Ph, 
eliminating the ASP Ph involvement. The same metrics used in the pilot 
program were collected for a 3-month follow-up period [2].
Results The pilot ASP resulted in a 47.7% reduction in AM cost from 
$58,544 (1 April to 30 Jun 2009) to $30,627 (1 April to 30 June 2010). 
The AM cost in the 3-month post-ASP period (1 July to 30 September 
2010) was $22,010. No new cases of nosocomial C. diffi   cile infections 
were identifi  ed during the pilot period. Based on an average of 1.4 
cases/1,000 patient-days, two cases were expected during the pilot 
duration. The post-pilot period observed 0.42 cases/1,000 patient-
days. The pilot ASP showed a 38.9% reduction of broad-spectrum anti-
pseudomonal AM usage as compared with the same time period of the 
previous year and a 28.5% reduction in the 3-month post-ASP period. 
No changes were noted in the Multiple Organ Dysfunction Score or 
mortality in the pilot and post-pilot groups as compared with the same 
time period of the previous year.
Conclusions  The ICU Ph developed the skills required through 
participation in the pilot ASP program and integrated it within their 
daily ICU practice. The post-ASP period showed sustained reductions in 
AM use, costs and nosocomial C. diffi   cile rates.
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Introduction Eff  ective timely antibiotic administration is associated 
with increased survival to discharge in patients with septic shock 
[1]. Time to antibiotic administration was the strongest predictor 
of outcome and is a key recommendation in sepsis management 
[2]. However, implementation faces barriers at clinician, patient and 
environmental levels [3].
Methods A retrospective review of antibiotic prescribing on a 30-bed 
university medical–surgical ICU. Data were extracted from the clinical 
informatics system (Intellivue Clinical Portfolio (ICIP) Philips). For a 
4-month period (baseline assessment September 2009 to January 
2010), patients initiated on new intravenous antibiotics were included. 
After baseline data review, the ICIP prescription order process was 
modifi   ed to automatically include STAT doses. A further 4-month 
period (post implementation) review followed.
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Median time to antibiotic administration was 127 minutes (IQR 29 to 
272). The proportion of antibiotics administered within 1 hour and 
3 hours was found to be 81/320 (25%) and 193/320 (60%), respectively. 
Analysis by antibiotic class revealed aminoglycosides and vancomycin 
had the lowest median time that in our unit are initiated as STAT 
doses, 86 minutes (IQR 43 to 195 minutes). Post modifi  cation of the 
ICIP prescription order process, 139 patients and 194 prescriptions 
were analysed. Median time to antibiotic administration improved 
to 79 minutes (IQR 43 to 159), P <0.0001. A greater proportion was 
administered within 1 hour (70/194, 37%) and 3 hours (153/194, 79%), 
P ≤0.001, for this cohort.
Conclusions  Barriers to timely administration of antibiotics exist, 
an intervention shown to signifi   cantly improve patient outcome. 
This study demonstrates modifi   cation of an electronic prescribing 
order process contributes to improved performance. However, a 
multifactorial problem may exist. It confi   rms clinical informatics 
systems play in improving the delivery of quality patient care in the ICU.
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Introduction  An audit of antibiotic dosing was conducted over 
the four critical care units at University Hospital Birmingham. The 
prescribed dose of four antibiotics (co-amoxiclav, meropenem, tazocin 
and ciprofl   oxacin) was audited against local prescribing guidance 
based on renal function and use of renal replacement therapy (RRT).
Methods The electronic prescribing system was interrogated for all 
prescriptions of the intravenous (i.v.) form of the antibiotics during 
2009. Antibiotic, dose and frequency, estimated glomerular fi  ltration 
rate (eGFR), prescriptions of diasylate solution (indicating RRT), and 
number of administrations were recorded. One-off   prescriptions and 
those without recent eGFR were discarded. A total of 2,472 records 
were included. Prescriptions were grouped by unit and antibiotic, then 
by renal function (normal, mild, moderate or severe impairment) or RRT, 
and by one of four categories (appropriate, underdosing, overdosing or 
incorrect regimen).
Results  Of the 2,472 prescriptions, 2,004 (81.1%) were correctly 
prescribed with regards to renal function and RRT. The total numbers 
of prescriptions per antibiotic are as follows: coamoxiclav (631 
prescriptions, of these 94.9% correct), ciprofl   oxacin (282, 98.9%), 
tazocin (696, 80.6%) and meropenem (863, 65.6%). On Unit 3, tazocin 
was underdosed in cases of normal renal function (15.2% of their ward’s 
prescriptions with regard to that antibiotic; median administrations 3, 
range 1 to 15), and during RRT (6.5%; 6, 0 to 29). On Unit 4, tazocin was 
underdosed during mild renal failure (7.0%; 9, 2 to 81) and during RRT 
(7.7%; 10, 3 to 30). Meropenem was overdosed during RRT on Unit 1 
(6.1%; 4, 0 to 30), Unit 3 (20%, 15, 1 to 38) and Unit 4 (13%; 15, 1 to 31), 
and underdosed during RRT on Unit 4 (17.9%; 7.5, 1 to 28).
Conclusions Tazocin was frequently underdosed in this critically ill 
population. It is possible that the minimum inhibitory concentration 
was not reached in some patients, with the associated risk of treatment 
failure [1,2]. Meropenem was underdosed on one unit; however, 
overdosing was more common. The clinical signifi   cance of this is 
equivocal as raised peak levels can be advantageous [3]. The electronic 
prescribing system currently lacks renal dosing decision support; 
this audit suggests a potential benefi  t to the integration of antibiotic 
prescribing guidelines.
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Introduction Appropriate and timely de-escalation of antimicrobial 
therapy has long been recognised as an important element in the 
optimal management of sepsis. When a causative pathogen has been 
isolated and its susceptibility profi  le known, the most suitable single 
therapy should be instituted to prevent the development of super-
infection with pathogenic or resistant organisms, as well as reduce 
toxicity and costs.
Methods  All blood cultures analysed on the BD BACTEC system 
were evaluated over a 6-week period (17 April 2010 to 30 May 2010). 
Organisms in positive blood cultures were then further identifi  ed by 
MALDI-TOF mass spectrometry (Brucker) and susceptibility testing 
was performed using the MicroScan WalkAway system (Siemens). 
The demographics, treatment regimens and clinical outcomes of all 
episodes of clinically signifi   cant Gram-negative bacteraemia were 
prospectively audited.
Results Two hundred and seventy sets of blood cultures were positive 
during our study period, representing 246 individual bacteraemic 
episodes. A total 143/270 were considered contaminants, 42/270 were 
signifi  cant Gram-positive bacteraemias, 1/270 Candida albicans, and 
84/270 Gram-negative bacteraemia. Of the latter, 70 were individual 
episodes, of which two died prior to susceptibility results being 
available. Of the survivors, following knowledge of the susceptibility 
profi  le, only 20.5% (14) were de-escalated to a narrower-spectrum 
agent and only 31% (21) were converted to suitable oral agents when 
practical. Twelve per cent (10) were treated with combination therapies 
even though single agents remained highly active. Of the group that 
failed to de-escalate antimicrobial therapy (54 patients), the 30-day 
mortality rate was 9% (5/54) versus 7% (1/14) in the group (14 patients) 
that adhered to the surviving sepsis guidelines. Likewise, the former 
group were more likely to develop diarrhoea, 38% (21/54) versus 21% 
(3/14), with three patients positive for Clostridium diffi   cile toxin in the 
former group (none in the latter). Multidrug-resistant organisms and 
fungal colonisation occurred more frequently in the fi  rst group – 38% 
(21/54) and 22% (12/54) versus 21% (3/14) and 0% (0/14), respectively.
Conclusions  Surviving sepsis guidelines have reiterated the need 
for timely use of appropriate empirical antimicrobials as well as the 
importance of de-escalation of therapy when the causative agent has 
been identifi  ed. However, as is the case in our study, this has not always 
been the prevailing practice. Many factors underlie this deviation from 
recommended guidelines, including worsening clinical condition, 
reported penicillin allergy as well as multiple co-morbidities.
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Introduction The aim was to assess the impact of empiric antibiotic 
adequacy on ICU outcome of patients with ventilator-associated 
pneumonia (VAP), the reasons for inadequacy and risk factors for 
potential multidrug-resistant organisms.
Methods During a 24-month period a multiple-centre observational 
study was conducted in fi  ve ICUs. Adult patients with documented 
VAP were segregated for analysis. Empiric antibiotic therapy was 
classifi   ed as adequate or inadequate according to in vitro effi   cacy 
against all isolated bacteria. The day of ICU discharge or death was 
recorded. Comparison between survivors and nonsurvivors was 
performed. Infection with potential multidrug-resistant organisms 
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Acinetobacter baumanii or Stenotrophomonas maltophilia) was 
evaluated for therapeutic inadequacy, ICU length of stay before 
diagnosis and previous use of antibiotics.
Results  One hundred and twenty-three patients with VAP (age 
62.7 ± 16.9 years, 65.9% men, and SAPS II 49.5 ± 15.5) were identifi  ed. 
Empiric antibiotic therapy was adequate in 65.9%. These patients’ 
ICU mortality was signifi  cantly lower in comparison with those with 
inadequate therapy (28.4% vs. 45.2%, P = 0.049). Patients infected with 
a potential multidrug-resistant organism were more likely to receive 
inadequate antibiotic therapy (80.1%, P  =  0.001), and to have had 
longer previous ICU stay (11.5 days vs. 7.2 days, P = 0.005), but there 
was no diff  erence in the previous use of antibiotics (65.2% vs. 50%, 
P = 0.102).
Conclusions An empiric adequate antibiotic therapy was associated 
with a lower mortality rate in VAP. Multidrug-resistant organisms were 
signifi  cantly associated with therapeutic inadequacy and longer ICU 
length of stay.
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Introduction Pneumonia remains one of the commonest infectious 
causes of intensive care unit (ITU) admissions. Despite recent advances, 
mortality in the ITU from this diagnosis remains around 50% [1]. Early 
targeted antibiotic therapy to minimise the development of ventilator-
associated pneumonia is recommended [2]. This requires an updated 
knowledge of aetiology of this common diagnosis in ITU settings.
Methods  We conducted a retrospective cohort study into 200 
consecutive admissions to our ITU with coded diagnosis of pneumonia. 
Baseline patient characteristics microbiological diagnosis, disease 
severity and mortality outcomes were studied.
Results The average patient age in this cohort was 58 years (range 
11 to 90 years). The male to female ratio was 1.35:1. All of the patients 
were admitted to ITU within 48  hours of their hospital admission, 
mainly due to worsening respiratory failure. Out of the total of 200 
cases, microbiological isolates were identifi  ed in 110 (55%). Eighty-fi  ve 
isolates were deemed likely to be pathogenic (42.5%) while 25 (12.5%) 
were likely to be the result of antibiotic use (candida and coliforms 
species in sputum). Gram-negative bacteria were responsible for 50.9% 
isolates. Streptococcus pneumoniae remained the single most common 
isolate (28/110; 25.4%). Pseudomonas species (23/110; 20.9%) and 
Haemophilus infl  uenzae (11/110; 10%) were the second and third most 
common isolates. Pseudomonas infection was more often associated 
with advanced age and existing lung pathology. Staphylococcus aureus 
was isolated in 8.1% (9/110) with one confi  rmed as methicillin resistant 
(MRSA). Atypical organisms (Legionella 2.7%, mycoplasma spp. 0.9%) 
and fastidious organisms (Stenotrophomonas maltophilia 2.7%) were 
also isolated. Other organisms isolated included enterobacter cloacae, 
Citrobacter koseri, Streptococcus Group A, Haemophilus parainfl  uenzae, 
Moraxella catarrhalis and Kleibsella species. Mortality amongst our 
patients was 28.5% (57/200). This was comparable with previously 
published fi  ndings.
Conclusions  Whilst the aetiology of pneumonia in our cohort is 
similar to that previously reported [3], the incidence of Gram-negative 
organisms is much higher. This, if reconfi  rmed, may have important 
implications in designing targeted antibiotic therapy for pneumonia in 
ITU settings.
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Introduction  During the spring of 2009, the infl   uenza A (H1N1) 
virus emerged, resulting in an estimated 12,000 deaths in the United 
States. We aimed to describe the critically ill patients with cancer who 
developed 2009 H1N1 in a comprehensive cancer center.
Methods We conducted an observational study of patients >17 years 
of age with confi  rmed infection from 1 June 2009 to 30 April 2010. 
Data collected included demographics, clinical characteristics and 
outcomes.
Results A total of 9/2,629 adult patients (0.3%) admitted to the ICU 
were diagnosed with 2009 H1N1 infl  uenza. Six patients were female, 
patient age ranged from 43 to 77 and all had hematological cancers. 
The ICU mortality rates were 16% for all-cause admissions and 78% for 
2009 H1N1cases. The most frequent co-morbidities were obesity and 
hypertension. Eight patients were diagnosed with bilateral pneumonia. 
The median hospital length of stay (LOS) was 28 days (range 9 to 45) 
and ICU LOS was 8 days (range 2 to 31). The ventilation course of 
the nonsurvivors was characterized by progressive hypoxemia. At 
admission, 67% of patients had a PaO2/FiO2 less than 200; at day 7, 71% 
of patients, and at day 14, 100% of patients. The nonsurvivors (seven 
patients) received respiratory care by a range of ventilation mechanisms: 
patients received non-invasive mechanical ventilation, were intubated, 
and then utilized one or a combination of bilevel, pressure control 
and pressure support ventilation. One patient used high-frequency 
ventilation. Invasive ventilation lasted a median of 7 days (range 4 to 
23). The survivors (two patients) received only supplemental oxygen. 
All patients were treated with antiviral medications and antibiotics. 
Four patients died from cardiac arrest and three patients died following 
life support therapy withdrawal. All nonsurvivors had DNR orders in 
place at death.
Conclusions At our center, the ICU mortality due to the 2009 H1N1 
infl   uenza was remarkably higher than that observed in patients 
with cancer without this infection. However, the number of patients 
developing the infection and requiring critical care was smaller than 
expected if considering we care for a population of patients with a high 
prevalence of immune suppression.
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Introduction Even though we found a small proportion of patients 
with severe H1N1 pneumonia developed multiple organ failure, 
hemodynamic characteristics are benefi  cial for optimizing treatment. 
We thus studied hemodynamics including echocardiographic fi  ndings 
in severe H1N1 infl  uenza pneumonia in a single center.
Methods  All hemodynamic data were collected from severe H1N1 
pneumonia patients admitted to the ICU during year 2009 to 2010. 
H1N1 infections were confi   rmed by the RT-PCR technique. These 
positive results were obtained from respiratory tract specimens.
Results We enrolled 18 severe pneumonia patients in this study. The 
mean arterial pressure was 82.62  ±  13.01  mmHg. Thirteen patients 
were measured for cardiac output (CO) by thermodilution method 
whereas the remaining cases were measured by echocardiogram. 
The average CO in the all patients was 5.81 ± 2.49 l/minute. The mean 
pulmonary artery pressure was 28.77 ± 7.83 mmHg. The central venous 
pressure and pulmonary capillary wedge pressure (PCWP) were 
12.2 ± 3.56 and 15.46 ± 5.22 mmHg, respectively. The SVRI and PVRI 
were 1,448 ± 457.10 and 293 ± 168.13 dynes•second/cm5/m2. The CO 
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vs. 3.86 ± 0.69, P = 0.002). The PCWP in ARDS patients was 16.08 ± 4.93 
that was higher than in the non-ARDS group (11.82 ± 1.01), but no 
statistical signifi  cance was demonstrated. The ejection fraction (EF) 
was measured in 14 patients. The average EF was 59.79 ± 12.87%. There 
was only one patient having EF less than 30%. There was no statistic 
signifi  cance found in the EF between the ARDS and non-ARDS groups. 
The E/a ratio and E/E’ were 1.29 ± 0.49 and 8.67 ± 2.25, respectively.
Conclusions The novel infl  uenza A (H1N1) severe pneumonia resulted 
in high CO in the ARDS group. The PCWP in these patients was also 
higher than that in non-ARDS patients. Due to almost all patients 
having good left ventricular contraction, the etiology of higher PCWP 
in ARDS patients might result from some degree of high-output cardiac 
dysfunction. Thus diuretics may have an important role to improve 
impaired gas exchange in these patients caused by this severe viral 
pneumonia with ARDS.
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Introduction Gram-positive aerobes are currently the leading cause 
of infection in many ICUs. Despite this trend, there are still no fi  rm 
recommendations for empiric Gram-positive antimicrobial coverage 
in patients with severe nosocomial infections. The current study is an 
extension of our previous work in this fi  eld, aiming to challenge some 
of the earlier trends and to bring out new clues.
Methods A prospective observational study was conducted including 
all episodes of documented nosocomial infection in a general ICU for a 
4-year period (2006 to 2009). Data on demographics, primary diagnosis, 
co-morbidity, number of indwelling devices, previous microbial isolates 
and current antibiotics were cross-tabulated according to the presence 
and type of Gram-positive pathogens. For the identifi  ed most likely risk 
factors, separate contingency tables were constructed and analyzed.
Results  A total of 339 patients with Gram-positive isolates were 
identifi  ed (51.21% of 662). Gram-positive isolates were more prevalent 
in patients with obesity (1.27; CI = 1.08 to 1.47) and diabetes (1.28; 
CI = 1.03 to 1.53). The following independent risk factors for Gram-
positive nosocomial infections (RR and 95% CI) were identifi  ed: MRSE-
gunshot wound (4.18; 2.35 to 5.19), stab wound (4.01; 2.03 to 4.59), 
polytrauma (1.91; 1.47 to 2.46), previous isolation of both Acinetobacter 
spp. and Pseudomonas or Candida spp. (2.01; 1.38 to 2.72 and 2.72; 
1.71 to 4.21), treatment with aminoglycoside or carbapenem (2.52; 
1.59 to 3.42 and 1.37; 1.03 to 1.80); Enterococcus – billiary peritonitis 
(2.23; 1.27 to 3.73), acute necrotizing pancreatitis (2.23; 1.27 to 3.73), 
traumatic lesion of urinary bladder with cystostomy (6.68; 3.26 to 9.65), 
previous isolation of both Klebsiella and Candida spp. (6.02; 1.85 to 
9.40), treatment with cefoperazone + sulbactam or third-generation 
cephalosporin (3.49; 2.18 to 5.34 and 1.87; 1.17 to 2.92); MRSA – clinical 
uroinfection (5.27; 1.74 to 13.52), previous isolation of both Acinetobacter 
and Pseudomonas spp. (4.21; 1.79 to 9.42); MSSE – treatment with fi  rst/
second/third-generation cephalosporin  ±  metronidazole (5.88; 1.84 
to 17.16 and 4.65; 1.71 to 12.18); Streptococcus – pelvic infl  ammatory 
disease (5.10; 1.35 to 15.75), soft tissue infection (8.32; 2.73 to 45.36), 
treatment with quinolones (3.45; 1.34 to 8.54).
Conclusions New light was shed on the identifi  cation of associated risk 
factors for Gram-positive nosocomial infections in our ICU. Suffi   cient 
data were gathered to aid empirical antibiotic choice in such high-risk 
patients.
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Introduction  Nosocomial infections in critically ill patients are 
increasing and they are often due to multidrug-resistant Gram-negative 
bacilli (GNB). Emerging resistance in common nosocomial pathogens is 
usually related to local antibiotic use. Gentamicin is the fi  rst-line empiric 
antibiotic for hospital-acquired infections in St Thomas’ Hospital ICUs. 
No decontamination therapy for GNBs is employed, but rectal and nose 
swabs are routinely taken from patients on admission to screen for 
resistance in GNB. This informs the choice of antimicrobial therapy in 
the event of nosocomial infection during the patient’s stay. We describe 
antibiotic resistance rates in GNB isolates at admission in critically ill 
adult patients over 8 years.
Methods  An 8-year retrospective observational cohort study using 
prospectively collected data in a 30-bed referral ICU. Patients: The 
cohort inclusion criterion was defi  ned as patients admitted to the ICUs 
at St Thomas’ Hospital and remaining in the ICU for more than 24 hours. 
In addition, the cohort inclusion was restricted to the fi  rst admission 
from each patient over the 8-year period where the length of stay was 
greater than 24 hours and the admission screen had been conducted 
within the fi   rst 2 days of admission. GNB screening: In patients 
admitted to the ICU, rectal and nose swabs were sent at admission for 
microbiological evaluation antibiotic resistance in GNB.
Results  Of the 8,095 ICU admissions, 4,753 patients satisfi  ed  the 
inclusion criteria. The case-mix characteristics and outcome did not 
show any statistically signifi  cant diff  erence during the study period. 
Overall, the number of patients presenting with gentamicin-resistant 
GNBs on admission has remained stable, although time trends depend 
on the bacterial genus considered (9.3% in 2002 to 8.4% in 2009). 
Hospital-associated (ICU admission >48  hours following hospital 
admission) gentamicin resistance in GNB has fallen (14.8% in 2002 to 
8.3% in 2009). Patients with a positive admission screen are more likely 
to have the same resistant genus isolated from a nosocomial infection 
during the same admission spell, as compared with those negative on 
admission.
Conclusions Screening for GNB resistance guides empiric antibiotic 
therapy.
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Risk factors to bloodstream infection due multidrug-resistant 
Acinetobacter baumanni in colonized patients in the ICU
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Introduction  Epidemic outbreaks caused by multidrug-resistant 
Acinetobacter spp. (MDR Aspp) in ICUs have emerged in recent years. 
The incidence of MDR Aspp bacteremia, which develops as a result of 
colonization, is increasing through widespread dissemination of the 
pathogen and may cause severe clinical disease that is associated with 
a high mortality. The aim of the study was to evaluate risk factors for 
MDR Aspp bacteremia in patients colonized with MDR Aspp in the ICU.
Methods  We conducted a prospective, observational study of all 
patients colonized with MDR Aspp in the ICU between January 
2007 and December 2010. Screening for MDR Aspp (using axillary, 
oropharynx and rectal swabs) was performed weekly. Only the fi  rst 
bacteremia was considered.
Results Of the 185 patients colonized with MDR AB, 74 developed MDR 
Aspp bacteremia. APACHE II and SOFA scores were higher in bacteremic 
than nonbacteremic patients at the time of ICU admission (22 vs. 16; 
P = 0.015, 16 vs. 9; P <0.001, respectively). There was no diff  erence 
between the two groups in the duration of time from ICU admission 
to colonization (8.2 vs. 7.8 days; P  =  0.923). In univariate analysis, 
advanced age, admission for clinical reason, use of broad-spectrum 
antibiotic agents, total parenteral nutrition, having a central venous 
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and acute renal failure requiring dialysis were signifi  cant risk factors 
for bacteremia (all P <0.05). In multivariate analysis, the number of 
recent invasive procedures (OR, 4.17; 95% CI, 1.6 to 11.1; P = 0.001) and 
previous administration of carbapenem (OR, 2.07; 95% CI, 1.47 to 2.91; 
P = 0.036) were independently associated with MDR Aspp bacteremia.
Conclusions Our results suggest that the nosocomial occurrence of 
MDRAspp bacteremia in colonized patients is strongly related to the 
number of invasive procedures and may be favored by the selection 
pressure of previous carbapenem administration.
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Blood cultures at central line insertion: a comparison with 
peripheral venipuncture
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Introduction The objective was to compare contamination rates of 
blood cultures obtained at central line (CVC) insertion with cultures 
obtained at peripheral venipuncture or arterial line (AL) insertion. 
Contamination of blood cultures adds to cost, length of hospital stay, 
and unnecessary antibiotic administration. As most contaminants come 
from patients’ skin, obtaining blood cultures after skin disinfection and 
under strict sterile precautions during CVC insertion might reduce 
contamination rates.
Methods A retrospective analysis of all blood cultures taken in the 
general and medical ICUs of a tertiary academic hospital over 8 years. 
Positive blood cultures were categorized as growing contaminants 
(Bacillus species, Corynebacterium species, Propionibacterium species, 
non-pneumococcal α-hemolytic Streptococci, and single-culture 
isolates of coagulase-negative Staphylococci), or true pathogens (all 
other results). Results of CVC insertion cultures were compared with 
peripheral venipuncture and AL insertion cultures.
Results A total of 17,384 blood cultures including 3,389 (19.5%) CVC, 
1,844 (10.6%) AL and 12,151 (69.9%) peripheral cultures were analyzed. 
CVC insertion cultures were contaminated more frequently than AL or 
peripheral cultures (455/3,389 (13.4%) CVC, 103/1,844 (5.6%) AL, and 
755/12,151 (6.2%) peripheral cultures, P <0.001 CVC vs. peripheral and 
CVC vs. AL). However, true pathogens were found more frequently 
in CVC insertion cultures (445/3,389 (13.1%) CVC, 192/1,844 (10.4%) 
AL and 1,112/12,151 (9.2%) peripheral cultures, P  <0.001 CVC vs. 
peripheral and CVC vs. AL). The contamination and true positive rates 
for each source were almost identical in each ICU. Although there was a 
general decrease in culture contaminants over 8 years, the proportion 
of contaminants in CVCs remained approximately double that found in 
peripheral cultures at all time points.
Conclusions  In complete contrast to the expected fi  ndings,  and 
despite superior sterile precautions, cultures taken at CVC insertion 
had a higher contamination rate than either peripheral or AL blood 
cultures. These data were consistent in two completely independent 
ICUs and in cultures obtained over 8 years. The higher contamination 
rate may be related to the increased skin and soft tissue manipulations 
performed during CVC insertion. The higher true positive rate in CVC 
insertion cultures may indicate that these cultures retain utility.
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Higher incidence of catheter-related bloodstream infection in 
femoral venous access than in subclavian venous access in the 
presence of tracheostomy
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Introduction  A higher incidence of catheter-related bloodstream 
infection (CRBSI) in femoral than in subclavian catheter sites has 
been found [1,2]. Diff  erent guidelines for the prevention of CRBSI 
recommend avoiding femoral venous access sites [3,4]. However, the 
incidence of CRBSI in subclavian sites in the presence of tracheostomy 
is higher than without tracheostomy [5,6]. In addition, the incidence of 
CRBSI in jugular sites with tracheostomy is higher than in femoral sites 
[7]. Currently, there are no comparative data on the incidence of CRBSI 
between the femoral venous and the subclavian venous catheter site 
in the presence of tracheostomy and there are no recommendations in 
the guidelines relating to this circumstance; and this was the objective 
of the present study.
Methods A prospective observational 6-year study was carried out in 
the ICU of the University Hospital of the Canary Islands (Tenerife, Spain). 
We included all patients undergoing insertion of subclavian venous 
catheter in the presence of tracheostomy (subclavian-CVC+tracheo) or 
femoral venous catheter (femoral-CVC).
Results  We diagnosed 26 CRBSI in 313 femoral-CVC during 2,565 
days (10.1 CRBSI episodes/1,000 catheter-days) and fi  ve CRBSI in 147 
subclavian-CVC+tracheo during 1,268 days (3.9 CRBSI episodes/1,000 
catheter-days). Subclavian-CVC+tracheo showed a lower incidence of 
CRBSI than femoral-CVC (OR = 0.39; 95% CI = 0.001 to 0.91; P = 0.03). 
Survival analysis showed that subclavian-CVC+tracheo had greater 
CRBSI-free time than femoral-CVC (chi-square = 4.69; P = 0.03).
Conclusions  Subclavian-CVC+tracheo could be considered a safer 
venous access site than femoral-CVC to minimize the risk of CRBSI.
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Introduction  Internal and external anti-infective coating of central 
venous catheters (CVCs) may reduce the rate of catheter colonization 
(CC) and bloodstream infection (BSI) [1]. Our objective was to evaluate 
the effi   cacy of a protective nonleaching polyhexanide coating on the 
rate of CC and BSI in ICU settings.
Methods A prospective, randomized, controlled, double-blind clinical 
trial was performed on multidisciplinary ICUs of two university hospitals 
in the Czech Republic between 2005 and 2010. A total of 680 patients 
were randomized to receive either coated CVC (Certofi  x® protect; B. 
Figure 1 (abstract P229).
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AG). Primary objectives were the diff  erence of the incidence of both 
CC and BSI between groups. Catheter colonization was defi  ned as the 
growth of >1,000 colony-forming units using the sonication method.
Results  A total of 674 catheters were evaluated among which 58 
catheters were excluded due to short indwelling time <3 days (an 
exclusion criterion). The two groups were similar with respect for the 
insertion site, place of insertion (ICU or surgical theatre), indwelling 
time, ICU stay and demographic indices. The coated CVC displayed 
similar incidence of CC as the standard CVCs (17.36% vs. 18.67%, 
P = 0.747) as well as incidence of catheter-related BSI (1.33% vs. 1.94%, 
P = 0.752). The rate of BSI was signifi  cantly lower in protected CVCs 
(2.00% vs. 6.47%, P = 0.008), and the incidence of BSI/1,000 catheter-
days was lower in coated catheters (3.21 vs. 8.30, P = 0.036) as well 
(Figure 1).
Conclusions  Our results suggest that the use of external/internal 
polyhexanide-coated CVCs is associated with signifi  cant reduction of 
BSI but not with the reduction of colonization rate.
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Introduction Central venous catheterization is routine in critical care, 
but a potential source of harm. Forty-two per cent of bloodstream 
infections in England are central-line related [1], at a substantial cost 
to the health service. Early catheter removal is vital for source control 
where catheter-related bloodstream infection (CRBSI) is suspected. 
Furthermore, a model encompassing daily review and removal of 
unnecessary catheters has been shown to reduce the risk [2]. We 
studied the time from decision to removal of existing central venous 
catheters (CVCs), and evaluated potential reasons for delay.
Methods This is a retrospective review of practice at a 43-bed medical/
surgical ICU at a London teaching hospital, using computerized patient 
records. All patients requiring a change of CVC over a 2-month period 
in 2010 were included. Change of CVC was defi  ned as the time from 
decision to removal of the old CVC, incorporating new CVC insertion. 
Sepsis was defi  ned as rising infl  ammatory markers, an impression of 
local/systemic infection, or emergency (unsterile) insertion. Routine 
was defi   ned as no signs of infection, usually at 5 to 7 days or if 
accidentally dislodged/blocked.
Results Seventy-eight CVC changes were performed, 45 (57.7%) for 
sepsis and 33 (42.3%) as routine. The median time to change a septic 
CVC was 742.5 minutes (106 to 2,038 minutes). The median time for a 
routine change was 611 minutes (130 to 1,759 minutes). On average, 
70% of the time taken to change a CVC involved new catheter 
insertion. Where the tip position was confi  rmed with a chest X-ray 
scan, it took a median of 182 minutes longer (–97 to 946 minutes) to 
change the CVC. Check X-ray review was documented in 28 (45.1%) of 
62 internal jugular/subclavian CVCs and only fi  ve X-ray scans resulted 
in repositioning. Where inotropes/vasopressors were administered, 
it took a median of 209 minutes longer (106 to 599 minutes) for CVC 
change. Where coagulation products were administered, it took a 
median of 168.5 minutes longer (209 to 279 minutes) for CVC change.
Conclusions Our data suggest that in our unit the duration of catheter 
change in the critically ill is a prolonged process, and took longer where 
potential harm is greatest. Check X-ray scans infrequently result in CVC 
repositioning, contribute to delays and could be performed after old-
CVC removal. We plan to audit the changes we have made, and believe 
that the timely exchange of old CVCs should be incorporated into 
models aiming to reduce the impact of CRBSI.
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Introduction  Clostridium diffi   cile-associated diarrhoea (CDAD) is 
associated with a mortality of up to 25% in susceptible patients. It 
occurs following long-term hospitalisation and prolonged antibiotic 
usage, particularly cephalosporins. Neurointensive care unit (NICU) 
patients on average have higher bed days, greater incidence of 
ventilator-associated pneumonia (VAP) and higher antibiotic use. We 
aimed to study the aetiology, acquisition rate and outcome of NICU-
acquired CDAD.
Methods  Intensive care admission and hospital infection control 
databases from April 2008 to August 2010 were studied and the case 
notes reviewed retrospectively. Patients who acquired CDAD within 
48 hours of NICU admission were excluded. Diarrhoea was classifi  ed as 
mild, moderate or severe based on frequency and volume. Information 
on use of antibiotics, frequency, duration and type was gathered. 
Admission diagnosis, days of NICU stay and incidence of complications 
were noted.
Results Of the 2,212 patients with a total of 10,825 bed-days, nine 
patients developed CDAD. The mean NICU stay was 26 (11 to 103) days. 
The median duration between ICU admission and development of 
CDAD was 11 (3 to 93) days (7 in other neurocritical care units). Median 
age of the patients was 55 (20 to 72) years. Patients had a mean 6.7 (±5.2) 
days of diarrhoea prior to a positive assay. At the time of diagnosis, four 
(44%) patients had moderate disease. Three patients had a perceived 
delay in discharge from the ICU (1 to 8 days) due to their infective 
status. Concurrent infections occurred in 77% of patients, 33% of 
which were VAP. Of the antibiotics used prior to CDAD diagnosis, 44% 
were cephalosporins. There were no major complications or mortality 
attributed to CDAD. Identifi   ed risk factors for ICU-acquired CDAD 
included age >65 (22%), antibiotics (67%), laxatives (100%), steroids 
(33%), proton pump inhibitors (88%) and medical device requirement 
(100%). All patients were emergency admissions, of which eight were 
neurosurgical. The one patient who had the most protracted disease 
was isolated with C. diffi   cile ribotype 027.
Conclusions  In spite of a patient population who is at high risk of 
CDAD, the rate of infection in our unit is 8.3 per 10,000 bed-days or 0.4% 
incidence, which is below the average incidence for general intensive 
care (10.6 per 10,000 bed-days) and neurocritical care units (0.6%) in 
the UK. This may be attributed to the presence of an effi   cient infection 
control team, isolation practices with patients immediately being 
isolated to barrier nursing and a protocol for CDAD detection as well as a 
high degree of awareness amongst the medical and nursing staff  .
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Introduction  Vancomycin minimum inhibitory concentration 
(MIC) creep has been observed in studies from western countries. 
Staphylococcus aureus strains with increased MIC to vancomycin are 
associated with worse outcomes compared with more susceptible 
strains. Recognition of this phenomenon – the development of reduced 
susceptibility to vancomycin, and the subsequent glycopeptide MIC 
creep – is important, since it may be a precursor to heterogeneous 
vancomycin intermediate S. aureus (hVISA) and VISA.
Methods In a study carried out in a tertiary care hospital in India, 176 
clinically signifi   cant Gram-positive bacterial isolates were collected 
from January 2009 to October 2009. MICs were determined for vanco-
mycin, teicoplanin, linezolid, daptomycin and cefoxitin (to screen for 
methicillin-resistant S. aureus) using the E strips.
Results Out of 176 isolates, 72 were MSSA, 16 MRSA, 68 Enterococcus 
spp. and 20 coagulase-negative staphylococcus. No VISA or VRSA was 
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values of MRSA and MSSA were 1.5 and 1, respectively. The MIC90 values 
of MRSA and MSSA were 2 and 1.5, respectively. A total 80.5% of MSSA 
isolates have MIC of vancomycin ≥1. Enterococcus spp. had MIC50 of 1 
and MIC90 of 3, whereas coagulase-negative staphylococci had MIC50 of 
1 and MIC90 of 2. MIC90 of all the isolates for teicoplanin was between 2 
to 3, for linezolid 1.5 to 3 and for daptomucin 0.50 to 0.75.
Conclusions A signifi  cant creep in the vancomycin MIC for S. aureus 
has occurred in an Indian hospital, which is of important concern as it 
may lead to treatment failure with vancomycin.
References
1. Wang  G,  et al.: J Clin Microbiol 2006, 44:3883-3886.
2. Chang  FY,  et al.: Medicine (Baltimore) 2003, 82:333-339.
P233
Prognostic impact of imported and newly-isolated methicillin-
resistant Staphylococcus aureus in the ICU
S Ohshimo, K Ota, T Tamura, Y Kida, J Itai, K Suzuki, T Inagawa, Y Torikoshi, 
T Otani, T Sadamori, R Tsumura, Y Iwasaki, N Hirohashi, K Tanigawa
Hiroshima University, Hiroshima, Japan
Critical Care 2011, 15(Suppl 1):P233 (doi: 10.1186/cc9653)
Introduction Methicillin-resistant Staphylococcus aureus (MRSA) is a 
leading pathogen of hospital-acquired pneumonia. The diff  erence in 
outcome between patients with imported and newly-isolated MRSA 
in the ICU has not been well investigated. The aim of our study was 
to explore the incidence, risk factors and outcome in patients with 
imported and newly-isolated MRSA.
Methods  Patients admitted to the ICU in our university between 
April 2009 and May 2010 were prospectively studied. Nasal swabs 
were collected from all patients on admission and subsequently 
collected weekly during the ICU stay. When patients were intubated, 
intratracheal aspirates were concurrently collected. The correlations of 
positive culture of MRSA with clinical variables were analyzed.
Results  A total of 1,270 consecutive patients were enrolled. The 
median follow-up period was 404 days (range, 187 to 609). There 
were 803 males and 467 females. Median age was 63 (range, 1 to 
97). Of these, imported MRSA was found in 124 (10%) patients, and 
newly-isolated MRSA in 57 (4%) patients. The incidence of imported 
MRSA was associated with the co-morbidity of cardiovascular disease 
or malignancy and long hospital stay before admission to the ICU, 
whereas the incidence of newly-isolated MRSA was associated with 
the positive culture in intratracheal aspirates or blood/intravenous 
catheter, the co-morbidity of shock, pneumonia, neurological diseases 
or trauma, increased number of isolated sites, higher APACHE II score, 
prolonged ICU stay and higher mortality during ICU stay. Although no 
statistical signifi  cance was found in total patients, the subset analysis 
of the male patients demonstrated that the outcome of newly-isolated 
patients was signifi   cantly poor compared with those of imported 
MRSA (P = 0.005). Multivariate analysis revealed that the new isolation 
of MRSA in the ICU (P = 0.03; hazard ratio (HR), 2.62), negative culture 
of MRSA in nasal swab (P = 0.02; HR, 4.18), ≥2 isolated sites (P = 0.01; 
HR, 4.59) and co-morbidity of ARDS (P = 0.002; HR, 4.63) were the 
independent poor prognostic factors.
Conclusions New isolation of MRSA during the ICU stay was associated 
with poor outcome particularly in male patients compared with 
imported MRSA. Clinicians should be aware of the high-risk group of 
MRSA infection. Strict hand hygiene plus a careful assessment of the 
patient, applying aggressive procedures such as patient isolation, staff   
cohorting, and active surveillance cultures should be indicated.
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Introduction Controversy continues regarding whether methicillin 
resis  tance increases mortality risk in Staphylococcus aureus infections. 
We assessed the role of methicillin resistance on survival of patients in 
the EPIC II study cohort with S. aureus infection.
Methods The EPIC II point-prevalence study of infection in critically ill 
patients was performed on 8 May, 2007. Demographic, physiological, 
bacteriological and therapeutic data were collected for all adult patients 
in 1,265 participating ICUs from 75 countries on the study day. ICU 
and hospital outcomes were recorded. We com  pared characteristics 
of patients with methicillin-sensitive (MSSA) and methicillin-resistant 
(MRSA)  S. aureus infection. Co-morbidities, age, simpli  fi  ed  acute 
physiology system (SAPS) II score, site of infection, geographical region, 
and MRSA/MSSA were entered into a multivariable model and adjusted 
odds ratios (ORs) (95% CI) were calculated for ICU and hospital mortality 
rates. 
Results On the study day, 7,087 of the 13,796 patients (51%) were 
classifi  ed as infected. There were 494 patients with MRSA and 505 
patients with MSSA infections. There were no signifi  cant diff  erences 
between the two groups in use of mechanical ventilation or 
hemofi   ltration/hemodialysis. Cancer and chronic renal failure were 
more prevalent in MRSA than in MSSA patients. ICU mortality rates 
were 29.1% and 20.5%, respectively (P  <0.01) and corresponding 
hospital mortality rates were 36.4% and 27.0% (P <0.01). Multivariable 
analysis of hospital mortality for MRSA infection showed an adjusted 
OR of 1.48 (1.05 to 2.10), P = 0.03.
Conclusion In ICU patients, MRSA infection is more common in 
patients with co-morbid conditions, such as cancer and chronic renal 
failure, and is independently associated with an almost 50% higher 
odds of hospital death compared with MSSA infection.
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Introduction Intraventricular therapy (IVT) with polymyxin B (PolyB), 
an antibiotic with similar pharmacological action to colistin (PolyE), 
by external ventricular derivation (EVD) has the main goal of off  ering 
major bioavailability of the drug, since its use by intravenous and direct 
action are restricted by the blood–brain barrier, with penetration of 
only 25%. Pseudomonas aeruginosa is a Gram-negative bacterium, 
multidrug resistant, which has a characteristic of secreting exotoxin A. 
Along with Acinetobacter baumannii, it has expressed a great risk to the 
lives of patients with meningoencephalitis. The patient of the present 
report had arterial venous malformations followed by hemorrhagic 
stroke, which caused elevated intracranial pressure. The objective 
is to show an example of the eff  ect of IVT PolyB in a patient with 
meningoencephalitis infection by multidrug-resistant Gram-negative 
bacteria (A. baumannii and P. aeruginosa), common in the ICU.
Methods A literature review was made on the subject of therapy with 
PolyB about the pharmacological characteristics, nephrotoxicity and 
neurotoxicity. A comparative table of the profi  le of resistance of the 
strain treated in this study was created, with the intrinsic resistance 
of the species. Also, the development of liquor evolution (culture 
and routine) of the patient before the treatment was monitored, until 
negative liquor. We analyzed the life and eff  ectiveness of EVD, the 
colonizer germ and monitoring of the serial aspect of the liquor.
Results  The patient was treated with intravenous and intrathecal 
administration of PolyB (IVT) between 14 November and 28 November 
2008. On 14 November 2008, therapy was started with PolyB 
intravenous administration of 1,500,000 UI (20,000 UI/kg/day) once a 
day, on every day of treatment, and IVT by EVD: 50,000 UI in solution 
once a day during the fi  rst 3 days, and on alternate days for all of the 
treatment. As a result of the use of intrathecal PolyB intravenously, 
eff  ectiveness was proven in the routines of liquor negative for such 
germs, showing no reports of neurotoxicity and nephrotoxicity.
Conclusions IVT PolyB proved to be very effi   cient, treating this meningo-
encephalitis quickly. No toxic eff  ect was associated with the drug.
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Introduction Tigecycline, the fi  rst drug in a new class of antibiotics, 
the glycylcyclines, is used in the treatment of severe abdominal and 
connective tissue infections. Tetracyclines, having a structure–activity 
relationship with tigecycline, exert anti-infl  ammatory eff  ects [1]. Some 
laboratory studies suggest that tigecycline may have anti-infl  ammatory 
properties in sepsis, but this has not previously been explored in a large 
animal integrative intensive care model.
Methods  Eighteen piglets weighting 25.0  ±  2.2 (mean  ±  SD) were 
randomized to receive tigecycline 100  mg, doxycycline 200  mg or 
placebo and subjected to 6 hours of endotoxin infusion of 2 μg/kg/hour. 
We measured infl  ammatory, hemodynamic and respiratory variables.
Results TNFα was lower in the doxycycline group compared with the 
tigecycline and placebo groups during the experiment 0 to 6 hours 
(P <0.05). The mean arterial pressure decline from baseline was greater 
during the experiment in the placebo group compared with the 
tigecycline group 0 to 6 hours (P <0.05), but not the doxycycline group.
Conclusions Doxycycline demonstrated anti-infl  ammatory properties. 
Tigecycline counteracted emerging circulatory deterioration without 
aff  ecting the proinfl  ammatory cytokine response in this model.
Reference
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Introduction  Blood transfusions are associated with infectious 
complications. Despite this, only a few studies link the use of blood 
transfusions with the development of fungal infections. This study was 
performed to assess risk factors associated with Candida colonization 
and infection.
Methods A retrospective study including all patients admitted to the 
ICU due to severe abdominal sepsis or severe pancreatitis between 
July 2005 and July 2010. Factors analyzed were: shock, insulin use, 
number of surgeries, mechanical ventilation, days of central catheters, 
treatment with corticosteroids, parenteral nutrition, red blood cell 
transfusions, and use of antibiotics. Risk factors for Candida colonization 
and infection were identifi  ed by multivariate logistic regression.
Results We analyzed 86 patients with severe abdominal sepsis and 
severe pancreatitis. Mean age 62 ± 16, SAPS II 47 ± 25, 70% required 
invasive ventilation, and 61% presented shock. Twenty patients (23%) 
were colonized by Candida. Independent risk factors for Candida 
colonization were the use of parenteral nutrition (OR, 3.6; 95% CI, 1.0 
to 12.6; P = 0.03) and transfusion of at least 4 volumes of red blood cells 
(OR, 12.8; 95% CI, 2.0 to 79; P = 0.006). Seven patients (8%) had invasive 
candidiasis. Independent risk factors associated with this infection 
were: prior colonization by at least two sites (OR, 10.6; 95% CI, 1.8 to 61; 
P = 0.008), and transfusion of at least 4 volumes of red blood cells (OR, 
9.7; 95% CI, 1.6 to 59; P = 0.01). Mortality in the Candida infection group 
was 71% versus 53% in non-infected nor colonized patients (P = 0.3).
Conclusions  Candida infection is always preceded by colonization. 
The need for antifungal treatment should be based on the degree of 
colonization. Restrictive transfusional strategies should be established 
in these patients to reduce invasive Candida infections.
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Introduction  To evaluate diff   erences in ICU patients with proven 
invasive candidiasis (Proven-IC), possible invasive candidiasis (Possible-
IC), probable Candida colonization (colonized), and non-infected, 
noncolonized (non-infected) patients.
Methods  EPIC II recruited 1,265 ICUs in 76 countries. Patient 
characteristics were collected on the study day. Outcome data were 
assessed at ICU and hospital discharge. Patients infected or colonized 
with non-Candida pathogens were excluded from this analysis. Patients 
with positive candida cultures may have had concurrent bacterial 
infections or colonization (*P <0.05 compared with the non-infected 
group). Numerical values are reported as mean ± SD and length of stay 
(LOS) data as median (IQ).
Results A total of 13,796 adult patients were in a participating ICU on 
the study day. Of these, 110 had Proven-IC, 278 had Possible-IC, and 371 
were colonized. In total, 6,507 patients were non-infected. Diff  erences 
in patient characteristics and outcomes (Table 1) are reported.
Table 1 (abstract P238)
 Proven-IC  Possible-IC  Colonized  Non-infected
 ( n = 110) (n = 278)   (n = 371) (n = 6,509)
SAPS II mean (SD)*  58 (14)  41 (15)  40 (16)  31 (14)
Mechanical ventilation (n, %)*  77 (71%)  204 (73%)  255 (70%)  2,822 (44%)
Vaspressors (n, %)*  37 (34%)  87 (31%)  129 (35%)  1,251 (19%)
ICU mortality (n, %)*  45 (42%)  93 (34%)  102 (29%)  649 (11%)
ICU LOS median (IQ)*  33 (18,52)  30 (16,52)  23 (11,41)  4 (1,4)
Conclusions ICU patients with proven invasive candidiasis, possible 
invasive candidiasis and candida colonization were more acutely ill and 
undergoing more ICU interventions than non-infected patients. The 
ICU mortality and LOS were also greater.
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Introduction This is the fi  rst national multicenter epidemiology study 
of invasive candida infections (ICIs) within ICUs in China. The objectives 
included describing the epidemiology, patient characteristics and 
management of these ICIs.
Methods The study used a prospective observational design. A total of 
68 ICUs in China participated. The study was initiated on 1 November 
2009 and will close on 30 April 2011. During the study period all 
consecutive patients above 18  years diagnosed as proven ICI after 
being admitted into the ICUs were eligible for enrollment. For each 
episode of ICI, demographic data, underlying diseases, severity of 
illness, risk factors, diagnosis, reported pathogen of fungal infection, 
process of treatment and survival at discharge were recorded. A total 
of 203 ICI cases were identifi  ed by the end of October 2010; since CRF 
collection and data management for part of the cases are ongoing, 
here we report the interim analysis results of 145 proven ICIs.
Results  Among 145 eligible ICI patients, 134 (92.4%) had isolated 
candidemia, two (1.4%) had invasive candidiasis with candidemia, and 
Critical Care 2011, Volume 15 Suppl 1 
http://ccforum.com/supplements/15/S1
S83nine (6.2%) had invasive candidiasis without documented candidemia. 
The median time ICI occurred was 9 days after ICU admission. The mean 
APACHE II was 26.6 at ICU admission (SD 7.2). The frequency of risk 
factors within 2 weeks before ICI were 107 patients (73.8%) with central 
venous catheterization, 117 (80.7%) with antibiotic therapy >5 days, 112 
(77.2%) with invasive mechanical ventilation and 62 (42.8%) with total 
parenteral nutrition. The case fatality ratio of ICI in the ICU was 34.5% 
(50/145). A total of 156 isolates were collected, C. albicans accounted 
for 48.1% (75/156) of the isolates, followed by C. parapsilosis (14.1%), 
C. tropicalis (14.1%) and C. glabrata (9.6%). Seventy-fi  ve patients were 
reported with C. albicans infection (51.7%), among them fi  ve patients 
were reported as co-infected with other candida. Forty-three patients 
(29.7%) received initial antifungal therapy before or on the day of fi  rst 
positive sample drawn, 81 patients (55.9%) initiated therapy after the 
ICI diagnosis was proven. Initial treatment was mainly based on the 
use of a single antifungal agent (98.4%), and the treatment protocol 
was modifi  ed in 64 patients (44%) due to identifi  cation of causative 
Candida species, susceptibility reports or other reasons.
Conclusions In China more than 90% of ICIs in the ICU were diagnosed 
by candidemia. Non-albicans Candida species accounted for one-
half of the Candida isolates. Mortality of ICIs in the ICU remains high; 
however, targeted therapy accounted for more than 50% of initial 
antifungal therapy.
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Introduction  A recent study found anidulafungin (ANI) safe and 
eff   ective for candidemia/invasive candidiasis (C/IC) in selected 
populations of ICU patients [1]. A post hoc analysis of this study was 
performed to evaluate the effi   cacy of ANI in the same populations, but 
in non-neutropenic C/IC patients only.
Methods A prospective, open label, multinational, phase 3b study in 
adult ICU patients (APACHE II score <25) with ≥1 of the following: post-
abdominal surgery; age ≥65 years; renal/hepatic insuffi   ciency; solid 
organ transplant; neutropenia; and/or solid tumor. C/IC was confi  rmed 
from 96 hours before to 48 hours after the start of study treatment. 
Patients received i.v. ANI (200 mg on day 1, 100 mg/day thereafter) 
for ≥10 days, with optional oral azole step-down therapy, for a total 
treatment duration of 14 to 56 days. Primary effi   cacy endpoint was 
global response at end of all therapy (EOT) in the evaluable modifi  ed 
intent-to-treat (eMITT) population; that is, excluding patients with 
missing/unknown responses. For the present analysis, all patients with 
neutropenia were excluded.
Results  The total MITT population (that is, confi  rmed C/IC and ≥1 
dose of ANI) included 170 patients, 157 (92.4%) of whom were non-
neutropenic. In these patients at baseline, 69.4% had candidemia, 
mean APACHE II score was 16.3 (range 4 to 26) and mean SOFA score 7.4 
(range 0 to 20). In non-neutropenic eMITT patients, global response at 
EOT was 71.1% (95% CI = 62.9, 78.4). At the end of i.v. therapy, 2 weeks 
post-EOT and 6 weeks post-EOT the global response was 72.4%, 61.2% 
and 52.0%, respectively. When missing/unknown responses were 
included and classed as failures, global success was 64.3% at EOT. The 
90-day Kaplan–Meier survival estimate was 55.0% (95% CI = 47.2, 62.9). 
Among all non-neutropenic patients with ≥1 dose of ANI, treatment-
related (due to ANI and/or azole) AEs and serious AEs occurred in 
29/201 (14.4%) and 3/201 (1.5%) of patients, respectively. The most 
common treatment-related AE was erythema in four patients (2.0%). 
Other treatment-related AEs occurred in ≤1.5% of non-neutropenic 
patients.
Conclusions ANI was eff  ective and safe for the treatment of C/IC in 
selected populations of non-neutropenic ICU patients.
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Introduction Micafungin (MCFG), an echinocandin antifungal agent, 
exhibits more potent antifungal activity against a broad spectrum of 
clinically important Candida and Aspergillus species [1]. However, there 
are few pharmacokinetic data of antifungal agents for burned patients, 
and determination of the dosage for these populations requiring 
initially a large quantity of fl  uid therapy can trouble burn surgeons and 
intensivists. The purpose of this study is to obtain the pharmacokinetic 
data for MCFG in severe burned patients.
Methods In six patients with severe burn injuries within 14 days after 
injuries (19 to 82 years old, 36 to 85% TBSA), we measured the plasma 
concentration of MCFG by high-performance liquid chromatography 
[2] after drip infusion of MCFG, at 200 to 300 mg/day over a 1-hour 
period. Blood samples were collected at the end of the initial 
administration of MCFG (peak value after initial administration; A 
point), immediately before the second dosing (trough value after initial 
administration; B), at the end of the fourth dosing (steady-state peak 
value; C), and immediately before the fi  fth dosing (steady-state trough 
value; D). The control value of plasma concentration of MCFG assumed 
the pharmacokinetics value obtained from healthy volunteers.
Results The plasma concentration of MCFG at the A point were 10.1 
to 24.2 μg/ml, 1.8 to 6.1 μg/ml at B, 11.3 to 27.9 μg/ml at C, and 2.3 
to 7.9 μg/ml at D. In both peak and trough values there was a good 
correlation between the plasma concentration of MCFG and the dose 
of MCFG per kilogram body weight the same as cases of healthy 
volunteers (Figure 1).
Conclusions These results suggest that MCFG can be administered 
safely to burned patients without adjusting the dose.
References
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Figure 1 (abstract P241). Correlation between the plasma concentration 
of MCFG and the dose of MCFG (mg/kg).
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Introduction Invasive aspergillosis (IA) is documented in up to 15% 
of critically ill hematology patients admitted for acute respiratory 
failure. The disease is believed to be mostly deadly. Because diagnostic, 
preventive and therapeutic strategies for IA have changed over the 
past decade, we sought to appraise outcomes in hematology patients 
receiving mechanical ventilation for IA.
Methods  Determinants of hospital mortality were identifi  ed  in 
hematology patients admitted to the ICU for acute respiratory failure 
from proven or probable IA.
Results  Fifty-nine patients received mechanical ventilation for IA 
over the 10-year study period. Thirty-six (62%) were neutropenic, 19 
(32%) were receiving long-term steroids, and 13 (22%) were recipients 
of allogeneic BMT. Diagnosis was based on clinical and radiographic 
features, associated with either Aspergillus isolation (48 patients, 
including 25 bronchial aspiration, 17 BAL, six BAL + bronchial aspiration) 
or circulating galactomanan alone (11 patients). In 33 patients positive 
galactomanan was associated with Aspergillus isolation. Five cases were 
proven on autopsy. Associated bacterial infection was documented 
in 21 (35.6%) patients. Antifungal therapy included conventional 
amphotericin (50%), voriconazole (49%), liposomal amphotericin 
(32%), or caspofungin (19%). Seventeen (28.8%) patients had two lines 
of therapy and nine patients received a combination of voriconazole 
and caspofungin. Hospital mortality was 73% overall, 85% in patients 
with associated bacterial infection, and 44% in patients treated with 
voriconazole. Associated bacterial infection was independently 
associated with increased mortality (OR = 5.91 (1.04 to 33.5)), whereas 
the use of voriconazole (OR = 0.19 (0.04 to 0.91)) and localized disease 
(OR = 0.12 (0.03 to 0.59)) were associated with lower mortality.
Conclusions  The use of mechanical ventilation in patients with IA 
complicating HM is associated with a high, yet not constant, mortality 
of 73%. Early management at a time where the disease is localized, as 
well as the use of voriconazole, translate into survival benefi  ts.
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Introduction  Diff  erent animal in vitro studies have concluded that 
lipopolysaccharide (LPS) can alter electrophysiological properties 
of ionic currents in cardiac myocytes. There is only one study in the 
literature that found reduced activation of the pacemaker funny 
current (IF), encoded by the hyperpolarization-activated cyclic 
nucleotide modulated-4 (HCN4) gene family, in human atrial cells after 
administration of LPS.
Methods  Twenty human embryonic kidney (HEK) 293 cells were 
transfected with Toll-like receptors-4 (TLR4), CD14 and HCN4 cDNAs 
and after 24 hours were incubated with 1 μg/ml (10 cells) or 10 μg/ml 
(10 cells) of LPS (from Escherichia Coli; Sigma, St Louis, USA). In addition, 
50 pM soluble MD-2 protein was added to the culture medium for 
enhancing the responsiveness of TLR4 to LPS. Twenty-four hours after 
LPS addition, electrophysiological recordings were performed at 36°C 
with the whole-cell patch clamp technique, using an Axopatch 200B 
amplifi  er (Molecular Devices, Sunnyvale, CA, USA). IF current properties 
were measured during 6-second hyperpolarizing steps (range –30 to 
–120 mV), from a holding potential of –30 mV. Voltage control, data 
acquisition and analysis were accomplished using custom software.
Results Incubation of cells with both 1 and 10 μg/ml LPS was found to 
signifi  cantly impair IF related to controls, by suppressing the current 
at membrane potentials between –60 and –90 mV and slowing down 
current activation. Funny current in LPS-treated cells showed more 
negative half-maximum activation voltage (V1/2) values and slope 
factor (k), derived from voltage-dependent activation curves after 
Boltzmann fi  tting to experimental data (1 μg/ml: V1/2 = –80 ± 3.7 mV and 
k = –14.9 ± 3.4 mV, 10 μg/ml: –96 ± 4.5 and –31.2 ± 6.7, respectively), 
than the control cells (V1/2 = –75 ± 2.8, k = 9.7 ± 2.3, P <0.001 for all 
comparisons). IF current densities between –60 and –90 mV were 
signifi  cantly higher in untreated cells (0.67 ± 0.5 pA/pF) than in 1 and 
10 μg/ml incubated LPS cells (0.43 ± 0.3 and 0.09 ± 0.05, respectively, 
P <0.001 for all comparisons).
Conclusions In conclusion, this study showed in HEK 293 cells a negative 
impact of LPS upon activation properties of the pacemaker IF current, 
confi  rming fi  ndings from previous studies on human atrial cells.
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Introduction  Immunoglobulin molecules have opposing functions 
by inducing proinfl   ammatory and anti-infl   ammatory responses in 
innate immune eff  ector cells. In the setting of acute infl  ammation, 
Toll-like receptors sense the presence of microbial components 
within minutes. TLR signalling in monocytes and macrophages leads 
to the production of numerous proinfl   ammatory cytokines which 
accumulate in the activation of both the innate and adaptive immune 
system. It is well established that repeated endotoxin stimulation 
triggers immunological hyporesponsiveness of the monocytic lineage, 
which is demonstrated by a reduced capacity to produce TNFα upon 
LPS stimulation. In an in vitro model we investigated the impact of 
immunoglobulins on activation of mononuclear cells obtained from 
healthy probands and from patients suff  ering Gram-negative sepsis.
Methods Whole blood (n = 5) and PBMCs (n = 5) from healthy volunteers 
as well as whole blood from patients in the early (n = 8) and in the late 
(n = 8) phase of sepsis were treated with an immunoglobulin-enriched 
solution containing IgG, IgA, and IgM (IgGAM). Cells were challenged 
with various concentrations of LPS in a second-hit model and TNFα 
secretion was measured by ELISA. In addition, monocyte HLA-DR, CD64 
and CD11b expression as well as phagocytosis and oxidative burst 
were analysed by fl  ow cytometry. Proliferation and cytokine release of 
ConA and/or IL-2 stimulated lymphocytes were undertaken.
Results  In healthy donors upon two-time LPS stimulation IgGAM 
incubation resulted in a signifi   cant decrease of TNFα secretion 
administration in a time-dependent and dose-dependent manner. 
Similar eff  ects were observed in whole blood from patients in the early 
phase of sepsis. HLA-DR, CD11b and CD64 expression from monocytes 
of healthy probands declined signifi  cantly after LPS expression, which 
was not observed in septic patients. Interestingly in both groups the 
administration of IgGAM had no eff  ects on phagocytosis and oxidative 
burst. Lymphocyte proliferation and cytokine release were signifi  cantly 
impaired in both groups.
Conclusions  The immunoglobulin-enriched solution possesses a 
distinct immune modulatory eff  ect in vitro on monocytes/monocyte-
derived macrophages and lymphocytes from both septic patients and 
healthy volunteers, especially upon short-term LPS exposure and in the 
early phase of sepsis.
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Introduction  Endothelial injury and dysfunction are key patho-
physiological processes in sepsis. The aim of the study was to evaluate 
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of rat primary cardiac microvascular endothelial cells (CMEC).
Methods CMEC were isolated from adult (250 to 300 g) male Wistar 
rats and cultured. Cells were exposed to LPS (1 μg/ml) for 4, 8, 16 hours 
and cellular respiration was measured by high-resolution respirometry 
(Oxygraph-2k; Oroboros Instruments, Innsbruck, Austria). Activation 
of caspase-3 protein as an early apoptotic event was examined by 
western blot analysis. Electron microscopy was performed to reveal any 
alterations in mitochondrial morphology.
Results After 4 and 8 hours of LPS incubation (1 μg/ml) no signifi  cant 
changes in CMEC mitochondrial respiration was observed. However, 
cells treated with LPS for 16 hours exhibited a signifi  cant reduction 
in the maximal complex I-dependent (control: 146  ±  45 pmol/
(second*million cells) vs. LPS: 127 ± 38 pmol/(second*million cells)) 
and IV-dependent (control:148  ±  89 pmol/(second*million cells) vs. 
LPS: 108 ± 80 pmol/(second*million cells)) mitochondrial respiration 
(n = 16) (Figure 1). Relatively little, if any, processing of procaspase-3 to 
active caspase-3 was detected in untreated cells or in cells treated with 
LPS (1 μg/ml, 16 hours of incubation) (data not shown), and electron 
microscopy examination revealed no major alterations in cellular and 
mitochondrial ultrastucture under LPS treatment (Figure 2). Statistical 
analysis for cellular respiration was performed using a paired t test.
Conclusions The data suggest that prolonged exposure to LPS impairs 
CMEC complex I-dependent and IV-dependent respiration slightly but 
signifi  cantly, without apparent signs of apoptosis or mitochondrial 
ultrastructural damage.
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Introduction The current gold standard animal model for sepsis is CLP 
[1]; however, this model does not allow segregation of the immune 
responses to infection from those due to surgical incision/trauma. We 
hypothesised that surgical incision of the peritoneal wall in mice would 
be a potent stimulus for the recruitment of monocytes, particularly 
the infl  ammatory Gr-1Hi subset [2], to the peritoneal space where 
they would be capable of mounting a proinfl  ammatory response to 
subsequent septic challenges.
Methods Sterile laparotomy (incision of peritoneum of ~1 cm) was 
performed on C57B6 mice under isofl  urane anaesthesia and closed in 
two layers. Control groups were skin incision only, or i.p. injection of 
20 ng LPS. At least three mice per group were euthanised at intervals 
up to 48 hours and lavage samples were obtained. For determination 
of monocyte responses in situ, fi  ve mice received an i.p. injection of LPS 
(20 ng) 24 hours post-surgery. Monocyte subset numbers and their 
expression of the proinfl  ammatory cytokine, TNF, were quantifi  ed by 
fl  ow cytometry.
Results In laparotomised mice, migration of Gr-1Hi subset monocytes 
became evident in lavage fl  uid at 8 hours, with numbers peaking at 
16 hours (7.27 ± 3.25 x 105). Numbers of the Gr-1Lo subset counterpart 
did not increase until 16 hours but remained high until 48 hours. The 
peak numbers of both subsets in peritoneal lavage were considerably 
higher than those observed after i.p. LPS (Gr-1Hi 2.45 ± 1.11 x 105 
and Gr-1Lo 2.69 ± 0.54 x 105). By contrast, skin incision alone did not 
induce detectable monocyte migration. In response to secondary i.p. 
LPS challenge, these monocytes recruited by laparotomy responded 
vigorously, expressing high levels of cell-associated TNF that did not 
diff  er signifi  cantly between subsets (Gr-1Hi MFI: 146.1; Gr-1Lo MFI: 93.6).
Conclusions Monocytes were recruited to the peritoneum in large 
numbers and for a prolonged period by abdominal surgical incision. 
The early appearance of the Gr-1Hi followed by Gr-1Lo subset 
monocytes may represent a delayed kinetic of the latter or the in situ 
maturation of Gr-1Hi to Gr-1Lo monocytes. In view of the numbers 
recruited and their substantial response to a septic stimulus, monocyte 
infi  ltration to the peritoneum could represent a signifi  cant risk factor 
for the development of local and systemic infl  ammatory conditions 
following abdominal surgery.
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Introduction  Accumulating data suggest a protective eff  ect  of 
obesity in the case of severe infections. Higher baseline levels of the 
proinfl  ammatory cytokine TNFα as well as more pronounced TNFα 
release following whole blood stimulation with endotoxin are reported 
in patients with a higher body mass index (BMI). This more pronounced 
proinfl  ammatory response in obese patients may enable a rapid and 
more eff  ective clearance of microbial pathogens. The eff  ect of the 
body mass index on the innate immune response in vivo has not been 
assessed.
Figure 1 (abstract P245). Cardiac microvascular endothelial cells’ oxygen consumption.
Figure 2 (abstract P245). CMEC cells under control and LPS treatment 
conditions.
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were included in several experimental endotoxemia studies were 
analyzed. Endotoxemia was induced by the administration of 2 ng/kg 
Escherichia coli lipopolysaccharide. Concentrations of TNFα and IL-10 
were serially determined (Luminex assay). Areas under the curve of 
cytokine levels were calculated and analyzed with unpaired t tests. All 
data are expressed as mean ± SEM of n subjects.
Results All subjects showed increased production of both proinfl  am-
matory cytokine TNFα and anti-infl  ammatory cytokine IL-10 (Figure 1). 
The area under the curve of TNFα levels was related to the BMI (Figure 
2) as subjects with BMI >24 kg/m2 released more TNFα than those with 
BMI <21 kg/m2 (P = 0.04). An opposite trend of IL-10 levels was observed 
in association with higher BMI (P = 0.12). The quotient of TNFα/IL-10 
AUC levels, serving as a readout of the pro/anti-infl  ammatory balance 
of a subject, showed a more proinfl  ammatory response in subjects with 
a higher BMI compared with those with a lower BMI (P = 0.03) (Figure 2).
Conclusions This study is the fi  rst to demonstrate that a higher BMI is 
associated with a shift in the pro/anti-infl  ammatory balance towards 
a more pronounced proinfl  ammatory immune response in humans in 
vivo.
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Introduction The clinical relevance of preclinical sepsis research has 
been questioned [1]. This may in part be the result of varying degrees 
of experimental infl  ammatory insults. The objective of this study was 
to quantify infl  ammation based on plasma TNFα levels after exposure 
to two diff  erent bacterial loads, and after diff  erent lengths of bacterial 
incubation in the peritoneal cavity.
Methods We retrospectively evaluated plasma TNFα concentrations 
measured before and 24 hours after fecal peritonitis induced by 1 g/
kg autologous feces (16 anesthetized pigs, median weight: 40.0 kg) 
and after 6, 12 and 24 hours of fecal peritonitis induced with 2 g/kg 
autologous feces (24 anesthetized pigs (n = 8/group); median weight: 
41.0 kg). All animals were resuscitated with fl  uids,  norepinephrine 
and antibiotics, and were mechanically ventilated according to 
standardized protocols. Diff  erences along time after fecal peritonitis 
induced with 2 g/kg feces were assessed by ANOVA for repeated 
measures. Comparison between the two models (1 g/kg vs. 2 g/kg) 
after 24 hours of peritonitis was performed with an independent t test.
Results TNFα increased from baseline to 6, 12 and 24 hours of peritonitis 
induced with 2 g/kg feces (P  <0.001 for time–group interaction) 
(Figure  1). The mean (± SD) plasma TNFα levels measured 24 hours 
after fecal peritonitis induced with 1 and 2 g/kg were 255 ± 178 pg/ml 
and 233 ± 124, respectively (P = 0.75; 95% CI for the diff  erence: –124 to 
169 pg/ml).
Figure 1 (abstract P247). Eff  ects of 2 ng/kg Escherichia coli endotoxin 
(LPS) (administered at 0 hours) in subjects with BMI <21 and BMI >24 kg/
m2 on the production of TNFα and IL-10. Data expressed as mean ± SEM.
Figure 2 (abstract P247). AUC of TNFα and IL-10 and the TNFα/IL-10 ratio 
in subjects with BMI <21, BMI 21 to 24 and BMI >24 kg/m2. Data expressed 
as mean ± SEM.
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TNFα concentrations was associated with the duration of bacterial 
incubation in the peritoneal cavity but not with the amount of bacterial 
load. This has implications for the interpretation of experimental sepsis 
fi  ndings.
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Introduction The role of apoptosis of leukocytes for the fi  nal outcome 
of necrotizing pancreatitis remains to be elucidated.
Methods  Experimental pancreatitis was induced in rabbits after 
ligation of the common pancreatic duct. Animals were assigned into 
sham-operated (group A, n = 8) infused 0.3 ml of ethanol 99% above 
the ligation; into nine infused 0.3 ml of one 10% solution of taurocholic 
acid above the ligation (group B, n = 9); and into 10 infused 0.3 ml of one 
20% solution of taurocholic acid above the ligation (group C, n = 10). 
Blood was sampled at serial time intervals; apoptosis of lymphocytes, 
monocytes and neutrophils was assessed after staining for annexin V 
and for propidium iodine and fl  ow cytometric analysis. On death or 
on sacrifi  ce the pancreas was removed. Fat necrosis was assessed by 
histology; quantitative tissue cultures were done.
Results Median survival of group A was 28 days; of group B was 5 days 
(log-rank vs. group A: 4.155, P = 0.042); and of group C was 1.5 days 
(log-rank vs. group A: 10.356, P = 0.001). Mean percentage pancreatic 
necrosis of groups A, B and C was 2.5, 45.0 and 42.0%, respectively. 
Respective mean log10 of bacteria in the liver was 1.00, 3.13 and 
2.48 cfu/g; in the lung 1.26, 2.90 and 2.56 cfu/g; in the spleen 1.00, 
3.72 and 2.37 cfu/g; and in the right kidney 1.00, 2.88 and 2.85 cfu/g. 
Respective median apoptosis of lymphocytes within the fi  rst 24 hours 
from induction of pancreatitis was 22.58, 23.45 and 24.19% (P = NS) 
whereas respective median apoptosis of monocytes was 41.02, 43.66 
and 47.92% (P = NS) and of neutrophils was 76.84, 79.49 and 83.94% 
(P = 0.034).
Conclusions Survival in experimental necrotizing pancreatitis depends 
on the density of taurocholate. In spite of the existence of marginal 
diff   erences in apoptosis of neutrophils occurring early during the 
course of the disease, it seems that apoptosis is not a major driver to 
death; instead, bacterial translocation seems to be the main route to 
death.
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Introduction IFNγ is a promising immunomodulator in sepsis because 
it is thought it may reverse immunoparalysis and improve phagocytosis. 
Its eff  ect was investigated in experimental pyelonephritis and sepsis.
Methods Experimental pyelonephritis by Escherichia coli was induced 
in 18 rabbits after ligation of the right pelvo-ureteral junction and 
infusion of one 1 x 107 log-phase cfu/ml inoculum above the ligation. 
Animals were assigned into 10 controls (group A) and into eight 
administered intravenously 0.1 μg/kg IFNγ 30 minutes after bacterial 
challenge (group B). Blood was sampled at serial time intervals; 
quantitative cultures were done; apoptosis of lymphocytes and of 
monocytes was assessed by fl  ow cytometry; malondialdehyde (MDA) 
was estimated by the thiobarbiturate assay and passage through an 
HPLC system. After death, quantitative tissue cultures were done.
Results Median survival of group A was 3 days and of group B was 18 
days (log-rank: 4.858, P = 0.028). Mean log10 of bacteria in blood for 
groups A and B at 2 hours was 1.59 and 1.21 (P = NS); at 4 hours 1.61 and 
1.97 (P = NS); at 24 hours 1.28 and 1.02; and at 48 hours 1.29 and 1.00 
(P = NS). Respective rates of apoptosis of lymphocytes at 2 hours were 
17.1 and 22.2% (P = NS); at 4 hours 17.9 and 24.0% (P = NS); at 24 hours 
18.3 and 21.9% (P = NS); and at 48 hours 20.5 and 22.8% (P = NS). 
Respective rates of apoptosis of monocytes at 2 hours were 32.8 and 
36.0% (P = NS); at 4 hours 42.8 and 39.3% (P = NS); at 24 hours 54.5 and 
62.1% (P = NS); and at 48 hours 52.5 and 64.3% (P = 0.042). Respective 
median serum MDA of groups A and B were 1.05 and 2.06 μmol/ml at 
baseline (P = NS); 0.93 and 2.54 μmol/ml at 2 hours (p: 0.028); 2.30 and 
1.02 μmol/ml at 4 hours (P = NS); 1.47 and 2.05 μmol/ml at 24 hours 
(P = NS); and 1.71 and 1.85 μmol/ml at 48 hours (P = NS). Mean log10 of 
bacterial growth in the liver of group A and of group B on sacrifi  ce was 
3.47 and 1.32, respectively (P = 0.043); and in the right kidney was 5.78 
and 1.94, respectively (P = 0.004).
Conclusions IFNγ prolongs survival when administered after induction 
of experimental pyelonephritis by E. coli. Its eff  ect is mediated through: 
enhanced phagocytosis as evidenced by increase of oxidant stress and 
decrease of tissue bacterial load; and modulation of infl  ammation as 
evidenced by increase of apoptosis of monocytes.
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Introduction  Thrombin and activated protein C (aPC) are two 
pleiotropic proteases whose opposing functions in hemostasis and 
endothelial function are dysregulated during sepsis. Exogenous 
supplementation of aPC, the ligand for endothelial protein C receptor 
(EPCR), is the only known therapeutic shown to reduce mortality in 
severe septic patients. Paradoxically, both thrombin and aPC signal 
the endothelium via the same receptor, protease-activated receptor-1 
(PAR-1), by cleaving its N-terminus to produce an identical tethered 
ligand, yet result in opposing signaling networks. Once activated, 
PAR-1 triggers at least three separate signaling pathways (Gi, Gq, G13) 
and it is the relative contribution of each pathway that determines 
the endothelial response. Thrombin is a potent proinfl  ammatory, 
endothelial barrier disruptive agonist, while aPC induces an anti-
infl   ammatory and barrier protective phenotype, thought to be 
important to its therapeutic mechanism. We hypothesized that when 
bound to its ligand, aPC, EPCR functionally dimerizes with activated 
PAR-1, thereby altering its specifi  city for Gq, an important mediator of 
proinfl  ammatory pathways in endothelial cells.
Figure 1 (abstract P248). Mean (95% CI) TNFα levels.
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dynamically monitor the interaction of recombinant PAR-1 and EPCR 
in HEK cells. The eff  ect of EPCR on PAR-1 G-protein selectivity was 
determined by EPCR siRNA knock down in cultured endothelial cells. 
Relative activation of Gq was determined by assaying agonist-induced 
intracellular calcium mobilization. G13 activation was determined 
by monitoring agonist-induced changes transendothelial electrical 
resistance across monolayers.
Results We found that in the absence of protease ligands, unactivated 
PAR-1 dimerizes with EPCR. However, proteolytically activated PAR-1/
EPCR interaction was maintained with aPC but not thrombin. Both aPC 
and thrombin induced G13 signaling; however, aPC failed to activate 
Gq compared with thrombin. aPC-induced PAR-1/Gq signaling appears 
to be impaired by aPC-bound EPCR and is relieved when EPCR is 
depleted using siRNA.
Conclusions  aPC-bound EPCR neutralizes the proinfl  ammatory 
function of PAR-1 signaling by maintaining interaction with activated 
PAR-1, thereby abrogating Gq signaling. Thus it is not the diff  erence 
in protease activation between thrombin and aPC, but rather the 
ability of aPC to direct PAR-1/EPCR dimerization that controls PAR-1 
signaling, and thereby provides the therapeutic barrier protective/anti-
infl  ammatory eff  ects associated with aPC treatment.
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Introduction The activation of poly-ADP-ribose-polymerase enzyme 
(PARP) plays an important role in the pathophysiology of sepsis [1]. 
In previous animal models, lipopolysaccharide-induced systemic 
infl  ammatory response was signifi  cantly reduced by the inhibition of 
PARP [2]. The aim of our study was to investigate the eff  ect of PARP 
inhibition on systemic infl  ammation in a septic animal model.
Methods In a prospective, randomized study, anaesthetized CFY rats 
were divided into four groups (fi  ve/group): cecal ligation group (CL), 
cecal ligation and punction group (CLP), CLP with PARP inhibition 
(CLP+Pi) group and sham group. PARP inhibition was performed by 
HO-3089 (a novel PARP inhibitor) given intraperitoneally (10 mg/kg). 
Heart rate, invasive blood pressure and the rectal temperature were 
monitored. Data were recorded every 15 minutes. To identify the 
infl  ammatory response, IL-6 and TNFα were measured by quantitative 
sandwich enzyme immunoassay technique. Blood samples were taken 
before the CLP (t0), 2 hours (t1) and 6 hours (t2) after the CLP.
Results IL-6 and TNFα were signifi  cantly higher in the CLP and CLP+Pi 
groups at t2 as compared with t0 (CLP: PIL-6 <0.001, PTNFα <0.001; CLP+Pi: 
PIL-6 = 0.002, PTNFα <0.001), and also as compared with the CL and sham 
groups at t2 (CL vs. CLP: PIL-6 <0.001, PTNFα = 0.002; CL vs. CLP+Pi: PIL-
6 = 0.008, PTNFα = 0.002; sham vs. CLP: pIL-6 <0.001, PTNFα = 0.002; sham vs. 
CLP+Pi: PIL-6 = 0.011, PTNFα = 0.002). Although in the CLP+Pi group the 
IL-6 level was lower than in the CLP group at t2, but the diff  erence was 
not signifi  cant (P = 0.074). There was no signifi  cant diff  erence in TNFα 
between the CLP and CLP+Pi groups either.
Conclusions  The initial results of this study could not show a 
signifi  cant eff  ect of the HO-3089 PARP inhibitor in CLP caused systemic 
infl  ammatory response. However, the tendency of lower IL-6 in the 
treated group warrants the completion of the experiment.
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Introduction Modulation of infl  ammatory mediators with specifi  c or 
selective adsorbents may represent a promising supportive therapy for 
septic patients. The aims of this study were to compare the infl  uence of 
specifi  c or selective polymeric adsorbents on endothelial cell activation 
and to test various adsorbents for binding of high mobility group box 1 
(HMGB1), a late mediator in sepsis.
Methods  Human umbilical vein endothelial cells (HUVEC) were 
activated with a conditioned medium that was obtained by stimulation 
of monocytic THP-1 cells with 10 ng/ml lipopolysaccharide from 
Pseudomonas aeruginosa [1]. Mediator modulation was performed 
with either a specifi  c adsorbent for TNFα, which is based on sepharose 
particles functionalized with anti-TNFα antibodies, or a selective 
albumin-coated polystyrene divinylbenzene copolymer (PS-DVB). 
Endo  thelial cell activation was monitored for up to 15  hours by 
measuring secretion of IL-6 and IL-8, as well as surface expression of the 
adhesion molecules ICAM-1 and E-selectin. In addition, PS-DVB beads 
and cellulose sulphate beads were screened for the binding of HMGB1.
Results Adsorption of infl  ammatory mediators from the conditioned 
medium either with the specifi  c TNFα adsorbent or with the selective 
PS-DVB beads resulted in decreased endothelial cell activation, as 
shown by statistically signifi  cant reduction of IL-6 and IL-8 secretion 
from HUVEC, as well as statistically signifi  cant reduction of surface 
expression of the adhesion molecules ICAM-1 and E-selectin. In the 
screening experiments, both PS-DVB beads and cellulose sulphate 
exhibited strong adsorption of HMGB1. Studies to test the eff  ect of 
HMGB1 removal on endothelial activation in the cell culture model are 
underway.
Conclusions  Infl   ammatory mediator modulation with specifi  c  or 
selective adsorbents reduces endothelial cell activation and thus may 
support the development of new therapies for sepsis. Hydrophobic PS-
DVB resins as well as cellulose sulphate exhibit strong adsorption of 
HMGB1, a late mediator of sepsis.
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Introduction Acute pancreatitis (AP) is a complicated immunological 
response that leads to multiple organ failure. Apoptosis is a benefi  cial 
form of cell death in AP. Acute lung injury is the most severe 
complication. Honokiol (HK) is a component of Asian herbal teas. It 
displays an anti-infl  ammatory and apoptotic induction eff  ect. In the 
experiments, we investigated the therapeutic effi   cacy of HK in AP.
Methods Adult BALB/c mice were divided into one control and fi  ve AP 
groups. Mice received six injections of cerulein at 1-hour intervals then 
on intraperitoneal injection (i.p.) of LPS for the induction of AP. Mice 
in the other groups had injections of cerulein and LPS as described 
above, but also received an i.p. of the diff  erent doses of HK 10 minutes 
after the fi  rst cerulein injection. Cytokine levels for the early and late 
infl  ammatory markers were obtained at 3 hours and 24 hours after the 
end of experiments.
Results HK protected against the severity of AP in serum amylase/
lipase, TNFα, IL-6, HMGB1, and pancreas and lung pathological injury 
(Figure 1A). Acinar cell apoptosis was increased in the pancreas. 
Treatment with HK caused markedly increased acinar cell apoptosis 
(Figure 1B).
Conclusions  HK attenuates the severity of AP and lung injury by 
acceleration of acinar cell apoptosis.
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Introduction  The endocannabinoid system (ECS) is upregulated 
during sepsis [1]. However, the functional outcomes of modulating 
endocannabinoid signaling during sepsis are currently unclear. 
Impairment of the intestinal microcirculation during sepsis may cause a 
breakdown of gut epithelial barrier function and bacterial translocation 
into the systemic circulation, increasing the systemic infl  ammatory 
response [2]. The aim of the present study was to examine the eff  ects 
of CB1 and CB2 receptor modulation on the intestinal microcirculation 
in a model of polybacterial sepsis (colon ascendens stent peritonitis 
(CASP)) using intravital microscopy (IVM).
Methods We studied six groups of animals (Lewis rats, n = 10 per 
group): sham operated controls (SHAM), septic controls (CASP), CASP 
animals treated with CB1 agonist ACEA (2.5 mg/kg i.v.), CASP animals 
treated with CB1 antagonist AM281 (2.5  mg/kg i.v.), CASP animals 
treated with CB2 agonist HU308 (2.5 mg/kg i.v.), and CASP animals 
treated with CB2 antagonist AM630 (2.5 mg/kg i.v.). All treatments were 
performed immediately after sepsis induction. IVM of the intestinal 
microcirculation was performed 16 hours following sepsis induction. 
Leukocyte adhesion and functional capillary density were measured in 
a blinded fashion.
Results Following 16 hours of CASP-induced experimental sepsis, a 
signifi  cant increase of leukocyte adhesion in the intestinal submucosal 
venules (for example, collecting venules (V1): SHAM 35.7  ±  6.2 n/
mm2, CASP 214.4  ±  22.6 n/mm2,  P  <0.05) was observed. Capillary 
perfusion of the muscular and mucosal layers of the intestinal wall 
was signifi   cantly reduced (for example, longitudinalis muscular 
layer: SHAM 143.5 ± 7.6 cm/cm2, CASP 77.1 ± 7.2 cm/cm2). Treatment 
of CASP animals with the CB1 receptor agonist ACEA reduced 
leukocyte adhesion (V1 venules: 107.4  ±  5.1 n/mm2), whereas CB2 
receptor stimulation did not aff  ect leukocyte adhesion. However, CB2 
receptor inhibition by AM630 reduced leukocyte activation signifi  cantly 
(V1 venules: 60.0  ±  14.1  n/mm2) and restored capillary perfusion 
(longitudinal muscular layer: 114.1 ± 7.6 cm/cm2).
Conclusions The data suggest that ECS signaling is involved in the 
impairment of the intestinal microcirculation during sepsis. Blocking 
CB2 receptor signaling reduces leukocyte activation and improves 
capillary perfusion in sepsis in rats. The long-term eff   ect of ECS 
modulation needs further investigation.
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Introduction  The vasopressin analogue desmopressin (DDAVP), a 
selective agonist of the vasopressin V2 receptor, is known to cause 
vasodilatation in addition to its haemostatic eff  ects. To verify whether 
desmopressin could be benefi  cial in sepsis we investigated its eff  ects 
on intestinal microcirculation in experimental endotoxemia in rats.
Methods In Lewis rats (six groups, 10 animals each) the eff  ects of 
vasopressin (VAS) (0.06 U/340 g/minute) and DDAVP (1 μg/kg/ml) 
on the terminal ileum microcirculation 2  hours after introducing 
endotoxemia (5 mg/kg lipopolysaccharide (LPS), i.v.) were examined 
using intravital fl  uorescence microscopy.
Results Although desmopressin administration (DES-group) increased 
the number of rolling leucocytes in V3 venules (P <0.05 vs. CON-group), 
the number of fi  rmly adhering leucocytes in V1 venules of the LPS-
group was signifi  cantly reduced (LPS-group: 259 ± 25.7 vs. LPS+DES-
group: 203  ±  17.2 n/mm2;  P <0.05) (Figure 1). Additionally, DDAVP 
treatment improved impaired functional capillary density (FCD) 
following LPS in all examined intestinal layers (P <0.001 vs. LPS-group), 
while the density of nonfunctional capillaries was signifi  cantly reduced 
(P <0.001 vs. LPS-group). Vasopressin administration deteriorated FCD 
in endotoxemic and non-endotoxemic rats (P <0.05 vs. CON-group 
or LPS-group). Three hours after LPS challenge, TNFα levels were 
Figure 1 (abstract P254).
Figure 1 (abstract P256). Number of adherent leucocytes in venules 
(n/mm2). *P <0.001 for all LPS vs. all controls; #P <0.05 for LPS+DES vs. LPS.
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(LPS-group: 429 ± 119; LPS+DES-group: 262 ± 21.9; LPS+VAS-group: 
249 ± 46.5 pg/ml; P <0.05).
Conclusions  Desmopressin administration improved microvascular 
perfusion and reduced infl   ammatory response in experimental 
endotoxemia.
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Introduction For a long time nitrite (NO2
–) was believed to be an inert 
metabolite of the endogenous vasodilator NO. Recently, however, 
nitrite was identifi   ed as an important biologic NO reservoir in 
vasculature and tissues, contributing to hypoxic signaling, vasodilation 
and cytoprotection after ischemia–reperfusion injury. Reduction of 
nitrite to NO may occur enzymatically at low pH and oxygen tension by 
deoxyhemoglobin or deoxymyoglobin, xanthine oxidase, mitochondria 
or NO synthase. Considering that NO may exert protective eff  ects 
in infl  ammatory and septic shock, and that circulating nitrite may 
function as a source of NO in hypoxic and/or acidic conditions present 
in ischemic microvasculature of vital organs during shock, we decided 
to test the protective capacity of nitrite on toxicity associated with 
infl  ammatory shock.
Methods We studied sterile models of shock (induced by intravenous 
TNF or LPS) and a septic CLP model in female C57Bl/6 mice. NaNO2 
treatments were done intravenously. To monitor morbidity, rectal body 
temperatures were measured and mortality was recorded. In addition, 
mice were sacrifi  ced 2 or 6 hours after challenge to analyze serum 
markers for organ damage, as well as mitochondrial parameters, ATP 
production and infi  ltration of myeloid cells. Hemodynamic parameters 
were determined in conscious mice via radiotelemetry, using PA-C10 
probes (Data Sciences International).
Results Low doses of nitrite signifi  cantly ameliorated hypothermia, 
organ damage and mortality induced by a lethal TNF challenge. 
Mechanistically, nitrite-dependent protection was associated with 
improved mitochondrial functioning, demonstrated by complex 
I, complex IV and aconitase activities in the liver and heart. In 
addition, nitrite protection was largely abolished in mice defi  cient 
for the α1-subunit of soluble guanylate cyclase (sGCα1), one of the 
principle intracellular NO receptors and signal transducers in the 
cardiovasculature. Interestingly, nitrite delayed and attenuated TNF-
induced bradycardia and hypotension as well. In addition, higher doses 
of nitrite could also protect against toxicity induced by Gram-negative 
LPS, but not against mortality induced by CLP.
Conclusions We show that nitrite can protect against mitochondrial 
and organ damage in infl  ammatory sterile shock via sGC-dependent 
signaling. This may include hypoxic vasodilation, necessary to maintain 
microcirculation and organ function, as well as cardioprotection.
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Introduction  The autonomic nervous system (ANS) and innate 
immunity are intimately linked. Heart rate variability (HRV) analysis is 
a widely employed method to assess cardiac ANS activity, and changes 
in HRV indices may correlate with infl  ammatory markers. Here, we 
investigated whether baseline HRV predicts the innate immune 
Figure 1 (abstract P258). Association between basal HRV indices (calculated at t = 0, just prior to LPS administration) and area under curve of the LPS-
induced proinfl  ammatory cytokine response (TNFα and IL-6, log pg/ml/hour) of 40 subjects. ms, milliseconds; AU, arbitrary units. Solid and dashed lines, TNFα 
and IL-6 regression lines, respectively. Pearson correlation coeffi   cients (none statistically signifi  cant) indicated.
Critical Care 2011, Volume 15 Suppl 1 
http://ccforum.com/supplements/15/S1
S91response. Second, we investigated whether the magnitude of the 
infl  ammatory response correlated with HRV alterations.
Methods Forty healthy volunteers received a single intravenous bolus 
of 2 ng/kg endotoxin (lipopolysaccharide (LPS), derived from Escherichia 
coli O:113). Of these, 12 healthy volunteers were administered LPS 
again 2 weeks later. HRV was determined at baseline (just prior to LPS 
administration) and hourly thereafter until 8 hours post LPS. Plasma 
cytokine levels were determined at various time points.
Results Baseline HRV indices did not correlate with the magnitude 
of the LPS-induced infl  ammatory response. Despite large alterations 
in HRV following LPS administration, the extent of the infl  ammatory 
response did not correlate with the magnitude of HRV changes. In 
subjects that were administered LPS twice, infl  ammatory cytokines 
were markedly attenuated following the second LPS administration, 
while LPS-induced HRV alterations were similar. See Figure 1.
Conclusions HRV indices do not predict the innate immune response 
in a standardized model of systemic infl  ammation. The innate immune 
response results in HRV changes; however, no correlations with 
infl  ammatory cytokines were observed. These fi  ndings suggest that 
cardiac ANS activity may not refl   ect ANS outfl   ow to other organs 
involved in the innate immune response. Furthermore, the magnitude 
of endotoxemia-related HRV changes does not refl  ect the extent of the 
infl  ammatory response.
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Introduction Despite intense eff  orts, sepsis remains a serious clinical 
problem, accounting for thousands of deaths every year. Many 
fi   ndings have shown that immune dysfunction in septic patients 
plays a very important role. Thus, a better understanding of the 
basic immune alterations in sepsis is needed to appropriately direct 
therapy. Here we sequentially measured TNFα, IL-1B, IL-6 and IL-10 de 
novo synthesis by monocytes via multiparametric fl  ow cytometry and 
monocyte expression of surface molecules that allow eff  ective antigen 
presentation, in patients with severe sepsis and septic shock up to 12 
days after admission.
Methods Twenty-fi  ve patients and 15 healthy, age and sex matched 
control subjects were enrolled. Each patient met the following criteria: 
an identifi  able site of infection; two or more systemic infl  ammatory 
response syndrome criteria. Septic shock was defi   ned as severe 
hypotension that lasts 1 hour, despite adequate fl  uid resuscitation and 
pharmacologic intervention with vasopressor agents. Cell stimulation 
PBMC from patients and controls were cultured for 18 hours in the 
presence of 100 ng/ml LPS and analysed by FACS to determine cell 
surface antigen expression and intracellular cytokine production.
Results  Cytokine production by monocytes during sepsis Monocytes 
from septic patients produced signifi   cantly higher amounts of 
IL-1B, TNFα and IL-6, but not IL-10 as compared with controls. In 
addition, monocytes from patients with septic shock responded to 
LPS stimulation with increased IL-1B, TNFα and IL-6 production with 
respect to cells from patients without septic shock. Serum cytokine 
levels All cytokines were readily detectable in septic patients. Eff  ect of 
sepsis on surface molecule expression Monocyte CD80, CD86 and HLA-
DR expression was signifi  cantly decreased in patients with sepsis as 
compared with healthy subjects. As opposed, the expression of ILT4 
was signifi  cantly increased in septic patients as compared with healthy 
controls.
Conclusions  It has been postulated that the immune response in 
sepsis represents the interplay of two contrasting phenomena: the 
early systemic infl  ammatory response syndrome followed by the late 
appearance of a compensatory anti-infl  ammatory response syndrome. 
The fi  ndings reported here suggest a scenario, characterized by the 
contemporary development of an intense proinfl  ammatory reaction 
and a marked alteration of the phenotype of antigen-presenting cells.
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Introduction  Although there has been progress in understanding 
the immunopathology of sepsis, the mortality rates remain high and 
there is still a lack of eff  ective immunomodulatory therapies. Possible 
reasons include heterogeneity of septic patients and ineffi   ciency of 
methods of monitoring the immune system status [1]. Most of both the 
experimental and clinical studies do not distinguish sepsis based on the 
primary sites of infection. Therefore, we studied the diff  erences in the 
cellular immune response during sepsis originating from pneumonia 
and peritonitis.
Methods Blood samples were obtained from 34 patients treated in 
our ICU in the fi  rst days of sepsis, severe sepsis or septic shock. Intra-
abdominal sepsis (IAS) was diagnosed when SIRS symptoms with 
intra-abdominal, postoperative infection source occurred. Pneumonia-
derived sepsis (PDS) diagnosis was based on SIRS accompanied by CXR 
lung consolidation. Samples were stained with the panel of antibodies 
against: CD45/CD14, CD3/CD19, CD3/CD4, CD3/CD8, CD3/CD16+56 
and isotypic control. Cells were analysed by fl  ow cytometry and total 
cell count per microliter was calculated. Comparative and simple 
regression statistical analyses were performed.
Results Fourteen patients were diagnosed with IAS and eight with PDS. 
Etiology of most IAS was Gram-negative, while Gram-positive in PDS. 
The mortality rate was higher in PDS. Monocyte absolute number and 
white blood count were the only variables with statistically signifi  cant 
diff  erences between IAS and PDS. The correlations between number of 
lymphocytes and monocytes, CD3+, CD4+ and CD19+ were high in both 
groups of patients. However, in IAS no correlation was found between 
the number of either cytotoxic CD8 lymphocytes and NK cells with 
lymphocyte count. Interestingly, a high correlation for the number of 
CD8+ and NK cells exists in both IAS and PDS patients.
Conclusions Our results indicate diff  erences in the immune response 
during sepsis originating from respiratory and abdominal infections. 
Independent correlations between NK cells and cytotoxic lymphocytes 
suggest existence of shared mechanisms of their regulation.
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Introduction The release of cytokines into the circulation is an essential 
part of the infl  ammatory cascade that underlies sepsis. Experimental 
and clinical data have shown that the proinfl  ammatory cytokine TNFα 
is a principal mediator of this cascade [1-3]. The investigational drug 
AZD9773, intended for intravenous infusion, contains ovine immune 
fragments (Fabs) of IgG that bind to human (hu)-TNFα. Here we 
describe the in vitro and in vivo pharmacology of AZD9773.
Methods AZD9773 binding to human TNFα was assessed using surface 
plasmon resonance (SPR) technology. AZD9773 functional potency 
was profi   led versus recombinant human (r-hu)-TNFα and natural 
(WHO International Standard) (n)-TNFα in TNFα-mediated cytotoxicity 
assays using the L929 cell line. Finally, humanised mice (Tg1278/TNF–/–: 
hu-TNFα transgenic, murine TNFα null) were used to assess AZD9773 
eff   ects on endotoxin-induced serum cytokines, chemokines and 
related factors.
Results  SPR assays revealed that r-hu-TNFα bound to immobilised 
AZD9773 total Fabs with an equilibrium dissociation constant (Kd) of 
~60 nM. AZD9773 neutralised both r-hu-TNFα and n-TNFα biological 
activity in the L929 cytotoxicity assays. AZD9773 neutralised r-hu-TNFα 
with an apparent inhibitory constant (Ki) of approximately 40  pM. 
In humanised mice, AZD9773 produced a statistically signifi  cant 
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hu-TNFα and murine IL-6).
Conclusions AZD9773 is a potent TNFα neutralising ovine immune 
Fab and, considering the modest AZD9773:TNFα binding affi   nity, these 
data indicate that there is signifi  cant synergy in neutralising TNFα 
bioactivity between the polyclonal anti-TNFα species that comprise 
AZD9773. The in vivo suppression of 29 out of 60 induced serum 
cytokines, chemokines and related factors confi  rms the signifi  cant role 
for TNFα in eliciting acute endotoxin responsiveness.
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Introduction The critical pathophysiological trigger of sepsis is thought 
to be a disturbance in the equilibrium between the proinfl  ammatory 
response and concomitant anti-infl  ammatory mechanisms. Data show 
that the proinfl  ammatory cytokine TNFα is a principal mediator of 
sepsis [1,2]. AZD9773 is a sterile lyophilised powder for solution for i.v. 
infusion containing ovine immune fragments (Fabs) of IgG that bind 
to human TNFα. We explored the PD and safety profi  le of AZD9773 in 
cynomolgus monkeys. AZD9773 PD data are compared with D-CytoFab 
(a similar ovine anti-TNFα IgG immune Fab product) that showed 
clinical benefi  t in a phase IIb study [3].
Methods AZD9773 binding and neutralisation of primate TNFα were 
assessed using surface plasmon resonance and TNFα-mediated 
cytotoxicity assay using L929 cells, respectively. AZD9773 did not 
show any unexpected binding to frozen primate tissue. The in vivo 
ability of either AZD9773 or D-CytoFab to suppress TNFα-mediated 
eff  ects was determined by the inhibition of endotoxin-induced TNFα 
and IL-6 production in cynomolgus monkeys. A mathematical (PK-PD) 
model was constructed to describe the cytokine PD profi  le. Safety 
assessments included monitoring electrocardiogram outputs, heart 
rate, blood pressure and toxicology indices in cynomolgus monkeys 
administered with AZD9773.
Results There was no signifi  cant diff  erence between AZD9773 and 
D-CytoFab in the binding of primate TNFα in vitro, and AZD9773 and 
D-CytoFab neutralised recombinant primate TNFα with only a twofold 
and 1.8-fold reduction in potency, respectively, compared with 
recombinant human TNFα. Both AZD9773 and D-CytoFab at equivalent 
doses with comparable exposure signifi  cantly suppressed endotoxin-
induced IL-6 production in cynomolgus monkeys to a similar extent. 
PK-PD analysis revealed the eff  ect of AZD9773 and D-CytoFab on 
serum TNFα and IL-6 levels and estimated model parameters were 
not signifi  cantly diff  erent. No toxicologically signifi  cant fi  ndings were 
observed in cynomolgus monkeys with AZD9773 at doses signifi  cantly 
higher than those currently under clinical investigation.
Conclusions Preclinical data indicate that AZD9773 has a good safety 
profi  le and is a well-tolerated anti-TNFα immune Fab product with PD 
characteristics similar to D-CytoFab.
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Introduction Sepsis remains a signifi  cant medical problem. TNFα is a 
central cytokine in sepsis pathophysiology. We conducted a phase IIa 
trial in patients with severe sepsis to assess the safety and tolerability 
of an intravenously infused ovine-derived polyclonal anti-TNFα Fab 
fragment (AZD9773).
Methods This was a double-blind, placebo-controlled, dose-escalation 
trial (NCT00615017) with 2:1 randomisation (active:placebo). Two 
single-dose cohorts (50 units/kg and 250 units/kg) and three multiple-
dose cohorts (250 units/kg followed by nine doses of 50 units/kg 
every 12 hours, 500 units/kg followed by nine doses of 100 units/kg, 
750 units/kg followed by nine doses of 250 units/kg) were studied. 
Safety was assessed by monitoring adverse events (AEs), mortality, and 
laboratory safety measures, including formation of human anti-sheep 
antibodies (HASA) and their association with AEs.
Results A total of 70 patients were studied. The mean age was 56 years, 
46% were male, and the mean APACHE II score was 26. About 50% of 
patients had two organ failures (both respiratory and cardiovascular). 
Multiple doses of AZD9773 reduced circulating TNFα towards the limit 
of detection in most patients throughout the 5 days of dosing. The most 
common serious AEs were mainly related to the underlying illness and 
included: sepsis, pneumonia, septic shock and respiratory failure across 
all groups. Table 1 summarises the safety outcomes. Development of 
HASA did not appear to be associated with either decreased TNFα 
reduction or specifi  c AEs.
Conclusions  Administration of AZD9773 in patients with severe 
sepsis reduced circulating TNFα levels and had a safety profi  le similar 
to placebo administration. A larger randomised phase IIb clinical 
trial (NCT01145560) is ongoing to further characterise the safety and 
effi   cacy of AZD9773 in patients with severe sepsis.
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Introduction Eritoran tetrasodium (E), a TLR4 antagonist, is currently 
being evaluated in phase 3 as a treatment for severe sepsis and has 
been well tolerated in clinical trials [1]. The primary objective of this 
study was to evaluate the eff  ect of E on QTc in healthy subjects.
Methods This was a single 12-hour intravenous infusion, double-blind, 
placebo-comparator and active-comparator controlled, parallel-group 
Table 1 (abstract P263). Safety outcomes with AZD9773 administration
  Single-dose cohorts  Multiple-dose cohorts 
 combined  (n = 17) combined  (n = 30) Placebo  (n = 23)
Mortality, n (%)  6 (35%)  7 (23%)  6 (26%)
Any treatment-emergent AEs  17 (100%)  27 (90%)  23 (100%)
Treatment-emergent AEs related to study drug  2 (12%)  7 (23%)  10 (43%)
Patients with any serious AEs  9 (53%)  14 (47%)  13 (57%)
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(T) total dose of 28 mg); Arm B, E 7 mg/hour (a supratherapeutic (S) 
total dose of 84 mg); Arm C, placebo; or Arm D, placebo + moxifl  oxacin 
(M) 400 mg p.o. The primary outcome parameter was the placebo-
corrected change from baseline in QTcF (ΔΔQTcF) based on the largest 
time-matched mean diff  erence 10, 12, 14, 16, 18, 24, 36, and 48 hours 
after the start of infusion. Categorical and pharmacokinetic (PK)/
pharmacodynamic (PD) evaluations were performed. Adverse events 
were reported.
Results Two hundred subjects (mean age 33.4 years; 81.5% male) were 
randomized. In the M group, the increase in QTcF from baseline (ΔQTcF) 
consistently exceeded placebo (maximum ΔΔQTcF 11.4 ms at 4 hours 
postdose). The lower bound of the one-sided 95% confi  dence limit was 
>5 ms at each time point between 2 and 8 hours postdose, indicating 
the study’s sensitivity to demonstrate small QTc eff  ects. The largest mean 
ΔΔQTcF for E was 2.1 ms (84 mg, 12 hours) and 1.6 ms (28 mg, 48 hours). 
The upper limit of the two-sided 90% CI (one-sided 95% CI) for the mean 
diff  erence did not exceed 4.6 ms and all 90% CIs were inclusive of zero. 
No subject in either E group had a ΔQTcF exceeding 30 ms and only one 
subject in the E 84 mg group had a single QTcF >450 ms at 16 hours. 
QTcB, QTci, categorical, and PK/PD results all confi  rmed those from the 
primary analysis. There was no obvious correlation between QTcF and 
plasma E concentration. E 28 mg or 84 mg was safe and well tolerated, 
with mild headache most frequently reported in the placebo (9.6%) and 
E 28 mg (8.7%) groups, injection site hemorrhage in the E 84 mg group 
(6.1%), and nausea in the M group (3.8%).
Conclusions At either a T or S dose of E, a QTc eff  ect exceeding 5 ms 
could be excluded. The upper bound of the 95% one-sided CI for 
ΔΔQTcF was <10 ms at both the S and T doses of E, indicating this is a 
negative thorough QT/QTc study.
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Introduction Activation of TLR4 signaling by endotoxin is believed 
to be a primary mediator of sepsis and septic shock, via excessive 
production of cytokines and proinfl  ammatory mediators [1]. Eritoran 
tetrasodium (hereafter eritoran), a synthetic analog of the endotoxin 
constituent lipid A, binds to the TLR4/MD-2 complex and thereby 
blocks the interaction of endotoxin with TLR4 [2]. Eritoran is being 
investigated for the treatment of severe sepsis [3]. We report results of 
a study conducted to assess the single-dose safety and tolerability, as 
well as pharmacokinetics and pharmacodynamics, of eritoran infusion 
in Japanese and Caucasian healthy adult males.
Methods This was a double-blind, randomized, single-center, placebo-
controlled, ascending single-dose, sequential-group study. Sixty-four 
subjects (aged 20 to 45 years; BMI 18 to 30 kg/m2) were randomized to 
four groups: 4 mg total dose (n = 12); 12 mg total dose (n = 24); 28 mg 
total dose (n = 12); placebo (n = 16). Adverse events were recorded 
by the investigator. Laboratory assessments included standard 
hematology and clinical chemistry, lipid analysis, and urinalysis.
Results  There were no serious adverse events. Eritoran in single 
doses up to 28 mg over 4 hours was well tolerated, with no apparent 
ethnic diff  erences noted. Plasma concentrations were slightly higher, 
while clearance and volume of distribution were lower, in Japanese 
versus Caucasian subjects; these diff  erences were not signifi  cant after 
adjustment for diff   erences in body weight. The ex vivo endotoxin 
inhibitory activity of eritoran was similar in Japanese and Caucasian 
subjects. Eritoran was distributed mainly to the HDL fraction in both 
Japanese and Caucasian subjects.
Conclusions Eritoran was safe and well tolerated in healthy Japanese 
and Caucasian subjects. The data do not indicate any need for clinical 
dose adjustment for possible ethnic-based diff   erences in drug 
distribution or metabolism.
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Introduction  Previous studies have shown that the endogenous 
nucleo  side adenosine is able to modulate infl   ammation and to 
prevent associated organ injury. Dipyridamole, an adenosine re-
uptake inhibitor, increases extracellular adenosine concentrations 
during unfavorable conditions (for example, infl  ammation),  and  as 
such may modulate the infl  ammatory response. We examined the 
eff  ects of dipyridamole treatment on innate immunity during human 
experimental endotoxemia.
Methods  In a randomized double-blind placebo-controlled study, 
20 healthy subjects received 2 ng/kg Escherichia coli endotoxin 
Figure 1 (abstract P266). Cytokine response following endotoxemia.
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retard twice daily, or placebo.
Results  Nucleoside transporter activity was signifi  cantly  reduced 
by dipyridamole treatment with 89  ±  2% (P <0.0001) and resulted 
in signifi   cantly augmented endogenous adenosine levels. Plasma 
concentrations of dipyridamole correlated with the peak adenosine 
concentration 2 hours after LPS administration (r = 0.82, P = 0.0038) and 
signifi  cantly augmented the anti-infl  ammatory IL-10 response during 
endotoxemia (P <0.0001; Figure 1), an eff  ect that correlated with the 
dipyridamole-induced increase in adenosine (r  =  0.82;  P  =  0.0035). 
Finally, IL-10 peak concentrations were associated with a more 
pronounced decline in TNFα (r = 0.54, P = 0.018).
Conclusions  Dipyridamole treatment increases adenosine concen-
trations during systemic infl  ammation associated with an augmented 
anti-infl  ammatory response and a faster decline in TNFα during human 
experimental endotoxemia.
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Introduction Use of statins in community-acquired pneumonia (CAP) 
and exacerbation of COPD has been widely studied [1-3]. Whilst there 
may be some outcome benefi  t with the use of statins in exacerbation of 
COPD, their role in CAP remains less clear. There are no studies looking 
at outcome benefi  ts from statin use in patients with CAP who are 
admitted to the intensive therapy unit (ITU). Therefore, we conducted 
a retrospective cohort analysis looking at statin use and outcomes in 
patients with CAP admitted to our ITU.
Methods We retrospectively analysed 200 consecutive admissions to 
our ITU who had an admission diagnosis of CAP. Use of statins in those 
diagnosed with CAP was determined and its relation to length of stay 
and in-patient mortality was assessed. Baseline patient characteristics, 
disease severity scores, dose and type of statin prescribed were also 
considered.
Results Out of the total 200 patients with a coded diagnosis of CAP, 
108 patients (54%) had CAP on notes review. Statins were prescribed 
in 43 (39.8%) of these patients. Statins were prescribed more often in 
patients >65 years old. Baseline characteristics were similar in both 
groups (>60 years: 62% vs. 65%, P = 0.7; CURB 65 2 to 3: 48% vs. 50%, 
P = 0.8; APACHE II <10: 16% vs. 20%, P = 0.5; APACHE II 10 to 20: 43% vs. 
42%, P = 1.00, APACHE II >20: 41 vs. 38, P = 0.7). The male:female ratio 
in our cohort was 1:1.3 (43% vs. 57%). Overall, in-hospital mortality in 
this CAP cohort was 45% (n = 48). This was higher than the previously 
reported studies [4]. We believe this represents the higher average 
age of the population with more accumulated co-morbidities that we 
cater for. Simvastatin was the most commonly prescribed statin (66% 
patients) in varying dosages (10 to 80 mg OD). There was no statistically 
signifi  cant diff  erence in mortality between those who received statins 
and those who did not (55% vs. 47%, P = 0.29). Length of stay amongst 
survivors was similar in both groups (<7 days: 58% vs. 61%, P = 0.7; 7 to 
14 days: 39% vs. 33%, P = 0.4; >14 days: 3% vs. 6%, P = 0.4).
Conclusions  According to this retrospective cohort study, use of 
statins in patients admitted to the ITU with a diagnosis of community-
acquired pneumonia does not seem to provide any statistically 
signifi  cant survival benefi  t. Also, there seems to be no benefi  t in terms 
of total length of stay amongst survivors.
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Introduction Statins have pleiotrophic eff  ects independent of their 
lipid-lowering properties and may modulate the pathophysiology of 
sepsis, prevent sepsis progression and improve outcomes [1]. This study 
evaluated the acute use of Atorvastatin in reducing sepsis progression 
compared with placebo in statin-naive individuals.
Methods  A single-centre, randomised placebo-controlled, double-
blind trial (RCT). Ethical approval and consents were obtained. Patients 
with sepsis, based on the Surviving Sepsis Campaign Guidelines 
(SSCG), were randomised to Atorvastatin 40 mg daily or placebo for 
length of hospital stay or 28 days if earlier. Patients on statins were 
excluded. Primary outcome was progression to severe sepsis, defi  ned 
by the SSCG.
Results One hundred patients were consented and randomised, 49 to 
Atorvastatin and 51 to placebo. Both were well matched for all baseline 
characteristics. The Atorvastatin group had a lower rate of sepsis 
progression P = 0.007 (Figure 1). The 28-day and 1-year mortalities were 
similar with an overall 12% mortality. There was no diff  erence in 28-
day readmissions (P = 0.83); however, 1-year readmissions were higher 
in the placebo group (P <0.001). A rise in matrix metallopeptidase 9 
(P = 0.01) at day 4 was observed in the Atorvastatin group.
Conclusions  This is the fi   rst RCT to show that the acute use of 
Atorvastatin can prevent sepsis progression in statin-naive individuals. 
A multicentred RCT is required to elucidate the mechanisms and 
clinical applications of these fi  ndings.
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Introduction  The mechanisms of sepsis are not understood in all 
aspects. We decided to measure the IgG and IgM serum level in these 
patients and tried to correlate our results with the mortality rate and also 
to establish the medium time in the blood of these immunoglobulins.
Figure 1 (abstract P268). Percentage of patients progressing to severe 
sepsis (%).
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classifi  cation of septic shock. As soon as the patients were selected we 
took samples at entrance, day 1, day 4 and day 8. We measured the 
serum level of IgG and IgM of all patients. There were 189 patients 
studied from 360 with septic shock. We excluded 171 patients for three 
reasons: they were neutropenic, had transfusions for <1 month or had 
recently undergone chemotherapy. Septic patients represented 17% of 
all patients in the ICU.
Results From these 189 selected patients we had a mortality rate of 
59 patients, which means 31%. From these patients 29 had combined 
defi  ciency of IgG and IgM levels, 17 had only IgG defi  ciency and 13 had 
IgM defi  ciency. We considered a defi  cient value as levels less than the 
minimum level for immunoglobulins according to our nephelometry 
measurement.
Conclusions Despite the fact that we had a small number of patients 
we can conclude that these measurements could be considered good 
prognostic markers, not only in terms of mortality rate but also to 
demonstrate that IgG and IgM levels do not have the 21 and 7 days of 
medium time in the circulation we can see in normal patients. Probably 
in the near future we could include immunoglobulin determination on 
a routine basis for septic shock patients.
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Introduction We sought to compare the association of whole blood 
lactate kinetics with survival in patients with septic shock undergoing 
early quantitative resuscitation.
Methods Preplanned analysis of a multicenter emergency department 
(ED)-based randomized control trial of early sepsis resuscitation 
targeting three physiological variables: central venous pressure, mean 
arterial pressure, and either central venous oxygen saturation or lactate 
clearance. Inclusion criteria: suspected infection, two or more systemic 
infl  ammatory response syndrome criteria, and either SBP <90 mmHg 
after a fl  uid bolus or lactate >4  mmol/l. All patients had a lactate 
measured initially and subsequently at two hours. Normalization of 
lactate was defi  ned as a lactate decline to <2.0 mmol/l in a patient 
with an initial lactate ≥2.0. Absolute lactate clearance (initial – delayed 
value), and relative ((absolute clearance) / (initial value) x 100) were 
calculated if the initial lactate was ≥2.0. The primary outcome was 
in-hospital survival. Receiver operating characteristic (ROC) curves 
were constructed and the area under the curve (AUC) was calculated. 
Diff  erences in proportions of survival between the two groups at 
diff  erent lactate cutoff  s were analyzed using 95% confi  dence intervals 
and Fisher exact tests.
Results Of 272 included patients, median initial lactate was 3.1 mmol/l 
(IQR 1.7, 5.8), and median absolute and relative lactate clearance 
were 1 mmol/l (IQR 0.3, 2.5) and 37% (IQR 14, 57). An initial lactate 
>2.0 mmol/l was seen in 187/272 (69%), and 68/187 (36%) patients 
normalized their lactate. Overall mortality was 19.7%. AUCs for initial 
lactate, relative lactate clearance, and absolute lactate clearance were 
0.70, 0.69, and 0.58, respectively. Lactate normalization best predicted 
survival (OR = 6.1, 95% CI = 2.2 to 21), followed by lactate clearance 
of 50% (OR = 4.3, 95% CI = 1.8 to 10.3), initial lactate of <2 mmol/l 
(OR = 3.4, 95% CI = 1.5 to 7.8), and initial lactate <4 mmol/l (OR = 2.3, 
95% CI  =  1.3 to 4.3), with lactate clearance of 10% not reaching 
signifi  cance (OR = 2.3, 95% CI = 0.96 to 5.6).
Conclusions In ED sepsis patients undergoing early quantitative resusci-
tation, normalization of serum lactate during resuscitation was more 
strongly associated with survival than any absolute value or absolute/
relative change in lactate. Further studies should address whether 
strategies targeting lactate normalization leads to improved outcomes.
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Introduction  Sepsis is associated with cell necrosis and apoptosis. 
Indeed, plasma DNA levels have been shown to be increased in patients 
with sepsis [1]. So we investigated the prognostic value of circulating 
levels of cell-free DNA in critically ill septic patients regarding the 
clinical course and fi  nal outcome.
Methods A total of 80 critically ill septic patients were included in a 
prospective, randomized, single-center study. All were subjected to 
the measurement of cell-free plasma DNA concentrations (by real-
time PCR assay for the β-globin gene), CRP levels and procalcitonin 
concentrations, all measured on ICU admission. APACHE II and SOFA 
scores were calculated. Clinical outcome (duration of ICU stay, need for 
MV, need for inotropic/vasopressor support, need for haemodialysis, 
and fi  nal outcome of survival/mortality rates) were recorded for all 
patients.
Results The median plasma DNA concentration in critically ill septic 
patients was 195.7 ng/ml and this was signifi  cantly (approximately 
sevenfold) higher than the DNA concentration in healthy subjects 
27 ng/ml (P <0.001). The median DNA concentration was signifi  cantly 
higher in those who need MV (205.6 ng/ml vs. 123.7 ng/ml; P = 0.006), 
in those who were on inotropic/vasopressor support (234.6 ng/ml vs. 
114.7 ng/ml; P <0.001) and in those who required renal supportive 
therapy (haemodialysis) (244.2 ng/ml vs. 181.1 ng/ml; P = 0.001). DNA 
concentration demonstrated a highly signifi   cant correlation with 
CRP concentration (r = 0.661, P <0.001), procalcitonin concentration 
(r = 0.820, P <0.001), SOFA score (r = 0.710, P <0.001), and APACHE II 
score (r = 0.559, P <0.001). The median plasma DNA concentration in 
nonsurvivors (38 of 80 patients, 47.5%) was 234.8 ng/ml, and this was 
signifi   cantly (approximately twofold) higher than that in survivors 
(115.5 ng/ml, P <0.001). Receiver operator characteristic analysis of the 
data indicated a sensitivity of 95% and a specifi  city of 81% when DNA 
concentration of 186.5 ng/ml was taken as a predictor of ICU mortality.
Conclusions Plasma cell-free DNA may be a potentially useful marker 
for the evaluation of ICU septic patients and for the prediction of their 
adverse outcomes. The ability for rapid risk stratifi  cation may allow 
clinicians to make more rational therapeutic decisions to ensure that 
the hospital resources are used effi   ciently and appropriately.
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Introduction  To assess the value of C-reactive protein (CRP) after 
prescription of antibiotics in order to defi   ne clinical resolution of 
community-acquired sepsis (CAS) admitted to the ICU.
Methods During 12 months a cohort multiple-centre observational 
study was conducted in 17 Portuguese ICUs segregating adults with 
CAS consecutively admitted. Patients were followed-up during the fi  rst 
5 ICU days, the day of ICU discharge or death and hospital outcome. 
Comparison between survivors and nonsurvivors was performed.
Results Eight hundred and ninety-one patients (age 60 ± 17 years, 
hospital mortality 38%) were studied. At D1, CRP of survivors and 
nonsurvivors was not statistically diff   erent, 19.8  ±  12.5  mg/dl vs. 
20.7 ± 12.8 mg/dl (P = 0.367). When we compared CRP of survivors 
and nonsurvivors at the diff  erent time points, we found that CRP of 
nonsurvivors was signifi   cantly higher since D3 onwards (P  <0.001, 
for D3, D4 and D5). After adjusting for SAPS II and severity of sepsis 
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signifi  cantly associated with hospital mortality (ORinitial = 1.01, 95% CI 
= (0.99, 1.02), P = 0.297). On the other side, the course of CRP, measured 
as the relative change, obtained from a patient’s specifi  c linear model 
for the 5-day measurement of CRP generated two new variables, an 
intercept (describes the initial CRP value) and a slope (describes the 
CPR rate of change per day for a specifi  c patient). We found that the 
slope was signifi   cantly associated with hospital mortality (OR CPR 
ratio = 1.03, 95% CI = (1.02, 1.04), P <0.001). A patient with an average 
decrease of the CRP concentration of 10% per day has 32% less 
chance of dying when compared with a patient with the same SAPS 
II and the same severity of sepsis but with no decrease of the CRP. The 
area under the ROC curve for the model including SAPS II, severity of 
sepsis, initial CRP and CRP course, was 0.77. No signifi  cant diff  erences 
between survivors and nonsurvivors were found on daily monitoring 
of temperature and white cell count, both at the fi  rst day (P = 0.799 and 
P = 0.496, respectively) and in the course of subsequent days (P = 0.360 
and P = 0.594, respectively).
Conclusions  Daily CRP measurement after antibiotic prescription 
was useful in identifi  cation, as early as day 3, of CAS patients with 
poor outcome. The slope of CRP course was markedly associated with 
prognosis.
Reference
1. Povoa  P:  Eur Respir J 2005, 25:804.
P273
Eff  ect of including procalcitonin and C-reactive protein in the 
Mortality in Emergency Department Sepsis risk prediction model
C Lee1, J Liu2, S Chen3, S Chen1
1National Taiwan University Hospital, Taipei, Taiwan; 2Harvard School of 
Public Health, Boston, MA, USA; 3Beth-Israel-Deaconess Hospital, Boston, MA, 
USA
Critical Care 2011, 15(Suppl 1):P273 (doi: 10.1186/cc9693)
Introduction The Mortality in Emergency Department Sepsis (MEDS) 
score has been gradually accepted as a reliable tool for bedside risk 
prediction of sepsis patients in the emergency department. Despite 
its clinical usefulness, the MEDS score did not take advantage of the 
prognostic information of biomarkers.
Methods We compared the clinical utility of MEDS score with and 
without CRP or PCT among participants in a prospective cohort of 
patients. All adult patients fulfi  lling the criteria for SIRS with a presumed 
infectious etiology were eligible for inclusion. Serum PCT and CRP were 
evaluated at admission. Initial severity was assessed with the MEDS 
score. Each patient was followed for at least 30 days for the 30-day 
survival. We built three extended models, including MEDS plus natural 
log PCT model (MEDS-LnPCT), MEDS plus natural log CRP model (MEDS-
LnCRP), and MEDS plus natural log PCT and natural log CRP model 
(MEDS-LnPCT & LnCRP) for comparison. The values of CRP and PCT 
were transformed to natural log scale to normalize the distributions. 
We assessed whether adding CRP, PCT or both biomarkers to the 
MEDS model signifi  cantly reclassifi  ed patients into more appropriate 
risk categories. The reclassifi  cation was then evaluated by comparison 
of the observed incidence of events in the cells of the reclassifi  cation 
table with the predicted probability from the original MEDS model.
Results The 63 patients who died (10.6%) had signifi  cantly increased 
levels of PCT and CRP. Adjusting for MEDS predictors, either high levels 
of CRP or PCT was independently associated with 30-day mortality. We 
fi   tted PCT-incorporated (MEDS-PCT), CRP-incorporated (MEDS-CRP), 
and PCT & CRP incorporated (MEDS-PCT & CRP) models for comparison. 
The MEDS-PCT model was the favored model as it improved model fi  t 
and calibration as measured by the Net Reclassifi  cation Improvement 
(NRI) score (14.1%, P = 0.047). MEDS-CRP and MEDS-CRP & PCT models 
improved model fi  t (likelihood ratio test P = 0.03, 0.009, respectively) 
but did not improve calibration (NRI 5.4%, P = 0.204; 13.2%, P = 0.055). 
All three models did not improve model discrimination as measured 
by c-statistics.
Conclusions Adding PCT levels to the MEDS score reclassifi  ed patients 
into groups that better predict actual 30-day mortality. Inclusion of CRP 
or both biomarkers off  ers limited additional predictive value. Further 
validation studies are needed to corroborate these fi  ndings.
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Introduction The objective of this study was to assess the usefulness of 
routinely admission measured biomarkers.
Methods From a sample of 256 patients enrolled between October 
2009 and November 2010, 193 had sepsis and 63 had septic shock 
based on the ACCP/SCCM criteria, and for each of them we measured 
reactive protein C (RPC), total cholesterol, protein C activity (PC), 
albumin, arterial lactate and the levels of IL-6 at admission.
Results Levels of lactate, IL-6 and PC (<40%) showed the best accuracy 
for prediction mortality in all of the study patients as much as in the 
arm of the septic shock patients (AUROC 0.76; 0.80; 0.75, respectively; 
and AUROC 0.86; 0.86; 0.75, respectively). See Table 1.
Table 1 (abstract P274)
  Septic shock  No septic shock  P value  No sepsis
SAPS II/mortality (%)  53.9 ± 19.1/52  35.1 ± 14.4/10  0.0001  30.2 ± 16/6.6
RPC 208 ± 115  185 ± 118  0.83  108 ± 105
Protein C  35.5 ± 17.8  56.1 ± 24  0.0001  65.8 ± 32.8
Albumin 2 ± 0.2  1.8 ± 0.6  0.5  2.3 ± 0.6
Lactate 4.5 ± 2.9  2.6 ± 2.6  0.0001  1.9 ± 1.8
Total cholesterol  77.8 ± 54  97.1 ± 48  0.02  136 ± 81
IL-6 42,252 ± 9,131  2,732 ± 725  0.001  1,434 ± 586
Conclusions Biomarkers at ICU admission revealed diff  erent accuracies 
in predicting septic shock mortality. Maximal lactate, mean IL-6 and 
minimum PC levels were associated with the higher mortality found in 
this ICU population.
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Introduction N-terminal pro-BNP (pBNP) could be useful to predict 
outcome in severe sepsis. We have conducted a study to compare 
pBNP and procalcitonin (PCT) in the setting of abdominal severe sepsis 
or septic shock.
Methods We performed a prospective study of 51 consecutive patients 
with abdominal severe sepsis or septic shock. Age, gender, APACHE II 
score at admission, in-unit survival, presence of septic shock and serum 
PCT and pBNP levels during 4 days after admission were determined. 
Statistics: chi-square test, Student’s t  test, Mann–Whitney’s test for 
samples without normal distribution and Cox’s logistic regression. 
P <0.05 was considered statistically signifi  cant.
Results The mean APACHE II score at admission was 20.52 ± 5.07. This 
value was found to be signifi  cantly higher in nonsurvivors (18.38 ± 4.56 
vs. 24.00 ± 4.03, P <0.05). Values of pBNP were signifi  cantly higher in 
nonsurvivors from the fi  rst day of the study. PCT levels were higher 
in nonsurvivors, but only reached statistically signifi  cance on day 2 
(Table 1). These results were not found to be infl  uenced by age, gender 
or presence of shock in multivariate analysis.
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PCT to discriminate the patients with abdominal severe sepsis and 
worse outcome.
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Introduction Community-acquired pneumonia (CAP) is the leading 
cause of death from infectious disease in western countries and 
supposes an important consumption of healthcare resources. Several 
studies suggest that proADM is possibly as good as validated severity 
scores in detecting critically ill patients with CAP and probably better 
than other biomarkers like procalcitonin (PCT).
Methods A single-centre prospective study between January 2009 and 
September 2009. Eligible patients were all consecutive adult patients, 
age 17 or older, admitted to the ICU with both a clinical and radiologic 
diagnosis of pneumonia as per Fine and colleagues, and meeting 
criteria for severe sepsis or septic shock. Venous blood samples were 
obtained at admission on the ICU and collected in tubes containing 
EDTA. After centrifugation, they were kept frozen at –80°C until assayed. 
MR-proADM, PCT and C-reactive protein (CRP) were measured in these 
samples.
Results In all cases, proADM values at ICU admission were pathological. 
ProADM consistently rose as PSI class advanced from II to V (P = 0.02). 
Diff  erences across PSI class were not signifi  cant for CRP (P = 0.73) and 
PCT (P = 0.12). Median proADM levels were higher (P = 0.007) in hospital 
nonsurvivors (8.1  ±  9.2 nmol/l) versus survivors (3.0  ±  3.2 nmol/l). 
These diff  erences were also signifi  cant with respect to ICU mortality 
(9.9  ±  10.4 vs. 3.2  ±  3.2 nmol/l; P  =  0.001). The receiver-operating 
characteristic curve for proADM yielded an AUC of 0.72; better than the 
AUC for PCT and CRP (0.40 and 0.44, respectively) and similar to PSI 
(0.74).The optimal prognostic cut-off   (maximum combined sensitivity 
and specifi  city) related to in-hospital mortality for proADM was 4.86 
nmol/l, with a sensitivity of 0.53, specifi  city of 0.84, positive likelihood 
ratio of 3.39, negative likelihood ratio of 0.56, positive predictive value 
of 64.3 and negative predictive value of 77.1. Those patients with a 
proADM level higher than 4.86 nmol/l on ICU admission had an in-
hospital mortality signifi  cantly higher than those with lower value.
Conclusions ProADM levels on ICU admission predict the severity and 
outcome of severe sepsis and septic shock CAP with a similar prognostic 
accuracy as the PSI and a higher prognostic accuracy compared with 
commonly measured laboratory parameters.
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Introduction The role of matrix metalloproteinases (MMPs) and tissue 
inhibitors of matrix metalloproteinases (TIMPs) in sepsis remains 
unclear. MMPs play a role facilitating the recruitment of leucocytes 
from the bloodstream (by proteolysis of the basement membrane) 
and modulating infl  ammatory response [1]. Besides, there has been 
reported a positive association between circulating levels of TIMP-1 
and plasminogen activator inhibitor (PAI)-1 in healthy adults [2] and 
myocardial infarction [3]. In addition there are in vitro studies showing 
that MMP-9 inhibits platelet aggregation [4,5]. Thus a high TIMP-1/
MMP-9 ratio could contribute to a prothrombotic state, and the 
development of organ dysfunction and fi  nally death in septic patients. 
The objectives of this study were to investigate the time course of 
MMP-9, MMP-10 and TIMP-1 levels, and the association with sepsis 
severity and PAI-1 levels.
Methods  This was a multicenter, observational and prospective 
study carried out in six Spanish ICUs. We included 192 (125 surviving 
and 67 nonsurviving) patients with severe sepsis. We obtained blood 
samples at three moments (time of diagnosis, 72 hours and 7 days) for 
the determination of MMP-9, TIMP-1, TNFα, IL-10 and PAI-1 levels. We 
assessed survival at 30 days as the endpoint.
Results  Nonsurvivor patients showed at the three moments lower 
MMP-9 levels, higher TIMP-1 levels and higher TIMP-1/MMP-9 ratios 
than survivors. There were at the three moments an association of the 
TIMP-1/MMP-9 ratio with lactic acid levels, SOFA score, PAI-1 levels, 
TNFα and IL-10. Logistic regression analysis showed that TIMP-1 levels, 
lactic acid levels and SOFA score were associated with death at 30 days.
Conclusions To our knowledge, this study includes the largest series 
reporting data on MMP levels in sepsis. The novel fi  ndings of our study 
are that nonsurviving septic patients showed a persistent higher TIMP-
1/MMP-9 ratio during the fi  rst week than survivors. From a therapeutic 
perspective, the development of modulators of MMP/TIMP activity 
could be used as a new class of drugs for the treatment of severe sepsis.
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Table 1 (abstract P275). Values of pBNP and PCT during the study period
    Day 1   Day 2  Day 3  Day 4
pBNP (median and Q25 to 75) (pg/ml)   
  Survivors  2,256.50 (1,071 to 2,832)*  1,598.00 (1,412.75 to 3,918.25)  2,102.50 (1,323.50 to 6,166.50)  1,809,00 (939.25 to 5,495.75)
  Nonsurvivors  4,090.50 (3,064 to 32,147.75)  8,994,00 (4,911 to 27,860.25)  9,528.00 (3,747.75 to 25,793.2)  5,498,00 (1542 to 19,947.25)
PCT (mean ± SD) (ng/ml)     
  Survivors  10.13 ± 13.02 11.68 ± 18.29* 12.75 ± 23.16 11.90 ± 24.24
  Nonsurvivors  19.81 ± 23.32 25.91 ± 26.87 26.82 ± 26.46  9.89 ± 8.87
*P <0.05.
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Introduction  Animal studies suggest matrix metalloproteinase-8 
(MMP8) (neutrophil collagenase) impairs neutrophil (PMN) recruitment 
in infl   ammation; in humans, MMP8 has been associated with 
infl   ammation. We hypothesized that septic patients with single 
nucleotide polymorphisms (SNPs) in the MMP8 promoter region will 
have a survival advantage, and this advantage is due to diff  erences in 
MMP8 enzymatic activity and not MMP8 levels.
Methods We examined data from patients with CAP-associated sepsis 
(GenIMS), analyzed three functional SNPs (rs3765620, rs1940475, 
rs11225395) in 1,567 Caucasians and tested associations with 60-day 
and 90-day mortality and severe sepsis incidence. We simulated 
functional MMP8 SNPs using anisotropic network modeling. Modeling 
suggested pro-domain structural stability aff  ecting  zymogen 
activation. Based upon the predictions, we then studied zymogen 
activation using bioluminescent resonance energy transfer (BRET). We 
generated recombinant pro-MMP8 with a pro-domain tag of luciferase 
and carboxy terminus tag of green fl  uorescent protein. BRET signal 
was generated when luciferase-cleaved substrate produced a photon 
transferring energy to the GFP acceptor. GFP in turn emitted a green 
light signal when the donor/acceptor pairs were spatially close. Upon 
MMP activation, pro-domain is cleaved causing a loss in BRET signal.
Results The rs1940475 genotype causing an amino acid mutation in 
the pro-domain was signifi  cantly associated with 90-day mortality (AA: 
8.5%, AG: 11.1%, GG: 14.7%, P = 0.007). Cumulative incidence showed 
that the A allele was associated with better 90-day survival. Computer 
simulation of the mutation suggests a delayed activation. BRET assay 
confi  rmed that pro-domain mutation of MMP8 (K87E) rendered it less 
amenable to activation.
Conclusions Our results suggest altering the structural stability of the 
inhibitory MMP8 pro-domain impacts enzyme activation. Therapeutics 
targeting pro-domain could be used to modulate MMP function and 
control downstream infl  ammatory processes in sepsis.
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Introduction Timely diagnosis of lung infection in critically ill patients 
is key to guide therapy and avoid futile antibiotic prescription. The gold 
standard for diagnosis is microbiological culture of bronchoalveolar 
lavage fl  uid (BALf). However, it takes up to 48 hours to disclose results. 
Pentraxin 3 (PTX3) is an acute phase mediator of infection that can be 
assayed in a few hours. We described a relationship between BALf PTX3 
presence and lung infection in acute respiratory distress syndrome 
patients. The aim of this study was to validate BALf PTX3 as an early 
marker of lung infection in critically ill patients.
Methods We collected 40 consecutive BALfs from 36 adult patients 
admitted to our general ICU. BALfs were collected by standard 
technique and cultured when lung infection was clinically suspected 
(that is, pulmonary infi   ltrate + presence of fever, leukocytosis or 
leukopenia and purulent secretions). We collected plasma samples at 
the same time as BALf sampling. We assayed PTX3 in BALf and plasma 
by ELISA (detection limit 0.1 ng/ml) and we recorded BALf microbiology 
results. We defi   ned lung infection when noncontaminant microbe 
was identifi  ed in ≥104 cfu/ml. Analyses were performed by simple 
regression, chi-square or Fisher exact test and ROC curve analysis, as 
appropriate.
Results  Lung infection was diagnosed in 14/40 cases (35%). Three 
out of 14 (21%) were defi  ned as community-acquired pneumonia, 
4/14 (28%) were hospital-acquired, while 7/14 (50%) were ventilator-
associated. PTX3 was detectable in 22/40 BALfs (55%, mean value 
5.66 ± 8.89 ng/ml). Plasma PTX3 was not signifi  cantly correlated with 
BALf PTX3. Circulating PTX3 was not higher when lung infection was 
present (83.07 ± 126.42 ng/ml vs. 104.7 ± 166.16 ng/ml, P = 0.65). At 
the opposite, PTX3 was more likely to be detectable in culture-positive 
BALfs in comparison with negative samples (13/14 (93%) vs. 9/26 (34%), 
P = 0.001). The ROC curves analysis showed that alveolar PTX3 was able 
to diagnose lung infection (AUC = 0.815 (95% CI = 0.675 to 0.954), 
P = 0.001) and that a value of alveolar PTX3 = 0.95 ng/ml predicted 
pneumonia with 77% specifi  city and 93% sensitivity.
Conclusions BALf PTX3 levels predicted lung infection presence in a 
relatively large population of critically ill patients. Enrolment of more 
patients in the present study may disclose the BALf PTX3 role in the 
diagnosis of pneumonia in the critical care clinical setting.
P280
Increased levels of soluble triggering receptor expressed on 
myeloid cells sTREM1 in ICU patients with cardiovascular disease 
and associated organ dysfunction
S Dewan, A Varma, M Talegaonkar
Fortis Escorts Heart Institute, New Delhi, India
Critical Care 2011, 15(Suppl 1):P280 (doi: 10.1186/cc9700)
Introduction  sTREM1, a new receptor of the immunoglobulin 
superfamily, is expressed on neutrophils and monocytes/macrophages. 
It has been reported to be a useful marker in infectious infl  ammatory 
conditions such as sepsis, pneumonia and pancreatitis. Cardiovascular 
disease with shock and associated organ dysfunction in the form of 
acute kidney injury (AKI) and acute liver damage (LD) is a unique subset 
of disease conditions mediated by the infl  ammatory process and there 
may be a role of sTREM1 levels in assessing the severity of disease and 
prognostication of the patient. We hypothesized that the sTREM1 level 
may be increased in patients with cardiovascular disease and organ 
dysfunction and it can be used as a prognostic marker.
Methods A retrospective analysis of sTREM1 levels of 139 (99 males, 
40 females) (P <0.004) patients admitted between October 2009 and 
January 2010 to the ICU of our hospital. Patients with cardiovascular 
disease and organ dysfunction like AKI and LD were analysed. sTREM1 
level >25 pg/ml was taken as abnormal.
Results A total of 139 patients were analysed. sTREM1 was abnormal 
in 82 (59%) of the patients (mean ± SD 63.26 ± 54.58) and normal in 
57 (41%) patients (15.35± 6.10), which is highly signifi  cant (P <0.0001) 
and correlates well with total leucocyte counts, which are (mean ± SD) 
15,283 ± 6,126 for patients with abnormal sTREM1 and 13, 001 ± 6,518 
for normal patients (P <0.05). Out of 75 patients with coronary artery 
disease (CAD), 50 (61%) patients had abnormal sTREM1 levels as 
compared with 25 (43.9%) with normal levels (P <0.046). Out of 18 
patients with AKI, 15 (83.3%) had abnormal sTREM1 levels and three 
(16.6%) had normal levels (P  <0.020). Out of 15 patients with LD, 
13 (84.1%) had abnormal value and two (15.9%) had normal levels 
(P  <0.017). Although patients with abnormal sTREM1 had higher 
mortality it was not statistically signifi  cant due to the small number of 
patients.
Conclusions sTREM1 levels rise signifi  cantly in all kinds of cardiovascular 
disease and associated organ dysfunction like AKI and LD. Abnormal 
levels are also related to higher mortality, although not statistically 
signifi  cantly. The level of sTREM1 can be used as a prognostic marker 
for patients with this kind of disease scenario. These results confi  rm the 
usefulness of sTREM1 as a biological marker for diagnosing the severity 
of disease.
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Introduction Biomarkers off  er the possibility to speed up diagnosis 
of ventilator-associated pneumonia (VAP) and diff  erentiate it from 
nonpulmonary infection. One such marker, the triggering receptor 
expressed on myeloid cells-1 (TREM-1), exists as a soluble protein and 
a surface receptor expressed on monocytes and neutrophils [1]. The 
purpose of the study was to determine the diagnostic utility of surface 
TREM-1 levels in VAP.
Methods  Paired bronchoalveolar lavage (BAL) and blood were 
obtained from 25 VAP patients, 15 ventilated non-infected controls, 10 
ventilated patients with nonpulmonary infection and 25 nonventilated 
controls. VAP diagnosis was by clinical pulmonary infection score (CPIS) 
and semiquantitative microbiology. BAL and blood monocytic and 
neutrophilic levels of surface TREM-1 and CD11b (leukocyte activation 
marker) were assessed using fl  ow cytometry. Monocytes were CD14-
positive. Soluble TREM-1, IL-1β, IL-6 and IL-8 were measured using 
ELISA. BAL dilution was corrected by urea assay.
Results See Figure 1. The BAL level of monocytic surface TREM-1 was 
elevated in VAP. For ventilated patients, the area under the ROC curve 
(AUC) was 0.87 for diagnosing VAP, with sensitivity 72% and specifi  city 
80%. Blood levels did not diff  er between the groups. However, the BAL/
blood ratio improved diagnostic accuracy further. The AUC was 0.97, 
sensitivity 84%, specifi  city 92% and positive likelihood ratio 10.5. The 
ratio diff  erentiated pulmonary from nonpulmonary infection. The BAL/
blood ratio of monocytic CD11b was 0.78. The BAL levels of neutrophil 
surface TREM-1, soluble TREM-1, IL-1β and IL-8 had AUCs of 0.75, 0.76, 
0.81 and 0.85, respectively.
Conclusions  The BAL/blood ratio of monocytic surface TREM-1 
diagnoses VAP and diff   erentiates pulmonary from nonpulmonary 
infection. CD14 and TREM-1 may have a role in the pathogenesis of VAP.
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Introduction Several studies of critically ill patients have suggested 
an association of the D/D genotype of the insertion/deletion (I/D) 
angiotensin-converting enzyme (ACE) polymorphism with poor 
outcome probably by enhancing the infl   ammatory response and 
leading to a procoagulant state. Our aim was to evaluate the eff  ect of 
both the ACE I/D polymorphism and its gene product, on the clinical 
outcome of critically ill septic patients.
Methods  The study cohort included 186 consecutive Caucasian 
patients with sepsis, severe sepsis or septic shock. Epidemiological, 
clinical data and co-morbidities along with severity scores were 
recorded. Measurements of serum ACE activity and genotyping for 
ACE I/D polymorphism were carried out in all patients. The primary 
outcomes were the 28-day and 90-day mortalities; secondary 
outcomes included the number of days without renal or cardiovascular 
failure, and ventilation-free days over the 28-day period following the 
study enrollment. One hundred and eighty healthy blood donors were 
genotyped and used as controls.
Results  The genotype distribution in the patients’ group was 
comparable with that observed in controls (P  =  0.45). ACE I/D 
polymorphism and circulating ACE levels were not associated with 
mortality (P >0.05) or with secondary outcomes including ventilation-
free days and days without cardiovascular or renal failure among septic 
critically ill patients (P >0.05). See Figure 1.
Conclusions Neither the ACE I/D polymorphism nor the serum ACE 
levels seem to be signifi  cant prognostic factors of the outcome of 
sepsis in critically ill patients.
Figure 1 (abstract P282). Kaplan–Meier curves of survival up to 28 days 
for the three ACE gene polymorphisms.
Figure 1 (abstract P281). BAL/blood monocytic TREM-1 ratio.
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Introduction Recombinant human soluble thrombomodulin (rhs-TM) 
has a potent anticoagulant eff  ect on septic disseminated intravascular 
coagulation (DIC) by binding to thrombin and activating protein C. 
The infusion dosage of rhs-TM should be reduced for patients with 
renal failure. The aim of this study was to compare the eff  ects of rhs-
TM for systemic infl  ammatory response syndrome (SIRS)-associated 
coagulopathy (SAC) with and without continuous hemodiafi  ltration 
(CHDF).
Methods The subjects were 12 patients with SAC treated with rhs-
TM in our ICU. Of these, six received 380 units/kg/day rhs-TM, and six 
who were undergoing CHDF received 130 units/kg/day for 6 to 7 days. 
We analyzed the changes in DIC, sequential organ failure assessment 
(SOFA) and SIRS scores, platelet counts, antithrombin levels, fi  brin/
fi   brinogen degradation products (FDP) and prothrombin time 
internationalized ratio (PT-INR) after each treatment with rhs-TM. The 
values are expressed as means ± SD and were analyzed using Student’s 
paired t test and the Wilcoxon t test (P <0.05).
Results SOFA, DIC and SIRS scores and the values of PT-INR decreased 
after the administration of rhs-TM in both groups. Platelet counts 
increased in the group without CHDF and decreased in the group with 
CHDF, but these changes were not statistically signifi  cant. Antithrombin 
levels also increased in both groups, but these changes were not 
statistically signifi  cant either. FDP decreased signifi  cantly only in the 
group without CHDF. The changes in platelet counts were infl  uenced 
by CHDF, because platelet counts were decreased only in the group 
with CHDF. Several reports have mentioned that rhs-TM has an eff  ect 
of decreasing FDP for SAC. In this study, we observed decreased FDP 
only in the group without CHDF. We speculate that these results were 
infl  uenced by an infusion dose of rhs-TM.
Conclusions rhs-TM has a potent eff  ect in improving septic DIC even 
with an infusion dose of 130 units/kg/day for patients with CHDF.
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Introduction Reduced microvascular perfusion has been implicated 
in organ dysfunction and multiple organ failure associated with severe 
sepsis. Near-infrared spectroscopy (NIRS) can provide a non-invasive 
estimation of local tissue oxygenation (StO2) related to microvascular 
circulation. Previous investigators have reported a prognosis value of 
StO2 measurements realized during severe sepsis. Hyperbaric oxygen 
(HBO) is recommended as an associated treatment during soft-tissue 
severe infection. Interestingly, a microcirculation improvement has 
been reportedly identifi  ed in septic animals treated by HBO. The aim of 
this study is to evaluate the microcirculatory eff  ect of HBO therapy in 
septic patients assessing dynamics changes in StO2.
Methods  A prospective study over 1  year investigating 14 septic 
shock patients secondary to a soft-tissue infection. A concomitant 
microcirculation (for example, dynamic changes in StO2), macro-
circulation and metabolic assessment was performed before and 
after each HBO session (for the fi  rst three). Thenar eminence StO2 was 
measured continuously by NIRS during a vascular occlusion test: a 
3-minute transient ischemia infl  ating an arm cuff   50 mmHg above the 
systolic arterial pressure (Figure 1). Primary end point: StO2 reperfusion 
slope variation induced by HBO.
Results The reperfusion slopes on day 1 were lower in nonsurvivors 
compared with survivors (P  =  0.05). HBO increases cardiac output 
(P = 0.003) and reduces arterial blood lactate (P = 0.001). HBO improves 
post-ischemic microcirculatory parameters: hyperemic area (P = 0.01), 
ΔStO2 ( P  =  0.02), maximum StO2 ( P  =  0.04) and tends to improve 
reperfusion slope (P = 0.1). A signifi  cant negative correlation between 
reperfusion slope and blood lactate was observed. No correlation 
between macrohemodynamic and microcirculatory parameters, 
including baseline StO2 with ScvO2, was observed.
Conclusions If microvascular dysfunction is the key to the development 
of multiple organ failure in sepsis, the microcirculation should be a 
key therapeutic target. Our data confi  rm a good predictive value for 
outcome of the StO2 reperfusion slope at admission. Originally, we 
demonstrated a post-ischemic NIRS parameter improvement by HBO 
therapy. This microcirculatory eff  ect, independent of the HBO action on 
systemic hemodynamic parameters, was associated with a signifi  cant 
reduction of arterial lactate, a major prognostic factor in septic patients. 
These variations are probably due to capillaries recruitment induced by 
microvascular reactivity modifi  cations.
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Introduction  Microdialysis (MD) is a bedside in vivo sampling 
technique that permits continuous analysis of a patient’s interstitial 
fl  uid chemistry without consuming blood. As the interstitial fl  uid bathes 
the cells, its composition refl  ects the local metabolic activities of those 
cells, thus refl  ecting intracellular metabolic changes and disorders. In 
vivo MD is performed by implanting a commercially available catheter 
that mimics a blood capillary at the site of interest. In this study, we 
used MD to assess the metabolic changes of lipids in mechanically 
ventilated patients with sepsis.
Methods  Thirty-seven (21 men) mechanically ventilated septic 
patients were studied. All patients met the ACCP/SCCM consensus 
criteria for sepsis. Upon sepsis onset, an MD catheter was inserted into 
the subcutaneous tissue of the upper thigh. The dialysate samples 
were collected and analyzed immediately for glycerol using a mobile 
analyzer. Measurements were performed six times/day during the 
fi  rst 6 days from the sepsis onset. The daily mean values of the MD 
measurements were calculated. Blood samples were taken on the same 
days and were analyzed for total cholesterol, high-density lipoprotein 
(HDL), low-density lipoprotein (LDL), triglycerides, glycerol and free 
Figure 1 (abstract P284). Dynamic changes of StO2 during ischemic 
challenge.
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SOFA scores were also calculated.
Results Thirty-seven (21 men) critically ill septic patients with a mean 
(± SD) age of 65 ± 18 years were studied. APACHE and SOFA at study 
entry were 22 ± 4 and 8 ± 3, respectively. Sepsis was related to SIRS 
(n = 1), severe sepsis (n = 7) and septic shock (n = 29). Mortality was 
43%. Serum cholesterol (81 ± 42 mg/l) along with HDL (16 ± 17 mg/dl) 
and LDL (63 ± 37 mg/dl) were low. Serum triglycerides (158 ± 91 mg/dl) 
were elevated and FFAs (0.41 ± 0.27 mmol/l) were within normal limits. 
Serum glycerol was high (26 ± 20 mmol/l). Interstitial glycerol was also 
elevated (331 ± 190 μmol/l). Serum FFAs correlated with both serum 
(r = 0.43, P = 0.009) and interstitial (r = 0.33, P = 0.04) glycerol.
Conclusions Critical care sepsis is characterized by an increase in serum 
and tissue glycerol and preserved FFA levels; these indicate enhanced 
lipolysis and an increased FFA uptake by peripheral tissues. Serum or 
interstitial glycerol are better indices of lipid mobilization than serum 
FFA levels in mechanically ventilated septic patients.
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Introduction The Institute for Healthcare Improvement advocates the 
use of bundles to implement the sepsis guidelines. There are limited 
data addressing which elements improve survival [1]. We analyzed 
the data from a previous study to determine the independent impact 
of each element on patient outcome. We hypothesized that not all 
elements of the bundle have equal impact on outcome.
Methods The seven elements of the sepsis resuscitation bundle include 
lactate measurement, blood culture before antibiotic, timely antibiotic, 
adequate fl  uid resuscitation, appropriate vasopressor use, appropriate 
red blood cell (RBC) transfusion, and appropriate inotrope use. Baseline 
variables and the elements of the resuscitation bundle associated with 
mortality by univariate analyses at P <0.1 were included the propensity 
score. The univariate associations between the baseline variables and 
mortality were obtained from our previous study. The propensity 
scores were estimated using multiple logistic regression analysis.
Results  The study included 962 patients. Lactate measurement, 
timely blood culture and antibiotic administration, appropriate fl  uid 
resuscitation, and appropriate inotrope use were associated with 
increased mortality at P  <0.1 using univariate analyses. Using the 
propensity score of each bundle element for adjustment, compliance 
with lactate measurement and inotrope administration were 
independently associated with decreased risk of death (Table 1). 
Timely antibiotic administration had a trend toward risk reduction, the 
P value did not reach statistical signifi  cance. Obtaining blood culture 
before antibiotic administration, vasopressor administration, and RBC 
transfusion were not associated with decreased risk of death.
Table 1 (abstract P286)
Bundle element  OR (95% CI)  P value
Lactate 0.581  0.022
Antibiotic 0.706  0.085
Inotrope 0.678  0.033
Conclusions  Using the propensity score to adjust for compliance 
with each bundle element, lactate measurement and inotrope 
administration were independently associated with reduced risk of 
death.
Reference
1. Ferrer  R,  et al.: JAMA 2008, 299:2294-2303.
P287
Multicenter trial of a perioperative protocol to reduce mortality in 
critically ill patients with peptic ulcer perforation: the PULP trial
M Hylander Møller
University Hospital Bispebjerg, Copenhagen, Denmark
Critical Care 2011, 15(Suppl 1):P287 (doi: 10.1186/cc9707)
Introduction The aim of the present intervention study was to evaluate 
the eff  ect of a multimodal and multidisciplinary perioperative care 
protocol on mortality in patients with peptic ulcer perforation (PPU). 
Sepsis is frequent and a leading cause of death in PPU patients, and 
morbidity and mortality is substantial [1,2].
Methods An externally controlled multicenter trial using historical and 
concurrent national controls in seven gastrointestinal departments in 
Denmark. Participants were 117 consecutive patients surgically treated 
for gastric or duodenal PPU between 1 January 2008 and 31 December 
2009. The intervention was a multimodal and multidisciplinary 
perioperative care protocol based on the Surviving Sepsis Campaign. 
The main outcome measure was 30-day mortality.
Results Demographic characteristics were not diff  erent between the 
groups. The 30-day mortality proportion following PPU was 17% in the 
intervention group, compared with 27% in all three control groups; 
P = 0.005 (Figure 1). This corresponds to a relative risk (95% confi  dence 
interval) of 0.63 (0.41 to 0.97), a relative risk reduction of 37% (5 to 58) 
and a number needed to treat of 10 (6 to 38).
Conclusions The 30-day mortality in patients with PPU was reduced 
by more than one-third after the implementation of a multimodal and 
multidisciplinary perioperative care protocol based on the Surviving 
Sepsis Campaign, as compared with conventional treatment.
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Introduction The objective was to assess correlation between organ 
failure and outcomes in patients admitted with neutropenic sepsis to 
an adult ICU in a district general hospital.
Methods  Retrospective data were collected for admissions with 
neutropenic sepsis to the ICU over a 3-year period. The Ward Watcher 
electronic system was used to collect data on the level of organ support 
on the ICU. Outcomes assessed were 30-day and 1-year mortality.
Results Twenty-nine neutropenic patients were admitted during the 
study period; 93% had haematological malignancy while 7% showed 
Figure 1 (abstract P287). Thirty-day mortality in the intervention group 
compared with the controls.
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and 52% had zero count during their ICU stay. A total of 41.3% had 
positive blood cultures. Mortality with negative blood cultures was 
73%. Overall 30-day mortality was 58.6% and 1-year mortality was 
79.3%. Ventilator support was needed in 83% with a mortality of 88%. 
Inotropes were required in 48.2% and there was a 71% 30-day mortality. 
Renal support was commenced in 27.5% with 100% mortality. The 30-
day mortality was 100% in patients requiring invasive ventilation and 
renal support. Mortality was also 100% in those requiring three-organ 
support (Figure 1).
Conclusions Our data suggest a signifi  cant mortality in mechanically 
ventilated patients with neutropenic sepsis. This rises to 100% if two or 
more organs are supported, especially if one of them is the kidney. Early 
recognition and intervention to prevent progression to multiorgan 
failure is paramount to improve outcomes.
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Introduction Early bystander cardiopulmonary resuscitation (CPR) is 
one of the most eff  ective interventions in improving outcome from 
sudden out-of-hospital cardiac arrest. However, despite large-scale 
community training programs, citizen-CPR rates have been persistently 
low. Therefore, a recent report of the 2010 European Resuscitation 
Council guidelines has re-emphasized the need for dispatchers to be 
specifi  cally trained in starting telephone CPR protocol for suspected 
cardiac arrest. In accordance, 112 Belgian dispatchers have been trained 
for resuscitation assistance by telephone, using a specifi  c protocol 
named ALERT (Algorithme Liègeois d’Encadrement à la Réanimation 
Téléphonique). The present work evaluates the educational aspects of 
this recent implementation.
Methods  This was a prospective multicentric study including all 
French-speaking dispatchers in Belgium (n  =  140). The aim was to 
assess the added value of the training, based on the model of Donald 
Kirkpatrick that allowed gathering information about perceptions of 
dispatchers, their satisfaction with the training and their actual ability 
to apply the protocol.
Results  Dispatchers had a good pre-existing overall knowledge of 
CPR (80%), which was nevertheless signifi   cantly increased by the 
training (97%). There was a signifi  cant improvement in perceptions 
of dispatchers regarding their assistance skills (+44%). The training 
provided a signifi  cant improvement in staff   perceptions on applicability 
of the approach on the fi  eld, and impacts for the victims. Participants 
(96%) were generally satisfi  ed with the training. Finally, participants’ 
knowledge on public health issues (33%), basic life support (+17%) and 
dispatching protocol (+19%) was signifi  cantly improved.
Conclusions French-language federal training in the 100/112 dispatch-
ing centers signifi   cantly improves dispatchers’ perceptions and 
knowledge of assistance to resuscitation by the ALERT protocol. Such 
results reinforce the pivotal role of standardized protocols and training 
in art and science medical dispatching.
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randomized trial. Resuscitation 2011, 82:57-63.
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Introduction Despite all the research and education that has gone 
into the fi  eld of cardiopulmonary resuscitation (CPR), survival rates 
remain bleak. A signifi  cant problem has been the discrepancy between 
teachings and witnessed clinical practice. As a result of this, and the 
deleterious outcomes associated with hyperventilation, we conducted 
a manikin-based study to evaluate three diff  erent ventilating devices 
and their ability to provide guideline-compliant ventilation during 
simulated adult CPR.
Methods A simulated cardiac arrest scenario was undertaken by 33 
healthcare professionals (α = 0.05, power = 80%). Participants were 
asked to ventilate a simulated cardiac arrest patient for a period of 1 
minute with all three devices, during which time various ventilatory 
parameters were recorded using a spirometer. The devices investigated 
were the Mapleson C circuit, adult (1.6 l) and paediatric (500  ml) 
self-infl  ating bags. P <0.01 was deemed statistical signifi  cant, due to 
multiple comparisons.
Results The paediatric self-infl  ating bag performed best, with signifi  -
cant improvement in the mean minute ventilation (P = 0.003), tidal 
volume (P <0.001) and peak airway pressure (P <0.001). Despite the 
signifi  cant diff  erences, the paediatric self-infl  ating bag still delivered 
a mean minute ventilation of 7.01 l/minute, which still exceeds the 
Resuscitation Council’s suggested 5 l/minute. See Table 1.
Table 1 (abstract P290). Comparison of data on ventilation parameters
 500 ml  1.6  l   
 self-  self-   
 infl  ating  infl  ating  Mapleson 
 bag  bag  C  circuit  P value
Minute ventilation (l/minute)   7.01 (3.22)  9.68 (4.22)  9.77 (3.45)  0.003*
Tidal volume (nl)  391 (51.5)  582 (86.7)  625 (103)  <0.001*
Respiratory rate (/minute)  16.7 (6.9)  18 (6.45)  17.3 (5.46)  0.704†
Peak airway pressure (cmH2O)  14.5 (5.18)  20.7 (9.03)  30.3 (11.4)  <0.001*
Data presented as mean (SD). *Statistically signifi  cant result. †Nonstatistically 
signifi  cant result.
Conclusions Participants were found to be hyperventilating simulated 
cardiac arrest patients with all devices. The paediatric self-infl  ating bags 
delivered the most guideline-compliant ventilation and its use in adult 
CPR may be a simple measure to ensure delivery of more guideline-
consistent ventilation.
Figure 1 (abstract P288). Outcomes depending on support level.
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Introduction  Nifekalant (NIF) is a pure potassium channel blocker 
developed in Japan and it has been used widely for treating fatal 
ventricular tachyarrhythmia since 1999. Because intravenous 
amiodarone (AMD) was approved in 2007 in Japan, there have been 
few studies about the comparison of the effi   cacy of NIF and AMD 
for resuscitation after cardiopulmonary arrest patients due to shock-
resistant ventricular fi  brillation.
Methods  We performed a retrospective study in 32 consecutive 
cardiopulmonary arrest patients treated by NIF or AMD due to more 
than twice shock-resistant ventricular fi  brillation from April 2005 to 
October 2010. The statistical analyses performed by chi-square test and 
nonpaired t test.
Results The mean (± SD) age was 62.2 ± 16.1 years and 25 of 32 were 
male patients. All 32 patients were treated with tracheal intubation 
and intravenous epinephrine. Seventeen patients received NIF 
administration and 15 patients received AMD. The average initial 
administration dose of NIF was 11.1 ± 3.4 mg and that of AMD was 
171.7 ± 59.7 mg. The rate of return of spontaneous circulation (ROSC) 
was 41.2% (7/17) in the NIF administration group and 26.7% (4/15) 
in the AMD group. The survived discharge rate from our hospital was 
29.4% (5/17) in the NIF group and 13.3% (2/15) in the AMD group. 
There were no signifi  cant diff  erences between the two groups with 
the rate of ROSC and survived discharge. The mean interval from the 
antiarrhythmic drug (NIF or AMD) administration to ROSC was 7.8 ± 6.6 
minutes (NIF) and 19.9 ± 11.7 minutes (AMD). There was signifi  cant 
diff  erence between the interval of NIF and that of AMD (P <0.05).
Conclusions  Although NIF is an anti-arrhythmic agent for life-
threatening ventricular tachyarrhythmia, it does not have negative 
inotropic activity. NIF changes shock-resistant ventricular fi  brillation 
to spontaneous circulation more quickly than AMD. NIF is strongly 
eff  ective for resuscitation of shock-resistant ventricular fi  brillation.
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Introduction The interval of call to arrival is one of the major factors 
associated with good outcomes of out-of-hospital cardiac arrests 
(OHCAs). The FAST system helps emergency vehicles reach a scene 
quickly by controlling the traffi     c signals. The aim of study is to 
investigate whether the FAST system may improve the outcomes of 
OHCAs by decreasing the response time.
Methods We analyzed the data from OHCAs that were witnessed or 
recognized by citizens from April 2003 to March 2010. The OHCA data 
were compared between the two groups transported by ambulances 
with and without FAST units. The comparisons were made in the central 
and peripheral areas with and without FAST-controlled signals.
Results Dispatch of and transportation by FAST-loaded ambulances 
signifi  cantly decreased the interval of call to arrival and signifi  cantly 
augmented the incidence of sustained ROSC and 1-year survival 
only in the central area (Figure 1). Monovariate analysis followed by 
logistic regression analysis revealed that FAST implementation is an 
independent factor associated with 1-year survival (adjusted odds ratio 
with 95% CI = 1.306 (1.014 to 1.691)) and sustained ROSC (1.249 (1.108 
to 1.410)).
Conclusions The implementation of FAST may improve the outcomes 
of OHCAs mainly by reducing the interval of call to arrival.
References
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3.  BMJ 2001, 322:1385-1388.
P293
Responsiveness to EMT-performed basic CPR and its duration 
predict unachievable sustained return of spontaneous circulation 
and unavoidable hospital death in unwitnessed out-of-hospital 
cardiac arrests without bystander CPR
H Inaba, Y Takei, M Enami, Y Goto, K Ohta
Kanazawa University Graduate School of Medicine, Kanazawa, Japan
Critical Care 2011, 15(Suppl 1):P293 (doi: 10.1186/cc9713)
Introduction  Various criteria to terminate resuscitation have been 
reported. EMTs in Japan are not permitted to terminate resuscitation in 
Figure 1 (abstract P292). Eff  ect of the FAST implementation on outcomes of OHCAs in the two regions.
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response to basic CPR and its duration may predict hospital death.
Methods  The basal data were prospectively collected from 1,437 
unwitnessed out-of-hospital cardiac arrests (OHCAs) that were 
resuscitated by EMTs without the ACLS technique in Ishikawa Prefecture 
(Figure 1). The cut-off   points of basic CPR duration for outcomes were 
determined. Sensitivity and specifi  city were calculated.
Results The improvement of the ECG rhythm by basic CPR predicted 
the sustained return of spontaneous circulation (SROSC) in hospital. 
The duration of EMT-performed CPR predicted the outcomes of the 
OHCAs that were unresponsive to the basic CPR (Figure 2).
Conclusions Responsiveness to basic CPR and its duration may predict 
unavoidable death in hospital.
References
1.  N Engl J Med 2006, 355:478-487.
2.  JAMA 2008, 300:1432-1438.
3.  Resuscitation 2010, 81:679-684.
P294
Is intraosseous access a safe option in adult cardiac arrest? A review 
of the literature
J Baombe, B Foex
Manchester Royal Infi  rmary, Manchester, UK
Critical Care 2011, 15(Suppl 1):P294 (doi: 10.1186/cc9714)
Introduction Intraosseous (IO) cannulation for the infusion of fl  uids 
and medications was fi   rst described by Drinker and colleagues in 
1922 [1]. Its use in the paediatric population has previously been 
validated and is now widely accepted worldwide. However, adult IO 
drug administration has been lagging behind for various reasons. The 
authors reviewed the literature to determine the feasibility and safety 
of this underused cannulation method.
Methods  The MEDLINE database (1950 to week 2 August 2010) 
was searched using the terms intraosseous infusions, heart arrest, 
cardiopulmonary arrest, cardiac arrest, resuscitation, cardiopulmonary 
resuscitation with their appropriate combinations and truncated terms. 
The Embase database (1980 to week 2 August 2010) was searched using 
the terms intraosseous drug administration, heart arrest, resuscitation, 
fl  uid resuscitation. Both searches were limited to English language, 
humans and adults only.
Results The MEDLINE search returned 518 papers, most of them case 
reports not included in our fi  nal table of summary as of low level of 
evidence. The two studies fi   nally included presented encouraging 
results but are limited by small numbers. Seventy-seven papers were 
found through the Embase search but none were relevant to our 
specifi  c questions.
Conclusions IO access in adults appears to be a fast and reliable method 
to deliver drugs and fl   uids during cardiopulmonary resuscitation, 
allowing achievement of adequate drug concentrations and desired 
pharmacological responses. Despite the limited literature, it should 
probably be considered if other traditional methods for drug and fl  uid 
delivery have failed.
Reference
1.  Drinker C, Drinker K, Lund C: The circulation in the mammalian bone 
marrow. Am J Physiol 1922, 62:1-92.
Figure 1 (abstract P293). Overview of out-of-hospital cardiac arrests 
analyzed.
Figure 2 (abstract P293). Duration of EMT-performed BLS determines the incidence of SROSC at hospital and 1-year survival in unwitnessed OHCAs without 
CPR before EMT arrival.
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Introduction  Although bystander cardiopulmonary resuscitation 
(CPR) can improve survival from cardiac arrest, the reported prevalence 
of bystander CPR remains low in most countries. This study was 
performed to investigate factors aff  ecting laypersons’ willingness in 
performing CPR.
Methods Questionnaires including 10 questions regarding personnel 
backgrounds, knowledge regarding the use of AED, CPR training, 
willingness in performing CPR, and EMS dispatcher’s advice were 
distributed to citizens who gathered at a ball park stadium, a typical 
public place in Hiroshima, Japan.
Results Ten thousand questionnaires were distributed and a total of 
5,956 were collected for analysis. Age distributions of the respondents 
were: <20 years old: 13%, 20 to 49 years old: 67%, 50 to 69 years old: 
16%, >70 years old: 3%. Fifty-seven percent were male. Ninety-one 
percent had heard of AED; however, only 45% knew how to use it. 
Forty-nine percent took CPR training before. As for the willingness to 
perform CPR, 38% answered they would start CPR, 34% would do it if 
any advice was available. On the other hand, 23% said they were not 
capable of performing CPR, and 4% were not willing to do it. Of those 
who were not capable of performing CPR, the reasons included lack of 
knowledge and/or skills to perform CPR (50%), no previous CPR training 
(27%), concern over harm to the victims (25%), and lack of confi  dence 
to determine cardiac arrest (19%). Of those who were willing to perform 
CPR, 61% answered they would prioritize rescue breathing over chest 
compression. In comparison of those with and without previous CPR 
training or knowledge of the use of AED, signifi  cant diff  erences were 
found in the willingness in performing CPR (88% vs. 58%, P <0.0001; 
91% vs. 58%, P <0.0001, respectively) and doing rescue breathing (55% 
vs. 29%, P <0.0001; 64% vs. 57%, P <0.0001, respectively). Fifty-two 
percent of the respondents did not know the service of dispatcher-
assisted CPR.
Conclusions  Our study indicated that proper knowledge of CPR, 
prior CPR training, and onsite bystander CPR assistance may enhance 
laypersons’ willingness in performing CPR. More emphasis should be 
exerted on the roles of chest compression and the EMS dispatcher 
assistance in CPR education.
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Introduction Correctly performed basic life support (BLS) and early 
defi  brillation are the most eff  ective measures to treat sudden cardiac 
arrest. Audiovisual feedback improves BLS. Automated external 
defi  brillators (AEDs) with feedback technology may play an important 
role in improving CPR quality. The aim of this simulation study was to 
investigate whether an AED with audiovisual feedback improves CPR 
parameters during standard BLS performed by trained laypersons.
Methods With ethics committee approval and informed consent, 68 
teams (two fl  ight attendants each) performed 12 minutes of standard 
CPR with the AED’s audiovisual feedback mechanism enabled or 
disabled. We recorded CPR quality parameters during resuscitation 
on a manikin in this open, prospective, randomized controlled trial. 
Between the feedback and control group we measured diff  erences 
in compression depth and rate as the main outcome parameters 
and eff  ective compressions, correct hand position, and incomplete 
decompression as secondary outcome parameters. An eff  ective 
compression was defi  ned as a compression with correct depth, hand 
position, and decompression.
Results The feedback group delivered compression rates closest to 
the recommended guidelines (101 ± 9 vs. 109 ± 15/minute, P = 0.009), 
more eff  ective compressions (20  ±  18 vs. 5  ±  6%, P <0.001), more 
compressions with correct hand position (96  ±  13 vs. 88  ±  16%, 
P <0.001), and less leaning (21 ± 31 vs. 77 ± 33%, P <0.001). However, 
only the control group adhered to the recommended compression 
depth (44 ± 7 mm vs. 39 ± 6, P = 0.003).
Conclusions Use of an AED’s audiovisual feedback system improved 
some CPR quality parameters, thus confi  rming  fi   ndings of earlier 
studies, with the notable exception of decreased compression depth, 
which is a key parameter that might be linked to reduced cardiac 
output.
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did not increase return of spontaneous circulation in a physician-
staff  ed prehospital emergency medical system
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Introduction  Cardiopulmonary resuscitation (CPR) guidelines 
published by the European Resuscitation Council are intended to 
improve survival of cardiac arrest by implementing medical practice 
based on scientifi  c  fi   ndings. This study investigated whether the 
introduction of the 2005 CPR guidelines, which mandated several 
fundamental practice changes, improved the rate of return of 
spontaneous circulation (ROSC) in a physician-staff  ed  prehospital 
emergency medical system.
Methods Emergency physician protocol sheets from calls responding 
to cardiac arrest were reviewed and the following data were collected: 
bystander CPR and bystander use of a semi-automatic defi  brillator, 
medication administered by emergency physicians, number of 
defi  brillations, on-the-scene thrombolysis, occurrence of ROSC. These 
parameters were compared in a 3-year period from each before and 
after the introduction of the 2005 CPR guidelines.
Results A total of 632 CPR protocols were analyzed, and the groups 
were comparable regarding age, sex, delay and initial rhythm. 
Bystander CPR was observed in 35% of the cases, with no diff  erence 
between before and after the introduction of the 2005 guidelines 
and was not associated with an increase in ROSC. Bystander use of a 
defi  brillator was rare (2.5%), but was associated with an increase in 
ROSC. When advanced life support by emergency physicians was 
conducted according to the 2000 guidelines, ROSC occurred in 29% 
of the cases, whereas ROSC occurred in 36% of the cases after 2005 
(P = 0.058). Adrenaline and manual defi  brillations were applied less 
frequently after 2005, whereas amiodarone and atropine were used 
more frequently. The application of thrombolysis was not diff  erent 
before and after 2005, but was associated with an increase in ROSC.
Conclusions In our setting, the 2005 CPR guidelines apparently failed 
to reach out to laypersons, as bystander CPR was neither more frequent 
nor associated with an increase in ROSC. The 2005 guidelines had an 
impact on advanced life support practice by emergency physicians, but 
there was only a trend to an increase in ROSC.
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Introduction  Intracranial hemorrhage, especially subarachnoid 
hemorrhage (SAH), may lead to cardiac arrest via a number of 
mechanisms. A recent prospective Japanese study found 16.2% of 
patients with SAH among those resuscitated from out-of-hospital 
cardiac arrest (OHCA) [1]. In contrast, a retrospective European study 
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of SAH prior to OHCA [2]. Hence, diff  erent recommendations regarding 
routine cranial imaging may be obtained from the two studies.
Methods We therefore evaluated retrospectively the rate of SAH in 
cardiac arrest patients consecutively admitted to our internal medicine 
ICU. For all patients, CCT and autopsy fi   ndings were obtained, if 
available. In addition we screened emergency room or fi  nal medical 
reports of SAH patients admitted to our neurosurgical ICU for OHCA 
and resuscitation.
Results Cranial computed tomography (CCT) was performed in 129 of 
421 (32.6%) cardiac arrest patients admitted to our internal medicine 
ICU, commonly on the day of admission (52% of CCTs) or within the 
fi  rst week (85%). None of the CCTs showed signs of SAH. Retrospective 
analysis of all autopsies (n = 18) revealed no postmortem diagnosis 
of SAH. A retrospective analysis of SAH patients admitted to our 
neurosurgical ICU revealed only one out-of-hospital resuscitation 
among 141 SAH patients (0.7%), in line with a recent study [3].
Conclusions Our data indicate a low rate of SAH in patients with OHCA, 
especially when not clinically suspected. For our patient cohort, routine 
CCT may not be indicated after cardiac arrest. The rate of SAH leading 
to OHCA seems to diff  er signifi  cantly between Japan and Germany. Our 
results have to be interpreted with care because of the retrospective 
study design and possible selection bias. Further prospective studies 
are needed to confi  rm the results.
References
1. Inamasu  J,  et al.: Subarachnoid haemorrhage as a cause of out-of-hospital 
cardiac arrest: a prospective computed tomography study. Resuscitation 
2009, 80:977-980.
2. Kürkciyan  I,  et al.: Spontaneous subarachnoid haemorrhage as a cause of 
out-of-hospital cardiac arrest. Resuscitation 2001, 51:27-32.
3.  Toussaint LG 3rd, et al.: Survival of cardiac arrest after aneurysmal 
subarachnoid hemorrhage. Neurosurgery 2005, 57:25-31.
P299
Predicting survival in cardiac arrest patients admitted to intensive 
care using the Prognosis After Resuscitation score
R Porter, I Goodhart, A Temple
Sheffi   eld Teaching Hospitals NHS Trust, Sheffi   eld, UK
Critical Care 2011, 15(Suppl 1):P299 (doi: 10.1186/cc9719)
Introduction Developed from meta-analysis in 1992, the Prognosis 
After Resuscitation (PAR) score consists of seven, relatively straight-
forward to calculate, variables with scores greater than 5 predicting 
nonsurvival [1]. The aim of this evaluation was to assess PAR scoring 
as a means of predicting nonsurvival of post-cardiac arrest patients 
admitted to the general intensive care unit (ITU) at Sheffi   eld Teaching 
Hospitals NHS Trust (STH).
Methods Previous local service reviews have collected data on hospital 
survival and PAR scoring between January 2002 and May 2008 [2,3]. In 
addition, from May 2008 to July 2010, post-cardiac arrest patients were 
identifi  ed from the admissions book and a medical notes review was 
carried out.
Results Since 2002 a total of 225 post-cardiac arrest patients have been 
admitted to the ITU. Forty per cent survived until hospital discharge. 
The PAR score ranged between –2 and 18, with 0 being the most 
common score. Four patients from the 37 (13.5%), admitted to the ITU, 
with a PAR score of greater than 5 survived until hospital discharge. 
Forty-six per cent of patients with a PAR score of 5 or less survived to 
hospital discharge. See Figure 1.
Conclusions Over the 8  years of review of our data we have only 
identifi  ed four patients where ongoing care was both appropriate and 
successful despite a PAR score greater than 5. We believe that these 
patients should have been admitted regardless of the PAR score due 
to the underlying pathology. The PAR score is an invaluable screening 
tool in justifying the decision not to admit a patient in whom it is felt 
critical care is not justifi  ed. However, caution must be used as the PAR 
score should be an aid to clinicians rather than the sole factor deciding 
appropriateness of critical care admission.
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Introduction Treatment of patients after sudden cardiac arrest remains 
a signifi  cant problem. Even after successful resuscitation, most patients 
have complications – one of the most serious and, unfortunately, very 
common being postanoxic brain injury. Aims of the study were to 
estimate the survival time for patients who had sinus rhythm restored 
after cardiac arrest but had neurological defi  ciency, and to estimate 
basic pathology that triggers cardiac arrest.
Methods Retrospective data analysis was performed in the coronary 
care unit of Lithuanian University of Health Sciences Hospital – Kaunas 
Clinics. Records of 56 patients were analysed (37.5% women and 62.5% 
men). Age ranged from 46 to 88 years. Average age was 65.32 ± 12.59. 
Sinus rhythm was restored for all patients after cardiac arrest, but had a 
neurological defi  ciency.
Results  A total 89.28% of patients suff  ered out-of-hospital cardiac 
arrest. For 28.6% of patients it was enough to make CPR less than 15 
minutes, before revival of sinus rhythm; 33.9% needed 15 to 30 minutes 
and 37.5% patients had to be resuscitated for more than 30 minutes. 
Almost one-half of patients (46.4%) did not survive 24  hours after 
resuscitation. The dominating basic pathology was acute myocardial 
infarction of the anterior wall (53.6%). The most common neurological 
defi  ciency was postanoxic coma (83.9%).
Conclusions Almost one-half of patients, which had revival of sinus 
rhythm after cardiac arrest and had neurological defi  ciency, did not 
survive 24 hours after resuscitation. The most common basic pathology, 
which caused cardiac arrest, was acute myocardial infarction with 
dominating anterior wall infarction.
Figure 1 (abstract P299). PAR score and hospital outcome (2002 to 2010).
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Introduction  Unconscious, mechanically ventilated survivors of 
cardiac arrest account for a large number of intensive care admissions. 
Such patients have a spectrum of outcomes, ranging from brain death 
to good recovery. Predicting the fi  nal neurological outcome during the 
early post-resuscitation phase is required and has been the centre of 
multiple studies.
Methods  We performed a literature review of studies assessing 
outcome predictors following cardiac arrest. We also reviewed national 
and international guidelines on the subject.
Results In comatose adult patients after cardiac arrest, and who have 
not been treated with hypothermia and who do not have confounding 
factors, the absence of the pupillary light response and corneal 
refl  ex at day 3 provides the most reliable predictor of poor outcome. 
The absence of vestibulo-ocular refl   exes at ≥24  hours and a GCS 
motor score of 2 or less at ≥72 hours are less reliable. The presence 
of myoclonus is not recommended for predicting poor outcome. The 
presence of myoclonic status epilepticus on day 1 is strongly associated 
with poor outcome. Several EEG fi  ndings are strongly, but not invariably 
associated with a poor outcome. Malignant EEG fi  ndings are associated 
with false predictive rate of 3%. Bilateral absence of the N2O cortical 
response to median nerve stimulation during somatosensory evoked 
potentials (SSEP) predicts poor outcome after 24 hours of cardiac arrest 
with FPR of 0.7%. There are no high-level studies that support the use 
of any imaging modality to predict outcome. There is some evidence 
that loss of distinction between grey and white matter on CT scan 
predicts poor outcome. Several studies have confi  rmed a relationship 
between serum neuron-specifi   c enolase and poor outcome but 
the cut-off    points are not clear. The value of serum S1000 and 
cerebrospinal fl  uid creatine kinase brain isoenzyme measurement is 
very limited. Therapeutic hypothermia after cardiac arrest complicates 
prognostication and evidence evaluating predictors of poor outcome 
in this situation is limited.
Conclusions Reliable predictors of poor outcome after cardiac arrest 
are the absence of the pupillary and corneal refl  exes at day 3. Bilateral 
absence of the N2O cortical response to median nerve stimulation 
during SSEP at day 1 is highly accurate. The use of EEG, CT, and 
neurological biomarkers is not reliable. Limited studies are available for 
predicting outcome after therapeutic hypothermia.
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Introduction Mild therapeutic hypothermia (MTH) is known to have 
a neuroprotective eff  ect after cardiac arrest (CA). Among the well-
recognized side eff  ects is an increased incidence of infections. A useful 
strategy in preventing lower respiratory tract infections (LRIs) during 
MTH is selective digestive tract decontamination (SDD). To this purpose, 
we examined the use of antibiotics and microbial fl  ora in sputum in 
post-CA patients treated with MTH and SDD and compared this with 
the infection rate during MTH that has been reported in literature.
Methods We examined sputum (endotracheal aspirate) of all post-CA 
patients who were treated with MTH (32 to 34°C) during 24 hours after 
ICU admission and SDD/cefotaxim (SDD/CFT) in our 16-bed mixed ICU 
in a teaching hospital in the Netherlands in the period January 2007 to 
December 2008 (n = 55; male = 44, female = 11). Sputum was collected 
at ICU admission and several days later as part of our SDD/CFT 
routine. Between 24 and 48 hours after admission, body temperature 
was actively held below 37°C. LRI was defi  ned as the presence of a 
potentially pathogenic microorganism (PPM) and the use of antibiotics 
other than SDD/CFT. The presence of Candida albicans/Candida spp. 
was considered colonisation and was treated with aerosol antifungal 
medication.
Results  The in-hospital mortality in our cohort was 30.9%. As can 
be concluded from our results, in 59.5% of cases a PPM was present 
in the fi  rst sputum during SDD/CFT treatment after admission, with 
C. albicans being the most prevalent (23.6%). As compared with the 
sputum on admission, the cultures of the fi  rst sputum with SDD/CFT 
more often showed a monomicrobial isolate (25.5 vs. 40.5%). In sputum 
of 9/37 (24%) of our patients, a PPM (other than C. albicans/C. spp.) that 
justifi  es the use of antibiotics was present, with S. aureus being the 
most prevalent PPM (13.5%); 5/9 patients were treated with antibiotics, 
1/9 received no additional antibiotics, 3/9 were lost to follow-up. Our 
results point towards a lower incidence of LRI in SDD/CFT-treated 
patients as compared with non-SDD/CFT-treated patients (88%) who 
were treated with MTH post-CA [1]. The incidence of LRI in our small 
cohort (24%) was also considerably lower as compared with a recent 
study by Nielsen and colleagues (48%) [2].
Conclusions Our results might point towards a benefi  cial role of SDD/
CFT in preventing LRI during treatment with MTH.
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Introduction Animal studies suggest a life-saving benefi  t for intra-
arrest cooling. Transnasal evaporative cooling has suffi   cient  heat 
transfer capacity for eff  ective intra-arrest cooling and improves survival 
in swine. A 200-patient study showed transnasal cooling to be a safe 
and feasible method of intra-arrest cooling. The study also showed a 
solid trend to improved neurologically intact survival rates in those 
patients receiving intra-arrest transnasal cooling.
Methods To determine eff  ects on neurologically intact survival at 90 
days from the addition of intra-arrest transnasal cooling compared with 
hospital-based cooling alone, patients in witnessed cardiac arrest of 
any rhythm and with CPR ≤15 minutes after a 112 call were randomized 
to intra-arrest transnasal cooling versus standard ACLS care in two 
European EMS systems. Transnasal cooling (RhinoChill (RC); BeneChill 
Inc., San Diego, CA, USA) was initiated using a mixture of volatile 
coolant plus oxygen for rapid evaporative heat transfer. In treatment 
patients, cooling was initiated pre-ROSC, during ongoing CPR. Patients 
in both groups were cooled upon hospital arrival.
Results Forty-one patients have been included thus far. The median 
time from the 112 call for EMS to start CPR was 7 minutes and the time 
to initiate cooling was 17 minutes. ROSC was achieved in 8/19 (42%) 
of the RC group versus 8/22 (36%) of the control group. Site 1 initiated 
cooling at 11 minutes, and the ROSC rate at this site was 3/6 (50%) for 
RC and 1/9 (11%) for controls. EMS CPR was initiated at 5 minutes in 
RC versus 7 minutes in controls. Site 2 initiated cooling at 20 minutes, 
and the ROSC rate for this site was 5/13 (39%) for RC compared with 
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9 minutes in controls.
Conclusions Initiating transnasal cooling extremely early during arrest 
may be superior to later intra-arrest initiation in relation to ROSC rates. The 
impact of this ultra-early cooling on outcome remains to be determined.
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Introduction  A recent US multicentre study demonstrated an 
increased mortality in intensive care patients exposed to high arterial 
oxygen levels following return of spontaneous circulation (ROSC) after 
cardiac arrest [1]. We attempted to ascertain the incidence of hyperoxia 
and associated mortality in a similar cohort of patients in the UK.
Methods  We performed a retrospective observational study of a 
computerised database (Draeger Innovian) over a 14-month period 
(March 2009 to May 2010). All adult, nontraumatic cardiac arrests 
within 24  hours of admission to the ITU were included. Sixty-nine 
patients were identifi   ed. The following data points were analysed: 
FiO2, pO2 and outcome. Time to fi  rst ABG and the PaO2/FiO2 (P/F) ratio 
were calculated. As per the US study, hypoxia was defi  ned as a pO2 
<60 mmHg or P/F ratio <300; hyperoxia as PaO2 >300 mmHg. Normoxia 
was the values in between.
Results Ninety per cent of patients had an arterial blood sample within 
the fi  rst hour after admission, compared with the US study where 
27.5% of patients did not receive an arterial sample within the fi  rst 
24 hours. Hyperoxia was only half as common in our population and 
was associated with the lowest mortality rate (50%). This is at odds with 
the Kilgannon study, which showed that hyperoxia was associated with 
the highest mortality [1]. Using their defi  nition of hypoxia, there is no 
signifi  cant diff  erence in mortality between hypoxia and normoxia in 
our study. If hypoxia is defi  ned as pO2 <60 mmHg then the hypoxia rate 
is only 2.9% with a mortality rate of 100%.
Conclusions In a single UK adult ICU attached to a cardiac arrest centre, 
hyperoxia after cardiac arrest was uncommon and associated with the 
lowest mortality. This is associated with increased vigilance in measuring 
arterial blood gases. Recent guidelines from the Resuscitation Council 
advise that inspired oxygen should be titrated to achieve a SaO2 of 94 
to 98% due to potential harm from hyperoxia [2]. This assertion is not 
borne out by our data. The defi  nition of hypoxia is important as there is 
a signifi  cant diff  erence in both incidence of hypoxia and mortality rates 
dependent on whether the P/F ratio is considered. In practical terms, 
clinicians can only aim to optimise their arterial oxygen saturations, not 
the P/F ratios.
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Introduction There is no reliable predictor on arrival at hospital for 
neurological outcome of the patient with out-of-hospital cardiac 
arrest (OHCA). We hypothesize that ammonia and lactate may predict 
neurological outcome.
Methods  We performed a prospective observational study. Non-
traumatic OHCA patients who gained sustained return of spontaneous 
circulation and were admitted to an acute care unit were included. 
Blood ammonia and lactate levels were measured on arrival at hospital. 
The patients were classifi  ed into two groups: favorable outcome group 
(Cerebral Performance Category (CPC) 1 to 2 at 6-month follow-up), and 
poor outcome group (CPC 3 to 5). Basal characteristics obtained from 
the Utstein template and biomarker levels were compared between 
these two outcome groups. Independent predictors were selected 
from all candidates using logistic regression analysis.
Results  Ninety-eight patients were included. Ammonia and lactate 
levels in the favorable outcome group (n = 10) were signifi  cantly lower 
than those in the poor outcome group (n = 88) (P <0.05, respectively). 
On receiver operating characteristic analysis, the optimal cut-off   
value for predicting favorable outcome was determined as 170 μg/dl 
ammonia, 12.0 mmol/l lactate (area under the curve: 0.714 and 0.735, 
respectively). Logistic regression analysis identifi  ed ammonia (≤170 μg/
dl), therapeutic hypothermia and witnessed by emergency medical 
service personnel as independent predictors of favorable outcome. 
When both these biomarker levels were over threshold, the positive 
predictive value (PPV) for poor outcome was calculated as 100%.
Conclusions  Ammonia and lactate blood levels on arrival are 
independent neurological prognostic factors for OHCA. The PPV with 
the combination of these biomarkers predicting poor outcome is high 
enough to be useful in clinical settings.
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Introduction  Patients admitted to intensive care (ITU) at Sheffi   eld 
Teaching Hospitals who have had a cardiac arrest are cooled according 
to the local therapeutic hypothermia (TH) protocol regardless of 
rhythm or location of arrest [1]. A previous audit identifi  ed poor effi   cacy 
in cooling patients to target [2]. Following this, the Medicool™ device 
was purchased to improve cooling. This aim of this evaluation is to 
assess the effi   cacy of cooling with Medicool™.
Methods Following local audit committee approval, patients admitted 
between May 2008 and July 2010 were retrospectively identifi  ed 
from ITU admission records. The following data were collected: 
demographics, arrest and admission characteristics, details of TH and 
outcome. Previous audit data from 2008 were also examined [2].
Results  Sixty-fi   ve patents were admitted to the ITU following 
cardiac arrest between May 2008 and July 2010. The median age 
was 67 years (29 to 81), 66% were male. Fifty-two per cent survived 
to hospital discharge. Forty-eight patients were eligible for cooling; 
in 43 cooling was performed: 26 were cooled using Medicool™ and 
17 using traditional techniques. The median time to reach the target 
temperature was 4 hours with Medicool™ and 5 hours with traditional 
techniques. In six patients, cooling was abandoned. In patients who 
completed 24 hours of cooling, 57% of the Medicool™ patients and 31% 
of the traditionally cooled patients remained in the target temperature 
for the entire 24 hours. No patients (n = 20) in the previous audit were 
Figure 1 (abstract P306). Patients in whom the target temperature was 
maintained for 24 hours (P = 0.006).
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techniques. See Figure 1.
Conclusions The Medicool™ system increases both the cooling rate 
and the effi     cacy of cooling in patients undergoing TH. We would 
advocate the use of Medicool™ over the traditional cooling techniques. 
It is more eff  ective and additionally when compared with other more 
invasive cooling techniques is cheaper to instigate, easy for healthcare 
professionals to use and is associated with less side eff  ects.
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Introduction  Lately it has been proven that mild therapeutic 
hypothermia (MTH) after cardiac arrest (CA) weakens the prognostic 
value of both neurological tests and serum markers, established 
before MTH was implemented [1-3]. Current prognostication and 
decision criteria have to be re-evaluated as well as new markers being 
necessary. Whole blood choline (WBCHO) and plasma choline (PLCHO) 
are promising new markers in cardiac arrest patients and they are 
under investigation as markers for global tissue ischemia [4-6]. It is 
unknown whether the recommended MTH treatment in patients after 
CA will infl  uence choline levels. Therefore we analyzed choline kinetics 
in CA patients undergoing hypothermia treatment as a feasibility trial.
Methods All patients received MTH irrespective of the initial rhythm. 
Blood samples were taken on admission then again when reaching the 
therapeutic temperature of 33°C and after 12 hours of MTH at 33°C. 
All samples were stored at –80°C [4]. In order to determine the whole 
blood and plasma choline levels; high-pressure liquid chromatography 
combined with a mass spectrometer technique was used.
Results Six patients after cardiac arrest were analyzed in this feasibility 
trial. Four patients were male, two female. Median age was 66.5 years 
(interquartile range 57.5 to 82.25). Choline analyses revealed in fi  ve 
patients increased choline levels (>10 μmol/l) on admission. Four 
patients showed a peak in both PLCHO and WBCHO when the 33°C 
target temperature during cooling was reached. Although MTH was 
maintained over 24  hours, in all cases the patients’ choline levels 
decreased already after 12 hours of treatment to low or even subnormal 
concentrations.
Conclusions Both whole blood choline and plasma choline demon-
strated a release pattern in patients after cardiac arrest undergoing 
hypothermia treatment. Larger studies have to evaluate the kinetics in 
detail and the potential prognostic implications of low or high choline 
levels in cardiac arrest patients.
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Introduction  Current guidelines recommend early institution of 
thera  peutic hypothermia (TH) in survivors of out-of-hospital cardiac 
arrest (OHCA). However, recent surveys show that TH is delivered 
inconsis  tently, incompletely, and with undue delay. Targeted 
knowledge translation (KT) strategies may increase the proportion of 
OHCA patients receiving TH.
Methods We conducted a stepped-wedge cluster randomized trial to 
evaluate the eff  ectiveness of a multi-faceted KT strategy for increasing 
TH use in a network of 37 hospitals. After a baseline period of 1 year, four 
wedges of six hospitals were randomized to receive 1 year of passive 
KT followed by 4 months of active KT. Passive KT included a generic 
protocol and order set; active KT included network events, performance 
feedback and ongoing nurse educator support. The primary outcome 
was the rate of successful TH, defi  ned as a temperature of 32 to 34°C 
within 6 hours of emergency department (ED) arrival.
Results  During the study 4,742 OHCA patients were transported 
to hospital and 1,063 (22%) were eligible for TH. Overall, both KT 
interventions were eff  ective at increasing the rate of successful TH 
(Figure 1), and passive KT led to marked improvements over baseline 
(96/395 vs. 30/320 patients; OR = 2.24, 95% CI = 1.54 to 3.26; P <0.05). 
Active KT did not improve the primary outcome compared with passive 
KT (86 of 348 patients with active KT; OR = 0.94, 95% CI = 0.70 to 1.28; 
P = 0.70); however, it did signifi  cantly increase rates of initiating TH in 
the ED (P = 0.04). Inappropriate TH remained rare (5 to 6% of patients) 
during both KT phases.
Conclusions A multifaceted KT intervention markedly improved rates 
of TH in a large network of hospitals. Simple passive KT strategies 
were highly eff  ective in increasing TH rates, whereas more active KT 
improved the use of TH in the ED.
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Introduction  The crucial role of the microcirculation for improved 
neurological outcome in patients after successful resuscitation has 
been discussed for many years. Near-infrared spectroscopy has 
been proposed as a non-invasive tool to measure continuously 
the haemoglobin saturation in the terminal vascularisation within 
the tissues (StO2) of thenar eminence and to detect microvascular 
dysfunction by performing a vascular occlusion test (VOT). This study’s 
purpose was to explore the alteration in microcirculation in patients 
after successful resuscitation.
Figure 1 (abstract P308). Successful TH across KT interventions.
Critical Care 2011, Volume 15 Suppl 1 
http://ccforum.com/supplements/15/S1
S110Methods  Since August 2010 to date, 23 successfully resuscitated 
patients were prospectively enrolled in an observational study in 
the medical intensive care department of Albert Ludwigs University, 
Freiburg. VOT and the time to recapillarisation were measured 
at admission to hospital (t1), after induction of mild therapeutic 
hypothermia (t2) and after re-warming (t3). The VOT was performed 
by stopping arterial infl  ow by infl  ating the arm cuff   defi  nitely above 
the systolic arterial pressure over 3 minutes and recorded with the 
InSpectra StO2 650 monitor (Hutchinson). The recorded StO2 alterations 
were analysed utilising the InSpectra StO2 Researcher´s Software V 4.01.
Results Patients after successful resuscitation showed a baseline StO2 
of 78.7 ± 8.3%. In all three time points a reduced occlusion slope (t1: 
–7.2 ± 1.8; t2: –5.8 ± 1.2; t3: 7.6 ± 2.7%/minute) as well as a reduced 
recovery slope (t1: 1.7 ± 1.1; t2: 1.2 ± 0.7; t3: 1.9 ± 1.7%/second) was 
seen. Time to recapillarisation was on average 2.7 ± 3.6 seconds.
Conclusions Here we could demonstrate important alterations of the 
tissue-dependent microvascular capacity in patients after successful 
resuscitation. Considering these data, patients in the post-resuscitation 
phase may have severe microvascular dysfunction compared with 
healthy people as described in the literature. This study may highlight 
a new potentially critical clinical paradigm: extending the duration of 
mild therapeutic hypothermia may result in favourable neurological 
outcome by improving post-resuscitation microcirculation.
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Introduction We carried out research of a brain blood-groove with 
the purpose of estimating cerebrovascular eff  ects with high-frequency 
artifi  cial ventilation of lungs in 30 patients with severe traumatic brain 
injury.
Methods Traditional intensive therapy in conditions of various modes 
of respiratory support was performed: CMV – 10 patients, SIMV – 10 
patients, HFJV – 10 patients. Adequacy of modes of ventilation was 
estimated on SpaO2 96 to 99%, and pCO2 34.7 to 35.2 mmHg. The 
median age was 36 ± 6 years, GCS was 7 to 9 points; the level of ICP 
exceeded 15 mmHg. We registered the cerebral blood fl  ow velocity 
(Vm), resistance pial vessels (Pi), and dilatation reserve (Ri).
Results  The analysis of parameters of central and system 
hemodynamics with varying respiratory support revealed signifi  cant 
distinctions. At mode CMV: ICP – 28.6 ± 0.7 mmHg; Vm – 51.1 ± 1.4 cm/
second; Pi – 1.84 ± 0.1; Ri – 1.28 ± 0.01; CPP – 67.4 ± 1.3 mmHg. At SIMV: 
ICP – 31.7 ± 1.7 mmHg; Vm – 52.6 ± 4.1 cm/second; Pi – 1.60 ± 0.1; Ri 
– 1.23 ± 0.02; CPP – 68.0 ± 2.8 mmHg. At HFJV: ICP – 18.8 ± 2.9 mmHg; 
Vm – 57.8 ± 7.1 cm/second; Pi – 1.39 ± 0.2; Ri – 1.36 ± 0.01; CPP – 
64.1 ± 6.1 mmHg. At CMV adverse conditions for venous return that 
can be accompanied by depression of intimate emission are created. 
Decrease in intimate emission will lead to decreased CPP that leads 
to spasm of pial vessels, and the dilatation reserve will not react to 
increased tone of pial vessels. At variance, SIMV is markedly similar to 
CMV interference of autoregulation parameters of the brain blood-
groove and system hemodynamics. At HFJV there are no negative 
phenomena inherent in traditional ventilation. Presence of the kept or 
increased intimate emission appears to provide more chance to keep 
cerebral perfusion. At HFJV an authentically lower level of resistance 
Pi, higher parameter of Ri and lower ICP is marked. This interferes with 
occurrence of the expressed spasm and ischemia of the brain. At both 
variants of traditional ALV, the expressed infringements of perfusion 
and resistance of vessels of the pial–capillary system accompanied by 
substantial growth are marked.
Conclusions  HFJV as respiratory support in severe traumatic brain 
injury, on a background of intracranial hypertension, has doubtless 
advantages before traditional methods of ALV. Its application provides 
preservation of active autoregulation of brain blood circulation, and 
promotes stabilization of intracranial pressure at a lower level.
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Introduction  In the ICU, dopamine agonists (DA) have been used 
in TBI patients to augment or accelerate cognitive recovery and 
rehabilitation. However, the effi   cacy and safety of DA in this population 
is not well established.
Methods We conducted a systematic review of randomized controlled 
trials (RCT) examining the clinical effi   cacy and safety of DA in TBI. We 
searched MEDLINE, Embase and the Cochrane Central Register of 
Controlled studies up to June 2010. We sought trials comparing the 
eff  ect of a DA with either placebo, standard treatment or another active 
comparator. We included trials addressing effi   cacy using any outcome 
measure as a primary outcome and/or safety. There was no restriction 
for age, date, or language of publication. We excluded unpublished 
and animal trials. Sensitivity analyses were planned to evaluate the 
potential eff  ect of timing of TBI, age, drugs and year of publication on 
effi   cacy.
Results  Among the 790 citations identifi   ed, 20 RCTs evaluating 
methylphenidate, amantadine and bromocriptine were eligible. 
Signifi   cant heterogeneity pertaining to timing from injury to 
randomization, mechanism of trauma, severity of TBI and age was 
observed between and within trials and precluded from any pooling of 
data. Effi   cacy outcomes included mainly neuropsychological measures 
of cognitive functioning. A total of 76 diff  erent neuropsychological 
tests were used, but most of them (59%) only once. For the 12 tests used 
in more than one study, statistically positive results were reproduced 
three times. Only fi   ve studies systematically assessed safety using 
predefi  ned objective measures or tools. No trend could be drawn from 
the analysis of effi   cacy and safety in any of the predefi  ned categories 
of outcome. Important sources of bias in the studies were of major 
concern, including inappropriate use of cross-over design and under-
reporting of randomization methods.
Conclusions We observed a variability of neuropsychological tests. 
This may refl  ect disagreement regarding clinical relevance of cognitive 
and behavioral outcomes and lack of a gold standard test for each 
domain. Considering the absence of consensus along with the high 
risk of bias in included trials, more research is warranted before DA 
can be recommended to improve cognitive recovery in critically ill TBI 
patients.
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Introduction The fundamental pathophysiological process following 
head injury is the development and propagation of an escalating cycle 
of brain swelling, increase in intracranial pressure (ICP), reduction 
in blood supply and oxygen delivery, energy failure and further 
swelling, enhancing brain injury and poor outcome. The aim of the 
RESCUEicp trial (Randomised Evaluation of Surgery with Craniectomy 
for Uncontrollable Elevation of ICP) is to provide class I evidence as to 
whether decompressive craniectomy is eff  ective for the management 
of patients with raised and refractory ICP following traumatic brain 
injury (TBI).
Methods  An international multicentre randomised trial comparing 
decompressive craniectomy with optical medical management 
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ICP (>25 mmHg for 1 to 12 hours, refractory to fi  rst-line treatment). 
Exclusion criteria: treatment with barbiturates pre-randomisation, 
primary decompression (during evacuation of mass lesion), bilateral 
fi  xed and dilated pupils, bleeding diathesis, devastating injury unlikely 
to survive >24 hours. In this study, patients are managed on ICUs using 
a standard protocol. The major objective of this protocol is to maintain 
ICP <25 mmHg by applying treatment measures in a number of stages. 
The total number of patients will be 400 (200 in each arm of the study) 
for a 15% diff  erence in outcome (power = 80%, P = 0.05). The primary 
outcome measure was extended Glasgow Outcome Score at 6 months.
Results Over 280 patients have been recruited to date from more than 
40 centres in 17 countries. The follow-up rate at 6 months is 96%. To 
date, evaluation of the fi  rst 182 patients shows equal distribution of 
characteristics between the two arms. Median age is 33 years and 80% 
of patients are male. Four percent were hypoxic and 13% hypotensive 
at initial presentation. Seventy percent had an initial GCS of 3 to 8, 19% 
a GCS of 9 to 12 and 11% a GCS of 13 to 15.
Conclusions  Randomising patients with TBI to decompressive 
craniectomy versus optimal medical management is feasible. Whether 
this operation is eff   ective remains to be seen. We welcome the 
participation of more centres.
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Introduction The purpose of this literature review is to look at the 
potential of cerebral oxygen monitoring in the intensive care setting 
and how this monitoring modality will impact our current practice.
Methods A PubMed literature search was conducted using the search 
items ‘cerebral, oxygenation, and monitoring’. The search was limited 
to adults and the search items limited to the title or abstract. Articles 
selected were those that demonstrated a positive or negative benefi  t 
of cerebral oxygen monitoring on neurological outcome after surgery 
or intensive care.
Results  The search revealed a total of 449 possible articles when 
conducted in December 2010. This was narrowed down to 18 articles 
related to monitoring cerebral oxygen. Patient outcomes: cerebral 
oxygen monitoring and the aggressive treatment of cerebral hypoxia 
reduced mortality and improved long-term outcomes after traumatic 
brain injury and coronary artery bypass surgery. Near-infrared 
spectroscopic cerebral oxygen monitoring is capable of detecting 
ischaemic cerebral perfusion defi  cits and may be more sensitive than 
transcranial Doppler in assessing blood fl  ow and detecting delayed 
ischaemic defi   cits in subarachnoid haemorrhage. Cerebral hypoxia 
can persist despite good cerebral perfusion and normal intracranial 
pressure. Cerebral oxygenation monitoring can prevent iatrogenically 
driven hyperoxia and hyperperfusion, and can detect cerebral hypoxia 
before drops in standard pulse oximetry monitoring.
Conclusions  The authors believe evidence is gathering suggesting 
that cerebral oxygen monitoring may play an important role in 
neurointensive and adult intensive care centres. Cerebral hypoxia 
worsens long-term neurological outcomes, and this modality has 
potential to help reduce morbidity.
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Introduction  Traumatic brain injury studies predominantly use an 
assessment of neurological function some time after hospital discharge 
as the primary endpoint. Recent studies have followed up patients at 
6 months after injury with very variable loss to follow up [1,2]. We have 
established an outcome process that minimises loss to follow up and 
maximises the quality of the outcome assessment.
Methods  The DECRA trial is a prospective randomised trial of 155 
patients from Australia, New Zealand, and Saudi Arabia. Patients with 
severe traumatic brain injury and refractory intracranial hypertension 
were randomly assigned to receive either a decompressive craniectomy 
or to continue with standard medical management. The primary 
outcome was patient’s neurological function using the Extended 
Glasgow Outcomes Scale (GOSE) at 6 months after injury. Patients were 
tracked following hospital discharge by the Research Coordinators 
at each participating site. The GOSE assessments were conducted by 
three blinded assessors using structured telephone questionnaires. The 
assessment team was led by an experienced assessor. Two assessors 
were located in Australia and one assessor in Saudi Arabia. Assessors 
were trained using a prepared training package of examples and self-
testing exercises. The chief assessor reviewed the outcome assessments 
performed by the other assessors. Any complex assessments were 
referred to an assessment panel for a consensus decision.
Results DECRA commenced recruitment in 2003 and the last patient 
was enrolled in April 2010. Research coordinators successfully tracked 
all surviving patients, which resulted in a 100% follow-up rate for the 
primary study outcome measure.
Conclusions  We have successfully completed a prospective 
randomised controlled trial with zero loss to follow up for the primary 
outcome measure of GOSE at 6 months. Assessments were reviewed 
by the chief assessor and a consensus panel if required to ensure 
consistency of the assessment.
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Introduction Severe traumatic brain injury (TBI) is a condition often 
associated with grave consequences and it remains a major public 
health problem globally. Clinical trials to improve management and 
treatment of this condition are a necessity; however, there are many 
issues that impact on the design and conduct of such trials including 
the complex and sensitive issue of consent. Obtaining consent for 
severe TBI trials is inherently complicated and diffi   cult because the 
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shocked, anxious, grieving and frequently physically exhausted. We 
established a process during the DECRA trial to minimise the diffi   culties 
and to ensure that consent was obtained with sensitivity and in an 
informed manner.
Methods  The DECRA trial is a prospective randomised trial of 155 
patients from Australia, New Zealand, and Saudi Arabia. Patients with 
severe traumatic brain injury and refractory intracranial hypertension 
were randomly assigned to receive either a decompressive craniectomy 
or to continue with standard medical management. Surrogate consent 
was obtained prior to randomisation and all participating hospitals had 
obtained approval from their Human Research & Ethics Committee.
Results Guidelines for obtaining consent were included in the protocol 
and manual of operations, and were discussed at the investigators’ 
meetings. The guidelines highlighted the importance of early 
communication with the patient’s medical team regarding possible 
recruitment into the trial, updating the family about the patient’s 
condition prior to the consent discussion, following a basic script to 
ensure all aspects of the trial were covered in the discussion, allowing 
time for the discussion including follow-up discussions and listening 
carefully to the family’s questions. DECRA commenced recruitment 
in 2003 and the last patient was enrolled in April 2010; 168 consent 
discussions were held with a 92% consent rate.
Conclusions Consent rates in brain injury studies in the critical care 
setting can be optimised by following a protocolised consent process.
Acknowledgements The authors thank the DECRA Trial Investigators, 
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Introduction  Given the burden of disability arising from severe 
traumatic brain injury (TBI) [1], plain assessment of mortality certainly 
underestimates the impact of TBI. Therefore, risk prediction models 
need to provide poor neurological outcome estimates other than 
mortality. The aim of the study was to determine whether a simple 
combination of early clinical indices may be predictive of disability 
after ICU discharge.
Methods  A prospective study enrolling 133 patients (109 male/76 
female) with TBI (associated or not with multiple trauma) and GCS ≤8 
admitted to our ICU. Demographics, acute care preadmission factors 
(hypotension and hypoxemia), injury severity (GCS, ISS, RTS, pupil 
reactivity, CT scan grade) and acute physiological disturbance (APACHE 
II – 24 hours, SOFA) were evaluated. According to functional outcome 
(GOS) upon ICU discharge, two subgroups of patients were identifi  ed: 
GOS 4 to 5 (favorable outcome), and GOS 1 to 3 (poor outcome). 
Independent t test, Mann–Whitney test, logistic regression, ROC curve 
and chi-squared analyses were used for statistical purposes.
Results Data are presented in Table 1. Overall mortality was 32.3% 
(n = 43). Logistic regression analysis identifi  ed APACHE II (P = 0.004), 
CT scan grade (P = 0.002) and pupil reactivity upon ICU admission 
(P = 0.01) as the strongest predictors of functional outcome. Area under 
the ROC curve for APACHE II score was 0.841 (95% CI: 0.767 to 0.899, 
P <0.0001).
Conclusions  Acute physiological disturbance, poor preadmission 
clinical data and neurological signs, presence of severe intracerebral 
injuries combined with additional extracerebral injuries and advanced 
age, seem to be powerful determinants that adversely infl  uence the 
early course of recovery and functional survival of patients with 
sustained severe TBI. Among them APACHE II, CT scan grade and pupil 
reactivity upon ICU admission were identifi  ed as the strongest early 
prognostic indicators.
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Introduction The association between levels of N-terminal fragment of 
pro-brain natriuretic peptide (NT-proBNP), troponin T and prognostic 
outcomes in patients after ischemic stroke were tested. Acute-phase 
levels of NT-pro-BNP and troponin T have been associated with 
mortality when measured in patients with an acute ischemic stroke. 
However, the value of pre-interventional levels of NT-pro-BNP and 
troponin T measured in the fi  eld as a prognosticator of in-hospital 
mortality after ischemic stroke is limited.
Methods  This prospective study was performed in the Center for 
Emergency Medicine Maribor, Slovenia from June 2006 to May 2010. 
Blood samples for NT-proBNP and troponin T levels were collected in 
the prehospital setting and examined with a portable Cardiac Raeder 
device after acute ischemic stroke in 106 consecutive patients (204 
patients with acute stroke were excluded). ECG and other variables 
previously associated with severity of stroke were also recorded and 
assessed as independent predictors of inpatient mortality.
Results Troponin T was elevated (>0.04 μg/l) in 16 out of 106 patients 
(15.1%). Twenty-three patients died in the hospital. Raised troponin 
T occurred in eight patients in this group (8/23; 34.8%) versus eight 
patients (8/83; 9.6%) who survived until hospital discharge (P <0.01). NT-
pro-BNP concentrations were signifi  cantly higher in decedents (508 pg/
ml, 10th to 90th percentiles 98 to 3,000) than in the 83 survivors (153 pg/
ml, 10th to 90th percentiles 49 to 690, P <0.001). In logistic regression 
analyses, a rise in troponin T (odds ratio, 1.8; 95% CI, 1,03 to 8.43, P <0.01) 
and NT-pro BNP (odds ratio, 5.80; 95% confi  dence interval, 1.33 to 22.72, 
P <0.01) were signifi  cantly associated with a poor short-term outcome.
Conclusions The NT-pro-BNP and troponin T concentrations measured 
during the prehospital phase of care after acute ischemic stroke are 
strong predictors of in-hospital mortality.
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Table 1 (abstract P316)
Parameter  GOS 1 to 3 (n =56)  GOS 4 to 5 (n = 77)  P value
Age (years)*  42.9 ± 22.8  31.9 ± 14.8  0.002
Hypotension (%)  28.6  9  0.03
Hypoxia (%)  23.2  5.2  0.01
ICU pupils (abnormal) (%)  35.7  1.3  0.000
CT scan grade >2 (%)  64.3  37.6  0.000
ISS* 35.9 ± 14.7  23.9 ± 10.3  0.000
APACHE II*  222.2 ± 5.5  15.03 ± 5.3  0.000
GCS* 4.9 ± 1.8  6.5 ± 1.8  0.000
RTS* 4.1 ± 1.3  5.02 ± 1.3  0.04
SOFA* 6.5 ± 3.0  4.1 ± 2.1  0.005
*Data presented as mean ± SD.
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Introduction The incidence of stroke doubles for every decade after 
45 years of age, and 70% of these events occur in the over 65s. A rational 
approach with a thrombolysis protocol can diminish this clinical and 
social burden.
Methods In the past 20 months all patients with acute stroke were 
referred to ICU staff    for evaluation and compliance to eff  ective 
thrombolysis until 4.30 hours from the onset of symptoms. All clinicians 
were advised and triage in the ED was adapted using NIHSS.
Results In this period 152 patients were evaluated and 34 (22.4%) 
were eligible for reperfusion treatment. Men were more prevalent 
than women (70.6 vs. 29.4%) and age was distributed between 29 and 
82 years. Risk factors were equally distributed (Table 1). Twenty-nine 
patients (88%) received thrombolysis within 3  hours of symptoms 
onset and 19 (63%) got better NIHSS after treatment. Eleven patients 
(37%) never recovered. Five out of 34 patients (12%) were treated in 
the 3 to 4.30 hours window and three received benefi  t. All deaths were 
related to ischemia progression. Table 2 presents complications during 
the ICU stay.
Table 1 (abstract P318). Stroke risk factors
Factor  n
High blood pressure  25
AF 4
>Lipids 6
Diabetes 4
>BMI 6
Smoke 10
Table 2 (abstract P318). Complications during the ICU stay
Complication  n
Bradycardia 8
Pneumonia 5
Hemorrhage 4
Death 4
Conclusions  The clinicians’ compliance and patients’ reference to 
dedicated teams (stroke teams) resulted in the treatment of 22.4% 
of observed patients (1 to 11% in the literature). Some complications 
could be avoided with simple measures. This protocol should continue 
and should be emphasized.
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Introduction In a previous report it was observed that acetazolamide-
induced cerebrovascular reactivity is impaired in patients with sepsis-
associated encephalopathy without organ dysfunction [1]. The aim of 
the present work was to assess whether patients suff  ering from severe 
sepsis also have these impaired cerebrovascular responses.
Methods Patients fulfi  lling the criteria of clinical sepsis and showing 
at least two organ dysfunctions other than the brain were included 
(n = 14). Nonseptic persons without previous diseases aff  ecting cerebral 
vasoreactivity served as controls (n = 20). Transcranial Doppler blood 
fl  ow velocities were measured at rest and at 5, 10, 15 and 20 minutes 
after intravenous administration of 15  mg/kg BW acetazolamide. 
The time course of the acetazolamide eff  ect on cerebral blood fl  ow 
velocity (cerebrovascular reactivity) and the maximal vasodilatory 
eff  ect of acetazolemide (cerebrovascular reserve capacity (CRC)) were 
compared among the groups.
Results  Mean blood fl   ow velocity in the middle cerebral artery 
was lower (41.7 ± 13.3 cm/second) in septic patients at rest than in 
controls (58.2  ±  12.0  cm/second, P  <0.01). Pulsatility indices were 
higher among septic patients at rest (1.56  ±  0.79) than in controls 
(0.85 ± 0.20, P <0.01). Assessment of the time course of the vasomotor 
reaction showed that patients with sepsis reacted in similar fashion 
and extent to the vasodilatory stimulus than did control persons. When 
assessing the maximal vasodilatory ability of the cerebral arterioles to 
acetazolamide during vasomotor testing, we found that patients with 
sepsis reacted to a similar extent to the drug than did control subjects 
(CRC controls:46.2 ± 15.9%, CRC SAE: 63.2 ± 28.4%).
Conclusions Cerebral vasoreactivity to acetazolemide is not impaired 
in patients with severe sepsis. Our data suggest that the reaction of 
the cerebral arterioles to vasoactive stimuli changes along with the 
severity of the septic process.
Reference
1. Szatmari  et al.: Crit Care 2010, 14:R50.
P320
Signifi  cance of admission temperature and impact on mortality in 
critically ill neurological patients
F Rincon1, C Schorr2, C Hunter2, B Milcareck2, R Dellinger2, J Parrillo2, 
S Zanotti2
1Thomas Jeff  erson University, Philadelphia, PA, USA; 2Cooper University 
Hospital, Camden, NJ, USA
Critical Care 2011, 15(Suppl 1):P320 (doi: 10.1186/cc9740)
Introduction The purpose of this study is to test the hypothesis that 
hyperthermia is associated with increased mortality after neurological 
injury using a robust multicenter ICU database.
Methods  A multicenter cohort study using the Project IMPACT 
critical care database of ICUs at 120 US hospitals between 2003 and 
2008. Patient inclusion criteria were age older than 17 years, acute 
neurological injury within 24 hours of admission (acute ischemic stroke 
(AIS), subarachnoid hemorrhage (SAH), intracerebral hemorrhage 
(ICH), subdural hematoma (SDH), and traumatic brain injury (TBI)), 
and admission to the ICU. Patients were divided into three main 
groups based on defi  nitions of hyperthermia and hypothermia in the 
ICU. Hyperthermia was defi  ned as temperature greater than 37.5°C, 
hypothermia as a temperature lower than 36.5°C, and normothermia, 
not classifi  ed as hyperthermia or hypothermia. The outcome measure 
was in-hospital mortality.
Results Over the 8-year period, the Project IMPACT database contained 
data on more than 700,000 ICU admissions. We found 16,889 patients 
that met the inclusion criteria. The mean age was 61 ± 19 years, 9,339 
(56%) were male, and 12,634 (76%) were white. Of these, 3,081 (18%) 
had AIS, 2,413 (14%) had SAH, 4,315 (26%) had ICH, 2,748 (16%) had 
SDH, and 4,317 (26%) had TBI. The mean admission temperature 
was 37.5  ±  3°C and the overall mortality was 3,628/16,676 (22%). 
Of the total cohort, 7,878 (47%) had hyperthermia, 689 (4%) had 
hypothermia, and 8,167 (49%) were normothermic. The hyperthermia 
group had a high in-hospital mortality (2,180/7,822 (28%)) compared 
with normothermia (1,169/8,167 (14%)) but the hypothermia group 
had signifi   cantly higher in-hospital mortality (279/687 (41%)). In a 
preliminary multivariate model controlling for potential confounders 
(age and gender), hyperthermia (OR, 1.2; 95% CI, 1.1 to 1.23) and 
hypothermia (OR, 1.9; 95% CI, 1.7 to 2.1) increased the odds of hospital 
mortality.
Conclusions  Among critically ill neurological patients admitted to 
the ICU, hyperthermia and hypothermia are associated with increased 
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of these fi  ndings require further study.
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Introduction Spontaneous cerebral hemorrhage is a major cause of 
morbidity and mortality. Bedside, multimodal cerebral monitoring 
is a safe and promising technique for the diagnosis and prevention 
of secondary brain damage. The aim of this study is to investigate 
whether microdialysis parameters can be used as prognostic factors 
in patients with spontaneous cerebral bleeding, and their association 
with the long-term outcome.
Methods Twenty-seven patients with GCS <8 were included in the 
study. Mean age was 57.78 ± 9.94 years. The outcome of the patients 
was evaluated according to the Glasgow Outcome Scale (GOS) 3 and 
6 months post-discharge. Data were evaluated using the SPSS 17.0 and 
P <0.05.
Results In a linear statistical model that included all of the microdialysis 
parameters, only glucose was inversely associated with the patient 
outcome.
Conclusions We can use microdialysis to determine cerebral glucose 
levels, which we found to be associated with patient outcome.
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Introduction Transcranial sonography (TCS) is used to image brain 
parenchyma and vasculature. There is a growing body of evidence 
suggesting a possible imaging role and that Doppler refl  ects intra-
cranial pressure. The authors conducted a review of this growing 
literature and propose potential uses of this modality in the assessment 
of the sick patient.
Methods A search for papers of special interest was conducted using 
PubMed and the search items: transcranial, ultrasound, sonography, 
raised intracranial pressure, haemorrhage, and traumatic head injury. 
Articles where restricted to adults and considered relevant if they 
described standardisation, comparisons with other modalities, case 
studies or explored potential novel uses.
Results TCS has been standardised and referenced to MRI imaging. It is 
able to identify intracerebral, and subarachnoid haemorrhage as areas 
of hyperechogenicity. Compared with CT, it identifi  es haemorrhage 
or infarct in 95% of cases. TCS is a reliable quantitative monitor of 
intracranial pressure. The pulsatility index (PI), a derived index from 
Doppler fl   ow parameters of the middle cerebral artery, correlates 
signifi   cantly with invasive measures of intracranial pressure (ICP); 
R = 0.98, P <0.001. A formula can be used to convert the PI into ICP.
Conclusions TCS has imaging potential, but is unlikely to replace CT 
for this purpose. The role for TCS in the assessment and monitoring of 
the sick patient starts where CT fails. It can be used as a quick screening 
adjunct to the primary survey looking for acute brain injury in those 
unstable for transfer. It can be used to monitor the size of CT-identifi  ed 
haemorrhage over time or with GCS removing the need for multiple 
trips to the scanner. It could help identify raised ICP and therefore extra 
risk from lumbar puncture in the meningitic patient with a normal CT. 
Finally it allows non-invasive monitoring of ICP in the head-injured 
patient in whom intubation and sedation are required, but invasive 
monitoring would be considered excessive.
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Introduction The purpose of this study is to investigate the relationship 
between continuously monitored regional cerebral blood fl  ow (CBF), 
brain tissue oxygen (PbrO2) and microdialysis values in subarachnoid 
hemorrhage and traumatic brain injury patients.
Methods Advanced multimodal neuromonitoring including monitor-
ing of PbrO2 (Licox; GMS), CBF (QFlow; Hemedex) and brain lactate, 
pyruvate, lactate/pyruvate ratio, glycerol and glucose values using 
microdialysis (CMA600; Microdialysis) was performed so far in eight 
patients with severe subarachnoid hemorrhage (n = 5) and traumatic 
brain injury (n = 3) for an average of 9.2 days. Additional recorded 
parameters include ICP, CPP, MABP, CVP, local brain temperature, body 
core temperature, PCO2, and blood glucose. The cerebral monitoring 
probes are inserted via a bolt (ICP, PbrO2, microdialysis) and an 
additional burr hole (CBF). All probes are positioned in the penumbra 
and location is verifi  ed by a brain CT. The study is to be conducted for 
an estimated total of 30 patients suff  ering the above pathologies.
Results The data so far indicate a strong correlation between CBF and 
PbrO2 values. There seems to be a link between brain glucose levels 
and CBF values; however, it is not as clear as regards the CBF–PbrO2 
correlation. This may be due to the fl  uctuation of brain glucose because 
of brain ischemia, hyperemia, hypermetabolism or hypometabolism. 
So far we were able to establish a correlation of CBF–PbrO2 and 
lactate/pyruvate ratio only in persistently low CBF–PbrO2 values (CBF 
<12 ml/100 g/minute, PbrO2 <10 mmHg for more than 64 minutes).
Conclusions This is a preliminary report of a study in human patients 
with severe subarachnoid hemorrhage and traumatic brain injury. 
The results indicate correlations of varying signifi  cance between the 
pooled data. We hope that the outcome of our study will be able to 
clarify the pathophysiology of severe brain injury and guide us in the 
titration of therapy, as it is needed by each individual patient.
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Introduction  Poor-grade subarachnoid haemorrhage patients have 
historically fared poorly and often been excluded from aggressive 
treatment. In a recent audit of practice at our ICU only 33% of these 
patients were transferred to a neurosurgical centre. Recent studies 
have demonstrated improved rates of survival with good neurological 
outcomes in patients receiving rapid resuscitation, control of ICP, 
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to determine national neurosurgical practice with regards to these 
patients.
Methods We conducted a telephone survey of all UK adult neurosurgical 
centres. We presented the neurosurgical registrar with two mock-up 
patients – one grade 5 and one grade 4. We asked questions regarding 
their transfer policy, surgical and medical management, estimated 
probability of good outcome (Glasgow Outcome Score 4 or 5), and 
recommendations regarding management if not for transfer.
Results None of the 30 units had a policy on whom to transfer. Twenty-
one out of 30 (70%) advised transfer of the grade 5 patient and all 30 
would transfer the grade 4 patient. Good outcome was estimated at 
10% for the grade 5 patient (range <5% to 60%) and 50% for the grade 
4 patient (range 20 to 90%). Of those recommending transfer of the 
grade 5 patient, 12 would proceed to CT angiography and endovascular 
coiling of the aneurysm within 24 hours. Eight centres would wake and 
reassess the patient and coil if the GCS improved, seven would place 
a prophylactic extraventricular drain and nine would routinely insert 
an intracranial pressure monitor. Of the nine centres that would not 
transfer, all would subsequently reconsider transfer if GCS improved or 
hydrocephalus developed. No centres recommended insertion of an 
intracranial pressure monitor in the referring hospital.
Conclusions  Treatment of poor-grade subarachnoid haemorrhage 
remains controversial. In the UK there are no national management 
guidelines and both recommendations and practice appear to vary 
considerably between hospitals. Further analysis of national data 
regarding morbidity and mortality in this patient group is needed. 
Debate is required to address the question of whether aggressive 
ICP control is warranted and if so whether this can be provided in a 
nonspecialist ICU.
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Introduction Neutrophil gelatinase-associated lipocalin (NGAL) and 
cystatin C (CyC) are powerful biomarkers predicting acute kidney 
injury (AKI) in the critically ill. In addition, both NGAL and CyC are 
related to systemic infl  ammation, cerebral ischemia and vascular wall 
damage. Aneurysmal subarachnoid hemorrhage (SAH) is frequently 
accompanied by cerebral ischemia and has been linked to systemic 
infl  ammation. We studied the relationship between NGAL and CyC 
levels and the severity grade of SAH at ICU admission.
Methods  Thirty-six patients with SAH were recruited from a large 
prospective study on NGAL and AKI between September 2007 and 
April 2008. Patients with non-aneurysmal SAH (n = 3) and one patient 
with eGFR <60 ml/minute/1.73 m2 were excluded. No subjects had 
AKI (RIFLE category Risk or more) or suff  ered from chronic kidney 
disease (CKD) stage 3 or more. We dichotomised patients into two 
groups: awake (GCS 15 to 11, n = 30) and comatose (GCS 10 to 3, n = 6), 
based on the Prognosis on Admission of Aneurysmal Subarachnoid 
Hemorrhage (PAASH) scale. Statistical comparisons were made with 
the Mann–Whitney U test and Spearman’s rho test.
Results  Plasma (p)NGAL was higher in comatose patients (median 
144 ng/ml vs. 89 ng/ml, P <0.05). No diff  erences were found in urine 
NGAL plasma CyC and urine CyC levels or regular infl  ammatory 
parameters (leucocyte count, CRP and temperature). A confounding 
eff  ect from mechanical ventilation on pNGAL production was excluded 
using the correlation statistics in intubated and non-intubated patients 
separately. After correction the correlation between GCS and pNGAL 
persisted in non-intubated patients (Spearman’s rho (non-intubated, 
n = 29) –0.36, P <0.05, and (intubated, n = 7) –0.62, P = 0.069). We found 
trends towards less positive fl  uid balance (P = 0.06) during the fi  rst 
24 hours of admission and higher serum lactate (P = 0.08) in comatose 
patients, which did not reach statistical signifi  cance.  Angiography-
related contrast exposure was similar in both groups.
Conclusions Our results indicate that poor-grade SAH is associated 
with increased pNGAL levels at ICU admission not related to AKI, CKD 
or infl  ammatory parameters. Alternative mechanisms linking NGAL 
to SAH grade should therefore be investigated, such as increased 
sympathetic/catecholamine activity in poor-grade SAH patients [1].
Reference
1. Mutoh  T,  et al.: Stroke 2007, 38:3218-3224.
P326
Spontaneous subarachnoid hemorrhage: clinical impact, prognostic 
value and complications
M Mourelo-Fariña, A Aller-Fernández, P Vidal-Cortés, R Galeiras, M García
University Hospital A Coruña, Spain
Critical Care 2011, 15(Suppl 1):P326 (doi: 10.1186/cc9746)
Introduction The aim of this study is to identify the characteristics 
of patients with spontaneous subarachnoid hemorrhage (SAH) and 
to analyze the complications, treatment, potential risk factors and 
prognostic value associated.
Methods A retrospective observational study of all patients admitted 
to our hospital with SAH during 4 years (2006 to 2009). We evaluate 
the functional outcome using the Glasgow Outcome Scale (GOS) at 
discharge and 6 months later. We compare variables with the chi-square 
and Student’s t tests. Multiple regression analysis was performed.
Results A total of 168 patients were included: age 57.5 years (SD 14.9), 
62.5% women, APACHE II 12 (SD 6.7), Glasgow Coma Scale (GCS) 9.9 (SD 
6.5). Punctuation in clinical grading scales was: Hunt-Hess (H-H) 2.8 (SD 
1.5); Fisher 3.0 (SD 1.0); World Federation Neurosurgeons Scale (WFNS) 
2.8 (SD 1.5). Personal antecedents: arterial hypertension (32.1%) 
followed by drug use (31.2%). Presentation was headache in 62.1%. We 
perform CT angiography in 9.6% and arteriography in 78.6% (delay was 
1 day). We found no aneurysm in 24.6%. The embolization was complete 
in 63.4%. The localization of the aneurysm was more frequent in the 
anterior communicating artery. Surgical treatment was performed in 
2.2%. Complications of SAH: vasospasm 31.5% (managed with triple-H 
therapy 71.7%), ischemic stroke occurred in 60.4%; 4.2% rebleeding; 
hydrocephalus in 23.2%. Mortality risk factors: univariate analysis found 
age (P = 0.004), worsening control CT (P <0.01), rebleeding (P <0.01), 
coma (P  =  0.02), hydrocephalus (P <0.01), intracranial hypertension 
(P = 0.002), H-H (P <0.01), Fisher (P <0.01), WFNS (P <0.01), initial GCS 
(P <0.01), GOS at discharge to ICU (P = 0.002) and time to embolization 
(P = 0.02). Multivariate analysis predictors of mortality: GCS at admission 
and at discharge to ICU (P = 0.013), worsening in control CT (P = 0.004) 
and length of stay (LOS) in the ICU (P = 0.04). ICU LOS was 10.6 days (SD 
9.9) and hospital LOS was 56.7 days (SD 26.3). Global ICU mortality was 
29.2% (77.5% brain death).
Conclusions The most frequent complications found were ischemic stroke, 
vasospasm and hydrocephalus. In our study we found that clinical grading 
scales predict mortality in univariate analysis. Predictors of mortality 
in SAH were age, GCS at admission and discharge; control CT, delay to 
embolization, and complications related to SAH are strong mortality 
predictors. In most patients, death is related to SAH complications.
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Introduction Global cerebral edema (GCE) is common amongst poor-
grade subarachnoid hemorrhage (SAH) patients and associated with 
poor outcome. Currently no targeted therapy exists largely due to an 
incomplete understanding of the underlying mechanisms.
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consecutive poor-grade SAH patients with multimodal neuro  monit-
oring. Levels of microdialysate lactate/pyruvate ratio (LPR), episodes of 
cerebral metabolic crisis (MC; LPR >40 and brain glucose <0.7 mmol/l), 
brain tissue oxygen tension (PbtO2), cerebral perfusion pressure (CPP), 
and transcranial Doppler sonography fl  ow velocities were analyzed.
Results Median age was 54 years (45 to 61) and 62% were female. 
Patients with GCE on admission (n = 24, 62%) had a higher incidence of 
MC in the fi  rst 12 hours of monitoring than those without GCE (n = 15; 
15% vs. 2%, P <0.05) and during the total time of neuromonitoring (20% 
vs. 3%, P <0.001). There was no diff  erence in PbtO2 and CPP between 
the groups; however, in patients with GCE a higher CPP was associated 
with lower LPR (P <0.05). Episodes of crisis were associated with poor 
outcome (modifi  ed Rankin Score 5 or 6, P <0.05).
Conclusions  In poor-grade SAH patients, GCE is associated with 
early brain metabolic distress. Optimizing cerebral blood fl  ow and 
homeostasis early after SAH may prove benefi  cial for patients with GCE.
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Introduction  We sought to determine the epidemiology of status 
epilepticus (SE), prevalence of risk factors and impact on hospital 
mortality in sepsis in the United States. We hypothesized that SE would 
be associated with increased mortality.
Methods Data were derived from the National Inpatient Sample from 
1998 to 2008. We included patients older than 18 years, with a primary 
diagnosis of sepsis and SE. Defi  nitions were based on the International 
Classifi  cation of Diseases, Ninth Revision, Clinical Modifi  cation Codes 
(ICD-9). Adjusted incidence rates, prevalence odds ratios (ORs) and 
95% confi  dence intervals (CIs) were calculated. Multivariate logistical 
models assessed for the impact of SE on hospital mortality.
Results We identifi  ed 7,672,551 admissions with diagnosis of sepsis 
and 7,619 with SE from 1998 to 2008. The population-adjusted rate 
of sepsis increased from 72/100,000 in 1998 to 250/100,000 in 2008. 
In septic patients, SE was more common in older patients, in women 
than men, in urban academic centers than rural centers, in those with 
respiratory dysfunction and metabolic dysfunction. Total in-hospital 
mortality fell from 20% in 1998 to 18.1% in 2008, yet the number of 
deaths increased over the study period. Mortality was highest among 
SE (OR = 1.7; 95% CI = 1.4 to 1.9) (Figure 1), older patients, men, those 
with respiratory dysfunction, cardiovascular dysfunction, hematologic 
dysfunction, metabolic dysfunction, renal dysfunction and hepatic 
encephalopathy.
Conclusions Our study demonstrates the incidence of SE in sepsis is 
increasing. Despite a decline in sepsis-related mortality, the presence 
of SE doubles the risk of in-hospital death. Further study is needed to 
determine whether detection and treatment of SE will impact mortality.
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Introduction Although occurrence of seizures is common in the course 
of viral encephalitis, its infl  uence on outcome is less known [1].
Methods  The frequency and type of seizures in 229 patients with 
viral encephalitis were studied. We compared frequency of loss 
of consciousness, mental disorders, respiratory failure, need for 
intubation, mechanical ventilation and hospitalization in the ICU, 
duration of hospitalization and degree of disability at discharge from 
the hospital according to the Glasgow Outcome Scale (GOS).
Results  Patients with seizures (31), signifi   cantly more frequent in 
comparison with patients without attacks (198), presented: mental 
disorders in 17 (54.83%) versus 62 (31.31%) patients (P <0.001), loss of 
consciousness in 28 (90.32%) versus 16 (8%) patients (P <0.001) and 
need for intubation, mechanical ventilation and hospitalization in the 
ICU (34 versus 8 times, P <0.001). The mean total time of hospitalization 
was substantially longer in patients with seizures in comparison with the 
group without them (24.43 vs. 15.9 days, P <0.001). Patients presenting 
seizures were prognosticated worse in the scope of good recovery as 
well as every degree of disability in comparison with a group of patients 
without attacks (P = 0.001). Outcome after viral encephalitis according to 
GOS in patients with seizures (31) and without them (198) was as follows: 
GOS 5 (good recovery) – 19 (61.2%) versus 180 (90.9), GOS 4 (moderate 
disability) – 7 (22.5%) versus 12 (6%), GOS 3 (severe disability) – 4 (12.9%) 
versus 5 (2.5%), GOS 1 (death) – 1 (3.2%) versus 1 (0.5%).
Conclusions The occurrence of single generalized seizures, epilepsy 
and particularly status epilepticus had substantial infl   uence on a 
course of viral encephalitis and worsened the outcome. Appearance of 
every type of seizure attack, independent of other clinical symptoms, 
was a good indicator of the disease severity.
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Figure 1 (abstract P328). In-hospital mortality in septic patients.
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Introduction  Patients with intracranial hemorrhages are at risk 
of seizure activity. Small cohort studies have shown that patients 
with subdural hemorrhages (SDH) may be at risk of developing 
status epilepticus (SE). In this study, we sought to determine the 
epidemiology of SE, the prevalence of risk factors, and the impact on 
hospital mortality in SDH, using a large administrative dataset.
Methods  Data were derived from the National Inpatient Sample 
from 1988 through 2008. We searched for admissions with a primary 
diagnosis of SDH, and SE. Defi  nitions were based on the International 
Classifi   cation of Diseases, 9th Revision. Adjusted incidence rates, 
prevalence odds ratios (ORs), and 95% confi  dence intervals (CIs) were 
calculated.
Results Over the 20-year period, we identifi  ed 890,153 admissions with 
primary diagnosis of SDH and 3,214 of SE. The population-adjusted 
rate of SDH increased from 9/100,000/year in 1988 to 22/100,000/
year in 2008, and similarly, the adjusted rate of SE in SDH increased 
from 0.05/100,000/year in 1988 to 0.11/100,000/year in 2008. In SDH 
patients, the risk of SE was higher in older than younger patients (OR, 
0.99; 95% CI, 0.99 to 1.0, P = 0.06), black than whites (OR, 1.5; 95% CI, 
1.2 to 1.9), and in the presence of respiratory failure (OR, 4.3; 95% CI, 3.5 
to 5.3), metabolic dysfunction (OR, 1.7; 95% CI 1.3 to 2.26), hematologic 
disorders (OR, 1.7; 95% CI, 1.3 to 2.26), renal failure (OR, 2.4; 95% CI, 2.1 
to 3.26), or central nervous system dysfunction (OR, 2.6; 95% CI, 2.1 to 
3.26). The total in-hospital mortality fell from 17% in 1988 to 11% in 
2008, yet the number of deaths increased over the study period. In-
hospital mortality was higher among SE (OR, 1.6; 95% CI, 1.3 to 2.0) 
older patients (OR, 1.01; 95% CI, 1.01 to 1.01), women (OR, 1.1; 95% CI, 
1.01 to 1.1); and in those with respiratory organ dysfunction (OR, 4.9; 
95% CI, 4.7 to 5.2), cardiovascular dysfunction (OR. 2.9; 95% CI, 2.7 to 
3.2), hematologic dysfunction (OR, 2.2; 95% CI, 2.1 to 2.3), metabolic 
dysfunction (OR, 2.5; 95% CI, 2.2 to 2.8), renal dysfunction (OR, 2.0; 95% 
CI, 1.9 to 2.1).
Conclusions Our study demonstrates that the incidence of SDH and 
SE in these patients is increasing in the United States. The risk of SE 
was higher among older patients, blacks, and in those with respiratory, 
metabolic, hematological, and renal system dysfunction. Despite a 
decline in overall SDH-related mortality, SE increased the risk of in-
hospital death.
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Introduction This study intends to develop a physiologic thumbprint 
for nonconvulsive seizures (NCSz) after acute brain injury. Abnormal 
electrographic brain activity including NCSz is common after acute brain 
injury and is associated with poor outcome. Mechanisms underlying 
this phenomenon are poorly understood but in animals periods of 
inadequate perfusion during seizures have been documented. In the 
present study we hope to gain better understanding of the relationship 
between abnormal electrographic patterns and brain homeostasis in 
patients with subarachnoid hemorrhage (SAH).
Methods  Between June 2006 and June 2010, 51 poor-grade SAH 
patients underwent multimodality monitoring with microdialysis, 
brain oxygen tension (pbtO2), regional cerebral blood fl  ow (rCBF), and 
intracranial pressure monitoring; 69% (n = 36) also with intracortical 
EEG (ICE; eight-contact miniature depth electrode). Each minute of EEG 
(total of 326,513 minutes) was categorized separately into non-ictal, on 
the ictal–interictal continuum (including periodic discharges at 2 Hz 
or faster), or seizures. We identifi  ed seizure onsets on ICE recordings 
and extracted the physiologic monitoring data 30 minutes pre and 
post seizure onset. Physiologic profi  les based on standard error of 
the means plots were generated using high-frequency time series 
physiologic measurements and interpreted by visual analysis.
Results Depth NCSz were recorded in 36% (13/36) of patients with ICE 
recordings (depth seizures in 11,017 minutes). NCSz were preceded 
by an increase in rCBF starting 15 minutes prior to onset of depth 
NCSz that stayed elevated throughout the observation period. Heart 
rate, mean arterial, intracranial, and cerebral perfusion pressures 
were elevated surrounding NCSZ. There was a small transient drop in 
PbtO2 and a drop in jugular bulb oxygen saturation seen between 1 
and 3 minutes following seizure onset. There was a small rise in brain 
temperature but no change in bladder temperature associated with 
the NCSZs, but water temperature of the cooling device dropped 
following seizure onset.
Conclusions  These fi  ndings  confi   rm in comatose human beings 
that NCSz detected by ICE are associated with hyperemia, increased 
metabolism, and possibly brain tissue hypoxia, which serve as surrogates 
for secondary brain injury. Future research should implement novel 
approaches for ICU time-series data analysis, evaluate surface seizures, 
and utilize other surrogates of brain metabolism such as microdialysis.
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Introduction  The objective of this study is to investigate the 
prevalence, risk factors, and impact on outcome of electrographic 
seizures (ESz), nonconvulsive status epilepticus (NCSE), and periodic 
epileptiform discharges (PEDs) in surgical ICU (SICU) patients.
Methods  This was a retrospective study of 156 consecutive SICU 
patients (mean age 65 years old (IQR 54 to 74); 40% women) who 
underwent continuous electroencephalography (cEEG) monitoring for 
altered mental status. Poor outcome was defi  ned as death or severe 
disability (Glasgow Outcome Score 4 or 5).
Results The majority of patients were admitted following abdominal 
surgery (36%) and post liver transplant (24%). Sepsis developed in 
102 (65%) patients, almost all patients were mechanically ventilated 
(94%) and approximately one-half were comatose at the time of EEG 
monitoring (55%). Sixteen percent (n = 25) had ESz, 5% (n = 8) NCSE, 
and 29% (n = 45) had PEDs. All eight patients with NCSE were septic. 
Comatose patients and those with previous liver disease were more 
likely to have ESz or PEDs compared with noncomatose and those with 
normal liver function (42% vs. 19%; P = 0.002 and 25% vs. 9%; P = 0.007, 
respectively). After controlling for age, coma, and organ dysfunction, 
the presence of ESz was independently associated with death at 
hospital discharge (75% with vs. 43% without ESz; adjusted OR = 3.4 
(95% CI = 1.04 to 10.9); P = 0.04).
Conclusions  In patients admitted to the SICU, ESz and PEDs are 
frequent and associated with poor outcome.
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Introduction The objective of this study was to analyze the prevalence, 
risk factors and impact on outcome of electrographic seizures (ESz), 
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discharges (PEDs) in critically ill patients admitted to two mixed 
medico-surgical ICUs.
Methods This was a retrospective study of 58 consecutive ICU patients 
(mean age 68 ± 23 years old; 50% women) who underwent continuous 
electroencephalography (cEEG) monitoring for altered mental status. 
Outcome was assessed as hospital mortality.
Results  Sixteen patients (28%) were admitted with a primary 
neurological diagnosis. Mean duration of cEEG was 12 ± 17 hours. Thirty-
four patients (59%) were comatose and 32 patients were mechanically 
ventilated (55%) during cEEG monitoring. Seventeen percent (n = 10) 
had ESz, 10% (n = 6) had NCSE, 19% (n = 11) had periodic lateralized 
epileptiform discharges and 26% (n = 15) had epileptiform discharges.
Conclusions In a mixed population of medical and surgical patients, 
ESz and NCSE are frequent and associated with increased hospital 
mortality.
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Introduction Delirium is a common and serious disorder in the ICU. It 
has been suggested that the ICU environment may play a role in the 
development of ICU delirium, but this has never been investigated. 
In this study we aimed to investigate the relationship between the 
nursing environment and the duration, incidence and severity of ICU 
delirium.
Methods  This prospective observational before/after study was 
performed in the 32-bed, mixed adult ICU of the University Medical 
Centre Utrecht. All patients admitted to the ICU were daily assessed 
on delirium by research physicians. Exclusion occurred when patients 
remained unresponsive (RASS <–3) during admission or when they 
were unable to understand Dutch and English. ICU delirium was 
compared between a ward-like setting, and a setting with single-
patient, noise-reduced rooms with diurnal light variation.
Results  A total of 55 patients (449 observations) were included in 
the old setting and 75 patients (468 observations) in the new setting. 
Demographic characteristics were similar for both groups. However, 
co-morbidity was more severe and emergency admissions were more 
frequent in the new setting. Delirium occurred in 28 (51%) patients in 
the old setting versus 34 (45%) patients in the new setting (P = 0.53). 
After adjusting for confounding, the days patients spent in delirious 
state decreased with 0.4 days in the new environment (P = 0.005). 
No diff  erence could be observed in the severity of delirium or in the 
medications prescribed.
Conclusions The number of days patients spent delirious during ICU 
admission was found to be shorter in patients who were treated in 
separate noise-reduced rooms with diurnal light variation despite a 
similar incidence and severity of ICU delirium.
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Introduction Delirium is a frequent and serious disorder in the ICU. 
Several tools have been developed for standardized delirium testing, of 
which the Confusion Assessment Method for the ICU (CAM-ICU) is the 
best validated and most widely used. The main limitations of the CAM-
ICU are, however, that it is a very brief assessment of a highly fl  uctuating 
disorder, and that the test may lack sensitivity when administered in 
daily practice. For research purposes, we extended the CAM-ICU.
Methods This ongoing prospective validation study was performed in 
a 12-bed, mixed adult ICU of the University Medical Centre Utrecht. All 
patients admitted to the ICU were assessed daily and independently on 
delirium by two means: a junior doctor or neurologist (gold standard); 
and an eight-item fl  owchart, based on the CAM-ICU, the reports of 
the bedside nurses and the administration of haloperidol. Exclusion 
occurred when patients remained unresponsive (RASS  <–3) during 
admission or when they were unable to understand Dutch and English. 
With both assessment methods, patients were classifi   ed as either 
awake without delirium, delirious for one or more moments in the past 
24 hours, or comatose during the whole past 24 hours.
Results A total of 55 patients (35 men, 63.6%; mean age 60.0, SD 17.9; 
mean APACHE II score 18.7, SD 6.1) were included and 379 assessments 
were made. The form, which excludes patients with neurological 
pathology for further analysis, showed a sensitivity of 85%, a specifi  city 
of 88%, a positive predictive value of 81% and a negative predictive 
value of 91%.
Conclusions While the CAM-ICU is a tool to assess delirium during 
a brief observation period, this extension can be used to classify the 
presence of delirium in the previous hours in an ICU where the CAM-
ICU is already implemented. The tool appeared to be easy in use and 
highly adaptable with good test characteristics.
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Introduction Delirium occurs frequently in the ICU and is associated 
with poor outcome. Screening for delirium in ICU patients is 
recommended by several medical organizations to improve prognosis 
by early diagnosis and treatment. The Confusion Assessment 
Method for the ICU (CAM-ICU) has high sensitivity and specifi  city for 
delirium when administered by research nurses. However, the test 
characteristics of the CAM-ICU as performed in routine practice are 
unclear. The objective of this study is to investigate the diagnostic value 
of the CAM-ICU in daily practice.
Methods  Teams of three alternating delirium experts including 
psychiatrists, geriatricians and neurologists visited 10 ICUs twice. Based 
on cognitive examination, inspection of medical fi  les and DSM-IV-TR 
criteria for delirium, the expert teams classifi  ed patients as awake and 
not delirious, delirious or comatose. This classifi  cation served as the gold 
standard to which the CAM-ICU as performed by the bedside ICU nurses 
was compared. Assessors were unaware of each others’ conclusions.
Results Thirteen delirium experts assessed 282 patients, of whom 101 
(36%) were classifi  ed as comatose and excluded. In the remaining 181 
(64%) patients, delirium was diagnosed in 75 by the experts of whom 
35 scored CAM-ICU positive. This yielded a sensitivity of 47% (95% 
CI = 35 to 58%), specifi  city of 98% (95% CI = 93 to 100%), positive 
predictive value of 95% (95% CI = 80 to 99%) and negative predictive 
value of 72% (95% CI = 64 to 79%).
Conclusions Specifi  city of the CAM-ICU as performed in routine, daily 
practice appears to be high but sensitivity low. The low sensitivity 
hampers early detection of delirium by the CAM-ICU.
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Introduction  Delirium remains a common but poorly diagnosed 
condition in the ICU [1]. Delirium is an independent predictor of 
cognitive decline and mortality [2]. The aims of this audit were: 
to measure the incidence of delirium in our unit; to consider the 
practicalities of using the CAM-ICU; whether a positive CAM-ICU test 
would change management; and the attitude of senior intensive care 
staff   regarding the usefulness of CAM-ICU.
Methods The CAM-ICU was used for 5 weeks in a mixed general ICU 
(14 beds) at Queen’s Hospital, Romford. Patients were included into the 
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test was positive, a senior physician responsible for the patient’s care 
was asked whether they would change the management of the patient. 
A survey was conducted to understand the attitude of intensive care 
consultants regarding the usefulness of the CAM-ICU test.
Results  Fifty-six patients were included, 10 of which tested positive 
for delirium (17.9%). Seven were found to be delirious within the fi  rst 
48 hours of admission. Eight patients had just one episode of delirium. 
Average length of delirium was 1.75 days. On no occasion did a positive 
CAM-ICU test result in a change of management. We were unable to assess 
22% of patients because they were too sedated (8), not cooperative (7) 
or for other reasons (8). Surprisingly the survey revealed that more than 
75% of the consultants believed a positive CAM-ICU test would result in 
change in the management of the patient. See Figures 1 and 2.
Conclusions The incidence in our unit was lower than in other studies. 
Daily assessment with the CAM-ICU had no eff  ect on management. It 
is possible to implement use of the CAM-ICU daily after a short period 
of training. There is a diff  erence in attitude and practice in senior staff   
with regard to use of the CAM-ICU. As most cases are short lived and 
occurred in the fi  rst 48 hours, prevention should be emphasized before 
admission to critical care.
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Introduction Delirium is associated with long-term cognitive decline 
and poor health-related quality of life (HRQOL). Little is known about 
long-term diff  erences on these aspects between critically ill patients 
with and without delirium during their ICU stay, diff  erences between 
delirium subtypes on HRQoL and the eff  ect of delirium duration on 
HRQoL.
Methods At 18 months after ICU discharge an HRQoL survey was sent 
to 1,292 ICU survivors with (n = 272) and without (n = 1,020) delirium 
during their ICU stay. The survey consisted of the Short Form (SF)-36, 
the Checklist Individual Strength (CIS)-fatigue and the Cognitive Failure 
Questionnaire (CFQ). Covariance analysis was performed to adjust for 
gender, sepsis, APACHE II score and length of stay.
Results  A total of 915 (71%) patients responded, of which 171 
patients were delirious during their ICU stay (median age 65 (IQR 58 
to 85), APACHE II score 17 (IQR 14 to 20)) and 745 patients were not 
(median age 65 (IQR 57 to 72), APACHE II score 13 (IQR 10 to 16)). After 
adjusting for covariates, no diff  erences were found between delirious 
and nondelirious ICU survivors on the SF-36 and CIS-fatigue. However, 
delirious ICU survivors were signifi   cantly more absent-minded 
(P = 0.02), suff  ered a more pronounced change in cognitive function 
compared with prior to their ICU stay (P <0.01), and their total CFQ 
score was signifi  cantly (P = 0.03) lower compared with ICU survivors 
that had not been delirious. Hypoactive delirious survivors performed 
signifi  cantly better on several domains of the SF-36 than mixed and 
hyperactive delirious patients. Duration of delirium tended to correlate 
with changed health condition after ICU stay (r = –0.15; P = 0.06).
Conclusions ICU survivors that were delirious during their ICU stay 
experience signifi  cantly more cognitive failure than those who were 
not, even after adjusting for relevant covariates. Hypoactive delirious 
patients are less aff  ected compared with other subtypes of delirium. 
Duration of delirium appears to relate to HRQoL.
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Introduction Delirium is frequently diagnosed in critically ill patients 
and is associated with adverse outcome. Impaired cholinergic 
neurotransmission seems to have an important role in the development 
of delirium. We aimed to establish the eff  ect of the cholinesterase 
inhibitor rivastigmine on the duration of delirium in critically ill patients.
Methods Patients (aged ≥18 years) who were diagnosed with delirium 
were enrolled from six ICUs in the Netherlands, and treated between 
November 2008 and January 2010. Patients were randomised (1:1 
ratio) to receive an increasing dose of rivastigmine or placebo, 
starting at 0.75 ml (1.5 mg rivastigmine) twice daily and increasing 
in increments to 3 ml (6 mg rivastigmine) twice daily from day 10 
onwards, as an adjunct to usual care based on haloperidol. The trial 
pharmacist generated the randomisation sequence by computer, and 
consecutively numbered bottles of the study drug according to this 
sequence to conceal allocation. The primary outcome was the duration 
of delirium during hospital admission. Analysis was by intention to 
treat. Duration of delirium was censored for patients who died or were 
discharged from hospital while delirious. Patients, medical staff  , and 
investigators were masked to treatment allocation. Members of the 
data safety and monitoring board (DSMB) were unmasked and did 
interim analyses every 3 months.
Results Although a sample size of 440 patients was planned, after 
inclusion of 104 patients with delirium who were eligible for the 
intention-to-treat analysis (n = 54 on rivastigmine, n = 50 on placebo), 
the DSMB recommended that the trial be halted because mortality in 
the rivastigmine group (n = 12, 22%) was higher than in the placebo 
Figure 1 (abstract P337). What is the incidence of delirium?
Figure 2 (abstract P337). Do positive CAM-ICU tests change management?
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the rivastigmine group (5.0 days, IQR 2.7 to 14.2) than in the placebo 
group (3.0 days, IQR 1.0 to 9.3; P = 0.06).
Conclusions  Rivastigmine did not decrease duration of delirium 
and might have increased mortality so we do not recommend use of 
rivastigmine to treat delirium in critically ill patients.
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number NCT00704301. Funded by ZonMw, the Netherlands Brain 
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Introduction Delirium occurs frequently in critically ill patients and 
is associated with disease severity and infection. Although several 
pathways for delirium have been described, biomarkers associated 
with delirium in ICU patients are unknown. We examined diff  erences 
in levels of several biomarkers in matched delirious and nondelirious 
patients admitted to the ICU.
Methods  Delirium in adult ICU patients was diagnosed using 
the Confusion Assessment Method-ICU (CAM-ICU). Delirious and 
nondelirious patients were meticulously matched for age, APACHE II 
score, presence or absence of infection or SIRS criteria, and length of 
ICU stay at the moment of blood withdrawal. Neurology and trauma 
patients were excluded. Within 24  hours after the development of 
delirium, blood was drawn for determination of biomarkers. Covariate 
analyses were performed using the C-reactive protein (CRP) level to 
adjust for severity of infection.
Results Fifty delirious and 50 nondelirious ICU patients were included. 
Levels of TNFα, IL-6, IL-8, MIF, IL-1ra, IL10, MCP-1, PCT, cortisol, and the 
brain-specifi  c protein amyloid-β truncated-40 were signifi  cantly higher 
in delirious ICU patients. The ratio of amyloid-β 42/40 and truncated 
42/40 were signifi  cantly lower in delirious compared with nondelirious 
ICU patients, suggesting more deposition of amyloid-β in the brain. In a 
multivariate logistic analysis adjusted for severity of infection, levels of 
TNFα, IL-8, IL-1ra, IL-10, MCP-1 and PCT were signifi  cantly higher in the 
delirious group. The ratio of amyloid-β 42/40 and truncated 42/40 (both 
P = 0.056), IL-6 (P = 0.057) and MIF (P = 0.081) tended to be diff  erent in 
delirious ICU patients.
Conclusions In ICU patients, delirium is associated with signifi  cantly 
increased concentrations of TNFα, IL-8, IL-1ra, IL-10, MCP-1, PCT 
and a decreased ratio of amyloid-β 42/40, even after adjusting for 
severity of infection. We conclude that several proinfl  ammatory 
and anti-infl  ammatory cytokines, PCT and amyloid-β are associated 
with delirium in ICU patients, and could therefore serve as possible 
biomarkers.
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Introduction  Delirium after cardiac surgery is associated with a 
prolonged length of stay in the ICU, prolonged ventilation time and 
higher in-hospital mortality. Although the exact pathophysiology of 
delirium is unknown, both the use of analgesics and the experience 
of pain have been suggested to be associated with the occurrence of 
delirium. The aim of the study was to evaluate the association between 
delirium and analgesics and pain in the ICU.
Methods  In a retrospective observational study, pain and delirium 
scores in patients admitted to the ICU after cardiac surgery via 
sternotomy during a 2-month period were analyzed. Delirium was 
scored using the Intensive Care Delirium Screening Checklist (ICDSC, 
range 0 to 8, ≥4 was deemed delirious). Pain was scored on the Numeric 
Rating Scale (NRS, range 0 to 10, ≥4 was deemed unacceptable). 
Morphine was administered according to a pain titration protocol.
Results ICDSC ≥4 was recorded at least once for 32 (26%) of the 121 
included patients. These patients received signifi  cantly less morphine 
than patients with all ICDSC scores <4 (mean dose 23  ±  8  mg/
day vs. 29 ± 13 mg/day, P <0.01), without diff  erence in pain scores 
between the groups (mean NRS 1.3 vs. 1.4, P <0.3 and 34% vs. 28%, 
P <0.51 experienced at least one unacceptable pain score). Delirious 
patients were older (70 ± 9 vs. 66 ± 11 years, P <0.03), and ventilation 
time and length of stay in the ICU were signifi  cantly longer (26 ± 34 
vs. 14 ± 20 hours, P <0.001 and 77 ± 53 vs. 48 ± 38 hours, P <0.001 
respectively). In-hospital mortality was signifi   cantly higher for this 
group (3 vs. 0 patients, P <0.02).
Conclusions  While delirious patients received signifi  cantly  less 
morphine than nondelirious patients, there was no signifi  cant relation 
between delirium and pain in patients following cardiac surgery in the 
ICU.
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Introduction Secondary brain ischaemia (SBI) usually develops after 
aneurysmal subarachnoid haemorrhage (SAH) and severe traumatic 
brain injury (TBI). The current management strategies are based on 
intracranial pressure-targeted therapy (ICP-targeted) with cerebral 
microdialysis monitoring (modifi   ed Lund concept) or cerebral 
perfusion pressure-targeted therapy (CPP-targeted) [1-3]. We present 
a randomised controlled study to compare the two management 
strategies.
Methods  Sixty comatose operated patients with SBI following 
aneurysmal SAH and severe TBI were randomized into ICP-targeted 
therapy with cerebral microdialysis monitoring and CPP-targeted 
therapy groups. Mortality rates in both groups were calculated and 
biochemical signs of cerebral ischaemia were analysed using cerebral 
microdialysis. Outcome for cerebral microdialysis was measured as 
poor outcome (Glasgow Outcome Scale score 1, 2 and 3) or good 
outcome (Glasgow Outcome Scale score 4 and 5).
Results  Patients treated by ICP-targeted therapy with cerebral 
microdialysis monitoring had a signifi   cantly lower mortality rate 
compared with those treated by CPP-targeted therapy (P  =  0.03). 
Patients undergoing cerebral microdialysis with poor outcome had 
lower mean values of glucose and higher mean values of glycerol and 
lactate/pyruvate ratio as compared with those with good outcome 
(glucose: P = 0.003; glycerol: P = 0.02; lactate/pyruvate ratio: P = 0.01). 
There was no diff  erence in the outcome between aneurysmal SAH and 
severe TBI in the two groups.
Conclusions  The ICP-targeted therapy based on modifi  ed  Lund 
concept showed better results compared with CPP-targeted therapy 
in the treatment of comatose patients sustaining SBI after aneurysmal 
SAH and severe TBI.
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Introduction Brain midline shift (MLS) is a life-threatening condition 
that requires urgent diagnosis and treatment [1]. Bedside MLS 
assessment with sonography has been proposed as a valuable method 
in stroke patients [2]. We aimed to validate this method in neurocritical 
care patients by comparing it with the brain CT gold standard method.
Methods This prospective study was conducted in a single neurocritical 
care unit. Patients who underwent brain CT scan were included 
and a concomitant brain sonography with MLS measurement was 
performed. Using sonography, the midline was determined bilaterally 
with a 2 to 4 MHz probe using the temporal window by visualizing 
the third ventricle, with a double hyperechogenic image above the 
mesencephalon. MLS was calculated as the diff  erence between both 
sides for midline line measurements. CT MLS was independently 
calculated by a specialist in neuroradiology as the maximal diff  erence 
between the ideal midline and the actual interventricular septum. A 
signifi  cant MLS was defi  ned on brain CT as >0.5 cm.
Results Fifty-fi  ve patients (with a total of 67 paired measured) were 
included (72% male with a median IGS II of 35.5 ranging from 12 to 
65) (35 TBI, eight subarachnoidal hemorrhage, fi  ve  intracerebral 
hematoma, seven postoperative care). The mean (± SD) MLS was 
0.34 ± 0.34 cm using sonography and 0.48 ± 0.68 cm using CT. The 
linear regression showed an r value at 0.64 between sonographic 
and CT MLS (P <0.0001). Bland–Altman plot showed a mean bias of 
0.09 cm and three values out of the limits of agreement (4% of the total 
measures) (Figure 1). For sonography, the area under ROC curve for the 
detection of signifi  cant MLS was 0.80 (0.68 to 0.89) with a best cut-off   
value of 0.46 cm with 74% sensitivity and 89% specifi  city.
Conclusions MLS measurement using sonography appears to have 
interesting performances for the detection of signifi  cant MLS (that is, 
>0.5 cm on brain CT). As the regression between sonographic and CT 
values for MLS was not very strong, and as the agreement between both 
methods showed relatively large limits of agreements, sonography 
would not replaced the gold standard CT method. However, the 
bedside estimate could be used as a detection tool in emergency in 
neurocritical care patients.
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Introduction Hypernatremia is a common medical complication in 
neurointensive care that is associated with worse outcome. It can be 
caused by water diuresis due to anti-diuretic hormone insuffi   ciency 
in central diabetes insipidus (cDI) or from diff  erent  mechanisms: 
osmotherapy, furosemide or renal failure. The aim of this prospective 
study was to analyse hypernatremias in neurointensive care over a 
period of 5 years.
Methods We evaluated all hypernatremias defi  ned as serum sodium 
(SNa+) >150 mmol/l in patients with acute brain disease hospitalised 
in the neurologic–neurosurgical care unit (NNICU). cDI was diagnosed 
according to serum and urine osmolality, hourly diuresis, electrolyte-
free water clearance (EWC) and response to desmopressin. The 
remaining hypernatremias were called non-cDI. We compared these 
groups in Glasgow Coma Scale (GCS) on onset of hyponatremia, 
incidence of cerebral complications, Glasgow Outcome Scale (GOS) 
upon discharge from the NNICU and mortality in the NNICU, and EWC.
Results  There were 133 hypernatremic patients (mean SNa+ 
154.9 ± 4.5 mmol/l) with mean age 60.6 years; male 72; diagnoses: 
stroke 88 patients, tumour 19 patients, trauma 19 patients, infection 
four patients, others three patients. The mean GCS on onset of 
hypernatraemia was 9.4 ± 4.3, the mean GOS upon discharge from 
the NNICU was 2.4 ± 1.2. We diagnosed cDI in 16 patients, the majority 
(117 patients) was fi  led as the non-cDI group. Patients with cDI had 
signifi   cantly higher SNa+ (160.1  ±  8.4  mmol/l, P  <0.001), diuresis 
(P <0.001), EWC (P <0.001), mortality in the NNICU (P = 0.012) than 
patients in the non-cDI group. There were no diff   erences in GCS 
(P = 0.192), GOS (P = 0.079), cerebral complications (P = 0.809), and 
anti-edematic therapy (P = 0.221). Patients in the non-cDI group (SNa+ 
154.4 ± 3.4 mmol/l) received more diuretics (P = 0.001) and 18 patients 
had renal failure.
Conclusions In this study cDI was not a common type of hypernatremia 
in neurointensive care, but it had higher mortality in the NNICU than 
other types of hypernatremias, which are caused mostly by diuretics 
and by renal failure.
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Introduction  Paracetamol given for fever is associated with 
hypotension [1]. Spectral analyses (Fourier, wavelet) can be used to 
identify low-frequency oscillations of skin blood fl  ow (skBF) [2]. The 
relationship of paracetamol to skBF and blood pressure (BP) in febrile 
patients was studied.
Methods Twenty-nine adults, 58 ± 15 years, were treated with enteral 
or intravenous paracetamol for fever. Forty-one percent (n = 12) were 
medical, 31% (n = 9) surgical, and 28% (n = 8) neurological. APACHE II 
score was 17.2 ± 8.3. Frequency domain analyses of the laser Doppler 
fl  owmetry (LDF) waveforms of two patients were undertaken. Both 
patients (A and B) had good LDF waveforms, both increased skBF whilst 
BP fell in patient B.
Results Temperature, BP and skBF were recorded 15 minutes prior 
to paracetamol, at administration (T0) and then every 15 minutes for 
60 minutes. Thirty datasets were recorded. Temperature at T0 was 
38.7  ±  0.6°C. BP decreased over the study period whilst skBF and 
cutaneous vascular conductance (CVC = skBF / mean arterial pressure) 
Figure 1 (abstract P343). Bland–Altman plot: agreement between 
sonography and CT for MLS assessment.
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(P <0.01) at all post-administration times and was 90 ± 13% of T0 at 
60 minutes (Figure 1). CVC was 128 ± 48% of T0 at 60 minutes. Systolic BP 
fell signifi  cantly (≥15%) in 17 patients (59%). Normalised average power 
spectral density (PSD) increased substantially in the 0.40 to 2.0 Hz band 
in patient A, corresponding to an increase in cardiac output (CO). Wavelet 
scalograms showed increased relative energy for <0.012 Hz (patients 
A and B) consistent with cutaneous vasodilation and around 0.02 Hz 
(patient A) consistent with increased sympathetic activity [2].
Conclusions Paracetamol induced increases in skBF consistent with its 
antipyretic action. Changes in PSD and wavelet analysis were consistent 
with cutaneous vasodilation.
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Introduction  The aim of this study was to describe paracetamol 
pharmacokinetics in neonates, to determine its covariates and suggest 
a dosing regimen for neonates (28 to 44 weeks postmenstrual age 
(PMA)).
Methods A population PK analysis of paracetamol time–concentration 
profi  les (943 observations) from 158 neonates (27 to 45 weeks PMA) 
was undertaken using nonlinear mixed-eff   ects models. Data from 
three earlier published studies involving neonates given either i.v. 
propacetamol or paracetamol were pooled with newly collected 
observations during repeated i.v. paracetamol administration (n = 60, 
343 observations, PARANEO study) [1-3].
Results  A two-compartment linear disposition model was used. 
Popu  lation parameter estimates (between-subject variability, %) 
were central volume (V1) 51.9 (21.6%) l/70 kg, peripheral volume of 
distribution (V2) 22.7 l/70 kg, clearance (CL) 5 (40%) l/hour/70 kg and 
inter-compartment clearance (Q) 16.2 l/hour/70 kg. About one-half 
(60.9%) of the overall CL variance is predictable from covariates. Weight 
was used to predict size and this was the major covariate (57.5%). 
Clearance expressed as mg/kg/hour increases only slightly with PMA 
(0.138 at 28 weeks, 0.167 l/hour/kg at 44 weeks PMA), contributing only 
2.2% of variance within this cohort. Unconjugated bilirubin contributed 
only an additional 1.2% of variance.
Conclusions An increased volume of distribution supports the use 
of a loading dose when instigating paracetamol therapy in neonates 
while size is the major covariate of clearance. Clearance matured 
slowly in this cohort and a mean paracetamol serum concentration 
of 11 mg/l is achieved in neonates (28 to 44 weeks) given a standard 
dose of paracetamol of 10 mg/kg/6 hours. Based on these estimates, 
we suggest a loading dose of 20 mg/kg followed by 6-hourly dosing 
(10 mg/kg) within the age range evaluated.
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Introduction To study the use of size, maturation and CYP2D6 genotype 
score as predictors of i.v. tramadol (M) disposition throughout human 
life, published observations were pooled [1-6].
Methods  M and O-demethyltramadol (M1) observations in 295 
subjects (25 weeks postmenstrual age to 84.8 years) were available 
for population PK analysis (NON-MEM, two-compartment model 
for M and two additional compartments for M1). Covariates were 
weight, age, sex, disease (healthy/patient) and CYP2D6 genotype 
score. A sigmoid maturation model was used to describe changes in 
M (CLPO + CLPM), M1 formation (CLPM) and M1 elimination (CLMO) 
clearance. Phenotype-based and genotype-based models were used 
to distinguish poor CLPM subjects.
Results Diff  erences in M disposition between children and adults were 
largely accounted for by maturation and size. CKLPM (TM50 40.3 weeks, 
Hill 9.09) and CLPO (TM50 39.1 weeks, Hill 5.8) display fast maturation, 
while CLMO matures slower. The phenotype-based mixture model 
estimated that 8.6 were slow metabolizers (18.3% of normal CLPM). 
Genotype-based estimates were also lower (68%) but not all subjects 
with a low CYP2D6 score were in the poor metabolizer group.
Conclusions Maturation of M elimination occurs early with 50% of 
adult values at full-term age. Maturation and age are key predictors, 
while CYP2D6 genotype score only explains some of the variability in 
M disposition.
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Introduction  Bispectral index (BIS) monitoring measures depth of 
anaesthesia, using electroencephalography (EEG). It has been validated 
against sedation scales used in intensive care. We hypothesized that 
using BIS during percutaneous tracheostomies would reduce sedation 
doses, resulting in fewer episodes of haemodynamic instability.
Methods  Patients undergoing percutaneous tracheostomy were 
randomised to the control or intervention groups. Norepinephrine was 
administered to prevent a fall of more than 20% in mean arterial blood 
pressure. Patients in the control group were sedated with a propofol 
infusion at a dose chosen by the operator. All personnel performing the 
tracheostomy were blinded to the BIS score. In the intervention group, 
patients were sedated with a propofol infusion adjusted so that the BIS 
Figure 1 (abstract P345).
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brain injury, and patients who had received sedative drugs other than 
alfentanil and propofol were excluded. All patients or their advocates 
gave written, informed consent. The primary outcome was the number 
of episodes of haemodynamic instability. Secondary outcomes were 
the dose of propofol administered to patients, BIS scores, time of 
recovery from sedation, total norepinephrine administered to patients, 
and time taken to do the procedure.
Results  Twenty patients entered the study. Results are presented 
as mean ± SD. There was no signifi  cant diff  erence in the incidence 
of hypotension (4.5 ± 6.8 events and 5.6 ± 6.9 events in control and 
intervention groups, respectively, P = 0.25). There were fewer episodes 
of hypertension in the intervention group (2.5  ±  4.6 events in the 
control group and 0.9 ± 2.2 events in the intervention group) (P = 0.12). 
The dose of propofol and norepinephrine dose were lower in the 
intervention group: 5.4 mg/kg/hour cf. to 6.8 mg/kg/hour for propofol 
(P = 0.21); 0.05 μg/kg/hour cf. to 0.09 μg/kg/hour for norepinephrine 
(P = 0.14). The mean time to waking was signifi  cantly shorter in the 
intervention group (54 minutes) as compared with that in the control 
group (96 minutes), P = 0.04.
Conclusions  BIS monitoring did not signifi   cantly reduce sedation 
requirements, or improve haemodynamics during percutaneous 
tracheostomy, although there was a trend to both reduced sedation 
requirements and improved haemodynamic stability. The time to 
waking was signifi  cantly reduced.
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Introduction Percutaneous dilatational tracheostomy (PDT) is commonly 
performed at the bedside in the ICU. Patients in the ICU often have 
multiple organ dysfunction, causing alterations in drug eff  ects  and 
metabolism. Alterations in sedative drug handling may make them 
vulnerable to awareness during PDT. Up to 40% of patients in the ICU 
report some awareness whilst receiving neuromuscular receptor blocking 
drugs [1] – these drugs are usually employed when performing PDT. 
Depth of anaesthesia monitoring may prevent awareness and has been 
used during PDT [2]. Various depths of anaesthesia monitors are available, 
including the bispectral index monitor (BIS), the Narcotrend Index and the 
State and Response Entropy, derived from the EEG. We report the results of 
a telephone survey on the sedation given for PDT in English ICUs.
Methods We contacted 240 adult ICUs in England by telephone. Two 
hundred and twenty-four units (93%) participated.
Results Two hundred and fourteen units (95%) perform PDT as their 
fi  rst-choice technique. Units that do not practice PDT (n = 10, 5%) 
perform open surgical tracheostomy. Most ICUs use simple infusions 
of propofol via standard infusion pumps during PDT (n = 202, 94%), 
and give additional boluses of propofol if necessary. In seven units 
(3.3%) anaesthesia is provided using intermittent boluses of propofol, 
without a background infusion. This may be of concern given that 
one study reported awareness during rigid bronchoscopies [3] and 
all the patients who reported awareness were anaesthetized using 
intermittent boluses of propofol. Nine units (4.2%) reported using a 
BIS during PDT. Three ICUs have used a BIS on a trial basis, but have 
discontinued. One reason given for discontinuing using a BIS was that 
it ‘made no diff  erence to the amount of sedation’ during PDT.
Conclusions  Depth of anaesthesia monitoring is not widely used 
in English ICUs during PDT. It is unclear whether a BIS is eff  ective for 
monitoring depth of anaesthesia during PDT, and further studies are 
needed to clarify this.
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Introduction The use of procedural sedation and analgesia (PSA) has 
increased in frequency and scope, including emergent settings inside 
and outside the hospital. Although end-tidal CO2 (EtCO2) monitoring 
is routinely used during general anesthesia to monitor ventilatory 
status, this is not the case for PSA. Pulse oximetry and visual inspection, 
both with inherent limitations, represent the current standards of 
care for monitoring ventilatory status during PSA. EtCO2 monitoring 
may be a preferable method for detecting alveolar hypoventilation 
and preventing hypoxemia during PSA but is not widely used in this 
setting. Our study objective was to determine whether capnography 
in addition to standard monitoring improved detection of respiratory 
events compared with standard monitoring alone.
Methods  A literature search was conducted using the electronic 
databases PubMed, CINAHL, and Cochrane Library (Cochrane Reviews, 
CENTRAL) for studies published between 1995 and 2009 reporting 
adverse respiratory events during procedural sedation and analgesia 
with clearly defi  ned  EtCO2 threshold, clear study design, P-value 
calculation, similar outcome and predictor variable defi  nitions, and 
binary independent and dependent variable raw data. To limit threats 
from variations in practice, only reports of adults in the USA were 
included. Five such studies were evaluated independently. A meta-
analysis of these studies was performed.
Results During PSA, cases of respiratory depression were 17.6 times 
more likely to be detected if monitored by capnography, versus cases 
not monitored by capnography (95% CI, 2.5 to 122.1; P <0.004).
Conclusions  This analysis suggests that EtCO2 monitoring is an 
important addition for detecting respiratory depression during PSA.
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Introduction Postoperative nausea and vomiting (PONV) is one of the 
factors that aff  ect the quality of postoperative patient care. We would 
like to report possible antiemetic eff  ects of dexmedetomidine (DEX), a 
selective α2-agonist sedative, in patients after off  -pump coronary artery 
bypass grafting (OPCAB).
Methods  Local Research Ethics Committee approval and written 
informed consent from patients or next of kin were obtained before 
this study. Patients after OPCAB were allocated into two groups 
(sedated with DEX; DEX(+), n = 123 and no sedation; DEX(–), n = 134). 
The incidence of PONV, postoperative morphine consumptions and 
amount of gastric fl  uid drained via a nasogastric tube were compared 
in the two groups.
Results There were no signifi  cant diff  erences in the patients’ profi  les 
and intraoperative opioid consumptions. Eight patients in the DEX(+) 
group had PONV whereas 35 patients had PONV in the DEX(–) group 
(6.5% vs. 26.1%, P <0.01) during a postoperative observation period 
of 12.5 (3.2) and 11.8 (2.4) hours, respectively (mean (SD)). The ratio 
of patients who required morphine for postoperative pain relief was 
lower in the DEX(+) group than the DEX(–) group (67.5% vs. 83.6%, 
P  <0.01), presumably due to analgesic eff   ects of DEX. Analysis of 
individual patients revealed that fi  ve out of eight patients and 12 
out of 35 patients had PONV after morphine use in the DEX(+) and 
DEX(–) groups, respectively. Repeated analysis without those patients 
revealed the same tendency (3.4% vs. 18.2% had PONV in the DEX(+) 
and DEX(–) groups, respectively; P <0.01) as obtained in all the patients, 
suggesting antiemetic eff  ects of DEX per se. There were no signifi  cant 
diff  erences in the amount of gastric fl  uid drained via a nasogastric tube 
between groups.
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gastric emptying like morphine. According to this report, the decreased 
incidence of PONV in the DEX(+) group in our study is not likely to be 
caused by peripheral eff  ects of DEX on the gastrointestinal tract. It 
is widely recognized that morphine induces PONV, and we analyzed 
the incidence of PONV without patients who had any suspicion of 
morphine-induced PONV, obtaining the same result. According to 
these considerations, we would like to conclude that DEX could have 
antiemetic eff  ects per se.
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Introduction Dexmedetomidine is an α2-agonist, used for sedation in 
the ICU, although much remains to be learned about the eff  ects on the 
autonomic nervous function. We therefore investigated them in the 
real-time monitoring of heart rate variabilities.
Methods From May through November 2010, 20 patients were selected 
if they were treated on total mechanical ventilatory support and they 
were treated with continuous infusion of dexmedetomidine in our 
ICU. The exclusion cases were with arrhythmia or pacemaker or other 
treatment during the measure time. Heart rate (HR) variability analysis 
was recorded using the MemCalc system (MemCalc/Tonam16C; Suwa 
Trust, Tokyo, Japan). The spectral bands were 0.04 to 0.15 Hz (low 
frequency (LF)), 0.15 to 0.40 (high frequency (HF)) and others. The HF 
component was an indicator of sympathetic balance, and LF/HF was 
that of parasympathetic balance. We measured the HR, CV-RR, HF, 
LF/HF, systemic blood pressure (SBP), CV-SBP, SBP-HF and SBP-LF/HF. 
The CV-RR was SD of RR intervals, and the CV-SBP was SD of systemic 
blood pressure. We compared them between before and after 30 
minutes administration of dexmedetomidine. The Wilcoxon signed-
ranks test was used to compare the diff  erences. P <0.05 was considered 
statistically signifi  cant.
Results The HR was signifi  cantly decreased (P = 0.017), and the CV-
RR was in a tendency of decrease (P = 0.085). Although the SBP was 
not signifi   cantly changed, the CV-SBP was signifi  cantly  decreased 
(P = 0.038). Other parameters (HF, LF/HF, SBP-HF and SBP-LF/HF) were 
not signifi  cantly changed.
Conclusions  We investigated the autonomic nervous functions in 
20 patients treated with dexmedetomidine. The HR and the CV-SBP 
were signifi   cantly decreased. Dexmedetomidine was aff  ected  with 
depression of sympathetic nerve system to the HR, the CV-RR and 
CV-SBP.
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Introduction The aim of this study was to characterize the pharmaco-
kinetics of long dexmedetomidine (dexmed) infusions and assess the 
dose linearity of high doses.
Methods Dexmed was infused to critically ill intensive care patients 
for 12 hours using a constant infusion rate determined by the prestudy 
dose of propofol or midazolam. After the fi  rst 12 hours, the infusion rate 
of dexmed was titrated between 0.1 and 2.5 μg/kg/hour using prefi  xed 
levels to maintain sedation in range of 0 to –3 on the Richmond 
Agitation–Sedation Scale (RASS). Dexmed was continued as long as 
required to a maximum of 14 days. Safety and tolerability were assessed 
by adverse events, heart rate, blood pressure, ECG and laboratory tests.
Results Dexmed concentration profi  les of the 13 patients during the 
infusion and 48-hour follow-up are depicted in Figure 1. The geometric 
mean values (CV%) for length of infusion, dexmed half-time, clearance 
and volume of distribution (elimination) were 91  hours (117%), 
3.7 hours (38%), 41 l/hour (47%) and 223 l (35%), respectively. There 
was a linear relationship (r2 = 0.95; P <0.001) between the areas under 
the dexmed plasma concentration–time curves and cumulative doses 
of dexmed. All but one patient needed propofol to keep the RASS value 
in the target zone. The most common adverse events were tachycardia, 
hypotension and hypertension.
Conclusions  The pharmacokinetics of dexmed was linear up to 
the dose of 2.5 μg/kg/hour. Despite the high dose and long-lasting 
infusions, safety fi  ndings were as expected for dexmed and the patient 
population.
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Introduction  The use of dexmedetomidine to achieve sedation, 
analgesia and mechanical ventilation has increased in critically ill 
patients, although little is known about its eff  ects in septic shock. The 
aim of this study was to assess hemodynamic, metabolic and infl  am-
matory eff  ects of dexmedetomidine in a pig model of septic shock.
Methods  Eighteen pigs were anesthetized, mechanically ventilated 
and randomly allocated into three groups of six animals: sham group, 
shock group (intravenous infusion of live Escherichia coli over 1 hour) 
and shock+dex group (E. coli + bolus and constant rate infusion 
treatment with dexmedetomidine). Both shock groups received 
fl  uid therapy with lactated Ringer’s (LR) and norepinephrine to reach 
central venous pressure of 8 to 12 mmHg and mean arterial pressure 
≥65 mmHg. T0 was considered the end of bacterial infusion and animals 
were monitored hourly for 240 minutes. Hemodynamic parameters 
were assessed with a pulmonary artery catheter and femoral arterial 
catheter. Blood gases, intestinal tonometry and infl  ammatory cytokines 
were also measured. Two-way ANOVA and Tukey test were used for 
statistical analysis (P <0.05).
Figure 1 (abstract P353). Dexmedetomidine concentration profi  les of 
the 13 patients.
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lung injury and metabolic acidosis. At T0, oxygen consumption was 
signifi  cantly greater in the shock+dex group (149.9 ± 25.6 ml/minute/m2) 
than in the shock group (111.5 ± 21.6 ml/minute/m2), as was Pr–Pa 
(53 ± 14 mmHg and 35 ± 11 mmHg, respectively). At T180, SvO2 in 
the shock+dex group was statistically lower than in the shock group 
(62.5 ± 9.0 vs. 74.2 ± 9.1%, respectively). At T240, cardiac index in the 
shock+dex group was lower than that in the shock and sham groups 
(2.8 ± 0.5 vs. 3.6 ± 1.7 vs. 4.7 ± 1.1 ml/minute/m2, respectively) while the 
oxygen extraction rate was larger in the shock+dex group (43 ± 20%) 
than in the shock group (25 ± 11%). TNFα levels were similar in both 
groups. Although plasma levels of IL-1β, IL-6 and IL-10 were elevated 
in the shock group, there was no statistical signifi   cance with the 
shock+dex group. No statistical diff  erence was found in treatment with 
LR or norepinephrine, nor in urine output.
Conclusions Dexmedetomidine is likely to cause a mismatch between 
oxygen delivery and consumption by aff  ecting microcirculation in 
critically ill patients, despite treatment with crystalloids and vasoactive 
agents. Its eff  ects on the infl  ammatory response remain unclear.
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Introduction It is of clinical interest to maintain patient comfort in the 
ICU and yet preserve their intellectual function, arousal and interaction. 
Recently, dexmedetomidine (DEX) was demonstrated in the ANIST Trial 
to preserve intellectual function as compared with propofol (PRO) 
when used as conscious sedation in both agitated neurologically intact 
and brain-injured critically ill patients [1]. The purpose of this study 
was to further understand whether selective areas of cognition were 
specifi  cally aff  ected by PRO and DEX through sub-analysis of the Trial’s 
results on each of the fi  ve subscales of the Adapted Cognitive Exam 
(ACE).
Methods  We preformed a post-hoc analysis of the prospective 
randomized, double-blinded cross-over designed ANIST trial that 
compared cognitive diff  erences between PRO and DEX on the validated 
100-point Hopkins ACE. This current study further investigated 
diff  erences by analyzing the fi  ve subscales of the ACE, which consist 
of Orientation, Language, Registration, Attention/Calculation and 
Recall. Analysis included a generalized estimating equations approach 
to estimate diff  erences between drugs while accounting for within-
subject correlation arising from the crossover design. We examined 
unadjusted and adjusted models both with and without inclusion 
of potential period eff  ects. We also accounted for period eff  ects, and 
robust variance estimates were used to calculate standard errors.
Results Sedation with PRO diminished adjusted scores on four of the 
ACE subscales (P <0.01), while DEX improved adjusted scores on two of 
the subscales (Attention/Calculation 2.35, 95% CI: 0.11 to 4.59; Recall: 
2.03, 95% CI: 0.03 to 4.04). The other estimates for the eff  ects of PRO 
and DEX on the ACE subscales were not statistically signifi  cant using 
a signifi  cance level of 0.05. The positive and signifi  cant diff  erence in 
the change of ACE score between DEX versus PRO held up in all of the 
subscales.
Conclusions Our fi  ndings indicate that DEX not only preserved but 
also improved Attention/Calculation and Recall in ICU patients who 
were awake, agitated and required sedation. This was evident by higher 
mean ACE subscale scores when compared with their baseline. Our 
fi  ndings suggest that DEX improved overall cognitive function without 
signifi  cantly compromising the ability to focus and recall events.
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Introduction Many patients describe pain and other adverse feeling 
from their ICU stay and the impact of such feelings impacts long-term 
psychological morbidity. Presently no objective method for detecting 
pain or distress is available. Skin conductance variability has been 
investigated as a monitor of perioperative pain. The method has not 
been studied in adult ICU patients.
Methods  Twenty-fi   ve (13 intubated and 12 non-intubated) patients 
were included in this observational study. Patients were monitored with 
the MED-STORM Stress Detector for 1 hour of intensive care treatment 
and care. Skin conductance variability (number of skin conductance 
fl   uctuations per second (NSCF)) was measured and patients were 
observed in parallel during rest and during procedures and staff  –patient 
interactions. The sedation–agitation level was monitored with the 
Motor Activity Assessment Scale. Pain was monitored with the Numeric 
Rating Scale (0 to 10) in communicating patients and by observation of 
expressions of pain in patients unable to communicate verbally.
Results In non-intubated patients, NSCF values were low when patients 
were unstimulated and comfortable and increased with increasing 
stimulation but also with increasing agitation without any apparent 
pain. The highest NSCF values were noted during combined pain and 
agitation. In intubated patients, a similar pattern was observed but 
with generally lower values, most likely due to sedation. Sensitivity 
and specifi  city of NSCF at a cut-off   value >0.13 for detecting expressed 
pain/discomfort were 74% and 55% for non-intubated patients and 
61.5% and 68% for intubated patients.
Conclusions  Skin conductance variability increases in critically ill 
patients with increasing stimulation but is also aff  ected by the level of 
sedation/agitation, making the method unsuitable for detecting pain 
alone in critically ill patients, but possibly of value to more generally 
monitor emotional stress with diff  erent etiology. Further studies of the 
method in critically ill patients, over longer time and with validated 
pain instruments are warranted.
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Introduction  Daily sedation holds, particularly when combined 
with protocolised spontaneous breathing trials, are one of the only 
strategies available to intensivists that produce an outcome benefi  t [1]. 
This evidence has also provoked a renewed interest in the choice of 
both hypnotic and analgesic agents. Midazolam is known to produce 
unpredictable awakening and may prolong time to extubation when 
infusions continue longer than 48 to 72 hours. In contrast, propofol 
may enhance the benefi  t to critically ill patients of the daily sedation 
hold due to its pharmacokinetic properties [2]. This study examines the 
hypothesis that the ratio of propofol/midazolam use can be used as 
a surrogate marker of good practice and utilises the potential of the 
pharmacy procurement database.
Methods The amount of propofol and midazolam supplied in grams 
per month was obtained from the pharmacy database for both the 
surgical and medical critical care units for the period April 2006 to 
July 2009. These data were compared with the number of monthly 
admissions, average monthly length of stay, APACHE II score (May 2008 
to July 2009) and standardised mortality rate (SMR) for that period. 
Sigmaplot 11.0 was used to determine statistical signifi  cance.
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per patient (r = 0.512; P = 0.0007) and reduction in midazolam use per 
patient (r = –0.384; P = 0.014) between April 2006 and July 2009. The 
mean ± SD monthly admission rate was 142 ± 15.3 patients. The use of 
propofol/midazolam was independent from length of stay and APACHE 
II score. Statistical signifi   cance was not reached when correlating 
propofol/midazolam use to fall in SMR (1.11 to 0.77) due to the limited 
number of data points.
Conclusions  Although a clear relationship between reduced 
midazolam use and improved outcome could not be demonstrated, 
information from the pharmacy database remains an important 
means to review prescribing practice. Monthly supply may not always 
accurately refl  ect use but over time will indicate signifi  cant changes in 
practice such as the reduced use of midazolam at this institution.
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Introduction There are few published data on the pharmacokinetics 
of propofol infusion for prolonged periods in critical care. Propofol is 
frequently infused for days or weeks in critically ill patients with organ 
dysfunction. We aimed to determine whether propofol concentrations 
in critically ill patients are predictable during constant rate infusion, 
and whether signifi  cant organ failure might lead to accumulation when 
compared with conventional pharmacokinetic models.
Methods  We compared blood propofol levels with total dose and 
duration of propofol infusion in 53 samples from 43 patients on a 
mixed critical care unit undergoing prolonged sedation. Estimated 
propofol concentration was calculated using the Marsh algorithm. The 
Richmond Agitation Scale at the point of propofol measurement was 
recorded, and the Sequential Organ Failure Assessment (SOFA) score 
was recorded for assessment of its impact on propofol levels.
Results  Propofol was infused for a mean of 33  hours (14 to 44 
interquartile range). The mean measured propofol concentration 
was 1.37 μg/ml (range 0.29 to 2.60). There was fairly good correlation 
between estimated propofol concentrations (based on the Marsh 
model) and measured levels with a R2 value of 0.500, shown in Figure 1. 
The level of organ failure did not impact signifi  cantly on the accuracy 
of predicted propofol levels.
Conclusions  We were able to demonstrate a correlation between 
predicted propofol levels and those measured in blood. Predicted 
propofol levels were on average lower than measured levels, 
suggesting a reduced capacity to metabolise propofol in critical 
illness, although this eff  ect was not marked, and we were unable to 
demonstrate an association between severity of organ failure and 
deviation of measured from predicted propofol levels.
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Introduction A protocol of no sedation has been shown to reduce the 
time patients receive mechanical ventilation and reduce intensive care 
and total hospital length of stay [1]. The long-term psychological eff  ect 
of this strategy has not yet been described.
Methods  We contacted all surviving patients who had been 
randomized to our original trial that compared a no-sedation strategy 
with a traditional strategy of sedation and daily wake-up trial. Patients 
were off   ered a follow-up interview with a neuropsychologist. The 
neuropsychologist was blinded to the randomized treatment. All 
patients were assessed with the same validated psychological tests. 
Post-traumatic stress disorder (PTSD) was evaluated with three tests: 
Revised Impact of Event Scale, State Anxiety Inventory Scale and Post-
Traumatic Stress Syndrome 10-Questions Inventory scale (PTSS-10). The 
generic quality of life was evaluated using the Medical Outcomes Study 
36-item short-form health survey (SF-36). Depression was evaluated 
using the Beck Depression Inventory-2 score (BDI-II). Patients were also 
assessed with a modifi  ed version ICU memory tool.
Results A total of 26 patients were interviewed (13 from each group). 
The time span between randomization and interview was 2 years (no-
sedation group 1.78 (1.46 to 2.10) years vs. sedated group 2.04 (1.55 to 
2.29) years, P = 0.32). No diff  erence was found with respect to baseline 
data. Very few patients suff  ered from PTSD and no signifi  cant diff  erence 
was found between the two groups. No diff  erence was found with 
respect to generic quality of life (SF-36). A very low rate of depression 
was found in both groups with no signifi  cant diff  erence. The modifi  ed 
ICU memory tool showed that two-thirds of patients from both groups 
had experienced nightmares during their ICU stay. Very few patients 
remembered pain or breathing diffi   culties in the ICU (NS).
Conclusions Our data disprove the popular supposition that a protocol 
of no sedation applied to critically ill patients undergoing mechanical 
ventilation increases the risk of long-term psychological sequelae 
after intensive care compared to standard treatment with sedation. 
With the reduced ventilator days, reduced ICU and hospital length of 
stay, this psychological follow up further supports the benefi  ts from 
a no-sedation strategy applied to critically ill patients undergoing 
mechanical ventilation.
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Introduction  In systemic infl   ammation and sepsis, the endo-
cannabinoid system is upregulated [1]. While it is known that neuronal 
Figure 1 (abstract P358). Correlation between measured and estimated 
propofol levels in critically ill patients.
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nervous system represents an intrinsic neuroprotective response [2] 
and exerts anti-epileptic activity [3], inhibition of CB1 (CB1inh) has 
been suggested as an experimental target for sepsis therapy [4]. We 
studied the eff  ects of CB1inh in rats with experimental sepsis during 
anesthesia induction with pentobarbital.
Methods Five groups of Lewis rats were included in the study: Group 
1 – sham-operated controls treated with CB1inh (AM281, 2.5 mg/kg 
i.v., n = 12), Group 2 – animals with colon ascendens stent peritonitis 
(CASP)-induced sepsis treated with CB1inh (n  =  12). As additional 
control groups we administered in CASP animals the CB1 agonist 
ACEA (2.5 mg/kg i.v.; Group 3; n = 4) or the solvent DMSO (Group 4; 
n = 4). In Group 5 we administered 50 mg/kg ketamine for induction 
of anesthesia 14  hours following the CASP treated by CB1inh. All 
other groups received a standard dose of pentobarbital (40 mg/kg i.v.) 
14 hours following CASP procedure.
Results In fi  ve out of 12 septic animals (42%) with CB1inh (Group 2) 
we observed tonic–clonic seizures immediately after induction of 
anesthesia with a standard dose of pentobarbital. In sham-operated 
animals (Group 1) or CASP animals without CB1inh (Group 4) we did not 
observe anesthetic-induced excitation. Replacement of the barbiturate 
by ketamine (Group 5) avoided seizures as well as treatment with the 
CB1 agonist (Group 3).
Conclusions CB1 inhibition in sepsis may increase the incidence of 
anesthetic-induced excitation and reduce CB1-mediated intrinsic 
neuroprotective response.
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Introduction Conventional sedation strategies in the ICU are based on 
the use of propofol or benzodiazepines for sedation in combination 
with morphine or other opioids for analgesia. An alternative strategy is 
based on analgo-sedation with remifentanil, a potent and very short-
acting opioid agent. However, evidence is scarce that such a strategy is 
more effi   cacious.
Methods In January 2010 we introduced a remifentanil-based analgo-
sedation protocol in our 32-bed academic general ICU. To evaluate 
the effi   cacy, we performed a retrospective comparison of all patients 
admitted between 1 April and 30 June 2010 with a control group 
consisting of patients admitted between 1 February and 30 September 
2009 who underwent a conventional sedation strategy. Exclusion 
criteria were mechanical ventilation <24 hours, brain trauma, any other 
neurologic pathology, and moribund.
Results In total, 596 patients were selected in the conventional group 
(C) and 214 in the remifentanil group (R); after exclusion, group C 
consisted of 163 patients and group R of 70 patients for analysis. 
Both groups were identical in age, sex and APACHE II score. The mean 
duration of mechanical ventilation was signifi  cantly lower in group R 
(P = 0.01); time to successful detubation was signifi  cantly shorter in 
group R (log-rank P = 0.0026, HR = 0.57 (0.40 to 0.82). Overall ICU stay 
was shorter in group R; time to discharge to the ward was shorter in 
group R as well (log-rank P = 0.01, HR = 0.63 (0.44 to 0.90). ICU and 
hospital mortality as well as overall hospital stay were comparable in 
both groups.
Conclusions  Introduction of a remifentanil-based analgo-sedation 
protocol signifi  cantly decreased duration of ventilation and ICU stay, 
most probably due to its short half-time, the easy titration of sedation 
and the absence of prolonged oversedation in critically ill patients.
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Introduction  Assessment of cognition in ICU patients is a critical 
component of evaluating cerebral dysfunction. Several cognitive tools 
also exist for assessment of delirium in the ICU. However, few are simple 
to use and none has been specifi  cally designed to focus on cognition 
in ICU patients. The Johns Hopkins Adapted Cognitive Exam (ACE) is 
an examination tool on a 100-point scale specifi  cally designed for the 
assessment and quantifi  cation of cognition in critically ill patients.
Methods  A prospective cohort study to establish the criterion, 
construct, and face validity, as well as inter-rater reliability and inter-
item reliability of the ACE.
Results A total of 106 patients were assessed, 46 intubated and 60 
non-intubated, resulting in 424 ACE measurements and 240 MMSE 
measurements. ACE and MMSE were performed by 76 diff  erent 
raters over the study period. For criterion validity we compared ACE 
with a neurointensivist’s assessment of cognitive status (rs  =  0.83, 
P <0.001). In addition we utilized an ordinal logistic regression model 
to establish optimal predicted cut-off    points for cognitive status 
classifi  cation (<28 = severely impaired, 29 to 55 = moderately impaired, 
>56 = mildly impaired or normal). Utilizing these cut-off   points, the 
ACE appropriately classifi   ed cognitive status 90% of the time as 
compared with the neurointensivist assessment. Construct validity was 
established by comparing ACE with MMSE in non-intubated patients 
(rs = 0.81, P <0.001). Face validity was assessed by surveying raters who 
used both the ACE and MMSE during the study, and indicated the ACE 
was an accurate refl  ection of the patient’s cognitive status, was more 
sensitive a marker of cognition than the MMSE, and was easy to use. 
The ACE demonstrated excellent inter-rater reliability (ICC  =  0.997, 
95% CI = 0.997 to 0.998). In addition, inter-item reliability of each of 
the fi  ve subscales of the ACE and MMSE was also assessed (Cronbach’s 
alpha: range for ACE = 0.83 to 0.88; range for MMSE = 0.72 to 0.81), 
demonstrating a higher degree of internal consistency across subscales 
for the ACE.
Conclusions The ACE is the fi  rst valid and reliable examination for the 
assessment and quantifi  cation of cognition in critically ill patients. It 
provides a useful, objective tool that can be utilized by any member 
of the interdisciplinary critical care team to support clinical assessment 
and research eff  orts.
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Introduction  Morphine remains the most widely used intravenous 
opioid in the perioperative setting worldwide. Maintaining therapeutic 
CNS concentrations of many opioids is confounded by considerable 
variability in disposition. Recent fi   ndings indicate a role for the 
UGT2B7 expressed in the liver, for variability of substrate eff  ects. This 
phenomenon is attributed to genetic and environmental factors. 
However, evidence for eff   ect variation due to UGT2B7-mediated 
glucuronization of morphine in humans is lacking.
Methods  We tested the hypothesis that variations of morphine 
eff  ects could be explained in part by genetic variation in the UGT2B7 
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volunteers, who were given 0.2  mg/kg morphine i.v. over 2 hours. 
This abstract reports the results for the UGT2B7 (rs7439366) SNP on 
chromosome 4, coding for a histidine or a tyrosine at position 268, 
resulting in decreased enzyme activity.
Results Ten subjects exhibited the wildtype, 20 were heterozygous and 
fi  ve were homozygous carriers of the allele. Peak eff  ects of miosis did 
not diff  er for the three variants (Figure 1). However, while the results for 
heat pain response indicate almost no eff  ect at all for wildtype subjects, 
carriers of the T allele experience a higher peak and an extended 
analgesia (Figure 2). Neither the parent drug nor the 3-glucuronide and 
6-glucuronide serum concentrations diff  ered signifi  cantly among the 
research subjects.
Conclusions While morphine eff  ects might be infl  uenced in part by 
UGT2B7 genotype, there is a diff  erential eff  ect on pupil contractility 
and heat pain response. This cannot be readily explained by drug or 
metabolite serum concentration and warrants further investigation, 
including diff   erent enzyme product eff   ects on cerebral morphine 
levels.
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Introduction Lactic acidosis during metformin intoxication is mainly 
attributed to impaired hepatic lactate clearance [1]. The aim of this 
present work was to clarify whether metformin at high dose also 
increases skeletal muscle lactate production.
Methods Reverse microdialysis was used in six healthy, sedated and 
mechanically ventilated pigs, equipped with two skeletal muscle 
catheters (CMA Microdialysis AB, Sweden). Following a baseline 
recording, a continuous infusion of saline (control) or metformin 
diluted in saline (1 mol/l) began. Outfl  ow lactate concentration was 
measured every 3 hours, up to 12 hours.
Results Data are presented as the mean and standard deviation in 
Figure 1. The interaction between infusion (saline vs. metformin) and 
time was statistically signifi  cant (P = 0.02; two-way repeated-measures 
ANOVA).
Conclusions In skeletal muscle, a high dose of metformin increases 
interstitial lactate levels, a fi   nding consistent with local lactate 
overproduction.
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Introduction  Serum bilirubin is routinely measured in the ICU. 
Physiologically, bilirubin is one of three heme metabolites such as iron 
and carbon monoxide (CO), but this fact is almost completely ignored 
in our daily physiological assessments. In this study, we examined 
the prognostic signifi  cance of these two heme metabolites (T-Bil and 
CO-Hb) in general ICU populations.
Methods We retrospectively studied 723 patients with 12,458 blood 
gas measurements. Finally, we analyzed paired samples of 1,882 blood 
gas measurements and laboratory results from 491 ICU patients. We 
specifi  cally assessed the prognostic signifi  cance of serum T-Bil and 
CO-Hb and their combination.
Results Our ICU patients had a mean age of 61.8 (SD: 16.1), APACHE II 
score of 12.1 (4.4). Their hospital mortality was 5.5%. The nonsurvivors 
had a signifi  cantly higher T-Bil compared with the survivors (4.43 (5.30) 
vs. 1.31 (1.51) mg/dl; P = 0.005). On the other hand, a mean of arterial 
CO-Hb did not diff  er signifi  cantly between the groups (1.52 (0.39)% 
vs. 1.54 (0.35)%; P = 0.86). When patients were divided by four groups 
according to T-bil (high or low) and CO-Hb (high and low) values, 
the high-high group had worst outcome (11.1%), but the low-high 
group had best outcome in the four groups (1.19%) (Figure 1). Finally, 
prognostic discrimination of T-Bil was signifi  cantly improved when 
arterial CO-Hb was included in the model (area under the ROC curve 
0.701 to 0.754).
Conclusions  Serum T-Bil values were signifi   cantly higher in the 
nonsurvivors than the survivors. Prognostic signifi  cance  of  T-Bil 
signifi  cantly improved when taking into account the CO-Hb levels. 
These results imply that, even in the general ICU patients, metabolites 
of heme protein had prognostic signifi  cance and importance.
Figure 1 (abstract P363). Miosis (mm) after the start of the morphine 
injection.
Figure 2 (abstract P363). Maximally tolerable temperatures (°C) hours 
after morphine injection.
Figure 1 (abstract P364). Muscle lactate level with saline or metformin 
infused by reverse microdialysis.
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Introduction  The aim of this study was to investigate the eff  ects 
of  N-acetylcysteine (NAC) on the levels of erythrocyte and liver 
cholinesterase (CE), nitric oxide (NO) and malondialdehyde (MDA) 
in acute organophosphate poisoning (AOP) and to compare with 
pralidoxime (PAM)–atropine treatment.
Methods Twenty rabbits were divided into sham (n = 8), PAM–atropine 
(n = 6), and NAC groups (n = 6). The basal blood samples were taken 
from each test subject to measure plasma and erythrocyte CE, NO, 
and MDA values before toxicity. All of the groups were given 50 mg/
kg DDVP orogastrically. The rabbits in the sham group did not receive 
treatment. The test subjects in the PAM–atropine and NAC groups were 
given 0.05 mg/kg atropine with repeated doses when required and 
30 mg/kg i.v. bolus, then 15 mg/kg PAM i.v. every 4 hours. In addition 
to PAM and atropine, the NAC group received 30 mg/kg NAC i.v. every 
6 hours. Blood samples were taken from the rabbits in all groups in 
the fi  rst, 12th and 24th hours to measure plasma CE, NO and MDA. 
Laparatomy was performed on all subjects in the 24th hour and liver 
tissue samples were obtained to evaluate CE, NO and MDA values in 
the tissues.
Results The erythrocyte CE levels of the NAC group were considerably 
higher than the sham and PAM–atropine groups in the 12th hour 
(P  =  0.001, 0.015, respectively). It was established that serum NO 
and MDA levels of the NAC group were signifi  cantly lower than the 
sham and PAM–atropine groups in the 12th hour (P = 0.043, 0.041, 
respectively). The erythrocyte CE levels of the NAC group in the 24th 
hour was signifi  cantly higher than the PAM–atropine group (P = 0.015). 
The erythrocyte NO and MDA levels of the NAC group in the 24th hour 
were signifi  cant lower than the PAM–atropine group (P = 0.037, 0.028, 
respectively). No signifi  cant diff  erence was determined between the 
NAC group and PAM–atropin group for liver tissue CE and NO levels 
(P = 0.055, 0.109, respectively). The liver tissue MDA levels of the NAC 
group were signifi   cantly lower than the sham and PAM–atropine 
groups (P = 0.004, 0.004, respectively).
Conclusions In the treatment of AOP, NAC has a favorable eff  ect on 
both blood and liver tissue CE activity, NO levels and lipid peroxidation. 
Adding to antidote treatment of NAC could reduce organ damage, 
morbidity and mortality. Further clinical studies could be elucidated for 
this subject.
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Introduction  The aim of this study was to examine the eff  ects of 
CoQ10 on malondialdehyde (MDA) and nitric oxide (NO) levels and on 
the choline esterase (CE) activity in the heart tissue and erythrocytes 
in acute organophosphate poisoning (AOP) and to compare it with 
antidote treatment.
Methods Twenty rabbits were divided into three groups as sham (n = 8), 
PAM–atropine (n = 6), and CoQ10 groups (n = 6). The blood samples 
were taken from each test subject to measure plasma and erythrocyte 
CE, NO, and MDA values before toxicity. To all of the groups were 
given 50 mg/kg DDVP by orogastric tube. After toxicity, venous blood 
samples were taken to establish post-toxicity plasma and erythrocyte 
CE, NO, and MDA levels in the fi  rst, 12th and 24th hours. The rabbits 
in the sham group did not receive treatment. The test subjects in the 
PAM–atropine group were given 0.05 mg/kg atropine with repeated 
doses when required and 30 mg/kg i.v. bolus, then 15 mg/kg PAM i.v. 
every 4 hours. The subjects in the CoQ10 group received 50 mg CoQ10 
i.v. Thoracotomy was performed in the 24th hour on the subjects in all 
groups and heart tissue samples were obtained to evaluate CE, NO and 
MDA values in the tissues. The test subjects were given high-dose i.v. 
anesthesia and were sacrifi  ced at the end of the study.
Results  In the 12th and 24th hours erythrocyte CE levels of the 
CoQ10 group were considerably higher than the PAM–atropine group 
(P = 0.007, 0.017, respectively). It was established that erythrocyte MDA 
and NO levels of the CoQ10 group were signifi  cantly lower than the 
PAM–atropine group in the 12th and 24th hours (P <0.05). Heart tissue 
CE levels of the CoQ10 group were considerably higher than the sham 
and PAM–atropine groups (P = 0.001). Heart tissue MDA and NO levels 
of the CoQ10 group were signifi  cantly lower than the sham and PAM–
atropine groups (P = 0.000, 0.000, 0.001, 0.000, respectively).
Conclusions  Treatment of AOP with CoQ10 plus PAM–atropine 
has a therapeutic eff  ect on both erythrocyte and heart tissue lipid 
peroxidation and CE activity. Using CoQ10 with PAM–atropine in AOP 
patients with cardiac damage could reduce morbidity and mortality. 
Further clinical studies would be of benefi  t to clarify this matter.
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Introduction In addition to the renin–angiotensin–aldosterone system, 
natriuretic peptides act as regulators of blood pressure. Natriuretic 
peptides increase sodium and water excretion, increase the glomerular 
fi  ltration rate, and are vasodilatators. We report a case in which a large 
atrial myxoma induced overproduction of natriuretic peptides, causing 
clinically relevant hyponatriemia, hypotension and polyuria.
Methods We present a 74-year-old Caucasian female who was referred 
by her cardiologist for resection of a large left atrial myxoma.
Results The patient’s medical history was unremarkable except for 
irritable bowel syndrome, mild hypertension, and recently paroxysmal 
atrial fi  brillation due to growth of her myxoma. A month preoperatively 
a laboratory study indicated a mild hyponatriemia. Clinical investigation 
postoperatively showed a hypovolemic patient, with a blood pressure 
of 85/32 mmHg, a heart rate of 54 bpm, and CVD <5 mmHg. There were 
Figure 1 (abstract P365). Hospital mortality divided by T-Bil and CO-Hb 
levels.
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any diuretic therapy, and remained high during 2 days after surgery. 
Laboratory investigation showed increased ANP levels during the 
patient’s stay. Sodium was 129 mmol/l and decreased to 127 mmol/l, 
GFR >60 ml/minute, serum osmolarity was 262 mOsmol/kg. Natriuresis 
was 175 mmol/l, urine osmolarity was 563 mOsmol/kg. Pathological 
examination showed a large myxoma, connected to the fossa ovalis 
(4.3 x 4.5 x 3 cm). On the third day her urine production decreased to 
70 ml/hour. Hyponatremia persisted and 10 days later her sodium level 
normalised.
Conclusions We propose a mechanism of hyponatremia caused by 
overproduction of physiologically active natriuretic peptides by atrial 
stretch and ventricular stretch caused by a large intracardial tumour. 
Atrial stretch releases ANP and ventricular stretch releases BNP from 
myocardial cells. Normally increased intracardial stretch implies a 
volume expansion, and release of natriuretic peptides act to regulate 
blood pressure by increasing sodium and water excretion. A large 
intracardial tumour attached to the embryonic remnant of the fossa 
ovalis caused intracardial stretch, mimicking a hypervolemic state. 
Overproduction of natriuretic peptides is seen in diff  erent  clinical 
aetiologies such as intracerebral haemorrhage, lung cancer and 
pneumonia, linking natriuretic peptides to cerebral salt wasting and 
SIADH. We provide evidence of a rare cause of hyponatremia and 
polyuria caused by overproduction of the physiological natriuretic 
peptide system by a large myxoma.
P369
Hypophosphatemia of prognostic value in acute exacerbation of 
COPD
N Makhoul1, R Farah2, L Jacobson3
1Western Galilee Hospital, Naharya, Israel; 2Ziv Hospital, Zfat, Israel; 3Naharia 
Hospital, Naharia, Israel
Critical Care 2011, 15(Suppl 1):P369 (doi: 10.1186/cc9789)
Introduction  Phosphorus is the most important anion and it is 
important to cell function, necessary to create the ATP energy, and an 
essential component of nucleic acids. Low levels of phosphorus in the 
blood may be due to a change in functioning of organs participating 
in the phosphorus balance and aff   ecting the performance of 
diff  erent systems. A low level of phosphorus in the blood increases 
the exacerbation and the severity of COPD, increasing the need for 
mechanical ventilation.
Methods All patients were hospitalized in our hospital due to acute 
COPD exacerbation during 6 months. Comparison was made between 
the group with normal blood phosphorus and the group with a low 
phosphorus level. We checked the length of hospital stay, the need for 
ventilation, ventilation duration, mortality and morbidity rates.
Results We examined 242 patients, 73% men 27% women, average 
age 66.6 years. One hundred and ninety-four patients (80%) were 
hospitalized in the internal medicine department and 48 (20%) needed 
mechanical ventilation in the ICU. On admission, 95% of patients 
had a normal phosphorus level, 5% had a low phosphorus level, in 
3.3% the phosphorus level was low, and 1.7% had a very low level of 
phosphorus. In the group of 48 ventilated patients, in 10% we observed 
a mild to moderate low phosphorus value and in 8% of patients a very 
low phosphorus level. See Figure 1.
Conclusions  Low blood phosphorus levels contribute to increased 
severity of COPD and the need for ventilation, signifi  cantly increase the 
duration of hospital stay in the ICU, and increase mortality. Correction 
of these disorders may increase the survival rate of patients with COPD 
and may improve prognosis.
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Introduction  There is a growing body of evidence linking the 
presence of hypocalcaemia with greater morbidity and mortality in 
the critically ill [1]. At present, no national guidelines for the treatment 
of hypocalcaemia in critically ill patients exist. The purpose of this 
investigation was to determine the prevalence of hypocalcaemia on 
admission to critical care, to assess the current diagnosis and treatment 
regime and to attempt to identify any correlation between severity of 
illness and the prevalence of hypocalcaemia.
Methods Data were collected for all patients admitted to a 13-bed 
ICU of a tertiary referral centre in September 2010 for at least three 
consecutive days of their stay. Three patients were subsequently 
excluded, as their data were incomplete. Serum and ionized calcium 
levels were reviewed for the presence of hypocalcaemia on admission 
and evidence of improvement over time. Sepsis was assessed according 
to the ACCP/SCCM Consensus defi  nitions and APACHE II scores were 
calculated. Calcium levels were compared using the Wilcoxon test.
Results Fifty-three patients, 62% men and 38% women, were included. 
Ionized calcium levels on admission showed 75.0% of patients to be 
hypocalcaemic, while serum calcium levels revealed hypocalcaemia in 
only 72.6%. Supplementation of calcium gluconate based on daily serum 
calcium levels was found to be an eff  ective treatment for hypocalcaemia 
and led to a signifi  cant increase in both ionized and serum calcium 
concentrations on day 3 (P  =  0.001 and 0.020). On the third day of 
their stay on the ICU, 43.1% and 34.7% of patients still had low ionized 
and serum calcium levels. Serum calcium levels generally mirrored 
ionized calcium levels; however, compared with ionized calcium levels, 
hypocalcaemia remained undetected in two out of 53 patients (3.8%). 
There was no correlation between the severity of disease and the 
occurrence of hypocalcaemia. Similarly, a diagnosis of sepsis, severe 
sepsis and septic shock was not associated with hypocalcaemia.
Conclusions  Serum calcium levels tend to underestimate hypo-
calcaemia compared with ionized calcium. Although the existing 
treatment strategy was found to be eff  ective in general, the use of 
ionized calcium levels for detection and treatment of hypocalcaemia 
might be more eff  ective [2].
References
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Introduction  In the past several years, an important immuno-
modulatory role for vitamin D has been identifi  ed. At high latitudes, 
Figure 1 (abstract P369). Phosphate level at admission.
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radiation exposure, which is necessary for the synthesis of vitamin D. 
In this retrospective study we investigated whether vitamin D levels 
are subject to seasonal variation and whether plasma levels of vitamin 
D correlate with the extent of the innate immune response during 
human endotoxemia.
Methods Plasma levels of 25-hydroxyvitamin D3 were determined in 
samples obtained just prior to administration of an intravenous bolus 
of 2  ng/kg endotoxin (lipopolysaccharide derived from Escherichia 
coli O:113) in 114 healthy male young volunteers. Plasma levels of the 
infl  ammatory cytokines TNFα, IL-6, IL-1RA and IL-10 were determined 
serially after endotoxin administration. Correlation analysis was 
performed to investigate the relationship between vitamin D status 
and infl  ammatory cytokine levels.
Results Vitamin D levels were not subject to seasonal variation in the 
studied population. Furthermore, vitamin D levels did not correlate 
with peak cytokine levels or areas under the curve of cytokine time 
courses. Finally, vitamin-D-defi  cient subjects (<40 nmol/l) displayed an 
identical innate immune response compared with vitamin-D-suffi   cient 
subjects.
Conclusions Vitamin D levels in young healthy males appear to be 
stable throughout the year. Plasma levels do not correlate with the 
extent of the innate immune response during human endotoxemia. 
These fi  ndings question the role of vitamin D in modulation of the 
innate immune response.
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High bone turnover in critically vitamin-D-defi  cient patients
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Introduction  Vitamin D defi   ciency, hypocalcemia and acute 
immobilization negatively aff  ect bone metabolism and are present in 
the majority of critically ill patients. Although high bone turnover is 
highly prevalent in the ICU and might compromise long-term outcome, 
there are currently no data on fracture risk after critical illness.
Methods We assessed bone turnover comparing placebo (P) with a 
cholecalciferol loading dose (VITD) over a 1-week observation period 
in critically ill medical patients with vitamin D defi  ciency (25(OH)D 
≤20 ng/ml). Markers of bone and mineral metabolism (β-CTx, 0.06 to 
0.35 ng/ml, C-terminal telopeptide of type I collagen; OC, osteocalcin, 
1.0 to 35.0 ng/ml) were analysed. Analyses were repeated at days 3 
and 7 after 540,000 IU cholecalciferol or matched placebo were given 
enterally.
Results Twenty-fi  ve critically ill patients with an expected ICU stay of 
more than 48 hours were included (76% male, age 62 ± 16 years, 84% 
mechanically ventilated). Bone turnover was accelerated indicating 
bone loss and further deteriorated during the ICU stay. Calcium levels 
increased signifi  cantly in the vitamin D group only (Table 1), the mean 
serum 25(OH)D increase in the intervention group was 25 ng/ml.
Conclusions Increased bone resorption is frequent in patients in the 
medical ICU. Intravenous bisphosphonates have been suggested to 
mitigate bone loss in patients at risk; however, correction of vitamin D 
defi  ciency might be a prerequisite for optimal effi   cacy in this vulnerable 
population.
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Introduction It has been shown that low selenium intake is a risk factor 
for mortality in several diseases and conditions. In the present study 
we assessed the association between preoperative selenium levels and 
outcome parameters in patients undergoing elective cardiac surgical 
procedures.
Methods Whole blood selenium levels were assessed in preoperatively 
sampled blood in 197 patients. Selenium levels were dichotomized 
according to the national reference values into low (< 100 μg/l = LS 
group) and normal (>100 μg/l = NS group). Preoperative risk factors 
and postoperative outcome parameters (such as mortality, ICU and 
hospital length of stay, postoperative complications) were compared 
among the two selenium groups.
Results The mean age of the patients in the LS group was 67.9 ± 8.9 
years, signifi  cantly higher than the NS group’s mean age of 62.05 ± 9.4 
years (P <0.01). The mean EuroSCORE was 0.0560 ± 0.069 in the LS group, 
while it was 0.1071 ± 0.1192 in the NS group (P <0.01). The relative 
risk of mortality in the LS group was 5.01. The ICU length of stay was 
longer in the LS group (4.55 ± 7.1 days) compared with the NS group 
(2.54 ± 4.5 days, P <0.01). Similar to this, the hospital length of stay was 
also longer in the LS group (12.46 ± 10.4 days) than in the NS group 
(8.44 ± 4.81 days, P <0.01). LS patients were more frequently presented 
in the postoperative phase with low cardiac output syndrome, atrial 
fi  brillation, postoperative renal failure and postoperative confusion.
Conclusions  We conclude that low selenium levels are associated 
with higher mortality and longer hospital stay in our Central-European 
cohort of cardiac surgical patients. Prospective randomized studies 
performed on homogeneous patient groups are encouraged to prove 
whether the postoperative outcome of the patients may be improved 
by preoperative normalisation of selenium levels.
P374
Eff  ects of high doses of selenium on the antioxidant status after 
liver resection
O Obukhova, S Kashiya, E Gorojanskaya, J Chekini, S Sviridova
N.N.Blokhin Russian Cancer Research Center, Moscow, Russia
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Introduction Selenium (Se) levels in serum for patients with colorectal 
liver metastasis are signifi   cantly lower than normal. The use of 
standard doses of Se has no eff  ect on serum concentrations of Se or 
the antioxidant status (AS) indicators. It is assumed that the use of 
high doses of Se for patients undergoing extensive liver resection can 
improve their condition by enhancing antioxidant protection. The 
objective of this study was therefore to evaluate the eff  ect of high 
doses of selenium on AS indicators, biochemical markers of hepatic 
failure and treatment results.
Methods Forty patients (M:F = 18:22, mean age 56) who were due to 
have a liver resection for metastatic colorectal carcinoma were recruited 
and were randomized into two groups. Patients of group 1 (G1, n = 20) 
received standard perioperative therapy. Patients of group 2 (G2, n = 20) 
additionally received sodium selenite according to the protocol: 2 mg on 
the fi  rst postoperative day, 1 mg in the next 4 days. The concentration of 
Se in serum, biochemical parameters (total bilirubin, AST, ALT), AS (toxic 
metabolites of nitrogen oxide (NOx), superoxide dismutase (SOD) and 
malondialdehyde (MDA)) and clinical data were assessed before surgery 
and on the fi  fth day after surgery. The signifi  cance of diff  erences was 
assessed by Student’s t test and the chi-square test.
Results There were no diff  erences in the concentrations of biochemical 
markers of hepatic failure, duration of hospitalization, and 28-day 
Table 1 (abstract P372). Biochemical markers of bone turnover (7-day 
observation)
    Day 0  Day 3  Day 7
β-CTx    
  P   0.68   0.89   0.97*
  VITD   0.57   0.76   0.81*
OC       
  P   13.7   15.1  13.9
 VITD  17.9  19.9  20.3
Ca ion       
 P  1.02  1.04  1.09
 VITD  1.07  1.13*  1.17*
*P <0.05.
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72.8 ± 3.9). The NOx, MDA and SOD levels were elevated (respectively 
35.1 ± 1.2 vs. 35.2 ± 1.8; 6.4 ± 0.4 vs. 6.6 ± 0.38; 106 ± 8.7 vs. 107 ± 8.8). 
After Se supplementation, Se levels were signifi  cantly higher in G2 
compared with G1 (90.8 ± 7.42 vs. 75.7 ± 9.91, P <0.05). On the fi  fth 
day the NOx, MDA and SOD levels decreased in G2 compared with G1 
(respectively 29.5 ± 1.2 vs. 39.3 ± 2.2; 6.59 ± 0.9 vs. 9.8 ± 1.2; 84 ± 10.1 
vs. 123  ±  7.7, P  <0.05). In G2, postoperative encephalopathy was 
signifi  cantly less (P = 0.013).
Conclusions Even in the early postoperative period, administration 
of high doses of sodium selenite in patients with colorectal liver 
metastasis who underwent extensive liver resection helps to improve 
AS. However, a small number of observations does not allow one to 
assess accurately the clinical eff  ect of high doses of Se for these patients.
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Nutritional support in severe traumatic brain injury
MN Cote, F Lauzier, V Bibeau, P Labbe, AF Turgeon
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Introduction Clinical guidelines recommend full caloric replacement 
within 7 days after severe traumatic brain injury (TBI) since it may 
improve clinical outcomes. However, enteral feeding is often poorly 
tolerated in this population. We hypothesized that most patients with 
severe TBI do not receive adequate caloric and protein intake.
Methods  We performed a retrospective cohort study of randomly 
selected patients with severe TBI (GCS ≤8) identifi  ed with ICD-10 codes 
and admitted to a 24-bed ICU of a Canadian level 1 trauma center between 
January 2005 and December 2006. We excluded patients <16 years old, 
with penetrating TBI or mechanically ventilated for <48 hours. Using a 
standardized pretested case report form, we collected daily kilocalories 
and proteins (ordered and received), sedation, use of prokinetic drugs 
and post-pyloric access. The primary endpoint was achievement of ≥90% 
of caloric and protein requirement within 7 days. Secondary endpoints 
were factors associated with achievement of nutritional goals and with 
gastric intolerance (one episode of residuals ≥250 ml/4 hours). A sample 
size of 100 patients was required to obtain a margin of error of 9%. 
Student t and chi-square tests were used to compare continuous data 
and proportions. We obtained ethics approval.
Results Among the 109 patients included, 82.6% were men (mean 
age 40.5 ± 20.5 years, GCS 3.7 ± 1.3 and BMI 25.3 ± 5.1 kg/m2). Patients 
had 1,204 potential feeding days. Ninety-six patients (88.1%) were 
fed by day 3. Mean caloric and protein orders were 32.6 ± 4.8 kcal/kg 
and 1.4 ± 0.2 g/kg, respectively. Two patients never received enteral 
nutrition. Nutrition was started at a mean rate of 32.6 ± 9.3% of the 
nutritional goal using the stomach as the initial access in 97.2%. The 
achievement of caloric, protein and both requirements was successful 
in 48 (44.0%, 95% CI = 34.7 to 53.4%), 64 (58.7%, 95% CI = 49.5 to 68.0%) 
and 42 (38.5, 95% CI = 29.4 to 47.7%) patients during the fi  rst week. 
The most associated factor with unsuccessful nutrition was gastric 
intolerance (RR = 1.40. 95% CI = 1.11 to 1.88, P <0.01), which occurred in 
49.5% patients. Factors associated with gastric intolerance were young 
age (P <0.001), increased intracranial pressure (P <0.001), high opioid 
doses (P = 0.004) and nonuse of prokinetic drugs (P = 0.05).
Conclusions Most patients with severe TBI did not achieve nutritional 
goals within 7 days, partially due to high gastric residuals. Although we 
identifi  ed factors associated high gastric residuals, improving feeding 
tolerance is unlikely to be the only intervention to signifi  cantly improve 
nutritional intakes.
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Energy defi  cit and hospital length of stay can be reduced by quality 
management of nutrition therapy: the ICU dietitian is essential
L Soguel1, JP Revelly2, C Longchamp2, MD Schaller2, MM Berger2
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Introduction Several studies show that nutrition delivery is insuffi   cient, 
resulting in large energy defi  cits during the ICU stay [1]: the problem 
persists despite the diff  usion of guidelines. The barriers to guideline 
implementation are known [2]. This study aimed at measuring the 
clinical impact of a two-step interdisciplinary quality nutrition program 
incorporating knowledge of the barriers.
Methods A prospective interventional study over three periods (A: 
baseline, B and C: intervention periods) in the mixed ICU of a university 
teaching hospital. Inclusion: patients requiring >72 hours of ICU. 
Intervention was a two-step quality program after baseline analysis: 
fi  rst, implementation of feeding guidelines; and second, additional 
presence of an ICU dietitian. Variables: anthropometry, severity scores, 
energy delivery and balances (daily, day 7, discharge), feeding route, 
length of stay, and mortality.
Results In total, 604 admissions and 6,073 days were analyzed. Patients 
in period A were less sick (lower SAPS and less rapidly fatal McCabe 
scores) than those of periods B and C. Energy delivery and balance 
increased gradually: impact was particularly marked in the cumulated 
energy balance on day 7 (P <0.001). The feeding technique changed: 
use of EN increased from A to B (stable in C); combined and PN 
increased progressively. Oral intakes were uniformly low (305 kcal/day). 
Hospital mortality paralleled severity in periods B and C. The hospital 
stay was shorter in period C (P = 0.048). See Table 1.
Conclusions A bottom-up protocol improved nutritional support. The 
ICU dietitian further improved the process (early introduction, feeding 
route), achieving better early energy balance.
References
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Introduction  Enteral feeding is the preferred nutrition method in 
critically ill patients, with early administration leading to improved 
outcome [1]. There are no studies documenting the feasibility of enteral 
feeding during therapeutic hypothermia following cardiac arrest and, 
in our experience, many intensive care clinicians withhold enteral feed 
during the hypothermic period.
Methods Data were collected retrospectively from patients admitted 
to the Royal United Hospital ICU for therapeutic hypothermia following 
out-of-hospital cardiac arrest between 2002 and 2008. We recorded 
the total enteral feed input, total volume of gastric aspirate, total 
volume of gastric aspirate that was discarded and the number of 
vomiting episodes for 72 hours. The fi  rst 24 hours was the period of 
Table 1 (abstract P376)
  Period A: baseline  Period B: new protocol  Period C: protocol + dietitian  P value
Cumulated energy balance day 7  –5,870 ± 3,314  –5,307 ± 3,131  –3,946 ± 3,682*  <0.001
Discharge energy balance  –6,972 ± 4,994  –5,996 ± 3,711*  –5,380 ± 4,998*  0.002
Energy delivery (kcal/kg/day)  14.8 ± 12.8  17.1 ± 12.7*  17.8 ± 12.6*  <0.0001
* Signifi  cant post hoc diff  erence.
Critical Care 2011, Volume 15 Suppl 1 
http://ccforum.com/supplements/15/S1
S133cooling, the second 24 hours included 14 hours of re-warming and 
10 hours of normothermia, and the third 24 hours was normothermia. 
Feed balance was calculated by subtracting the volume of discarded 
aspirate from the volume of enteral input.
Results Thirty-two patients were included in the study. The median 
feed balance, percentage of patients with a positive feed balance, 
number of vomiting episodes and percentage of patients vomiting for 
each day is given in Table 1.
Table 1 (abstract P377). Median feed balance (MFB), positive feed balance 
(PFB) and vomiting episodes
Day  MFB (ml) (IQR)  PFB (n (%))  Vomiting (n (%))
1  265 (53 to 788)  25 (78.1)  8 (9.4)
2  400 (69 to 1,229)  24 (82.6)  6 (10.3)
3  572 (122 to 1,131)  22 (84.6)  6 (7.7)
Conclusions  Absorption of enteral feed increased with increasing 
core temperature. Even during hypothermia, the median feed 
balance was positive by 265 ml and 78% of patients had a positive 
feed balance and 9.4% of patients experienced vomiting. This implies 
that at a core temperature of 33°C there is suffi   cient gastrointestinal 
function to enable some enteral feed to be absorbed in most patients 
without a signifi  cant increase in vomiting. This suggests that it may 
be appropriate to feed patients undergoing therapeutic hypothermia 
following cardiac arrest.
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Introduction The aim of this study was to assess the adequacy of 
nutrition provision to mechanically ventilated patients in the acute 
phase after cervical cord injury. High spinal cord injury is associated 
with reduced gastric emptying due to excessive sympathetic activity 
from the isolated thoracolumbar cord [1], which is believed to 
compromise nasogastric delivery of nutrition and worsen clinical 
outcomes. However, the success of feeding early after high spinal cord 
injury has not been formally evaluated.
Methods A retrospective cohort study. Success of enteral feeding and 
associated factors were reviewed for 28 days (or until ICU discharge) in 
all patients mechanically ventilated for at least 48 hours with cervical 
cord injury in a mixed, level 3 ICU, over a 2-year period. Adequacy of 
nutrition was defi  ned as net calories delivered (including propofol) as 
a percentage of goal calories prescribed. Energy requirements were 
determined using the Schofi  eld equation or a weight-based method 
(25 kcal/actual body weight). Data are presented as median and range.
Results Seventeen patients were recruited (14 male, aged 37 years (18 
to 78), BMI 27 (23 to 35), APACHE II 14 (8 to 26), ASIA score A – 13, B – 4, 
ICU length of stay (LOS) 40 days (14 to 78), hospital LOS 82 days (34 
to 219), of which two died. Six patients were discharged prior to day 
28. Goal calories were 2,140/day (1,867 to 3,400). Patients commenced 
enteral feeding 44 hours (1 to 107) after ICU admission and received a 
mean 73% (SD = 19%) of nutritional goals over the 28-day study period. 
Energy delivery by day 4 reached 88% of goals. There was a signifi  cant 
relationship (r = 0.564; P = 0.029) between feed volume and hospital 
LOS. Feeding did not infl  uence any other clinical outcomes including 
ICU LOS and mortality. Eleven (65%) patients received prokinetics for 
7 days (2 to 20). No patients received TPN or post-pyloric feeding.
Conclusions  Despite a high proportion of patients requiring pro-
kinetics, most received adequate nasogastric nutrition during their 
stay in the ICU. Anecdotal evidence of weight loss and wasting after 
cervical spinal cord injury suggests that there are complex nutritional 
requirements in this group of patients and will form the basis for 
further studies.
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Introduction  The aims of this study were to determine when 
patients develop feed intolerance, the prevalence of feed intolerance 
in subgroups, and other factors that infl   uence feed intolerance. 
Nasogastric delivery of nutrition commonly fails in critically ill patients. 
However, studies to date have been underpowered to formally defi  ne 
the determinants of feed intolerance.
Methods A prospective observational study. Data were collected for 
14 days (or until ICU discharge/or death) after commencement of 
gastric feeding in consecutive, ventilated patients. Gastric aspirates 
were performed 6 hourly. Feed intolerance was defi  ned as ≥1 gastric 
aspirate(s) ≥250 ml. Data are presented as median (range). The 
association between feed intolerance and LOS was calculated using 
the Mann–Whitney U test. The ANCOVA test was used to test for a 
diff  erence between groups in LOS adjusting for covariates.
Results  In 214 patients (138 male:76 female, 56 (18 to 90) years, 
APACHE II 21 (5 to 46), ICU LOS 9 (1 to 94) days, hospital LOS 29 (3 to 
177) days), feed intolerance occurred in 78 (37%). The fi  rst occurrence 
of feed intolerance was within 5 days of commencing feeding (97%). 
Patients with trauma (60%), traumatic brain injury (57%) and sepsis 
(42%) had higher incidence of intolerance than the total population. 
The neurological group had signifi  cantly lower incidence of intolerance 
(17%; P = 0.02). Prokinetics were administered to 29%; duration 1 (1 
to 7) day. Feed intolerance was not associated with ICU or hospital 
mortality (ICU; intolerant 48% vs. tolerant 52% died, P = 0.08: hospital; 
intolerant 40% vs. tolerant 60% died, P = 0.31), but was associated with 
longer ICU and hospital LOS (ICU; intolerant 13 (1 to 94) days vs. tolerant 
7 (1 to 51) days, P ≤0.001: hospital; intolerant 32 (10 to 120) days vs. 
tolerant 26 (3 to 177) days, P = 0.02). There was no diff  erence in APACHE 
II score between intolerant and tolerant groups (intolerant = 23 (7 to 
46), tolerant = 21 (5 to 35), P = NS).
Conclusions The majority of feed intolerance occurred early in the 
patient’s illness. While mortality was unaff  ected, ICU and hospital LOS 
were longer in feed-intolerant patients that were not explained by 
severity of illness on admission. Further research is needed to determine 
whether increasing calorie delivery improves clinical outcomes in feed-
intolerant patients.
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Introduction  Pharmaceutical companies have introduced to the 
market many products for enteral nutrition. The diff  erent products 
off  er a wide variety of compositions or have specifi  c macronutrients 
or micronutrients added and are marketed for specifi  c patient groups 
or conditions. Thus an individualised therapy may be associated with 
the use of a wide variety of products. For practical reasons, easier 
stock management, economic reasons, increased experience and error 
prevention, a standardised nutritional care would be more common 
practice. It is unknown to which extent these two options are applied in 
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nutritional products in diff  erent ICUs from the data of NutritionDay 
(ND).
Methods  The ICU ND is an ECCRN-supported cross-sectional audit 
in 10 languages. We have analysed from the 4-year database which 
enteral products were received by patients enrolled from 2007 to 2010 
in the ND study. The aim of our study was to fi  nd which and how many 
diff  erent enteral products are given in each ICU.
Results Two hundred diff  erent enteral products have been used in 237 
ICUs. Nearly 50% of ICUs used one or two products (Figure 1). Most ICUs 
recruited 10 to 30 patients during the ICU ND audits (Figure 2).
Conclusions There is a very huge off  er of enteral nutrition products 
but it is very common that in most ICUs (almost 70%) only one to 
three diff  erent products have been given. Individualisation of nutrition 
therapy in terms of diet composition is not common practice.
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Introduction Acute renal failure (ARF) is a highly catabolic state and 
mean normalized catabolic rates of 1.5 g/kg/day protein have been 
reported. In hemodynamically unstable ARF patients, continuous 
renal replacement therapy (CRRT) has become a popular treatment 
modality, but may have the disadvantage of producing substantial 
protein losses, reported to be as high as 1.3 g/l. In the USA and Europe, 
CRRT outputs reach 50 l/day, and this value would amount to protein 
losses of up to 65 g/day. ASPEN and ESPEN guidelines recommend that 
these patients should receive increased protein, up to a maximum of 
2.5 g/kg/day, and that protein should not be restricted in patients with 
ARF as a means to avoid or delay initiation of dialysis therapy. But most 
previous studies were conducted in the era when energy requirements 
were adjusted by stress factors, and without intense glucose control 
therapy. So the optimal amount of protein supplementation in ARF 
patients in recent nutritional control is still unknown. In Japan, due to 
the limitation of doses of dialysate by health insurance it remains only 
15 l/day, and protein losses are expected to be smaller than western 
countries. We measured the amount of nitrogen concentration in 
dialysate/ultrafi  ltrate samples, and calculated the nitrogen balance in 
such patients.
Methods We analysed eight critically ill patients requiring CRRT in the 
ICU in a university hospital retrospectively. Patients received NPC 25 kcal/
kg/day increasing to the target over the next 2 to 3 days, preferably 
by enteral (postpyloric) route if possible. The dose of protein intake 
diff  ered mainly due to BUN concentration (70 mg/dl was acceptable).
Results Of eight patients, six died (D) and two survived (S). Days of 
CRRT treatment were 11.7 ± 5.2 (4 to 20) in group D versus 9.0 ± 5.7 
(5 to 13) in group S, and 24 hours creatinine clearance of CRRT was 
9.6 ± 2.9 versus 10.5 ± 3.6 ml/minute/m2, dialysate/ultrafi  ltrate nitrogen 
loss was 6.4 ± 3.3 versus 8.5 ± 4.1 g/day, and nitrogen balance was 
–0.08 ± 0.48 versus –0.034 ± 0.44 g/kg/day (–5.7 ± 6.6 vs. 2.6 ± 6.1g/day), 
retrospectively. The estimated amount of protein loss was expected to 
be almost 40 g/day.
Conclusions  Nitrogen losses in dialysate/ultrafi   ltrate samples were 
larger than previously reported even in a smaller dialysate/ultrafi  ltrate 
dose. In ICU patients with ARF, protein requirements can diff  er and have 
to be assessed individually. Large, prospective, randomized, controlled 
studies are needed to optimize the dosing of protein in critically ill 
patients with ARF who are treated with CRRT and the eff  ects on patient 
morbidity and mortality.
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Impact of cumulative calorie and protein defi  cits in critically ill patients
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Introduction This study aims to assess the outcome of cumulative 
protein and calorie defi  cits in critically ill patients.
Methods  A prospective observational study conducted in a mixed 
medical–surgical ICU in a tertiary care hospital in India. Patients 
receiving nutritional support for 2 days were included. Requirements 
of calories and protein were fi  xed as per the ASPEN guidelines. Calorie 
and protein defi  cits were calculated daily by subtraction of delivered 
from prescribed calories and protein in each patient. This defi  cit (<80% 
of prescribed were given to the patient) was correlated with outcome 
and complications.
Results A total of 768 patients of age 61 (SD ±17.67) were analyzed, 
of which 66.54% were male. In total, 530 (69%) were calorie defi  cient 
and 696 (90%) were protein defi  cient during the whole ICU stay. The 
correlation coeffi   cient of ICU length of stay (LOS) was –0.443 and –0.465, 
and of days on mechanical ventilation of alive patients was –0.338 and 
–0.392 for calorie and protein defi  cit, respectively (P <0.001). Infectious 
complications were also signifi   cantly correlated (–0.346 for calorie 
defi  cit, –0.298 for proteins, P <0.001). The mean calorie defi  cit of the 
patients discharged alive from the ICU was –2,135.62 ± 1,918.63, which 
was less compared with patients who expired (–2,564.44 ± 2,173.45 
(P = 0.027)). This was also seen in hospital outcome. The mean calorie 
defi  cit of patients discharged from hospital was –2,039.36 ± 1,888.82, 
which was less than the patients who expired after discharge from the 
ICU (–2,603.99 ± 2,126.53 (P = 0.002)). See Tables 1 and 2 overleaf.
Conclusions  The cumulative nutrient defi   cits (calorie and protein) 
were correlated with increasing number of complications in critically 
ill patients.
Figure 1 (abstract P380). Relationship products/ICU.
Figure 2 (abstract P380). Relationship patients/ICU.
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Lipid-enriched and protein-enriched enteral nutrition limits 
infl  ammation in a human endotoxemia model
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Introduction  Enteral administration of lipid-enriched nutrition was 
previously shown to attenuate infl  ammation and organ damage via 
a cholecystokinin-mediated vagovagal refl  ex in animal studies. The 
current proof-of-principle study investigates the immunomodulatory 
potential of enteral lipid-enriched and protein-enriched nutrition 
during experimental human endotoxemia.
Methods After an overnight fast, 18 healthy male subjects received 
an intravenous bolus of Escherichia coli lipopolysaccharide (LPS; 
2 ng/kg). Subjects in the fasted group (n = 6) were deprived of food 
throughout the study, while subjects in the intervention groups were 
fed either enriched (n = 6) or isocaloric control nutrition (n = 6) via a 
nasojejunal tube, starting 1 hour prior to LPS administration until 
6 hours afterwards.
Results LPS administration resulted in a marked infl  ammatory response. 
Continuous postpyloric administration of nutrition increased plasma 
cholecystokinin levels. Enriched nutrition attenuated circulating levels 
of the proinfl  ammatory cytokines TNFα and IL-6 and the IL-1 receptor 
antagonist compared with control nutrition (all: P <0.01) and fasted 
subjects (all: P  <0.05). Additionally, enriched nutrition augmented 
the anti-infl  ammatory response, refl  ected by increased IL-10 release 
compared with fasted subjects (P <0.0001). See Figure 1.
Conclusions  The current study establishes the anti-infl  ammatory 
potential of enriched nutrition in humans. The immediate anti-
infl  ammatory eff  ect of enriched nutrition suggests that the benefi  cial 
eff  ects are mediated via a cholecystokinin-dependent vagovagal refl  ex. 
Enteral administration of enriched nutrition is a promising intervention 
to modulate the immune response in the early course of systemic 
infl  ammation.
P384
Infl  ammation causes arginine to become an essential amino acid in 
critically ill children
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Introduction In critically ill children we previously found decreased 
plasma levels of arginine (Arg) and its precursor citrulline (Cit), with 
a strong inverse relation to C-reactive protein (CRP) [1]. Cit is the sole 
precursor of Arg de  novo synthesis in the body. We hypothesized 
that Arg becomes an essential amino acid, because Cit availability 
is reduced during infl  ammation. Therefore we studied Cit and Arg 
production, using stable isotope technology, in relation to the severity 
of infl  ammation in critically ill children.
Methods Twenty-two critically ill children (age 0.89 ± 0.04 years) with 
diff  erent levels of infl  ammation were studied on day 3 post-admission; 
viral bronchiolitis (group 1, n = 9), infectious disease without shock 
(group 2, n = 6) and septic shock (group 3, n = 7). A 2-hour stable 
isotope tracer protocol was performed after at least 4 hours fasting to 
determine Arg and Cit kinetics. Data presented as mean ± SE. Statistics 
by ANOVA, Spearman’s correlation.
Results  See Figure 1 for results per group. CRP was signifi  cantly 
diff  erent between groups. Cit production was signifi  cantly lower in 
the group with highest infl  ammation compared with the group with 
lowest infl   ammation. Cit production was inversely correlated with 
plasma CRP (r = –0.58, P <0.001).
Conclusions Our data show that with increasing rate of infl  ammation 
the production of Arg’s precursor Cit is severely depressed. Previously 
we found that de novo Arg production is almost equal to Cit production 
Table 1 (abstract P382). Correlation of complications with calorie and protein defi  cits
Variable  Correlation with calorie defi  cit (r)a (n = 530)  Correlation with protein defi  cit (r)a (n = 696)  P value
LOS (ICU)  –0.443  –0.465  <0.001
Days on mechanical ventilationb  –0.338 –0.392  <0.001
Number of infectious complications  –0.346  –0.298  <0.001
aCorrelation coeffi   cient. bMechanical ventilation days only in alive patients.
Table 2 (abstract P382). ICU and hospital outcome related to cumulative calorie and protein defi  cits
  Cumulative calorie defi  cit  Cumulative protein defi  cit   P value
Alive in ICU  –2,135.62 ± 1,918.63  –258.48 ± 205.58  0.027
Expired in ICU  –2,564.44 ± 2,173.45 –274.44 ± 241.33  0.392
Discharged alive from ICU  –2,039.36 ± 1,888.82  –257.27 ± 208.33  0.002
Expired in hospital  –2,603.99 ± 2,126.53  –271.67 ± 226.85  0.395
Data presented as mean ± SD.
Figure 1 (abstract P383). Plasma cytokine levels in the three 
experimental groups.
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tissue protein breakdown and nutrition. Infl  ammation causes Arg to 
become an essential amino acid in critically ill children.
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intravenous supply of glutamine on malnutrition in sepsis
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Critical Care 2011, 15(Suppl 1):P385 (doi: 10.1186/cc9805)
Introduction  Our aim was to compare the eff  ects of intravenous, 
enteral and intravenous + enteral supplemented glutamine on predic-
tion of positive feeding parameters (transferrin, nitrogen balance and 
creatine/height index) for malnutrition in septic patients.
Methods This was a prospective, randomized, controlled, single-blind, 
clinical study. Forty septic patients with malnutrition were randomly 
divided into four groups (n  =  10 each group). All patients were 
receiving enteral access, and had a clinical diagnosis of either severe 
sepsis or septic shock. All patients received enteral nutrition during 15 
days. Enteral feeding was delivered at a constant rate to achieve energy 
expenditure (Harris–Benedict equation). Blood and urine samples were 
obtained for transferrin, nitrogen balance and creatine/height index at 
least at baseline and on study days 7 and 15. Group 1: received 30 g/day 
intravenous glutamine, Group 2: received 30 g/day enteral glutamine, 
Group 3: received 15 g/day enteral + 15 g/day intravenous glutamine, 
Group 4: control group, without glutamine only enteral feeding. Data 
were compared by the Tukey HSD test.
Results  Nitrogen balance levels were not signifi  cantly  diff  erent 
between groups on the fi  rst 7 and 15 days. The transferrin level was 
higher in Group 2 than Group 4 on the fi  rst 7 days (P <0.001). Transferrin 
levels were not signifi  cantly  diff   erent between the other groups. 
Transferrin levels were higher in Group 3 than Group 2 (P <0.05) and 
Group 4 (P <0.001) in 15 days. Creatine/height index was higher in 
Group 3 than Group 4 (P <0.05) in 15 days.
Conclusions Enteral plus intravenous supplemented glutamine has 
more benefi  cial eff  ects on transferrin and creatine/height index than 
only enteral or intravenous supply of glutamine. Also, we observed that 
enteral feeding of supplemented glutamine has benefi  cial eff  ects on 
transferrin, nitrogen balance and creatine/height index in Groups 1, 2 
and 3 when compared with Group 4.
Reference
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cellular damage and may contribute to sustained organ failure in 
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Introduction Prolonged critically ill patients face a high risk of death, 
which is most often due to nonresolving multiple organ failure and 
muscle weakness. Increased oxidative stress, accumulation of damaged 
proteins and mitochondrial dysfunction contribute to cellular and 
organ dysfunction, and persistence of these abnormalities may trigger 
additional damage. Autophagy is the only degradation pathway able to 
remove toxic protein aggregates and damaged mitochondria. Feeding 
and insulin are two powerful suppressors of autophagy. We therefore 
hypothesized that in fed, prolonged critically ill patients receiving 
insulin, the required activation of autophagy to clear cellular damage 
could be impaired.
Methods We studied autophagy in liver and skeletal muscle biopsies 
from fed, prolonged critically ill patients, in whom hyperglycemia was 
tolerated or treated with insulin in the context of two randomized, 
clinical studies on intensive insulin therapy [1,2], as compared with 
biopsies from matched controls. We quantifi  ed  (ultra)structural 
abnormalities and hepatic and skeletal muscle protein levels of key 
players in autophagy.
Results Morphologically, both liver and muscle revealed an autophagy-
defi  ciency phenotype. Proteins involved in initiation and elongation 
steps of autophagy were induced 1.3-fold to 6.5-fold by critical illness 
(P ≤0.01), but mature autophagic vacuole formation was 62% impaired 
(P = 0.05) and proteins normally degraded by autophagy accumulated 
up to 97-fold (P ≤0.03). Markers of mitophagy (selective autophagy of 
mitochondria) were unaltered or downregulated (P = 0.05). Although 
insulin preserved hepatocytic mitochondrial integrity (P  =  0.05), it 
further reduced the number of autophagic vacuoles by 80% (P = 0.05).
Conclusions Activation of autophagy appeared insuffi   cient in liver and 
skeletal muscle biopsies from prolonged critically ill patients and may 
be further suppressed by insulin treatment. Incomplete clearance of 
cellular damage infl  icted by illness and aggravated by hyperglycemia 
could explain lack of recovery from organ failure in critically ill patients. 
These data open perspectives for therapies that activate autophagy 
during critical illness.
References
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Figure 1 (abstract P384). CRP, Cit and Arg production. CRP, P <0.01 between all groups (a, b, c); d, P <0.05.
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Glucose absorption following gastric and small intestinal nutrient 
administration in the critically ill
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Introduction  Glucose absorption from the stomach is abnormal 
related to slow gastric emptying and impaired in critically ill patients 
(CIP) with normal gastric emptying, suggesting that small intestinal 
(SI) factors may also be responsible. Small intestinal absorption of 
nutrient has not been formally quantifi  ed in this group. The aim was 
to quantify and compare glucose absorption following gastric and SI 
administration in CIP and healthy volunteers (HV).
Methods  Data from studies where glucose absorption had been 
measured were analysed. Sixty-six CIP (age: 51 ± 2, APACHE II: 17 ± 1) 
and 50 HV (age: 43 ± 3) were administered 100 ml Ensure (liquid nutrient 
1.06 kcal/ml), labelled with 3 g 3-O-methylglucose (3-OMG) to evaluate 
glucose absorption. Nutrient was administered via nasogastric (n = 44; 
CIP = 24; HV = 20) or SI (n = 72; CIP = 42; HV = 30) catheters. Plasma 
3-OMG concentrations were measured at intervals for 240 minutes; 
peak, time to peak and area under the concentration curve (AUC) were 
calculated. Feed-intolerant patients were defi  ned by gastric residual 
volume >250 ml in the 24 hours prior to study or requiring prokinetics 
for pre-existing feed intolerance. Data are mean  ±  SEM or median 
(range) and were analysed using nonpaired Student’s t tests.
Results Glucose absorption was markedly reduced in patients following 
both intragastric (AUC 0 to 240: CIP: 49 ± 7 vs. HV: 80 ± 4 mmol/l/
minute; P <0.001; peak concentration CIP: 0.32 (0.004 to 0.804) vs. HV: 
0.51 (0.343 to 0.679) mmol/l; P <0.001; time to peak CIP: 140 (30 to 240) 
vs. HV: 74 (45 to 120) minutes; P <0.001) and SI nutrient (AUC 0 to 240: 
CIP: 57 ± 4 vs. HV: 72 ± 4 mmol/l/minute; P = 0.008; peak concentration 
CIP: 0.37 (0.01 to 0.88) vs. HV: 0.47 (0.28 to 0.88) mmol/l; P = 0.02; 
time to peak CIP: 87 (15 to 240) vs. HV: 54 (15 to 120) min; P = 0.01). 
Gastric glucose absorption was delayed when compared with SI 
administration in CIP (time to peak; gastric: 140 (30 to 240) vs. SI: 86 (15 
to 240) minutes; P = 0.005); however, there was no diff  erence in overall 
glucose absorption when comparing gastric and SI administration 
in both HV and CIP. Feed-intolerant patients had reduced SI glucose 
absorption (AUC 240: intolerant 44 (2 to 98) vs. tolerant 75 (15 to 
101) mmol/l; P = 0.01).
Conclusions Glucose absorption is substantially impaired in the CIP 
even when delivered directly into the SI. This suggests mechanisms 
in the SI contribute to nutrient malabsorption. Delivery of nutrient 
directly into the SI (particularly in those CIP who are feed intolerant) 
may not result in improved nutrient absorption.
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Introduction  Eff   ective tight glycemic control (TGC) can improve 
outcomes, particularly in cardiovascular surgery, but is diffi   cult  to 
achieve. Variability in insulin sensitivity/resistance resulting from the 
level and evolution of stress response, particularly early in a patient’s 
stay, can lead to hyperglycemia and variability, which are associated 
with mortality. This study quantifi   es the daily evolution of the 
variability of insulin sensitivity for cardiovascular surgical and all other 
ICU patients.
Methods  Retrospective analysis of SPRINT TGC study data. Model-
based insulin sensitivity (SI) was identifi  ed hourly from data. Hour-
to-hour percentage changes in SI were assessed for cardiovascular 
surgical (CVS) patients (n = 76) and all other, noncardiovascular surgery 
(Non-CVS) patients (n = 317). Results are compared for days 1, 2, 3 
and days 4 onward. Cumulative distribution functions (CDFs), median 
values, and interquartile points (25th and 75th percentiles) are used to 
assess diff  erences between groups and their evolution over time.
Results  CVS patients are more variable than Non-CVS patients on 
days 1 to 2 (P <0.005) and similar on days 3 and 4 onward (P ≥0.13). 
Variability declines by day. CVS and Non-CVS patients are both more 
variable on each of days 1 to 3 than the overall day 4 onward values 
(P <0.005). At the interquartile percentiles, CVS patients are 1.4 to 2.0 
times more variable than Non-CVS patients on day 1, 1.40 to 1.44 times 
on day 2, and 1.1 to 1.2 times on day 3, but identical (<1.1x diff  erence) 
for day 4 onward. Absolute SI increases daily for both groups, and the 
diff  erence between groups shrinks from 33% to 12% over days 1 to 
3 and is 4% on day 4 onward (P <0.005 for all). Glycemic control was 
equivalent for both groups (P >0.05) and thus these results were not 
due to diff  erences in TGC achieved, but patient-specifi  c factors instead.
Conclusions All ICU patients exhibit greater insulin sensitivity variability 
over days 1 to 3, and cardiovascular surgery patients are more variable 
than others. Clinically, the results imply that TGC patients, especially 
cardiovascular surgery patients, will require greater measurement 
frequency, reduced reliance on insulin, and more explicit specifi  cation 
of carbohydrate nutrition in days 1 to 3 to safely minimise glycemic 
variability and maximise control for best outcome.
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Introduction Insulin infusions over 2 U/hour can suppress endogenous 
insulin secretion in healthy subjects 30 to 45% [1]. Virtually all tight 
glycemic control (TGC) protocols deliver insulin via infusion. This 
study examines the impact of bolus delivery of insulin in TGC on the 
endogenous insulin secretion of critically ill patients.
Methods Eighteen patients from the Christchurch Hospital ICU enrolled 
in a prospective clinical trial studying sepsis each had two sets of blood 
samples assayed for insulin and C-peptide. The fi  rst set was taken at the 
commencement of the SPRINT TGC protocol for patients with suspected 
sepsis. The second set was taken when their SIRS score was consistently 
below 2. Each set had four samples taken at: –1, 10, 40 and 60 minutes 
following bolus delivery of insulin as required by SPRINT to capture 
endogenous insulin secretion during the bolus profi  le. Bolus size was 
dictated by the protocol, but was in the range 2 to 6 units. Model-based 
methods [2] were used to calculate the endogenous insulin secretion 
rate for each set of samples. The level of suppression was calculated 
as the ratio of the secretion rate between 5 and 15 minutes (just after 
peak plasma insulin) and average of the 0 to 5 minutes (basal) and 15 to 
60 minutes (return to basal) secretion rates identifi  ed.
Results Median (IQR) endogenous insulin secretion rates for the fi  rst 
and second set of samples, respectively, were 4.0 (1.4 to 5.4) U/hour and 
1.5 (1.0 to 3.3) U/hour, indicating a signifi  cant drop in secretion, post-
sepsis and later in stay (P <0.05). Median (IQR) level of suppression for 
the fi  rst set of samples of each patient was 1.08 (0.96 to 1.29), showing 
an increase in secretion for most patients during suspected sepsis. 
Second set suppression post-sepsis was 1.02 (0.83 to 1.12), indicating 
limited or no suppression outside C-peptide assay error of 9%. Analyses 
of blood glucose levels, culture-confi  rmed sepsis and diabetic status 
show no consistent trends.
Conclusions  TGC can be benefi   cial, but carries a high risk of 
hypo  glycemia. Bolus insulin may provide more eff  ective  TGC  as 
unsuppressed endogenous insulin supplements the exogenous dose, 
possibly lowering the required doses and the risk of hypoglycemia. 
These results suggest a comparative study between bolus and infused 
insulin in TGC.
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Introduction Treating hyperglycemia with intensive insulin therapy 
(IIT) may improve outcome of critically ill patients. However, this benefi  t 
may be counteracted by the increased risk of hypoglycemic episodes 
with this intervention, which may cause brain damage. We determined 
the eff  ects of hyperglycemia and IIT on neurons and glial cells during 
critical illness.
Methods  We performed a postmortem examination of the 
hippocampus and frontal cortex of 10 critically ill patients who were 
randomized to conventional insulin therapy (CIT, n = 5) or IIT (n = 5) 
in two previous studies [1,2]. Glucose levels diff  ered between CIT (9.3 
(8.5 to 11.2) mmol/l) and IIT (6.1 (5.3 to 6.2) mmol/l) patients (P <0.01). 
Neuronal damage and density and function of glial cells were assessed 
by histochemistry and western blot. Data were compared with eight 
age-matched controls who died suddenly from extracranial injury. 
Mechanisms were explored in a validated burn injury model of 
prolonged critical illness. Critically ill rabbits were allocated to four 
groups, each a combination of normal or elevated blood glucose with 
normal or elevated insulin levels. Brain samples were collected after 
7 days of illness. Healthy rabbits were included as controls.
Results In the hippocampus of CIT patients, neuronal damage (P = 0.002) 
and microglia activation (P = 0.003) were increased as compared with 
controls. Density (P = 0.02) and activation status (P = 0.03) of astrocytes 
were decreased. IIT did not aff  ect neuronal damage, but reduced 
microglia activation (P  =  0.03) and restored astrocyte function and 
density (P = 0.009) versus CIT. Findings in the frontal cortex were largely 
similar. The experimental model showed pronounced neuronal damage 
and microglia activation with hyperglycemia, which were restored to 
normal levels with normoglycemia. Astrocytes were activated only in 
rabbits with high insulin and normal glucose levels, without increased 
network formation, as assessed by connexin-43 levels. MnSOD protein 
expression levels suggested reduced oxidative stress by glycemic 
control under high insulin levels.
Conclusions  Critical illness is characterized by increased neuronal 
damage and microglia activation in the hippocampus and frontal 
cortex under hyperglycemia. Our data suggest that maintaining 
normoglycemia with IIT reduces brain infl   ammation and may 
be neuroprotective, despite the risk of brief episodes of severe 
hypoglycemia.
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Introduction  Dysglycaemia is associated with poorer outcomes 
in critically ill patients. Maintenance of normoglycaemia by the 
administration of intravenous insulin is an important therapy in 
the ICU, but many factors can aff  ect plasma glucose levels in often 
unpredictable ways. Even if insulin could be delivered to patients 
at a guaranteed rate, the process of controlling glucose levels with 
exogenous insulin infusions is not straightforward. The preparation and 
administration of any drug for infusion is potentially subject to error. 
Insulin infusions are of particular concern, since they must be diluted 
from a concentrated stock solution. Random errors in the preparation 
of insulin infusions could result in signifi  cant diff  erences between the 
concentration of insulin prescribed and that seen in the infusion. This 
would aff  ect the rate of insulin delivery and could potentially result in 
unstable plasma glucose levels.
Methods Samples of 22 insulin infusions were taken over a 2-week 
period on a 14-bed adult general ICU. Each infusion had been prescribed 
as 1 IU/ml. After 10,000-fold dilution, samples were assayed using a 
two-step time-resolved fl  uorometric assay. To quantify the intra-assay 
variability, multiple aliquots were taken from a single sample of insulin. 
These were diluted and assayed in the same way as the ICU samples. 
Statistical analysis was performed via the SPSS computer package.
Results The 22 insulin solutions had a mean concentration of 0.99 IU/
ml (SD 0.10, 95% CI: 0.95 to 1.03 IU/ml). The coeffi   cient of variation was 
10% (95% CI: 7.8 to 14.0%), with the insulin concentration ranging from 
0.84 IU/ml to 1.16 IU/ml. Intra-assay coeffi   cient of variation was found 
to be 3.6% (95% CI: 2.4 to 6.8%).
Conclusions The concentration of the insulin solutions studied varied 
from the prescribed concentration by up to 16%. This is probably 
due to random errors arising from diff   erences in the methods of 
preparations of infusions by diff  erent nursing staff   in the ICU. Insulin 
solutions could be prepared more accurately in a central location (for 
example, pharmacy), taking advantage of standardised techniques 
and equipment. This may reduce some of the random errors we have 
demonstrated and could potentially improve glycaemic control.
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Introduction  Blood glucose variability (BGV) has been associated 
with outcome of critically ill patients [1-3]. Diff  erent BGV metrics exist, 
including mean absolute glucose (MAG) [4], which is the mean of 
absolute change per hour in glucose level. We hypothesized MAG to 
depend on the blood glucose level (BGL) measurement frequency, as 
doing more measurements could lead to more changes in the insulin 
infusion rate and hence in changes in the follow-up BGL.
Methods  We developed and implemented an evidence-based 
guideline for intensive insulin therapy on a mixed medical–surgical 
ICU in the Netherlands. The new guideline explicitly specifi  es when the 
follow-up BGL measurements should be taken, and hence infl  uences 
BGL measurement frequency. We collected all BGL measurements, 
patient demographics and outcome information for 1 year before 
and 1  year after the guideline’s implementation, and analyzed the 
association of MAG and mortality.
Results Data for 758 and 601 patients were collected 1 year before 
and 1 year after implementation. The two cohorts had similar baseline 
characteristics: median age 71 (59 to 80) years, median APACHE II 
scores 17 (13 to 23). Hospital mortality did not change (30.7% and 
31.6%, P = 0.729). After implementation, median BGL decreased from 
117 (97 to 144) to 106 (90 to 130) mg/dl (P <0.001), and the median BGL 
measurement frequency doubled, from 4 (3 to 6) to 8 (4 to 11) per day 
per patient (P <0.001). MAG increased from 4.5 (2.5 to 7.0) to 6.6 (3.6 
to 9.7) mg/dl/hour (P <0.001). Both BGL measurement frequency and 
the APACHE II score signifi  cantly correlated with the MAG (Pearson’s 
correlation coeffi     cient 0.574 and 0.19, respectively). The MAG was 
not independently associated with mortality when adjusting for both 
measurement frequency and the APACHE II score (odds ratio 1.01 (0.98 
to 1.05), P = 0.42).
Conclusions The association between MAG and BGL measurement 
frequency and severity of illness requires careful interpretation when 
comparing cohorts diff   ering in BGL measurement frequencies. It 
also requires adjustment for these variables when investigating the 
association between MAG and mortality, as it did not emerge as an 
independent predictor in our cohort.
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Introduction  Eff   ective tight glycemic control (TGC) can improve 
outcomes, but is diffi   cult to achieve. In-silico virtual patients and trials 
off  er signifi   cant advantages in cost, time and safety for designing 
eff  ective TGC protocols. However, no such method has been fully 
validated. This study tests two matched cohorts from the Glucontrol 
trial treated with diff  erent protocols. The goal is to validate the ability 
of in-silico virtual patient models and methods to accurately predict 
patient-specifi  c and clinical trial glycemic outcomes.
Methods The analysis uses records for a 211-patient subset of the 
Glucontrol trial (Liege, Belgium). Glucontrol-A (n = 142) targeted 4.4 
to 6.1 mmol/l and Glucontrol-B (n = 69) targeted 7.8 to 10.0 mmol/l. 
Cohorts were matched by APACHE II score, age and sex (P >0.3). The 
Glucontrol A cohort was slightly older (P = 0.04). Virtual patients are 
created by fi  tting a clinically validated model to the data, yielding 
time-varying insulin sensitivity profi  les (SI(t)) that create in-silico virtual 
patients. Model fi   t and intra-patient (forward) prediction are used 
to validate individual in-silico virtual patients. Self-validation (tests 
A protocol on Group A virtual patients; and B protocol on B virtual 
patients) and cross-validation (tests A protocol on Group B virtual 
patients; and B protocol on A virtual patients) assess ability to predict 
a clinical trial result.
Results Model fi  t errors were small (<0.25%) for Group A, Group B and 
the entire cohort (A + B), indicating model fi  tness. Median prediction 
errors were 4.3, 2.8 and 3.5% for Group A, Group B and (A + B), 
indicating individual virtual patients were accurate representations of 
real patients. Self-validation and cross-validation results were within 1 
to 10% of the clinical data for both Group A and Group B. Self-validation 
indicated clinically insignifi  cant model and compliance errors. Cross-
validation clearly showed that the virtual patients enabled by identifi  ed 
patient-specifi  c SI(t) profi  les can accurately predict the performance of 
TGC protocols diff  erent from those used to create the virtual patients.
Conclusions This study validates these virtual patients and in-silico 
virtual trial methods, and clearly shows they can accurately simulate, 
in advance, the clinical results of a TGC protocol, enabling rapid in-silico 
protocol design and optimization. It is the fi  rst rigorous validation of a 
virtual in-silico patient and virtual trials methodology.
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Introduction Intensive insulin therapy (IIT) has been shown to reduce 
morbidity and mortality of critically ill patients [1,2]. A survey among 
ICU managers and nurse clinicians showed that <10% of participants 
evaluated costs surrounding the implementation of IIT [3]. We 
hypothesized IIT-associated costs to diff  er substantially between ICUs.
Methods Three ICUs developed and implemented an evidence-based 
guideline for IIT. For 1 year before and 1 year after implementation, all 
disposables and devices explicitly used for IIT were identifi  ed in each 
hospital. Local costs were calculated, based on costs for disposables 
and devices. Variable cost included costs associated with disposables. 
Fixed cost included costs associated with syringe pumps and point-of-
care devices for blood glucose level (BGL) measurements.
Results  A total of 2,490 patients were subjected to IIT. Patient 
demographics did not diff  er among the three ICUs and did not change 
over time. Median BGL declined from 119 (99 to 150) to 105 (85 to 
130) mg/dl (P <0.001). The number of BGL measurements per patient 
per day doubled from 4 (3 to 7) to 9 (5 to 12) per day (P <0.001). Yearly 
variable costs increased from €58.574 to €118.624 (P <0.001), yearly 
fi  xed costs increased from €450 to €14.282 (P <0.001). Importantly, costs 
diff  ered substantially from one centre to another: variable costs per 
patient increased from €34 (€13 to 75) to €116 (€61 to 212) (P <0.001), 
from €13 (€5 to 44) to €48 (€32 to 88) (P <0.001) and from €15 (€7 to 
34) to €31 (€15 to 70) (P <0.001) for the three ICUs, respectively. Fixed 
costs per bed per year increased from €0 to €250 (P <0.001), from €13 
to €384 (P <0.001) and from €25 to €544 (P <0.001) for the three ICUs, 
respectively.
Conclusions  Glucose control-associated costs rise with the 
implementation of IIT. Major diff  erences in costs are noticed when 
comparing ICUs with similar patient cohorts and similar blood glucose 
control metrics after implementation of IIT.
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Introduction Recent studies failed to confi  rm survival benefi  t of tight 
glucose control (TGC). Moreover, they reported high rates (6 to 18%) 
of hypoglycemia (<2.5 mmol/l) associated with signifi  cant mortality. 
The protocols used for TGC may be diffi   cult to apply. The reasons for 
blood glucose level variations are complex and TGC requires in-depth 
individualized knowledge of the patient condition. Frequent blood 
glucose measurements are mandatory for continue adaptations of 
insulin and glucose administration. We report the evolution of blood 
glucose level through various phases of TGC implementation, which 
become progressively completely nurse driven.
Methods An internal audit performed in 2002, in fi  ve of our 32 adult ICU 
beds, showed 26% of hyperglycemia (>10 mmol). TGC was introduced 
in 2003 for all patients in the ICU and supported by detailed guidelines 
for bedside glucose control. TGC was progressively transferred from 
physicians to nurses since 2007. Nurses are specifi  cally trained to adapt 
infusion rates of glucose (nutrition), insulin according to medically 
predefi  ned targets (4.5 to 6.0; 6.0 to 8.0; >10 mmol/l). Arterial and 
venous glucose levels are determined by the central laboratory or by 
blood gas analyzers in the ICU. Glycemia (n = 750,178) was extracted 
from our electronic clinical information system (Metavision®) and 
analyzed with STATA.
Results Suppression of the lowest target (4.5 to 6.0 mmol/l) in May 2009 
may explain the mean increase in 2009. Improved TGC is confi  rmed 
by a continuous decrease in yearly standard deviations (IQR). The 
proportion of hyperglycemia decreases to less than 10% in 2008, with 
rates of hypoglycemia (<2.5 mmol/l) 50-fold to 100-fold lower than 
those reported in the literature. See Figure 1.
Figure 1 (abstract P395).
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control to ICU nurses in a large mixed adult ICU signifi  cantly decreased 
the proportion of hyperglycemia to less than 10%, and maintained 
extremely low rates of hypoglycemia (<0.1%).
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Introduction The blood glucose (BG) target has not been determined 
especially in acutely ill patients. The purpose was to investigate the BG 
target in order to reduce the mortality in terms of clinical phases (Early 
(E) phase and Late (L) phase) as well as to clarify mutual relationships 
among the BG parameters.
Methods  Patients with daily mean BG (BGm) below 200  mg/dl in 
whom BG was controlled by a bedside-type artifi  cial pancreas (AP), 
STG22, were researched in the E phase (3.3 ± 2.5 days after admission, 
n = 67) and L phase (10.1 ± 3.4 days after admission, n = 77). Nutritional 
support for all the patients was performed by total parenteral nutrition. 
Studied items: BG parameters (mg/dl; BGm, daily standard deviation of 
BG (BGsd), daily maximal and minimal BG (BGmax, BGmin), and daily 
BG diff  erence (BGd: BGmax – BGmin)), maximal value of the accuracy 
(%) of the BG parameters for predicting survival (AS), and correlation 
coeffi   cients (r) among the BG parameters.
Results AS (%): E phase/L phase; BGm below 196 (75%)/BGm below 
175 (68%), BGsd below 17 (73%)/BGsd below 20 (62%), BGmax below 
225 (72%)/BGmax below 218 (65%), BGmin below 172 (72%)/BGmin 
below 158 (73%), and BGd below 80 (70%)/BGd below 98 (68%). 
Strong positive correlation (r) was found in both phases (E phase/L 
phase) between BGsd and BGd (r = 0.87/r = 0.95), BGsd and BGmax 
(r = 0.79/r = 0.78), and BGd and BGmax (r = 0.77/r = 0.82). There was 
no signifi  cant correlation in both phases (E phase/L phase) between 
BGm and BGsd (r = 0.16/r = 0.37), BGm and BGd (r = 0.13/r = 0.38), and 
BGmax and BGmin (r = 0.07/r = 0.29).
Conclusions  The above-mentioned values of the BG parameters 
were considered to be the BG targets. Strict BG control in the E phase 
is signifi  cant, from the data indicating that the AS values in the E 
phase were greater than those in the L phase except BGmin. BGm, BG 
variability (BGsd, BGd), and BGmin were suggested to be independent 
BG parameters. AP was essential for determining the BG target.
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Introduction Severe hypoglycemia (blood glucose level (BGL) <40 mg/
dl) is independently associated with an increased risk of mortality in 
critically ill patients. The impact of milder hypoglycemia (BGL <70 mg/
dl) on outcome is less clear.
Methods Prospectively collected data from two observational cohorts in 
the USA and in the Netherlands and from the prospective GLUCONTROL 
trial were analyzed. Hospital mortality was the primary endpoint.
Results We analyzed data from 3,262 patients admitted to Stamford 
Hospital (ST), 2,063 patients admitted to three institutions in the 
Netherlands (NL; loose glycemic protocol (L, n  =  1,098) and strict 
glycemic protocol (S, n  =  965)) and 914 patients who participated 
in the GLUCONTROL trial (GL; control arm (C, n = 460) and intensive 
insulin therapy arm (IIT, n = 454)). The percentage of patients with 
hypoglycemia varied widely among the diff  erent cohorts. Patients with 
hypoglycemia experienced higher mortality than did those without 
hypoglycemia within each subgroup (P <0.0001 for all comparisons), 
even after stratifi   cation by severity of illness or diabetic status. 
Multivariable logistic regression analysis revealed that hypoglycemia 
had a greater impact on the mortality of surgical patients than of 
medical patients. The impact of hypoglycemia on mortality occurred 
independently of mean glucose level during ICU stay or glycemic 
variability.
Conclusions Even a single episode of mild hypoglycemia was associated 
with a signifi  cantly increased risk of mortality in heterogeneous cohorts 
of critically ill patients, independently of severity of illness, diabetic 
status, diagnostic category and glycemic variability.
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Introduction Infections that develop after admission to the ICU cause 
substantial morbidity and increases in resource utilization. The purpose 
of this investigation was to study the relationship of malglycemia, 
defi  ned as blood glucose level (BGL) <70 or >139 mg/dl and the risk 
of developing ICU-acquired infection, occurring more than 2 days after 
ICU admission.
Methods This is a retrospective evaluation of prospectively collected 
data from the ICU’s clinical database. Infection control nurses using 
standard defi  nitions prospectively identifi  ed ICU-acquired infections.
Results A total of 3,263 patients were admitted to a medical–surgical 
ICU between 1 December 2007 and 31 May 2010 and had at least three 
BGL measurements. In this group, 142 (4.4%) patients developed 171 
infections. Patients who developed infection had signifi  cantly longer 
ICU length of stay (P  <0.0001), higher scores for severity of illness 
(mean APACHE IV predicted mortality 34.8% vs. 18.5%, P <0.0001) and 
greater mortality (32.4% vs. 13.3%, P  <0.0001) than did those who 
did not develop infection. Of 505 patients who did not have a single 
episode of malglycemia, none developed infection. In contrast, 16.8%, 
13.1% and 7.2% of patients with lowest BGL <40, 40 to 54 and 55 to 
69 mg/dl as well as 0.8%, 3.3%, 5.7% and 9.6% of patients with highest 
BGL 140 to 159, 160 to 179, 180 to 249 and >249 mg/dl developed 
infection. Multivariable logistic regression analysis identifi  ed BGL <70 
and >139 mg/dl as independent predictors of the risk of developing 
infection (odds ratio (95% CI) 2.23 (1.45 to 3.44), P = 0.003 and 13.94 
(1.91 to 101.90), P = 0.0094, respectively).
Conclusions Malglycemia is strongly associated with increased risk of 
ICU-acquired infections. Eff  orts to decrease the rate of hypoglycemia 
and hyperglycemia may reduce morbidity in the ICU.
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Introduction Intensive insulin therapy (IIT) has been shown to reduce 
mortality in intensive care patients [1,2]. A large study on IIT was 
stopped prematurely due to high incidence of severe hypoglycemia 
(SH) (blood glucose level (BGL)  <40  mg/dl) [3]. It remains unclear, 
however, whether short episodes of IIT-associated SH are truly harmful 
[4]. We investigated long-term quality of life and functional and 
cognitive outcome in patients with and without IIT-associated SH.
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based guideline for IIT; we collected all BGL measurements and patient 
demographics for the 2 years after implementation. We captured all 
patients with SH, and randomly selected the same number of patients 
without SH as controls. To evaluate long-term outcome, we used the 
following scores: Glasgow Outcome Scale (GOS), Short-Form (SF)-12 for 
health-related quality of life (HRQOL) expressed as physical (PCS-12) 
and mental component score (MCS-12), Informant Questionnaire on 
Cognitive Decline in the Elderly (IQ–CODE) and the Modifi  ed Blessed 
Dementia Rating Scale (MBDRS) by proxies.
Results Our analysis included 93 patients, 43 patients with at least one 
episode of SH, and 50 control patients. Median length of an SH episode, 
assuming linear changes of glucose values between measurements, 
was 20 (10 to 50) minutes. Patient demographics (age, gender, APACHE 
II scores) were similar. Median length of ICU stay was longer in patients 
with SH, 12 (6 to 20) versus 4 (8 to 23) days (P <0.001). Median BGL was 
lower in patients with SH, 101 (97 to 106) versus 113 (102 to 123) mg/
dl (P <0.001). Outcome indicators were similar between patients with 
at least one episode of SH and control patients: GOS; 1 (1 to 1) versus 1 
(1 to 2) (P = 0.173); PCS-12; 44 (33 to 50) versus 42 (34 to 52) (P = 1.000); 
MCS-12; 49 (38 to 56) versus 45 (35 to 52) (P = 0.093), IQ–CODE; 3.0 (3.0 
to 3.3) versus 3.0 (3.0 to 3.1) (P = 0.116) and MBDRS 1; (0.5 to 1.5) versus 
0.5 (0.5 to 2.5, P = 0.734).
Conclusions  Neither long-term functional and cognitive outcome, 
nor HRQOL of patients who encountered IIT-associated SH diff  ered 
from patients who never had SH. However, it should be noted that 
the analyzed groups are small. Our data suggest IIT-associated SH not 
being harmful.
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Introduction  Critical illness induced hyperglycemia in critically 
ill children can be treated with intensive insulin therapy, but 
hypoglycaemia is a potential serious side eff  ect. We have investigated 
whether decreasing intravenous glucose intake, as an alternative 
method, improves plasma glucose levels without aff  ecting glucose 
production and protein balance in postsurgical children.
Methods  Eight children (age 9.8  ±  1.9 months, weight 9.5  ±  1.1 
kg) admitted to the pediatric ICU after surgical correction for 
nonsyndromal craniosynostosis were studied in a randomized blinded 
cross-over setting to receive standard glucose (SG, 5.0 mg/kg/minute) 
or low glucose (LG, 2.5 mg/kg/minute). A 10-hour stable isotope tracer 
protocol was conducted 6 hours after surgery to study glucose and 
protein metabolism.
Results During SG, hyperglycemia (>110 mg/dl) was present, while LG 
resulted in normoglycemia (LG 105 ± 10 vs. SG 133 ± 30 mg/dl; P = 0.02), 
but not in hypoglycemia. Endogenous glucose production increased 
during LG (LG 2.6 ± 1.5 vs. SG 1.1 ± 1.4 mg/kg/minute; P = 0.05). Whole 
body protein balance was slightly negative in both groups and was not 
aff  ected by glucose intake.
Conclusions Standard glucose intake in postsurgical children induced 
hyperglycemia. Decreasing the intake by one-half of current standards 
resulted in normoglycemic levels, with increased endogenous glucose 
production. Patients were in a slight catabolic state and decreasing 
glucose intake did not deteriorate this. Decreasing glucose intake is 
a safe method to prevent hyperglycemia in critically ill postsurgical 
children.
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Introduction Glycaemic control remains an important therapeutic goal 
in critically ill patients; however, safety and workload are important 
concerns in its implementation. The enhanced model predictive control 
(eMPC) algorithm has demonstrated effi   cacy and safety in critically 
ill medical and surgical patients. It is integrated in the BBraun Space 
GlucoseControl system (SGC, project title: Space TGC) which consists 
of three Space pumps (two for nutrition, one for insulin). A central user 
interface (Space Control) and central hardware connected to Space 
Control (SGC Module) provide suggestions for insulin rate and glucose 
measurement interval.
Methods Performance of SGC was tested in mechanically ventilated 
medical ICU patients for up to 14 days. It was operated by 54 trained 
nurses and the target range was 80 to 150 mg/dl (4.4 to 8.3 mmol/l). 
Patients with an expected ICU stay >3 days were recruited in this 
single-centre, noncontrolled trial.
Results From February to November 2010, 18 patients (age 63 ± 17, BMI 
29.1 ± 7.3, APACHE II 26 ± 7, 13 male, four diabetic) were included for a 
period of 7.0 ± 3.7 days and 1,583 blood glucose values were analysed, 
corresponding to a sampling interval of 2 hours. The percentage of 
glucose values within predefi   ned ranges was as follows: ≤40  mg/
dl: 0.0%; >40 and <60 mg/dl: 0.3%; ≥60 and <80 mg/dl: 4.3%; ≥80 
and ≤150 mg/dl: 74.7%; and >150 mg/dl: 20.7%. Mean arterial blood 
glucose was 127 ± 35 mg/dl (7.0 ± 2.0 mmol/l). No hypoglycaemic 
episodes (≤40 mg/dl) occurred during the trial.
Conclusions Performance of SGC with incorporated eMPC algorithm 
was excellent. Seventy-fi  ve per cent of all glucose values were within 
the target range and no hypoglycaemic episodes occurred. SGC 
is a safe and reliable method to control blood glucose in critically ill 
patients in the medical ICU.
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Introduction  Glycemic excursion or glucose variability (GV) was 
explored recently as a contributor of mortality, when studies 
concentrating on strict blood sugar control failed to show consistent 
results. The objective of this study was to determine the implication of 
glucose variability on ICU mortality in a heterogeneous ICU population.
Methods The study was conducted in a medical/surgical ICU (45 beds) 
in a private teaching tertiary care hospital in India. A nurse-driven 
subcutaneous and intravenous insulin protocol (modifi  ed Yale) was 
followed for sugar control with a target CBG of ≤150 mg/dl. Blood sugar 
was checked as per patient requirement, both by point-of care-testing 
and central laboratory. The outcome measure was ICU mortality. From 
the prospectively collected glucose values, mean blood glucose (MBG) 
was measured for each patient and glycemic variability (GV) calculated 
as the standard deviation (SD) and glycemic lability index of MBG. GV 
was correlated with mortality.
Results The study was conducted from January 2009 until November 
2009. All consecutive patients with four or more blood sugar 
measurements were considered. A total of 11,335 blood sugar records 
were analyzed from 2,208 patients during this time. The mean age of 
the study population was 61 (SD ±16.71). In total, 58.96% were male 
and 77.8% were medical admissions. Mean APACHE IV score was 56.9. 
MBG of the study population was divided into fi  ve subgroups. Each 
subgroup had four quartiles of rising SD along with mortality. Mortality 
was higher in the highest quartiles of SD in each of fi  ve subgroups of 
patients. Mortality was highest in the subgroup with lowest range of 
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cohort, 212 patients (9.6%) had hypoglycemia. In this cohort also 
mortality increased from 6, 10, 11, 16%, respectively, with rising SD in 
the same way as the whole cohort. See Figure 1.
Conclusions  In summary, this study demonstrated that glucose 
variability is associated with ICU mortality in a large heterogeneous 
cohort of ICU patients. This eff   ect was particularly strong among 
patients in the euglycemic range.
P403
Glycemic control in critically ill infants and children: achieved 
quality of control in daily clinical practice in Leuven after a RCT
E Voets, T Van Herpe, L Desmet, D Vlasselaers, P Wouters, 
G Van den Berghe
UZ Leuven, Belgium
Critical Care 2011, 15(Suppl 1):P403 (doi: 10.1186/cc9823)
Introduction A large RCT of our research group demonstrated that 
targeting age-adjusted normal fasting blood glucose concentrations 
with insulin infusion improves outcome in critically ill infants, children 
and adults [1-3]. Tight glycemic control according to the Leuven 
guideline has been implemented as a standard of care in all Leuven 
ICUs. This study aims to document the quality of glycemic control in 
daily clinical practice in the Leuven pediatric ICU (PICU).
Methods We performed a retrospective data analysis on all pediatric 
patients admitted to the Leuven PICU over a 12-month period, from 1 
January 2009 to 31 December 2009.
Results One hundred and forty-two of the 333 PICU admissions (43%) 
were infants (<1 year) and 191 of 333 (57%) were children (1 to 16 years). 
We obtained a total of 12,208 blood samples in the infant group. The 
mean blood glucose level per infant was 98 mg/dl, the median was 
86 mg/dl (interquartile range 67 to 111 mg/dl). Forty-six infants (32%) 
experienced at least one hypoglycemic period. Hypoglycemia (<40 mg/
dl) was noted in 168 (1.4%) of the samples, and 37 samples (0.3%) were 
extreme hypoglycemic (≤30 mg/dl). A total of 8,008 blood samples were 
taken in the children’s group. The mean blood glucose level per child was 
116 mg/dl, the median was 103 mg/dl (interquartile range 88 to 125 mg/
dl). Sixteen (8%) children experienced at least one hypoglycemic period. 
Twenty-two samples (0.3%) were hypoglycemic (<40 mg/dl) and three 
samples (0.04%) were extreme hypoglycemic (≤30 mg/dl).
Conclusions  Even outside the setting of a RCT, the blood glucose 
control achieved in clinical practice mimicked that during the study on 
tight glycemic control in critically ill infants and children [3]. The risk of 
hypoglycemia was even lower than during the RCT. These outstanding 
results were achieved by standardized management by experienced 
nurses who were allowed to make anticipative decisions. The principles 
of managing tight glycemic control in the PICU will be shared onsite.
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Introduction  Continuous glucose monitoring system (CGMS) 
technology provides the opportunity to measure glycemia in diff  erent 
tissues [1]. The aim of our study was to determine the lag-time between 
blood, brain and adipose tissue during rapid glucose changes.
Methods Fifteen male hereditary hypertriglyceridemic rats underwent 
the experimental protocol. After intraperitoneal anesthesia, the 
internal jugular vein and carotid artery were catheterized. A CGMS 
sensor (Medtronic) was inserted into the brain by micromanipulators 
and to the abdominal subcutaneous tissue. At the beginning of 
the experiment (–120 minutes), basal glycemia was measured and 
calibration of the sensors was started. Thereafter, insulin infusion 
was started (50 mU/kg/minute) and 20% glucose at a variable rate of 
infusion. Blood glucose was measured every 5 minutes with manual 
correction of the glucose infusion rate to maintain the glycemia level 
of 6 mmol/l. At a time of –10 minutes, the calibration procedure was 
fi  nished and actual glycemia was recorded to sensors. At a time of 
0 minutes, a bolus of glucose 0.5g/kg was administered; and at a time 
of 50 minutes, a bolus of insulin 5 IU/kg was administered. Moreover 
glucose and insulin infusion were stopped at this time. The experiment 
was fi  nished at time 130 minutes and animals were euthanized.
Results  After an intravenous glucose bolus of 0.5 g/kg, glycemia 
rose rapidly to 14 mmol/l in 5 minutes. On the contrary, the glucose 
content in the brain and subcutaneous tissue was increased in a slower 
manner, with a maximum in about 50 minutes (brain) and 60 minutes 
(subcutaneous tissue). Intravenous insulin bolus of 5 U/kg was followed 
by lowering blood glucose concentration to a minimum of 4.5 mmol/l. 
The brain and subcutaneous tissue glucose content decreased slowly 
to a minimum of 4.2 mmol/l (brain) and 5.5 mmol/l (subcutaneous 
tissue). The median glucose lag-time blood versus brain and blood 
versus subcutaneous tissue was 10 (10; 15) minutes and 15 (15; 25) 
minutes, respectively (P = 0.01).
Conclusions Contrary to a previous study, which showed no changes 
in glucose dynamics after a bolus of glucose between brain, adipose 
tissue and muscle, our data showed that glucose in the brain follows 
blood excursions during acute glycemic changes more closely 
compared with subcutaneous tissue [2].
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Introduction Glycemic control in critically ill patients has been shown 
to be benefi  cial. In this prospective study we therefore evaluated the 
accuracy and technical feasibility of a continuous glucose monitoring 
system using intravascular microdialysis.
Methods Fifty patients undergoing cardiac surgery were monitored 
using a 4Fr intravenous microdialysis catheter (Eirus SLC®; CMA Micro-
dialysis AB, Solna, Sweden), percutaneously placed with the tip of 
the catheter positioned in the superior vena cava. The catheter was 
connected to the Eirus monitoring system and the patients were 
monitored for up to 48 hours postoperatively in the ICU. As reference, 
arterial blood samples were taken every hour and analyzed in a blood 
gas analyzer (ABL800 FLEX®; Radiometer Medical, Copenhagen, 
Denmark).
Results Data were available from 48 patients. A total of 994 paired 
(arterial blood gas–microdialysis) samples were obtained. The glucose 
correlation coeffi   cient (R2) was 0.85. Using Clarke error grid analysis, 
100% of the paired samples were in region AB and 99% in region A 
Figure 1 (abstract P402). Mortality rates in quartile ranges of SD within 
subpopulations.
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mean absolute relative diff  erence was 5%. A total 99.2% of the paired 
samples were correct according to ISO criteria. Bland–Altman analysis 
showed bias ± limits of agreement were 0.02 ± 1.1 mmol/l.
Conclusions  Central venous microdialysis is a highly accurate and 
reliable method for continuous blood glucose monitoring up to 
48 hours in ICU patients undergoing cardiac surgery. The system may 
thus be useful in critically ill ICU patients.
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Accuracy of glucose measurements in critically ill patients
V Claverie, L Lonjaret, B Riu-Poulenc, S Silva, T Geeraerts, O Fourcade
University Paul Sabatier, Toulouse, France
Critical Care 2011, 15(Suppl 1):P406 (doi: 10.1186/cc9826)
Introduction  The aim as to compare the accuracy of glucose 
measurements using a glucose meter analyser in fi  ngerstick, arterial 
blood and laboratory tests in critically ill patients and to determine 
factors infl  uencing the bias between these methods.
Methods This prospective observational study included 75 consecutive 
ICU patients, corresponding to 302 pairs of measures (aged 56 ± 16 
years, SOFA 8 ± 4, IGS2 56 ± 20). Findings from two diff  erent methods of 
glucose measurement were compared with laboratory blood glucose 
measurements: glucose meter analysis of capillary blood (fi  ngerstick), 
and glucose meter analysis of arterial blood during the fi  rst 3 days in 
the ICU. Agreement between measurements was assessed using the 
Bland–Altman method.
Results The correlation coeffi   cient between fi  ngerstick and laboratory 
results was 0.91 (95% CI = 0.89 to 0.99) and 0.92 (95% CI = 0.92 to 0.94) 
between arterial glucose meter analysis and laboratory testing. The 
mean bias between fi  ngerstick and laboratory testing was 0.16 g/l, and 
between arterial glucose meter and laboratory testing was 0.10 g/l. 
Norepinephrine used did not aff  ect the bias between methods (P = NS 
for all comparisons). See Figure 1.
Conclusions  The agreement between methods for glucose level 
measurements appears not to be clinically acceptable. Either fi  ngerstick 
or arterial glucose meter analysis have large limits of agreement with 
the gold standard laboratory testing for blood glucose measurements.
P407
Comparison of glucose variability measures
M Bhattacharyya, S Todi
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Critical Care 2011, 15(Suppl 1):P407 (doi: 10.1186/cc9827)
Introduction  Glycemic excursion or glucose variability (GV) is 
associated with short-term ICU mortality. There is a heterogeneity 
among studies in using measures of GV. The objective of this study was 
to compare diff  erent formulas used to assess GV in predicting mortality.
Methods The study was done in a 45-bed medical–surgical unit. All 
patients admitted to the ITU and with four or more blood glucose (BG) 
readings were included from January 2009 to November 2009. Sugar 
control was protocolised with a target CBG of ≤150 mg/dl. Glucose 
was measured from central laboratory or point-of-care checking at an 
interval of 6 hours or when required. From the prospectively collected 
glucose values, diff  erent measures of glycemic variability have been 
calculated and compared among themselves. We used standard 
deviation (SD), glycemic lability index (GLI), maximum glucose change 
(MGC), mean amplitude of glucose excursion (MAGE), and average 
daily risk range (ADRR) as measures of GV.
Results  A total of 11,335 blood sugar records were analyzed from 
2,208 patients during this time. Mean age of the study population was 
61 (SD ±16.71). In total, 58.96% were male and 77.8% were medical 
admissions. The mean APACHE IV score was 56.9. All the variables of GV 
could predict mortality with equal power. See Figures 1 and 2.
Conclusions All of the GV measures have almost the same prediction 
power. Any one measure can be used as a quality indicator of GV in an 
ICU.
Figure 1 (abstract P405). Error grid analysis of arterial blood gas and 
microdialysis glucose samples.
Figure 1 (abstract P406).
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Critical Care 2011, 15(Suppl 1):P408 (doi: 10.1186/cc9828)
Introduction The ability of a continuous glucose monitor (CGM) to 
provide actionable information is of utmost importance in the critical 
care setting. Medtronic has developed a new CGM specifi  cally for the 
hospital environment. A human feasibility trial was conducted to assess 
the performance of this system in the ICU. While often overlooked, 
alarm performance is essential to characterizing both the safety and 
value of any clinical system – especially in a critical care setting. An 
analysis was conducted on the sensitivity and specifi  city of the alarm 
algorithm to simulate the expected performance when used in the 
clinical setting.
Methods A feasibility study was targeted to enroll 10 ICU patients for 
72 hours in the surgical ICU of an academic institution. Enrollment was 
determined by two consecutive glucose values greater than 140 mg/
dl. The sensor data were collected while blinded to the clinicians 
and hourly reference glucose data were collected using a chemistry 
analyzer (YSI 2300D). Data analysis was performed to mimic a clinical 
setting that samples glucose every 6 hours. Sensors were calibrated 
with four reference values per day. Paired sensor glucose values and 
YSI values were analyzed for sensitivity and specifi  city of alarm setting 
(100 to 140 mg/dl) based on a target range of 100 to 140 mg/dl. For 
sensitivity and specifi   city, hypoglycemia was defi   ned as 90  mg/dl 
or less, and hyperglycemia was defi  ned as 160 mg/dl or greater. This 
analysis was repeated for paired sensor glucose values and point-of-
care meter values in the same alarm settings and target range.
Results Two patients completed 72 hours at the time of this abstract. 
There were not enough paired points in the hypoglycemic range 
(<90  mg/dl) to complete an analysis (8/136). In the hyperglycemic 
range (101/136), the algorithm showed an average sensitivity of 91% 
and an average specifi  city of 93% against hourly reference. A high 
sensitivity score indicates that the new hospital CGM has few false 
alarms for untrue hyper events; and a high specifi  city score indicates 
that the new hospital CGM rarely misses a true hyper event.
Conclusions Alarms are more than convenient features; they are an 
important component of product and patient safety. However, poor or 
inconsistent sensitivity and specifi  city can quickly diminish the value 
of an alarm, reducing it to little more than a nuisance. This analysis 
shows that the novel CGM has the potential to provide sensitivity and 
specifi  city to satisfy the demands of the hospital environment. Given 
the growing reliance on automated and semi-automated clinical 
systems and the inherent safety implications resulting from this trend, 
alarm performance should be an important consideration when 
evaluating these products.
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Introduction Salivary cortisol is a reliable tool to evaluate the normal 
or disordered control of the hypothalamic–pituitary–adrenal (HPA) axis. 
Despite this, salivary cortisol has been rarely assessed in the setting of 
intubated, critically ill patients. The purpose of the current study was to 
investigate the utility of salivary cortisol measurements in an intensive 
care population.
Methods Thirty-nine (25 men) consecutive, critically ill patients with 
a mean (± SD) age of 65  ±  22 years having various illnesses were 
included in the present study. Sixteen patients had sepsis. Mean 
APACHE II and SOFA scores were 17 ± 10 and 7 ± 3, respectively. Mean 
albumin was 3.0 ± 0.7 g/dl. Within 48 hours of ICU admission, morning 
cosyntropin stimulation tests (250 μg, i.v.) were performed. Serum total 
cortisol and salivary cortisol were measured before and 30 minutes 
after consyntropin administration. In eight healthy controls, baseline 
salivary cortisol was also measured.
Results  Patients had higher baseline salivary cortisol than healthy 
controls (1.13 ± 0.80 μg/dl vs. 0.33 ± 0.80 μg/dl, P = 0.002). Baseline and 
cosyntropin-stimulated serum total cortisol were 21 ± 11 μg/dl and 31 ± 13 
μg/dl, respectively (P <0.001). Baseline and cosyntropin-stimulated salivary 
cortisol were 1.13 ± 0.80 μg/dl and 1.4 ± 0.90 μg/dl, respectively (P = 0.004). 
Baseline serum total cortisol correlated with baseline salivary cortisol in 
patients with albumin values >2.5 g/dl (r = 0.60, P = 0.01). In contrast, there 
was no correlation between these variables in patients having albumin 
concentrations ≤2.5 g/dl. Stimulated serum total cortisol did not correlate 
with stimulated salivary cortisol in either of the two subgroups.
Conclusions  Salivary cortisol measurement is easy to obtain in 
critically ill patients. Salivary cortisol is higher compared with healthy 
controls and increases signifi   cantly following stimulation with 
cosyntropin. Whether salivary cortisol is superior to serum total cortisol 
measurements in the assessment of the HPA axis activity requires 
further investigation.
P410
Plasma free cortisol and b-type natriuretic peptide in septic shock
D Sturgess, B Venkatesh
The University of Queensland, Brisbane, Australia
Critical Care 2011, 15(Suppl 1):P410 (doi: 10.1186/cc9830)
Introduction  Previous studies of patients with septic shock have 
independently demonstrated alterations in plasma concentrations of 
b-type natriuretic peptide (BNP) and plasma free cortisol (PFC). Previous 
data suggest that a reciprocal relationship might exist. However, the 
relationship between these hormones in patients with septic shock is 
unclear. We sought to compare paired measurement of both BNP and 
PFC in a preliminary study of septic shock patients.
Methods Twenty-one consecutive adult patients from a tertiary-level, 
multidisciplinary ICU underwent blood collection within 72 hours of 
developing septic shock.
Figure 1 (abstract P407). Comparison of deciles of diff  erent GV formulas 
with mortality.
Figure 2 (abstract P407). ROC of formulas.
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was 29%. Log PFC demonstrated positive correlation with log BNP 
(r = 0.55; P = 0.019). Log PFC also correlated with APACHE III (r = 0.67; 
P <0.001) and norepinephrine dose (r = 0.55; P = 0.01). APACHE III 
(P  =  0.001) and norepinephrine dose (P  =  0.02) were independent 
predictors of PFC. A model incorporating both variables explained 68% 
of variation in PFC (R2 = 0.682).
Conclusions  This preliminary study of patients with septic shock 
demonstrates a modest positive correlation between PFC and BNP 
concentration. The APACHE III score and norepinephrine dose were 
independent predictors of PFC.
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Introduction The aim of this study was to measure cortisol in the 
interstitial fl  uid of mechanically ventilated septic patients using MD 
and to examine the correlation between interstitial cortisol levels and 
total along with free serum cortisol.
Methods A prospective study including 31(20 men) septic patients. 
All patients met the ACCP/SCCM criteria for sepsis. Upon sepsis an MD 
catheter was inserted in the subcutaneous tissue of the upper thigh. 
MD sampling was done on days 1 and 2, six times/day. The collected 
samples were analyzed for free cortisol, glucose, pyruvate, lactate, 
glycerol and lactate/pyruvate ratio. Blood samples were collected for 
routine hematology and biochemistry on the same days. Age, gender, 
sepsis stage, administration of vasopressors, death in the ICU and 
28-day mortality were recorded. APACHE II scores for day 1 and SOFA 
scores for days 1 and 2 were calculated.
Results Seventeen patients were given norepinephrine. Albumin on 
day 1 was uniformly low. One-third of patients died. Cortisol values in 
the interstitial fl  uid remained constant (P = 0.480). Serum total cortisol 
(P = 0.116) and serum total cortisol/albumin ratio (P = 0.127) were 
also constant. On day 2 serum-free cortisol was higher than MD-free 
cortisol. Log MD cortisol correlated strongly with the log serum total 
cortisol and serum-free cortisol on day 2 correlated well with serum 
total cortisol. Day 1 log MD cortisol correlated positively with log MD 
pyruvate and log APACHE II. Day 2 log MD cortisol correlated positively 
with norepinephrine dose and log SOFA score. There were no other 
signifi  cant correlations of MD cortisol.
Conclusions Adipose tissue cortisol is strongly correlated with serum 
total and free cortisol, suggesting that serum cortisol refl  ects tissue 
cortisol availability. The utility of MD in studying cortisol dynamics 
needs to be further investigated.
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Introduction The CORTICUS trial doubts the value of hydrocortisone 
replacement for fi  nal outcome of septic shock [1]. We hypothesized that 
the time of starting hydrocortisone may impact on the fi  nal outcome.
Methods Retrospective analysis was made of prospectively collected 
data for 41 patients with septic shock (ACCP/SCCM 1992 defi  nition) in 
the past year in two ICUs. Hydrocortisone was infused as suggested [2]. 
The time lapsing from start of vasopressors until start of hydrocortisone 
was determined by the patients’ charts.
Results Early start of hydrocortisone was determined by the quartiles 
of lapsing time as less than 24 hours. The impact of early start is shown 
in Figure 1. The mean APACHE II score for patients in early start was 
22.09 and for patients in late start was 18.33 (P = NS). Cox regression 
analysis revealed that the only factor aff  ecting fi  nal outcome was early 
start of hydrocortisone (HR: 4.85, 95% CI: 1.11 to 21.22, P = 0.036) as 
opposed to appropriateness of antimicrobial treatment (HR: 2.80, 95% 
CI: 0.56 to 13.91, P = NS).
Conclusions  Despite the observational approach, early start of 
hydrocortisone replacement in septic shock is a critical factor for 
outcome.
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Introduction Evaluation of operational risk is an important goal of 
perioperative management of patients in cardiac surgery. The aim 
of this study was to investigate the prognostic value of preoperative 
total lymphocyte count (PTLC) in peripheral blood as a predictor of 
postoperative complications and mortality in cardiac surgery.
Methods A retrospective observational study of 1,380 adults who were 
operated on the heart using cardiopulmonary bypass (CPB) in 2009. 
Patient characteristics, hospital mortality, postoperative complications, 
ventilation time, ICU and hospital stay were analysed. Patients were 
divided into four groups depending on their PTLC: <1,000 cells/μl, 40 
patients; 1,000 to 1,500 cells/μl, 199 patients; 1,501 to 2,000 cells/μl, 
414 patients; and >2,000 cells/μl, 715 patients. Analysis was performed 
using univariate analysis, Kruskal–Wallace test or Fisher–Freeman–
Halton exact test (for qualitative characteristics). Univariate and 
multivariate logistic regression analysis of in-hospital mortality also 
were performed. P <0.05 was considered statistically signifi  cant.
Results PTLC <1,500 cells/μl was associated with signifi  cantly higher 
mortality by univariate (OR = 3.53; CI = 1.98 to 6.28; P <0.0001) and 
multivariate (OR  =  2.06; CI  =  1.02 to 4.15; P  <0.044) analysis. Low 
Figure 1 (abstract P412). Survival in relation to start of hydrocortisone.
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frequent inotropic support (P <0.001); postoperative heart arrhythmia 
(P  <0.001); dialysis-dependent acute renal failure (P  <0.001); and a 
prolonged ventilation time (P = 0.001), ICU stay (P <0.001), and hospital 
stay (P = 0.007). Furthermore, patients with low PTLC were readmitted 
to the ICU more often (P = 0.008). There were no intergroup diff  erences 
in age and body mass index.
Conclusions PTLC is an informative, simple and easily reproducible 
criterion for evaluating the operational risk in cardiac surgery. 
However, detailed mechanisms responsible for correlations between 
preoperative PTLC and cardiovascular morbidity and mortality remain 
unknown.
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for the diagnosis and severity of sepsis in systemic infl  ammatory 
response syndrome
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Introduction CD14 is present in macrophage, monocyte, and granulo-
cyte cells and their cell membranes, and is said to be responsible for 
intracellular transduction of endotoxin signals. Its soluble fraction is 
present in blood and is thought to be produced in association with 
infections. It is called the soluble CD14 subtype (sCD14-ST), and in 
the text below it will be referred to by its generic name, presepsin. We 
have previously reported that presepsin is produced in association 
with infection and that it is specifi  cally expressed in sepsis. In the 
present study we developed a new rapid diagnostic method using a 
chemiluminescent enzyme immunoassay, and it made automated 
measurements in a shorter time possible.
Methods The subjects were 41 inpatients (25 males and 16 females), 
62 ± 19 years old, who had been brought to the Critical Care and 
Emergency Center of Iwate Medical University, and who fulfi  lled at 
least two of the diagnostic criteria for systemic infl  ammatory response 
syndrome (SIRS) on arrival. Blood specimens were collected a total of 
six times – that is, on admission, and 12 and 24 hours and 3, 5, and 
7 days later – and the presepsin values were measured. The sepsis 
markers PCT, IL-6, and CRP were also measured for comparison.
Results The results of using this method to measure presepsin values 
in diff  erent pathological conditions were: normal, 294.2 ± 121.4 pg/
ml; local infection, 721.0 ± 611.3 pg/ml; SIRS, 333.5 ± 130.6 pg/ml; 
sepsis, 817.9 ± 572.7 pg/ml; and severe sepsis 1,992.9 ± 1,509.2 pg/
ml, and the presepsin values were signifi  cantly higher in patients with 
local infection, sepsis, and severe sepsis than in patients who did not 
have infection as a complication. In a comparative study with other 
diagnostic markers of sepsis based on ROC curves, the area under the 
curve (AUC) of presepsin was 0.845, and higher than the AUC of PCT 
(0.652), CRP (0.815), or IL-6 (0.672).
Conclusions  In the present study we were able to obtain results 
similar to those obtained with the conventional ELISA method, and 
it was possible to diagnose sepsis more rapidly and conveniently by 
using the immunoassay analyzer. We are currently using the analyzer 
in a multicenter clinical study, and are in the process of conducting a 
further clinical dynamics analysis in various pathological conditions. 
Based on the results of the present study, it appears that presepsin 
will soon be widely used as a diagnostic marker of sepsis in clinical 
settings.
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Introduction IL-18 is said to be involved in organ injury. We investigated 
the IL-18 values of septic acute lung injury (ALI) and acute respiratory 
distress syndrome (ARDS) patients.
Methods The subjects were 38 patients during the 3-year period from 
2004 to 2007 from whom it was possible to collect a blood specimen 
within approximately 6 hours of the onset of septic ALI or ARDS. Their 
mean age was 67 years, and their mean APACHE II score was 29. Their 
SOFA score was 13, and their mean PaO2/FiO2 (P/F) ratio was 170. The 
P/F ratio was 246 in the ALI group and 135 in the ARDS group. There 
were four cases (10.5%) in the 28-day mortality group, and six cases 
(15.8%) in the 90-day mortality group.
Results The value of IL-18 in the died group was signifi  cantly higher 
than in the survived group (1,649 ± 1,056 pg/ml vs. 4,523 ± 2,798 pg/
ml; P <0.05), and in the ARDS group also signifi  cantly higher than in ALI 
group (2,467 ± 1,880 pg/ml vs. 1,314 ± 800 pg/ml); P <0.05).
Conclusions These results suggested that IL-18 may play an major role 
in progression of ARDS in respiratory disorder as multiple organ failure.
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Introduction The objective was to verify the possibility of endothelial 
damage induced by cytokines in ischemia/reperfusion (extracorporeal 
circulation).
Methods Forty-one patients were included in the study. All patients 
diagnosed with coronary artery disease were operated on in the 
amount of coronary artery bypass grafting under normothermic 
cardiopulmonary bypass nonpulsed (CB) with cold blood cardioplegia. 
Systemic infl  ammatory response (SIRS) was defi  ned as: SIRS I – 57%, 
SIRS II – 24%, SIRS III – 19%. Ischemia/reperfusion was confi  rmed 
by oxygen status and lactate of arterial and mixed venous blood 
(StatProfi  le). We investigated by enzyme immunoassay analysis (ELISA): 
soluble triggering receptor expressed on myeloid cells (sTREM-1), 
TNFα, IFNγ, soluble vascular cell adhesion molecules (sVCAM-1), 
soluble intercellular adhesion molecule (sICAM-1), and soluble platelet/
endothelial cell adhesion molecule (sPECAM-1); sets from Bender 
Medsystems and CanAg. Data are presented as mean  ±  standard 
deviation.
Results In all patients was reported a decrease in the content of TNFα, 
and IFNγ (fi  rst point – before the extracorporeal circulation, second 
point – after). However, after the separation of patients according to 
severity of SIRS, a group of patients with the defi  nition of the three 
signs of the cellular adhesion molecules (which corresponds to the 
most severe course of clinical and laboratory manifestations of systemic 
infl  ammation) recorded an increase in the concentration of TNFα, as 
well as sVCAM-1 (4.45 ± 0.9 vs. 8.9 ± 0.9 pg/ml), and sPECAM-1 (3.4 ± 0.9 
vs. 6.7 ± 0.9 pg/ml). The level of sICAM-1 increased both in the general 
population and separately in groups of patients with diff  erent levels 
of expression of the cellular adhesion molecules. Similar results were 
obtained for the level of sTREM-1. A direct correlation was observed 
between the level of leading cytokines, the level of sTREM-1 and the 
level of cell adhesion molecules.
Conclusions  There is endothelial damage, activated by cytokines, 
reaching the highest value at SIRS III during ischemia/reperfusion and 
systemic infl  ammation.
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Introduction  The objective was to determine the prognostic 
signifi  cance of serum markers of apoptosis in patients with polytrauma.
Methods The study included 34 male patients (38 ± 21 years old) with 
polytrauma. The severity of patients on admission according to the 
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SOFA scale was 7 ± 4. We investigated the serum markers of apoptosis: 
sAPO-1/Fas (soluble Fas receptor, sFas), sFas-L (soluble Fas ligand), 
Bcl-2 and p53 (Bender MedSystems, Austria). Data are presented as 
mean ± standard deviation.
Results In patients with severe injury on the fi  rst day determined by the 
initial high level of sAPO-1/Fas (410.9 ± 89.7 pg/ml), which decreased 
on the second day, while remaining signifi  cantly above control values, 
the component for sAPO-1/Fas was 108 ± 12 pg/ml (P = 0.001). The 
level of sAPO-1/Fas increased, reaching a maximum on the fi  fth day 
(419.5 ± 94.5 pg/ml). The level of sFas-L was initially almost three times 
higher than the reference values at 48 ± 14 pg/ml, and on the third day 
rose in parallel to sAPO-1/Fas, reaching a maximum on the fi  fth day. In 
response to increased Fas-L, sFas is released. With increased expression 
of FasL and sFas lack of apoptosis leads to the development of multiple 
organ failure, and an excess of sFas massive death of lymphocytes may 
cause immunosuppression. The level of Bcl-2 in serum on the fi  rst day 
was signifi  cantly higher than in the control group (7.11 ± 5.55 ng/ml, 
P = 0.001) and amounted to 26.5 ± 6.3 ng/ml. On the fi  fth day there was 
a signifi  cant increase in the concentration of Bcl-2 to 39.8 ± 8.8 ng/ml, 
but by the seventh day the level of Bcl-2 decreased to 22.8 ± 4.3 ng/
ml. Increased levels of p53 induced by hypoxia lead to increased 
concentrations of Bcl-2.
Conclusions  The progressive development of multiple organ dys-
function syndrome in polytrauma is associated with serum concen-
trations of sAPO-1/Fas and sFas-L ratio, Bcl-2 and p53.
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Introduction It has been emphasized that severe sepsis often leads 
to shock and ARDS in critically ill patients. We reported previously that 
sulfonated immunoglobulin (sIG) administration signifi  cantly inhibited 
the increase of in lung MPO activities and the increase of pulmonary 
vascular permeability. In the present study, we examined whether sIG 
improves not only ARDS but also cardiovascular dysfunction in patients 
with severe sepsis.
Methods  ARDS patients with severe sepsis were divided into two 
groups, the sIG administrated group and the polyethylene glycol-
treated immunoglobulin (pIG) administrated group. We evaluated 
them by measuring the value of IGF-1, lactate, PF ratio, cathecholamine 
index, septic severity score (SSS) and SOFA score.
Results The serum IGF-1 levels in the sIG group were increased at the 
seventh day signifi  cantly (P <0.05). PF ratios in the sIG group were 
increased signifi  cantly at the seventh day (P <0.05). The serum lactate 
levels and catecholamine index in the sIG group were decreased 
signifi  cantly at the seventh day (P <0.05). The total score of SSS and 
SOFA also signifi  cantly improved in the sIG group at the seventh day 
(P <0.05).
Conclusions  These observations suggest that sIG might improve 
cardiopulmonary functions by promoting IGF-I production in ARDS 
patients with severe sepsis.
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Introduction Volatile anaesthetics are known as immunomodulatory 
substances in infl   ammatory as well as in ischemia/reperfusion 
pro  cesses [1,2]. We investigated in a model of acute pulmonary 
infl  ammation whether these immunomodulatory eff  ects arise from the 
ether basic structure or from characteristics in their halogenation.
Methods Infl  ammatory response in pulmonary epithelial and endo-
thelial cells as well as in neutrophils after co-exposure to endotoxin 
and sevofl   urane, diethyl-ether or various water-soluble molecules 
carrying trifl  uorinated carbon groups (CF3) was evaluated. Expression 
of monocyte chemotactic protein-1 and cytokine-induced neutrophil 
chemoattractant protein-1, IL-6, and IL-8 as a measure of infl  ammatory 
activity were analyzed by ELISA. Chemotactic activity of supernatants 
regarding neutrophil recruitment was assessed. Flow cytometric 
analysis of neutrophil activation was performed measuring CD11b 
and CD62L expression. Viability was observed using fl  uorescence 
DNA quantitation. Cytotoxicity was evaluated by measuring lactate 
dehydrogenase in supernatants.
Results Expression of infl  ammatory mediators to lipopolysaccharide 
stimulation in epithelial and endothelial cells was dose-dependently 
decreased upon exposure to sevofl  urane and other molecules with 
CF3 groups. This was not observed for diethyl-ether or structure-similar 
nonfl  uorinated molecules. In neutrophils, chemotactic activity as well 
as expression of surface CD11b and CD62L was decreased by molecules 
carrying CF3 groups. Cytotoxicity could be excluded.
Conclusions  These fi   ndings show that the immunomodulatory 
eff   ects are not limited to volatile anesthetics, but are associated 
with a much broader class of CF3 group-containing molecules. The 
immunomodulatory eff  ects could now be provided in a hydrophilic, 
injectable formulation for the future treatment of patients suff  ering 
from acute pulmonary infl  ammation in environments not suitable for 
volatile anesthetics.
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Introduction  The objective was to determine the diagnostic 
signifi  cance of soluble triggering receptor expressed on myeloid cells 
(sTREM-1) as a marker of the systemic infl  ammatory response syndrome 
(SIRS) in ischemia/reperfusion (extracorporeal circulation).
Methods Eighty-nine patients were included in the study. All patients 
were divided into: group 1 (n = 41) – coronary heart disease (CHD), 
group 2 (n = 47) – acquired heart diseases (AHD). All the operations 
were performed with normothermal nonpulsatile extracorporeal 
circulation (EC) with cold blood cardioplegia (coronary artery bypass 
surgery in the group with CHD and prosthetics/plastic valves for the 
group with AHD). Systemic infl  ammatory response (SIRS) was defi  ned 
by Bone and colleagues [1]; ischemia and reperfusion by lactate 
and oxygen status of arterial and mixed venous blood (StatProfi  le). 
We studied by enzyme immunoassay level (ELISA): high-sensitivity 
C-reactive protein (hsCRP), procalcitonin (PCT-Q) and sTREM-1, using 
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presented as mean ± standard deviation.
Results All patients registered the increased level of hsCRP, without 
signifi  cant diff  erence between the two groups. At the point after the 
operation, the rate of hsCRP was signifi  cantly higher for the group AHD. 
Correlations were noted between levels of hsCRP and the frequency of 
occurrence of criteria for SIRS (r = 0.22 for the group of IHD, P = 0.03; 
r = 0.39 for the group AHD, P = 0.01). The odds ratio (OR) likelihood of 
SIRS complications on hsCRP was 2.4 in the group with CHD and 3.9 
in the group with AHD. There was no signifi  cant diff  erence between 
the rates of PCT for the corresponding points of comparison groups. 
The highest predictive value (OR = 2.9, P = 0.03) has a PCT in relation 
to the severity of SIRS in patients with AHD (infectious endocarditis 
and rheumatic heart disease). The sTREM-1 level was higher compared 
with the postoperative period (55.5 ± 8.8 vs. 77.8 ± 9.1 pg/ml, P = 0.005; 
49.9 ± 6.7 vs. 87.5 ± 8.9 pg/ml, P = 0.004). We studied the correlation 
between the level of sTREM-1 and the frequency of occurrence of 
symptoms SIRS (r = 0.77 for the group of IHD, P = 0.002; r = 0.79 for the 
group AHD, P = 0.04). The OR sTREM-1 probability of SIRS complications 
was highest in comparison with all of the markers.
Conclusions  sTREM-1 has the greatest diagnostic signifi  cance  in 
relation to non-infectious SIRS in ischemia/reperfusion.
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Introduction The aim was to describe the anemia profi  le of medical or 
surgical patients with severe sepsis or septic shock in the ICU, assessing 
severity scale, length of stay and mortality.
Methods  From January to May 2009, we prospectively selected 
79 patients; we excluded hematologic disease. Two groups were 
established: medical (n = 52, 65.8%) and surgical (n = 27, 34%) septic 
patients. The microcytic anemia profi  le was set in the fi  rst 24 hours: 
CBC, transferrin, serum iron concentration, transferrin saturation index 
(TSI) and ferritin. There is anemia when haemoglobin (Hb) is <12.5 
g/dl (severe when  <10 g/dl); mean corpuscular volume (MCV)  <80 
fl  ; ferritin <30 ng/ml; TSI <20%; serum iron <50 μg/dl. The reference 
values of transferrin are 200 to 360 mg/dl. The program used for the 
data processing and statistical analysis was SPSS.
Results The mean age was 60 ± 17 years, 60% were men, APACHE II 
was 23.46 ± 6.7 and SOFA 9.68 ± 2.93; the length of stay in the ICU was 
9.3 ± 5.7 days and 20.3% of mortality. The average values related to 
microcytic anemia were Hb = 10.02 ± 1.8 g/dl, serum iron = 36 ± 25 
μg/dl, MCV = 88.37 fl   and TSI = 20.29%. The prevalence of microcytic 
anemia in our septic patients was 53.8%. In both studied groups we 
found signifi  cant diff  erences in the SOFA (10.17 vs. 8.7, P = 0.03) and 
in transferrin (147 mg/dl vs. 114 mg/dl, P = 0.002). The length of stay 
was higher in the surgical patients (P = NS). The mortality showed 
signifi  cant diff  erences in age (58 vs. 66, P = 0.03), APACHE II (22 vs. 27, 
P = 0.01), SOFA (9 vs. 12, P = 0.0001) and in Hb (10.2 vs. 9.3, P = 0.08) and 
transferrin (141 vs. 117, P = 0.02).
Conclusions  The prevalence of microcytic anemia is more than 
one-half of our septic patients. There are iron metabolism disorders 
without signifi  cant diff  erences between medical and surgical patients. 
Transferrin, a protein related to malnutrition, infl  ammatory response 
and organ dysfunction, is signifi  cantly lower in the most severe patients 
with higher organ dysfunction scores.
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Introduction A novel approach to increase erythropoietin (EPO) using 
oxygen has been reported in healthy volunteers. The purpose of this 
study is to investigate whether the EPO increase is suffi   cient to induce 
erythropoiesis.
Methods  We compared exposure to daily versus every other day 
oxygen administration on haemoglobin variation during a 12-day 
period. Each subject underwent the two protocols at a 6-week interval 
period to achieve the same baseline values.
Results See Figure 1. Nine subjects underwent the study. We observed 
a signifi  cant increase in haemoglobin values in the every other day 
group compared with the each day group and with baseline. At the 
end of each day period, haemoglobin values increased to achieve a 
signifi  cant diff  erence as compared with baseline. There was a signifi  cant 
rise of reticulocytes in the every other day group as compared with the 
each day group (182 ± 94% vs. 93 ± 34%, P <0.001). These data provide 
demonstration of an enhanced production of erythrocytes.
Conclusions  The normobaric oxygen paradox seems eff  ective  to 
increase haemoglobin in non-anaemic healthy volunteers assuming 
there is a suffi   cient time interval between the two oxygen applications. 
This could permit interesting clinical applications in perioperative 
medicine as an adjunct therapy to EPO for blood predonation.
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Introduction  We investigated the skin oxygen tension (tcpO2) of 
critically ill patients before, during and after transfusion (XF) of packed 
red blood cells (RBC).
Methods Nineteen critically ill patients (11 men, age 67 ± 15 years, 
SAPS II 60.1  ±  19) who received 2 U RBC due to hemoglobin (Hb) 
<8 g/l underwent measurement of tcpO2 (TCM400; Radiometer Ltd, 
Figure 1 (abstract P422). Comparison between haemoglobin variations 
after 30 minutes of 100% O2 breathing every day or every other day. 
**Statistically signifi  cant diff  erence from baseline (P <0.01) for oxygen 
breathing every other day (protocol B). §§Statistically signifi  cant diff  erence 
from baseline (P <0.01) for Oxygen breathing each day (protocol A).
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served as her/his own control (baseline, after XF of 1, and second RBC). 
Ventilation and pressors were kept constant. Patients with bleeding, in 
shock and with circulatory assists were excluded. Cardiac index (CI) was 
determined by FloTrac™/Vigileo™.
Results  Hb signifi  cantly increased (P  <0.002), while tcpO2 was not 
signifi  cantly  diff   erent throughout XF (Figure 1; P  =  0.72). Arterial 
pO2 (86 ± 14 vs. 91 ± 11 vs. 88 ± 18 mmHg, P = 0.68) and global 
hemodynamics (CI, P = 0.89, Figure 1; SVR: 822 ± 360 vs. 703 ± 233 vs. 
941 ± 410, P = 0.13) did not change. Oxygen delivery (DO2) signifi  cantly 
increased (644 ± 188 vs. 744 ± 234 vs. 818 ± 214 ml/minute, P = 0.049). 
Interestingly, central venous oxygen saturation (ScvO2) decreased 
signifi  cantly during XF and did not completely recover until the end of 
XF (P <0.05 midst XF vs. baseline; Figure 1).
Conclusions XF signifi  cantly increased Hb and calculated DO2 but not 
true tcpO2. Increase in DO2 occurred in the absence of changes in CI 
and oxygenation. ScvO2 signifi  cantly decreased during XF but did not 
completely recover until the end of the study period.
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Introduction  Transfusion-related acute lung injury (TRALI) is an 
important problem in the critically ill. CD40L has been implicated as 
a cofactor or even the cause of TRALI [1]. (1) We hypothesized that 
blocking of the CD40–CD40L interaction protects against lung injury 
in a murine model of TRALI. (2) Furthermore, we hypothesized that 
plasma sCD40 levels are elevated in TRALI patients compared with 
controls.
Methods  (1) Male BALB/c mice (n  =  96) were challenged with 
monoclonal MHC-1 antibody (Ab), a previously used murine TRALI 
model [2]. In separate experiments, mice were pretreated with 
Ciglitazone, an inhibitor of the expression of CD40L on platelets, or 
anti-CD40L Ab, which antagonizes CD40L–CD40 interaction. Controls 
received vehicle or isotype Ab. After 2 hours, mice were killed and 
bronchoalveolar lavage fl  uid (BALF) was obtained. The wet lung to 
body weight ratio was calculated. Total protein, keratinocyte-derived 
chemokine (KC) and macrophage-infl  ammatory protein-2 (MIP-2) were 
measured in BALF. (2) Cardiac surgery patients were prospectively 
followed for the onset of TRALI (by applying the consensus defi  nition). 
Sixteen TRALI cases were compared with controls (transfused patients 
not developing lung injury). Plasma levels of sCD40L were measured 
before surgery and at onset of TRALI.
Results  (1) Infusion of MHC-1 Ab resulted in pulmonary edema, 
accompanied by elevated BALF levels of total protein and KC and MIP-2 
compared with infusion of isotype Ab (P <0.05 to all). Treatment with 
ciglitazone or anti-CD40L Ab did not result in a decrease of pulmonary 
edema compared with MHC-1 Ab, nor did it reduce BALF KC levels 
(33 ± 6.1 vs. 27 ± 19 vs. 13 ± 9.4 ng/ml respectively) and MIP-2 levels 
(5.3 ± 3.0 vs. 1.5 ± 1.7 vs. 2.0 ± 2.9 ng/ml respectively). (2) Surgery 
resulted in a decrease in sCD40L levels, with a concomitant decrease 
in platelet count. We found no diff  erence in plasma levels of sCD40L 
between cardiac surgery patients developing TRALI and controls 
(275 ± 192 vs. 258 ± 346 and 93 ± 82 vs. 93 ± 123 pg/ml respectively, 
NS).
Conclusions CD40L does not play a role in this model of antibody-
mediated TRALI. Moreover, sCD40L levels are not diff  erent in cardiac 
surgery patients developing TRALI compared with transfused controls, 
further suggesting that sCD40L is not a mediator of TRALI.
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Introduction Evidence exists that blood transfusions may be more 
harmful for patients than once suspected [1]. Optimal goals for 
transfusion therapy remain elusive. Lower rates of blood transfusion 
seem to lead to better patient outcomes. Tissue oxygenation monitoring 
may off  er a novel insight into blood transfusion requirements as it 
represents an indication of oxygen content further down the oxygen 
cascade than the blood oxygen content defi  ned by pulse oximetry and 
hematocrit. Our hypothesis is that the use of this monitor may defi  ne a 
safer, lower threshold for blood transfusion that may lead to decreased 
transfusion rates.
Methods  We performed chart reviews of 100 patients who 
underwent cardiac surgery (coronary artery bypass graft surgery and 
valvular surgery) with heart–lung bypass. The fi  rst 50 surgeries were 
performed with standard hemodynamic monitors and intraoperative 
transesophageal echocardiography. Indications for transfusion 
included ongoing bleeding, hematocrit less than 20% with a heart 
rate over 95 bpm or blood pressure less than 90 mmHg systolic. The 
subsequent 50 cases consisted of a similar patient population, surgical 
indications and medical group; however, the use of the Hutchinson 
InSpectra tissue oxygen monitor intraoperatively and postoperatively 
was employed. Our review sought to identify whether the transfusion 
threshold criteria were modifi  ed due to the availability of this additional 
monitoring information.
Results A lower hematocrit value was found to be tolerated as long as 
tissue oxygen values were within an acceptable range; that is, above 
70% or less than a 20% drop from baseline. There was a statistical 
diff  erence between transfusion rates, in the fi  rst group was 30% and in 
the second group was 18%. This represents a relative decrease of nearly 
50% in blood transfusions. Outcomes in both groups were identical. 
The mortality rate was nil. There was no signifi  cant diff  erence between 
outcomes or length of stay.
Conclusions  Although optimal goals for blood transfusion remain 
elusive, it does appear that even slight overtransfusion may be 
detrimental [1]. The tissue oxygen monitor appears to defi  ne a new, 
lower safe threshold for transfusion. An outcome benefi  t will probably 
be observed in future studies. Long-term outcome benefi  ts from the 
routine implementation of this device have already been suggested in 
the trauma [2] and intensive care [3] settings.
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Introduction Anemia can cause an imbalance in oxygen delivery (DO2) 
and consumption (VO2), which may be diffi   cult to detect. Recently the 
venous to arterial carbon dioxide diff  erence has been shown to be 
increased (>5 mmHg) in certain critically ill conditions [1,2]. No study 
has yet investigated its signifi  cance in severe normovolemic anemia. 
Therefore, the aim of this study was to investigate the course of the 
central venous to arterial carbon dioxide gap (dcvCO2) in isovolemic 
anemia.
Methods An experimental animal study on anesthetized Vietnamese 
mini-pigs. After splenectomy, mini-pigs (n = 13, weight range: 18 to 
30 kg) were bled in fi  ve stages (~10% of estimated blood volume/5 
minutes, T0 to T5) and blood loss was replaced by the same volume 
of colloid, after which hemodynamic measurements and blood gas 
analysis were performed.
Results The fall of hemoglobin was signifi  cant from the fi  rst bleeding, 
from T0 to T5: median = 125 (interquartile range = 113 to 134) to 49 
(43 to 55) g/l, P <0.05, respectively. Despite a signifi  cant increase in 
cardiac index by T1 (T0 = 2.6 (2.3 to 2.8) vs. T1 = 3.3 (2.7 to 3.6) l/minute/
m2, P <0.05), which remained so for the rest of the experiment, the 
O2 extraction (VO2/DO2) increased signifi  cantly only from T3 (T0 = 29 
(18 to 33) vs. T3 = 35 (21 to 40)%, P <0.05). Anemia was accompanied 
by a signifi  cant increase in dcvCO2 from T0 = 5 (3 to 9) to T5 = 6 (6 to 
11) mmHg, P <0.05. There was a strong signifi  cant correlation between 
VO2/DO2 and dcvCO2: r = 0.65, r2 = 0.43, P <0.001. Furthermore, dcvCO2 
with a cut-off   value >5 mmHg had a sensitivity of 69% and specifi  city 
of 82% to show a VO2/DO2 >30%, and receiver operating characteristics 
showed an area under the curve of 0.787 ± 0.054 (CI: 0.682 to 0.892), 
P <0.001, for the same VO2/DO2 threshold.
Conclusions To our best knowledge, this is the fi  rst study to show that 
dcvCO2 could be used to detect oxygen debt in isovolemic anemia.
References
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Introduction Blood transfusion is associated with increased morbidity 
and mortality in cardiac surgery patients, but the cause and eff  ect 
relation remains unknown. We hypothesized that blood transfusion 
is associated with changes in pulmonary and systemic infl  ammation 
and coagulopathy, occurring in patients who do not meet the clinical 
diagnosis of transfusion-related acute lung injury (TRALI).
Methods We performed a case–control study in an ICU of a university 
hospital. Cardiac surgery patients were grouped as having received 
no transfusion (n = 17), restrictive transfusion (1 to 2 units) (n = 18) or 
multiple transfusions (≥5 units) (n = 10). Bronchoalveolar lavage fl  uid 
(BALF) and blood were obtained postoperatively. Data are presented 
as median (IQR).
Results  Restrictive transfusion increased BALF levels of IL-1β 
compared with nontransfused controls (P  <0.05), and levels were 
further enhanced by multiple transfusion (P  <0.01; 2.9 (9.4) vs. 9.5 
(35) vs. 15 (148) pg/ml, respectively). BALF levels of IL-8, TNFα and 
thrombin–antithrombin complex (TATc) were increased after multiple 
transfusion compared with nontransfused controls (P <0.01, P <0.001 
and  P  <0.01 respectively), but not after restrictive transfusion. 
Restrictive transfusion was associated with increased pulmonary levels 
of plasminogen activator inhibitor-1 compared with nontransfused 
controls with a further increase after multiple transfusions (P <0.001; 
3.4 (1.2) vs. 4.4 (1.4) vs. 6.3 (2.5) ng/ml, respectively). Concomitantly, 
levels of plasminogen activator activity (PAA%) were lower (P <0.001; 
42 (6.5) vs. 34 (6.5) vs. 32 (7.8)%, respectively), indicating impaired 
fi  brinolysis. In the systemic compartment, transfusion was associated 
with a signifi  cant increase in levels of TNFα, TATc and PAA (P <0.05).
Conclusions  Transfusion during cardiac surgery is associated with 
activation of infl   ammation and coagulation in the pulmonary 
compartment of patients who do not meet TRALI criteria, an eff  ect 
that was partly dose dependent, suggesting transfusion as mediator 
of acute lung injury. These pulmonary changes were accompanied by 
systemic coagulopathy.
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Introduction In children with severe sepsis or septic shock, the optimal 
red blood cell (RBC) transfusion threshold is unknown. We analyzed 
the subgroup of patients with sepsis in the TRIPICU (Transfusion 
Requirements in Pediatric Intensive Care Units) study in order to 
determine the impact of a restrictive versus liberal transfusion strategy 
on clinical outcome.
Methods This study is a subgroup analysis of a prospective multicenter 
randomized controlled trial (TRIPICU). One hundred and thirty-seven 
stabilized critically ill children (mean systemic arterial pressure >2 SD 
below normal mean for age and cardiovascular support not increased 
for at least 2 hours before enrolment), with a hemoglobin ≤9.5 g/
dl within 7 days after PICU admission, were randomized to receive 
RBC transfusion if their hemoglobin dropped below either 7.0 g/dl 
(restrictive group) or 9.5 g/dl (liberal group).
Results In the restrictive group (69 patients), 30 patients did not receive 
any RBC transfusion, whereas only one patient in the liberal group 
(68 patients) was never transfused (P <0.01). No clinically signifi  cant 
diff   erences were found for the occurrence of new or progressive 
multiple organ dysfunction syndrome (18.8% vs. 19.1%; P  =  0.97), 
for PICU length of stay (P = 0.74) or PICU mortality (P = 0.44) in the 
restrictive versus liberal group.
Conclusions In this subgroup analysis of stable septic children, we found 
no evidence that a restrictive red-cell transfusion strategy, as compared 
with a liberal one, increased the rate of new or progressive MODS. On 
the other hand, a restrictive transfusion threshold signifi  cantly reduced 
exposure to blood products. Our data suggest that a hemoglobin level 
of 7 g/dl may be safe for stabilized septic children but further studies 
are required to support this recommendation.
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Introduction  The non-invasive pulse CO-oximeter provides an 
immediate and continuous estimation of hemoglobin concentration 
non-invasively, and so has the potential to improve ICU patient care. 
We determined whether non-invasive hemoglobin measurement by 
pulse CO-oximetry could provide clinically acceptable absolute and 
trend accuracy in critically ill patients, compared with other invasive 
methods of hemoglobin assessment available at bedside and the gold 
standard, the laboratory analyzer.
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of a university teaching hospital. Blood samples from subjects 
continuously monitored with pulse CO-oximetry (SpHb) were 
analyzed for hemoglobin concentration determination by a point-of-
care device (HemoCue301, HbHC), satellite laboratory CO-oximetry 
(Siemens RapidPoint 450, HbABG) and a laboratory hematology 
analyzer (Sysmex XT-2000i, tHB), which was considered the reference 
device. Hemoglobin values reported from the invasive methods were 
compared with the values reported by the Masimo Radical-7 Pulse CO-
Oximeter at the time of the blood draw.
Results Sixty-two patients requiring 471 blood samples were included. 
Compared with the reference method, the bias and limits of agreement 
were 0.0 ± 1.0 g/dl for SpHb, 0.3 ± 1.3 g/dl for HbHC and 0.9 ± 0.6 g/dl 
for HbABG compared with the reference device. Accuracy assessed with 
ARMS was 0.8 g/dl for SpHb and 1.1 g/dl for HbABG and HbHC. Pulse 
CO-oximetry showed similar trend accuracy as CO-oximetry, whereas 
the point-of-care device did not follow the trend of the laboratory 
device as well as the other analyzers. See Table 1.
Table 1 (abstract P429). Accuracy summary of test devices compared with 
laboratory hematology analyzer
  SpHb vs. tHb  HbHC vs. tHb  HbABG vs. tHb
Bias (g/dl)  0.0  –0.3  –0.9
Agreement(g/dl)  –1.0 to 0.9  –1.6 to 1.0  –1.6 to –0.3
ARMS (g/dl)  0.8  1.1  1.1
Conclusions  When compared with laboratory reference values, 
hemoglobin measurement with pulse CO-oximetry has absolute and 
trending accuracy similar to widely used, invasive methods such as 
CO-oximetry and a point-of-care device. Hemoglobin measurement 
with pulse CO-oximetry has the additional advantages of providing 
continuous measurements, non-invasively, which may facilitate 
hemoglobin monitoring in the ICU.
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Introduction  Although tranexamic acid (TA) has been eff  ective in 
reducing bleeding after cardiac surgery, the TA dosing scheme varies 
extremely and the agent is highly overdosed in most relevant trials. In 
a dose-dependent fashion, TA is associated with an increase of adverse 
events, particularly the observation of seizures. In this study we aimed 
to assess the safety and eff  ectiveness of diff  erent treatment regimes of 
TA in cardiopulmonary bypass (CPB) patients.
Methods A cohort study. The TA treatment regimes were: A: none, B: 
40 mg/kg before CPB, C: 25 mg/kg before and 25 mg/kg after CPB, 
and D: 40 mg/kg before and after CPB. Demographic variables, co-
morbidity, perioperative clinical data, and postoperative outcomes 
(bleeding, RIFLE classifi   cation, seizures, stroke and mortality) were 
recorded. SPSS v15 was used.
Results We studied four hundred and fi  ve patients (66, 80, 179 and 
80 in the A, B, C and D groups, respectively). Surgical procedures were 
209 (52%) coronary artery bypass grafting, 135 (33%) valvular, 41 
(10%) combined surgery and 20 (5%) other procedures. The 24-hour 
postoperative bleeding was: A: 992 (95% CI = 808 to 1,177) ml; B: 829 
(95% CI = 708 to 950) ml; C: 686 (95% CI = 607 to 765) ml; and D: 671 
(95% CI = 550 to 793) ml (F: 18.98, P <0.001). The post-hoc analysis 
(Scheff  é test) showed signifi  cant diff  erences between group A versus 
group C (P = 0.002), and between group A versus group D (P = 0.003). 
The 24-hour postoperative red blood cell requirements were A: 384 
(95% CI = 248 to 520) ml; B: 200 (95% CI = 119 to 280) ml; C: 253 
(95% CI = 184 to 323) ml; and D: 156 (95% CI = 82 to 231) ml (χ2: 8.24 
P = 0.041). We did not fi  nd signifi  cant diff  erences after surgery between 
groups regarding the development of stroke (1.3 to 2.5%), RIFLE: I (2.5 
to 7.5%) and seizures (0 to 2.5%), even though seizures were present in 
a dose-dependent fashion.
Conclusions A dose higher than 25 mg/kg before and after CPB does 
not show a clinically relevant decrease in blood loss with a potential 
increase of adverse events, particularly the observation of seizures.
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Introduction Prothrombin complex concentrates (PCCs) are currently 
used to treat congenital or acquired coagulation factor defi  ciency. 
PCC preparations mostly contain heparin to prevent thromboembolic 
events. In factor VIII and IX defi  cient plasma, Takeyama and colleagues 
observed in vitro a heparin eff  ect of PCCs [1]. The aim of the present 
experiment was to investigate anticoagulant eff  ects of PCCs at clinically 
relevant concentrations in whole blood. In an in vitro experiment we 
compared the PCC preparation used in the experiments of Takeyama 
and colleagues with a new heparin-free PCC preparation.
Methods  After ethics committee approval and informed consent, 
citrated whole blood was obtained from 10 healthy volunteers. 
Two commercially available PCCs were tested: heparin-containing 
Prothromplex® (Baxter, Austria) and heparin-free Cofact® (Sanquin, 
the Netherlands) at concentrations of 0.3125, 0.625 and 1.25 IU/ml. 
Protamine was added to another set of samples (1:1 heparin:protamine). 
For global coagulation monitoring we used the NATEM test in the 
rotational thrombelastometry ROTEM® (Pentapharm, Germany).
Results  In the heparin PCC preparation we observed a signifi  cant 
concentration-dependent prolongation in coagulation time (CT) and 
coagulation formation time (CFT), even at the lowest concentration. The 
maximum clot fi  rmness (MCF) was signifi  cantly reduced too. Heparin-
dependent anticoagulation was reversible by protamine. The heparin-
free PCCs did not aff  ect onset of coagulation. The interpretation of the 
α-angle showed no increased thrombus formation in heparin-free PCC 
preparation.
Conclusions Our results confi  rm and extend the report of Takeyama 
and colleagues. At clinical relevant concentrations, PCC has an 
anticoagulant eff  ect. The heparin content of PCCs should be considered 
in the clinical routine.
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Introduction  Supratherapeutic international normalized ratio (INR) 
levels have been shown to be a signifi  cant predictor of death among 
patients with anticoagulant-related (ACR) intracranial hemorrhage 
(ICH). We assessed factors associated with 90-day mortality and time 
to death in patients receiving fresh frozen plasma (FFP) for ACR major 
bleeding in clinical practice.
Methods  A retrospective analysis was undertaken using electronic 
medical records from an integrated system. Patients who received 
FFP between 1 January 2004 and 31 December 2010, and who met 
the following criteria were selected: major hemorrhage diagnosis the 
day before to the day after initial FFP administration; INR ≥2 on the 
day before or the day of FFP and another INR result up to 1 day after 
FFP; and warfarin supply within 90 days prior to hospitalization. INR 
correction (defi  ned as INR ≤1.3) was evaluated at the last available 
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surrounding FFP were excluded. Kaplan–Meier survival curves were 
estimated and time to death was assessed using Cox proportional 
hazards models. In sensitivity analysis, an INR threshold ≤1.5 was used 
to account for clinical practices that aim to avoid adverse outcomes (for 
example, thrombosis) of certain co-morbidities.
Results A total of 405 patients met the selection criteria (mean age 
75 years, 53% male), and 67% remained uncorrected. Overall, 19% 
of patients died within 90 days of hospital admission, with a higher 
proportion of uncorrected versus corrected patients dying (24% vs. 
13%, P = 0.013). In Cox regression analysis, patients with a fi  rst elevated 
INR value >4 (HR = 2.21; 95% CI = 1.36 to 3.60), with an ICH bleed versus 
gastrointestinal or other bleed (HR = 2.08; 95% CI = 1.27 to 3.40), and 
with uncorrected INR (HR = 2.33; 95% CI = 1.30 to 4.16) were signifi  cantly 
more likely to die within 90 days of admission. In a sensitivity analysis 
(correction defi  ned as INR ≤1.5), 39% remained uncorrected within 24 
hours of FFP administration, with factors predicting 90-day mortality 
remaining robust in regression analysis.
Conclusions Among ACR major bleed patients, not correcting to either 
INR ≤1.3 or INR ≤1.5 with FFP is associated with an increased rate of 
mortality at 90 days. Further assessment of co-morbidities associated 
with hemostasis and other predictors of mortality risk in this population 
is warranted.
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Introduction  Recombinant factor VIIa (rFVIIa) may produce rapid 
hemostasis in warfarin-associated intracerebral hemorrhage (WICH) but 
may carry high thromboembolic risks. We compared baseline thrombo-
embolic risk factors and thromboembolism rates in WICH patients 
treated with rFVIIa to those treated with FFP and vitamin K alone.
Methods  We identifi  ed 45 consecutive WICH patients treated with 
rFVIIa and 34 treated with FFP and vitamin K, and compared their 
incidence of pre-existing thromboembolic risk factors, troponin 
elevation, EKG changes, ischemic stroke, pulmonary embolism (PE), 
and deep vein thromboses (DVT).
Results  Both rFVIIa-treated and control WICH patients have high 
prevalence of pre-existing thromboembolic risk factors including atrial 
fi  brillation (73% vs. 68%), DVT/PE (10% vs. 6%), coronary artery disease 
(CAD) (38% vs. 32%), and abnormal EKG (78% vs. 85%). Troponin 
elevation is common in WICH and incidence of troponin elevation 
(47% vs. 41%) and clinically signifi  cant myocardial infarction (MI) (13% 
vs. 6%) are similar between treatment groups. Past history of CAD 
(P = 0.0061) and baseline abnormal EKG (P = 0.02) were independently 
associated with clinically signifi  cant MI following WICH. Incidence of 
DVT/PE (2% vs. 9%) and ischemic stroke (2% vs. 0%) are comparable 
between rFVIIa-treated and control groups. Recombinant FVIIa-treated 
patients had lower mean INR at 3 (P = 0.0001) and 6 hours (P <0.0001) 
and received fewer units of FFP transfusion (3 vs. 5; P = 0.003).
Conclusions Recombinant FVIIa use in WICH is not associated with 
increased thromboembolic complications compared with FFP and 
vitamin K alone and may decrease the quantity of FFP use. A prospective 
randomized study is necessary to determine whether rFVIIa improves 
outcome of WICH.
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Introduction  There is great variation in practice and opinions 
regarding the safety in inserting central venous lines in patients with 
coagulopathy. The authors reviewed the medical literature reporting 
the incidence of complications (haemorrhagic and nonhaemorrhagic) 
following the insertion under ultrasound guidance of a central venous 
line.
Methods The authors searched the MEDLINE and Embase databases 
for relevant terms. The MEDLINE database (1950 to week 2 December 
2010) was explored with the terms central line, catheterization, 
coagulopathy, blood coagulation disorder, international normalized 
ratio, thrombocytopenia with their appropriate combinations and 
truncated terms. The Embase database (1980 to week 2 December 
2010) was searched with the terms central venous catheter, blood 
clotting disorder, thrombocytopenia, international normalized ratio, 
complications with their appropriate combinations and truncated 
terms. Both searches were limited to English language, humans and 
adults only.
Results We found 413 papers with the MEDLINE search strategy. After 
abstract review and critical appraisal, only fi  ve articles were deemed 
to be directly relevant to our question and of level of evidence high 
enough to be considered. These were included in our fi  nal summary 
table. The Embase search returned 257 papers, only one relevant but 
also a duplicate from the previous search.
Conclusions The retrieved studies seem to suggest that the insertion 
of central lines under ultrasound guidance do not require correction of 
haemostatic abnormalities prior to intervention. Rates of haemorrhage 
are low in patients with elevated prothrombin time, activated 
partial thromboplastin time, international normalized ratio or low 
thrombocyte count and appear to be closely related to the level of 
experience of the physician rather than the defects of haemostasis.
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Introduction Despite the evidence of perioperative hypercoagulability 
in cancer patients, there are no consistent data evaluating the extent, 
duration, and specifi  c contribution of platelets and procoagulatory 
proteins by in vitro testing. This study compared effi   cacy of haemo-
viscoelastography (HVG) versus thromboelastography for monitoring 
of coagulation imbalance.
Methods  A total of 536 patients undergoing open surgery for 
abdominal cancer received HVG, a viscoelastic test, which measures 
clot formation and includes information on the cellular as well as the 
plasmatic coagulation system. We examined the effi   cacy of a variety 
of coagulation tests. A complete coagulation screen activated clotting 
time (ACT), thromboelastography (TEG) and HVG were performed 
before surgery, at the end of surgery, and bemiparin anticoagulation 
monitoring on postoperative days 1, 2, 3, and 7. These were analyzed 
for the reaction time and the maximal amplitude (MA).
Results We calculated the elastic shear modulus of standard MA and 
HVG MA, which refl   ect the total clot strength and procoagulatory 
protein component, respectively. The diff  erence was an estimate of 
the platelet component. There was a l6% perioperative increase of 
standard MA, corresponding to a 49% increase of HVG MA (P <0.05) 
and a 79 to 85% contribution of the calculated platelet component 
to HVG MA. We conclude that serial standard thromboelastography 
and HVG may reveal the independent contribution of platelets 
and procoagulatory proteins to clot strength. Using multiple linear 
regressions, all coagulation, TEG and HVG variabilities were used to 
model postoperative hypercoagulation. Results showed that some 
components of the TEG failed to identify hypercoagulation (r  <0.2, 
P >0.75). However, three components of the routine coagulation 
assay, including the bleeding time, prothrombin time, and platelet 
count, could be modeled to show prolonged postoperative hyper-
coagulability (P <0.01). We conclude that all components of the HVG 
refl  ect postoperative coagulopathies; these results suggest that it may 
be useful in determining the coagulation status of cancer patients 
perioperatively.
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1 week after major cancer abdominal surgery, may be demonstrated 
by HVG. Hypercoagulability is not refl  ected completely by standard 
coagulation monitoring and TEG and seems to be predominantly 
caused by increased platelet reactivity.
P436
Overuse of coagulation parameter testing in critically ill patients
V Bibeau, F Lauzier, MN Cote, AF Turgeon
CHA-Hôpital de l’Enfant-Jésus, Université Laval, Quebec, Canada
Critical Care 2011, 15(Suppl 1):P436 (doi: 10.1186/cc9856)
Introduction The international normalized ratio (INR) is one of the 
most commonly ordered laboratory tests in the ICU. Recently, it was 
raised that laboratory tests are widely overused in critically ill patients. 
We hypothesized that most INRs are inappropriately ordered and could 
lead to inadequate frozen plasma (FP) transfusion.
Methods  We performed a retrospective cohort study in a 24-bed 
medical–surgical ICU of a Canadian teaching hospital. Patients with 
≥1 INR testing admitted between 1 January and 30 June 2009 were 
randomly selected. Admission diagnosis, APACHE II score, drugs 
aff   ecting coagulation, liver function, invasive procedures, recent 
or planned surgery, and recent or current bleeding were recorded. 
INRs ordered for warfarin adjustment were excluded. The primary 
endpoint was the proportion of inappropriate INRs, based on a blinded 
assessment of the clinical context by two independent investigators. 
Secondary endpoints were contributing factors to INR ordering and 
impact on FP transfusion. We used a standardized case report form. 
Inter-rater agreement was evaluated using weighted kappa. A third 
independent investigator resolved disagreement. We used the Student 
t and chi-square tests to compare continuous data and proportions. We 
obtained ethics approval.
Results We included 43 patients (mean age 61.9 ± 16.0, APACHE II 
score 20.0 ± 8.6, 53.5% males) admitted for nontraumatic bleeding 
(41.9%), respiratory failure (16.3%), trauma (11.6%), sepsis (11.6%) or 
other reasons (18.6%). A total of 208 INRs were analyzed, representing 
4.9 ± 4.2 INRs per patient. Twenty-fi  ve percent of INRs were ordered 
in the context of bleeding, 6.7% before and 22.1% after surgery, 4.8% 
before an invasive procedure and 3.8% for suspected liver dysfunction. 
A total 5.8% of INR were above the normal limit. Inter-rater agreement 
for INR inappropriateness was good (weighted kappa = 0.61, 95% CI: 
0.50 to 0.72). Thirty-one out of 43 (72.1%) patients had at least one INR 
ordered inappropriately. One hundred and twenty-four out of 208 INRs 
were inappropriate (59.6%, 95% CI: 52.8 to 66.0). Intravenous heparin 
was associated with inappropriate INR (RR = 1.47, 95% CI: 1.18 to 1.74). 
Patients with inappropriate INR had lower APACHE II score (16.9 ± 9.4 
vs. 22.8 ± 6.9, P = 0.002) and were less likely to receive vasopressors 
(25.0% vs. 65.2%, P = 0.008). No inappropriate INR was followed by FP 
transfusion.
Conclusions Nearly 60% of INR orders were inappropriate. Patients on 
i.v. heparin, not on vasopressors, and with low APACHE II score were 
more likely to have inappropriate INRs. Despite no FP transfusion 
following inappropriate INRs, rationalizing INR testing is warranted to 
decrease associated costs and resource utilization.
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Introduction It is known that deep vein thrombosis of lower extremities 
and pulmonary embolism occupies an important place in the structure 
of postoperative morbidity and mortality.
Methods  After ethics approval and informed consent, we studied 
the functional state of hemostasis in a group of 40 healthy volunteers 
who were not receiving drugs aff  ecting coagulation and in 37 patients 
with postphlebothrombotic syndrome (PPTS). In patients with 
PPTS we conducted baseline studies of coagulation state and daily 
monitoring of dynamic changes in the functional state of hemostasis, 
a comparative evaluation of performance low-frequency piezoelectric 
vibration hemoviscoelastography (LPVH) and the platelet aggregation 
test (PAT), standard coagulation tests (SCT), and thromboelastogram 
(TEG).
Results It was found that the LPVH correlated with SCT, PAT and TEG. 
However, our proposed method is more voluminous: indexes ICC (the 
intensity of the contact phase of coagulation), t1 (the time the contact 
phase of coagulation), and A0 (initial rate of aggregation of blood) 
were consistent PAT indexes; indexes ICD (the intensity of coagulation 
drive), CTA (a constant thrombin activity) and CIP (the clot intensity of 
the polymerization) for SCT and TEG. In addition, the advantage of this 
method is to determine the intensity of fi  brinolysis – with indicator IRLS 
(the intensity of the retraction and clot lysis).
Conclusions  LPVH allows one to make the total assessment of all 
parts of hemostasis: from initial viscosity and platelet aggregation to 
coagulation and lysis of clots, as well as their interaction. These data are 
objective and informative, as evidenced by close correlation with the 
performance of traditional coagulation methods.
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Introduction  To guide the administration of blood products, 
coagulation screening of trauma patients should be fast and accurate. 
Conventional coagulation tests (CCT) are frequently not useful in the 
initial assessment of multiply injured patients, due to the delay in 
availability of results. The purpose of this study is to determine whether 
Rapid thrombelastography (RapidTEG®) results in 15 minutes correlate 
with Kaolin TEG or CCT.
Methods A 6-month prospective observational study of adult patients 
with suspected multiple injuries was conducted at a Level 1 trauma 
center of a university hospital. TEG, RapidTEG®, and CCT (INR, aPTT, 
TT, fi   brinogen, platelet count) were performed within 10 minutes 
of the patient’s arrival. Physicians blinded to TEG/RapidTEG® results 
made the decision to transfuse based on clinical evaluation and prior 
threshold (cut-off  ) values for CCT. Cut-off   values for RapidTEG® were 
retrospectively assessed. Correlations between TEG and CCT and 
between TEG and RapidTEG® parameters were calculated, as well as 
sensitivity and specifi  city of CCT and RapidTEG® for any blood product 
transfused on day 1.
Results Seventy-six predominantly blunt trauma (96%, n = 73) patients 
comprised the dataset. The mean ISS was 18. Only weak correlation 
existed between CCT and relevant TEG parameters (r = 0.097 to 0.615). 
Strong correlation exists between Kaolin TEG and RapidTEG® for K, MA, 
G and LY30 (r = 0.844 to 0.988). At the predetermined cut-off   points 
for treatment in trauma, CCT demonstrated poor sensitivity. Cut-off   
points for RapidTEG® demonstrated good sensitivity and specifi  city: 
RapidTEG®: Rapid K (seconds) 1.2; 80.0%; 59.2%; 0.785 (cut-off  ; 
sensitivity; specifi  city; AUC), Rapid angle (°) 74.7; 84.0%, 56.9%; 0.765, 
Rapid MA (mm) 61.5; 72.0%; 71.4%; 0.745. CCT: TT (seconds) 15; 28.6%; 
88.9%; 0.529, aPTT (seconds) 60; 4.8%; 97.8%; 0.735, INR 1.5; 19.0%; 
96.0%; 0.730.
Conclusions In this study of severely injured blunt trauma patients, 
RapidTEG® can be utilized in lieu of kaolin TEG to provide faster test 
results. Cut-off   points for treatment can be determined with RapidTEG® 
to provide improved sensitivity and specifi  city compared with CCT with 
respect to blood product transfusion.
Critical Care 2011, Volume 15 Suppl 1 
http://ccforum.com/supplements/15/S1
S154P439
Eff  ect of hypothermia on coagulation functions in Sprague–Dawley 
rats with uncontrolled hemorrhagic shock
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Introduction  Acute coagulopathy, hypothermia, and acidosis are 
known as the lethal triad of major trauma patients. Major trauma 
patients with hypothermia and acidosis developed clinically signifi  cant 
bleeding despite adequate transfusion [1]. Recent animal experiment 
studies reported that hypothermia is associated with improved survival 
in controlled hemorrhagic shock [2,3]. Post-traumatic hypothermia is 
an unproven therapy unlike hypothermia as a postcardiac arrest care. 
The objective of this study was to investigate the eff  ect of hypothermia 
on coagulation function in uncontrolled hemorrhagic shock with major 
trauma.
Methods Thirty-two male Sprague–Dawley rats were divided into four 
groups randomly: Group 1 with normothermia (control, 37 to 38°C); 
Group 2 with hypothermia (33 to 34°C on rectal temperature); Group 
3 with hypothermic hemorrhagic shock; Group 4 with normothermic 
hemorrhagic shock. Hemorrhagic shock was induced by splenic 
laceration or blood shedding. Coagulation functions were measured by 
rotation thrombelastometry (ROTEM®). The clotting time, clot formation 
time (CFT), and maximum clot fi   rmness (MCF) were measured at 
baseline, after 1 hour shock, and after 1 hour resuscitation. They were 
compared among the four groups using the Kruskal–Wallis test with 
Bonferroni correction, and the Friedman test was used to detect the 
diff  erences in the repeated measures in the same group, taking P <0.05 
as a signifi  cant level.
Results  No signifi  cant  diff   erences showed among the groups at 
baseline. CFT after the shock period of group 2 was longer than that 
of group 4. MCF after resuscitation of group 2 was higher than that of 
groups 3 and 4. When the factors were compared as a time process, 
CFT and MCF after shock and resuscitation of group 3 decreased 
signifi  cantly compared with baseline. Four in group 3 and two in group 
4 died during 48 hours of observation.
Conclusions  Although it took a shorter time to form a clot in 
normothermic shock compared with hypothermia, clot fi  rmness 
was poorer in hemorrhagic shock. In addition, clot fi  rmness  was 
signifi  cantly worse in the shock period and after resuscitation in the 
hypothermic shock group. Only hypothermia does not deteriorate 
coagulation, but hypothermia combined with hemorrhagic shock 
deteriorates coagulation.
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Introduction Thrombocytopenia is a prognostic marker in the critically 
ill population [1], aff  ecting, indistinctly, patients presenting low platelet 
count on admission or developing it during their stay in the ICU. It has 
been shown that a drop in platelet count to ≤50% of admission is 
associated with high death rates [2]. We aimed to observe the outcome 
of thrombocytopenic septic patients in our ICU.
Methods A retrospective observational cohort study in an 11-month 
period (August 2009 to July 2010) in an eight-bed medical–surgical 
ICU at a university hospital. This study included patients who fulfi  lled 
the criteria for sepsis as defi  ned in the Surviving Sepsis Campaign 
and excluded those who spent less than 24 hours in the ICU. 
Thrombocytopenia (T) was defi  ned as platelet count  <150 x 109/l, 
recovering thrombocytopenia (RT) platelet count returning to >150 
x 109/l and not recovering thrombocytopenia (NRT) platelet count 
consistently  <150 x 109/l. We focused on the demographic data, 
APACHE II score, platelet count on admission, platelet count during 
stay and platelet count at the time of discharge from ICU. The primary 
outcome was ICU mortality.
Results Complete data were available for 62 patients. Six were excluded. 
Twenty-eight males (50%), mean age 58 years (12 to 88 years), median 
APACHE II score 16.7 (interval 2 to 37). During the sepsis course 34 
patients (60.7%) developed T, 15 (44.1%) had a drop in platelet count 
to <50% of admission and NRT occurred in 18 (53%). Mortality in the T 
group was 76.4% (RR = 1.9; 95% CI = 1.17 to 2.74; P <0.01), in platelet 
count drop to  <50% of admission group it was 93.3% (RR  =  1.47; 
95% CI = 1.02 to 2.2; P <0.05), and in RT patients 50% survived to be 
discharged from the ICU. In the NRT group the mortality was 100% 
(RR = 2; 95% CI = 1.3 to 3; P <0.001) while in nonthrombocytopenics 
the total mortality was 40.9% (P <0.01). In T group patients the APACHE 
II score did not predict accurately the mortality risk. In both APACHE II 
groups (>22 (P = 0.007) or <22 (RR = 1.7; P = 0.05)) thrombocytopenia 
was highly associated with death. The ICU overall mortality in this 
period was 32%.
Conclusions  Thrombocytopenia – and its behavior – is a simple 
prognostic marker for ICU mortality independently of and comple-
mentary to established severity of disease scores. For septic patients 
thrombocytopenia is bad, not recovering thrombocytopenia is worse.
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Introduction  The prognostic signifi   cance of thrombocytopenia in 
critically ill patients has not been thoroughly explored. Our study 
aimed at investigating the incidence of thrombocytopenia among 
ICU patients, its association with ICU-acquired infection and its clinical 
impact on ICU mortality.
Methods All patients admitted to the ICU were prospectively followed 
with daily platelet (PLT) count measurement until ICU outcome. 
Thrombocytopenia was defi  ned as PLT count lower than 150,000/mm3 
and severe thrombocytopenia as PLT count lower than 20,000/mm3. 
Data were analyzed with one-way ANOVA and logistic regression with 
statistical signifi  cance set at P <0.05.
Results We studied 169 consecutive patients (119 males, 50 females) 
aged (mean ± SD) 53.4 ± 19.8 years, with admission APACHE II score 
22.7 ± 5.3. Thrombocytopenia during ICU stay was recorded in 101 
patients (59.8%). Emergency surgical and trauma patients displayed 
the highest incidence of thrombocytopenia (77.3% and 72.1%, 
respectively). Emergency surgical and medical patients displayed the 
highest of severe thrombocytopenia (18.2% and 10.6%, respectively). 
Trauma and emergency surgical patients developed thrombocytopenia 
earlier during the ICU stay (that is, after 4.9 and 5.1 days, respectively) 
compared with medical and elective surgical patients (that is, after 13.3 
and 10.9 days, respectively) (P = 0.001). Thrombocytopenia was more 
often recorded in patients with ICU-acquired infection compared with 
patients without infection. In particular, severe thrombocytopenia 
was recorded in 18.9% of patients with bloodstream infection and 
9.0% of patients with other ICU-acquired infection. ICU mortality was 
signifi   cantly higher in patients who developed thrombocytopenia 
compared with patients with normal PLT counts throughout the ICU stay 
(30% vs. 9.4%, P = 0.002). In a logistic model adjusted for age, gender, 
admission diagnosis, admission APACHE II score and the occurrence 
of ICU-acquired infection, thrombocytopenia was independently 
associated with ICU mortality (P = 0.017) and the degree of PLT count 
decrease signifi  cantly increased the ICU mortality in a dose-dependent 
manner; that is, odds ratios of 3.4 for PLT 100,000 to 150,000/mm3, 3.5 
for PLT 50,000 to 100,000/mm3, 14.9 for PLT 20,000 to 50,000/mm3 and 
25.2 for PLT below 20,000/mm3.
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of ICU patients. Although the time of occurrence and the degree of 
PLT count decrease varied, refl  ecting a wide spectrum of pathogenic 
mechanisms, thrombocytopenia was independently associated with 
ICU mortality in a dose-dependent manner.
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Introduction Thrombocytopenia is a common problem in the ICU, 
considered to be associated with increased morbidity and mortality. 
Risk factors for sepsis-induced thrombocytopenia have not been yet 
specifi  ed. Our study focuses on its development and consequences in 
the general ICU.
Methods A prospective observational study was conducted including 
all cases of sepsis for a 2-year period. Data on demographics, primary 
diagnosis and source of infection, current infectious pathogens, 
presence/severity of shock and outcome were cross-tabulated 
according to the presence and severity of thrombocytopenia. Eff  ects 
of immunotherapy and substitution with thrombocyte concentrate on 
outcome were also tested. Analyses of disease prescription, length of 
ICU stay (LOS), severity and dynamics of organ dysfunction/disease/
systemic infl  ammation (serum creatinine levels, SOFA, SAPS II, SIRS, 
lung injury score) for each group of patients was performed.
Results The study included 118 patients with thrombocytopenia of 
variable severity (39.33% out of 300 septic patients). The following 
independent prognostic factors for supervening thrombocytopenia 
(reported with respective RR and 95% CI) were identifi  ed: platelet 
count  <150 g/l – prescription >48 hours (1.31; 1.02 to 2.67), SOFA 
score on inclusion >6 (1.36; 1.02 to 1.78), ΔSOFA >5 (2.77; 2.17 to 3.50), 
initial SAPS II exp. score >5.5 (1.39; 1.04 to 1.82), LIS >1.75 (1.56; 1.13 to 
2.19), serum creatinine >122 μmol/l (2.38; 1.72 to 3.36), Gram-positive 
infectious pathogen, especially if Gram-positive co-infection or if 
concomitant invasive candidiasis (1.44, 1.08 to 1.94; 1.9, 1.33 to 2.46 
and 2.60; 1.31 to 3.02), Streptococcus spp. infection (2.04; 1.17 to 2.64), 
disruption of the lower GIT (1.48; 1.06 to 1.97), polytrauma (0.39; 0.22 
to 0.65); and platelet count <20 g/l – urosepsis (6.53; 1.76 to 16.96), 
soft tissue infection (9.87; 2.75 to 22.07), initial SAPS II exp. score >6.2 
(4.90; 2.02 to 11.71), SOFA score on inclusion >8 (6.52; 2.68 to 15.04), 
female sex (1.74; 1.13 to 2.26). Mortality was signifi  cantly higher for the 
thrombocytopenic patients (66.95% vs. 41.76%, P = 0.000), except for 
those who underwent specifi  c therapy (37.5%, P = 0.000).
Conclusions New insight was gained into the prediction of imminent 
sepsis-induced thrombocytopenia. Applied immunotherapy and 
substitution therapy for the most severely but early identifi  ed 
thrombocytopenic patients contributes to the inadvertently reduced 
mortality within this group.
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Introduction  Early diagnosis of sepsis and its diff  erentiation from 
non-infective SIRS is very important. The links between infl  ammation 
and coagulation play an important role in the SIRS/sepsis process. We 
investigated hematological and biochemical parameters (including 
thromboelastography (TEG)) in patients after surgical resection of 
esophagus. The aim of our project was to fi  nd out whether there are 
any changes in these parameters that could help in diff  erentiation 
between SIRS and sepsis.
Methods  In our study we enrolled 38 patients (aged 41 to 74) 
undergoing esophagectomy. Blood samples were obtained in the 
morning before the operation and then every 24 hours for the next 
6 postoperative days (POD). Blood samples were analysed for the 
following parameters: procalcitonin (PCT), C-reactive protein (CRP), 
IL-6, aspartate transaminase (AST), lactate, white blood count (WBC), 
D-dimers, antithrombin (AT), international normalised ratio (INR), 
activated partial thromboplastin time (APTT) and parameters of TEG.
Results Nine patients developed sepsis within 6 postoperative days. 
Five of them had pneumonia and in four patients the cause of sepsis 
was dehiscention of gastroesophageal anasthosmosis. Signifi  cant 
diff   erences between patients with SIRS and patients with sepsis 
were found in the following parameters: 0-day (before operation): no 
signifi  cant diff  erences; POD 1: diff  erences in AST (P <0.002) only; POD 
2: AST (P <0.003), lactate (P <0.006), D-dimers (P <0.02), PCT (P = 0.03), 
IL-6 (P  <0.03), WBC (P  <0.03); POD 3: AST (P  <0.03), PCT (P  <0.02), 
IL-6 (P = 0.006), CRP (P <0.04), WBC (P <0.05); POD 4: AST (P = 0.006), 
PCT (P = 0.007), IL-6 (P <0.02), CRP (P = 0.03), D-dimers (P <0.05), INR 
(P  =  0.03); POD 5: PCT (P  <0.003), IL-6 (P  <0.04), CRP (P  <0.04), AT 
(P = 0.03); and POD 6: PCT (P = 0.0001), CRP (P <0.013), WBC (P = 0.03), 
TEG-LY30 (P <0.04).
Conclusions  Sequential measurement of biochemical and hemato-
logical parameters, mainly AST, PCT, IL-6, WBC, CRP and D-dimers, can 
help in early diagnosis of sepsis in patients after extensive operation 
such as esophagectomy. On the contrary, TEG does not seem to be 
helpful in diff  erentiation of SIRS/sepsis during the early postoperative 
period. However, it seems to be useful after the fi  fth postoperative day.
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Introduction  Thromboelastography (TEG) is a global test of 
coagulation that records the viscoelastic changes in blood during clot 
formation. Cardiosurgery and liver transplantation are established 
fi  elds of application for TEG. Severe sepsis is often characterized by 
an imbalance of the haemostatic equilibrium between clot formation 
and fi  brinolysis in favor of a procoagulant status, especially in the fi  rst 
phase. A hypocoagulant status due to coagulation factor consumption 
could occur later. In spite of this, the correlation between TEG and 
sepsis is not clearly established. Moreover, there are doubts about 
which TEG-detected variable is best correlated with sepsis. The aim of 
this study is to clarify this correlation.
Methods We enrolled 62 patients in an observational study: 31 severe 
sepsis (ACCP/SCCM sepsis criteria plus two organ dysfunction at least) 
and 31 postoperative patients (without sepsis criteria), all admitted to 
our ICU. Patients with primary hematologic dysfunction/malignancy 
were excluded. The SOFA score was registered before enlistment. We 
obtained a 5 ml whole blood sample into a citrate 0.15 M test tube 
within 12 hours of diagnosis in the sepsis group or surgery in the 
postoperative group from each patient. A sample of 340 μl blood were 
extracted from each sample and put into a heparinase cup; coagulation 
was initiated with the addition of 20 μl CaCl 0.2 M. All of the tests were 
performed by Haemoscope® TEG5000. According to TEG analysis, r, 
k, α-angle, MA, G, A, lysis 30 and coagulation index were compared 
between the two groups using the t test.
Results The mean age in the sepsis group was 59.8 whereas it was 62.2 
in the postoperative group. The SOFA score was statistically diff  erent 
between the two groups (t = 3.359; P = 0.0015), being higher in the 
sepsis group. The α-angle parameter was found to be statistically 
signifi  cant higher in the postoperative group than in the sepsis group 
(t = 2.240; P = 0.0288). No signifi  cant diff  erences were founded between 
the other TEG parameters.
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parameters between severe sepsis and postoperative patients apart 
from the α-angle, which seems to be lower in the fi  rst group. The 
α-angle is supposed to be high in the procoagulant state; our result 
could be thought of as linked to the late phase characterizing our 
severe sepsis group wherein factor consumption coagulopathy could 
occur.
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Introduction It is known that red blood cells are involved in hemo  stasis. 
They can support and improve coagulation in diff  erent ways. Therefore 
recommendations are given for red blood cell transfusions in anemic 
patients with massive bleeding to reach a hemoglobin concentration of 
8 to 10 g/dl. Although blood transfusions can be life-saving, a number of 
negative or even potentially life-threatening eff  ects are described.
Methods In this study we investigated the eff  ect of anemia on platelet 
function and plasmatic hemostasis with two diff  erent point-of-care 
methods: the multiple electrode aggregometry Multiplate® (MEA) and 
the rotational thrombelastometry ROTEM®. Blood was taken from 13 
healthy volunteers to arrange in vitro anemia-series with 10, 7 and 3 
g/dl hemoglobin. For the MEA we applied the agonists collagen, 
arachidonic acid, adenosine diphosphate (ADP), thrombin-receptor-
activating peptide (TRAP) and ristocetin. For the ROTEM® analysis we 
used the tests EXTEM, INTEM and FIBTEM.
Results The MEA showed signifi  cantly increased velocity of platelet 
aggregation in anemic blood samples. The agonists TRAP and ADP 
demonstrated the highest eff  ects. The Aggregation Units and the area 
under the curve were not infl  uenced by anemia. The ROTEM® analysis 
displayed signifi   cantly an amplifi   ed maximum clot fi  rmness  (MCF), 
a shortened clot formation time (CFT) und an increased α-angle. The 
CFT and lysis index at 30 minutes did not show any changes through 
lowering hemoglobin. The calculated eff  ect of platelets on ROTEM® 
coagulation (MCFplatelet = MCFEXTEM – MCFFIBTEM) was unchanged.
Conclusions  In our study platelet function in anemic blood was 
observed with the MEA for the fi   rst time. Our results showed 
accelerated platelet aggregation through lowering hemoglobin. Our 
fi  ndings of a hypercoagulable profi  le in ROTEM® are in accordance with 
earlier observations. Future clinical studies are needed to evaluate risk 
of bleeding or hypercoagulability in anemic patients.
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Introduction The combination of acidosis, hypothermia and coagulo-
pathy is associated with high mortality in polytrauma [1]. Acidosis 
impairs coagulation [2]. Whether acidosis leads to a reduced platelet 
function has not so far been evaluated.
Methods In this in vitro study we evaluated the eff  ects of pH levels 
(7.6, 7.4, 7.2, 7.0 and 6.8) on platelet aggregation and coagulation with 
human whole blood of healthy male volunteers. We used multiple 
electrode aggregometry (MEA) Multiplate® (tests: ADP, ASPI, TRAP) 
for platelet function testing. The global coagulation was evaluated at 
pH 6.8 and 7.4 with ROTEM®, which is a rotational thrombelastometry 
(tests: NATEM and APTEM). The pH levels of the blood samples were 
achieved by titration of HCl and NaOH.
Results In MEA the AUC was signifi  cantly reduced for pH 7.0 and pH 
6.8 in all three tests (ADP, ASPI and TRAP), as well as aggregation and 
velocity. Platelet function was not infl  uenced by alkalosis (pH 7.6). In 
ROTEM® the AUC, CT, CFT and MCF showed no signifi  cant alterations. 
The α-angle and lysis index for 60 minutes were signifi  cantly reduced at 
pH 6.8. NATEM values were signifi  cantly diff  erent from those measured 
with APTEM.
Conclusions  In our study we evaluated a signifi   cant decrease of 
platelet function at pH 7.0 and 6.8 with MEA. The results of the analysis 
with the ROTEM® system showed a signifi  cant reduction of thrombus 
formation at pH 6.8, as described in the literature. In the APTEM test, we 
could identify hyperfi  brinolysis.
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Introduction Among infectious complications in patients with serious 
heat injury, the most dangerous is sepsis developing in the early 
stages of burn disease. Sepsis is characterized by a fulminant, severe 
course, complex diagnostics, and a high case fatality rate. Hemostasis 
system disorders are one of the key pathogenic links of organ failure 
development in sepsis.
Methods The hemostasis system condition was studied in 100 patients 
with over 20% of the body burned, from the fi  rst to 12th day after burn. 
Examined patients were divided into two groups: in the fi  rst group an 
acute period of burn disease was complicated by progress of sepsis (33 
patients), and in the second group complications in the form of sepsis 
were not observed. The groups of patients studied were balanced in 
age and severity of the disease. Sepsis was diagnosed on the basis of 
clinical, laboratory and bacteriological fi  ndings, as well as confi  rmed by 
morphological studies in casualties. The control group consisted of 130 
apparently healthy people.
Results Comparative analysis of hemostasis system disorders in severe 
burn patients with early sepsis and those without similar complication 
showed that the progress of generalized infection in the acute period of 
burn disease is accompanied by reliable decreased activity of antithrombin 
III, XIIa-dependent fi  brinolysis, blood plate count, and prothrombin time 
prolongation. There were no diff  erences revealed between the studied 
groups of severe burn when determining fi  brinogen content, soluble fi  brin 
monomeric complexes, activated partial thromboplastin time, thrombin 
clotting time and echitox time, and the test revealing fragmented 
erythrocytes. Correlation analysis showed that the most contingency 
between progress of sepsis and hemostasis system data was noted on the 
third to fourth days after burn (with decreased activity of XIIa-dependent 
fi  brinolysis (r = 0.58, P <0.0001), antithrombin III (r = –0.57, P <0.0001), 
prothrombin time (r = 0.49, P <0.0001) and thrombocytopenia (r = –0.48, 
P <0.0001)). On the basis of a retrospective analysis of case histories of 
severe burns with verifi  ed generalized infection, it was determined that the 
development of an acute form of DIC syndrome manifesting in a marked 
imbalance of coagulation and anticoagulative blood mechanisms as well 
as severe hepatorenal failure has a lead time of 1 to 8 days in revealing 
sepsis in the clinic.
Conclusions Hemostasis system disorders corresponding to an acute 
form of DIC syndrome not only accompany the progress of sepsis in 
severe burn but can be an indirect predictor of its development.
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Introduction The muscular compartment syndrome (MCS) is consecu-
tive to an increase in intramuscular compartment pressures [1]. 
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spectroscopy (INVOS) monitors tissular oxygenation continuously and 
non-invasively. Our objective was to develop a model mimicking the 
physiopathology of MCS and to assess the interest of the INVOS in this 
case [1-3].
Methods  After approval of the ethics committee, we infl  ated  a 
tourniquet in nine healthy volunteers at a pressure equal to the mean 
arterial pressure (MAP), obtaining a model of slight venous congestion 
and arterial hypoperfusion. The INVOS monitoring was compared with 
sensory defi  cits, pain, motor activity, electromyography and invasive 
pressure.
Results A profound motor nerve conduction block (>30% decrease 
in action potential amplitude from baseline) was observed in the 
seven volunteers completing the protocol, immediately reversible 
after releasing the external pressure. At baseline, the values of MAP, 
INVOS and intracompartmental pressure (ICP) were respectively 
94.3 ± 6.5 mmHg, 73.3 ± 8.9% and 16.9 ± 8.6 mmHg. At the time 
of appearance of a signifi   cant block, the values of INVOS were 
46.4 ± 10.9%; the absolute decrease of INVOS was 28.7 ± 10.6% and 
the ICP values were 70.0 ± 5.5 mmHg. The times to reach this signifi  cant 
block from baseline and from the time of an absolute INVOS decrease 
of 10% were respectively 33.0 ± 10.9 minutes and 27.43 ± 10.4 minutes 
(Figure 1).
Conclusions Our model is appropriate since it mimics perfectly MCS 
[3]. The time after achieving an absolute decrease of the INVOS value 
of 10% from baseline is as accurate as the time of intracompartmental 
hyperpression to predict MCS (Figure 2).
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Introduction Sepsis has several eff  ects on microcirculation, including 
microthrombosis, interstitial edema and reduced reactivity of arteriolar 
tone leading to shunt areas [1]. Little is known about the eff  ects 
of sepsis on the venous component of microcirculation. Changes 
of venular compliance and volume of the venular bed may aff  ect 
cardiac preload, which has a key role in occurrence of cardiac failure. 
Near-infrared spectroscopy (NIRS) is a widely used, non-invasive 
technique that enables one to quantify the tissue oxyhemoglobin and 
deoxyhemoglobin (Hb) concentration, through which microvascular 
blood fl  ow, compliance and oxygen consumption can be extrapolated 
[2]. The aim of our study was to evaluate the eff  ects of sepsis on venous 
compliance and volume of the venular bed.
Methods Seven ICU patients with sepsis (according to ACCP/SCCM 
criteria [3]) and seven healthy subjects were studied. NIRS data were 
collected during several venous compressions at 20 to 30 to 40 mmHg. 
The venular bed volume increase at 20 mmHg was obtained from the 
total Hb concentration increase. Venular compliance was calculated as 
the volume increase and pressure infl  ated ratio. Results expressed as 
mean values ± SD for compliance and volume. The Mann–Whiney U 
test was performed to compare values in patients and controls.
Results The mean venular bed volume increase in the sepsis group was 
3.32 ± 0.90 ml while in controls it was 7.80 ± 4.24 ml (P <0.05). Venous 
compliance was signifi  cantly lower in the sepsis group compared with 
the control group (0.17 ± 0.06 ml/mmHg*l vs. 0.44 ± 0.10 ml/mmHg*l; 
P <0.05).
Conclusions Sepsis aff  ects the venous component of microcirculation 
by decreasing venular compliance and volume of the venular bed. 
This might be caused by a real decrease of venular bed volume, due 
to microthrombosis, or by an increase of venular tone. However, the 
clinical relevance of our fi  ndings is not known, and further studies are 
needed.
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Introduction  Seventy-fi   ve percent of ICU mortality after the fi  rst 
72 hours following major trauma is due to multiple organ dysfunction 
syndrome (MODS) [1]. How to follow this evolution is not completely 
understood yet and new parameters are still needed. The aim of 
this study was to evaluate the eff  ects of polytrauma on sublingual 
microcirculation and to search correlations among it, Sequential Organ 
Failure Assessment (SOFA) score and biochemical markers and to use 
these factors for monitoring patients [2].
Methods  This prospective study included 12 patients. Sublingual 
micro  circulation has been registered using sidestream dark fi  eld 
imaging and analysed with AVA software, searching for indices of 
Figure 1 (abstract P448).
Figure 2 (abstract P448).
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parameters, hemocoagulation indices, cytonecrosis criteria and 
hypoperfusion measures have been evaluated at admission and 
every 48 hours, for a minimum of 96 hours, and correlation between 
these and microcirculatory parameters has been researched. We then 
evaluated the discriminating capacity of these parameters versus 
microcirculatory indices, calculating the area under the ROC curve.
Results No correlation was found between microcirculatory indices 
and the others. The following parameters had good discriminating 
capacity: SOFA-platelets (area = 0.745), total-SOFA (0.724) and D-dimer 
(0.670) for perfused vessel density (PVD) values; Hb (0.693) and SOFA 
platelets (0.714) for total vessel density (TVD); myoglobin (0.680), 
lactate (0.732) and total-SOFA (0.703) for microcirculatory fl  ow index 
(MFI). See Figures 1 and 2.
Conclusions  Even in polytrauma, microcirculatory dysfunction is 
important for MODS appearance, and its analysis (PVD, TVD, De Backer 
score, MFIs) can help to evaluate this evolution, according to biochemical 
markers and severity index: joined with macrohaemodynamic indices, 
they allow one to better investigate organ features.
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Introduction A retrospective analysis based on the data of the German 
Trauma Registry has shown a signifi  cant increase in the probability of 
survival in polytrauma patients submitted to whole body CT (WBCT). 
However, even when the CT is installed in the Emergency Department, 
the time required for positioning the patient for CT may signifi  cantly 
prolong the duration of CT diagnosis.
Methods Our hospital is a level 1 trauma center with a catchment 
population of 2.5 million; there are two CT scans in the ED. All severely 
injured patients are submitted to US on admission. WBCT is performed 
as the fi   rst-line radiologic investigation in haemodynamic-stable 
patients or in unstable patients with negative abdominal US and 
without a clear source of bleeding. Unstable patients with severe head 
trauma and lateral signs are also submitted to CT. To evaluate whether 
the use of CT in the severely unstable patients brings a signifi  cant delay 
in emergency surgery, we retrospectively analyzed all early trauma 
death from January 2009 to November 2010.
Results  Seven hundred severe trauma patients (ISS >15) were 
brought in alive. Thirty-eight (5.4%) died before ICU admission: 21 
died in the shock room before any surgical intervention. One patient 
was submitted to thoracotomy and laparothomy in the shock room 
and died. One more died on the CT table. The remaining 15 patients, 
severely hypotensive, were alive on admission to the OR. One of them 
was brought directly to the OR with no investigation because of massive 
bleeding from the extremities. The others had US on admission. US was 
the only investigation for seven of them; they all had a positive US 
showing important bleeding in the abdomen or in the chest. The other 
seven, who had no evidence of bleeding on the US, were submitted to 
WBCT. The mean time elapsed from hospital admission to OR entrance 
was 23 minutes (15 to 30 minutes) for patients who had only US and 
70 minutes (52 to 90 minutes) for the CT group. The seven patients 
who had only US were all submitted to shock room decompressive 
minithoracotomy (fi  ve bilateral) with the suspicion of pneumothorax.
Conclusions  Recent reports suggest implementation of multi-slice 
CT integrated into the resuscitation room, thus enabling resuscitation 
to be performed directly on the ER CT. Unless this new technology 
is adopted, even the ED-based CT still needs excessive time to be 
performed in most unstable patients. In a cohort of patients who 
eventually died in the OR, a diagnostic process including ED-based 
WBCT was associated with a threefold increase in the time needed from 
hospital admission to surgery.
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Introduction Traumatic events are one of the major causes of arterial 
injuries. Physical examination is not a good predictor of these injuries 
and arteriography is considered the gold standard for this purpose. 
In recent years, non-invasive modalities are increasingly replacing 
diagnostic arteriography. Duplex ultrasonography is an excellent 
method for investigation of arterial diseases. In this study, we analyze 
the diagnostic value of duplex ultrasonography in comparison with 
angiography in traumatic arterial injuries of the extremities.
Methods  Duplex ultrasonography was performed for patients 
with suspicious arterial injury due to extremity trauma just before 
angiography. The Doppler pattern and fl   ow states were obtained, 
then standard angiography was performed. The results of duplex 
ultrasonography were compared with angiography.
Figure 1 (abstract P450). ROC curve: discriminating capacity of D-dimer, 
SOFA-Plt, and SOFA-tot versus PVD.
Figure 2 (abstract P450). ROC curve: discriminating capacity of 
myoglobin, lactate and tot-SOFA versus MFIs.
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their extremities were investigated. Duplex ultrasonography had 95% 
sensitivity and 98% specifi  city in the diagnosis of arterial injury in this 
study.
Conclusions We suggest that duplex ultrasonography can be used 
as a reliable tool, both sensitive and specifi  c, in screening of hemo-
dynamically stable patients with suspicious limb arterial injury.
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Introduction VAP is associated with high mortality in trauma patients. 
However, detailed data on the prediction of VAP in such patients 
are limited. We therefore conducted a retrospective study aimed at 
developing a VAP predictive scoring system for trauma patients.
Methods We retrospectively analyzed 187 consecutive patients with 
trauma who were ventilated for more than 72 hours between April 
2006 and April 2010. VAP was diagnosed by CDC criteria. Patients 
were divided into the VAP group and non-VAP group and their clinical 
and laboratory data were compared by univariate analysis using the 
chi-square and Mann–Whitney U tests. Multivariate analysis using the 
stepwise method was used to identify predictors of VAP.
Results Victims of blunt trauma accounted for 90.9% of the sample 
population. The median age of the patients was 50 (32 to 67) years, the 
median injury severity score (ISS) was 29 (22 to 32), and the hospital 
mortality rate was 12.3%. Seventy patients were assigned to the VAP 
group (27.5/1,000 mechanical ventilator-days) and 117 to the non-VAP 
group. The independent predictors for VAP were thoracic cage trauma 
(odds ratio (OR) 2.5 (P = 0.02; 95% confi  dence interval (CI): 1.1 to 5.5)), 
history of chronic heart failure (CHF; OR 8.9 (P <0.01; 95% CI: 2.4 to 
33.0)), chronic obstructive pulmonary disease (COPD; OR 5.9 (P <0.01; 
95% CI: 1.9 to 18.3)), muscle relaxant (MR) use (OR 5.2 (P <0.01; 95% CI: 
1.7 to 15.3)), tracheal intubation (TI) in the prehospital setting (OR 4.7 
(P <0.01; 95% CI: 1.8 to 12.4)), use of a nasogastric (NG) tube (OR 6.5 
(P <0.01; 95% CI: 2.7 to 15.4)), cervical vertebrae external fi  xation (CVEF; 
OR 9.0 (P <0.01; 95% CI: 2.2 to 36.7)), and ISS >25 (OR 5.0 (P <0.01; 95% 
CI: 1.8 to 13.7)). Based on these results, we developed a VAP predictive 
scoring system. The following simplifi  ed clinical risk assessment tool 
was developed from the results of multivariate analysis, with scoring 
based on a cut-off   point related to the adjusted odds ratio. VAP score: 
thoracic cage trauma = 2 points, CHF = 8 points, COPD = 5 points, MR 
use = 5 points, TI in the prehospital setting = 4 points, NG tube = 6 
points, CVEF = 9 points, ISS >25 = 5 points. The area under the receiver 
operating characteristic curve for VAP in this scoring system was 
0.847 (P <0.001; 95% CI: 0.79 to 0.90). The cut-off   value for this score 
according to the sensitivity specifi  city curve in relation to VAP was 15 
points. Sensitivity was determined at 91.1%, and specifi  city 74.5%.
Conclusions The simple predictive scoring system developed for VAP 
in trauma will help physicians in the planning of early patient care.
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Introduction  Improvements in trauma care are driven by an 
understanding of the patient population and their outcome after injury. 
In order to achieve this, many centres submit data to trauma registries. 
This process relies on accurate and comprehensive documentation. 
The aim of this study was to evaluate whether the introduction of a 
standardised proforma for major trauma patients improved the quality 
of documentation in an urban Emergency Department (ED).
Methods In September 2010 a proforma was introduced within the ED 
for use in patients presenting after major trauma. Prior to this, clinical 
documentation for these patients was recorded on the standard ED 
record. The last 30 patients attending the ED prior to introduction of 
the proforma, with major injuries requiring admission to a critical care 
bed or the operating room, were identifi  ed. In addition, 15 completed 
proformas were available for comparison. In order to set a standard for 
this comparison, the Utstein template for uniform reporting of data 
following major trauma [1] was examined to identify core variables that 
should reasonably be recorded in the ED. Of 31 variables, 23 were felt 
to be relevant. The ED record or proforma for each patient was then 
scrutinised in an attempt to extract these variables. A comparison was 
made between the two groups.
Results In those attending prior to the introduction of a proforma, 
the mean number of variables identifi  able from the clinical record was 
12/23 (52%); after the introduction of the proforma this improved to 
20/23 (87%). Several parameters were well documented amongst both 
groups including age, gender and those relating to mechanism of injury 
(accountable for 5/23 variables). These were identifi  able in greater than 
95% of cases. Use of the proforma improved the documentation of the 
remaining 18 variables, including base excess, level of prehospital care 
and fi  rst key emergency intervention. The most marked improvements 
were seen in the documentation of prehospital observations (GCS, 
GCS motor component, systolic blood pressure and respiratory rate). 
Among the pre-proforma group, 0/30 patients had a fully recorded set 
of prehospital care observations; this improved to 9/15 (60%) in the 
proforma group.
Conclusions Improvements in trauma care are reliant on our ability to 
audit current practice, this in turn relies upon robust data collection. In 
a busy and stressful resuscitation room this is easily over looked. The 
introduction of standard documentation improves the clinician’s ability 
to record such information.
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Introduction ELISA (Echelle Liégeoise d’Index de Sévérité à l’Admission) 
is a valid new Emergency Department (ED) triage algorithm including 
fi   ve levels of categorisation (from U1, high emergency degree, to 
U5, low degree), based on vital signs and selected anamnestic data. 
Previous work has demonstrated that ELISA evidenced a strong inter-
rater and intra-rater agreement [1]. In this study, we aimed at further 
evaluating its effi   ciency.
Methods From March 2008 to May 2008, we prospectively investigated 
545 consecutive admissions to study the potential correlation between 
ELISA score and impact on resource consumption as well as ED stay.
Resources were classifi  ed following three categories: complementary 
examinations (ECG, blood analysis, X-ray, and so forth), medical 
treatments (i.v. medications, casts, sutures, and so forth), and outcome 
after ED admission (discharge, hospitalisation, ICU admission or death). 
Each resource was considered a binary variable and was analyzed 
owing to four statistical tests: chi-square, Wald Wolfowitz, Kolmogorov–
Smirnov and Mann–Whitney.
Results Statistical analysis evidenced an eff  ect of ELISA score on the 
overall need for complementary examinations except for serology, 
X-rays and Holter ECG. The initial index severity had also related the need 
for urgent treatments. Outcomes were also signifi  cantly correlated with 
ELISA: the smaller the index, the bigger the number of hospitalisations, 
ICU admissions and deaths. This study demonstrates ELISA’s effi   ciency; 
when the initial severity index is close to U1, more complementary 
examinations are needed and more medical treatments are necessary. 
Wounds do not have a high emergency degree, which explains why 
there was no infl  uence of initial index severity on the realisation of 
sutures. The same reasoning is applied to X-rays that are frequently 
requested for light traumatic cases with low emergency degree. Finally, 
hospitalisation, ICU admission and death are more frequent when the 
ELISA score evidences the highest emergency degree.
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inter-rater and intra-rater agreement, the present study points out the 
potent effi   ciency of ELISA, allowing its further use in the ED.
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Introduction Current medical scores have limited effi   ciency and safety 
to assign the most appropriate treatment site to patients with lower 
respiratory tract infections (LRTIs) [1-4]. We describe our current triage 
practice and assessed the potential of a combination of CURB65 with 
proadrenomedullin (ProADM) levels for triage decisions.
Methods Consecutive patients with LRTIs were prospectively followed 
and retrospectively classifi  ed according to CURB65 and ProADM levels 
(CURB65-A). Low medical risk patients were further subgrouped 
according to biopsychosocial and functional risks. We compared 
proportions of patients virtually allocated to triage sites with actual 
triage decisions and assessed the added impact of ProADM in a 
subgroup.
Results Ninety-six percent of 253 patients were hospitalized. Among 
the 138 patients with available CURB65-A, 17.4% had low medical risk 
indicating possible treatment in an outpatient or nonacute medical 
setting; 34.1% had intermediate medical risk (short hospitalization); 
and 48.6% had high medical risk (hospitalization). Fewer patients 
were in a low CURB65-A class (I) than a low CURB65 class (0, 1) (17.4% 
vs. 44.6%, P  <0.001). Mean length of hospitalization was 9.4 days 
including 3.5 days after reaching medical stability. In 56.9% of patients, 
hospitalization was prolonged after medical stability mainly for 
medical reasons.
Conclusions Current rates of hospitalization are high in patients with 
LRTI and the length of stay frequently extended beyond time of medical 
stabilization. The lower proportion of patients reclassifi  ed as low risk by 
adding ProADM to the CURB65 score might improve confi  dence in the 
triage algorithm.
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Introduction Pain is one of the most common reasons why patients 
visit the Emergency Department (ED) and is a healthcare problem 
for patients [1,2]. The purpose of this study was to determine the 
agreement between patient self-reported pain intensity and nurse 
pain assessment in the ED.
Methods A purposive sample of 100 patients and 36 nurses in the 
triage and clinical area within the ED was selected from 5Azar Hospital 
in Gorgan. The questionnaire included two components: participant 
characteristics and the Numeric Rating Scale (NRS). A questionnaire was 
administered twice to each patient. In triage the patients were asked to 
rate their pain intensity. Separately, the nurses assessed the patient’s 
pain intensity. This process was repeated with the same patients after 
referring them to a clinical area within the ED, but the nurses were 
diff   erent. Gathered data were described by frequency distribution 
tables and analyzed by Wilcoxon, Mann–Whitney and Spearman tests. 
P <0.05 was considered signifi  cant.
Results  Most of the patients were male (61%), with mean age of 
39.16  ±  16.83 years. Fifty-four percent of the patients had chronic 
pain. Most of them had a diagnosis of abdominal pain and chest 
pain (61%). In the triage, the mean nurses’ pain intensity score was 
signifi  cantly lower than patients’ score (7.60 ± 2.1 vs. 9.13 ± 1.26), as 
signifi  cant diff  erences in mean scores were observed (P <0.001). In the 
clinical area, patients’ scores were also signifi  cantly higher than nurses 
7.36 ± 2.56 and 5.94 ± 2.33, respectively (P <0.001). Nurses signifi  cantly 
underestimated pain on the NRS. See Table 1.
Table 1 (abstract P457). Patients’ (n = 100) and nurses’ (n = 36) pain intensity 
scores
  Triage area  Clinical area  Total
Nurses  7.60 (2.1)  5.94 (2.33)  6.77 (2.36)
Patients  9.13 (1.26)  7.36 (2.56)  8.24 (2.20)
Correlation  r = 0.612  r = 0.373  r = 0.528
Data presented as mean (SD).
Conclusions  The fi   ndings have implications for the management 
of patients’ pain by highlighting the need for more accurate pain 
assessment. Further research is required to elucidate the way in which 
nurses and patients conceptualize pain and to understand better the 
process of pain assessment in clinical nursing practice.
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Introduction  Delayed admissions to the ICU from the Emergency 
Department (ED) may be associated with increase in mortality and 
morbidity [1]. We wanted to answer the following questions: is there an 
association between the timing of presentation to the ED and mortality; 
and is the time interval between the patient presenting to the ED and 
admission to the ICU associated with increase in mortality and morbidity?
Methods We collected the number of patients admitted from the ED 
to the ICU from April 2009 to March 2010. The time duration from the 
patient presenting to the ED and the patient admitted to the ICU was 
collected. We defi  ned any admission to the ICU more than 4 hours from 
the ED as delayed admission, as per the national standards. We assessed 
the APACHE score of the patient on admission, the length of stay in the 
ICU (LOS), relationship to the time of ED admission (either offi   ce hours 
08:00 to 17:00 or out of hours 17:01 to 07:59) and the hospital mortality 
associated with each admission.
Results We had 547 admissions to the ICU from the ED. There was no 
signifi  cant association between out of offi   ce admission to the ED and 
hospital mortality (OR = 0.858, 95% CI = 0.457 to 1.610) after adjustment 
for age and APACHE score. There was also no statistically signifi  cant 
diff  erence between patients that took more than 4 hours between 
ED and ICU, with respect to the hospital mortality (OR = 1.00 and 95% 
CI = 0.999 to 1.001). We performed a COX regression analysis to establish 
whether delays were associated with increased LOS, using age and 
APACHE as the covariates. There was no statistically signifi  cant association 
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95% CI = 0.934 to 0.962). There was no diff  erence between APACHE scores 
>25 and ICU admission delays (chi-square P = 0.897).
Conclusions There was no association between delay in ED to ICU 
admission on mortality or length of stay in the hospital. This might be 
due to the fact that the sick patients presenting in the ED are seen by 
a physician early, thereby leading to appropriate triage of the patient 
to the ICU. APACHE II scoring seems to be an independent variable and 
has a linear relation to the mortality and length of stay in the hospital.
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Case note and chart review of mortality in patients with a predicted 
low risk of death on admission to the ICU
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University Hospital Lewisham, London, UK
Critical Care 2011, 15(Suppl 1):P459 (doi: 10.1186/cc9879)
Introduction  The aim was to establish whether suboptimal care 
or system failures in the delivery of care contributed to mortality in 
patients admitted with a predicted low risk of death to our ICU.
Methods We defi  ned low risk of death as a predicted mortality of less 
than 20% based on either the ICNARC or APACHE II risk prediction 
models [1]. We reviewed the case notes and ICU charts of patients with 
a low risk of death admitted to our ICU during July to December 2008 
and April to September 2009.
Results  Seven hundred and fi   fty patients (799 admissions, 49 
readmissions) were admitted during the periods under review. The 
hospital mortality rate was 20.7% (155 patients) and of the 155 
nonsurvivors 29 patients had a predicted low risk of death. Case notes 
for fi  ve patients could not be obtained and notes and charts for 24 of 
the 29 patients were reviewed. Errors identifi  ed in data collection: in 
two patients, incorrect data collection was identifi  ed that may have 
underestimated the risk of death. Suboptimal care identifi  ed: in four 
patients (16.7%), fi  ve instances of suboptimal care or system failures 
in care delivery were identifi  ed – delay in obtaining investigations 
(one laboratory, one radiology) delayed defi   nitive treatment (two 
cases), delay in referring patient to the ICU (one case), elective surgical 
procedure caused bowel injury in a high-risk patient (one case), and 
delay in obtaining medical records caused the inappropriate admission 
of a patient to the ICU (one case). Patients with severe progressive 
illness: some patients were admitted with a low physiology score 
and low predicted risk of death but with a poor prognosis due to an 
underlying progressive illness.
Conclusions  A case note review of ICU nonsurvivors can identify 
areas where service delivery and patient safety can be improved. Four 
patients (16.7%) with alcoholic liver disease (ALD) died despite a low 
physiology score on admission. The increased incidence of ALD in our 
unit is in line with the national trend.
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Introduction  Effi     cient management of ICU patient turnover can 
signifi   cantly impact patient survival, medical expenses, overall 
satisfaction, and hospital operating expenses. Movement within a 
constrained healthcare delivery system is a dynamic and stochastic 
process that eludes traditional analysis and prediction tools. We 
hypothesized that simulation-based approaches allow for a better 
capture of the interaction between reality and policy, and therefore 
guide effi   cient ICU management. We developed a simulation process, 
modeling constrained hospital patient fl  ow in a tertiary care center 
and generated a cost-variance analysis derived from diff  erences in that 
patient fl  ow.
Methods This study consists of a retrospective analysis of a compre-
hensive sample of 3,518 patients admitted to the VA Pittsburgh Health 
System from 27 April 2010 to 3 November 2010. Patient movement 
data are extracted to produce a cohort dataset and time-series analysis 
of patients transitioning in the following units: the medical ICU (nine 
beds), surgical ICU (11 bed), coronary care unit (18 beds), step-down 
unit (nine beds), monitored medical (15 beds), monitored surgical (12 
beds), nonmonitored medical (44 beds) and surgical (19 beds). Cost 
data are extracted from the VAPHS annual budget review and cost 
allocation records for specifi  c patient units and levels of care. Blocking 
time is the diff  erence between time of assignment and movement to 
a specifi  ed location. Assignment diff  erence is the probability of being 
assigned to a location other than requested location. Cost variance 
is the diff  erence between cost allocations based on the standard of 
clinically indicated LOS and the cost allocations based on real LOS 
averaged per unit location.
Results  This model graphically depicts LOS rates, blocking times, 
assignment diff  erence rates, and cost variance. The worst blocking 
time is observed for monitored medical beds (44 hours) while the worst 
assignment diff  erence is observed for surgical monitored beds (0.55). 
The worst cost variance is recorded in the surgical ICU ($572,000). The 
total cost variance is $849,000.
Conclusions ICU fl  ow is a dynamic process aff  ected by constraints 
manifesting in large blocking times, assignment diff  erences  and 
signifi   cant cost variance. This novel fl   ow management tool could 
systematically and objectively aid managerial decision-making at both 
the unit and hospital levels.
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ICU readmission: good or bad?
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Introduction Patients requiring ICU management risk deterioration 
following discharge. Readmission to the ICU is used as a marker of 
performance [1] with some controversy [2]. It is established that 
higher APACHE II scores and longer length of ICU stay are associated 
with higher risk of ICU readmission [3]. However, there are no criteria 
available to identify those patients most likely to benefi  t  from 
readmission [4].
Methods Prospective data were collected on all patients admitted to 
a multidisciplinary adult ICU between 2001 and 2009 and entered into 
a computerised database. This included length of ICU stay, ICU and 
hospital outcomes, readmission to ICU and days prior to readmission. 
Data for all ICU admissions were analysed annually.
Results  There were 5,004 patients admitted during 2001 to 2009; 
1,315 (26%) were elective postoperative admissions and 3,689 
(74%) emergency admissions. The ICU mortality during this period 
was 15.8% and mean APACHE II score was 17.7 (1 to 55). There were 
299 readmissions (6%). The average time between discharge and 
readmission was 8.5 days (0 to 89) with a mean length of ICU stay of 
5.89 days (0.2 to 48.8). The average hospital mortality rate of readmitted 
patients was 33% and fell from 69% in 2003 to 24% in 2007. The 
proportion of readmitted patients increased from 3% (11) in 2001 to 
10% (68) in 2007. As the proportion of patients readmitted increased, 
the hospital mortality rates for all ICU admissions fell 10% from 31% in 
2001 to 21% in 2009.
Conclusions  As the number of patients readmitted has increased, 
hospital mortality of both readmitted patients and total ICU patients 
have fallen. Those readmitted have had a short length of stay (mean 
5.89 days).
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Introduction  The physical state of the patient before surgery is 
defi   ned by the American Society Anesthesiology (ASA) physical 
status classifi   cation system. The Simplifi   ed Acute Physiology Score 
(SAPS II) provides an estimate for the risk of intrahospital death for 
ICU patients. The Sequential Organ Failure Assessment (SOFA) score is 
used to monitor the patient’s condition during his/her stay in the ICU, 
assessing the extent of organ dysfunction or failure. Is the ASA physical 
status classifi  cation system a good prognostic index for determining 
postsurgical patient’s admittance to the ICU? What is the evolution of 
these patients? Could we predict the outcome of these patients?
Methods A retrospective analysis of the ASA, SAPS II and SOFA of 
all postsurgical patients admitted to an ICU, between 1 May and 31 
October 2010.
Results  Total ICU admissions: 323 patients, 118 being postsurgical 
patients (mortality: 12 patients – 10.17%). Maximum patient SOFA: 
between 0 and 19. Patient SAPS II: between 8 and 99. Of the 118 
patients, fi  ve had ASA 5, a mortality of 100% being expected but only 
three died. The expected mortality rate of the three deceased (SAPS II: 
58, 99, 80) was 5.2%, 92.5%, 98.4%, respectively. The two patients who 
got better had a SAPS II of 21 and 56 with a maximum SOFA of 4 and 16, 
which means that they improved signifi  cantly, against all odds. Most 
ICU admitted patients were ASA 3 and ASA 4. Fifty per cent of ASA 3 
patients presented a maximum SOFA between 0 and 5; maximum 
SOFA was higher in 34% of ASA 3 patients (5 to 10) with predicted ICU 
mortalities of up to 7% and 46%, respectively. Four patients of the ASA 3 
group died. Of the ASA 4 patients, 43% had a maximum SOFA between 
5 and 10, and 34% presented a lower maximum SOFA (0 to 5). In 10 
(26%) ASA 4 patients, maximum SOFA exceeded 11 with a mortality 
ICU predicted rate of 56%. In fact, fi  ve died. The reason for admission 
to the ICU of the 20 patients with lower ASA (17 ASA 2 patients, three 
ASA 1 patients) was a need for tighter monitoring or stabilization of 
postsurgical complications. Indeed, all deaths in the ASA 2 (1/17) and 
ASA 3 (4/38) groups were related to complications from co-morbidities.
Conclusions ASA 3 and ASA 4 patients are those who benefi  t the most 
from a stay in an ICU, enabling one to reduce mortality predicted by 
SAPS II and SOFA scores. The ASA physical status classifi  cation system 
is not a good indicator of mortality, but its association with SAPS II 
and maximum SOFA scores defi  ne more eff  ectively the severity and 
prognosis of the postsurgical patient.
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process of patients from an adult critical care unit
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Introduction Adult intensive care beds are a scarce and expensive 
resource. Effi   cient utilisation of these beds necessitates safe and timely 
discharge of patients to the general ward. However, the discharge 
process is complex and often delayed. This study aimed to look at the 
processes and consequences that cause a delay in the discharge of 
patients from an adult ICU.
Methods This was a retrospective study of our data collection databases 
based in a 17-bed London teaching hospital ICU. We examined the 
process of patient discharge from ICU to the ward over a 3-year period.
Results The study period was from July 2007 until June 2010. There 
were 3,511 patient discharge episodes to hospital wards. A delay of 
over 4 hours occurred in 2,829 patient episodes (81%). The delays in 
discharge to the wards increased by over 100% for the year following a 
reduction of 28 beds in total intrahospital ward bed capacity [1]. There 
were over 42,000 hours (equal to 1,751 days) of delays in discharges for 
the patient episodes. Delays were caused by all stakeholders involved 
in the discharge process. The main reasons were insuffi   cient ward 
bed availability (21%), delays in bed allocation (30%), delays in the 
completion of administrative tasks on the ICU (4%), delays in adequate 
preparation of ward beds (27%) for the arrival of the ICU patient, and 
delays that were attributable to intrahospital transport arrangements 
(5%). Overall, discharge delays to surgical wards were twice as likely 
compared with medical wards as they were also trying to deal with 
elective and emergency surgical admissions. Medical wards had fewer 
delays in transfer but were more likely to have longer delay times as 
a result of subsequent delays in discharging patients back to the 
community.
Conclusions Delays were multifactorial and accumulative in nature 
and dependent on the individual processes involved in the transfer of 
patients. Themes were related to organisational, individual, teamwork 
and patient factors.
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Introduction ITU resources represent 13% of hospital costs. Patients 
requiring ITU should be admitted promptly. However, those identifi  ed 
as suitable for discharge to the ward should also be transferred swiftly.
Methods A retrospective study of notes for 269 people admitted to the 
ITU between April and September 2010. Variables included length of 
ITU stay, discharge destination, reason for admission to ITU, primary 
pathology, disease severity on admission (APACHE II), health on 
discharge (MEWS) and ward bed availability.
Results Most discharges occur out of hours (64%). The average length 
of ITU stay is 90 hours and the average discharge delay is 26 hours. As 
length of stay increases, so too does discharge delay. Discharge delay 
was not signifi   cantly correlated with increased hospital mortality. 
Those discharged to the ward were delayed by an average of 32 hours. 
Primary reasons for ITU admission included monitoring, diagnosis and 
support of physiological function, with the latter by far the commonest. 
Discharge delay was signifi  cantly longer for those admitted in order to 
establish a diagnosis (40 hours). Discharge delay was very short for 
biliary and cerebral disease, at 3 and 2 hours respectively, but much 
longer for pneumonia, acute renal failure and heart failure, at 38, 58 
and 72 hours. No correlation was found between discharge delay and 
APACHE II score on admission or MEWS score on discharge.
Conclusions  ITU patients have complex care needs and transition 
through several departments. We focused on ITU factors and found 
discharge was delayed by long ITU stay, acute renal failure, heart failure, 
pneumonia and a lack of diagnosis on admission. The commonest 
ward factors are bed availability, emergency department activity, ward 
discharge practices and patient deterioration. In the community there 
are fi  nite resources for special care. ITU patients should be prioritised 
for ward beds. Multispeciality involvement on intensive care and the 
presence of advanced diagnostic facilities on site, such as CT and 
angiography, would expedite diagnosis. Adequate step-down facilities, 
such as dialysis and respiratory support, should be available in order to 
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discharge from intensive care.
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Introduction We hypothesised that for the general ICU population, a 
longer length of hospital stay prior to ICU admission was associated 
with a poor outcome. Previous work in specifi  c ICU populations has 
suggested that a longer length of hospital stay prior to ICU admission is 
associated with a higher mortality [1,2], and longer and therefore more 
costly ICU stays [3]. We undertook an evaluation of the relationship 
between pre-ICU length of hospital stay (LOS), and hospital mortality 
over a 1-year period.
Methods Using prospectively collected data, we undertook a retro spec tive 
evaluation of all patients admitted to the ICU of Glasgow Royal Infi  rmary 
from 1 August 2008 to 1 August 2009. Patients were identifi  ed from 
Wardwatcher (Critical Care Audit Ltd). Only the initial event was included 
in those patients with readmissions during the same hospital stay. The 
patients were divided into hospital survivors (Group A) and nonsurvivors 
(Group B). Statistical analysis was performed using SPSS version 15.0 for 
Windows (SPSS Inc, Chicago, IL, USA). Medians, interquartile ranges (IQRs) 
and Mann–Whitney U tests were applied as appropriate.
Results A total of 419 patients were admitted during the study period. 
After excluding those with missing data and the outliers, 397 were 
included in the data analysis. There were 268 in the survivor group 
(Group A), and 129 in the group that died (Group B). Median patient 
age: Group A, 50 (IQR 36 to 66), Group B, 62 (IQR 50 to 70), P <0.001. 
Median APACHE II scores: Group A, 15 (IQR 10 to 20), Group B, 23 (IQR 18 
to 29), P <0.001. Median predicted hospital mortality (%): Group A, 15.9 
(IQR 6.3 to 31.6), Group B, 46.8 (IQR 30.8 to 67.4), P <0.001. Median pre-
ICU LOS (days): Group A, 1 (IQR 0 to 2), Group B, 1 (IQR 0 to 4), P = 0.001. 
Median ICU LOS (days): Group A, 2 (IQR 1 to 6), Group B, 2 (IQR 1 to 7), 
P = 0.297. Median hospital LOS (days): Group A, 18 (IQR 7 to 36), Group 
B, 8 (IQR 3 to 23), P <0.001.
Conclusions In our cohort, the critically ill patients who survived to 
hospital discharge were younger, were less severely unwell and had a 
signifi  cantly shorter length of stay prior to ICU admission. What cannot 
be determined from this study is the bias of individual clinicians when 
seeing referrals. Assuming we admit the patients we anticipate to have 
the best chance of hospital survival, patients with a longer length of 
hospital stay prior to ICU appear to have worse outcomes.
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Introduction Triage criteria recommended by various governmental 
bodies are part of a process to cope with increased demand for 
intensive care resources during a pandemic [1]. It is unknown whether 
UK intensive care physicians agree with the proposed criteria that could 
automatically exclude a patient from receiving ICU care if adopted.
Methods We conducted an online survey amongst the members of 
the UK Intensive Care Society. We asked respondents to grade their 
opinion about each criterion of a Department of Health (DoH) triage 
tool and provide some additional information about their own health. 
We used Cronbach’s alpha (CA) to assess how close the opinions of the 
respondents were with regard to each criterion and each of three sets 
of criteria. We used a chi-squared analysis to see whether these factors 
diff  ered between intensive care consultants and nonconsultants.
Results A total of 550 questionnaires were returned; 182 (33.1%) were 
from intensive care consultants. For six of the DoH 11 criteria, the 
agreement score was >4/5 indicating agreement or strong agreement. 
For both consultants and nonconsultants, the CA was >0.8 (signifi  cant 
inter-responder agreement). A total 19.4% of those currently meeting 
exclusion criteria and 34.6% of those in good health would give up the 
chance of a level 3 bed voluntarily if they fulfi  lled one of the proposed 
criteria during a pandemic.
Conclusions  The results indicate a general acceptance of the 
requirement for triage but nearly 40% have signifi  cant reservations 
about the proposed tool. Sixty-fi  ve to 80% of respondents would not 
withdraw from the triage process in a pandemic even if they knew the 
proposed criteria would exclude them. While approximately 60% of 
respondents accepted the triage tool, it seems the majority would not 
wish it to be used to determine their own care.
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Introduction  The consolidation of intensive care fundamentals was 
accompanied by growth of ICUs and increased utilization of intensive care 
services. Unfortunately it was not followed by national health planning. 
The demographic changing profi  le with a higher number of elderly 
patients and a changing case mix with less trauma patient admissions, 
associated with the high prevalence of cardiovascular diseases and the 
early approach to septic patients, will have implications on intensive care 
organization. A regulatory policy system for public ICUs was started in 
Rio de Janeiro to ensure appropriate selection and  allocation of patients 
who need intensive care. The aim of this study is to report the profi  le of 
patients admitted to the ICU since the beginning of this new policy.
Methods A retrospective, 1-year, analysis of data from the Regulation 
Center. A nonchecklist medical application form is transmitted by fax 
for ICU patient allocation. Requests originated both from the hospital 
emergency room (HER) and nonhospital emergency units of care 
(Unidade de Pronto Atendimento (UPA)). The age, gender and the main 
prevalent diseases were recorded. Acute cerebrovascular disease (CVD) 
was considered all forms of stroke, both ischemic and hemorrhagic 
injuries; acute coronary disease (ACD) was considered stable and 
unstable angina and acute myocardial infarction; sepsis for severe 
sepsis and septic shock; trauma for any severe trauma, multiple trauma, 
burns and brain trauma; pneumonia for any severe lung infection with 
or without respiratory failure; and cardiac failure for any severe heart 
failure and acute pulmonary edema due to cardiac disease.
Results There were 15,036 applications, 10,360 (68.9%) forms from HER 
and 4,676 (31.1%) forms from UPA. From 12,591 adult requests, 7,333 
were men and 5,258 were women. Mean age was 61.54 years old, and 
461 (4%) were >80 years old. Major diseases that motivated the requests 
for admission were ACD (1.871, 15%), CVD (1.753, 14%), pneumonia with 
or without organ failure (1.678, 13%), sepsis (1.423, 11%), cardiac failure 
(825, 7%), trauma (741, 6%) and others (4,300, 34%).
Conclusions There was a signifi  cant number of ICU requests, mainly 
from in-hospital demand. The discussion regarding the indication of 
ICU care and knowledge of the patient profi  le may improve quality of 
the health critical care policy.
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Introduction The UK population is getting older and consequently our 
attitudes, together with the number of very older person admissions 
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aged 80 or over (very older people) to our ICU and compared this with 
10 years ago.
Methods Retrospective data collection was completed for all patients 
admitted to our ICU for a 12-month period starting in August 2009, 
and a comparable 12-month period starting August 1999. Data were 
retrieved from an electronic database of ICU admissions.
Results The number of very older patients admitted for the 1999 period 
was 87 out of a total 702 (12.4%) and for the 2009 period was 156 out of 
a total 1,071 (14.6%). There was a marked increase in emergency medical 
(from 24% to 47%) and emergency surgical (from 31% to 41%) admissions 
in the 10 years. This was in contrast to elective surgical admissions, which 
have reduced from 42% to 12%. The mean ICU admission APACHE II score 
for patients over 80 years old decreased from 21.2 to 18.6. The ICU and 
hospital mortality for the very older people is summarised in Table 1. 
The ICU mortality for this age group increased from 29% to 33% but the 
hospital mortality was unchanged at 44%.
Conclusions  Changes in population demographics are refl  ected in 
our critical care by an increase in the number of very older person 
admissions. The ICU mortality was higher in this group compared 
with 10 years ago. One possible explanation is the marked increase 
in emergency admissions. This may refl  ect an increased willingness to 
refer the very older patient for critical care support.
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Introduction A 2-year F2 programme was implemented nationally in 
the UK in 2005. The curriculum consists of core competencies against 
which trainees are assessed, with a syllabus setting out specifi  c 
knowledge, skills and attitudes to develop. An essential component of 
this curriculum is that trainees must meet specifi  c objectives in relation 
to recognition and treatment of the acutely ill. Assessment tools 
used are: MSF (multisource feedback), Mini-CEX (clinical evaluation), 
DOPS (direct observation of procedural skills), and CbD (case-based 
discussion). Specifi  c training programmes were introduced in 2008 to 
assist staff   with conducting these assessments, as trainees had reported 
diffi     culty in completing them. Training was delivered using mixed 
methods of face-to-face contact backing up e-learning. Aims were to 
assess the number and grade of medical staff   involved in assessment; 
to assess their willingness to be involved in F2 training and any 
barriers existing; to assess the degree of training and understanding of 
assessment tools; and to compare with historical data.
Methods The Modernising Medical Careers website [1] was used to 
create a questionnaire. Data were analysed retrospectively and results 
compared with those from a previous survey, conducted within our 
department in 2006.
Results  Comparisons (bracketed) are with 2006 data. Sixty-four 
completed forms were returned, representing 51% of those surveyed. 
A total of 87.5% (80%) were involved in teaching and 68% (42%) in 
assessment of F2s, with 66% (61%) being consultants. Seventy-six 
per cent felt that those involved in assessment should have specifi  c 
training with 72% having received such training, compared with 42% in 
2006. Twenty-two per cent would not assess an F2 if approached, with 
the majority (57%) citing lack of specifi  c training as the reason. Twenty-
seven per cent (48%) of those involved in assessment had not received 
any specifi  c training. Of those who had been trained, all respondents 
had at least some knowledge of DOPS, Mini-CEX and CbD.
Conclusions Introduction of training has improved participation in 
both assessment and teaching, in addition to highlighting the need for 
those who were untrained not to undertake assessments they had not 
been trained to do. There is now a good understanding of assessment 
tools although further training is warranted to emphasise the valuable 
role of critical care experts in delivering training and assessment to 
foundation doctors.
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Introduction  The healthcare workforce shortage is a global 
phenomenon, especially in the ICU. Use of a register nurse–unlicenced 
assistive personal model is an undeniable reality that fi  lls the void 
created. Model Team is a structured training program for healthcare 
assistants to expand their role, facilitating them to perform nursing 
tasks that require nursing skill and knowledge. The purpose of the 
study is to investigate whether the Model Team approach could reduce 
bedside nursing activities.
Methods This was a prospective cohort study. All bedside nurses working 
in an ICU were recruited. Intensive care assistants have undergone 
3-month structuralized training for specifi   c nursing skills, and then 
served four ICU beds under the supervision of a bedside nurse. Activities 
of all involved nurses were recorded before and after the implementation 
of an intensive care assistant service using the work-sampling method. 
Activities were categorized into six groups: patient care activities 
consigned to TISS-28; patient care activities not indicated in TISS-28; 
patient care activities that are not interventions in direct contact with the 
patient; organizational activities; personal activities; and miscellaneous 
activities [1]. The TISS-28 score of each patient was recorded during 
both sampling periods, serving as an indicator for complexity of nursing 
activity. A statistical test was performed to compare the frequency of 
patient care activities related to TISS-28 score (Question A) and nursing 
activities not related to direct patient contact (Questions C, D, E and F), 
before and after the Modal Team approach.
Results In total 29 nurses were recruited, 14 nurses during the control 
period and 15 nurses after the Model Team approach. Patients in both 
periods were comparable with no signifi  cant  diff  erence in TISS-28 
score. Patient care activities related to TISS-28 score reduced by 16.33% 
(mean frequency 3.43 to 2.87, P = 0.249) after the implementation of 
the intensive care assistant, but were not statistically signifi  cant. For 
nursing activities not related to bedside care, there was an insignifi  cant 
increase of 1.67% (mean frequency 4.79 to 4.87, P = 0.448).
Conclusions The Model Team approach may reduce bedside nursing 
activities, without eff   ect on nonbedside nursing activities. Further 
study with a larger sample size should be done to test the hypothesis.
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Impact of implementing a critical care team in an open general ICU
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Critical Care 2011, 15(Suppl 1):P471 (doi: 10.1186/cc9891)
Introduction High-intensity ICU physician staffi   ng is associated with 
reduced ICU mortality [1]. We formed a critical care team (CCT) that 
consisted of fi  ve teaching staff   interested in critical care management. 
Table 1 (abstract P468). Mortality of very older patients by specialty at ICU/
hospital discharge
 Medical  Emergency  Elective  Overall
  (%)  surgical (%)  surgical (%)  (%)
1999  to  2000  33/52 41/48 18/36 29/44
2009  to  2010  38/48 34/47 11/16 33/44
Data presented as ICU/hospital mortality (%).
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and had provided rapid medical services including consultation. We 
evaluated the impact of implementing the CCT on open general ICU 
patient outcomes.
Methods We performed a prospective observational study in an open 
general ICU between March 2009 and February 2010 according to CCT. 
We compared demographic data, ICU mortality rates, length of ICU 
stay, APACHE II scores, Sequential Organ Failure Assessment (SOFA) 
scores, patients who received mechanical ventilation, and success rates 
of weaning in CCT with those in non-CCT.
Results We analyzed 857 patients’ data (161 cases in CCT vs. 696 cases 
in non-CCT), excluding readmission cases. Patients who received CCT 
management were more severe than those who received non-CCT 
management signifi   cantly (APACHE II 21.4 vs. 17.7; SOFA 5.8 vs. 4.9). 
Although there were more patients on applied mechanical ventilation 
(46% vs. 23.6%) in CCT than those in non-CCT and a higher success rate 
of weaning (60.8% vs. 43.9%) in CCT than those in non-CCT, there was no 
signifi  cant diff  erence of unadjusted ICU mortality rates in both groups 
(14.3% in CCT vs. 12.2% in non-CCT). Using a multivariate logistic regression 
model, the ICU mortality rate was associated with non-CCT, APACHE II 
scores, SOFA scores, and applied mechanical ventilation (Table 1).
Conclusions Although the CCT was not a full-time coverage team in 
the open general ICU, the CCT model was associated with reduced ICU 
mortality, especially in patients who received mechanical ventilation.
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Impact of a program of training on the performance of a track and 
trigger system and outcome of ICU admissions
M Waraich, J Zwaal, M Johnson
Kingston Hospital, Kingston Upon Thames, UK
Critical Care 2011, 15(Suppl 1):P472 (doi: 10.1186/cc9892)
Introduction  The introduction of track and trigger systems for 
hospitalised patients has been associated with improvement in 
outcome through earlier identifi  cation of sick patients [1]. We set out 
to improve the performance of our track and trigger system through a 
program of intense training of frontline medical and nursing staff   with 
the aim to improve outcome of patients admitted to ICU.
Methods A retrospective chart survey of all ICU admissions from the 
ward 3 months before and after conclusion of a program of training was 
carried out. Out of a total of 64 charts, four were incomplete and three 
concerned planned postoperative ICU admissions and were therefore 
omitted from analysis. Training emphasized triggering of the pathway if 
two or more physiological parameters were outside the normal range: 
respiratory rate <10 or ≥25, SaO2 <90%, systolic blood pressure <90, 
heart rate <50 or ≥110 and/or neurological response to painful stimulus 
only. The pathway could also be triggered by clinical concern about the 
patient. Triggering progressed through involvement of junior medical 
and nursing staff   at step 1, intermediate level at stage 2 and senior 
medical and ICU staff   at step 3. Outcome parameters: compliance with 
pathway steps and mortality of ICU admissions. Diff  erences between 
proportions were tested according to the method described by Armitage 
and colleagues [2] with P <0.05 taken as signifi  cant.
Results Signifi  cant improvement was found in triggering at steps 1 and 
3 with a reduction in noncompliance at step 1 from 51.7% to 28.1% 
(P = 0.044) and at step 3 from 31% to 9% (P = 0.018). The pathway 
compliance overall showed a nonsignifi  cant improvement from 17.2% 
to 33.3%. Pathway noncompliance showed a trend towards occurrence 
out of hours (70% vs. 60.5%). Pathway sensitivity was unchanged (69% 
before vs. 61.4% after). There was no diff  erence in ICU mortality pre and 
post training (41.4% vs. 47.4%, P = 0.6). Neither was there a diff  erence 
in ICU mortality between pathway followers and nonfollowers (57.9% 
vs. 42.1%, P = 0.95).
Conclusions Improved performance of the track and trigger system 
did not lead to improved outcome in patients admitted to the ICU.
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outcome in a central London teaching hospital
V Metaxa, C Bell, A Feehan, K Peters, T Chang, P Hopkins, M Ervine
King’s College Hospital, London, UK
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Introduction The standardised mortality ratio (SMR) is a key parameter 
by which ICUs quantify their performance. We report the eff  ect of 
increased ICU consultant numbers on mortality and SMR in a central 
London teaching hospital.
Methods The study was registered with the Clinical Audit Support 
System. Data were collected prospectively from March 2005 to date by 
a dedicated audit team and were analysed as part of routine audit.
Results Table 1 shows the reduction in mortality and SMR from 2005 
to date, comparing these data with patient and consultant numbers.
Table 1 (abstract P473). SMR and mortality reduction from 2005 to date
 Number  Number    ICU 
 of  of  Median  mortality  ICU
  admissions  consultants  APACHE II   (%)  SMR
2005 to 2006  646  5  18  34.4  0.93
2006 to 2007  774  5  17  19.3  1.15
2007 to 2008  842  9  14  16.8  0.91
2008 to 2009  1,510  13  14.5  14.7  0.77
2009 to 2010  1,671  13  17  19.3  0.67
2010 to 2011   1,434  17  19  19  0.62
(incomplete)
Conclusions In this study we describe the remarkable reduction in 
both mortality and SMR that has occurred in the general ICU at King’s 
College Hospital over the past 5 years. The improvement in outcomes 
was associated with a quadrupling of ICU consultant numbers. We 
hypothesize that this increase in intensivist numbers allowed the 
reinforcement of a closed model of ICU care. We are now further 
analysing these data to search for quantitative improvements in 
surrogate markers of quality of care over the same time frame.
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Intensivist-led on-call service: key step in mortality reduction
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Critical Care 2011, 15(Suppl 1):P474 (doi: 10.1186/cc9894)
Introduction We conducted an audit to determine whether a change 
to a dedicated intensivist rota in our district general hospital ICU 
improved patient outcome. Our unit, like many others around the 
Table 1 (abstract P471). Multivariate logistic regression analysis of factors 
aff  ecting ICU mortality
  P value
Male 0.864
Age 0.237
LOS, ICU  0.281
CCT 0.049
APACHE II  0.012
SOFA 0.004
Mechanical ventilation  <0.001
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rather than specialists in intensive care medicine. This audit therefore 
had potentially far-reaching implications for many other similar ICUs 
in the UK.
Methods We conducted a retrospective analysis on data obtained from 
the ICNARC database, patient notes, drug charts and ICU charts over 
two cycles. The fi  rst ran from 1 December 2008 to 31 January 2009, 
when the conventional on-call consultant rota was still in operation. 
The second ran from 1 January 2010 to 31 March 2010, following 
implementation of a dedicated intensivist rota. Our primary outcome 
measure was unit mortality. We analysed a further eight parameters 
as indirect markers of good clinical practice. These were tidal volume, 
urine output, glycaemic control, lactate, mixed venous oxygen, and 
appropriate prescription of gastric protection, antibiotics and venous 
thromboembolism prophylaxis.
Results Patient demographics were similar between the two cohorts 
under investigation, but the mean admission APACHE II score was 
found to be signifi  cantly lower following the rota change, as shown in 
Table 1. This reduced inpatient unit mortality from 39% in cycle 1 to 
25% in cycle 2. However, the change to an intensivist rota made little 
diff  erence to our markers of good clinical practice.
Conclusions Our study suggests that the improvement to unit mortality 
was secondary to patient selection, rather than a fundamental change 
in clinical practice within the ICU. This indicates that a dedicated rota, 
in which consultant intensivists lead on out-of-hours referrals, reduces 
the number of inappropriate admissions to the ICU.
P475
Mews Anesthesia Team: a project for in-hospital patient safety
R Oggioni, L Tadini Buoninsegni, G Iannello, C Rosati
Azienda Sanitaria Firenze, Borgo San Lorenzo, Italy
Critical Care 2011, 15(Suppl 1):P475 (doi: 10.1186/cc9895)
Introduction In past years, to improve in-hospital patient safety, rapid 
response teams were put in place to treat, on ward’s call, the patients at 
risk in order of their severity.
Methods  In the Azienda Sanitaria Firenze, a dedicated group 
of intensivists and nurses developed a project called the Mews 
Anesthesia Team (MAT) in order to prevent and manage clinical 
deterioration of patients. This would be achieved through the 
activation of a rapid response team lead by an intensivist acting in 
accordance with an intervention fl  owchart. The project was based on 
the Modifi  ed Early Warning Score (MEWS), a validated warning score 
designed to alert ward nurses to patients at risk (MEWS >3) and/or 
to trigger MAT intervention (MEWS >5). Previously the group realized 
a pilot phase involving 420 patients, preceded by a 1-day dedicated 
course addressed to ward staff  ; the preliminary results showed in 12% 
of patients with MEWS >3, that sicker patients were located more in 
medical wards, while more calls/interventions of MAT were performed 
in surgical wards. Subsequently MEWS was plugged into the nurse 
electronic health record (EHR) allowing one to display automatically the 
score and to stratify patients according to level of care and frequency 
of monitoring required. The fi  nal phase of the project started from our 
hospital, preceded by courses for the ward staff   (mostly nurses).
Results The performance indicator, that is nurse’s compliance in MEWS, 
was high in surgical wards compared with medical ones (88% vs. 71%); 
this diff  erence is because until recently medicine nurses fi  ll in MEWS 
only by sheet records. The adherence to the interventional fl  owchart 
was extremely low in medicine wards versus surgical ones (25% vs. 
60%) despite recurrent meetings with ward staff  , owing to reluctance 
of physicians to call the MAT. There were more critically ill patients in 
surgery, notably in orthopedics, than in medicine wards (MEWS >3: 
22% vs. 7%). As a result of MAT intervention, 30% of patients were 
admitted to the ICU (mostly from surgery).
Conclusions MAT is ongoing with good acceptance from nurses and 
good compliance, especially in surgery wards; the inclusion of MEWS 
into the EHR turned out to be a great support for the nurses. MAT 
represents a safety system for in-hospital patients at risk, as advocated 
also by the Tuscany Health Agency for Quality that, in the aim of 
developing good practices for patient safety, recommends MEWS for 
tracking and managing critical in-hospital patients.
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Does implementing a rapid response system decrease the number 
of in-hospital cardiac arrests?
R So, L Te Velde, H Ponssen, M Frank, S Hendriks, E Oskam
Albert Schweitzer Hospital, Rotterdam, the Netherlands
Critical Care 2011, 15(Suppl 1):P476 (doi: 10.1186/cc9896)
Introduction Resulting from the Dutch VMS Safety Program ‘Prevent 
Injury, Work Safely’, we recently started to implement a rapid response 
system (RRS) in our hospital. The purpose of the RRS is to recognize 
and treat the patients with clinical warning signs early on the ward to 
reduce preventable hospital-wide avoidable injury. We present the fi  rst 
outcome data for the implementation of the RRS.
Methods From 1 May 2008 to 1 May 2009 we implemented in both 
clinical locations of our hospital a RRS, which has three basic limbs: an 
aff  erent limb (RRS activation card), a physician-led medical emergency 
team (MET) and an evaluation/feedback limb. We collected data 
regarding all MET calls from 1 May 2008 to 1 July 2010 and we focused 
on the number of in-hospital cardiac arrests (CA).
Results See Table 1.
Table 1 (abstract P476). Number per 1,000 discharged patients
    2007 2008 2009 2010
MET calls       
 Dordrecht  0  1.2  3.2  2.9
 Zwijndrecht  0  6.4  11.8  10.9
In-hospital CA       
  Dordrecht  1.4 1.2 1.4 1.4
  Zwijndrecht 2.6 1.3 0.6 0.6
Conclusions Implementation of a RRS can decrease the number of in-
hospital cardiac arrests dramatically and thus avoid (serious) adverse 
events and possible deaths. Possible success factors include: timely 
activation of the RRS, the degree of implementation of the RSS, and 
timely agreed restrictive measurements on the general ward.
P477
Impact of training in the use of an early warning system on 
in-hospital cardiac arrests
A Raj, J Zwaal
Kingston Hospital NHS Trust, Kingston upon Thames, UK
Critical Care 2011, 15(Suppl 1):P477 (doi: 10.1186/cc9897)
Introduction The introduction of an early warning system (EWS) has 
been associated with a reduction in in-hospital cardiac arrest (CA) [1]. 
We set out to determine the impact of a programme of training in the 
use of an EWS on the number and nature of CAs in our hospital.
Methods  We conducted a retrospective chart survey of all adult 
CA patients pre and post implementation of a training programme 
in the use of the EWS. If a patient develops abnormalities in two or 
more physiological parameters, the system forces escalation of care 
through three levels of care, with involvement of junior medical staff   
Table 1 (abstract P474). Patient demographics
Factor  Cycle 1  Cycle 2
Subjects 82  76
‰ male  48  59
Mean age (years)  63  64
Age range (years)  19 to 91  21 to 91
APACHE 24.8  17.6
Range  5 to 36  5 to 42
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was defi  ned as: SaO2 <90%, HR <50 or ≥110/minute, systolic blood 
pressure  <90  mmHg, conscious level: only responsive to pain, 
respiratory rate  <10 or ≥25/minute or clinical concern about the 
patient. Outcome parameters: CA/1,000 bed-days, percentage of CPR 
attempts deemed inappropriate by two senior intensivists, percentage 
of patients (in whom CPR attempts were deemed appropriate) with 
abnormal physiology prior to CA and survival post CA. Charlson’s co-
morbidity index (CCI) [2] was calculated for both periods. Diff  erences 
between mean values were tested with Student’s t-test and diff  erences 
between percentages were tested according to the method described 
by Armitage [3].
Results  After adjusting for age (mean pre: 81.7, post: 81.8 years 
(P = 0.99)), sex and co-morbidity (CCI pre: 6.4, post: 6.66 (P = 0.79)): 
CA/1,000 bed-days pre: 0.89, post: 0.76 (P  =  0.24); percentage of 
inappropriate CPR attempts pre: 62.5%, post: 33% (P = 0.11); percentage 
of cases with abnormal physiology identifi  ed prior to arrest pre: 68.8%, 
post: 75% (P = 0.72); and survival pre: 12.5%, post: 0% (P = 0.20).
Conclusions  Training in EWS was associated with a reduction in 
the number of CAs and percentage of inappropriate CPR attempts, 
both of which are in keeping with the literature. However, there was 
no signifi  cant diff  erence in the percentage of cases with abnormal 
physiology identifi  ed prior to CA between both periods and there was 
no survival benefi  t after CA. An early warning tool may be unable to 
prevent CA in a subset of patients with deranged physiology.
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adherence in a London teaching hospital ICU
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Introduction Individual, clearly defi  ned physiological goal-setting can 
help to optimize patient care [1]. At our ICU, eight physiological goals 
can be prescribed on the daily ICU observation chart. These include 
Hb, MAP, ICP, CPP, pO2, pCO2, fl  uid balance and sedation scores. We 
performed a prospective audit assessing doctors’ compliance with 
goal-setting, nursing adherence to these, and what goals nurses used 
when none were documented.
Methods An audit was carried out from December 2009 to March 2010. 
A total of 90 bedside charts were reviewed at random. Data collected 
included the total number of goals specifi  ed by the ICU medical team, 
the percentage of time those goals were achieved and what goals 
nurses set themselves if no goal had been previously documented.
Results  Goals were prescribed for only 53% of patients. Most 
commonly prescribed were CPP targets for 63% of those with ICP bolts. 
The remaining parameters were prescribed for between 17 and 38% 
of patients, with balance and sedation goals being least commonly 
specifi  ed. For the ARDS subgroup of patients, no fl  uid balance goals 
were documented. Certain patterns were also evident; for example, 
pCO2 goal was more commonly stipulated for patients in the neuro 
group (for 41% of the group). However, there was no pattern seen in 
the number of goals specifi  ed per patient or according to the length 
of patient stay on the ICU. When goals were set, all targets were met 
62% of the time, with >80% of targets met 79% of the time. When goals 
were not documented, however, 46% (pCO2) to 78% (fl  uid balance) of 
nursing staff   were unable to specify what range of parameters they 
aimed to keep within. The remainder that did aim for particular target 
ranges stated they were aiming for physiologically normal parameters. 
Whilst sensible, this may not have been appropriate for some patients. 
For example, for fl  uid balance, a small number aimed for goals specifi  ed 
on previous days but 78% did not aim to achieve any goal, occasionally 
resulting in an inappropriately positive fl  uid balance.
Conclusions Adherence with physiological goal prescription amongst 
doctors is poor. When goals have been set, nursing adherence to them 
is very good. However, when no goals have been set, the physiological 
parameters that nursing staff    aim for can be both variable and 
inappropriate, potentially resulting in both increased morbidity and 
prolonged length of stay on the ITU.
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Introduction Safety checklists, long used in aviation, have migrated 
to the critical care setting in an eff  ort to reduce complications and 
improve patient outcomes. We developed an automated system to 
provide real-time feedback to the healthcare team on safety bundle 
compliance in the ICU.
Methods A program was written in Cerner Command Language to 
automatically search data within the EMR for the most recent values 
of the following data: ventilation mode, respiratory rate, tidal volume, 
ideal body weight, administration of any sedative infusion, analgesic 
infusion, neuromuscular blocking agent, stress ulcer prophylaxis, 
DVT prophylaxis and regular diet, enteral nutrition, or total parenteral 
nutrition. Nursing documents oral decontamination, head-of-
bed elevation, and whether a sedation vacation was conducted. A 
customized document was created to capture any patient/family/proxy 
discussions about end-of-life issues. High and low glucose values and 
the percentage of all glucose values within the range of 60 to 180 mg/
dl are also reported. A summary score was calculated by subtracting 
(from a baseline of 9) one point each for inappropriate tidal volume, 
failure to do a weaning trial, lack of oral care, head-of-bed elevation and 
stress prophylaxis, no sedation vacation and absent DVT prophylaxis, 
absent nutritional support or glucose values out of range. A perfect 
score is 9; lower scores indicate an opportunity for improvement. 
Clinicians access the report from within the hospital’s EMR and can 
view it on a portable device (iPad) or print it to carry on rounds.
Results A partial report with data for two patients is shown in Table 1.
Conclusions Automatic reporting of compliance with patient safety 
protocols is a useful performance improvement tool that further 
identifi   ed areas for improvement. Future study should assess the 
impact of this tool on actual compliance with patient safety goals.
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Prevalence, clinical management and risks associated with 
acute faecal incontinence in the critical care setting: the FIRST 
questionnaire survey
R Binks
Airedale NHS Foundation Trust, Bradford, UK
Critical Care 2011, 15(Suppl 1):P480 (doi: 10.1186/cc9900)
Introduction  The FIRST survey was designed to examine the 
prevalence, awareness and management of acute faecal incontinence 
Table 1 (abstract P479). ICU safety bundle report
Loc  Vent  f/Vt  Vt/IBW  Stress  NM block  Oral  HOB  DVT  24-hour glucose  % glu  Pain  Sed  Sed vac  Nutr  Score
4202  AC  0 6 Y N Y  Y  Y  105.216  67  Y  N Y R 6
4203  PSV  15 Y N N Y  Y  Y  NA  0  Y  N Y R 6
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healthcare professionals (HCP) in the critical care setting.
Methods  A descriptive cross-sectional survey. Data were collected 
from ICUs or critical care units in Germany, Italy, Spain and the UK 
using a questionnaire. The questionnaire contained 20 questions for 
completion by HCP, and six specifi  c questions for hospital pharmacists 
or purchasing personnel. Questions concerned the epidemiology, 
awareness and management of AFI, and associated clinical issues. 
Analysis of the results was conducted so that respondents remained 
anonymous.
Results  A total of 960 questionnaires were completed (Germany 
n = 200; Italy n = 261; Spain n = 267; UK n = 232) by nurses (60%), 
physicians (29%) and pharmacists or purchasing personnel (11%). 
Estimated prevalence of AFI ranged from 9 to 37% of patients 
on the day of the survey. The majority of respondents reported a 
moderately low awareness of the clinical challenges associated with 
AFI and its prioritisation in their units. Patients with AFI commonly 
had compromised skin integrity (perineal dermatitis, moisture lesions 
or sacral pressure ulcers). Reducing the risk of cross-infection and 
protecting skin integrity were rated as the most important clinical 
challenges. Forty-nine per cent responded that they had no hospital 
protocol or guideline for the management of AFI. There was generally 
low awareness of nursing time spent managing AFI episodes by some 
hospital personnel, but 60% of respondents estimated that 10 to 
20 minutes are required for managing an AFI episode, requiring two or 
three healthcare staff  . The key reported benefi  ts of faecal management 
systems included: reduced risk of cross-contamination and infection, 
reduced risk of skin breakdown, and improved patient comfort and 
dignity. In those not using a faecal management system, the main 
reason reported was lack of availability or that devices were not 
included in the hospital guidelines.
Conclusions AFI in the critical care setting may be an underestimated 
problem that is associated with a high use of nursing time. In many 
institutions there is a lack of protocols or guidelines, which might 
improve the management of AFI in the critical care setting.
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Introduction  ICUs are complex settings, with critically ill patients 
submitted to invasive care, involving a multidisciplinary team, 
requiring urgent high-risk decision-making, taking place in an 
expensive structure with new technologies of increasing complexity. 
All these conditions facilitate the development of adverse events (AEs). 
We aimed to determine the occurrence of AEs in four tertiary academic 
ICUs in Brazil, disclosing their potential risk factors.
Methods  This prospective cohort was conducted in four medical 
ICUs of a major academic, tertiary hospital in Brazil, enrolling all adult 
admissions during June to August 2009. AEs were identifi  ed by direct 
daily monitoring of medical and nursing rounds and chart review. Age, 
sex, APACHE II scores, length of stay (LOS), and the Nursing Activities 
Score (NAS) were also registered. The association with the occurrence 
of AEs was analyzed with logistic regression.
Results A total of 180 ICU admissions were included, regarding 176 
patients (male/female: 86/90; age: 52.7 ± 1.8 years). The mean LOS, 
APACHE II scores and NAS were 10.0 ± 0.8 days, 15.7 ± 0.5 points and 
69.0 ± 1.5%. Nearly 78% of the admissions (141 admissions) suff  ered 
1,065 AEs. The most frequent AEs were: new dermatitis/pressure ulcers 
(195 events = 18.3% of events); hypoglycemic episodes not related to 
insulin use (HENI) (168 events = 15.8%); diagnostic/treatment failures 
(156 events = 14.6%); and drug AEs (195 events = 12.8%). Those four 
categories responded for 61.5% of all detected AEs. In the fi  nal logistic 
regression model, three independent variables remained as important 
risk factors for the occurrence of at least one AE: LOS >3 days, APACHE 
scores >13 points and NAS >70%, with adjusted OR estimates of 19.5, 
3.4 and 3.3, respectively (P <0.02).
Conclusions  This prospective study was essential to identify the 
proportion of our ICU admissions aff  ected by AEs, disclosing their 
nature. Our AE rates, aff  ecting nearly 78% of admissions, were higher 
than those previously described. The direct observation of the ICUs 
contributed to those rates. Six out of 10 AEs corresponded to new 
cutaneous lesions, HENI, diagnostic/treatment failures and drug AEs. 
Length of stay, severity on admission and nursing workload were 
important risk factors for the occurrence of at least one AE.
Acknowledgements This study was sponsored by FAPESP.
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Introduction  This observational prevalence study applies three 
defi  nitions of level 1 care to a hospital-wide cohort of adult patients 
in a university hospital and a district general hospital, to test the 
validity of measures to defi  ne at-risk patients outwith critical care. 
This report provides a fi  rst look at the university arm of the study. The 
importance of correctly applying an acceptable defi  nition is twofold. 
Firstly, an individual at risk of deterioration may be highlighted to 
critical care outreach services (CCOS). Secondly, a population of at-risk 
patients may identify an unmet resource need. The three common 
defi  nitions are: Intensive Care Society (ICS) [1], Department of Health: 
Comprehensive Critical Care (CCC) [2] and Association of UK University 
Hospitals (AUKUH) [3]. The earliest defi  nition of a level 1 patient by CCC 
identifi  es recent critical care discharges and/or deteriorating patients 
needing CCOS [1]. The ICS defi  nition adds detail to this by scoping the 
options for monitoring or clinical intervention [2]. The AUKUH identifi  es 
two subgroups within level 1: acutely ill or deteriorating patients, and 
stable patients with greater nursing dependency [3].
Methods Data were collected from all inpatients by a team of trained 
researchers, using hand-held computers, over 5 days. The paediatric, 
maternity, oncology and emergency units were excluded. A central 
data controller guarded against omissions or duplications. The acuity 
criteria dataset was constructed by a regional expert critical care 
steering committee. The dataset from the university and district 
hospital sites have not yet been combined.
Results A total of 696 patients were included, representing >97% of 
patients in surveyed wards. Within the 24-hour period before data 
collection: four patients had CCOS review, nine had stepped down from 
level 2/3 care and 51 had MEWS >3. In total, 371 patients (53%) met the 
criteria of at least one of the defi  nitions, if not all three.
Conclusions A signifi  cant proportion of adult patients meet one or 
more of the current defi  nitions for level 1. We suggest that the current 
defi  nitions may be unhelpful in identifying at-risk patients outside 
critical care. Further work is planned to investigate whether certain 
criteria, or combinations thereof, are better predictors of unmet clinical 
need, or contribute more to patient safety.
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Introduction Telepresence using robots (TPR) in acute care facilities 
(ACF) is being increasingly accepted as a new and practical way of 
solving the shortage of intensivists in community hospitals (CH) where 
there are not specialists available 24/7 [1,2]. The main objective of this 
study is to show the early experience of using TPR in four CH in Mexico.
Methods  Four CH with 60 beds each were fully equipped with a 
telepresence system that includes: high-speed connectivity, wireless 
Internet access, a RP-7i robot (INTOUCH HEALTH, Santa Barbara, CA, 
USA), three computers (laptops) per hospital and one central computer 
based at the MPH. Additionally, all four CH has a specifi  c team for 
technical support. The CH cover medical care to people without social 
security and are far away from the capital city at not less than 42 km 
(Tenancingo 42 km, Atlacomulco 63 km, Valle de Bravo 85 km and 
Tejupilco 90 km). The program includes a team of certifi  ed intensivists 
that is based at MPH. The task of the team is to assist physicians in ACF, 
which includes the emergency room (ER), ICUs and the operating room 
(OR). The program includes: rounds at ACF every day three times a day 
24/7 and every time that it is needed. The MPH team gives assistance 
in: advanced trauma life support (ATLS), advanced cardiovascular life 
support (ACLS), advance life support for pregnant women (APLS), 
neurological support (NS), rapid response team support (RRTS), and air 
transportation assistance (AT). Hospitalization, discharge, transfer to 
high-care hospitals, and mortality were recorded.
Results From 1 May to 30 November 2010, 319 patients were attended 
by the MPH team: 54 ER patients, 16 ATLS and 66 ACLS interventions, 
106 ICU patients, 17 interventions as RRTS, 76 APLS, six AT, 27 OR 
assistances, and 22 NS. Forty-fi  ve percent of patients were discharged 
home, 25% were transferred to high-care hospitals, 9% were still in 
hospital and the total mortality rate was 19%.
Conclusions  This preliminary report shows that the practice of 
telepresence using robots in ACF is feasible at community hospitals in 
Mexico. Additionally, we observed minimal resistance to the expertise 
given by the MPH team.
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Introduction  In the United States, critical care bed allocation is 
increasing, despite a decline in the number of hospitals. This process 
suggests a centralization of intensive care may be occurring even 
without central planning. In an eff   ort to provide more effi   cient 
healthcare, many national healthcare systems have considered 
deregulating and decentralizing authority but have been wary about 
whether nongoverned, deregulated healthcare would yield naturally 
centralized care as a function of market forces. We evaluated the 
concentration of critical care services for mechanically ventilated 
patients in the state of Pennsylvania over time as a model for this in a 
decentralized system that is undergoing concentration.
Methods  We performed a retrospective cohort study using 
Pennsylvania discharge data. All adult intensive care discharges 
between 2004 and 2008 with procedure codes for mechanical 
ventilation were eligible. We examined regional population-adjusted 
mechanical ventilation rates and the concentration of services over 
time. We evaluated changes in the Herfi  ndahl–Hirshman Index (HHI), 
an accepted measure of overall market concentration, with larger 
numbers indicating greater concentration.
Results Hospital numbers declined over the 4 years (180, 177, 173, 
173), while the number of discharges remained constant (37,635, 
36,883, 37,701, 37,793). At the state level, the annual rate of discharge 
did not change (3.04 per 1,000 persons in 2004 to 3.05 in 2008). 
However, there was substantial regional variability, with three regions 
increasing in volume, two decreasing, and four remaining unchanged. 
At the state level, services were unconcentrated and did not change 
over time: the HHI was 160 in 2005 and 166 in 2008; however, some 
regions substantially concentrated while others remained the same. 
The most concentrated regions in 2005 (HHIs: 1,751, 2,239 and 2,886) 
became more concentrated by 2008 (HHIs: 1,925, 3,532, 3,564).
Conclusions Left to their own devices, some regions seem to centralize 
while others remain stagnant. Isolation of factors that drive adaptive 
concentration of services could be fruitful for national health systems 
interested in combining deregulation with centralization. Policy is 
needed to support outcomes-based regionalization, as a haphazard 
redistribution risks falling out of step with overall public health 
objectives if only global control of bed allocation is used.
Acknowledgements Supported by NIH grant T32-HL07820.
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Introduction Despite extensive use of QI collaboratives in healthcare 
and in critical care, little is known about the impact of the collaborative 
approach on how the intervention is taken up within participating 
organizations. This in-depth qualitative study investigates the frontline 
critical care staff   perspective on being involved in a large collaborative 
network for ICU quality improvement.
Methods  One-on-one key informant interviews were conducted 
with 32 staff   members from a sample of the ICUs who participated in 
the Ontario ICU Best Practice Collaborative between 2006 and 2008. 
Using a grounded theory approach, open coding was completed by 
two qualitative researchers. The open codes were then grouped in to 
broad theme-oriented categories and all text segments belonging 
to the same category were then compared. The theme-oriented 
categories became further refi  ned and formulated into fewer analytic 
categories through an inductive, iterative process of going back and 
forth between the data and the analytic framework of the study.
Results This research reveals that frontline staff   do not feel the need 
for their unit to be ‘like’ high-performing peer organizations; they feel 
that belonging to a collaborative provides the chance to be recognized 
for providing a high level of care despite their inequalities. The existing 
QI communication structure within ICUs is highly ineff  ective for staff   
engagement, and a QI bubble seems to exist in terms of knowledge 
transfer. Finally, the idea of collaboration is exhibited more internally 
in increased intra-team cooperation than externally between 
organizations, where friendly competition is a more prominent driver. 
A conceptual framework for QI collaborative design is proposed for 
future testing.
Conclusions These fi  ndings indicate that QI collaboratives for ICUs 
may not function by commonly held inter-organizational assumptions 
of legitimization, communication and collaboration, which may 
explain typically mediocre results. Hopefully this work can contribute 
insight into strategies for more eff  ective use of collaborative eff  orts for 
healthcare QI and support new perspectives on their design for use in 
the ICU environment.
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Introduction  To improve medication safety on the Critical Care 
Complex (CCC), Norfolk & Norwich University Hospital, an anonymous 
electronic reporting system was introduced. Reports captured populate 
a local database of incidents, which identifi   es themes. Medication 
incidents are common; studies reveal up to 10.5 incidents per 100 bed-
days [1]. Under-reporting of incidents in the CCC was highlighted in a 
paper-based 2-week reporting project. The electronic reporting system 
expands this work, introducing a sustainable, integrated reporting 
system, addressing some of the reporting barriers.
Methods A staff   survey identifi  ed barriers to incident reporting such as 
access to forms, time taken to complete reports and fear of disciplinary 
action. An anonymous medication incident system was developed and 
implemented in the bedside clinical information system, Metavision®. 
One-to-one education sessions highlighted the system and a survey 
informed optimal form design. Incidents reported were entered into 
a database and categorised by time, error types and themes. The 
database allowed identifi  cation of processes needing improvement. 
Subsequently, targeted changes to the systems surrounding 
medications were introduced to reduce specifi  c incident types.
Results  Over 34 weeks, 194 medication incidents were reported. 
The most common types of incidents were infusion documentation 
(Gantt), wrong dose, duplication, wrong rate and wrong frequency 
errors. System changes in response to these errors have reduced their 
incidence (Figure 1).
Conclusions  Incident reporting has improved signifi  cantly  from 
a baseline of 19 reports in 2 years. The new reporting system has 
enabled targeted changes, eliminating some of the most common 
errors, improving medication safety. Fluctuating numbers of reports 
may still indicate under-reporting. Themes remain that have yet to be 
addressed.
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Introduction  Education in eff   ective hand hygiene in the ICU is 
often neglected. The scope of this study is to detect the eff  ects of an 
educational program on the incidence of VAP in a mixed ICU.
Methods  Two groups of patients in two comparable time periods 
(9 months each) before and 6 months after implementation of 
various hygiene measures were analyzed. The measures implied: 
implementation of foot-operated hand washbasins, training in the 
eff   ective use of hand washing followed by use of alcohol-based 
antiseptic dispensers near each ICU bed, and others. The diagnosis of 
VAP was by using clinical, microbiological, radiographic criteria, and by 
the CPIS index. Statistics was with ANOVA and x2.
Results Despite the comparable APACHE II scores at ICU admission 
(17.6 ± 6.5 vs. 18.1 ± 6.9) the two groups diff  ered in variables as shown 
in Table 1. The incidence of VAP and mortality of Group 2 patients 
were signifi  cantly reduced. The RR of death in the control group was 
signifi  cantly increased (RR = 1.364, 95% CI: 1.055 to 1.763). The mortality 
of trauma patients in the protocol group was signifi  cantly lower (Group 
1: 57.1% vs. 0% (Group 2), P <0.05).
Conclusions The implementation of protocols regarding hand hygiene 
by healthcare professionals in the ICU, together with a reconstruction, 
may lead to a signifi   cant reduction in the incidence of VAP and 
mortality both in the crude ICU patient population and in the subgroup 
of polytrauma patients.
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Introduction Data were collected for paediatric admissions to an adult 
ICU in a district general hospital in the UK over a 6-year period to look 
for feasibility and the associated problems of training and skills after 
centralisation of PICUs in the country.
Methods We searched the ICNARC database for all entries relating to 
children for their age, gender, and diagnosis at admission, source of 
referral, length of stay, level of support, outcome/discharge and any 
other problems highlighted during their stay in the unit between the 
years 2002 and 2009.
Results Thirty-eight children were admitted to the adult critical care 
unit during this period. The age range was from 6 months to 16 years 
(average 9.12 years). Seventeen patients were male and 23 female. 
The most common reason for admission to the unit was respiratory 
problems followed by trauma. Seventeen patients received level 2 care 
and 21 received level 3 care. Twenty children needed endotracheal 
intubations, 12 needed arterial lines, 10 needed central lines and two 
needed intercostal drains. Twenty-one patients received sedation, most 
commonly with midazolam and morphine. The average length of stay 
in the ITU was 1.5 days and 80% of patients were discharged from the 
ITU within 2 days. Twenty-two patients were discharged to the ward 
Figure 1(abstract P486). Eff  ect of system changes.
Table 1 (abstract P487). Mortality in crude ICU patients and trauma patients with VAP
    Incidence of patients with  Incidence of trauma
  Mortality of all patients (%)  VAP/mortality (%)  VAP patients/mortality (%) 
Group 1 (n = 201, control)  44.3%# 10.4/67.6  15.9/57.1
Group 2 (n = 191, protocol)   32.5%**  5.2/40.0*  8.9/0*
Data are in total numbers (n) or proportions (%). *P <0.05, **P <0.01 for comparisons between two groups. #Relative risk = 1.364 (95% CI: 1.055 to 1.763) compared 
with Group 2 (protocol).
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transfers were to a local specialist centre and three to other specialist 
centres. The national paediatric transport service was used in seven 
instances, and local service in nine instances. The number of admissions 
to the ICU was few, and it was able to manage the cases and institute 
appropriate therapy. Less than 50% of these patients were transferred 
to a speciality hospital and most level 2 care could be managed in the 
district general hospital. In those needing transfer to specialist units, 
the availability of protocols for sedation and analgesia resulted in less 
delay in handover and transfers. Communications between various 
teams involved in transfer and preparation was eff  ective and no critical 
incidents were reported.
Conclusions With the specialist centre bed occupancy remaining high, 
district general ICUs provide more and more ongoing level 2 care to 
critically ill children. This also confi  rmed the fi  ndings of other studies 
that widespread use of a specialist retrieval service has not resulted in 
loss of vital stabilisation skills.
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Introduction  ICU nurses work in a demanding environment and 
they are repetitively exposed to traumatic situations and stressful 
events. There is a growing interest in the phenomenon of compassion 
fatigue (CF) and its impact on healthcare professionals; however, 
its impact on ICU nurses is basically unknown. The primary aim of 
this study was to investigate the risk for CF (the trauma suff  ered by 
the helping professional) and burnout (BO – emotional exhaustion, 
depersonalization and reduced sense of personal accomplishment), 
and the potential for compassion satisfaction (CS – the fulfi  llment 
from helping others and positive collegial relationships) among ICU 
nurses. An additional goal was to test the relationship between nurses’ 
characteristics (demographic and occupational) and CF risk.
Methods The Professional Quality of Life Scale (ProQOL R_IV, CF, BO 
and CS subscales) and a demographic tool were distributed to 335 ICU 
nurses in 22 public hospitals in the Athens greater area, Greece.
Results Findings revealed that 57.9% of ICU nurses are at the high level 
of risk for CF and 56.1% are at the high level of risk for BO, while 61.5% 
of participants reported low potential for CS. Female nurses (P = 0.016), 
with low income (P = 0.041), married (P = 0.001) or widowed (P = 0.023), 
who work as assistant nurses (P = 0.014) and also registered nurses 
with Master of Science (P = 0.008) or Nursing Specialty (P = 0.003) were 
found to have higher risk for CF. Additionally, higher risk for CF had also 
participants who characterized their relationship with their colleagues 
as neutral (P = 0.001) or bad (P = 0.030), believed that the staff   work 
sometimes as a team (P = 0.016), spend 26 to 100% of their work time 
in direct contact with the patients (26 to 50%: P = 0.001, 51 to 75%: 
P = 0.043, 76 to 100%: P = 0.024) and described their mental health as 
poor (P = 0.001), average (P <0.001) or good (P <0.001). Nurses who 
want to retain in the ICU (P = 0.003) and those who want to leave the 
hospital in few years (P = 0.005) were associated with lower risk for CF.
Conclusions The high prevalence of CF in our sample indicated that 
large numbers of ICU nurses may be experiencing these negative 
eff   ects. Knowledge of CF-related variables may help healthcare 
organizations identify nurses at risk, provide intervention strategies 
to maintain healthy outcomes for nurses and increase job satisfaction.
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Introduction  The aims were to identify whether there is burnout 
and the burnout levels of doctors and nurses working in ICUs (adult 
polyvalent units in northern Portugal). Also, to identify factors that may 
lead to the development of burnout in doctors and nurses working in 
the ICU.
Methods Application of a self-completion questionnaire with three 
items: the sociodemographic data of the study population, experiences 
in the workplace, and the Maslach Burnout Inventory – General Survey 
(Portuguese Version for Investigation 2006). For the implementation of 
methodological tools, we requested the authorization of the relevant 
institutional bodies, the ethics committee and directors of services. The 
professionals who participated in the study were asked for informed 
consent, whether formal or informal. Observation of the contexts of 
work and interviews was also done. In this study we will focus on the 
results of the questionnaire. Statistical analysis was performed using 
SPSS v.17.0.
Results A total of six hospitals, 10 polyvalent adult ICUs in the north of 
the country, 300 professionals, 73% nurses. Age of respondents was a 
median 32 years, with 8 years of professional experience and 4 years on 
the ICU. Results of the MBI: average levels of burnout in physicians and 
nurses working in the ICU. The risk of developing burnout is highest 
being a nurse 1:54 OR, yet there is no statistically signifi  cant diff  erence 
at 95% (0.837, 2.834). Nine percent of professionals studied showed 
burnout, 31% with Burnout syndrome  and high risk of burnout. 
Distribution of levels of burnout by occupational category: higher 
levels of emotional exhaustion in nurses, personal and professional 
achievement smaller in nurses, and higher depersonalization in 
doctors.
Conclusions  The results of the study underline the importance of 
promoting the prevention of burnout in doctors and nurses in the ICU.
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Introduction Medical handover is critical for quality of care in the ICU. 
Time assigned to medical handovers can vary across diff  erent units, 
with signifi  cant impact on the organization of medical work. We aimed 
to study the time spend for medical handover in ICU and its variation 
across academic, general and private hospitals in the area of the South 
West of France, the Midi-Pyrénées region.
Methods  Between August and October 2010, we questioned by 
telephone 86 physicians issued from 19 diff  erent ICUs. This prospective 
observational study mainly focused on four items: unit characteristics, 
health diary organization, medical handover procedures, and self-
assessment of satisfaction for medical handover (numeric scale from 
0 to 10).
Results Eleven general hospital centers, three private hospitals, and 
fi  ve university hospitals were concerned by the survey. The mean time 
spent for medical handover was 59 ± 35 minutes on Monday morning, 
signifi  cantly longer than other days, evening, and weekend handovers 
(P <0.001 for all comparisons). When reporting it with the number of ICU 
beds, the time spent for handover per patient was signifi  cantly shorter 
in private hospitals compared with general and academic hospitals 
(P <0.05 for all comparisons). This was true for every day. The median 
satisfaction for quality and duration were both 8, with a signifi  cantly 
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other hospital for both). See Figure 1.
Conclusions  Time spent for the medical ICU is important, with an 
approximate total time of 1 hour 30 minutes on Monday, and 1 hour the 
other days. Physicians in private hospitals spend less time for medical 
handovers. This fact should be considered for medical timework 
organization, especially in academic hospitals and in hospitals with 
large ICUs.
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Introduction The purpose of this study was to investigate whether 
the introduction of a closed ICU policy aff  ected the prognosis of the 
critically ill pediatric patients in a general ICU.
Methods  Our ICU is a general acute-care one. The Department of 
Emergency and Critical Care Medicine was established in January 2004. 
Since then, full-time intensivists performed daily rounds and decided 
the ventilatory setting, cardiovascular treatment and antimicrobial 
agents (closed policy). We collected the Pediatric Index of Mortality 2 
(PIM2) score for each pediatric patient (≤15 years old) admitted to our 
ICU from 2001 to 2009. We divided the patients into three terms: the 
early (2001 to 2003), middle (2004 to 2006), and latest (2007 to 2009) 
groups. We obtained the predicted number of deaths by summing the 
PIM2 score for every patient. We compared the ratio of observed to 
predicted deaths (O/P ratio) between the three groups.
Results The patient profi  le and results are shown in Tables 1 and 2. In 
total, 532 pediatric patients were collected. The PIM2 score increased 
signifi  cantly from 0.066 ± 0.130 in 2001 to 2003 to 0.114 ± 0.239 in 2004 
to 2006 and to 0.086 ± 0.147 in 2007 to 20009. However, the O/P ratio 
decreased from 1.49 in 2001 to 2003 to 0.82 in 2004 to 2006 and 0.82 
in 2007 to 2009.
Conclusions  The O/P ratio improved after the establishment of a 
closed policy in our general ICU.
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Introduction One in 10 patients admitted to Scottish hospitals are 
unintentionally harmed and around 50% of these events could have 
been avoided if lessons from previous incidents had been learned. A 
National Audit Offi   ce report estimated that patient safety incidents 
cost the NHS an estimated £2 billion a year.
Figure 1 (abstract P491).
Table 1 (abstract P492). Patient profi  le
  2001 to 2003  2004 to 2006  2007 to 2009
Total 194  181  157
Male  90 (46%)  94 (52%)  67 (43%)
Age (years)  2.8 ± 3.7  3.5 ± 3.9  4.1 ± 4.6
Table 2 (abstract P492). Results
  2001 to 2003  2004 to 2006  2007 to 2009
PIM2 score  0.066 ± 0.130  0.114 ± 0.239  0.086 ± 0.147
Observed death  19  17  11
Sum of PIM2  12.75  20.71  13.43
O/P ratio  1.49  0.82  0.82
Figure 1 (abstract P493). Average ICU length of stay.
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should concentrate on in order to produce reliable critical care. They 
included VAP, CVC insertion and maintenance, peripheral vascular 
catheter maintenance, daily goals, multidisciplinary ward rounds, hand 
hygiene, and glycaemic control.
Results We have seen signifi  cant reductions in our VAP and Cr-BSI 
rates with more than 230 days and 440 days between events achieved, 
respectively. Despite an increase in the complexity and severity of 
cases in the last year due to Pandemic H1N1 2009, our average length 
of stay (Figure 1) has still reduced by 2.4 days with a 0.23 reduction in 
our standardised mortality ratio (Figure 2) from 0.92 to 0.69.
Conclusions  The public display of our infection rates has helped 
change the culture in our ICU to one of transparency and safety. 
Multiple small-scale tests of change are integral to changing practice in 
a high-risk environment. Bundles of care, daily goals and checklists all 
help produce high-quality reliable healthcare.
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Introduction Critical care (CC) outcome in pulmonary hypertension 
(PH) is not well documented, but is generally assumed to be poor. 
We therefore investigated the critical care outcome in 8 years of 
noncardiothoracic admissions to a PH supraregional centre.
Methods We recorded the following data in PH patients admitted to 
CC: demography, aetiology, cardiovascular parameters including NYHA 
classifi  cation, R heart catheter and shuttle test distance (most recent 
assessment) along with organ support data. We recorded the length 
of stay (hours) in CC, CC and hospital outcome, 1-year survival and 
eventual outcome.
Results Forty-seven patients were admitted (33 women), six required 
invasive ventilation, another six required non-invasive ventilation (NIV), 
18 needed inotropic support and nine required CVVH. For survival to 
discharge, ROC analysis of shuttle distance demonstrated an asymptotic 
signifi  cance of P = 0.04 and an area of 0.71 (95% CI = 0.52 to 0.91) with 
83% sensitivity and 65% specifi  city for a shuttle of 255 metres. Those 
with a shuttle over 255 metres had an average unit survival of 94%, 
88% at hospital discharge and 47% at 1 year. Those below 255 metres 
had an average survival of 56%, 44% and 33%, respectively. Five out 
of six invasively ventilated patients died in hospital, but one lived for 
more than a year after discharge. Three out of six patients receiving NIV 
died in hospital but three lived for more than a year after discharge. 
Seventeen out of 18 who required inotropic support were dead at 1 
year and 74% died before hospital discharge. For CVVH, fi  ve died 
and four lived. Overall survival: 64% survived to leave CC, 55% were 
discharged home alive and 34% were alive at 1 year. See Table 1.
Conclusions More than one-half of PH patients admitted to CC survive 
to be discharged home. Shuttle distance gives an indication of likely 
average survival.
P495
Outcomes of haematopoietic stem cell transplant patients admitted 
to the ICU
G Bird, K Mohammed, P Farquhar-Smith, P Gruber
The Royal Marsden NHS Foundation Trust, London, UK
Critical Care 2011, 15(Suppl 1):P495 (doi: 10.1186/cc9915)
Introduction Use of haematopoietic stem cell transplant (HSCT) has 
become standard care for many types of haematological malignancies. 
Figure 2 (abstract P493). Standardised mortality ratio.
Table 1 (abstract P494)
 Age  NYHA  SpO2 RA MPAP CI  PVR  MVsats  Shuttle  LOS
Average  44 2.9 93 13 50 2.8  751 61 231  126
SD  18 0.6  6  9  14 1.1  324 12 125  154
Median  43  3  93  10  49 2.8 689 65 255 72
25th  centile  29 3 92 5 40  2.0  515  54  92  43
75th  centile 59  3  96 19 58 3.2  997  68 96  165
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sepsis, respiratory failure and graft versus host disease (GvHD) requiring 
ICU admission. Traditionally the prognosis of these patients has been 
poor with an in-hospital mortality of 60 to 95% [1]. The aim of this study 
was to determine outcomes and establish prognostic indicators of in-
hospital mortality. This may assist clinicians in identifying patients most 
likely to benefi  t from ICU therapy.
Methods  Following research approval, a retrospective study was 
undertaken in a 12-bed specialist cancer ICU over a 5-year period 
(October 2004 to September 2009). Patient variables including 
demographics, haematological diagnosis, reason for ICU admission, 
type of transplant, APACHE II, number of organ failures and type of 
organ support were recorded. The primary objective was to determine 
ICU, hospital and 6-month mortality. The secondary objective was to 
identify key prognostic variables in determining in-hospital mortality 
using univariate and multivariate analysis.
Results Eighty-four patients with were admitted to the ICU following 
HSCT. Patient characteristics: median age 53 (range 19 to 76), female 
(43%), haematological diagnosis (49% leukaemia, 30% myeloma, 
20% lymphoma), previous transplant (26%) and allogenic transplant 
(61%). Common reasons for ICU admission were respiratory failure 
(49%), sepsis (19%) and acute renal failure (11%). Median APACHE II 
was 20 (range 9 to 36) and number of organ failures was 2.5 (range 0 
to 5). In the fi  rst 24 hours of ICU admission, 65% of patients received 
mechanical ventilation, 49% renal replacement and 57% vasopressor 
therapy. ICU, in-hospital and 6-month mortalities were 38%, 51% and 
63%, respectively. Univariate analysis revealed allogenic transplant, 
GvHD, mechanical ventilation, vasopressor support, time post 
transplant >30 days and organ failure >2 were all signifi  cant predictors 
of in-hospital mortality with P values of <0.001, 0.02, 0.001, 0.02, 0.01 
and 0.002 respectively. Multivariate analysis revealed that allogenic 
transplant, mechanical ventilation and time post transplant >30 days 
were independent prognostic predictors of in-hospital mortality.
Conclusions Our outcome data were favourable in comparison with 
other published studies. Allogenic transplant, mechanical ventilation 
and time post transplant >30  days were independent factors that 
predicted poor outcome.
Reference
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Patterns of infection and impact on outcome in haematology 
patients admitted to intensive care
R José, I McDonald, P Pfeff  er, S Shaw, C Kibbler, B Agarwal
Royal Free Hospital, London, UK
Critical Care 2011, 15(Suppl 1):P496 (doi: 10.1186/cc9916)
Introduction Infections with opportunistic pathogens in stable chronic 
haematological patients are well known. Recent reports suggest that 
these patients admitted to intensive care (ICU) tend to do as well as or 
better than those without infection [1]. We sought to study the pattern 
of all infections diagnosed in haematology patients in our ICU.
Methods Data on infections were retrospectively collected for haemato-
logy patients consecutively admitted to our unit (tertiary haematology 
referral centre) for the period of January 2005 to December 2008. Re-
admissions (9/106) were excluded. Bacteria, mycobacteria and fungi were 
identifi  ed by culture and viruses detected by DNA PCR. Coagulase-negative 
staphylococcus was excluded from the analysis, as they most probably 
represented contaminants. Data were analysed with SPSS software.
Results  Ninety-seven patients were admitted during the study 
period, 71% with known or clinically suspected infection. The most 
commonly identifi  ed bacteria were Pseudomonas aeruginosa (15.4%) 
and Enterococcus faecalis (11.3%); viruses were cytomegalovirus (CMV) 
(17.5%) and respiratory syncytial virus (RSV) (17.5%); and fungi were 
Candida species (6.2%). Known or clinically suspected infection at 
admission, identifying an organism, presence of infection with multiple 
organisms, and infection type were not associated with increased ICU or 
hospital mortality (P >0.05), but resulted in signifi  cantly longer ICU and 
hospital LOS. Increased ICU LOS (days) (mean (SD)) was associated with 
identifying an organism (7 (8) vs. 16 (6); P <0.001), number of organisms 
per patient (0, 1, 2, 3) (7 (7), 13 (13), 16 (8), 41 (29); P = 0.006), infection 
type (not identifi  ed, bacterial, viral, mixed, fungal) (7 (8), 15 (19), 16 (12), 
17 (9), 26 (24); P <0.001)), viral infection (11 (15), 16 (11); P = 0.005), CMV 
viraemia (11 (14), 18 (12); P = 0.002), while increased hospital LOS (days) 
(mean (SD)) was associated with identifying an organism (37 (34) vs. 61 
(60); P = 0.004) and infection type (not identifi  ed, viral, fungal, bacterial, 
mixed) (37 (34), 47 (34), 52 (41), 67 (77), 69 (36); P = 0.025).
Conclusions Most patients with haematological diagnoses admitted 
to our ICU had a clinically suspected or documented infectious cause. 
Although infection characteristics are not associated with overall 
mortality, they are associated with prolonged ICU and hospital LOS.
Reference
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Outcome of haematology patients admitted to intensive care 
in a tertiary centre: primary haematological diagnosis, recent 
chemotherapy and bone marrow transplantation are not associated 
with outcome
R José, I McDonald, P Pfeff  er, S Shaw, B Agarwal
Royal Free Hospital, London, UK
Critical Care 2011, 15(Suppl 1):P497 (doi: 10.1186/cc9917)
Introduction Acute illness in patients with underlying haematological 
disease is associated with poor prognosis. Recent reports suggest 
improved outcomes in these patients except for those with bone 
marrow transplantation (BMT) or recent chemotherapy [1]. We sought 
to audit the overall outcome and potential determinants of outcome in 
these patients admitted to our ICU.
Methods  Retrospective data on demographics, underlying 
haematological diagnosis, BMT, recent chemotherapy, reason for acute 
illness, severity of acute physiological derangement (severe acute 
physiological score (SAPS), number of failed organs, need for invasive 
mechanical ventilation and renal support), and ICU and hospital 
outcomes were collected for 106 consecutive admissions (97 patients) 
between January 2005 and December 2008. Re-admissions were 
excluded (9/106 patients). Data were analysed with SPSS software.
Results Of the 97 patients, NHL (30.9%) and AML (26.8%) accounted 
for most haematological diagnoses. A total 24.7% were post-BMT, 
and 36.1% had chemotherapy within a month of admission or on 
the ICU. The mean (SD) age was 49 (15), SAPS 55 (16) and 56.7% were 
males. The mortality at ICU and hospital discharge was 51.5% and 
63.9%, respectively. Gender, neutropaenia (≤1 x 109/l), haematological 
diagnosis, admission reason, HIV status, BMT and recent chemotherapy 
were not predictive of ICU or hospital outcome (P >0.05). SAPS, invasive 
mechanical ventilation (IMV), renal support (RS) and sequential number 
of organs supported (OS) were predictive of both ICU and hospital 
mortality outcomes (P <0.05).
Conclusions There is ongoing heightened risk of mortality in patients 
with haematology diagnoses admitted to the ICU with acute illness, 
related to both the severity of the initial physiological disturbance and 
requirements for organ support. In our patient population, BMT and 
recent chemotherapy were not associated with increased mortality, 
but this will need further evaluation with a larger sample size.
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New prognosis infl  ammatory and nutritional indexes: comparison 
with the Prognostic Infl  ammatory and Nutritional Index as 
reference index
F Ziegler, L Codevelle, E Houivet, J Benichou, A Lavoinne, P Dechelotte
Université et CHU, Rouen, France
Critical Care 2011, 15(Suppl 1):P498 (doi: 10.1186/cc9918)
Introduction The Prognostic Infl  ammatory and Nutritional Index (PINI) 
was previously developed to improve the diagnosis and monitoring of 
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and mortality risk, especially in ICU patients [1]. The formula includes the 
determination of four serum protein concentrations: PINI = (C-reactive 
protein (CRP) (mg/l) x orosomucoid (OROSO) (g/l)) / (albumin (ALB) 
(g/l) x transthyretin (TTR) (g/l)). Since CRP may be considered now as 
the gold standard for assessing and monitoring infl  ammatory states 
in clinical practice, OROSO is generally unavailable for PINI calculation. 
Elsewhere, the strong and rapid changes in CRP levels (0 to 600 mg/l) 
in acute infl  ammation may lead to an overestimation of the risk of 
morbidity and mortality suggested by the PINI. The aim of this study 
was to evaluate alternative biological formulas by removing OROSO 
from the PINI and replacing CRP value by its logarithm (Log), in order to 
reduce the mathematical weighting of this biomarker.
Methods Blood samples of 106 patients hospitalized in intensive care, 
gastrointestinal surgery, vascular and thoracic surgery, pneumology, 
gastroenterology or internal medicine units were drawn to measure 
serum concentrations of ALB, TTR, CRP and OROSO. Proteins were 
determined using an immunonephelometry method (BN2; Siemens, 
Germany). The correlations between six new formulas and the PINI 
were studied – that is, CRP / ALB x TTR, Log(CRP) / ALB x TTR, CRP / TTR, 
Log(CRP) / TTR, CRP / ALB and Log(CRP) / ALB – using the Spearman 
rank test.
Results The relations obtained between the PINI and the experimental 
formulas were linear (y =  ax  +  b) with formulas without Log and 
nonlinear when a Log was used (y = ax2 + bx + c or y = log(x) + b). All 
six formulas were correlated with the PINI (0.78 <R <0.94, P <0.0001). 
CRP / ALB x TTR, Log(CRP) / ALB and CRP / TTR showed the highest 
correlations, with R = 0.94, 0.91 and 0.90, respectively. The less elevated 
correlation was observed using CRP / ALB (R = 0.78).
Conclusions Among the six new formulas compared with the PINI, 
that omitting only OROSO provided the best performance. The control 
of CRP weighting obtained with Log(CRP) in the formula Log(CRP) / 
ALB appears promising in current clinical practice, since it involves the 
most often used serum proteins to assess infl  ammatory and nutritional 
status.
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Feasibility and utility of frailty assessment in the over 80s on critical 
care
B Charles, R Porter, D Bryden
Sheffi   eld Teaching Hospitals NHS Trust, Sheffi   eld, UK
Critical Care 2011, 15(Suppl 1):P499 (doi: 10.1186/cc9919)
Introduction A recent UK-wide audit in perioperative care of the over 
80s recommended the use of frailty assessment as an independent 
marker of risk in older people [1]. Our critical care unit (CCU) has 
a fully integrated patient data management system (Metavision®) 
incorporating notes, patient data and laboratory results. We wished to 
determine the feasibility and utility of performing frailty assessments 
using our existing data collection tools on all patients over 80 years old.
Methods Retrospective data collection identifi  ed all patients >80 years 
old admitted to CCU over a 22-month period to November 2010. 
Frailty was assessed by means of the Canadian Study of Health and 
Aging index, which has been validated as a simple assessment tool [2]. 
APACHE II scores and numerical assessments of polypharmacy were 
also noted.
Results A total of 112 patients were identifi  ed with a median age of 83 
years (80 to 92). Seventy-three per cent (n = 83) were discharged from 
critical care alive and 57% survived to leave hospital. Survival for those 
aged under 80 was signifi  cantly higher with 83% (P = 0.01) and 73% 
(P = 0.00) surviving until critical care and hospital discharge, respectively. 
Frailty was only able to be assessed in 66 (58.9%) of patients. Scores 
were as shown in Figure 1 but bore no relationship to survival. On 
multivariate analysis, APACHE II scores but not polypharmacy or frailty 
score were independent predictors of mortality.
Conclusions Our patients had a signifi  cantly lower unit and hospital 
survival than those aged under 80 and this may refl  ect the need for 
better assessment tools of frailty and co-morbidity in the critical care 
population. Current critical care data collection is not suffi   cient to 
adequately assess and record frailty in our unit. The National Institute 
for Health and Clinical Excellence will be producing a guideline for 
critical care in older patients and this should include a review of frailty 
assessment.
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Introduction The aim of this study was to determine the quality of 
life (QOL) in patients over 80 years old following intensive care who 
were admitted with a medical diagnosis. The older ICU population is 
increasing, and using QOL after critical illness rather than mortality 
may represent a better outcome measure. The evidence is confl  icting, 
with some studies suggesting good QOL scores in the older patients 
compared with younger patients, whilst others show the opposite. This 
may be due to diff  erences in study design with variations in age group 
studied and the follow-up period. Our study uses a novel approach to 
evaluate QOL using aged-matched controls.
Methods A total of 296 patients aged ≥80 years with a medical diagnosis 
were admitted to the ICU between 1 January 2006 and 31 December 
2009. Patients alive in May 2010 were sent two questionnaires, one 
assessing subjective changes before and after ICU admission in four key 
areas (QOL, physical ability, mood and memory) and a second validated 
QOL scoring tool (SF-36). Patient views regarding their ICU stay were 
also explored. A control group of age-matched patients was identifi  ed 
from outpatient clinics and given similar questionnaires to complete.
Results Of 261 ICU admissions fulfi  lling the study criteria, 201 survived 
to ICU discharge and 148 to hospital discharge (73.6%). Of these, 81 
were alive in May 2010. Forty-nine were sent questionnaires and 
27 were returned (55%). Questionnaires were sent to 33 controls. 
Questionnaire 1 (subjective QOL) – in all key areas patients felt that 
their QOL had decreased following admission to ICU. Questionnaire 
2 (SF-36) – there was no statistical diff  erence between patients and 
controls in any of the SF-36 domains (Mann–Whitney U test, P <0.05). 
Views regarding intensive care: 24/25 former ICU patients believed that 
admission to intensive care was in their best interest, 21/25 would want 
to be treated in intensive care again if needed, compared with 15/27 
of controls. Eleven out of 25 former ICU patients had discussed their 
wishes regarding future treatment on intensive care with someone 
compared with 6/28 controls.
Conclusions The SF-36 results indicated that QOL scores in elderly 
survivors of medical intensive care are not signifi  cantly below those 
of their peers. There is, however, a subjective reduction in QOL. The 
majority of ICU survivors in this age group would want such treatment 
again
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Figure 1 (abstract P499). Frequency of frailty scores.
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Is age a predictor of mortality in medical high-dependency units?
E Hood, A Bhangu, D Pandit, A Michael
Russells Hall Hospital, Dudley, UK
Critical Care 2011, 15(Suppl 1):P501 (doi: 10.1186/cc9921)
Introduction The population aged >65 years is set to rise by 32% by 
2033. As resources are limited, diffi   cult decisions regarding access to 
high-dependency care for the older person will become increasingly 
important. The aim of this study was to determine whether age is a 
predictor of mortality in patients admitted to an open medical high-
dependency unit (MHDU).
Methods A prospective observational cohort study of 100 consecutive 
patients admitted to a MHDU with a medical diagnosis over a 3-month 
period. The primary endpoint was 30-day mortality.
Results Overall mortality at 30 days was 21% (n = 21). Forty-one per 
cent of patients were aged <65 years, 29% 65 to 74 years and 30% 
75+ years. There were no signifi  cant diff  erences in mortality between 
groups (12%, 31% and 23%, respectively). When considering APACHE 
II scores ≥25, there was no signifi  cant diff  erence in mortality between 
age groups (35% <70 years (7/20) vs. 29% ≥70 years (4/14), P = 1.000). 
The fi  nal model at multivariable regression analysis identifi  ed that 
≥2 organ support (odds ratio = 10.843, 95% CI = 3.281 to 35.836) and 
preadmission moderate/nursing home care (4.437, 95% CI  =  1.053 
to 18.697) were signifi   cantly associated with worse outcome. ROC 
curve analysis for death showed that APACHE II score was a moderate 
discriminator (area under the curve = 0.64, 95% CI = 0.53 to 0.75), and 
age (0.60, (0.48 to 0.72)) was a poor predictor for 30-day mortality. The 
majority of survivors (88%) were discharged at their preadmission 
functional status; those who declined in function were not signifi  cantly 
older than those who did not. See Figure 1.
Conclusions  Age does not predict outcome from MHDU. Patients 
requiring ≥2 organ support and/or higher levels of preadmission home 
support had higher mortality. Selected elderly medical patients can be 
expected to have outcomes comparable with younger patients and 
should not be denied MHDU care.
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Inadvisably presenting APACHE scores as parametric data: a study 
of 200 original articles from leading journals
R Kam1, C Bunce2, JM Handy3
1Imperial College London, UK; 2Moorfi  elds Eye Hospital NHS Foundation Trust, 
London, UK; 3Chelsea & Westminster Hospital, Imperial College London, UK
Critical Care 2011, 15(Suppl 1):P502 (doi: 10.1186/cc9922)
Introduction The APACHE score, used to indicate severity of systemic 
illness in patients, is the sum of separate points given for diff  erent 
aspects of organ dysfunction. It is therefore ordinal data, and in 
intensive care patients should not simply be assumed to be well 
approximated by a normal distribution. This study aimed to discover 
what proportion of recent intensive care literature is presenting this 
score inadvisably as normal data.
Methods  Twenty of the most recent original articles containing 
‘APACHE’ or ‘Acute Physiology and Chronic Health Evaluation’ were 
identifi  ed from each search engine of 10 highly cited journals with 
notable intensive care literature content. Studies presenting an 
average score and a measure of central spread were included. Statistical 
methods used were recorded.
Results Approximately 70% of identifi  ed papers presented APACHE 
data as means and standard deviations, and 48% used these data in 
parametric tests. Eighty-one per cent did not mention assessment of 
skewness or kurtosis and only 7% documented the test used to assess 
whether the distribution appeared normal.
Conclusions Inadvisable presentation and processing of APACHE data 
is commonplace in critical care journals and authors should exercise 
greater awareness of the potentially skewed distribution of the 
data. Medians and interquartile ranges suit its ordinal nature better. 
Subjecting APACHE data to parametric analysis when non-normally 
distributed will increase the risk of type 1 or type 2 errors depending 
on the nature of departure from non-normality.
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ICU scoring systems: which one to use in oncology patients?
D Juneja, P Nasa, O Singh, R Dang, Y Javeri, G Singh
Max Superspeciality Hospital, Delhi, India
Critical Care 2011, 15(Suppl 1):P503 (doi: 10.1186/cc9923)
Introduction The aim was to assess the performance of various ICU 
scoring systems in oncology patients.
Methods  A prospective analysis of data for all oncology patients 
admitted to the ICU over 6 months. For mortality prediction, SMR was 
computed. Calibration was assessed by Lemeshow–Hosmer goodness-
of-fi  t test and discrimination by AUROC curves. Primary outcome was 
ICU mortality.
Results ICU mortality was 36.5%. Mortality predicted by SAPS II score 
was closest to that of actual mortality with a SMR of 1.003, followed by 
that of MPM II0 (0.855) and APACHE II (1.181) scores (Table 1). SAPS II 
(χ2 = 1.842; P = 0.985) had the best calibration. Mechanical ventilation 
Figure 1 (abstract P501). Survival of high-risk (2+ organ support and 
high preadmission care levels) versus low-risk groups, split by age.
Table 1 (abstract P503). AUC for predicting ICU mortality
Parameter Survivors Nonsurvivors  P value
Males 44  26  0.854
Females 22  12   
Metastasis 42  22  0.562
Ventilation 5  35  0.00
Vasopressors 7  37  0.00
Table 2 (abstract P503). Baseline characteristics of survivors and 
nonsurvivors
Scoring system  AUC  95% CI
APACHE II  0.726  0.629 to 0.824
APACHE III  0.818  0.733 to 0.903
APACHE IV  0.793  0.707 to 0.880
SAPS II  0.718  0.615 to 0.820
SAPS III  0.781  0.686 to 0.877
MPM II0  0.750  0.648 to 0.853
MPM III0  0.684  0.573 to 0.795
SOFA  0.769  0.678 to 0.859
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(Table 1). All of the scores tested had good effi   cacy but none reached 
statistical signifi  cance (Table 2).
Conclusions The SAPS II and APACHE III scores showed good accuracy, 
calibration and mortality prediction. Nevertheless, the diff  erence 
in effi   cacy was not statistically signifi  cant and the choice of scoring 
system may depend on the ease of use and local preferences.
P504
Do scoring systems predict mortality following emergency 
abdominal aortic aneurysm repair? The Norwich experience
S Kumar, J Nortje
Norfolk & Norwich University Hospital, Norwich, UK
Critical Care 2011, 15(Suppl 1):P504 (doi: 10.1186/cc9924)
Introduction  APACHE II scores [1] and Glasgow Aneurysm Scores 
(GAS) [2] are commonly used in ICUs to predict mortality. These scoring 
systems (scores α mortality), when applied to postoperative emergency 
open abdominal aortic aneurysm (AAA) repair patients, yield varying 
results. We applied these scoring systems to our patients to establish 
their predictive value in our clinical setting.
Methods This retrospective audit included patients who underwent 
emergency open AAA repair and were admitted to our ICU, over a 
period of 1 year (November 2008 to November 2009). These patients 
were identifi  ed from our local ICU database (Metavision®) and scores 
(APACHE II and GAS) were calculated for each of these patients. The 
mortality rates were compared with the national average [3].
Results A total of 98 AAA repair patients were identifi  ed, of whom 
35 patients (32 males and three females) had undergone emergency 
(ruptured) repair. Seven patients (20%), including two females, died 
in the ICU. There is an increase in mortality with increasing APACHE II 
scores (Figure 1). The same does not apply for GAS scores but all the 
patients who died had a GAS score >89. Our mortality rate was 20% 
compared with the national mortality of 38% (Figure 2).
Conclusions APACHE II scores seem to be more predictive of our unit 
AAA mortality rates than GAS scores. We aim to apply these scores 
to a larger dataset and also determine possible reasons for improved 
survival.
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APACHE IV and SAPS III
MT Keegan, O Gajic, B Afessa
Mayo Clinic, Rochester, MN, USA
Critical Care 2011, 15(Suppl 1):P505 (doi: 10.1186/cc9925)
Introduction The presence of a do-not-resuscitate (DNR) order is an 
independent predictor of mortality in ICU patients [1]. Of the major 
ICU prognostic scoring systems, only MPM III includes DNR status as a 
predictor. The infl  uence of DNR status on APACHE III and IV and SAPS 
III is unknown. We hypothesized that there would be diff  erences in the 
performances of APACHE III, APACHE IV, and SAPS III when DNR status 
was included as a predictor variable.
Methods A retrospective cohort study was performed. Demographic, 
physiologic and outcome data for 2,596 patients admitted to one 
of three ICUs (medical, surgical, mixed) at our tertiary referral center 
in 2006 were collected. The presence or absence of a DNR order on 
ICU admission and at the end of the fi  rst ICU day was recorded. The 
performance of each of the four models, with and without inclusion 
of fi  rst-day DNR status, was assessed using the area under the receiver 
operating characteristic curve (AUC) for discrimination and the 
Hosmer–Lemeshow statistic (HLS) for calibration. Comparison of model 
performance was as described by Hanley [2].
Results  Of the 2,596 patients studied, 211 (8.1%) and 252 (9.7%) 
had DNR orders on ICU admission and at the end of the fi  rst ICU day, 
respectively. Two hundred and eighty-three patients (10.9%) did not 
survive to hospital discharge. A total 19.4% of the nonsurvivors had 
DNR orders on admission versus 6.7% of the survivors, P <0.01. At the 
end of the fi  rst ICU day, 32.5% of nonsurvivors were DNR versus 6.9% 
of survivors, P <0.01. The AUCs (95% CI) of the models for prediction of 
hospital mortality were 0.868 (0.854 to 0.880), 0.861 (0.847 to 0.874) and 
0.801 (0.785 to 0.816) for APACHE III and IV, and SAPS III, respectively. 
When DNR status at end of the fi  rst ICU day was included in the models, 
the AUCs were 0.876 (0.855 to 0.897), 0.868 (0.846 to 0.891), and 0.816 
(0.791 to 0.841), respectively. There were no signifi  cant diff  erences 
between the discriminative ability of the models with and without DNR 
status (APACHE III P = 0.103, APACHE IV P = 0.145, SAPS III P = 0.072). 
The HLS for the models with and without DNR status were 33.7 and 
29.3, 31.0 and 33.3, and 36.6 and 29.0 for APACHE III and IV and SAPS III, 
respectively. Each of the HLS generated P <0.05.
Conclusions  Neither the discrimination nor calibration of APACHE 
III and IV and SAPS III were signifi  cantly improved by the inclusion of 
resuscitation status at the end of the fi  rst ICU day in the prognostic 
models.
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Figure 2 (abstract P504). AAA mortality NNUH versus UK.
Figure 1 (abstract P504). AAA mortality versus APACHE mortality.
Critical Care 2011, Volume 15 Suppl 1 
http://ccforum.com/supplements/15/S1
S178P506
Limitations of the use of the Glasgow Coma Scale in intensive 
care patients with non-neurological primary disease: a search for 
alternatives
PV Dong, OL Cremer
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Introduction Numerous scoring systems have been devised to assess 
the severity of illness and predict outcome in critically ill patients in the 
ICU, many of which incorporate the Glasgow Coma Scale (GCS) as a key 
component. However, the GCS requires observation of a verbal score 
(which is often unavailable in the ICU), must be interpreted in cases of 
concurrent sedation, and is insensitive to more subtle derangements 
of consciousness (such as delirium). Furthermore, its relationship with 
outcome may be nonlinear. In this study we quantifi  ed the practical 
limitations of using the GCS in daily routine. We then aimed to provide 
alternative methods for neurological assessment scoring in case of 
missing GCS scores.
Methods We performed an observational study of all patients admitted 
to a large tertiary ICU from January 2009 until September 2010. Patients 
following elective surgery, having an uncomplicated stay <96 hours, 
were excluded from analysis. We collected data on neurological status 
and sedation. All variables were assessed for their ability to predict 
hospital mortality, using multivariate logistic regression analyses 
that included the variables of primary interest as well as any relevant 
covariates.
Results In total 1,128 patients were included (62% males, mean age 
58  ±  17 years, 40% surgical admissions). We observed an overall 
26% hospital mortality rate (compared with 30% predicted by the 
APACHE IV model). In patients with maximum GCS motor scores of 
M1 and M2–3 on their fi  rst day in the ICU, the mortality rate was 62% 
and 79%, respectively. Within the large majority of patients with a 
M6 score, we observed a broad range of clinical variance, expressing 
low discriminative ability of the GCS motor score. We found inferior 
predictive power of the APACHE IV model in patients with non-
neurological primary disease (c statistic = 0.75 to 0.79) compared with 
patients with acute neurological injury (0.85 to 0.86). The predictive 
power of the APACHE IV model improved when substituting missing 
GCS components by other neurological observables.
Conclusions The GCS is diffi   cult to obtain and interpret, and shows 
inconsistent predictive power. In patients with non-neurological 
primary disease, the use of alternative observables, such as pupillary 
anomaly, RASS score and sedative use, may serve as a substitute score 
in cases of missing or unobservable GCS assessments.
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Introduction  Unrecognised clinical deterioration resulting in near 
or actual cardiorespiratory arrest in hospitalised children sadly still 
occurs. The majority of these events may be preventable. Royal 
Manchester Children’s Hospital (RMCH) introduced a simple track and 
trigger Early Warning System (ManChEWS) in 2005 by which variation 
in six key physiological parameters is scored according to a traffi   c-
light system in routine nursing observations. The aim was to evaluate 
use of ManChEWS since its introduction, in order to allow continued 
improvement and development.
Methods  Three audits were carried out: an audit to evaluate 
ManChEWS in emergency admissions to the PICU or PHDU (2006 to 
2007), a prospective audit of children who trigger EWS on the ward 
but do not require admission to the PHDU/PICU (2009), and an audit to 
evaluate the use of ManChEWS in children that died between 2005 and 
2008 following an acute deterioration on the wards.
Results ManChEWS correctly identifi  es the clinically deteriorating child 
on the ward. ManChEWS is over-triggering, leading to staff   becoming 
immune to triggers. This is due to the high frequency of underlying 
illness in children admitted to RMCH. Medical staff   are not currently 
redefi  ning parameters for children with abnormal baseline parameters. 
ManChEWS is not being universally used in RMCH. Twenty-fi  ve per cent 
of deaths in RMCH were attributable in part to ‘the failure to recognise 
a sick child’. These might have been prevented by the correct use of 
ManChEWS.
Conclusions  ManChEWS correctly identifi  es the deteriorating child 
and off  ers staff   a clear pathway for escalation of care and senior review. 
ManChEWS is not being used correctly on the wards by medical or 
nursing staff  . For patients with underlying disease, ManChEWS over-
triggers, leading to staff   becoming immune to triggers. Developments 
and the future Development of an EWS Steering Group. Daily review 
of patients triggering ManChEWS by development of an outreach 
team. Electronic EWS implementation across the Trust. Patients with 
underlying illness may have individualised parameters set by senior 
medical staff  .
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Does an open level 2 medical high-dependency unit improve 
outcomes for critically ill patients? Using the APACHE II scoring 
system in a district general hospital in the UK
V Hurley, D Pandit
Russells Hall Hospital, Birmingham, UK
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Introduction  Improving care of acutely ill medical patients led to 
formation of a six-bed level 2 medical high-dependency unit (MHDU). 
The aim of this study was to look at outcomes of medical patients 
admitted to an open level 2 MHDU.
Methods One hundred and nine patients were consecutively admitted 
to the MHDU in a prospective observational study. APACHE II derived 
mortality scores averaged for two groups of patients – those who 
survived the admission and those who did not – and were assessed 
using a chi-squared test.
Results A total 48.6% of patients were male, mean age 59.3 years (range 
0 to 98 years). Average total length of stay in hospital was 16.55 days 
with average 4.29 days in the MHDU (range 0 to 18 days). In total, 
34.9% admissions were respiratory in origin, 22% sepsis, 10% GI, 7.4% 
poisonings, 5.5% other, 4.6% renal, 3.6% cardiac, 2.8% neurological 
and <1% unclassifi  ed. A total 29.3% of patients were admitted directly 
from A&E, 37.6% from the emergency admissions unit and 33% from 
the wards (27% of these from ITU). Two per cent of patients required 
ITU admission after the MHDU. Twenty-two patients out of 109 died 
during this admission, 13 of them while admitted to the MHDU. Deaths 
were classifi  ed according to diagnosis on admission to the MHDU, with 
45% with GI disease dying, 29% with sepsis, 22% endocrine and 21% 
respiratory. These patients were deemed not suitable for escalation to 
level 3 care. Of 109 patients, full APACHE II data were available for 87. Of 
this subcohort, 16 patients died and 71 survived. Expected values were 
calculated and predicted that 26 should have died and 61 survived 
(P <0.05) from the APACHE II data.
Conclusions The cost of NHS care is becoming increasingly important 
in the UK and anecdotal evidence suggests a high proportion of 
patients managed in level 3 care could more appropriately be managed 
with a lower level of care ideally in an HDU setting, while decisions 
can be made whether the physiological status of the patient justifi  es 
escalation of care. This observational study raises questions about 
appropriateness of admission to MHDU and has led to improvement 
of gatekeeping to the unit. This study also demonstrates increasing 
involvement of critical care in managing end-of-life challenges. We 
have used this study to demonstrate to our colleagues what critical 
care can and cannot off  er. Future studies to characterise performance 
of our unit will use the SAPs and risk profi  le management method.
Reference
1. Knaus  WA  et al.: APACHE 2: a severity of disease classifi  cation system. Crit 
Care Med 1985, 13:818.
Critical Care 2011, Volume 15 Suppl 1 
http://ccforum.com/supplements/15/S1
S179P509
Gastrointestinal failure score alone and in combination with SOFA 
score in the assessment of the critically ill patients
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Introduction  Gastrointestinal problems occur frequently and are 
associated with an adverse outcome in critically ill patients; despite 
this, gastrointestinal (GI) function is not included in any of the widely 
used scoring systems assessing organ failures in critical illness. Several 
studies have demonstrated an impact of intra-abdominal hypertension 
(IAH) on mortality [1]. With the goal of developing a scoring system for 
GI failure, Reintam and colleagues combined GI symptoms and IAH into 
a fi  ve-grade scale – the Gastrointestinal Failure Score – and tested it 
among critically ill patients in Estonian ICUs [2]. The aim of our study 
was to evaluate the GIF score in our Egyptian ICUs regarding validity 
and impact on mortality and comparing this with the SOFA score.
Methods We studied 109 mechanically ventilated patients on day 1 
admitted to the general ICU of Kasr El Aini Hospital and Theodor Bilharz 
Research Institute in the period from March 2009 to November 2009. 
The SOFA + GIF scores were calculated each day by summarizing the 
SOFA score and the GIF score of the respective day in each patient.
Results FI developed in 35.8%, IAH in 26.9% and both of them together 
in 14.7% of all patients. Compared with patients with mean GIF = 0, 
patients with mean GIF higher than 0 and lower than or equal 2 and 
mean GIF higher than 2 show higher ICU mortality (100%, 81.4% vs. 
48.2% P <0.0001), respectively. The GIF score integrated into the SOFA 
score allowed a better prediction of ICU mortality than the SOFA score 
alone shown by AUC 0.92 and 0.890, respectively.
Conclusions The mean GIF score in the fi  rst 3 days on the ICU demon-
strated a high prognostic value in prediction of ICU mortality. Further 
multicenter studies should confi  rm whether GIF score could be advo-
cated as an adjuvant subscore for GI tract assessment in the SOFA score.
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Introduction We aimed to clarify the associations between lactate 
levels and ICU mortality and their changes over 6 years in one ICU.
Methods All patients admitted to the general ICU of university hospital 
from 2005 to 2010 were studied. Highest lactate on admission day in 
the ICU was documented.
Results In total, 1,830 patients were treated, 417 were excluded due 
to incomplete data and 1,413 patients were included in the study. 
Survivors had a mean blood lactate level of 2.8 ± 3.3 versus 8.9 ± 7.2 
mmol/l in nonsurvivors (P <0.001). The lactate levels of survivors versus 
nonsurvivors over the years are presented in Figure 1. The survival in 
diff  erent lactate groups is presented in Figure 2.
Conclusions There is a linear correlation between blood lactate levels 
and ICU mortality. A considerable amount of patients with very high 
lactate levels survive the ICU. There is no certain lactate level that may 
reliably predict an adverse outcome.
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Outcome prediction in haematological patients requiring admission 
to the ICU
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Introduction The outcome of haematological patients admitted to 
the ICU is improving [1,2]. However little is known of the predictive 
factors that determine hospital outcome in this group of patients. We 
hypothesised that certain haematological factors may predict a worse 
outcome in these patients requiring admission to the ICU.
Methods  We retrospectively reviewed all haematological patients 
admitted to a 15-bed medicosurgical ICU of a teaching hospital over 
a 5-year period from 1 April 2005 to 31 March 2010. Data on validated 
outcome predictors including age, APACHE II score, APACHE II 
predicted mortality, length of ICU stay, and requirement for mechanical 
ventilation were collected. Furthermore outcome predictors deemed 
important in haematological patients were also collected, including 
neutropaenic status at onset of illness, malignancy status at onset 
of illness and whether chemotherapy was received within 30  days 
of admission to the ICU. We performed logistic regression analysis to 
model these variables against hospital mortality.
Results  Fifty-six haematological patients were admitted to the ICU 
during the study period. Data from three patients were incomplete and 
they were therefore excluded from the analysis. Mean age (SD) 54 (18.5) 
years; mean APACHE II score (SD) 23.4 (6.8); mean APACHE II predicted 
mortality (SD) 50.6 (23.8)%; mean ICU stay (SD) 4.6 (3.7) days. Twenty 
patients (35.7%) were mechanically ventilated on admission to the ICU. 
Thirteen patients (26%) were neutropaenic at onset of critical illness; 
40 patients (75.5%) had a haematological malignancy and 31 patients 
(56.6%) had received chemotherapy within 30  days of the onset of 
critical illness. The standardised mortality ratio (95% CI) for this cohort of 
patients was 0.86 (0.82 to 0.91). Logistic regression analysis revealed no 
relationship between these variables and hospital mortality even after 
adjusting for age, APACHE II score, length of ICU stay and requirement for 
mechanical ventilation. Adjusted OR (95% CI) for neutropaenic status at 
Figure 1 (abstract P510). Lactate levels of survivors versus nonsurvivors 
over the years. #Diff  erence between survivors and nonsurvivors, P <0.005.
Figure 2 (abstract P510). ICU survival rates according to lactate levels.
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illness OR was 0.54 (0.1 to 3.7) P = 0.53. Chemotherapy within 30 days of 
admission to ICU OR was 0.4 (0.1 to 2.2) P = 0.30.
Conclusions  Haematological factors including neutropaenia, 
haematological malignancy and recent chemotherapy do not predict 
worse outcomes in this group of patients. With improving mortality 
rates, all haematological patients should be considered for admission 
to the ICU.
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Introduction  Our purpose is to study the eff   ect of high-activity 
antiretroviral treatment (HAART) on the epidemiology and outcome of 
human inmunodeffi   ciency virus (HIV) patients in the ICU. HAART has 
modifi  ed the outcome of patients infected with HIV, increasing survival 
and reducing infectious complications. In the fi  rst years of HAART use a 
signifi  cant change in the diagnosis and prognosis of ICU-admitted HIV 
patients has been identifi  ed, but there are no studies investigating this 
issue in the most recent years.
Methods A retrospective study. HIV patients admitted to a 36-bed 
ICU, between January 2005 and December 2009 (HIV incidence in 
our population: 42 cases/million hab/year). We studied demographic 
characteristics, having or not HAART, fi  nal diagnosis, need for organ 
support and outcome (length of stay (LOS) and mortality).
Results  One hundred and fi   ve HIV-infected patients (70.5% being 
male), 52 (49.5%) having HAART. Mean age: 41  ±  8.57 years. More 
common co-morbidities were: hepatic disease (61%), cirrhosis in a 
10.5%, followed by chronic respiratory disease and dyslipemia (12.4%), 
cardiac disease (5.7%), solid and hematologic malignancy (5.7% and 
2.9%, respectively). A total 70.5% had a history of intravenous drugs 
use, and 13.3% were heavy alcohol consumers. Average CD4 count 
was 275.4 ± 362/ml, mean viral load was 3,656 ± 3,000/ml. A total 
52.1% were on their CD4 nadir at admission time. Most frequent fi  nal 
diagnosis (grouped): infectious disease, 58.3% (focus: lung 66.7%, CNS 
16.7%), cardiac disease (12.7%), intoxication and trauma (5.8% each 
one). Average APACHE II: 20.9. A total 48.6% of patients needed support 
with vasopressors, 64.7% mechanical ventilation and 15.2% renal 
support. A total 69.5% of patients needed at least one organ support. 
ICU LOS: 8.7 ± 9.9 days, hospital LOS: 29 ± 29.5. ICU mortality: 28.6%, 
hospital mortality: 35.2%.
Conclusions Despite the benefi  cial eff  ects of HAART on inmune status, 
infection (especially pneumonia) remains the most common cause of 
ICU admission. Our results confi  rm the trend to a lower mortality saw in 
early HAART period studies.
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Introduction  Despite therapeutic advances during this century, 
maternal mortality remains an important public health problem. 
So it was logical to study these patients who were referred from the 
Gynecology and Obstetric Department to our ICU aiming to review 
a series of these patients in order to assess the spectrum of diseases, 
required interventions, complications that occurred and maternal 
mortality and to identify conditions associated with maternal death.
Methods A retrospective cohort study in the Critical Care Medicine 
Department, Cairo University. The medical records of all obstetric ICU 
admissions over the period from January 2005 to December 2009 were 
reviewed.
Results Over these 5 years, 169 women required ICU admission (1.6% 
of all ICU admissions). The mean age was 29.29 ± 6.06 years; mean 
gestational age was 34.56 ± 3.01 weeks, and the mean length of ICU stay 
was 3.32 ± 3.6 days. Most patients (77%) were admitted with obstetric 
cause, the most common cause of maternal morbidity was pregnancy-
induced hypertension (56.21%), followed by obstetric hemorrhage 
(17.75%). Heart failure (13.6%) was the principal nonobstetric cause. 
Maternal mortality rate was 4.14%, with hypovolemic shock and 
MODS (71.4%) as main causes. Despite the incidence of death being 
higher among patients with obstetric versus nonobstetric cause (4.6% 
and 2.6%, respectively), this was not statistically signifi  cant (P = 0.91). 
Twenty-fi  ve percent of patients had prior medical diseases, 76.74% of 
them had cardiac problems. The most common interventions were 
central venous catheterization (91.1%), endotracheal tube intubation 
(16.6%), and mechanical ventilation (12.4%). Disturbed conscious 
level, MODS, shock, ARF, bleeding, and ARDS were present in 17.8%, 
12.4%, 10.7%, 10.7%, 8.9% and 7.1% of patients, respectively. Anemia, 
leucocytosis, and thrombocytopenia were more present in the 
obstetric group.
Conclusions  The admission rate to the ICU may be reduced by 
improving the management of the hypertensive disease during 
pregnancy. Early admission to the ICU decreases the maternal mortality 
and morbidity. Despite several complications occurring with obstetric 
patients, the prognosis is still good.
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Introduction  Eclampsia is a serious complication of pregnancy, it 
remains a frequent condition in our context. The aim of this study is 
to measure the incidence of eclampsia, its risk factors associated 
with adverse maternal outcome and to identify its most common 
presentations in our practice.
Methods Through a prospective descriptive study spread over 1 year 
(November 2009 to October 2010), all cases of eclampsia gathered in 
the maternity ICU of Marrakesh Teaching hospital are included, and 
epidemiological and prognostic data were analyzed by either chi-
squared analysis or the unpaired Student test as appropriate.
Results  The incidence of eclampsia was 6.68/1,000 deliveries, it is 
behind 11% of hospitalizations in our ICU (59 cases during study period) 
with 87% of patients referred from all southern Morocco. Sixty-two 
percent of seizures occurred antepartum, 20% during labor and 18% 
postpartum. Two peaks of age are observed, 22 ± 5 years and 36 ± 4 
years. Major maternal complications included HELLP syndrome (12%), 
abruptio placentae (8%), disseminated intravascular coagulopathy 
(8%), pulmonary edema (5%), acute renal failure requiring dialysis 
(4%), aspiration pneumonia (3%) and neurologic complications (3%) 
including hemorrhage, ischemia and cerebral venous thrombosis. 
Maternal mortality was 6.7% and perinatal mortality was 16.9%. 
Parturients with antepartum eclampsia have signifi  cantly  higher 
incidences of HELLP syndrome (14% vs. 6%; P = 0.02) and abruptio 
placentae (12% vs. 4%; P = 0.006) than did those in whom eclampsia 
developed intrapartum and postpartum. In contrast, women with 
postpartum eclampsia were more unlikely to have acute renal failure 
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P = 0.001) than were those with antepartum eclampsia. In addition, 
older women develop more renal failure than younger ones (9% vs. 2%; 
P = 0.001).
Conclusions Pregnancies complicated by eclampsia are purveyors of 
high maternal morbidity and mortality. Antepartum and postpartum 
cases were more severe than intrapartum cases; the same observation 
is made among older women.
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Introduction Treatment of ischemic damage to organs and tissues 
by mechanical ventilation with a high content of oxygen in the 
inspired mixture (FiO2) can lead to oxidative stress and reperfusion 
of tissue alteration, which is particularly characteristic of infants with 
their characteristic low levels of antioxidant protection. From this 
perspective, there is optimal mode selection in mechanical ventilation 
and FiO2 of vital organs and tissue, namely in brain tissue, which was 
made possible through the use of transcranial cerebral oximetry (TCO).
Methods  At stage 1 of the study, with the consent of the ethics 
committee and informed parental consent, we examined 24 infants 
born in the physiological department of the maternity hospital RNIIAP 
of gestation 38 to 40 weeks, with Apgar 7 to 10, and birth weight 2,500 
to 3,900 in the state of physiological sleep after feeding. In all children, 
we measured the cerebral tissue oxygen saturation (SctL, SctR) using 
the cerebral oximeter Fore-sight (USA) at 1, 3 and 5 days after birth. 
Later, in a controlled, randomized study were included two groups of 
neonates on mechanical ventilation. In patients of group 1 (n = 35), 
modes and ventilator FiO2 were determined under the control of TCO in 
a way that is as close as possible to indicators of cerebral oxygenation 
for the age norm. In patients of group 2 (n = 33), mode selection and 
FiO2 ventilation was carried out under the supervision of pulse oximetry 
and partial oxygen tension (pO2), according to acid–base balance, 
excluding indicators for TCO.
Results  At stage 1 the study defi   ned age-norm TCO indicators 
for healthy infants amounting in the left hemisphere of the brain 
to 79.2  ±  4.06% (0.01  <P  <0.05) and in the right hemisphere to 
84.89 ± 5.1% (0.01 <P <0.05). At phase 2 of the study group infants, the 
selection of modes and ventilator FiO2 on the basis of indicators for TCO 
statistically signifi  cantly (in all cases 0.01 <P <0.05) decreased length of 
stay on the ventilator (from 9.4 to 5.6 bed-days), mortality (from 2.7% 
to 0%), and number of complications (cases of radiologically confi  rmed 
pneumonia from 4.2% to 0.2%) compared with the control group.
Conclusions  The use of TCO for the optimization of mechanical 
ventilation and oxygen saturation monitoring in brain tissue in 
newborn infants in critical condition is a promising method for reducing 
mortality, reducing the term of ventilation and reducing complications 
of oxygen therapy in this group of patients.
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Introduction Artifi  cial ventilation (AV) is an essential resource that is 
not always available at Salvadorian public hospitals. Approximately 
40% of hospital-related deaths may have required AV [1]. The main 
indication for AV is respiratory insuffi   ciency requiring support for these 
patients. Variations in ventilation modality and time among others 
can aff  ect patient health [2]. The aim of this study was to clarify the 
AV situation in national hospitals of El Salvador’s public health system.
Methods This study is transversal descriptive. A representative sample 
(n = 5) of public national hospitals was selected. These included four 
second-level hospitals and one third-level hospital. Two hospitals 
were from the central metropolitan region, one from the par central, 
west and east region; representing 36.1% of available hospital beds 
nationwide. To complete AV data of the totality of public hospitals, 
a telephone survey was used. All data about patients, AV type, costs, 
maintenance and operative personnel, among others, were collected.
Results  Only 18% of all public hospitals around the country have 
mechanical AV. The majority of mechanical AV on the public health 
network is focused on Rosales National Hospital (HNR), with 61.9% 
of mechanical ventilators nationwide. Mechanical AV is operated by 
respiratory therapy personnel at HNR and Zacamil National Hospital; 
however, in another two hospitals from the east and west region, 
mechanical AV is operated by residents; and manual AV is provided 
by self-infl  ating resuscitator bag operated by interns only. The main 
causes of AV are nonsurgical; representing 88.9% of the reasons to 
employ mechanical AV, and 100% for manual AV. The mean patient 
ventilation time for mechanical AV was >48 hours, and for manual 
AV was >24 hours. No patient with manual AV had normal pO2. The 
maintenance cost for all mechanical AV was less than $100 per month 
per ventilator and only 68% of mechanical ventilators were functional, 
the most frequent model being Servo900.
Conclusions The actual mechanical AV existence is very limited, since 
only four out of 14 departments have this resource, representing 18% 
of public health centers nationwide, centralized in the department 
of San Salvador, leaving 82% of these centers with no mechanical 
ventilation at all, being probably supplanted by manual AV. Results 
show the necessity for cheaper, effi   cient and easy-to-use AV systems.
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Introduction The UK is a multifaith culture and 77% of the population 
considered themselves to belong to a religious group in the 2001 
UK Census [1]. Diff   ering faiths have diff   ering customs and views 
surrounding end-of-life decisions and care. Treatment withdrawal 
and withholding of life-sustaining care or CPR have been shown to be 
signifi  cantly infl  uenced by both patient and physician religion [2]. We 
wanted to determine whether the population faith mix was refl  ected 
amongst UK intensive care physicians.
Methods We conducted an online survey amongst the members of 
the UK Intensive Care Society. We asked them to state whether they 
considered themselves to belong to a faith group.
Results A total of 550 questionnaires were returned; 182 (33.1%) were 
from intensive care consultants. These are compared with UK 2001 
Census data. Over 50% abstained from the question (vs. 7.8% in the 
Census). A total 11.8% of respondents were atheists (vs. 15.05% in 
the Census). Members of the Catholic Church and Church of England 
formed 8.4% and 10.2% of respondents. These faiths are grouped 
together in the Census as Christians and formed 71.8% in that sample. 
A total 1.8% were Hindu (0.98% in the Census) and 1.5% were Muslim 
(vs. 2.78% in the Census). Those belonging to other faiths formed 14.5% 
amongst respondents and 1.59% in the Census.
Conclusions The proportionately smaller UK faith groups are repre-
sented to largely similar extents amongst physicians. A much larger 
proportion of our study sample abstained from the question than 
in the UK Census (51.8% vs. 7.8%). Our questionnaire was presented 
along with questions regarding decisions to exclude patients from the 
ICU; abstainers may have felt their religious beliefs were being unfairly 
judged as a source of bias in their other answers. The religious makeup 
of a group of physicians can clearly not be manipulated to match that 
of the population but consideration should be given to how this factor 
may infl  uence treatment decisions. This is likely to be of particular 
relevance where physician and patient do not share the same faith.
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Introduction Approximately 20 to 30% of ICU patients are palliated in 
the ICU. Many of these patients have not had goals of care discussions 
prior to being admitted to the ICU. Several of these patients may 
have prolonged courses that can cause anguish for patients and their 
families and may have been prevented if goals of care discussions 
occurred earlier. There has been increasing evidence that palliative 
care involvement in critical care improves outcomes such as quality 
of end-of-life care [1], decreased length of stay [2] and better pain 
and symptom management [3]. No studies have looked at medical 
emergency teams/Outreach with respect to palliative care and end-
of-life care. We performed a retrospective descriptive study looking 
at the characteristics of Outreach patients who received end-of-life 
counseling (EOLC).
Methods We evaluated 80 patients from The Ottawa Hospital General 
campus that were seen by Outreach and received EOLC in 2007. From 
the Outreach database and the hospital computerized health record 
system, we obtained patient demographics and medical information 
such as admission diagnosis and reason for Outreach call. We compared 
these patients with ones that did not receive EOLC. We also subdivided 
the patients that received EOLC into patients that were successfully 
palliated versus ones that were not palliated and compared patient 
characteristics.
Results Twenty-one percent of all Outreach patients received EOLC 
in 2007. Comparing patients that received EOLC with those with no 
EOLC, mean age was 72.3 ± 11.5 versus 68.9 ± 17.6 (mean ± SD). Fifty-
two percent had cancer versus 38%. Dementia was involved in 17% of 
EOLC patients versus 8% in non-EOLC patients. Length of stay (LOS) was 
26.3 ± 26.1 days versus 34 ± 30.7. Admission to Oncology/Hematology/
Radiation Oncology was 33% in the EOLC group compared with 20%. 
The proportion of patients seen during the day was 49% versus 64%. 
Call indication was mostly respiratory in the EOLC group (53% vs. 32%). 
Sex, number of co-morbidities, days admitted prior to Outreach call and 
admission diagnosis were similar in both groups. Amongst the patients 
that received EOLC, 49% were palliated and 51% were not palliated. 
Patient characteristics were similar in these two groups. (t-Score testing 
is pending.)
Conclusions At our tertiary center, the Outreach patients that receive 
EOLC tend to be older, admitted for respiratory illness and have a 
diagnosis of cancer.
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Introduction Most of the literature regarding communication between 
health professionals and patients at the end of life and their families 
has focused on specifi  c topics, like breaking bad news and discussing 
treatment decisions such as CPR and advanced directives. Conversation 
about end-of-life issues often takes place over time rather than as a 
single discussion. The objective of this paper is to explore the optimal 
content and phrasing of information when discussing the dying process 
and E-O-L issues with terminally ill cancer patients and their families.
Methods We conducted focus groups and individual interviews with 
20 palliative care patients and their families treated in Clinical Hospital 
Stip in the past 12 months. The focus groups and individual interviews 
were fully transcribed. Further individual interviews were conducted 
until no additional topics were raised. Participant’s narratives were 
analyzed using qualitative methodology.
Results Distinct content areas emerged for discussing E-O-L issues: 
treatment decisions at the E-O-L; potential future symptoms; 
preferences for place of death; the process of dying; what needs to be 
done immediately after death; and existential issues. When discussing 
process of dying participants are recommended: exploring the person’s 
fears about dying; describing the fi  nal days and unconscious period; 
and the reduced need for food and drinks. Many participants identifi  ed 
the dilemma regarding whether to discuss potential complications 
around the time of death.
Conclusions This paper provides strategies, phrases and words that 
may inform about the process of dying and E-O-L issues. This will be 
useful especially for patients’ families. Further research is needed to 
determine the generality of these fi  ndings.
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Introduction Traumatic brain injury (TBI) mortality remains high and 
often follows withdrawal of life-sustaining therapy (WLST). Studies 
reporting the determinants of WLST in this population are scarce. We 
analyzed data from a multicenter retrospective cohort study to identify 
factors associated with WLST in TBI.
Methods We randomly selected charts of 720 mechanically ventilated 
severe TBI patients (identifi  ed using ICD-10 codes) admitted to the 
ICUs of six participating centers (120 patients per center) over a 2-year 
period. Data were abstracted using a standardized case report form 
and operations manual. Among nonsurvivors (n = 228), we compared 
patients who died following WLST with those who did not in order to 
investigate the potential infl  uence of variables pertaining to the injury 
and management. Our fi  nal model to WLST included four baseline 
characteristics (age, gender, GCS and pupillary refl   ex) and factors 
with P <0.2. Research ethics approval was obtained in all participating 
centers.
Results  We analyzed 225 patients (three missing data) including 
predominantly male patients (69.7%) with a mean age of 50.7 
years. Among nonsurvivors, brain herniation on initial CT scan was 
more often reported in patients dying following WLST (OR  =  2.91, 
95% CI = 1.16 to 7.30, P = 0.02), while the opposite was observed 
for epidural hematoma (OR = 0.18, 95% CI = 0.06 to 0.56, P <0.01). 
Craniotomy (OR = 0.12, 95% CI = 0.02 to 0.68, P = 0.02) and other non-
neurosurgical procedures (OR = 0.08, 95% CI = 0.02 to 0.43, P <0.01) 
were associated with a lower odds of death following WLST. Other 
interventions, such as vasopressor use (OR = 0.50, 95% CI = 0.22 to 1.11, 
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and insulin infusions (OR = 2.13, 95% CI = 0.99 to 4.62, P = 0.06) were 
not signifi  cantly associated with lower and higher odds of death due to 
WLST, respectively.
Conclusions Death due to WLST was associated with several patient 
and clinical factors. We also observed that WLST was less frequent 
among patients that had received more aggressive treatments, for 
example craniotomy. Further research is required to understand factors 
that infl  uence decisions to WLST in severe TBI patients, since these 
decisions may be modifi  able and based on physicians’ and surrogates’ 
perceptions of prognosis.
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Introduction  The Liverpool Care Pathway (LCP) is the accepted 
gold standard in the documentation of end-of-life care in the UK. A 
computerized version of the LCP in the form of a digital proforma (DP) 
exists as an option on our unit. Some clinicians choose to use free-
text (FT) entry citing as this can be more comprehensive. Our study 
investigates whether usage of the DP is likely to result in a greater 
degree of compliance with LCP standards than FT alone.
Methods  All deaths occurring between 1 January 2009 and 30 
June 2009 were identifi  ed from the record of ITU admissions. Cases 
of cardiac arrest and brain stem death were excluded. Quality of 
documentation was scored by a nurse and doctor assessor (for each 
LCP goal: 0 = nothing entered, 1 = goal partially addressed, 2 = goal fully 
addressed). The average of the total scores for each case was calculated. 
Performance of the DP was analysed by comparing average total scores 
for DP versus FT alone using simple nonparametric descriptors.
Results There were 52 deaths and 45 after exclusions. Use of the DP 
resulted in considerably higher total average scores (range 13.50 to 
17.5, interquartile range 15.50 to 16.75, median 15.50) than use of FT 
alone (range 0.00 to 9.50, interquartile range 1.75 to 6.25, median 4.00). 
Statistical signifi  cance is suggested by the lack of overlap in the range 
values. See Figure 1.
Conclusions  Using the DP for end-of-life documentation is highly 
likely to improve compliance with accepted standards in end-of-life 
care. Doctors using FT alone were unlikely to document all of the broad 
issues that require consideration. The use of a DP can function as a 
useful checklist ensuring patients receive the best care when organ 
support is withdrawn.
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Introduction  End-of-life care is an unavoidable component of 
critical care. Despite palliative care guidelines, wide variations exist in 
patient selection and implementation of limitations in care decisions. 
Understanding why some patients have care limited and some are 
provided full resuscitative eff  orts allows opportunities for improving 
care at the end of life.
Methods All consecutive deaths (n = 151 patients) in a tertiary-care 
surgical ICU over a 2.2-year period were reviewed. Patients were 
divided into groups: withhold (WH) = patients who had potentially 
life-saving therapies withheld/withdrawn; full care (FC)  =  patients 
who had full resuscitative eff  orts prior to death. Demographics, acute 
physiology score (APS), and APACHE IV scores were used to compare 
groups. Fisher’s exact test and Student’s t test (signifi  cance: P <0.05 
level) were used.
Results A total of 1,764 patients were admitted and 151 (8.6%) died. 
Patients who died had a mean age of 63 ± 14 years and 83 (55%) 
were male. One hundred and eleven (74%) had potentially life-saving 
therapy withheld/withdrawn (WH group). Forty patients (26%) had 
full resuscitative eff  orts until time of death (FC group). Age, admission 
APACHE IV, and APACHE IV at time of death/withdrawal of care were 
similar between genders, however signifi  cantly more males had care 
withdrawn than females (83% vs. 47%, P <0.005). Compared with the 
FC group, the WH group was less sick at ICU admission (APS: 76.7 ± 28.3 
vs. 91.7 ± 37.0, P <0.01) but had similar pre-existing co-morbidities 
(chronic health points: 13.3 ± 7.2 vs. 11.7 ± 6.9). Compared with their 
admission APS, both groups had similar deteriorations in clinical status 
and the FC group remained signifi  cantly more ill (APS 93.6 ± 31.4 vs. 
109.4 ± 44.7, P <0.02 between groups and P <0.05 compared with 
admission). Factors not diff  erent between groups included: APACHE 
diagnosis, admitting service, admitting source (ED, OR, fl  oor, other 
hospital), need for mechanical ventilation, or readmissions. Specifi  cally 
there were no diff  erences between groups in types of chronic illnesses 
including cancer, liver disease, COPD, diabetes or in ICU length of stay 
(18 ± 17 vs. 16 ± 37).
Conclusions  Gender more than age, severity of illness, diagnosis, 
and co-morbidities had a profound infl  uence on end-of-life care and 
decisions. Duration of the ICU stay and deteriorating status did not 
appear to impact decisions to limit care. The FC group was more sick at 
ICU admission and at time of death than the WH group. Gender issues 
at end of life need to be further studied to optimize limitations of care 
for all patients.
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Introduction In the UK, the diagnosis of brain stem death (BSD) is 
mainly confi  rmed by clinical testing. The Code of Practice guidelines 
regarding the time interval between cessation of sedative drugs and 
testing allow for considerable variation in interpretation and practice 
[1]. In some countries, ancillary tests are used as an alternative to 
clinical diagnosis [2]. Our aim was to survey current attitudes and 
practice surrounding the use of ancillary tests in the diagnosis of BSD.
Methods We confi  rmed ethics committee exemption and the survey 
was peer-reviewed by the Neuro-critical Care Network. We distributed 
it electronically to the 31 neuro-critical care centres in the UK, collecting 
responses anonymously.
Results We had a response rate of 94%. The majority of centres had 
four-vessel angiography (4VA) and spiral CT angiography (CTA) 
available (25 and 24, respectively), 13 centres had access to transcranial 
Figure 1 (abstract P521).
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had used or would consider ancillary tests in addition to clinical tests 
where these could not be completed due to the nature of injury (for 
example, facial trauma); 19 centres had used or would consider this 
when drug levels were unavailable. Four centres had used ancillary 
tests alone to confi  rm BSD where depressant drug levels had precluded 
clinical testing; a further eight centres would consider this approach. 
First-choice investigation was CTA in 48% of centres, 30% preferred 
4VA, and 4% TCD. Following cessation of sedative drugs, there was 
considerable variation in timing of clinical testing and pharmacokinetic 
factors considered. Whilst 33% of centres measure thiopentone levels 
in all cases, 22% never do. In fi  ve centres, delays in testing due to raised 
drug levels exceeded 5 days. Where raised levels preclude testing, 17 
centres were confi  dent that 4VA would diagnose BSD in some or all 
circumstances; 13 centres were confi  dent with CTA. TCD and EPs were 
considered less reliable.
Conclusions There is considerable variation in UK opinion and practice. 
Measurement of drug levels is not universal but raised levels delay 
diagnosis signifi  cantly. More than one-half of the centres surveyed 
would be confi  dent in using an ancillary test alone to diagnose BSD. 
Further consensus is needed.
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Introduction  Albumin binds and detoxifi   es endotoxin in healthy 
people. Oxidative stress leads to protein oxidation and thus to impaired 
binding properties of albumin. This, in combination with increased 
gut permeability, leads to appearance of endotoxin in the systemic 
circulation and further to impaired organ function. We hypothesise 
that these processes occur in serum of brain-dead organ donors.
Methods  Eighty-four consecutive brain-dead organ donors were 
enrolled. Endotoxin was determined with an adapted limulus 
amoebocyte lysate assay. Albumin fractions and binding capacity were 
determined by HPLC. FlowCytomix™ was used for determination of 
cytokine levels and RT-PCR for analysis of tight junction protein (TJP) 
mRNA expression. Brain-dead organ donors were categorized by the 
length of ICU stay. Survival data of 76 organ recipients were collected.
Results Albumin binding capacity for dansylsarcosine was reduced in 
brain-dead organ donors compared with controls. Endotoxin positivity 
in was found in 16.7% of brain-dead organ donors. Endotoxin positivity 
but not length of ICU stay was associated with a further decrease of 
binding capacity. In organ donors albumin was higher oxidized than 
in controls. Lengths of ICU stay increased albumin oxidation further. 
In addition, IL-6, IL-8, IL-10 and IL-1β levels were elevated in patients 
whereas IFNγ levels were within the normal range. Recipients of organs 
from endotoxin-positive donors showed a signifi  cantly worse survival 
as compared with recipients from endotoxin-negative donors (log-rank 
P <0.05). Length of ICU stay of the donor did not have any infl  uence 
on outcome of the recipients. Preliminary data for TJP expression in 
duodenum samples showed a trend towards lower expression in the 
endotoxin-positive sample.
Conclusions We therefore conclude that oxidative stress, as well as 
systemic endotoxemia, is present in a proportion of in brain-dead organ 
donors that might have a negative impact on outcome of recipients. 
High endotoxin levels might be due to increased gut permeability and 
decreased binding capacity of albumin facilitated by higher albumin 
oxidation.
P525
Children visiting the ICU
KK Borges, L Genaro, M Monteiro
Clinica Sao Vicente, Rio de Janeiro, Brazil
Critical Care 2011, 15(Suppl 1):P525 (doi: 10.1186/cc9945)
Introduction Most hospitals only allow children above 12 years old 
to visit adult ICU patients. However, younger children participating in 
the hospitalization process manifest, through their family members, 
their willingness to visit their hospitalized relatives. This raises diff  erent 
healthcare team members’ opinions on how to manage their visits to 
the ICU and prevent psychological harm. This study suggests some 
relevant steps to allow and receive a child in an adult ICU.
Methods A literature review on children visiting the ICU was performed 
to construct the steps. The fl  owchart was based on Torres’ studies of the 
child in the face of death, based on Piaget’s cognitive development. 
The fl  owchart: Identify the family request, either to the psychologist or 
to the team, to allow the child’s visit / Understand the family context 
and information provided to the child / Healthcare team discussion – 
team consensus and ICU routine adjustment / Psychologist interview 
and accompaniment to the bed / After-visit evaluation and follow-up 
during the ICU stay from family information.
Results The literature search has shown diversifi  ed results. The use of 
the fl  owchart, adjusted to each case requirement, has been very useful 
in our institution’s practice. We could perceive that the healthcare 
team feels more serene and confi  dent with this guidance and that 
the families feel more relieved and assured by sharing their affl   ictions 
related to their children.
Conclusions The interdisciplinary work is fundamental to using the 
fl  owchart, requiring a healthcare team aligned with its aims and, above 
all, sensitive to the essence of the bioethical principle of autonomy, 
ruled by the patient’s and family member’s will. However, due to this 
subject relevance and sensitivity, new discussions are required to 
deepen the studies and therefore systematize children’s visits to ICUs.
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Introduction  The objective was to identify whether there are 
diff  erences in the degree of satisfaction among family members of 
survivors and nonsurvivors on admission to the ICU. Also, to identify 
who they are and what are the sociodemographic characteristics of 
the relatives answering a questionnaire for assessing the needs of 
relatives of patients admitted to our ICU, and what are the clinical and 
sociodemographic characteristics of patients.
Methods A letter was sent to all families who had a relative in the ICU 
in the period of 1 year, with a sealed envelope with the address, and the 
questionnaire: characterization of the family, assessing the satisfaction 
of the needs in family-gathering areas for support, comfort, access, 
information, and trust. We also collected sociodemographic data and 
patient records. Statistical analysis was performed using SPSS v.17.0.
Results We obtained responses from 90 families, 43% spouses, mean 
age 47 years, 65% female. Characterization of patients (median (P25 to 
P75)): 78% male, age 60 years (41 to 73), SAPS 43 (33 to 54), number 
of hospital days in the ICU 9 days (4 to 16). We obtained a higher and 
statistically signifi  cant (P <0.05) response rate in relatives of patients 
hospitalized longer and in those who survived. The family satisfaction 
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in all dimensions evaluated (a value closer to greater satisfaction), 
although this diff  erence was statistically signifi  cant only in the comfort 
dimension (P = 0.003).
Conclusions  Contrary to other studies we found that relatives of the 
survivors are more satisfi  ed with most aspects of care received, better 
meeting their needs than family members of nonsurvivors, although 
this diff  erence is statistically signifi  cant only in the dimension comfort. 
The results emphasize the need for improved measures of comfort in the 
ICU. One factor, among others, to explain this result may be that on one 
hand the aspects of patient-centered care and family were similar in both 
groups, but on the other hand the relatives of the survivors feel more a lack 
of space suitable for families that currently do not exist in our ICU. There is 
a growing recognition that families are an integral part of the modern ICU 
and that we should incorporate the fi  ndings of this evaluation of needs 
and family satisfaction in quality improvement in the ICU.
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Introduction  The ICU is an environment that generates permanent 
anguish in family patients due to the possibility of the death of the patient 
[1]. The stressful situation might induce families to call upon strategies 
of facing diff  erent levels and intensities to keep the harmony of its own 
emotional structure. The objective is to describe the strategy processes 
used by families of severely ill patients in the ICU to face the situation.
Methods  A prospective study covering 14 families. We applied a 
qualitative method of interviewing and observing participants, 
complementing the data-gathering by applying the Strategies 
Inventory of Coping, by Folkman and Lazarus, adapted by Savoia 
and colleagues [2]. The mixed method used to interpret the results 
combines the quantitative and qualitative data into only one phase 
of the study, prioritizing the descriptive-analytical logic. Among the 
criteria of inclusion are: one member of the patient family in the ICU for 
more than 1 week, being an adult, must be present in most of the visit 
periods and receiving physician’s information of the patient conditions.
Results Families utilize diverse strategies and at diff  erent levels, but the 
most used strategies almost always and most of the time are: escape 
and avoid (93%), positive re-evaluation and a strategy of problem-
solving (79%), social support (43%) and responsibility acceptance (7%). 
The strategies were considered nonadaptative and the less used were 
distance, confronting and self-control.
Conclusions Escaping and avoidance were the most used due to religious 
aspects, expressed through perseverance and optimistic attitudes 
as a way to solve problems, which is directly related to responsibility 
acceptance and self-control. Positive re-evaluation looks for signifi  cance 
and encouragement to overcome adversity and maintain hope. Knowing 
such psychological recourses allowed the hospital team to identify the 
necessity for human assistance to families, making them available in the 
relationship and prepared in the art of communication.
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Introduction Relatives of patients in the ICU undergo considerable 
stress. Eff  ective communication with relatives has been shown to: 
provide support, reduce stress, and improve their well-being and 
decision-making. Satisfaction also depends on communication by 
a senior caregiver. Our aim was to determine how well relatives of 
patients in the Norfolk & Norwich University Hospital (NNUH) ICU are 
kept informed.
Methods  The Metavision® Clinical Information System is used for 
documentation at the 20-bed NNUH ICU. Retrospective data analysis 
was conducted for patients staying >4 days during 1 October 2009 
to 1 January 2010. Data from the ‘Relatives Communication’ page 
included: how often and when relatives were fi  rst spoken to, and the 
staff   involved. These variables were compared with patient outcome 
and length of stay on the ICU. During 1 August to 1 October 2010 
relatives were asked to anonymously complete a survey evaluating 
consultations in the ICU.
Results Of 64 notes, communication with relatives was documented 
in 55% of patients. Of these, 60% of communication was conducted 
by a consultant. More discussions occurred with relatives of patients 
who died. Increasing duration of stay on the ICU resulted in a higher 
percentage of relatives being spoken to. Sixty-seven per cent of 
relatives of patients staying >20 days were not communicated with 
until after day 4 of admission. Of 40 surveys, all relatives agreed that 
the patient’s condition was discussed with them quickly enough after 
admission. Ninety-three per cent thought that they were spoken to 
often enough and 95% felt by the right staff  . Eighty per cent were 
spoken to by senior staff   but 45% stated updates were mostly given 
by nursing staff  . Ninety percent felt they were given the right amount 
of information and in an appropriate location. Ninety percent were 
satisfi  ed with their consultations. Seventy-three per cent agreed or 
partially agreed that written information about critical care would have 
been helpful.
Conclusions Analysis of the notes indicated that communication with 
relatives of patients on the ICU was poor. This prompted surveying 
relatives’ satisfaction directly, which found that most are satisfi  ed with 
their experiences of communication in the ICU. Hence, we conclude 
that relatives are well informed – mainly by nursing staff    – but 
documentation of communication requires improvement. The system 
currently favours recording of formal conversations by medical staff   
whilst nursing updates are often documented elsewhere. A solution 
may be to develop a multidisciplinary record of communication.
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Introduction Muscle weakness often complicates critical illness and 
is associated with prolonged duration of rehabilitation, increased 
mortality and limiting functional outcome even years later [1]. To 
examine the eff  ects of interventions on this complication, reliable 
measurements of muscle force in critically ill patients are needed. We 
aimed to examine, in critically ill patients, the inter-observer agreement 
on the Medical Research Council (MRC)-sum score and handgrip 
strength, two methods to quantify muscle force.
Methods  All patients were included in an ongoing randomized 
controlled trial examining two feeding strategies (ClinicalTrials.
gov:NCT 00512122) and constituted a cross-sectional, randomly 
selected sample. Patients were studied on median ICU day 17 (11 to 
29.5). Two observers independently measured the MRC-sum score in 
75, and handgrip strength in 46 critically ill patients.
Results  The intra-class correlation coeffi     cient (ICC) for the MRC-
sum score was 0.95 (0.92 to 0.97), with weighted kappa coeffi   cient 
for individual muscle group scores of 0.83 ± 0.03. Kappa coeffi   cient 
was 0.68  ±  0.09 for identifying patients with MRC-sum score  <48, 
0.88 ± 0.07 for MRC-subtotal in the upper limbs <24, and 0.93 ± 0.07 for 
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respectively 0.97 (0.94 to 0.98) and 0.93 (0.86 to 0.97).
Conclusions  We found very good inter-observer agreement, both 
for MRC-sum score and for handgrip strength in critically ill patients. 
When applying MRC-sum score <36 as a cut-off   for severe weakness, 
agreement was excellent supporting its use as an outcome parameter 
for interventional studies. Agreement on identifying signifi  cant 
weakness (MRC-sum  <48) was good. For an equivalent cut-off    to 
identify signifi  cant weakness in the upper limbs (<24), agreement was 
very good. It remains to be determined whether this may be used as a 
substitute for the total MRC-sum score.
Reference
1. Herridge  MS,  et al.: N Engl J Med 2003, 348:683-693.
P530
Assessment of functional capacity after discharge from the ICU
E Caser, P Simões, A Casati, C Barbas
CIAS, Vitória, Brazil
Critical Care 2011, 15(Suppl 1):P530 (doi: 10.1186/cc9950)
Introduction Functional capacity refers to the degree of involvement 
in activities and is often used as synonymous with performance in 
activities of daily living such as self-care. These measures of capacity 
are useful and provide some understanding on the prognosis and 
outlook for independence after discharge. This study was designed to 
analyze the functional capacity before ICU admission and after hospital 
discharge.
Methods  A 7-month prospective observational study (1 October 
2007 to 1 May 2008) was carried out in a 16-bed medical–surgical ICU. 
Patients >18 years old and admitted >72 hours were included. We 
interviewed cooperative patients or close relatives using the Barthel 
Index to evaluate the ability of a patient in daily life activities. Questions 
were applied upon admission to the ICU and 7, 90 and 180 days after 
hospital discharge.
Results  Out of 322 admissions, 135 patients met trial criteria for 
inclusion in the study (mean age 66 ± 22 years and 55.6% male). The 
mean APACHE II score was 18 ± 6 and the mean length of ICU stay 
was 17 ± 7 days. A total of 15.9% were abed at admission, 39.1% at 
7 days, 23.9% at 90 days and 28.3% at 180 days after discharge were 
still abed. Upon admission 43.5% practiced some type of physical 
activity, 7 days after discharge 21.7%, and at 90 and 180 days 40% and 
34.8%, respectively, had some physical activity. The functional capacity 
assessed by the Barthel index at admission, 7, 90 and 180 days after 
hospital discharge were respectively 84 ± 28, 71 ± 32, 78 ± 31 and 
79 ± 31 points. There was a statistically signifi  cant diff  erence between 
functional capacity at baseline, at 7, 90 and 180 days with APACHE II 
and age. The ICU mortality was 14.2%, hospital mortality was 31.9% 
and cumulative mortality at 7 days after hospital discharge was 32.6%, 
at 90 days was 36.3% and at 180 days was 38.5%.
Conclusions  The independence in daily life activities decreased 
signifi  cantly after admission to the ICU; however, at 90 and 180 days 
after hospital discharge they increased but did not return to their levels 
prior to admission. The presence of an ill population of older people in 
the ICU may have contributed to these results.
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Introduction To audit the holistic assessment and treatment planning 
of critical care patients of more than 5  days stay, in line with the 
National Institute of Clinical Excellence (NICE) guidelines published 
in March 2009. The guidelines state that each patient should have 
a full comprehensive assessment and reassessment of all physical 
and nonphysical potential problems, individual goal-setting and 
documented communication between patient, MDT and family 
members.
Methods  An audit form was developed from NICE guidelines and 
piloted with 10 patients, feedback on the audit form from the staff   was 
then collected and the audit form amended as necessary. A sample of 
patients was identifi  ed (10% of 2008/2009 admissions of >5 days) and 
the fi  rst 10 sets of notes were assessed for inter-rater reliability between 
the staff   collecting the information (doctors, occupational therapists, 
physiotherapists, nurses and speech and language therapists). The 
results were then compiled and new documentation developed to 
prompt consideration of potential physical and nonphysical problems. 
Weekly MDT rehabilitation ward rounds and goal-setting meetings 
were also commenced. A repeat audit using the same tool is to 
commence in December 2010/January 2011 with a second sample 
planned for June 2011/July 2011 in line with original audit samples.
Results Physical problems were comprehensively assessed in 100% 
of the sample population; however, there was little evidence of 
assessment of potential nonphysical problems in most patients. There 
was poor documentation of information-giving to patient relatives 
in all aspects of their care, particularly around goal-setting and social 
aspects of care. Transition from critical care to the ward was highlighted 
as an area to be improved, with poor information provision to the ward 
and to the patient/carer.
Conclusions  Following the initial audit, in order to resolve the 
highlighted issues several initiatives were put in place: a rehabilitation 
ward round was commenced with weekly MDT goal-setting, a 
psychosocial history form was introduced along with a critical care MDT 
assessment tool. We are now beginning to re-audit following these 
changes in practice. Subjectively, collaborative working has enhanced 
patient care by optimising communication across the whole MDT. At 
the time of the conference 50% of the second audit will be completed, 
which will give some indication of the impact of our change in practice.
Reference
1. [www.guidance.nice.org/CG83]
P532
An audit of adult critical care rehabilitation processes in a UK 
district general hospital based on NICE guidelines
R Agarwala, N Ahmed, K Patil
Croydon University Hospital, Croydon, UK
Critical Care 2011, 15(Suppl 1):P532 (doi: 10.1186/cc9952)
Introduction The majority of patients who survive critical illness have 
signifi  cant physical and nonphysical morbidity [1]. Current UK National 
Institute of Clinical Excellence guidelines set a minimum standard for 
the provision of rehabilitation services following ICU admission [2]. 
We audited local adherence to these guidelines in our 670-bed district 
general hospital and required a standard of 100% adherence to all 
parameters.
Methods A retrospective review of all patients ventilated, on the ICU, 
from September to November 2009 who survived to hospital discharge. 
Data reviewed included critical care and hospital discharge summaries, 
and notes from outreach follow-up, psychiatry follow-up and the ICU 
outpatient clinic.
Results  Seventy-fi   ve patients were ventilated on our ICU during 
the period specifi  ed. Forty-two out of 75 (56%) survived to hospital 
discharge and records were available in 32 patients for inclusion in 
analysis. Mean total hospital stay was 44 days. Thirty-two out of 32 
(100%) patients were formally assessed for their risks of developing 
physical and nonphysical morbidity before leaving the ICU, with short-
term and medium-term rehabilitation goals being set in 28/32 (87%) 
of patients. Thirty-two out of 32 (100%) patients had a comprehensive 
clinical assessment following discharge from the ICU to identify 
rehabilitation needs during their ward stay. Thirteen out of 32 (41%) 
patients were seen by a psychologist. Seven out of 19 (37%) of those 
who did not see a psychologist did not meet criteria for referral, but in 
10/19 (53%) who did meet criteria no referral was made. Thirteen out of 
32(41%) patients were seen in an ICU outpatient clinic. Reasons given 
by the 59% who did not attend were multiple follow-up with other 
specialities and lack of perceived benefi  t from attendance.
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standards of assessment with regards to their rehabilitation needs. 
A more robust system is required to ensure referral to a psychologist 
when indicated, as anxiety and depression following ICU admission is 
reported in up to 40% of patients [1]. A patient leafl  et explaining these 
risks and the benefi  ts of attending ICU follow-up clinics may improve 
outcomes.
References
1. Jones  C,  et al.: Crit Care Med 2001, 29:573-580.
2. Brett  S,  et al.: Guideline 83. London: National Institute of Clinical Excellence; 
2009. [http://guidance.nice.org.uk/GC83]
P533
Follow-up after critical care
M Slattery, P Temblett, A Houghton, D Hope
ABM University Trust, Swansea, UK
Critical Care 2011, 15(Suppl 1):P533 (doi: 10.1186/cc9953)
Introduction  Many patients experience physical and psychological 
morbidity following a stay in critical care [1]. The National institute of 
Clinical Excellence (NICE UK) recommends access to follow-up and 
rehabilitation services for this patient group [2]. We aim to present 1 
year’s experience following the establishment of a follow-up service at 
our university teaching hospital.
Methods The multidisciplinary follow-up team consisted of a consultant 
in critical care, a senior nurse and a critical care physiotherapist. Patients 
completed a preclinic questionnaire followed by a semi-structured 
interview to identify potential issues. Twenty-four clinics took place 
over the 12-month period.
Results A total of 221 patients were recruited. Of the patients studied 
26% attended the clinic and completed the evaluation questionnaire, 
30% did not engage follow up services. We identifi  ed recurrent themes 
in both physical and nonphysical problems. Example physical problems 
include limited physical activities in 77%, with 54% of patients studied 
fi  nding diffi   culties with activities of daily living. Alteration in taste, smell, 
hearing and vision modalities was frequently described. In terms of 
psychological morbidity, anxiety and post-traumatic stress symptoms 
seem to predominate. Signifi  cant numbers of patients retain memory 
of their ITU stay, with one-third in the form of fl  ashback memories. Only 
5% of patients studied returned to work.
Conclusions Our fi  ndings demonstrate that a wide variety of problems 
can be identifi  ed in an ICU follow-up clinic. The challenge now is to 
identify those groups of patients who will benefi  t most from follow-up, 
to develop eff  ective rehabilitation programmes for these patients, and 
to fi  nd methods to increase patient participation.
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Introduction The biological infl  uence of light on human physiology 
(for example, circadian rhythms, cortisol and melatonin) has long been 
recognized. Recent interest has been directed to understanding the 
ramifi  cations of light on immune function, particularly in the context of 
patient care. Although light and seasonal variations have been shown 
to modulate leucocyte count and lymphocytes B and T activity and 
proliferation in mammals, little is understood about these interactions 
in the course of illness. Thus, we hypothesized that sunlight is directly 
associated with improved outcome in critically ill patients.
Methods We conducted a retrospective, cohort study of all patients 
admitted to the ICU at a single center between the years 2000 and 
2004. Light exposure was assessed by theoretical insolation (kWh/
m2/day), a measure of solar energy striking a unit of earth surface 
area that was obtained from the National Aeronautics and Space 
Administration. Daily and total insolation was determined for each 
patient, accounting for hospital geographic location, period and 
duration of hospitalization, and adjusted by day-specifi  c admission/
discharge–sunrise/sunset times. To adjust for diff  erences in case mix, 
we abstracted data regarding patient age, race, injury severity score, 
length of stay (LOS) and admission diagnostic categories. Patients who 
died before 24 hours were excluded from the analysis. The hypothesis 
was modeled using a multivariate logistic regression submodel for 
survival and a linear mixed submodel for the insolation measurement. 
Both were linked by the random intercept parameter in the mixed 
submodel.
Results A total of 22,730 patients were available for study. The majority 
was male (52.7%) and Caucasian (80.0%) with a mean age of 59.4 ± 17.7 
years. The leading ICU admission diagnoses were cardiovascular 
conditions (23.4%), trauma (13.4%) and sepsis (5.9%). The mean 
APACHE III score was 52.8 ± 28.3, LOS was 3.3 ± 2.3 days and mortality 
was 13.4%. The total insolation per patient was 14.8 ± 33.2 kWh/m2 
(mean ± SD). After adjusting for diff  erences in case mix, there was no 
signifi  cant association between survival and total insolation dose at 
24 hours and up to the 10th day of ICU hospitalization (P = 0.64). A 
tendency towards lower mortality with higher insolation was observed 
for trauma patients (P = 0.15), although this did not attain statistical 
signifi  cance.
Conclusions Sunlight has no impact on general ICU patient survival 
according to our analysis. In other relevant outcomes (mechanical 
ventilation requirements, sedation, delirium incidence, and so forth), 
the impact of sunlight still has to be elucidated.
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Introduction  The objective of this study was to determine the 
incidence and type of incidents related to intrahospital transport (IHT) 
of critically ill patients in our ICU and to identify contributing factors of 
these incidents.
Methods  Since 2006 an electronic incident registration system 
was implemented on our tertiary university mixed adult ICU. Two 
investigators identifi  ed incidents related to IHT between 2006 and 
2009. IHT incidents were categorized according to phase of occurrence: 
before, during or after IHT. The physical derangement of the patients 
could be cardiovascular, respiratory, or neurologic. By means of a 
structured incident analysis method, potential causal and contributory 
factors were determined.
Results In a 1-year period (2009) 568 transports were performed in 
1,821 ICU patients. Thus about one-third of all ICU patients needed 
IHT. Of all incidents reported from 2006 to 2009, 2.1% was IHT related. 
IHT had an incident rate of 3.7%. Of all IHT incidents (n = 124), 35% 
occurred pre-transport, 50% during transport and 15% post-transport. 
Thirty-two patients (25.8%) had a physical derangement. The most 
involved organ system was the respiratory system (n = 20) followed by 
the cardiovascular system (n = 10) and neurological problems (n = 2). 
Indentifi  ed causes were technical (n = 39), organizational (n = 50) and 
human error (n = 86); more than one cause per case could be assigned. 
Technical causes occurred mostly during transport (n = 28) followed by 
pre-transport (n = 9) and after transport (n = 2). Contributing factors 
were mostly equipment related (n = 22). Human error was divided 
between during transport (n = 35) and pre-transport (n = 33) and fewer 
occurred after transport (n = 18). Contributing factors were coordination 
errors (n = 37) and external factors (n = 19). Organizational causes were 
mostly pre-transport (n = 26) and during transport (n = 20) and fewer 
after transport (n = 4). Almost all contributing factors were due to 
information transfer (n = 31). Overall, the most important contributing 
factors were coordination errors (n = 37), information transfer (n = 31), 
equipment failure (n = 22), and insuffi   cient supervision (n = 22).
Conclusions Incidents related to IHT have an incidence of 3.7%. Most 
incidents occurred pre-transport and during transport. The incidents 
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Human failure is an important cause of IHT. Contributing factors 
were coordination errors, equipment failure, information transfer and 
insuffi   cient supervision. Given the contributing factors we think the 
number of incidents could be reduced by means of a transportation 
checklist.
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Introduction Funding sources may infl  uence the focus and conduct of 
randomized controlled trials (RCTs). We undertook a systematic review 
to examine diff  erences between industry-funded and non-industry-
funded (including mixed funding) RCTs.
Methods We searched MEDLINE for RCTs that enrolled at least 100 
subjects and were published between 1990 and 2009 in fi  ve critical 
care journals (AJRCCM, CCM, ICM, Chest, Shock), two pediatric journals 
(Pediatric CCM and J Pediatrics), and fi  ve general medical journals (NEJM, 
Lancet, JAMA, BMJ, Ann Intern Med). We screened 1,094 abstracts to 
identify potentially eligible trials independently, and two investigators 
abstracted data independently and in duplicate. Statistical analysis was 
by the Mann–Whitney U test, t test or Fisher’s exact test; the α level for 
signifi  cance was set at P <0.05.
Results We identifi  ed 313 RCTs for which the funding source could 
be ascertained; 83 (26.5%) were fully industry-funded, 78 (24.9%) had 
mixed funding, and 152 (48.6%) received no industry funding. RCTs 
fully funded by industry randomized more patients (median 385 vs. 255 
patients, P = 0.0006), used more hospital sites (63.3 ± 92.9 vs. 10.3 ± 14.8, 
P  <0.0001) and were more likely to originate from North America 
(51/83; 61.4% vs. 84/231; 36.4%, P  <0.0001). Studies investigating 
drugs and devices accounted for over 90% of industry-funded RCTS. 
Non-industry-funded trials were more likely to investigate weaning/
ventilation and feeds/nutrition. A higher proportion of industry-
funded RCTs recruited sepsis patients (35/83, 42.2% vs. 28/230, 12.1%, 
P  <0.0001), whereas non-industry-funded RCTs were more likely to 
randomize neonatal or pediatric patients (22.2% vs. 10.8%, P = 0.02). 
The number of published critical care RCTs has increased over time, 
from 34 from 1990 through 1994 to 116 from 2005 through 2009. 
The proportion of fully industry-funded trials has been constant over 
time. Reporting of Data and Safety Monitoring Board involvement also 
increased over time for both industry-funded and non-industry-funded 
RCTs. Studies investigating drug interventions increased over time for 
industry-funded RCTs, but has remained relatively constant for non-
industry-funded trials.
Conclusions The total number of critical care RCTs has increased over 
time; a minority of these is fully funded by industry. Industry-funded 
trials are larger, more frequently originate from North America, and 
more frequently target patients with sepsis.
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Introduction In various scientifi  c fi  elds, including medical research, 
men have been found to have a higher scientifi  c output than women. 
These diff  erences may be due to women’s lower integration in the 
scientifi   c community [1]. Even though the proportion of female 
authors has increased in the past decades, women still contribute less 
to prominent medical journals [2].
Methods Thirty-fi  ve top-10-ranked journals of eight diff  erent medical 
categories were analysed: Medicine, General & Internal (M,GI), Critical 
Care (CC), Anaesthesiology (A), Surgery (S), Emergency Medicine (EM), 
Radiology (R), Haematology (H) and Clinical Neurology (N). Over a 
12-month period, we evaluated the fi  rst and senior authors’ fi  rst name 
for gender.
Results  Thirty-one percent of evaluable fi   rst authors were female, 
compared with 18% of all senior authors. There were signifi  cant 
diff   erences between the evaluated categories, with the lowest 
percentage of female fi  rst authors in the category Surgery, followed 
by Emergency Medicine (Table 1). In every category, the proportion of 
female senior authors was signifi  cantly lower than that of fi  rst authors.
Conclusions There is a wide variation in the proportion of contributing 
female authors between the subspecialties analysed, probably 
refl  ecting the varying percentage of female scientists. However, in all 
evaluated medical categories, the proportion of papers authored by 
females was signifi  cantly lower than those authored by men.
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Introduction  Critically ill patients with inadequate lid closure are 
susceptible to developing exposure keratopathy. Protective measures 
can prevent this and reduce the risk of subsequent microbial keratitis 
and irreversible visual loss. Of two published surveys [1,2], one was 
carried out before there was any evidence-based research in this area 
and the other did not address which methods were in use in ICUs. This 
study aims to describe the current eye care methods used in ICUs in 
England, the perceived incidence of eye complications, their nature 
and the eff  ectiveness of protocols in use.
Methods A team of researchers telephoned all general ICUs and other 
specialty critical care units in England caring for sedated, ventilated 
patients and asked a supervising nurse questions from a questionnaire 
piloted earlier in London.
Results  Two hundred and seventeen out of 267 ICUs (81%) 
participated. One hundred and thirty out of 217 (60%) ICUs had an 
eye care protocol. Sixty-six per cent of units with protocols assessed 
lid closure compared with 65% of those without. Geliperm application 
was the most common protective therapy (106 units, 49%), followed by 
Lacrilube (76 units, 35%). Most ICUs used a combination of methods. 
The total estimated incidence of ocular complications in the last year 
was 502. The most recent complications witnessed included corneal 
ulceration (23 cases), microbial keratitis (11) and chemosis (23). Cases of 
severe visual loss were caused by anterior ischaemic optic neuropathy 
following prone positioning (two cases) and microbial keratitis in a 
patient’s only functioning eye.
Conclusions There is a need for protocols that encourage proper eyelid 
position assessment, eff  ective protection of the ocular surface and 
referral to ophthalmologists in the event of any complications or any 
loss of corneal clarity.
Table 1 (abstract P537). Percentage of female authors
  First authors  Senior authors
S 20.8  12.8
EM 22.1  15.3
CC 25.6  13.8
M,GI 30.3  19.8
R 35.1  17.1
H 35.7 17.2
N 38.6 17.1
A 38.7  23.6
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Introduction Sleep disturbances are common in critically ill patients 
on the ICU, with possibly serious consequences [1]. More attention is 
needed for the sleep–wake cycle of ICU patients. The aim of this study 
was to gain insight into factors that are important for sleep of critically 
ill patients on the ICU.
Methods We conducted a multicentre, exploratory survey sent to nurse 
managers of all adult ICUs in the Netherlands. We used a self-developed 
questionnaire to describe which factors are important for sleep of ICU 
patients. Surveys were distributed via mail with subsequent written 
reminders. Relevant factors in relation with sleep of ICU patients were 
included in the questionnaire.
Results The survey response rate was 60% (68/114). Characteristics 
of the sleeping patient on the ICU most often included: lying quiet 
with closed eyes (89.7%), decreased pulse rate (88.2%) and slower 
respiration (83.8%). Nonpharmacological interventions to improve 
sleep of the ICU patients most often comprised: keeping patients 
awake during the day (94.2%), lights out in the ICU (92.6%), use of a 
clock (91.2%), reducing noise of the ICU staff   (89.7%) and reducing 
nursing interventions (86.8%). The type of sleep medication was 
mostly determined only by physicians (57.4%). The assessment of the 
eff  ects of the sleep medication was mostly determined by nurses and 
physicians together (58.8%). Most frequent medications used were 
midazolam (92.6%), propofol (85.3%) and temazepam (75.1%). Nursing 
autonomy regarding sleep and sedation practices of patients (rated on 
a 10-point numerical scale) was judged as poor (median 5, IQR 3 to 7). 
How much nursing observations infl  uences sleeping practices in the 
ICU was judged as good (median 8, IQR 7 to 8). How the average patient 
was sleeping on the ICU was judged as moderate (median 6, IQR 5 to 
7). Furthermore, 69.1% of the ICUs mentioned a disturbed sleep–wake 
cycle, judged predominantly due to too much noise (61.8%), delirium 
(55.9%), and nursing interventions (48.5%). Most ICUs (83.8%) did 
not have a sleeping protocol, but 67.6% of these ICUs preferred to 
implement such a protocol.
Conclusions The average ICU patients are sleeping moderately well, 
mostly due to a disturbed sleep–wake cycle, delirium and nursing 
interventions. ICU nurses experience only a moderate feeling of 
autonomy and infl  uence on sleeping practices. Most ICUs did not have 
a sleeping protocol, but more than one-half of these ICUs preferred to 
implement one.
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Introduction Limited evidence exists regarding the effi   cacy of inhaled 
antibiotics in ventilator-associated tracheobronchitis (VAT) [1,2]. 
The aim of this study was to assess the eff  ect of monotherapy with 
nebulized colistin on clinical and microbiological outcomes in critically 
ill patients with VAT due to polymyxin-only susceptible Gram-negative 
bacteria.
Methods  Patients were eligible for the study if they had clinical 
symptoms suggestive of VAT (for example, fever, purulent secretions), 
an absence of an evolving infi  ltrate on chest X-ray, and microbiological 
confi   rmation of VAT with quantitative cultures of endotracheal 
aspirates (ETAs) with a diagnostic threshold for VAT ≥105 colony-
forming units (CFU)/ml. Susceptibility to colistin was determined using 
the Vitek technique (Biomerieux, France). Selected patients received 
inhaled colistin at a dose of 1 million units every 8 hours for 7 days via 
a vibrating-mesh nebulizer (Aeroneb Pro; Aerogen, Galway, Ireland). 
Assessed clinical outcomes were cure, defi  ned as resolution of signs 
and symptoms at day 5, and development of ventilator-associated 
pneumonia (VAP) at day 10 after initiation of treatment. Microbiological 
outcomes were defi  ned as eradication and decline termed as isolation 
of ≤102 CFU/ml and were assessed by ETA quantitative cultures received 
at days 3 and 5 after initiation of treatment.
Results Our study included 12 patients (eight men and four women) 
with mean age 58.7 years. The mean values of APACHE II and SOFA 
scores were 15.5 and 6.8, respectively. Two patients had polymicrobial 
Gram-negative VAT. Isolated pathogens from ETAs were: Pseudomonas 
aeruginosa  (8/12 patients), Acinetobacter baumannii (5/12 patients), 
and Klebsiella pneumoniae (1/12 patients). Cure was achieved in nine 
out of 12 patients. In the three patients with clinical failure, intravenous 
colistin was administered. Two of them were subsequently cured and 
one patient developed VAP. Microbiological eradication was achieved 
in fi  ve out of 12 patients while decline was achieved in three out of 12 
patients.
Conclusions  According to our limited data, monotherapy with 
nebulized colistin might be eff  ective in the treatment of patients with 
VAT. Further investigation is warranted to evaluate whether nebulized 
antibiotics could eff  ectively treat VAT and reduce the need for systemic 
antibiotics.
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